497
Table of Contents

Filed Pursuant to Rule 497
Registration No. 333-196526

 

PROSPECTUS SUPPLEMENT

(to Prospectus dated December 11, 2014)

Up to $20,000,000

Saratoga Investment Corp.

7.50% Notes due 2020

 

 

We are an externally managed non-diversified closed-end management investment company that has elected to be treated as a business development company under the Investment Company Act of 1940, or the “1940 Act.” Our investment objective is to generate current income and, to a lesser extent, capital appreciation from our investments.

On May 29, 2015 we entered into a Debt Distribution Agreement, pursuant to which we may offer for sale, from time to time, up to $20,000,000 in aggregate principal amount of 7.50% fixed-rate notes due 2020, which we refer to as the “Notes,” through Ladenburg Thalmann & Co. Inc., acting as our sales agent. Sales of the Notes, if any, may be made in negotiated transactions or transactions that are deemed to be “at the market offerings” as defined in Rule 415 under the Securities Act of 1933, as amended, or the Securities Act, including sales made directly on the NYSE or similar securities exchange or sales made to or through a market maker other than on an exchange at prices related to prevailing market prices or at negotiated prices. If any of the Notes are sold at prices above the par value of $25 per Note, the effective yield on such Notes to the purchasers may be less than 7.50%.

As of July 16, 2015, the aggregate market value of our outstanding common stock held by non-affiliates, or the public float, was approximately $61.9 million which was calculated based on 3,599,158 shares of outstanding common stock held by non-affiliates and on a price per share of $17.22, the closing price of our common stock on July 16, 2015. Pursuant to certain SEC rules, in no event will we sell our securities in a public primary offering with a value exceeding more than one-third of our public float in any 12-month period so long as our public float remains below $75.0 million. We have not offered any securities pursuant to the SEC rules noted above during the 12 calendar months prior to and including the date of this prospectus.

Ladenburg Thalmann & Co. Inc. will receive a commission from us equal to 2.0% of the gross sales price of any Notes sold through Ladenburg Thalmann & Co. Inc. under the Debt Distribution Agreement. Ladenburg Thalmann & Co. Inc. is not required to sell any specific principal amount of Notes, but will use its commercially reasonable efforts consistent with its sales and trading practices to sell the Notes offered by this prospectus supplement and the accompanying prospectus. See “Plan of Distribution” beginning on page S-78 of this prospectus supplement.

The Notes will mature on May 31, 2020. We will pay interest on the Notes on February 15, May 15, August 15 and November 15 of each year. Interest on the Notes will accrue from the most recent interest payment date immediately preceding the date of issuance of the Notes from time to time, except that, if you purchase Notes after the record dates noted below (or your settlement of a purchase of Notes otherwise occurs after such record date), your Notes will not accrue interest for the period from such purchase date to the interest payment date immediately following such record date. The interest payable on each interest payment date will be paid only to holders of record of the Notes at the close of business on February 1, May 1, August 1, and November 1 of each year, as the case may be, immediately preceding the applicable interest payment date. As a general matter, holders of the Notes will not be entitled to receive any payments of principal on the Notes prior to the stated maturity date. We may redeem the Notes in whole or in part at any time or from time to time on or after May 31, 2016, at the redemption price set forth under “Specific Terms of the Notes and the Offering—Optional redemption” in this prospectus supplement. The Notes will be issued in minimum denominations of $25 and integral multiples of $25 in excess thereof.

The Notes offered hereby will be a further issuance of, are fungible with, rank equally in right of payment with, and form a single series for all purposes under the indenture including, without limitation, waivers, amendments, consents, redemptions and other offers to purchase and voting, with approximately $48,300,000 in aggregate principal amount of 7.5% fixed-rate notes due 2020, initially issued by us in May 2013, or the “Existing Notes.” The Existing Notes, as well as any newly issued Notes, will mature on May 31, 2020, and may be redeemed in whole or in part at any time or from time to time at the Company’s option on or after May 31, 2016. The Notes will have terms identical to the Existing Notes and will have the same CUSIP number as, and will be fungible and vote together with, the Existing Notes immediately upon issuance. From May 29, 2015, the date that we commenced this offering, through July 16, 2015, the Company sold 227,863 Notes in an aggregate principal amount of $5,696,575 at an average price of $25.32 for aggregate net proceeds of $5,653,305 (net of transaction costs).


Table of Contents

The Existing Notes are listed on the New York Stock Exchange, or the NYSE, and trade on the NYSE under the symbol “SAQ.” We intend to list the Notes offered hereby on the NYSE under the same trading symbol. The Notes are expected to trade “flat,” which means that purchasers in the secondary market will not pay, and sellers will not receive, any accrued and unpaid interest on the Notes that is not reflected in the trading price.

On July 16, 2015, there were 2,159,863 Notes issued and outstanding and the last reported sales price on the NYSE was $25.75 per Note.

The Notes will be our direct unsecured obligations and rank pari passu, or equal in right of payment, with all outstanding and future unsecured unsubordinated indebtedness issued by us. We currently do not have any indebtedness outstanding that is subordinated to the Notes and have no intention of issuing any such subordinated indebtedness. The Notes will be effectively subordinated, or junior in right of payment, to our future secured indebtedness and structurally subordinated, or junior in right of payment, to all existing and future indebtedness and other obligations of any of our subsidiaries. In any liquidation, dissolution, bankruptcy or other similar proceeding, the holders of any of our existing or future secured indebtedness and any indebtedness of any future subsidiaries may assert rights of payment prior to the holders of the Notes. See the related disclosure in “Supplementary Risk Factors” beginning on page S-18 of this prospectus supplement.

The Notes will not be rated by a rating agency and, as a result, the lack of a rating on the Notes may subject the Notes to greater price volatility.

Substantially all of the debt investments held in our portfolio hold a non-investment grade rating by one or more rating agencies (which non-investment grade debt is commonly referred to as “high yield” and “junk debt”) or, if not rated, would be rated below investment grade and “junk” if rated. A majority of our debt portfolio consists of debt securities for which issuers were not required to make principal payments until the maturity of such debt securities, which could result in a substantial loss to us if such issuers are unable to refinance or repay their debt at maturity. In addition, a majority of our debt investments had variable interest rates that reset periodically based on benchmarks such as LIBOR and the prime rate. As a result, significant increases in such benchmarks in the future may make it more difficult for these borrowers to service their obligations under the debt investments that we hold.

Please read this prospectus supplement and the accompanying prospectus before investing in our Notes and keep each for future reference. This prospectus supplement and the accompanying prospectus contain important information about us that a prospective investor ought to know before investing in our Notes. We file annual, quarterly and current reports, proxy statements and other information with the Securities and Exchange Commission. This information is available free of charge by contacting us at 535 Madison Avenue, New York, New York 10017, by telephone at (212) 906-7800, or on our website at http://www.saratogainvestmentcorp.com. Information contained on our website is not incorporated by referenced into this prospectus supplement or the accompanying prospectus, and you should not consider information contained on our website to be part of this prospectus supplement or the accompanying prospectus. The Securities and Exchange Commission also maintains a website at http://www.sec.gov that contains information about us.

Investing in our securities involves a high degree of risk and should be considered speculative. For more information regarding the risks you should consider, including the risk of leverage, please see “Supplementary Risk Factors” on page S-18 of this prospectus supplement and “Risk Factors” on page 22 of the accompanying prospectus. For example, our investment in the subordinated notes of one collateralized loan obligation fund, Saratoga Investment Corp. CLO 2013-1, Ltd., represents a first loss position in a portfolio that is composed predominantly of senior secured first lien term loans. A first loss position means that we will suffer the first economic losses if losses are incurred on loans held by the collateralized loan obligation fund or losses are otherwise incurred by the collateralized loan obligation fund, including its incurrence of operating expenses in excess of its operating income.

Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities, or determined if this prospectus is truthful or complete. Any representation to the

THE NOTES ARE NOT DEPOSITS OR OTHER OBLIGATIONS OF A BANK AND ARE NOT INSURED BY THE FEDERAL DEPOSIT INSURANCE CORPORATION OR ANY OTHER GOVERNMENT AGENCY.

Delivery of the Notes in book-entry form only through The Depository Trust Company will be made on or about the third trading date following the date of the purchase.

 

 

Ladenburg Thalmann

Prospectus Supplement dated July 17, 2015


Table of Contents

TABLE OF CONTENTS

PROSPECTUS SUPPLEMENT

 

     Page  

About this Prospectus Supplement

     S-3   

Summary

     S-4   

Specific Terms of Our Notes and The Offering

     S-11   

Supplementary Risk Factors

     S-18   

Cautionary Statement Regarding Forward-Looking Statements

     S-22   

Use of Proceeds

     S-24   

Ratio of Earnings to Fixed Charges

     S-25   

Management’s Discussion and Analysis of Financial Condition and Results of Operations

     S-26   

Senior Securities

     S-59   

Material U.S. Federal Income Tax Consequences

     S-60   

Description of the Notes

     S-66   

Plan of Distribution

     S-78   

Legal Matters

     S-80   

Independent Registered Public Accounting Firm

     S-81   

Available Information

     S-82   

Index to Consolidated Financial Statements of Saratoga Investment Corp.

     S-83   

Index to Consolidated Financial Statements of Saratoga CLO

     S-178   

PROSPECTUS

 

     Page  

Prospectus Summary

     1   

The Offering

     12   

Fees and Expenses

     16   

Selected Financial and Other Data

     19   

Risk Factors

     22   

Use of Proceeds

     43   

Ratio of Earnings to Fixed Charges

     43   

Notice About Forward-Looking Statements

     44   

Price Range of Common Stock and Distributions

     45   

Dividend Reinvestment Plan

     49   

Management’s Discussion and Analysis of Financial Condition and Results of Operations

     51   

Senior Securities

     80   

Business

     81   

Our Portfolio Companies

     93   

Management Agreements

     97   

Management

     105   

Portfolio Management

     113   

Certain Relationships and Transactions

     114   

Control Persons and Principal Stockholders

     114   

Regulation

     117   

Material U.S. Federal Income Tax Considerations

     123   

Determination of Net Asset Value

     128   

Sales of Common Stock Below NAV

     131   

Description of Our Securities

  

Description of Our Capital Stock

     137   

Description of Our Subscription Rights

     143   

Description of Our Debt Securities

     145   

Description of Our Warrants

     159   

Plan of Distribution

     161   

Brokerage Allocation and Other Practices

     163   

Custodian, Transfer and Dividend Paying Agent and Registrar

     163   

Legal Matters

     163   

Independent Registered Public Accounting Firm

     163   

Available Information

     163   

Privacy Notice

     164   

Index to Consolidated Financial Statements

     F-1   


Table of Contents

ABOUT THIS PROSPECTUS SUPPLEMENT

We have filed with the SEC a registration statement on Form N-2 (File No. 333-196526) utilizing a shelf registration process relating to the securities described in this prospectus supplement, which registration statement was declared effective on December 11, 2014. This document is in two parts. The first part is the prospectus supplement, which describes the terms of this offering of Notes and also adds to and updates information contained in the accompanying prospectus. The second part is the accompanying prospectus, which gives more general information and disclosure. To the extent the information contained in this prospectus supplement differs from or is additional to the information contained in the accompanying prospectus, you should rely only on the information contained in this prospectus supplement. Please carefully read this prospectus supplement and the accompanying prospectus together with the additional information described under the headings “Available Information” and “Supplementary Risk Factors” included in this prospectus supplement and under the headings “Available Information” and “Risk Factors” in the accompanying prospectus before investing in the Notes.

Neither we nor the Ladenburg Thalmann & Co. Inc. have authorized any dealer, salesman or other person to give any information or to make any representation other than those contained in this prospectus supplement or the accompanying prospectus. If anyone provides you with different or inconsistent information, you should not rely on it. This prospectus supplement and the accompanying prospectus do not constitute an offer to sell or a solicitation of any offer to buy any security other than the registered securities to which they relate, nor do they constitute an offer to sell or a solicitation of an offer to buy any securities in any jurisdiction or to any person to whom it is unlawful to make such an offer or solicitation in such jurisdiction. The information contained in this prospectus supplement and the accompanying prospectus is accurate as of the dates on their respective covers. Our financial condition, results of operations and prospects may have changed since those dates. To the extent required by law, we will amend or supplement the information contained in this prospectus supplement and the accompanying prospectus to reflect any material changes subsequent to the date of this prospectus supplement and the accompanying prospectus and prior to the completion of any offering pursuant to this prospectus supplement and the accompanying prospectus.

 

S-3


Table of Contents

SUMMARY

The following summary contains basic information about the offering of our Notes pursuant to this prospectus supplement and the accompanying prospectus. It is not complete and may not contain all the information that is important to you. For a more complete understanding of the offering of our Notes pursuant to this prospectus supplement, we encourage you to read this entire prospectus supplement and the accompanying prospectus, and the documents to which we have referred in this prospectus supplement and the accompanying prospectus. Together, these documents describe the specific terms of the Notes we are offering. You should carefully read the sections entitled “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in the accompanying prospectus, and “Supplementary Risk Factors,” “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and our consolidated financial statements included in this prospectus supplement.

On May 10, 2013, we and U.S. Bank National Association, or the “Trustee,” entered into the first supplemental indenture, or the “first supplemental indenture,” to the indenture, or the “base indenture,” between us and the Trustee, dated May 10, 2013, relating to our issuance, offer and sale of approximately $48.3 million aggregate principal amount of 7.5% fixed-rate notes due 2020, or the “Existing Notes.” We refer to the base indenture, along with the first supplemental indenture thereto, as the “indenture.” We will issue the Notes offered hereby under the same first supplemental indenture. The Notes offered hereby will be a further issuance of, rank equally in right of payment with, and form a single series for all purposes under the Indenture, including, without limitation, waivers, amendments, consents, redemptions and other offers to purchase and voting, with the Existing Notes. Unless otherwise indicated, the Notes offered hereby and the Existing Notes are collectively referred to herein as the “Notes.”

Except where the context requires otherwise, the terms “we,” “us,” “our,” the “Company,” or “Saratoga” refer to Saratoga Investment Corp. and its wholly owned subsidiaries, Saratoga Investment Funding LLC and Saratoga Investment Corp. SBIC LP, and does not refer to Saratoga Investment Corp. CLO 2013-1 Ltd. In addition, the terms “Saratoga Investment Advisors” and “investment adviser” refer to Saratoga Investment Advisors, LLC, our external investment adviser.

Overview

We are a specialty finance company that invests primarily in leveraged loans and mezzanine debt issued by private U.S. middle-market companies, which we define as companies having annual EBITDA (earnings before interest, taxes, depreciation and amortization) of between $5 million and $50 million, both through direct lending and through participation in loan syndicates. Our investment objective is to generate current income and, to a lesser extent, capital appreciation from our investments. We are externally managed and advised by Saratoga Investment Advisors, LLC, a New York-based investment firm affiliated with Saratoga Partners, a middle market private equity investment firm.

Our portfolio is comprised primarily of investments in leveraged loans (both first and second lien term loans) issued by middle market companies. Term loans are loans that do not allow the borrowers to repay all or a portion of the loans prior to maturity and then re-borrow such repaid amounts under the loan again. Leveraged loans are generally senior debt instruments that rank ahead of subordinated debt of the portfolio company. Leveraged loans also have the benefit of security interests on the assets of the portfolio company, which may rank ahead of, or be junior to, other security interests. We also purchase mezzanine debt and make equity investments in middle market companies. Mezzanine debt is typically unsecured and subordinated to senior debt of the portfolio company.

While our primary focus is to generate current income and capital appreciation from our debt and equity investments in middle market companies, we may invest up to 30% of the portfolio in opportunistic investments in order to seek to enhance returns to stockholders. Such investments may include investments in distressed debt,

 

 

S-4


Table of Contents

including securities of companies in bankruptcy, foreign debt, private equity, securities of public companies that are not thinly traded and structured finance vehicles such as collateralized loan obligation funds.

As of May 31, 2015 we had total assets of $272.8 million and investments in 35 portfolio companies and an additional investment in the subordinated notes of one collateralized loan obligation fund, Saratoga Investment Corp. CLO 2013-1, Ltd. (“Saratoga CLO”), which investment had a fair value of $16.9 million as of May 31, 2015. The overall portfolio composition as of May 31, 2015 consisted of 6.8% of syndicated loans, 59.8% of first lien term loans, 15.4% of second lien term loans, 2.2% of unsecured notes, 6.4% of subordinated notes of Saratoga CLO and 9.4% of common equity. As of May 31, 2015, the weighted average yield on all of our debt investments, including our investment in the subordinated notes of Saratoga CLO, was approximately 12.0%. As of May 31, 2015 approximately 98.0% of our first lien debt investments were fully collateralized in the sense that the portfolio companies in which we held such investments had an enterprise value or our investment had an asset coverage equal to or greater than the principal amount of the related debt investment. Our investment in the subordinated notes of Saratoga CLO represents a first loss position in a portfolio that, at May 31, 2015, was composed of $306.6 million in aggregate principal amount of predominantly senior secured first lien term loans. A first loss position means that we will suffer the first economic losses if losses are incurred on loans held by the Saratoga CLO. As a result, this investment is subject to unique risks. See “Risk Factors—Our investment in Saratoga CLO constitutes a leveraged investment in a portfolio of predominantly senior secured first lien term loans and is subject to additional risks and volatility.”

We are an externally managed, closed-end, non-diversified management investment company that has elected to be regulated as a business development company (“BDC”) under the Investment Company Act of 1940 (“1940 Act”). As a BDC, we are required to comply with various regulatory requirements, including limitations on our use of debt. We finance our investments through borrowings. However, as a BDC, we are only generally allowed to borrow amounts such that our asset coverage, as defined in the 1940 Act, equals at least 200% after such borrowing.

We have elected to be treated for U.S. federal income tax purposes as a regulated investment company (“RIC”), under Subchapter M of the Internal Revenue Code of 1986 (the “Code”). As a RIC, we generally will not have to pay corporate-level federal income taxes on any net ordinary income or capital gains that we distribute to our stockholders if we meet certain source-of-income, distribution and asset diversification requirements.

In addition, we have a wholly-owned subsidiary that is licensed as a small business investment company (“SBIC”) and regulated by the Small Business Administration (“SBA”). See “Regulation—Small Business Investment Company Regulations.” The SBIC license allows us, through our wholly-owned subsidiary, to issue SBA-guaranteed debentures. We received exemptive relief from the Securities and Exchange Commission to permit us to exclude the debt of our SBIC subsidiary guaranteed by the SBA from the definition of senior securities in the 200% asset coverage test under the 1940 Act. This allows us increased flexibility under the 200% asset coverage test by permitting us to borrow up to $150 million more than we would otherwise be able to absent the receipt of this exemptive relief.

The Investment Adviser

Our investment adviser was formed in 2010 as a Delaware limited liability company and became our investment adviser in July 2010. Our investment adviser is led by four principals, Christian L. Oberbeck, Michael J. Grisius, Thomas V. Inglesby, and Charles G. Phillips, with 26, 24, 27 and 17 years of experience in leveraged finance, respectively. Our investment adviser is affiliated with Saratoga Partners, a middle market private equity investment firm. Saratoga Partners was established in 1984 to be the middle market private investment arm of

 

 

S-5


Table of Contents

Dillon Read & Co. Inc. and has been independent of Dillon Read since 1998. Saratoga Partners has a 28-year history of private investments in middle market companies and focuses on public and private equity, preferred stock, and senior and mezzanine debt investments.

We utilize the personnel, infrastructure, relationships and experience of Saratoga Investment Advisors to enhance the growth of our business. We currently have no employees and each of our executive officers is also an officer of Saratoga Investment Advisors.

We have entered into an investment advisory and management agreement with Saratoga Investment Advisors. Pursuant to the investment advisory and management agreement, Saratoga Investment Advisors implements our business strategy on a day-to-day basis and performs certain services for us under the direction of our board of directors. Saratoga Investment Advisors is responsible for, among other duties, performing all of our day-to-day investment-related functions, determining investment criteria, sourcing, analyzing and executing investments, asset sales, financings and performing asset management duties.

Saratoga Investment Advisors has formed an investment committee to advise and consult with its senior management team with respect to our investment policies, investment portfolio holdings, financing and leveraging strategies and investment guidelines. We believe that the collective experience of the investment committee members across a variety of fixed income asset classes will benefit us. The investment committee must unanimously approve all investments in excess of $1 million made by us. In addition, all sales of our investments must be approved by three out of four investment committee members. The current members of the investment committee are Messrs. Oberbeck, Grisius, Inglesby, and Phillips.

Investments

Our portfolio is comprised primarily of investments in leveraged loans issued by middle market companies. Investments in middle market companies are generally less liquid than equivalent investments in companies with larger capitalizations. These investments are sourced in both the primary and secondary markets through a network of relationships with commercial and investment banks, commercial finance companies and financial sponsors. The leveraged loans that we purchase are generally used to finance buyouts, acquisitions, growth, recapitalizations and other types of transactions. Leveraged loans are generally senior debt instruments that rank ahead of subordinated debt of the portfolio company. Leveraged loans also have the benefit of security interests on the assets of the portfolio company, which may rank ahead of, or be junior to, other security interests. For a discussion risks pertaining to our secured investments, see “Risk Factors—Our investments may be risky, and you could lose all or part of our investment.”

As part of our long-term strategy, we also purchase mezzanine debt and make equity investments in middle market companies. Mezzanine debt is typically unsecured and subordinated to senior debt of the portfolio company. See “Risk Factors—If we make unsecured debt investments, we may lack adequate protection in the event our portfolio companies become distressed or insolvent and will likely experience a lower recovery than more senior debtholders in the event our portfolio companies defaults on their indebtedness.”

Substantially all of the debt investments held in our portfolio hold a non-investment grade rating by one or more rating agencies (which non-investment grade debt is commonly referred to as “high yield” and “junk” debt) or, if not rated, would be rated below investment grade and “junk” if rated. As of May 31, 2015, 37.53% of our debt portfolio at fair value consisted of debt securities for which issuers were not required to make principal payments until the maturity of such debt securities, which could result in a substantial loss to us if such issuers are unable to refinance or repay their debt at maturity. In addition, 62.47% of our debt investments at May 31, 2015 had variable interest rates that reset periodically based on benchmarks such as LIBOR and the prime rate. As a result, significant increases in such benchmarks in the future may make it more difficult for these borrowers to service their obligations under the debt investments that we hold.

 

 

S-6


Table of Contents

While our primary focus is to generate current income and capital appreciation from our debt and equity investments in middle market companies, we may invest up to 30% of the portfolio in opportunistic investments in order to seek to enhance returns to stockholders. Such investments may include investments in distressed debt, private equity, securities of public companies that are not thinly traded and structured finance vehicles such as collateralized loan obligation funds.

Prospective portfolio company characteristics

Our investment adviser generally selects portfolio companies with one or more of the following characteristics:

 

    a history of generating stable earnings and strong free cash flow;

 

    well-constructed balance sheets, including an established tangible liquidation value;

 

    reasonable debt-to-cash flow multiples;

 

    industry leadership with competitive advantages and sustainable market shares in attractive sectors; and

 

    capital structures that provide appropriate terms and reasonable covenants.

Investment selection

In managing us, Saratoga Investment Advisors employs the same investment philosophy and portfolio management methodologies used by Saratoga Partners. Through this investment selection process, based on quantitative and qualitative analysis, Saratoga Investment Advisors seeks to identify portfolio companies with superior fundamental risk-reward profiles and strong, defensible business franchises with the goal of minimizing principal losses while maximizing risk-adjusted returns. Saratoga Investment Advisors’ investment process emphasizes the following:

 

    bottoms-up, company-specific research and analysis;

 

    capital preservation, low volatility and minimization of downside risk; and

 

    investing with experienced management teams that hold meaningful equity ownership in their businesses.

Our investment adviser’s investment process generally includes the following steps:

 

    Initial screening. A brief analysis identifies the investment opportunity and reviews the merits of the transaction. The initial screening memorandum provides a brief description of the company, its industry, competitive position, capital structure, financials, equity sponsor and deal economics. If the deal is determined to be attractive by the senior members of the deal team, the opportunity is fully analyzed

 

    Comprehensive analysis. A comprehensive analysis includes:

 

    Business and Industry analysis—a review of the company’s business position, competitive dynamics within its industry, cost and growth drivers and technological and geographic factors. Business and industry research often includes meetings with industry experts, consultants, other investors, customers and competitors.

 

    Company analysis—a review of the company’s historical financial performance, future projections, cash flow characteristics, balance sheet strength, liquidation value, legal, financial and accounting risks, contingent liabilities, market share analysis and growth prospects.

 

    Structural/security analysis—a thorough legal document analysis including but not limited to an assessment of financial and negative covenants, events of default, enforceability of liens and voting rights.

 

 

S-7


Table of Contents
    Approval of the investment committee. The investment is then presented to the investment committee for approval. The investment committee must unanimously approve all investments in excess of $1 million made by us. In addition, all sales of our investments must be approved by four out of five investment committee members.

Investment structure

In general, our investment adviser intends to select investments with financial covenants and terms that reduce leverage over time, thereby enhancing credit quality. These methods include:

 

    maintenance leverage covenants requiring a decreasing ratio of debt to cash flow;

 

    maintenance cash flow covenants requiring an increasing ratio of cash flow to the sum of interest expense and capital expenditures; and

 

    debt incurrence prohibitions, limiting a company’s ability to re-lever.

In addition, limitations on asset sales and capital expenditures should prevent a company from changing the nature of its business or capitalization without our consent.

Our investment adviser seeks, where appropriate, to limit the downside potential of our investments by:

 

    requiring a total return on our investments (including both interest and potential equity appreciation) that compensates us for credit risk;

 

    requiring companies to use a portion of their excess cash flow to repay debt;

 

    selecting investments with covenants that incorporate call protection as part of the investment structure; and

 

    selecting investments with affirmative and negative covenants, default penalties, lien protection, change of control provisions and board rights, including either observation or participation rights.

Valuation process

We carry our investments at fair value, as approved in good faith using written policies and procedures adopted by our board of directors. Investments for which market quotations are readily available are recorded in our financial statements at such market quotations subject to any decision by our board of directors to approve a fair value determination to reflect significant events affecting the value of these investments. We value investments for which market quotations are not readily available at fair value as approved in good faith by our board of directors based on input from Saratoga Investment Advisors, our audit committee and, on a selected basis, a third party independent valuation firm. Determinations of fair value may involve subjective judgments and estimates. The types of factors that may be considered in determining the fair value of our investments include the nature and realizable value of any collateral, the portfolio company’s ability to make payments, the markets in which the portfolio company does business, market yield trend analysis, comparison to publicly traded companies, discounted cash flow and other relevant factors.

Our investment in the subordinated notes of Saratoga CLO is carried at fair value, which is based on a discounted cash flow model that utilizes prepayment, re-investment and loss assumptions based on historical experience and projected performance, economic factors, the characteristics of the underlying cash flow, and comparable yields for similar collateralized loan obligation fund subordinated notes or equity, when available. Specifically, we use Intex cash flow models, or an appropriate substitute, to form the basis for Saratoga CLO’s valuation. The models use a set of assumptions including projected default rates, recovery rates, reinvestment rate and prepayment rates in order to arrive at estimated cash flows. The assumptions are based on available

 

 

S-8


Table of Contents

market data and projections provided by third parties as well as management estimates. We use the output from the Intex models (i.e., the estimated cash flows from our investment in Saratoga CLO) to perform a discounted cash flows analysis on expected future cash flows from our investment in Saratoga CLO to determine a valuation for the subordinated notes of Saratoga CLO held by us.

We undertake a multi-step valuation process each quarter when valuing investments for which market quotations are not readily available, as described below:

 

    each investment is initially valued by the responsible investment professionals of Saratoga Investment Advisors and preliminary valuation conclusions are documented and discussed with our senior management; and

 

    an independent valuation firm engaged by our board of directors independently values at least one quarter of our investments each quarter so that the valuation of each investment for which market quotes are not readily available is independently valued by an independent valuation firm at least annually.

In addition, all our investments are subject to the following valuation process:

 

    the audit committee of our board of directors reviews each preliminary valuation and our investment adviser and independent valuation firm (if applicable) will supplement the preliminary valuation to reflect any comments provided by the audit committee; and

 

    our board of directors discusses the valuations and approves the fair value of each investment in good faith based on the input of our investment adviser, independent valuation firm (if applicable) and audit committee.

Because such valuations, and particularly valuations of private investments and private companies, are inherently uncertain, they may fluctuate over short periods of time and may be based on estimates. The determination of fair value may differ materially from the values that would have been used if a ready market for these investments existed. Our net asset value could be materially affected if the determinations regarding the fair value of our investments were materially higher or lower than the values that we ultimately realize upon the disposal of such investments.

Ongoing relationships with and monitoring of portfolio companies

Saratoga Investment Advisors closely monitors each investment we make and, when appropriate, conducts a regular dialogue with both the management team and other debtholders and seeks specifically tailored financial reporting. In addition, in certain circumstances, senior investment professionals of Saratoga Investment Advisors may take board seats or board observation seats.

Recent Developments

On July 8, 2015, the Company declared a dividend of $0.33 per share payable for the fiscal quarter ended May 31, 2015 to all stockholders of record at the close of business on August 3, 2015. Shareholders will have the option to receive payment of the dividend in cash, or receive shares of common stock pursuant to the Company’s dividend reinvestment plan.

Our Corporate Information

Our headquarters are located at 535 Madison Avenue, New York, New York 10022 and our telephone number is (212) 906-7800.

Summary Supplementary Risk Factors

The value of our assets, as well as the market price of our securities, will fluctuate. Our investments may be risky, and you may lose all or part of your investment in us. Investing in our securities involves other risks, including those discussed under the caption “Risk Factors” beginning on page 22 of the accompanying

 

 

S-9


Table of Contents

prospectus. In addition, the other information included in this prospectus supplement and the accompanying prospectus contains a discussion of factors you should carefully consider before deciding to invest in our securities. Some of these risks include:

 

    The Notes will be unsecured and therefore will be effectively subordinated to any secured indebtedness we may incur.

 

    The Notes will be subordinated structurally to the indebtedness and other liabilities of our subsidiaries.

 

    The indenture governing the Notes will contain limited protection for holders of the Notes.

 

    An active trading market for the Notes may not be maintained, which could limit the market price of the Notes or your ability to sell them.

 

    We may choose to redeem the Notes when prevailing interest rates are relatively low.

 

    If we default on our obligations to pay our other indebtedness, we may not be able to make payments on the Notes.

 

    We may be unable to invest a significant portion of the net proceeds from this offering, which could harm our financial condition and operating results.

 

 

S-10


Table of Contents

SPECIFIC TERMS OF OUR NOTES AND THE OFFERING

This prospectus supplement sets forth certain terms of the Notes that we are offering pursuant to this prospectus supplement and supplements the accompanying prospectus that is attached to the back of this prospectus supplement. On May 10, 2013, we and U.S. Bank National Association, or the “Trustee,” entered into the first supplemental indenture, or the “first supplemental indenture,” to the indenture, or the “base indenture,” between us and the Trustee, dated May 10, 2013, relating to our issuance, offer and sale of approximately $48.3 million aggregate principal amount of 7.5% fixed-rate notes due 2020, or the “Existing Notes.” We will issue the Notes offered hereby under the same first supplemental indenture. We refer to the base indenture, along with the first supplemental indenture thereto, as the “indenture.” The Notes offered hereby will be a further issuance of, rank equally in right of payment with, and form a single series for all purposes under the Indenture, including, without limitation, waivers, amendments, consents, redemptions and other offers to purchase and voting, with the Existing Notes. Unless otherwise indicated, the Notes offered hereby and the Existing Notes are collectively referred to herein as the “Notes.” This section outlines the specific legal and financial terms of the Notes. You should read this section together with the more general description of the Notes in the accompanying prospectus under the heading “Description of Our Debt Securities” before investing in the Notes. Capitalized terms used in this prospectus supplement and not otherwise defined shall have the meanings ascribed to them in the accompanying prospectus.

 

Issuer Saratoga Investment Corp.
Title of the securities 7.50% Notes due 2020
Initial aggregate principal amount being offered $20,000,000 (From May 29, 2015, the date that we commenced this offering, through July 16, 2015, we have issued $5,696,575 in aggregate principal amount of the Notes in this offering)
Manner of offering “At the market” offering that may be made from time to time through Ladenburg Thalmann & Co. Inc., as sales agent, using commercially reasonable efforts. See “Plan of Distribution.”
Principal payable at maturity 100% of the aggregate principal amount; the principal amount of each Note will be payable on its stated maturity date at the office of the Trustee, Paying Agent, Registrar and Transfer Agent for the Notes or at such other office in New York, New York as we may designate.
Type of Note Fixed-rate note
Interest rate 7.50% per year. However, if any of the Notes are sold at prices above the par value of $25 per Note, the effective yield on such Notes to the purchasers may be less than 7.50%.
Day count basis 360-day year of twelve 30-day months
Issuance date The third trading date following the date of the “at the market” purchase of the Notes.
Stated maturity date May 31, 2020
Date interest started accruing on Existing Notes May 10, 2013
Interest payment dates February 15, May 15, August 15 and November 15 of each year, commencing on the first applicable interest payment date following a given purchase of

 

 

S-11


Table of Contents
the Notes under this prospectus. The interest payable on each interest payment date will be paid only to holders of record of the Notes at the close of business on the record date immediately preceding the applicable interest payment date. Interest payments on the Existing Notes have been made since August 15, 2013. If an interest payment date falls on a non-business day, the applicable interest payment will be made on the next business day and no additional interest will accrue as a result of such delayed payment.
Interest periods Interest periods will be the periods from and including an interest payment date to, but excluding, the next interest payment date or the stated maturity date, as the case may be. Interest on the Notes will accrue from the most recent interest payment date immediately preceding the date of issuance of the Notes from time to time, except that, if you purchase Notes after the record dates noted below (or your settlement of a purchase of Notes otherwise occurs after such record date), your Notes will not accrue interest for the period from such purchase date to the interest payment date immediately following such record date.
Record dates for interest February 1, May 1, August 1, and November 1 of each year, commencing with the first such date to follow a given purchase of the Notes under this prospectus.
Specified currency U.S. Dollars
Place of payment New York City
Ranking of Notes The Notes will be our direct unsecured obligations and will rank:

•    pari passu (equally in right of payment) with our other outstanding and future unsecured indebtedness, including the Existing Notes;

•    senior to any of our future indebtedness that expressly provides it is subordinated to the Notes. We currently do not have any indebtedness outstanding that is subordinated to the Notes and have no intention of issuing any such subordinated indebtedness.

 

•    effectively subordinated to all of our existing and future secured indebtedness (including indebtedness that is initially unsecured to which we subsequently grant security), to the extent of the value of the assets securing such indebtedness. Effective subordination means that any right you have to participate in any distribution of our assets upon our liquidation or insolvency

 

 

S-12


Table of Contents

will be subject to the prior claims of our secured creditors; and

 

•    structurally subordinated to all existing and future indebtedness and other obligations of any of our subsidiaries, financing vehicles or similar facilities, including without limitation, $6.0 million of borrowings under our senior secured revolving credit facility with Madison Capital Funding LLC and $79.0 million of borrowings by Saratoga Investment Corp SBIC LP, each as of July 13, 2015. Structural subordination means that creditors of a parent entity are subordinate to creditors of a subsidiary entity with respect to the subsidiary’s assets.

Except as described under the captions “Description of the Notes—Events of Default,” “—Other Covenants,” and “—Merger or Consolidation” in this prospectus supplement, the indenture does not contain any provisions that give you protection in the event we issue a large amount of debt or we are acquired by another entity.
Denominations We will issue the Notes in denominations of $25 and integral multiples of $25 in excess thereof.
Business day Each Monday, Tuesday, Wednesday, Thursday and Friday that is not a day on which banking institutions in New York City are authorized or required by law or executive order to close.
Optional redemption The Notes may be redeemed in whole or in part at any time or from time to time at our option on or after May 31, 2016, upon not less than 30 days nor more than 60 days written notice by mail prior to the date fixed for redemption thereof, at a redemption price of 100% of the outstanding principal amount of the Notes to be redeemed plus accrued and unpaid interest payments otherwise payable for the then-current quarterly interest period accrued to but not including the date fixed for redemption.
You may be prevented from exchanging or transferring the Notes when they are subject to a written notice of redemption issued by us even though the Notes are listed for trading on the NYSE. In case any Notes are to be redeemed in part only, the redemption notice will provide that, upon surrender of such Note, you will receive, without a charge, a new Note or Notes of authorized denominations representing the principal amount of your remaining unredeemed Notes.
Any exercise of our option to redeem the Notes will be done in compliance with the 1940 Act, to the extent applicable.

 

 

S-13


Table of Contents

If we redeem only some of the Notes, the Trustee will determine the method for selection of the particular

Notes to be redeemed, in accordance with the indenture, the 1940 Act, to the extent applicable, and the rules of the NYSE, and any unredeemed Notes will have the same rights and be entitled to the same benefits that the Notes had prior to any such redemption. Unless we default in payment of the redemption price, on and after the date of redemption, interest will cease to accrue on the Notes called for redemption.

Sinking fund The Notes will not be subject to any sinking fund (i.e., no amounts will be set aside by us to ensure repayment of the Notes at maturity). As a result, our ability to repay the Notes at maturity will depend on our financial condition on the date that we are required to repay the Notes.
Repayment at option of Holders Holders will not have the option to have the Notes repaid prior to the stated maturity date.
Defeasance The Notes are subject to defeasance by us. “Defeasance” means that, by depositing with a trustee an amount of cash and/or government securities sufficient to pay all principal and interest, if any, on the Notes when due and satisfying any additional conditions noted below, we will be deemed to have been discharged from our obligations under the Notes. We are under no obligation to exercise any such rights of defeasance.
Covenant defeasance The Notes are subject to covenant defeasance by us. In the event of a “covenant defeasance,” upon depositing such funds and satisfying similar conditions discussed below we would be released from the restrictive covenants under the indenture relating to the Notes. The consequences to the holders of the Notes is that, while they no longer benefit from the restrictive covenants under the indenture, and while the Notes may not be accelerated for any reason, the holders of Notes nonetheless are guaranteed to receive the principal and interest owed to them. We are under no obligation to exercise any such rights of covenant defeasance.
Form of Notes The Notes will be represented by global securities that will be deposited and registered in the name of The Depository Trust Company, or DTC, or its nominee. This means that, except in limited circumstances, you will not receive certificates for the Notes. Beneficial interests in the Notes will be represented through book-entry accounts of financial institutions acting on behalf of beneficial owners as direct and indirect participants in DTC. Investors may elect to hold interests in the Notes through either DTC, if they are a participant, or indirectly through organizations which are participants in DTC.
Trustee, Paying Agent, Registrar and Transfer Agent

U.S. Bank National Association

 

 

S-14


Table of Contents
Other limited covenants

As described in this prospectus supplement under the caption “Description of the Notes—Other Covenants,” the indenture contains certain limited covenants.

However, the terms of the indenture and the Notes will not place any restrictions on our or our subsidiaries’ ability to:

 

•    issue securities or otherwise incur additional indebtedness or other obligations, including (1) any indebtedness or other obligations that would be equal in right of payment to the Notes, (2) any indebtedness or other obligations that would be secured and therefore rank effectively senior in right of payment to the Notes to the extent of the values of the assets securing such debt, (3) indebtedness of ours that is guaranteed by one or more of our subsidiaries and which therefore is structurally senior to the Notes with respect to the assets of the applicable subsidiary and (4) securities, indebtedness or obligations issued or incurred by our subsidiaries or that would be senior to our equity interests in those entities and therefore rank structurally senior to the Notes with respect to the assets of our subsidiaries, in each case other than an incurrence of indebtedness or other obligation that would cause a violation of Section 18(a)(1)(A) as modified by Section 61(a)(1) of the 1940 Act or any successor provisions (whether or not we are subject thereto), but giving effect, in each case, to any exemptive relief granted to us by the SEC;

 

•    pay dividends on, or purchase or redeem or make any payments in respect of, capital stock or other securities ranking junior in right of payment to the Notes, including subordinated indebtedness, in each case other than dividends, purchases, redemptions or payments that would cause a violation of Section 18(a)(1)(B) as modified by Section 61(a)(1) of the 1940 Act or any successor provisions, but giving effect to (i) any exemptive relief granted to us by the SEC and (ii) any no-action relief granted to us or another BDC by the SEC permitting the payment of a dividend to maintain RIC status under the Code;

 

•    sell assets (other than certain limited restrictions on our ability to consolidate, merge or sell all or substantially all of our assets);

 

•    enter into transactions with affiliates;

 

•    create liens (including liens on the shares of our subsidiaries) or enter into sale and leaseback transactions;

 

 

 

S-15


Table of Contents

•    make investments; or

 

•    create restrictions on the payment of dividends or other amounts to use from our subsidiaries.

Events of Default

You will have rights if an Event of Default occurs with respect to the Notes.

 

The term “Event of Default” in respect of the Notes means any of the following:

 

•    We do not pay the principal (or premium, if any) of any Note when due.

 

•    We do not pay interest on any Note when due, and such default is not cured within 30 days.

 

•    We remain in breach of any other covenant with respect to the Notes for 60 days after we receive a written notice of default stating we are in breach. The notice must be sent by either the Trustee or holders of at least 25.0% of the principal amount of the Notes.

 

•    A final judgment for the payment of $15 million or more (excluding any amounts covered by insurance) rendered against us or any significant subsidiary, which judgment is not discharged or stayed within 60 days after (i) the date on which the right to appeal thereof has expired if no such appeal has commenced, or (ii) the date on which all rights to appeal have been extinguished.

 

•    We file for bankruptcy or certain other events of bankruptcy, insolvency or reorganization occur and in the case of certain orders or decrees entered against us under any bankruptcy law, such order or decree remains undischarged or unstayed for a period of 60 days.

 

•    On the last business day of each of twenty-four consecutive calendar months, the Notes have an asset coverage, as defined in the 1940 Act, of less than 100% after giving effect to any exemptive relief granted to us by the SEC.

 

•    A default by us or any of our significant subsidiaries, which is not cured within 30 days, under any agreement or instrument relating to indebtedness for borrowed money in excess of $10 million, which default (i) results in such indebtedness becoming or being declared due and payable or (ii) constitutes a failure to pay the principal or interest of any such debt when due and payable at its stated maturity, upon required repurchase, upon declaration of acceleration or otherwise.

 

 

S-16


Table of Contents
See “Risk Factors—The indenture governing the Notes will contain limited protection for holders of the Notes.”
Listing The Existing Notes are traded on the New York Stock Exchange under the trading symbol “SAQ.” We intend to list the Notes offered hereby on the NYSE under the same trading symbol.
Use of Proceeds We intend to use substantially all of the net proceeds from the sale of our Notes to increase the amount of regulatory capital (which approximates equity capital) that we have invested in SBIC LP, which will allow us to increase our borrowings from the SBA, and for general corporate purposes. The SBIC LP is able to borrow funds up to twice its regulatory capital from the SBA. The net proceeds from the sale of our Notes invested in SBIC LP, and the funds borrowed from the SBA, can be used to make investments in loans and equity securities of eligible small businesses, in accordance with our investment objectives and strategies described in this prospectus supplement and the accompanying prospectus. Pending such use, we will invest the net proceeds primarily in high quality, short-term debt securities consistent with our business development company election and our election to be taxed as a RIC. See “Use of Proceeds” in this prospectus supplement.
Global Clearance and Settlement Procedures Interests in the Notes will trade in DTC’s Same Day Funds Settlement System, and any permitted secondary market trading activity in such Notes will, therefore, be required by DTC to be settled in immediately available funds. None of the Company, the Trustee or the paying agent will have any responsibility for the performance by DTC or its participants or indirect participants of their respective obligations under the rules and procedures governing their operations.

 

 

S-17


Table of Contents

SUPPLEMENTARY RISK FACTORS

Investing in our securities involves a number of significant risks. Before you invest in our securities, you should be aware of various risks, including those described below and those set forth in the accompanying prospectus. You should carefully consider these risk factors, together with all of the other information included in this prospectus supplement and the accompanying prospectus, before you decide whether to make an investment in our securities. The risks set out below are not the only risks we face. Additional risks and uncertainties not presently known to us or not presently deemed material by us may also impair our operations and performance. If any of the following events occur, our business, financial condition, results of operations and cash flows could be materially and adversely affected. In such case, our net asset value and the trading price of our securities could decline, and you may lose all or part of your investment. The risk factors described below, together with those set forth in the accompanying prospectus, are the principal risk factors associated with an investment in us as well as those factors generally associated with an investment company with investment objectives, investment policies, capital structure or trading markets similar to ours.

The Notes will be unsecured and therefore will be effectively subordinated to any secured indebtedness we may incur.

The Notes will not be secured by any of our assets or any of the assets of our subsidiaries. As a result, the Notes are effectively subordinated to any secured indebtedness we or our subsidiaries have outstanding as of the date of this prospectus supplement or that they may incur in the future (or any indebtedness that is initially unsecured to which we subsequently grant security) to the extent of the value of the assets securing such indebtedness. In any liquidation, dissolution, bankruptcy or other similar proceeding, the holders of any of our existing or future secured indebtedness and the secured indebtedness of our subsidiaries may assert rights against the assets pledged to secure that indebtedness in order to receive full payment of their indebtedness before the assets may be used to pay other creditors, including the holders of the Notes. As of July 13, 2015, we had approximately $85.0 million in outstanding indebtedness that is senior to the Notes. Certain amounts of this indebtedness are secured by certain of our assets and the indebtedness thereunder is therefore effectively senior to the Notes to the extent of the value of such assets.

The Notes will be subordinated structurally to the indebtedness and other liabilities of our subsidiaries.

The Notes are obligations exclusively of Saratoga Investment Corp. and not of any of our subsidiaries. None of our subsidiaries is a guarantor of the Notes. Except to the extent we are a creditor with recognized claims against our subsidiaries, all claims of creditors, including trade creditors, and holders of preferred stock, if any, of our subsidiaries will have priority over our claims (and therefore the claims of our creditors, including holders of the Notes) with respect to the assets of such subsidiaries. Even if we were recognized as a creditor of one or more of our subsidiaries, our claims would still be effectively subordinated to any security interests in the assets of any such subsidiary and to any indebtedness or other liabilities of any such subsidiary senior to our claims. Consequently, the Notes will be subordinated structurally to all indebtedness and other liabilities, including trade payables, of any of our subsidiaries and any subsidiaries that we may in the future acquire or establish as financing vehicles or otherwise. All of the existing indebtedness of our subsidiaries would be structurally senior to the Notes. In addition, our subsidiaries may incur substantial additional indebtedness in the future, all of which would be structurally senior to the Notes.

 

S-18


Table of Contents

The indenture governing the Notes will contain limited protection for holders of the Notes.

The indenture governing the Notes offers limited protection to holders of the Notes. The terms of the indenture and the Notes do not restrict our or any of our subsidiaries’ ability to engage in, or otherwise be a party to, a variety of corporate transactions, circumstances or events that could have an adverse impact on your investment in the Notes. In particular, the terms of the indenture and the Notes will not place any restrictions on our or our subsidiaries’ ability to:

 

    issue securities or otherwise incur additional indebtedness or other obligations, including (1) any indebtedness or other obligations that would be equal in right of payment to the Notes, (2) any indebtedness or other obligations that would be secured and therefore rank effectively senior in right of payment to the Notes to the extent of the values of the assets securing such debt, (3) indebtedness of ours that is guaranteed by one or more of our subsidiaries and which therefore is structurally senior to the Notes with respect to the assets of the applicable subsidiary and (4) securities, indebtedness or obligations issued or incurred by our subsidiaries or the that would be senior to our equity interests in those entities and therefore rank structurally senior to the Notes with respect to the assets of our subsidiaries, in each case other than an incurrence of indebtedness or other obligation that would cause a violation of Section 18(a)(1)(A) as modified by Section 61(a)(1) of the 1940 Act or any successor provisions (whether or not we are subject thereto), but giving effect, in each case, to any exemptive relief granted to us by the SEC. Currently, these provisions generally prohibit us from making additional borrowings, including through the issuance of additional debt or the sale of additional debt securities, unless our asset coverage, as defined in the 1940 Act, equals at least 200% after such borrowings;

 

    pay dividends on, or purchase or redeem or make any payments in respect of, capital stock or other securities ranking junior in right of payment to the Notes, including subordinated indebtedness, in each case other than dividends, purchases, redemptions or payments that would cause a violation of Section 18(a)(1)(B) as modified by Section 61(a)(1) of the 1940 Act or any successor provisions, but giving effect to (i) any exemptive relief granted to us by the SEC and (ii) any no-action relief granted to us or another BDC by the SEC permitting the payment of a dividend to maintain RIC status under the Code. These provisions generally prohibit us from declaring any cash dividend or distribution upon any class of our capital stock, or purchasing any such capital stock if our asset coverage, as defined in the 1940 Act, is below 200% at the time of the declaration of the dividend or distribution or the purchase and after deducting the amount of such dividend, distribution or purchase;

 

    sell assets (other than certain limited restrictions on our ability to consolidate, merge or sell all or substantially all of our assets);

 

    enter into transactions with affiliates;

 

    create liens (including liens on the shares of our subsidiaries) or enter into sale and leaseback transactions;

 

    make investments; or

 

    create restrictions on the payment of dividends or other amounts to us from our subsidiaries.

In addition, the indenture does not require us to offer to purchase the Notes in connection with a change of control or any other event.

Furthermore, the terms of the indenture and the Notes do not protect holders of the Notes in the event that we experience changes (including significant adverse changes) in our financial condition, results of operations or credit ratings, as they do not require that we or our subsidiaries adhere to any financial tests or ratios or specified levels of net worth, revenues, income, cash flow or liquidity except as required by the 1940 Act.

 

S-19


Table of Contents

Our ability to recapitalize, incur additional debt and take a number of other actions that are not limited by the terms of the Notes may have important consequences for you as a holder of the Notes, including making it more difficult for us to satisfy our obligations with respect to the Notes or negatively affecting the trading value of the Notes.

Certain of our current debt instruments include more protections for their holders than the indenture and the Notes. In addition, other debt we issue or incur in the future could contain more protections for its holders than the indenture and the Notes, including additional covenants and events of default. The issuance or incurrence of any such debt with incremental protections could affect the market for and trading levels and prices of the Notes.

An active trading market for the Notes may not develop or be maintained, which could limit the market price of the Notes or your ability to sell them.

Although the Existing Notes are listed on the NYSE under the trading symbol “SAQ,” we cannot provide any assurances that an active trading market will develop or be maintained for the Notes or that you will be able to sell your Notes. If the Notes are traded after their initial issuance, they may trade at a discount from their initial offering price depending on prevailing interest rates, the market for similar securities, our credit ratings, general economic conditions, our financial condition, performance and prospects and other factors. The sales agent has advised us that it intends to make a market in the Notes, but they are not obligated to do so. The sales agent may discontinue any market-making in the Notes at any time at its sole discretion. Accordingly, we cannot assure you that a liquid trading market will develop or be maintained for the Notes, that you will be able to sell your Notes at a particular time or that the price you receive when you sell will be favorable. To the extent an active trading market does not develop, the liquidity and trading price for the Notes may be harmed. Accordingly, you may be required to bear the financial risk of an investment in the Notes for an indefinite period of time.

We may choose to redeem the Notes when prevailing interest rates are relatively low.

On or after May 31, 2016, we may choose to redeem the Notes from time to time, especially when prevailing interests rates are lower than the rate borne by the Notes. If prevailing rates are lower at the time of redemption, you would not be able to reinvest the redemption proceeds in a comparable security at an effective interest rate as high as the interest rate on the Notes being redeemed. Our redemption right also may adversely impact your ability to sell the Notes as the optional redemption date or period approaches.

If we default on our obligations to pay our other indebtedness, we may not be able to make payments on the Notes.

Any default under the agreements governing our indebtedness, including a default under the Credit Facility or other indebtedness to which we may be a party that is not waived by the required lenders, and the remedies sought by the holders of such indebtedness could make us unable to pay principal, premium, if any, and interest on the Notes and substantially decrease the market value of the Notes. If we are unable to generate sufficient cash flow and are otherwise unable to obtain funds necessary to meet required payments of principal, premium, if any, and interest on our indebtedness, or if we otherwise fail to comply with the various covenants, including financial and operating covenants, in the instruments governing our indebtedness, we could be in default under the terms of the agreements governing such indebtedness, including the Notes. In the event of such default, the holders of such indebtedness could elect to declare all the funds borrowed thereunder to be due and payable, together with accrued and unpaid interest, the lender under the Credit Facility or other debt we may incur in the future could elect to terminate its commitment, cease making further loans and institute foreclosure proceedings against our assets, and we could be forced into bankruptcy or liquidation. In addition, any such default may constitute a default under the Notes, which could further limit our ability to repay our debt, including the Notes. If our operating performance declines, we may in the future need to seek to obtain waivers from the lender under the Credit Facility or other debt that we may incur in the future to avoid being in default. If we breach our covenants

 

S-20


Table of Contents

under the Credit Facility or other debt and seek a waiver, we may not be able to obtain a waiver from the required lenders. If this occurs, we would be in default under the Credit Facility or other debt, the lender could exercise its rights as described above, and we could be forced into bankruptcy or liquidation. If we are unable to repay debt, lenders having secured obligations could proceed against the collateral securing the debt. Because the Credit Facility has, and any future credit facilities will likely have, customary cross-default provisions, if the indebtedness under the Notes, the Credit Facility or under any future credit facility is accelerated, we may be unable to repay or finance the amounts due.

We may be unable to invest a significant portion of the net proceeds from this offering, which could harm our financial condition and operating results.

Delays in investing the net proceeds raised in this offering may cause our performance to be worse than that of other fully invested business development companies or other lenders or investors pursuing comparable investment strategies. We cannot assure you that we will be able to identify any investments that meet our investment objective or that any investment that we make will produce a positive return. We may be unable to invest the net proceeds of this offering on acceptable terms within the time period that we anticipate or at all, which could harm our financial condition and operating results.

We anticipate that, depending on market conditions and the amount of the capital, it may take us a substantial period of time to invest substantially all of the net proceeds from this offering in investments meeting our investment objective. During this period, we will invest the capital primarily in cash, cash equivalents, U.S. government securities or high-quality debt securities maturing in one year or less from the time of investment. These securities may earn yields substantially lower than the income that we anticipate receiving once we are fully invested in accordance with our investment objective.

 

S-21


Table of Contents

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS

This prospectus supplement and the accompanying prospectus contains forward-looking statements that involve substantial risks and uncertainties. These forward-looking statements are not historical facts, but rather are based on current expectations, estimates and projections about our company, our current and prospective portfolio investments, our industry, our beliefs, and our assumptions. Words such as “anticipates,” “expects,” “intends,” “plans,” “will,” “may,” “continue,” “believes,” “seeks,” “estimates,” “would,” “could,” “should,” “targets,” “projects,” and variations of these words and similar expressions are intended to identify forward-looking statements. The forward-looking statements contained in this prospectus supplement and the accompanying prospectus involve risks and uncertainties, including statements as to:

 

    our future operating results;

 

    our business prospects and the prospects of our portfolio companies;

 

    the impact of investments that we expect to make;

 

    our contractual arrangements and relationships with third parties;

 

    the dependence of our future success on the general economy and its impact on the industries in which we invest;

 

    the ability of our portfolio companies to achieve their objectives;

 

    our expected financings and investments;

 

    the adequacy of our cash resources and working capital; and

 

    the timing of cash flows, if any, from the operations of our portfolio companies.

These statements are not guarantees of future performance and are subject to risks, uncertainties, and other factors, some of which are beyond our control and difficult to predict and could cause actual results to differ materially from those expressed or forecasted in the forward-looking statements, including without limitation:

 

    an economic downturn could impair our portfolio companies’ ability to continue to operate, which could lead to the loss of some or all of our investments in such portfolio companies;

 

    a contraction of available credit and/or an inability to access the equity markets could impair our lending and investment activities;

 

    interest rate volatility could adversely affect our results, particularly if we elect to use leverage as part of our investment strategy;

 

    risks associated with possible disruption in our operations or the economy generally due to terrorism or natural disasters; and

 

    the risks, uncertainties and other factors we identify in “Risk Factors” in the accompanying prospectus and elsewhere in this prospectus supplement, the accompanying prospectus and in our filings with the SEC.

Although we believe that the assumptions on which these forward-looking statements are based are reasonable, any of those assumptions could prove to be inaccurate, and as a result, the forward-looking statements based on those assumptions also could be inaccurate. Important assumptions include our ability to originate new loans and investments, certain margins and levels of profitability and the availability of additional capital. In light of these and other uncertainties, the inclusion of a projection or forward-looking statement in this prospectus supplement or the accompanying prospectus should not be regarded as a representation by us that our plans and objectives will be achieved. These risks and uncertainties include those described or identified in “Risk Factors” in the accompanying prospectus and elsewhere in this prospectus supplement and the accompanying prospectus. You should not place undue reliance on these forward-looking statements, which apply only as of the

 

S-22


Table of Contents

respective dates of this prospectus supplement and the accompanying prospectus. However, we will update this prospectus supplement and the accompanying prospectus to reflect any material changes to the information contained herein. The forward-looking statements contained in this prospectus supplement and the accompanying prospectus are excluded from the safe harbor protection provided by Section 27A of the Securities Act of 1933, as amended, or the “Securities Act.”

 

S-23


Table of Contents

USE OF PROCEEDS

We intend to use substantially all of the net proceeds from the sale of our Notes to increase the amount of regulatory capital (which approximates equity capital) that we have invested in SBIC LP, which will allow us to increase our borrowings from the SBA, and for general corporate purposes. The SBIC LP is able to borrow funds up to twice its regulatory capital from the SBA. The net proceeds from the sale of our Notes invested in SBIC LP, and the funds borrowed from the SBA, can be used to make investments in loans and equity securities of eligible small businesses, in accordance with our investment objectives and strategies described in this prospectus supplement and the accompanying prospectus.

Pending such use, we will invest the net proceeds primarily in high quality, short-term debt securities consistent with our business development company election and our election to be taxed as a RIC. See the accompanying prospectus, “Regulation—Business Development Company Regulations—Temporary Investments.” Our ability to achieve our investment objective may be limited to the extent that the net proceeds from an offering, pending full investment, are held in interest-bearing deposits or other short-term instruments. See “Supplementary Risk Factors— We may be unable to invest a significant portion of the net proceeds from this offering, which could harm our financial condition and operating results” in this prospectus supplement for additional information regarding this matter.

 

S-24


Table of Contents

RATIO OF EARNINGS TO FIXED CHARGES

 

For three months ended May 31, 2015, and the fiscal years ended February 28, 2015, 2014 and 2013, February 29, 2012 and February 28, 2011 and 2010, the ratios of earnings to fixed charges of the Company, computed as set forth below, were as follows:

 

    Three months
ended May 31,
2015
    Year ended
February 28,
2015
    Year ended
February 28,
2014
    Year ended
February 28,
2013
    Year ended
February 29,
2012
    Year ended
February 28,
2011
    Year ended
February 28,
2010
 

Earnings to Fixed Charges

    4.76        2.53        2.40        6.53        10.87        7.41        (1.55

For purposes of computing the ratios of earnings to fixed charges, earnings represent net increase in net assets resulting from operations plus (or minus) income tax provision (benefit) including excise tax expense plus fixed charges. Fixed charges include interest and credit facility fees and amortization of deferred financing fees.

 

S-25


Table of Contents

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL

CONDITION AND RESULTS OF OPERATIONS

The information contained in this section should be read in conjunction with the Selected Financial and Other Data and our Financial Statements and notes thereto appearing elsewhere in this prospectus supplement and the accompanying prospectus. In addition to historical information, the following discussion and other parts of this prospectus supplement and the accompanying prospectus contain forward-looking information that involves risks and uncertainties. Our actual results could differ materially from those anticipated by such forward-looking information due to the factors discussed under “Supplementary Risk Factors” and “Cautionary Statement Regarding Forward-Looking Statements” appearing elsewhere in this prospectus supplement and under “Risk Factors” in the accompanying prospectus.

OVERVIEW

We are a Maryland corporation that has elected to be treated as a BDC under the Investment Company Act of 1940 (the “1940 Act”). Our investment objective is to generate current income and, to a lesser extent, capital appreciation from our investments. We invest primarily in leveraged loans and mezzanine debt issued by private U.S. middle market companies, which we define as companies having EBITDA of between $5 million and $50 million, both through direct lending and through participation in loan syndicates. We may also invest up to 30.0% of the portfolio in opportunistic investments in order to seek to enhance returns to stockholders. Such investments may include investments in distressed debt, which may include securities of companies in bankruptcy, foreign debt, private equity, securities of public companies that are not thinly traded and structured finance vehicles such as collateralized loan obligation funds. We have elected and qualified to be treated as a RIC under Subchapter M of the Internal Revenue Code of 1986, as amended (the “Code”).

Corporate History and Recent Developments

We commenced operations, at the time known as GSC Investment Corp., on March 23, 2007 and completed an initial public offering of shares of common stock on March 28, 2007. Prior to July 30, 2010, we were externally managed and advised by GSCP (NJ), L.P., an entity affiliated with GSC Group, Inc. In connection with the consummation of a recapitalization transaction on July 30, 2010, as described below we engaged Saratoga Investment Advisors (“SIA”) to replace GSCP (NJ), L.P. as our investment adviser and changed our name to Saratoga Investment Corp.

As a result of the event of default under a revolving securitized credit facility with Deutsche Bank we previously had in place, in December 2008 we engaged the investment banking firm of Stifel, Nicolaus & Company to evaluate strategic transaction opportunities and consider alternatives for us. On April 14, 2010, GSC Investment Corp. entered into a stock purchase agreement with Saratoga Investment Advisors and certain of its affiliates and an assignment, assumption and novation agreement with Saratoga Investment Advisors, pursuant to which GSC Investment Corp. assumed certain rights and obligations of Saratoga Investment Advisors under a debt commitment letter Saratoga Investment Advisors received from Madison Capital Funding LLC, which indicated Madison Capital Funding’s willingness to provide GSC Investment Corp. with a $40.0 million senior secured revolving credit facility, subject to the satisfaction of certain terms and conditions. In addition, GSC Investment Corp. and GSCP (NJ), L.P. entered into a termination and release agreement, to be effective as of the closing of the transaction contemplated by the stock purchase agreement, pursuant to which GSCP (NJ), L.P., among other things, agreed to waive any and all accrued and unpaid deferred incentive management fees up to and as of the closing of the transaction contemplated by the stock purchase agreement but continued to be entitled to receive the base management fees earned through the date of the closing of the transaction contemplated by the stock purchase agreement.

On July 30, 2010, the transactions contemplated by the stock purchase agreement with Saratoga Investment Advisors and certain of its affiliates were completed, the private sale of 986,842 shares of our common stock for $15.0 million in aggregate purchase price to Saratoga Investment Advisors and certain of its affiliates closed, the Company entered into the Credit Facility, and the Company began doing business as Saratoga Investment Corp.

 

S-26


Table of Contents

We used the net proceeds from the private sale transaction and a portion of the funds available to us under the Credit Facility to pay the full amount of principal and accrued interest, including default interest, outstanding under our revolving securitized credit facility with Deutsche Bank. The revolving securitized credit facility with Deutsche Bank was terminated in connection with our payment of all amounts outstanding thereunder on July 30, 2010.

On August 12, 2010, we effected a one-for-ten reverse stock split of our outstanding common stock. As a result of the reverse stock split, every ten shares of our common stock were converted into one share of our common stock. Any fractional shares received as a result of the reverse stock split were redeemed for cash. The total cash payment in lieu of shares was $230. Immediately after the reverse stock split, we had 2,680,842 shares of our common stock outstanding.

In January 2011, we registered for public resale the 982,842 shares of our common stock issued to Saratoga Investment Advisors and certain of its affiliates.

On March 28, 2012, our wholly-owned subsidiary, Saratoga Investment Corp. SBIC, LP (“SBIC LP”), received a SBIC license from the Small Business Administration (“SBA”).

In May 2013, we issued $48.3 million in aggregate principal amount of our 7.50% unsecured notes due 2020 for net proceeds of $46.1 million after deducting underwriting commissions of $1.9 million and offering costs of $0.3 million. The proceeds included the underwriters’ full exercise of their overallotment option. Interest on these notes is paid quarterly in arrears on February 15, May 15, August 15 and November 15 of each year, at a rate of 7.50% per year, beginning August 15, 2013. The notes mature on May 31, 2020 and may be redeemed in whole or in part at any time or from time to time at our option on or after May 31, 2016. The notes are listed on the NYSE under the trading symbol “SAQ” with a par value of $25.00 per note.

On April 3, 2015, the SBA issued a “green light” or “go forth” letter inviting us to continue our application process to obtain a license to form and operate a second SBIC subsidiary. If approved, a second SBIC license would provide us an incremental source of long-term capital by permitting us to issue $75 million of additional SBA-guaranteed debentures in addition to the $150 million already approved under the first license. Receipt of a green light letter from the SBA does not assure an applicant that the SBA will ultimately issue an SBIC license and we have received no assurance or indication from the SBA that we will receive an SBIC license, or of the timeframe in which it would receive a license, should one be granted.

On May 29, 2015, we entered into a Debt Distribution Agreement with Ladenburg Thalmann & Co. Inc. through which we may offer for sale, from time to time, up to $20.0 million in aggregate principal amount of the Notes through an At-the-Market (“ATM”) offering. From May 29, 2015 through July 16, 2015, the Company sold 227,863 Notes in an aggregate principal amount of $5,696,575 at an average price of $25.32 for aggregate net proceeds of $5,653,305 (net of transaction costs).

Critical Accounting Policies

Basis of Presentation

The preparation of financial statements in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) requires management to make certain estimates and assumptions affecting amounts reported in the Company’s consolidated financial statements. We have identified investment valuation, revenue recognition and the recognition of capital gains incentive fee expense as our most critical accounting estimates. We continuously evaluate our estimates, including those related to the matters described below. These estimates are based on the information that is currently available to us and on various other assumptions that we believe to be reasonable under the circumstances. Actual results could differ materially from those estimates under different assumptions or conditions. A discussion of our critical accounting policies follows.

 

S-27


Table of Contents

Investment Valuation

The Company accounts for its investments at fair value in accordance with the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 820, Fair Value Measurements and Disclosures (“ASC 820”). ASC 820 defines fair value, establishes a framework for measuring fair value, establishes a fair value hierarchy based on the quality of inputs used to measure fair value and enhances disclosure requirements for fair value measurements. ASC 820 requires the Company to assume that its investments are to be sold at the statement of assets and liabilities date in the principal market to independent market participants, or in the absence of a principal market, in the most advantageous market, which may be a hypothetical market. Market participants are defined as buyers and sellers in the principal or most advantageous market that are independent, knowledgeable, and willing and able to transact.

Investments for which market quotations are readily available are fair valued at such market quotations obtained from independent third party pricing services and market makers subject to any decision by our board of directors to approve a fair value determination to reflect significant events affecting the value of these investments. We value investments for which market quotations are not readily available at fair value as approved, in good faith, by our board of directors based on input from Saratoga Investment Advisers, the audit committee of our board of directors and a third party independent valuation firm. Determinations of fair value may involve subjective judgments and estimates. The types of factors that may be considered in determining the fair value of our investments include the nature and realizable value of any collateral, the portfolio company’s ability to make payments, market yield trend analysis, the markets in which the portfolio company does business, comparison to publicly traded companies, discounted cash flow and other relevant factors.

We undertake a multi-step valuation process each quarter when valuing investments for which market quotations are not readily available, as described below:

 

    Each investment is initially valued by the responsible investment professionals of Saratoga Investment Advisors and preliminary valuation conclusions are documented and discussed with our senior management; and

 

    An independent valuation firm engaged by our board of directors reviews approximately one quarter of these preliminary valuations each quarter so that the valuation of each investment for which market quotes are not readily available is reviewed by the independent valuation firm at least annually.

In addition, all our investments are subject to the following valuation process:

 

    The audit committee of our board of directors reviews each preliminary valuation and Saratoga Investment Advisors and independent valuation firm (if applicable) will supplement the preliminary valuation to reflect any comments provided by the audit committee; and

 

    Our board of directors discusses the valuations and approves the fair value of each investment, in good faith, based on the input of Saratoga Investment Advisors, independent valuation firm (to the extent applicable) and the audit committee of our board of directors.

Our investment in Saratoga Investment Corp. CLO 2013-1, Ltd. (“Saratoga CLO”) is carried at fair value, which is based on a discounted cash flow model that utilizes prepayment, re-investment and loss assumptions based on historical experience and projected performance, economic factors, the characteristics of the underlying cash flow, and comparable yields for equity interests in collateralized loan obligation funds similar to Saratoga CLO, when available, as determined by SIA and recommended to our board of directors. Specifically, we use Intex cash flow models, or an appropriate substitute, to form the basis for the valuation of our investment in Saratoga CLO. The models use a set of assumptions including projected default rates, recovery rates, reinvestment rate and prepayment rates in order to arrive at estimated valuations. The assumptions are based on available market data and projections provided by third parties as well as management estimates. We use the output from the Intex models (i.e., the estimated cash flows) to perform a discounted cash flows analysis on expected future cash flows to determine a valuation for our investment in Saratoga CLO.

 

S-28


Table of Contents

Revenue Recognition

Income Recognition

Interest income, adjusted for amortization of premium and accretion of discount, is recorded on an accrual basis to the extent that such amounts are expected to be collected. The Company stops accruing interest on its investments when it is determined that interest is no longer collectible. Discounts and premiums on investments purchased are accreted/amortized over the life of the respective investment using the effective yield method. The amortized cost of investments represents the original cost adjusted for the accretion of discounts and amortizations of premium on investments.

Loans are generally placed on non-accrual status when there is reasonable doubt that principal or interest will be collected. Accrued interest is generally reserved when a loan is placed on non-accrual status. Interest payments received on non-accrual loans may be recognized as a reduction in principal depending upon management’s judgment regarding collectability. Non-accrual loans are restored to accrual status when past due principal and interest is paid and, in management’s judgment, are likely to remain current, although we may make exceptions to this general rule if the loan has sufficient collateral value and is in the process of collection.

Interest income on our investment in Saratoga CLO is recorded using the effective interest method in accordance with the provisions of ASC Topic 325-40, Investments-Other, Beneficial Interests in Securitized Financial Assets, based on the anticipated yield and the estimated cash flows over the projected life of the investment. Yields are revised when there are changes in actual or estimated cash flows due to changes in prepayments and/or re-investments, credit losses or asset pricing. Changes in estimated yield are recognized as an adjustment to the estimated yield over the remaining life of the investment from the date the estimated yield was changed.

Paid-in-Kind Interest

The Company holds debt investments in its portfolio that contain a payment-in-kind (“PIK”) interest provision. The PIK interest, which represents contractually deferred interest added to the investment balance that is generally due at maturity, is generally recorded on the accrual basis to the extent such amounts are expected to be collected. We stop accruing PIK interest if we do not expect the issuer to be able to pay all principal and interest when due.

Capital Gains Incentive Fee

The Company records an expense accrual relating to the capital gains incentive fee payable by the Company to its investment adviser when the unrealized gains on its investments exceed all realized capital losses on its investments given the fact that a capital gains incentive fee would be owed to the investment adviser if the Company were to liquidate its investment portfolio at such time. The actual incentive fee payable to the Company’s investment adviser related to capital gains will be determined and payable in arrears at the end of each fiscal year and will include only realized capital gains for the period.

Revenues

We generate revenue in the form of interest income and capital gains on the debt investments that we hold and capital gains, if any, on equity interests that we may acquire. We expect our debt investments, whether in the form of leveraged loans or mezzanine debt, to have terms of up to ten years, and to bear interest at either a fixed or floating rate. Interest on debt will be payable generally either quarterly or semi-annually. In some cases, our debt investments may provide for a portion of the interest to be PIK. To the extent interest is paid-in-kind, it will be payable through the increase of the principal amount of the obligation by the amount of interest due on the then-outstanding aggregate principal amount of such obligation. The principal amount of the debt and any accrued but unpaid interest will generally become due at the maturity date. In addition, we may generate revenue

 

S-29


Table of Contents

in the form of commitment, origination, structuring or diligence fees, fees for providing managerial assistance or investment management services and possibly consulting fees. Any such fees will be generated in connection with our investments and recognized as earned. We may also invest in preferred equity securities that pay dividends on a current basis.

On January 22, 2008, we entered into a collateral management agreement with Saratoga CLO, pursuant to which we act as its collateral manager. The Saratoga CLO was refinanced in October 2013 and its reinvestment period ends in October 2016. The Saratoga CLO remains 100% owned and managed by Saratoga Investment Corp. We receive a senior collateral management fee of 0.25% and a subordinate collateral management fee of 0.25% of the outstanding principal amount of Saratoga CLO’s assets, paid quarterly to the extent of available proceeds. We are also entitled to an incentive management fee equal to 20.0% of excess cash flow to the extent the Saratoga CLO subordinated notes receive an internal rate of return equal to or greater than 12.0%.

We recognize interest income on our investment in the subordinated notes of Saratoga CLO using the effective interest method, based on the anticipated yield and the estimated cash flows over the projected life of the investment. Yields are revised when there are changes in actual or estimated cash flows due to changes in prepayments and/or re-investments, credit losses or asset pricing. Changes in estimated yield are recognized as an adjustment to the estimated yield over the remaining life of the investment from the date the estimated yield was changed.

Expenses

Our primary operating expenses include the payment of investment advisory and management fees, professional fees, directors and officers insurance, fees paid to independent directors and administrator expenses, including our allocable portion of our administrator’s overhead. Our investment advisory and management fees compensate our investment adviser for its work in identifying, evaluating, negotiating, closing and monitoring our investments. We bear all other costs and expenses of our operations and transactions, including those relating to:

 

    organization;

 

    calculating our net asset value (including the cost and expenses of any independent valuation firm);

 

    expenses incurred by our investment adviser payable to third parties, including agents, consultants or other advisers, in monitoring our financial and legal affairs and in monitoring our investments and performing due diligence on our prospective portfolio companies;

 

    interest payable on debt, if any, incurred to finance our investments;

 

    offerings of our common stock and other securities;

 

    investment advisory and management fees;

 

    fees payable to third parties, including agents, consultants or other advisers, relating to, or associated with, evaluating and making investments;

 

    transfer agent and custodial fees;

 

    federal and state registration fees;

 

    all costs of registration and listing our common stock on any securities exchange;

 

    federal, state and local taxes;

 

    independent directors’ fees and expenses;

 

    costs of preparing and filing reports or other documents required by governmental bodies (including the SEC and the SBA);

 

S-30


Table of Contents
    costs of any reports, proxy statements or other notices to common stockholders including printing costs;

 

    our fidelity bond, directors and officers errors and omissions liability insurance, and any other insurance premiums;

 

    direct costs and expenses of administration, including printing, mailing, long distance telephone, copying, secretarial and other staff, independent auditors and outside legal costs; and

 

    administration fees and all other expenses incurred by us or, if applicable, the administrator in connection with administering our business (including payments under the administration agreement based upon our allocable portion of the administrator’s overhead in performing its obligations under an administration agreement, including rent and the allocable portion of the cost of our officers and their respective staffs (including travel expenses)).

Pursuant to the investment advisory and management agreement that we had with GSCP (NJ), L.P., our former investment adviser and administrator, we had agreed to pay GSCP (NJ), L.P. as investment adviser a quarterly base management fee of 1.75% of the average value of our total assets (other than cash or cash equivalents but including assets purchased with borrowed funds) at the end of the two most recently completed fiscal quarters, and appropriately adjusted for any share issuances or repurchases during the applicable fiscal quarter, and an incentive fee.

The incentive fee had two parts:

 

    A fee, payable quarterly in arrears, equal to 20.0% of our pre-incentive fee net investment income, expressed as a rate of return on the value of the net assets at the end of the immediately preceding quarter, that exceeded a 1.875% quarterly (7.5% annualized) hurdle rate measured as of the end of each fiscal quarter. Under this provision, in any fiscal quarter, our investment adviser received no incentive fee unless our pre-incentive fee net investment income exceeded the hurdle rate of 1.875%. Amounts received as a return of capital were not included in calculating this portion of the incentive fee. Since the hurdle rate was based on net assets, a return of less than the hurdle rate on total assets could still have resulted in an incentive fee.

 

    A fee, payable at the end of each fiscal year, equal to 20.0% of our net realized capital gains, if any, computed net of all realized capital losses and unrealized capital depreciation, in each case on a cumulative basis, less the aggregate amount of capital gains incentive fees paid to the investment adviser through such date.

We deferred cash payment of any incentive fee otherwise earned by our former investment adviser if, during the then most recent four full fiscal quarters ending on or prior to the date such payment was to be made, the sum of (a) our aggregate distributions to our stockholders and (b) our change in net assets (defined as total assets less liabilities) (before taking into account any incentive fees payable during that period) was less than 7.5% of our net assets at the beginning of such period. These calculations were appropriately pro-rated for the first three fiscal quarters of operation and adjusted for any share issuances or repurchases during the applicable period. Such incentive fee would become payable on the next date on which such test had been satisfied for the most recent four full fiscal quarters or upon certain terminations of the investment advisory and management agreement. We commenced deferring cash payment of incentive fees during the quarterly period ended August 31, 2007, and continued to defer such payments through the quarterly period ended May 31, 2010. As of July 30, 2010, the date on which GSCP (NJ), L.P. ceased to be our investment adviser and administrator, we owed GSCP (NJ), L.P. $2.9 million in fees for services previously provided to us; of which $0.3 million has been paid by us. GSCP (NJ), L.P. agreed to waive payment by us of the remaining $2.6 million in connection with the consummation of the stock purchase transaction with Saratoga Investment Advisors and certain of its affiliates described elsewhere in this Annual Report.

 

S-31


Table of Contents

The terms of the investment advisory and management agreement with Saratoga Investment Advisors, our current investment adviser, are substantially similar to the terms of the investment advisory and management agreement we had entered into with GSCP (NJ), L.P., our former investment adviser, except for the following material distinctions in the fee terms:

 

    The capital gains portion of the incentive fee was reset with respect to gains and losses from May 31, 2010, and therefore losses and gains incurred prior to such time will not be taken into account when calculating the capital gains fee payable to Saratoga Investment Advisors and, as a result, Saratoga Investment Advisors will be entitled to 20.0% of net gains that arise after May 31, 2010. In addition, the cost basis for computing realized gains and losses on investments held by us as of May 31, 2010 equal the fair value of such investment as of such date. Under the investment advisory and management agreement with our former investment adviser, GSCP (NJ), L.P., the capital gains fee was calculated from March 21, 2007, and the gains were substantially outweighed by losses.

 

    Under the “catch up” provision, 100.0% of our pre-incentive fee net investment income with respect to that portion of such pre-incentive fee net investment income that exceeds 1.875% (7.5% annualized) but is less than or equal to 2.344% in any fiscal quarter is payable to Saratoga Investment Advisors. This will enable Saratoga Investment Advisors to receive 20.0% of all net investment income as such amount approaches 2.344% in any quarter, and Saratoga Investment Advisors will receive 20.0% of any additional net investment income. Under the investment advisory and management agreement with our former investment adviser, GSCP (NJ), L.P. only received 20.0% of the excess net investment income over 1.875%.

 

    We will no longer have deferral rights regarding incentive fees in the event that the distributions to stockholders and change in net assets is less than 7.5% for the preceding four fiscal quarters.

To the extent that any of our leveraged loans are denominated in a currency other than U.S. dollars, we may enter into currency hedging contracts to reduce our exposure to fluctuations in currency exchange rates. We may also enter into interest rate hedging agreements. Such hedging activities, which will be subject to compliance with applicable legal requirements, may include the use of interest rate caps, futures, options and forward contracts. Costs incurred in entering into or settling such contracts will be borne by us.

New Accounting Pronouncements

In February 2015, the FASB issued ASU 2015-02, Consolidation (ASC Topic 810): Amendments to the Consolidation Analysis (“ASU 2015-02”). ASU 2015-02 significantly changes the consolidation analysis required under GAAP and ends the deferral granted to investment companies from applying the variable interest entity guidance. ASU 2015-02 is effective for interim and annual reporting periods in fiscal years that begin after December 15, 2015 and early adoption is permitted. Management is currently evaluating the impact these changes will have on the Company’s consolidated financial statements and disclosures.

In August 2014, the FASB issued new accounting guidance that requires management to assess an entity’s ability to continue as a going concern by incorporating and expanding upon certain principles that are currently in U.S. auditing standards. The amendments provide a definition of the term “substantial doubt” and include principles for considering the mitigating effect of management’s plans. The amendments also require an evaluation every reporting period, including interim periods for a period of one year after the date that the financial statements are issued (or available to be issued), and certain disclosures when substantial doubt is alleviated or not alleviated. The amendments in this update are effective for reporting periods ending after December 15, 2016. Management is currently evaluating the impact of adopting this new accounting guidance update on the company’s consolidated financial statement.

In June 2014, the FASB issued ASU 2014-11, Repurchase-to-Maturity Transactions, Repurchase Financings, and Disclosures, (“ASU 2014-11”). ASU 2014-11 makes limited changes to the accounting for repurchase agreements, clarifies when repurchase agreements and securities lending transactions should be

 

S-32


Table of Contents

accounted for as secured borrowings, and requires additional disclosures regarding these types of transactions. The guidance is effective for fiscal years beginning on or after December 15, 2014, and for interim periods within those fiscal years. Management is currently evaluating the impact these changes will have on the Company’s consolidated financial statement disclosures.

In May 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2014-09, Revenue from Contracts with Customers (Topic 606), which supersedes the revenue recognition requirements in Revenue Recognition (Topic 605). Under the new guidance, an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. This guidance is effective for annual and interim reporting periods beginning after December 15, 2016, and early application is not permitted. The Company is currently evaluating the impact this ASU will have on its consolidated financial statements.

Portfolio and investment activity

Corporate Debt Portfolio Overview

 

     At May 31,
2015
    At February 28,
2015
 
     ($ in millions)     ($ in millions)  

Number of investments(1)

     65        63   

Number of portfolio companies(1)

     35        34   

Average investment size(1)

   $ 3.8      $ 3.5   

Weighted average maturity(1)

     3.5yrs        3.7yrs   

Number of industries(1)

     14        14   

Average investment per portfolio company(1)

   $ 7.0      $ 6.6   

Non-performing or delinquent investments(1)

   $ 0.0      $ 0.0   

Fixed rate debt (% of interest bearing portfolio)(2)

   $ 83.0(37.5)   $ 82.5(40.6)

Weighted average current coupon(2)

     11.9     12.0

Floating rate debt (% of interest bearing portfolio)(2)

   $ 138.2(62.5)   $ 120.8(59.4)

Weighted average current spread over LIBOR(2)

     8.9     8.7

 

(1) Excludes our investment in the subordinated notes of Saratoga CLO and limited partnership interests.
(2) Excludes our investment in the subordinated notes of Saratoga CLO, investments in common stocks and limited partnership interests.

During the three months ended May 31, 2015, we made $23.2 million investments in new or existing portfolio companies and had $7.3 million in aggregate amount of exits and repayments resulting in net investments of $15.9 million for the period.

During the three months ended May 31, 2014, we made $21.6 million investments in new or existing portfolio companies and had $8.7 million in aggregate amount of exits and repayments resulting in net investments of $12.9 million for the period.

 

S-33


Table of Contents
     At February 28,
2015
    At February 28,
2014
    At February 28,
2013
 
     ($ in millions)     ($ in millions)     ($ in millions)  

Number of investments(1)

     63        59        44   

Number of portfolio companies(1)

     34        37        28   

Average investment size(1)

   $ 3.5      $ 3.2      $ 2.9   

Weighted average maturity(1)

     3.7 yrs      4.3 yrs      3.7 yrs 

Number of industries(1)

     14        16        15   

Average investment per portfolio company(1)

   $ 6.6      $ 5.0      $ 4.6   

Non-performing or delinquent investments(1)

   $ 0.0      $ 0.3      $ 6.7   

Fixed rate debt (% of interest bearing portfolio)(2)

   $ 82.5(40.6)   $ 70.6(40.1)   $ 53.4(43.9)

Weighted average current coupon(2)

     12.0     12.5     12.6

Floating rate debt (% of interest bearing portfolio)(2)

   $ 120.8(59.4)   $ 105.4(59.9)   $ 68.2(56.1)

Weighted average current spread over LIBOR(2)

     8.7     7.3     7.5

 

(1) Excludes our investment in the subordinated notes of Saratoga CLO and limited partnership interests.
(2) Excludes our investment in the subordinated notes of Saratoga CLO, investments in common stocks and limited partnership interests.

During the fiscal year ended February 28, 2015, we invested $104.9 million in new or existing portfolio companies and had $73.3 million in aggregate amount of exits and repayments resulting in net investments of $31.6 million for the year.

During the fiscal year ended February 28, 2014, we invested $121.1 million in new or existing portfolio companies and had $71.6 million in aggregate amount of exits and repayments resulting in net investments of $49.5 million for the year.

During the fiscal year ended February 28, 2013, we invested $71.6 million in new or existing portfolio companies and had $21.5 million in aggregate amount of exits and repayments resulting in net investments of $50.1 million for the year.

Our portfolio composition at May 31, 2015 and February 28, 2015 at fair value was as follows:

Portfolio composition

 

     At May 31, 2015     At February 28, 2015  
     Percentage
of Total
Portfolio
    Weighted
Average
Current
Yield
    Percentage
of Total
Portfolio
    Weighted
Average
Current
Yield
 

Syndicated loans

     6.8     6.3     7.6     6.2

First lien term loans

     59.8        11.2        60.3        11.0   

Second lien term loans

     15.4        11.0        14.8        11.2   

Unsecured notes

     2.2        10.8        1.8        13.7   

Saratoga CLO subordinated notes

     6.4        28.8        7.1        25.2   

Equity interests

     9.4        N/A        8.4        N/A   
  

 

 

   

 

 

   

 

 

   

 

 

 

Total

     100.0     12.0     100.0     11.8
  

 

 

   

 

 

   

 

 

   

 

 

 

Our investment in the subordinated notes of Saratoga CLO represents a first loss position in a portfolio that, at May 31, 2015 and February 28, 2015, was composed of $306.6 million and $296.9 million, respectively, in

 

S-34


Table of Contents

aggregate principal amount of predominantly senior secured first lien term loans. This investment is subject to unique risks. (See “Risk Factors—Our investment in Saratoga CLO 2013-1 LTD. constitutes a leveraged investment in a portfolio of predominantly senior secured first lien term loans and is subject to additional risks and volatility”). We do not consolidate the Saratoga CLO portfolio in our financial statements. Accordingly, the metrics below do not include the underlying Saratoga CLO portfolio investments. However, at May 31, 2015, $301.1 million or 98.8% of the Saratoga CLO portfolio investments in terms of market value had a CMR (as defined below) color rating of green or yellow and three Saratoga CLO portfolio investments were in default with a fair value of $1.4 million. At February 28, 2015, $291.6 million or 98.8% of the Saratoga CLO portfolio investments in terms of market value had a CMR (as defined below) color rating of green or yellow and two Saratoga CLO portfolio investments were in default with a fair value of $2.7 million.

Our portfolio composition at February 28, 2015, February 28, 2014 and February 28, 2013 at fair value was as follows:

Portfolio composition

 

     At February 28, 2015     At February 28, 2014     At February 28, 2013  
     Percentage
of Total
Portfolio
    Weighted
Average
Current
Yield
    Percentage
of Total
Portfolio
    Weighted
Average
Current
Yield
    Percentage
of Total
Portfolio
    Weighted
Average
Current
Yield
 

Syndicated loans

     7.6     6.2     15.7     6.2     —       —  

First lien term loans

     60.3        11.0        53.6        11.5        69.0        11.0   

Second lien term loans

     14.8        11.2        13.5        11.1        6.2        11.1   

Unsecured notes

     1.8        13.7        2.7        15.2        3.1        16.4   

Saratoga CLO subordinated notes

     7.1        25.2        9.5        18.6        16.5        27.1   

Equity interests

     8.4        N/A        5.0        N/A        5.2        N/A   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total

  100.0   11.8   100.0   11.8   100.0   14.0
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Our investment in the subordinated notes of Saratoga CLO represents a first loss position in a portfolio that, at February 28, 2015, February 28, 2014 and February 28, 2013, was composed of $296.9 million, $301.1 million and $383.3 million, respectively, in aggregate principal amount of predominantly senior secured first lien term loans. This investment is subject to unique risks. (See “Risk Factors—Our investment in Saratoga CLO 2013-1 LTD. constitutes a leveraged investment in a portfolio of predominantly senior secured first lien term loans and is subject to additional risks and volatility”). We do not consolidate the Saratoga CLO portfolio in our financial statements. Accordingly, the metrics below do not include the underlying Saratoga CLO portfolio investments. However, at February 28, 2015, $291.6 million or 98.8% of the Saratoga CLO portfolio investments in terms of market value had a CMR (as defined below) color rating of green or yellow and two Saratoga CLO portfolio investments were in default with a fair value of $2.7 million. At February 28, 2014, $298.9 million or 99.5% of the Saratoga CLO portfolio investments in terms of market value had a CMR (as defined below) color rating of green or yellow and zero Saratoga CLO portfolio investments were in default with a fair value of $1.6 million. For more information relating to Saratoga CLO, see the audited financial statements for Saratoga CLO included elsewhere herein.

Saratoga Investment Advisors normally grades all of our investments using a credit and monitoring rating system (“CMR”). The CMR consists of a single component: a color rating. The color rating is based on several criteria, including financial and operating strength, probability of default, and restructuring risk. The color ratings are characterized as follows: (Green)—strong credit; (Yellow)—satisfactory credit; (Red)—payment default risk, in payment default and/or significant restructuring activity.

 

S-35


Table of Contents

The CMR distribution of our investments at May 31, 2015 and February 28, 2015 was as follows:

Portfolio CMR distribution

 

     At May 31, 2015     At February 28, 2015  

Color Score

   Investments
at
Fair Value
     Percentage
of Total
Portfolio
    Investments
at
Fair Value
     Percentage
of Total
Portfolio
 
     ($ in thousands)  

Green

   $ 211,564         80.5   $ 191,606         79.7

Yellow

     9,611         3.7        11,635         4.8   

Red

     103         0.0        101         0.0   

N/A(1)

     41,466         15.8        37,196         15.5   
  

 

 

    

 

 

   

 

 

    

 

 

 

Total

   $ 262,744         100.0   $ 240,538         100.0
  

 

 

    

 

 

   

 

 

    

 

 

 

 

(1) Comprised of our investment in the subordinated notes of Saratoga CLO and equity interests.

The CMR distribution of Saratoga CLO investments at May 31, 2015 and February 28, 2015 was as follows:

Portfolio CMR distribution

 

     At May 31, 2015     At February 28, 2015  

Color Score

   Investments
at
Fair Value
     Percentage
of Total
Portfolio
    Investments
at
Fair Value
     Percentage
of Total
Portfolio
 
     ($ in thousands)  

Green

   $ 284,908         93.5   $ 278,769         94.4

Yellow

     16,166         5.3        12,875         4.4   

Red

     3,118         1.0        2,978         1.0   

N/A(1)

     491         0.2        617         0.2   
  

 

 

    

 

 

   

 

 

    

 

 

 

Total

   $ 304,683         100.0   $ 295,239         100.0
  

 

 

    

 

 

   

 

 

    

 

 

 

 

(1) Comprised of Saratoga CLO’s equity interests.

The CMR distribution of our investments at February 28, 2015 and February 28, 2014 was as follows:

Portfolio CMR distribution

 

     At February 28, 2015     At February 28, 2014  

Color

Score

   Investments
at
Fair Value
     Percentage
of Total
Portfolio
    Investments
at
Fair Value
     Percentage
of Total
Portfolio
 
     ($ in thousands)  

Green

   $ 191,606         79.7   $ 159,207         77.4

Yellow

     11,635         4.8        8,466         4.1   

Red

     101         0.0        8,270         4.0   

N/A(1)

     37,196         15.5        29,902         14.5   
  

 

 

    

 

 

   

 

 

    

 

 

 

Total

   $ 240,538         100.0   $ 205,845         100.0
  

 

 

    

 

 

   

 

 

    

 

 

 

 

(1) Comprised of our investment in the subordinated notes of Saratoga CLO and equity interests.

 

S-36


Table of Contents

The CMR distribution of Saratoga CLO investments at February 28, 2015 and February 28, 2014 was as follows:

Portfolio CMR distribution

 

     At February 28, 2015     At February 28, 2014  

Color

Score

   Investments
at
Fair Value
     Percentage
of Total
Portfolio
    Investments
at
Fair Value
     Percentage
of Total
Portfolio
 
     ($ in thousands)  

Green

   $ 278,769         94.4   $ 284,796         94.8

Yellow

     12,875         4.4        14,106         4.7   

Red

     2,978         1.0        1,589         0.5   

N/A(1)

     617         0.2        —           —     
  

 

 

    

 

 

   

 

 

    

 

 

 

Total

   $ 295,239         100.0   $ 300,491         100.0
  

 

 

    

 

 

   

 

 

    

 

 

 

 

(1) Comprised of Saratoga CLO’s equity interests.

Portfolio composition by industry grouping at fair value

The following table shows our portfolio composition by industry grouping at fair value at May 31, 2015 and February 28, 2015:

 

     At May 31, 2015     At February 28, 2015  
     Investments
at
Fair Value
     Percentage
of Total
Portfolio
    Investments
at
Fair Value
     Percentage
of Total
Portfolio
 
     ($ in thousands)  

Software as a Service

   $ 59,940         22.8   $ 50,362         20.9

Business Services

     52,494         20.0        52,128         21.7   

Consumer Services

     28,977         11.0        27,332         11.4   

Healthcare Services

     20,027         7.6        20,641         8.6   

Food and Beverage

     17,285         6.6        10,348         4.3   

Structured Finance (1)

     16,860         6.4        17,031         7.1   

Media

     15,494         5.9        15,026         6.2   

Metals

     15,262         5.8        15,262         6.3   

Automotive Aftermarket

     10,540         4.0        10,980         4.6   

Electronics

     6,576         2.5        6,667         2.8   

Publishing

     6,421         2.4        1,985         0.8   

Utilities

     5,955         2.3        5,955         2.5   

Building Products

     3,775         1.5        3,436         1.4   

Consumer Products

     3,035         1.2        3,284         1.4   

Education

     103         0.0        101         0.0   
  

 

 

    

 

 

   

 

 

    

 

 

 

Total

   $ 262,744         100.0   $ 240,538         100.0
  

 

 

    

 

 

   

 

 

    

 

 

 

 

(1) Comprised of our investment in the subordinated notes of Saratoga CLO.

 

S-37


Table of Contents

The following table shows Saratoga CLO’s portfolio composition by industry grouping at fair value at May 31, 2015 and February 28, 2015:

 

     At May 31, 2015     At February 28, 2015  
     Investments
at
Fair Value
     Percentage
of Total
Portfolio
    Investments
at
Fair Value
     Percentage
of Total
Portfolio
 
     ($ in thousands)  

Services: Business

   $ 42,819         14.1   $ 42,751         14.4

Healthcare & Pharmaceuticals

     34,030         11.1        35,341         12.0   

Chemicals/Plastics

     26,610         8.7        25,758         8.7   

Conglomerate

     21,103         6.9        19,928         6.7   

Retailers (Except Food and Drugs)

     20,873         6.9        22,026         7.4   

Financial Intermediaries

     16,026         5.3        10,806         3.7   

Industrial Equipment

     14,933         4.9        15,290         5.2   

Electronics/Electric

     12,448         4.1        12,904         4.4   

Leisure Goods/Activities/Movies

     11,587         3.8        12,629         4.3   

Telecommunications

     8,950         2.9        6,675         2.3   

Aerospace and Defense

     8,733         2.9        7,287         2.5   

Automotive

     6,651         2.2        6,650         2.2   

Utilities

     6,243         2.0        6,281         2.1   

Food Products

     5,866         1.9        5,856         2.0   

Lodging and Casinos

     5,702         1.9        5,826         2.0   

Oil & Gas

     5,699         1.9        6,070         2.1   

Publishing

     5,584         1.8        5,627         1.9   

Insurance

     5,415         1.8        5,425         1.8   

Food Services

     5,378         1.8        5,886         2.0   

Brokers/Dealers/Investment Houses

     4,866         1.6        4,832         1.6   

Containers/Glass Products

     4,320         1.4        4,313         1.5   

Drugs

     4,043         1.3        10,091         3.4   

Retail

     4,013         1.3        —           —     

Technology

     3,959         1.3        1,008         0.3   

Media

     3,500         1.1        2,004         0.7   

Food/Drug Retailers

     2,917         1.0        5,861         2.0   

Cable and Satellite Television

     2,632         0.9        2,646         0.9   

Telecommunications/Cellular

     2,425         0.8        2,431         0.8   

Consumer Goods: Durable

     2,114         0.7        —           —     

Nonferrous Metals/Minerals

     1,790         0.6        1,835         0.6   

Hotels, Gaming, and Leisure

     1,010         0.3        —           —     

Consumer Goods: Non-Durable

     995         0.3        —           —     

Services: Consumer

     502         0.2        —           —     

Broadcast Radio and Television

     445         0.1        467         0.2   

Environmental

     251         0.1        250         0.1   

Building and Development

     251         0.1        485         0.2   
  

 

 

    

 

 

   

 

 

    

 

 

 

Total

$ 304,683      100.0 $ 295,239      100.0
  

 

 

    

 

 

   

 

 

    

 

 

 

 

S-38


Table of Contents

The following table shows our portfolio composition by industry grouping at fair value at February 28, 2015 and February 28, 2014:

 

     At February 28, 2015     At February 28, 2014  
     Investments
at
Fair Value
     Percentage
of Total
Portfolio
    Investments
at
Fair Value
     Percentage
of Total
Portfolio
 
     ($ in thousands)  

Business Services

   $ 52,128         21.7   $ 57,330         27.9

Software

     50,362         20.9        21,738         10.5   

Consumer Services

     27,332         11.4        21,897         10.6   

Healthcare Services

     20,641         8.6        23,810         11.6   

Structured Finance(1)

     17,031         7.1        19,570         9.5   

Metals

     15,262         6.3        6,645         3.2   

Media

     15,026         6.2        —           —     

Automotive Aftermarket

     10,980         4.6        10,621         5.2   

Food and Beverage

     10,348         4.3        17,286         8.4   

Electronics

     6,667         2.8        6,741         3.3   

Utilities

     5,955         2.5        —           —     

Building Products

     3,436         1.4        901         0.4   

Consumer Products

     3,284         1.4        6,118         3.0   

Publishing

     1,985         0.8        1,191         0.6   

Education

     101         0.0        90         0.0   

Manufacturing

     —           —          5,970         2.9   

Environmental

     —           —          5,249         2.5   

Aerospace

     —           —          344         0.2   

Homebuilding

     —           —          344         0.2   
  

 

 

    

 

 

   

 

 

    

 

 

 

Total

$ 240,538      100.0 $ 205,845      100.0
  

 

 

    

 

 

   

 

 

    

 

 

 

 

(1) Comprised of our investment in the subordinated notes of Saratoga CLO.

The following table shows Saratoga CLO’s portfolio composition by industry grouping at fair value at February 28, 2015 and February 28, 2014:

 

     At February 28, 2015     At February 28, 2014  
     Investments
at
Fair Value
     Percentage
of Total
Portfolio
    Investments
at
Fair Value
     Percentage
of Total
Portfolio
 
     ($ in thousands)  

Business Equipment and Services

   $ 42,751         14.5   $ 28,386         9.4

Healthcare

     34,400         11.6        37,896         12.6   

Chemicals/Plastics

     25,758         8.7        26,345         8.8   

Retailers (Except Food and Drugs)

     22,026         7.4        15,314         5.1   

Conglomerate

     19,928         6.7        24,285         8.1   

Industrial Equipment

     15,290         5.2        24,143         8.0   

Electronics/Electric

     12,904         4.4        11,861         4.0   

Leisure Goods/Activities/Movies

     12,629         4.3        8,990         3.0   

Financial Intermediaries

     10,806         3.7        8,138         2.7   

Drugs

     10,091         3.4        11,873         4.0   

Aerospace and Defense

     7,287         2.5        20,465         6.8   

Telecommunications

     6,675         2.3        6,627         2.2   

Automotive

     6,650         2.2        10,279         3.4   

Utilities

   $ 6,281         2.1   $ 5,830         1.9

Oil & Gas

     6,070         2.1        2,488         0.8   

 

S-39


Table of Contents
     At February 28, 2015     At February 28, 2014  
     Investments
at
Fair Value
     Percentage
of Total
Portfolio
    Investments
at
Fair Value
     Percentage
of Total
Portfolio
 
     ($ in thousands)  

Food Services

     5,886         2.0        5,612         1.9   

Food/Drug Retailers

     5,861         2.0        5,012         1.7   

Food Products

     5,856         2.0        12,450         4.1   

Lodging and Casinos

     5,826         2.0        499         0.2   

Publishing

     5,627         1.9        2,913         1.0   

Insurance

     5,425         1.8        5,517         1.8   

Brokers/Dealers/Investment Houses

     4,832         1.6        3,740         1.2   

Containers/Glass Products

     4,313         1.5        2,906         1.0   

Cable and Satellite Television

     2,646         0.9        2,666         0.9   

Telecommunications/Cellular

     2,431         0.8        2,460         0.8   

Media

     2,004         0.7        1,000         0.3   

Nonferrous Metals/Minerals

     1,835         0.6        4,328         1.4   

Technology

     1,008         0.3        —           —     

Healthcare & Pharmaceuticals

     499         0.2        —           —     

Building and Development

     485         0.2        3,246         1.1   

Broadcast Radio and Television

     467         0.2        1,505         0.5   

Health Insurance

     442         0.1        —           —     

Environmental

     250         0.1        —           —     

Computers & Electronics

     —           —          1,479         0.5   

Ecological Services and Equipment

     —           —          1,241         0.4   

Gaming And Hotels

     —           —          500         0.2   

Leasing

     —           —          497         0.2   
  

 

 

    

 

 

   

 

 

    

 

 

 

Total

   $ 295,239         100.0   $ 300,491         100.0
  

 

 

    

 

 

   

 

 

    

 

 

 

Portfolio composition by geographic location at fair value

The following table shows our portfolio composition by geographic location at fair value at May 31, 2015 and February 28, 2015. The geographic composition is determined by the location of the corporate headquarters of the portfolio company.

 

     At May 31, 2015     At February 28, 2015  
     Investments
at
Fair Value
     Percentage
of Total
Portfolio
    Investments
at
Fair Value
     Percentage
of Total
Portfolio
 
     ($ in thousands)  

Southeast

   $ 116,223         44.2   $ 92,069         38.3

Midwest

     55,152         21.0        55,767         23.2   

West

     39,415         15.0        40,259         16.7   

Northeast

     34,094         13.0        34,412         14.3   

Other(1)

     16,860         6.4        17,031         7.1   

International

     1,000         0.4        1,000         0.4   
  

 

 

    

 

 

   

 

 

    

 

 

 

Total

   $ 262,744         100.0   $ 240,538         100.0
  

 

 

    

 

 

   

 

 

    

 

 

 

 

(1) Comprised of our investment in the subordinated notes of Saratoga CLO.

 

S-40


Table of Contents

The following table shows our portfolio composition by geographic location at fair value at February 28, 2015 and February 28, 2014. The geographic composition is determined by the location of the corporate headquarters of the portfolio company.

 

     At February 28, 2015     At February 28, 2014  
     Investments
at
Fair Value
     Percentage
of Total
Portfolio
    Investments
at
Fair Value
     Percentage
of Total
Portfolio
 
     ($ in thousands)  

Southeast

   $ 92,069         38.3   $ 83,161         40.4

Midwest

     55,767         23.2        41,453         20.1   

West

     40,259         16.7        44,470         21.6   

Northeast

     34,412         14.3        17,191         8.4   

Other(1)

     17,031         7.1        19,570         9.5   

International

     1,000         0.4        —           —     
  

 

 

    

 

 

   

 

 

    

 

 

 

Total

$ 240,538      100.0 $ 205,845      100.0
  

 

 

    

 

 

   

 

 

    

 

 

 

 

(1) Comprised of our investment in the subordinated notes of Saratoga CLO.

Results of operations

Operating results for the three months ended May 31, 2015 and May 31, 2014 are as follows:

 

     For the three months ended  
     May 31,
2015
     May 31,
2014
 
     ($ in thousands)  

Total investment income

   $ 7,561       $ 6,144   

Total expenses, net

     5,790         4,081   
  

 

 

    

 

 

 

Net investment income

  1,771      2,063   

Net realized gains

  73      82   

Net unrealized appreciation/(depreciation) on investments

  5,541      (385
  

 

 

    

 

 

 

Net increase in net assets resulting from operations

$ 7,385    $ 1,760   
  

 

 

    

 

 

 

Operating results for the fiscal years ended February 28, 2015, February 28, 2014 and February 28, 2013 are as follows:

 

     For the Year Ended  
     February 28, 2015      February 28, 2014      February 28, 2013  
     ($ in thousands)  

Total investment income

   $ 27,375       $ 22,893       $ 17,007   

Total expenses, net

     17,701         14,019         10,537   
  

 

 

    

 

 

    

 

 

 

Net investment income

  9,674      8,874      6,470   

Net realized gains

  3,276      1,271      431   

Net unrealized gains (losses)

  (1,943   (1,648   7,143   
  

 

 

    

 

 

    

 

 

 

Net increase in net assets resulting from operations

$ 11,007    $ 8,497    $ 14,044   
  

 

 

    

 

 

    

 

 

 

As described in Note 2 to the consolidated financial statements and notes thereto, we identified errors that impacted the years ended February 28, 2014, February 28, 2013, February 29, 2012 and February 28, 2011. The corrections for the errors, which we have concluded are immaterial to all prior period consolidated financial statements, are reflected in the consolidated financial statements and selected financial data included in this Form 10-K.

 

S-41


Table of Contents

Investment income

The composition of our investment income for the three months ended May 31, 2015 and May 31, 2014 are as follows:

 

     For the three months ended  
     May 31,
2015
     May 31,
2014
 
     ($ in thousands)  

Interest from investments

   $ 6,931       $ 5,602   

Management fees from Saratoga CLO

     379         392   

Interest from cash and cash equivalents and other income

     251         150   
  

 

 

    

 

 

 

Total

   $ 7,561       $ 6,144   
  

 

 

    

 

 

 

For the three months ended May 31, 2015, total investment income increased $1.4 million, or 23.1% compared to the three months ended May 31, 2014. Interest income from investments increased $1.3 million, or 23.7%, to $6.9 million for the three months ended May 31, 2015 from $5.6 million for the three months ended May 31, 2014. This reflects an increase of 20.1% in total investments to $262.7 million at May 31, 2015 from $218.7 million at May 31, 2014, despite the weighted average current coupon reducing from 12.9% to 11.9%.

For the three months ended May 31, 2015 and May 31, 2014, total PIK income was $0.7 million and $0.3 million, respectively.

The Saratoga CLO was refinanced in October 2013. As a result, proceeds from principal payments in the loan portfolio of Saratoga CLO must now be used to paydown its outstanding notes. The management fee income and investment income that we receive from Saratoga CLO has remained relatively unchanged at $0.4 million for the three months ended May 31, 2015 and 2014.

The composition of our investment income for the fiscal years ended February 28, 2015, February 28, 2014 and February 28, 2013 are as follows:

 

     February 28, 2015      February 28, 2014      February 28, 2013  
     ($ in thousands)  

Interest from investments

   $ 24,684       $ 20,179       $ 14,444   

Management fees from Saratoga CLO

     1,520         1,775         2,000   

Interest from cash and cash equivalents and other income

     1,171         939         563   
  

 

 

    

 

 

    

 

 

 

Total

   $ 27,375       $ 22,893       $ 17,007   
  

 

 

    

 

 

    

 

 

 

For the fiscal year ended February 28, 2015, total investment income increased $4.5 million, or 19.6% compared to the fiscal year ended February 28, 2014. Interest income from investments increased $4.5 million, or 22.3%, to $24.7 million for the year ended February 28, 2015 from $20.2 million for the fiscal year ended February 28, 2014. This reflects an increase of 16.9% in total investments to $240.5 million at February 28, 2015 from $205.8 million at February 28, 2014, despite the weighted average current coupon reducing from 12.5% to 12.0%.

For the fiscal year ended February 28, 2014, total investment income increased $5.9 million, or 34.6% compared to the fiscal year ended February 28, 2013. Interest income from investments increased $5.7 million, or 39.7%, to $20.2 million for the year ended February 28, 2014 from $14.4 million for the fiscal year ended February 28, 2013. This reflects an increase of 32.7% in total investments to $205.8 million at February 28, 2014 from $155.1 million at February 28, 2013, while the weighted average current coupon remained relatively unchanged at 12.5%.

 

S-42


Table of Contents

For the fiscal years ended February 28, 2015, February 28, 2014, and February 28, 2013, total PIK income was $1.2 million, $0.9 million, and $1.1 million, respectively.

The Saratoga CLO was refinanced in October 2013. As a result, proceeds from principal payments in the loan portfolio of Saratoga CLO must now be used to paydown its outstanding notes. Thus, the management fee income and investment income that we receive from Saratoga CLO has declined from historical periods, decreasing $0.3 million or 14.3% to $1.5 million and $0.2 million or 10%, to $1.8 million, for the years ended February 28, 2015 and 2014, respectively.

Operating expenses

The composition of our operating expenses for the three months ended May 31, 2015 and May 31, 2014 are as follows:

 

     For the three months ended  
     May 31,
2015
     May 31,
2014
 
     ($ in thousands)  

Interest and debt financing expense

   $ 1,964       $ 1,787   

Base management fees

     1,124         969   

Professional fees

     333         435   

Incentive management fees

     1,798         378   

Administrator expenses

     250         250   

Insurance

     87         85   

Directors fees and expenses

     51         53   

General & administrative

     183         124   
  

 

 

    

 

 

 

Total expenses

$ 5,790    $ 4,081   
  

 

 

    

 

 

 

For the three months ended May 31, 2015, total operating expenses increased $1.7 million, or 41.9% compared to the three months ended May 31, 2014.

For the three months ended May 31, 2015 and May 31, 2014, the increase in interest and credit facility expense is primarily attributable to an increase in outstanding debt as compared to the prior years, with increased levels of both the SBA debentures and the revolving credit facility outstanding. The credit facility increased from $4.7 million at May 31, 2014 to $11.8 million at May 31, 2015, while our SBA debentures increased from $64.0 million to $79.0 million for these same periods. For the three months ended May 31, 2015, the weighted average interest rate on our outstanding indebtedness was 4.94% compared to 5.27% for the three months ended May 31, 2014. This decrease was primarily driven by an increase in SBA debentures that carry a lower interest rate but now make up a higher proportion of our overall debt, increasing from 54.7% of overall debt as of May 31, 2014 to 56.8% as of May 31, 2015.

For the three months ended May 31, 2015, base management fees increased $0.2 million, or 16.1% compared to the three months ended May 31, 2014. The increase in base management fees results from the increase in the average value of our total assets, less cash and cash equivalents, from $219.6 million to $254.8 million as of May 31, 2014 and May 31, 2015, respectively.

For the three months ended May 31, 2015, professional fees decreased $0.1 million, or 23.4% compared to the three months ended May 31, 2014.

For the three months ended May 31, 2015, incentive management fees increased $1.4 million, or 375.0% compared to the three months ended May 31, 2014. These increased fees reflect two factors, being (i) an increase in accrued incentive fees this year, as higher total assets has led to increased net investment income above the

 

S-43


Table of Contents

hurdle rate pursuant to the investment advisory and management agreement, and (ii) an increased second part of the incentive fees of $1.1 million, related primarily to the redemption of one of our investments in which we held both debt and equity, resulting in an unrealized gain of $4.2 million for the three months ended May 31, 2015.

As discussed above, the increase in interest and credit facility expense for three months ended May 31, 2015 and May 31, 2014 is primarily attributable to an increase in the amount of outstanding debt as compared to the prior periods. For the three months ended May 31, 2015 and May 31, 2014, the weighted average interest rate on the outstanding borrowings under the Credit Facility for three months ended May 31, 2015 and May 31, 2014 was 6.00% and 7.50%, respectively. For three months ended May 31, 2015 and May 31, 2014, the weighted average interest rate on the outstanding borrowings of the SBA debentures was 3.25% and 3.06%, respectively.

For the year ended February 28, 2015, incentive management fees increased $1.6 million, or 171.4% compared to the fiscal year ended February 28, 2014. The increase in incentive management fees is primarily attributable to an increase in accrued incentive fees this year, as higher total assets has led to increased net investment income above the hurdle rate pursuant to the investment advisory and management agreement. In addition, for the year ended February 28, 2015, the incentive management fees related to capital gains changed from a $0.07 million reduction of expense to a $0.3 million increase in expense compared to the fiscal year ended February 28, 2014. For the year ended February 28, 2014, incentive management fees decreased $1.7 million, or 63.9% compared to the fiscal year ended February 28, 2013. The decrease in incentive management fees is primarily attributable to the second part of the incentive fee accrual related to capital losses, with the year ending February 28, 2013 being an accrual of $1.6 million as compared to the year ending February 28, 2014 being a reversal of the accrual of $0.1 million.

As discussed above, the increase in interest and credit facility expense for the years ended February 28, 2015, February 28, 2014 and February 28, 2013 is primarily attributable to an increase in the amount of outstanding debt as compared to the prior periods. For the years ended February 28, 2015, February 28, 2014 and February 28, 2013, the weighted average interest rate on the outstanding borrowings under the Credit Facility for the years ended February 28, 2015, February 28, 2014 and February 28, 2013 was 6.75%, 7.50% and 7.50%, respectively. For the years ended February 28, 2015, February 28, 2014, and February 28, 2013, the weighted average interest rate on the outstanding borrowings of the SBA debentures was 2.93%, 3.03% and 1.42%, respectively.

Net realized gains/losses on sales of investments

For the three months ended May 31, 2015, the Company had $7.3 million of sales, repayments, exits or restructurings resulting in $0.1 million of net realized gains. The most significant realized gains and losses during the three months ended May 31, 2015 were as follows:

Three Months ended May 31, 2015

 

Issuer

  

Asset Type

   Gross
Proceeds
     Cost      Net
Realized
Gain/
(Loss)
 
          ($ in thousands)  

PrePaid Legal Services, Inc

   First Lien Term Loan      2,091         2,065         26   

Expedited Travel, LLC

   First Lien Term Loan      732         722         10   

For the three months ended May 31, 2014, the Company had $8.7 million of sales, repayments, exits or restructurings resulting in $0.1 million of net realized gains. There were no significant realized gains and losses during the three months ended May 31, 2014.

 

S-44


Table of Contents

For the fiscal year ended February 28, 2015, the Company had $73.3 million of sales, repayments, exits or restructurings resulting in $3.3 million of net realized gains. The most significant realized gains and losses during the year ended February 28, 2015 were as follows:

Fiscal year ended February 28, 2015

 

Issuer

   Asset Type    Gross
Proceeds
     Cost      Net Realized
Gain/(Loss)
 
          ($ in thousands)  

Community Investors, Inc.

   Term Loan A Senior Fac    $ 6,983       $ 6,886       $ 97   

HOA Restaurant GP/Finance

   Senior Secured Notes      4,225         3,938         287   

USS Parent Holding Corp

   Non Voting Common Stock      248         133         115   

USS Parent Holding Corp

   Voting Common Stock      5,650         3,026         2,624   

For the fiscal year ended February 28, 2014, the Company had $71.6 million of sales, repayments, exits or restructurings resulting in $1.3 million of net realized gains. The most significant realized gains and losses during the year ended February 28, 2014 were as follows:

Fiscal year ended February 28, 2014

 

Issuer

   Asset Type    Gross
Proceeds
     Cost      Net Realized
Gain/(Loss)
 
          ($ in thousands)  

Penton Media, Inc.

   First Lien Term Loan    $ 4,887       $ 4,679       $ 208   

Sourcehov, LLC

   Second Lien Term Loan      3,030         2,659         371   

Worldwide Express Operations, LLC

   Warrants      128         —           128   

For the fiscal year ended February 28, 2013, the Company had $21.5 million of sales, repayments, exits or restructurings resulting in $0.6 million of net realized gains. The most significant realized gains and losses during the year ended February 28, 2013 were as follows:

Fiscal year ended February 28, 2013

 

Issuer

   Asset Type    Gross
Proceeds
     Cost      Net Realized
Gain/(Loss)
 
          ($ in thousands)  

Grant US Holdings LLP

   Second Lien Term Loan    $ 183       $ —         $ 183   

Energy Alloys LLC

   Warrants      146         —           146   

 

S-45


Table of Contents

Net unrealized appreciation/depreciation on investments

For the three months ended May 31, 2015, our investments had net unrealized appreciation of $5.5 million versus net unrealized depreciation of $0.4 million for the three months ended May 31, 2014. The most significant cumulative changes in unrealized appreciation and depreciation for the three months ended May 31, 2015, were the following:

Three Months ended May 31, 2015

 

Issuer

  

Asset Type

   Cost      Fair
Value
     Total
Unrealized
Appreciation/
(Depreciation)
    YTD Change
in Unrealized
Appreciation/
(Depreciation)
 
          ($ in thousands)  

Saratoga CLO

   Other/Structured Finance Securities      15,173         16,860         1,687        609   

Network Communications, Inc.

   Common Stock      —           3,206         3,206        2,906   

Network Communications, Inc.

   Unsecured Notes      2,868         3,214         346        1,297   

Smile Brands Group, Inc.

   First Lien Term Loan      4,366         3,745         (621     (406

The $2.9 million and $1.3 million of unrealized appreciation in our investments in Network Communications, Inc. is due to the sale of the company to a third party and reflects the realization value pursuant to that transaction.

The $0.6 million unrealized appreciation in our investment in the Saratoga CLO was primarily due to a decline in the discount rate based on prevailing market conditions.

The most significant cumulative changes in unrealized appreciation and depreciation for the three months ended May 31, 2014, were the following:

Three Months ended May 31, 2014

 

Issuer

 

Asset Type

  Cost     Fair
Value
    Total
Unrealized
Appreciation/
(Depreciation)
    YTD Change
in Unrealized
Appreciation/
(Depreciation)
 
        ($ in thousands)  

Saratoga CLO

  Other/Structured Finance Securities   $ 16,556      $ 20,119      $ 3,563      $ 549   

Elyria Foundry Company, LLC

  First Lien Term Loan     8,860        5,721        (3,139     (923

USS Parent Holding Corp.

  Voting Common Stock     3,026        4,510        1,484        (518

The $0.5 million of unrealized appreciation in our investment in the Saratoga CLO subordinated notes was due to decline in the discount rate for CLO equity securities from fiscal year end.

The $0.9 million of unrealized depreciation in our investment in Elyria Foundry Company, LLC was due to a decline in oil and gas end markets from fiscal year end.

The $0.5 million of unrealized depreciation in our investment in the common stock of USS Parent Holding Corp. was due to a decline in the EBITDA multiple from fiscal year end used to determined equity value.

 

S-46


Table of Contents

For the year ended February 28, 2015, our investments had net unrealized depreciation of $1.9 million versus net unrealized depreciation of $1.6 million for the year ended February 28, 2014. The most significant cumulative changes in unrealized appreciation and depreciation for the year ended February 28, 2015, were the following:

Fiscal year ended February 28, 2015

 

Issuer

   Asset Type    Cost      Fair
Value
     Total
Unrealized
Appreciation/
(Depreciation)
    YTD Change
in Unrealized
Appreciation/
(Depreciation)
 
          ($ in thousands)  

Legacy Cabinets, Inc.

   Common—Voting A-1      221         1,493         1,272        941   

Targus Holdings, Inc.

   Common      567         —           (567     (730

Saratoga CLO

   Other/Structured Finance Securities      15,953         17,031         1,078        (1,935

The $0.9 million of unrealized appreciation in our investment in Legacy Cabinets, Inc. was driven by significant fundamental growth, which increased the fair market value of the equity.

The $0.7 million of unrealized depreciation in our investment in Targus Holdings, Inc. was due to a decline in earnings resulting from weakened demand in the company’s end markets.

The $1.9 million unrealized depreciation in our investment in the Saratoga CLO was primarily due to a higher discount rate based on prevailing market conditions.

For the year ended February 28, 2014, our investments had a decrease in net unrealized depreciation of $1.6 million versus an increase in net unrealized appreciation of $7.0 million for the year ended February 28, 2013. The most significant cumulative changes in unrealized appreciation and depreciation for the year ended February 28, 2014, were the following:

Fiscal year ended February 28, 2014

 

Issuer

  Asset Type   Cost     Fair
Value
    Total
Unrealized
Appreciation/
(Depreciation)
    YTD Change
in Unrealized
Appreciation/
(Depreciation)
 
        ($ in thousands)  

Saratoga CLO

  Other/Structured Finance
Securities
  $ 16,556      $ 19,570      $ 3,014      $ (3,558

Targus Holdings, Inc.

  Common Stock     567        730        163        (2,595

USS Parent Holding Corp.

  Voting Common Stock     3,026        5,028        2,002        2,162   

Group Dekko, Inc.

  Second Lien Term Loan     6,902        6,741        (161     (56

Elyria Foundry Company, LLC

  Senior Secured Notes     8,860        6,645        (2,215     (2,215

 

S-47


Table of Contents

For the year ended February 28, 2013, our investments had an increase in net unrealized appreciation of $7.0 million versus an increase in net unrealized appreciation of $19.8 million for the year ended February 29, 2012. The most significant cumulative changes in unrealized appreciation and depreciation for the year ended February 28, 2013, were the following:

Fiscal year ended February 28, 2013

 

Issuer

  Asset Type   Cost     Fair
Value
    Total
Unrealized
Appreciation/
(Depreciation)
    YTD Change
in Unrealized
Appreciation/
(Depreciation)
 
        ($ in thousands)  

Saratoga CLO

  Other/Structured Finance
Securities
  $ 18,945      $ 25,517      $ 6,572      $ 4,266   

Targus Holdings, Inc.

  Common Stock     567        3,325        2,758        649   

USS Parent Holding Corp.

  Voting Common Stock     3,026        2,866        (160     641   

Group Dekko, Inc.

  Second Lien Term Loan     6,825        6,721        (104     464   

Worldwide Express Operations, LLC

  First Lien Term Loan     6,461        6,504        43        352   

Penton Media, Inc.

  First Lien Term Loan     4,497        4,670        173        798   

The $4.3 million net unrealized appreciation in our investment in the Saratoga CLO subordinated notes was due to higher cash flow projections based on an increase in principal balance and an improvement in the overcollateralization ratios, a decrease in the assumed portfolio default rate (based on better than forecast actual default rates and improved default forecasts) and an improvement in reinvestment assumptions based on current market conditions and projections.

Changes in net assets resulting from operations

For the three months ended May 31, 2015 and May 31, 2014, we recorded a net increase in net assets resulting from operations of $7.4 million and $1.8 million, respectively. Based on 5,422,491 weighted average common shares outstanding as of May 31, 2015, our per share net increase in net assets resulting from operations was $1.36 for the three months ended May 31, 2015. Based on 5,379,616 weighted average common shares outstanding as of May 31, 2014, our per share net increase in net assets resulting from operations was $0.33 for the three months ended May 31, 2014.

For the fiscal years ended February 28, 2015, February 28, 2014 and February 28, 2013 we recorded a net increase in net assets resulting from operations of $11.0 million, $8.5 million and $14.0 million, respectively. Based on 5,385,049 weighted average common shares outstanding as of February 28, 2015, our per share net increase in net assets resulting from operations was $2.04 for the fiscal year ended February 28, 2015. This compares to a per share net increase in net assets resulting from operations of $1.73 for the fiscal year ended February 28, 2014 (based on 4,920,517 weighted average common shares outstanding as of February 28, 2014), and a per share net increase in net assets resulting from operations of $3.42 for the fiscal year ended February 28, 2013 (based on 4,110,484 weighted average common shares outstanding as of February 28, 2013).

FINANCIAL CONDITION, LIQUIDITY AND CAPITAL RESOURCES

We intend to continue to generate cash primarily from cash flows from operations, including interest earned from our investments in debt in middle market companies, interest earned from the temporary investment of cash in U.S. government securities and other high-quality debt investments that mature in one year or less, future borrowings and future offerings of securities.

Although we expect to fund the growth of our investment portfolio through the net proceeds from SBA debenture drawdowns and future equity offerings, including our dividend reinvestment plan, and issuances of

 

S-48


Table of Contents

senior securities or future borrowings, to the extent permitted by the 1940 Act, we cannot assure you that our plans to raise capital will be successful. In this regard, because our common stock has historically traded at a price below our current net asset value per share and we are limited in our ability to sell our common stock at a price below net asset value per share, we have been and may continue to be limited in our ability to raise equity capital. Our stockholders approved a proposal at our annual meeting of stockholders held on September 30, 2014 that authorizes us to sell shares of our common stock at an offering price per share to investors that is not less than 85% of our then current net asset value per share in one or more offerings for a period ending on the earlier of September 30, 2015 or the date of our next annual meeting of stockholders. We would need stockholder approval of a similar proposal to issue shares below net asset value per share at any time after the earlier of September 30, 2015 or our next annual meeting of stockholders.

In addition, we intend to distribute to our stockholders substantially all of our taxable income in order to satisfy the distribution requirement applicable to RICs under Subchapter M of the Code. In satisfying this distribution requirement, we have in the past relied on IRS issued private letter rulings concluding that a RIC may treat a distribution of its own stock as fulfilling its RIC distribution requirements if each stockholder may elect to receive his or her entire distribution in either cash or stock of the RIC subject to a limitation on the aggregate amount of cash to be distributed to all stockholders, which limitation must be at least 20% of the aggregate declared distribution. We may rely on these IRS private letter rulings in future periods to satisfy our RIC distribution requirement.

Also, as a BDC, we generally are required to meet a coverage ratio of total assets, less liabilities and indebtedness not represented by senior securities, to total senior securities, which include all of our borrowings and any outstanding preferred stock, of at least 200%. This requirement limits the amount that we may borrow. Our asset coverage ratio, as defined in the 1940 Act, was 313.8% as of May 31, 2015, 321.1% as of February 28, 2015 and 348.2% as of February 28, 2014. To fund growth in our investment portfolio in the future, we anticipate needing to raise additional capital from various sources, including the equity markets and other debt-related markets, which may or may not be available on favorable terms, if at all.

Consequently, we may not have the funds or the ability to fund new investments, to make additional investments in our portfolio companies, to fund our unfunded commitments to portfolio companies or to repay borrowings. Also, the illiquidity of our portfolio investments may make it difficult for us to sell these investments when desired and, if we are required to sell these investments, we may realize significantly less than their recorded value.

Madison revolving credit facility

Below is a summary of the terms of the senior secured revolving credit facility we entered into with Madison Capital Funding (the “Credit Facility”) on June 30, 2010.

Availability. The Company can draw up to the lesser of (i) $40.0 million (the “Facility Amount”) and (ii) the product of the applicable advance rate (which varies from 50.0% to 75.0% depending on the type of loan asset) and the value, determined in accordance with the Credit Facility (the “Adjusted Borrowing Value”), of certain “eligible” loan assets pledged as security for the loan (the “Borrowing Base”), in each case less (a) the amount of any undrawn funding commitments the Company has under any loan asset and which are not covered by amounts in the Unfunded Exposure Account referred to below (the “Unfunded Exposure Amount”) and (b) outstanding borrowings. Each loan asset held by the Company as of the date on which the Credit Facility was closed was valued as of that date and each loan asset that the Company acquires after such date will be valued at the lowest of its fair value, its face value (excluding accrued interest) and the purchase price paid for such loan asset. Adjustments to the value of a loan asset will be made to reflect, among other things, changes in its fair value, a default by the obligor on the loan asset, insolvency of the obligor, acceleration of the loan asset, and certain modifications to the terms of the loan asset.

 

S-49


Table of Contents

The Credit Facility contains limitations on the type of loan assets that are “eligible” to be included in the Borrowing Base and as to the concentration level of certain categories of loan assets in the Borrowing Base such as restrictions on geographic and industry concentrations, asset size and quality, payment frequency, status and terms, average life, and collateral interests. In addition, if an asset is to remain an “eligible” loan asset, the Company may not make changes to the payment, amortization, collateral and certain other terms of the loan assets without the consent of the administrative agent that will either result in subordination of the loan asset or be materially adverse to the lenders.

Collateral. The Credit Facility is secured by substantially all of the assets of the Company (other than assets held by our SBIC subsidiary) and includes the subordinated notes (“CLO Notes”) issued by Saratoga CLO and the Company’s rights under the CLO Management Agreement (as defined below).

Interest Rate and Fees. Under the Credit Facility, funds are borrowed from or through certain lenders at the greater of the prevailing LIBOR rate and 2.00%, plus an applicable margin of 5.50%. At the Company’s option, funds may be borrowed based on an alternative base rate, which in no event will be less than 3.00%, and the applicable margin over such alternative base rate is 4.50%. In addition, the Company pays the lenders a commitment fee of 0.75% per year on the unused amount of the Credit Facility for the duration of the Revolving Period (defined below). Accrued interest and commitment fees are payable monthly. The Company was also obligated to pay certain other fees to the lenders in connection with the closing of the Credit Facility.

Revolving Period and Maturity Date. The Company may make and repay borrowings under the Credit Facility for a period of three years following the closing of the Credit Facility (the “Revolving Period”). The Revolving Period may be terminated at an earlier time by the Company or, upon the occurrence of an event of default, by action of the lenders or automatically. All borrowings and other amounts payable under the Credit Facility are due and payable in full five years after the end of the Revolving Period.

Collateral Tests. It is a condition precedent to any borrowing under the Credit Facility that the principal amount outstanding under the Credit Facility, after giving effect to the proposed borrowings, not exceed the lesser of the Borrowing Base or the Facility Amount (the “Borrowing Base Test”). In addition to satisfying the Borrowing Base Test, the following tests must also be satisfied (together with Borrowing Base Test, the “Collateral Tests”):

 

    Interest Coverage Ratio. The ratio (expressed as a percentage) of interest collections with respect to pledged loan assets, less certain fees and expenses relating to the Credit Facility, to accrued interest and commitment fees and any breakage costs payable to the lenders under the Credit Facility for the last 6 payment periods must equal at least 175.0%.

 

    Overcollateralization Ratio. The ratio (expressed as a percentage) of the aggregate Adjusted Borrowing Value of “eligible” pledged loan assets plus the fair value of certain ineligible pledged loan assets and the CLO Notes (in each case, subject to certain adjustments) to outstanding borrowings under the Credit Facility plus the Unfunded Exposure Amount must equal at least 200.0%.

 

    Weighted Average FMV Test. The aggregate adjusted or weighted value of “eligible” pledged loan assets as a percentage of the aggregate outstanding principal balance of “eligible” pledged loan assets must be equal to or greater than 72.0% and 80.0% during the one-year periods prior to the first and second anniversary of the closing date, respectively, and 85.0% at all times thereafter.

The Credit Facility also requires payment of outstanding borrowings or replacement of pledged loan assets upon the Company’s breach of its representation and warranty that pledged loan assets included in the Borrowing Base are “eligible” loan assets. Such payments or replacements must equal the lower of the amount by which the Borrowing Base is overstated as a result of such breach or any deficiency under the Collateral Tests at the time of repayment or replacement. Compliance with the Collateral Tests is also a condition to the discretionary sale of pledged loan assets by the Company.

 

S-50


Table of Contents

Priority of Payments. During the Revolving Period, the priority of payments provisions of the Credit Facility require, after payment of specified fees and expenses and any necessary funding of the Unfunded Exposure Account, that collections of principal from the loan assets and, to the extent that these are insufficient, collections of interest from the loan assets, be applied on each payment date to payment of outstanding borrowings if the Borrowing Base Test, the Overcollateralization Ratio and the Interest Coverage Ratio would not otherwise be met. Similarly, following termination of the Revolving Period, collections of interest are required to be applied, after payment of certain fees and expenses, to cure any deficiencies in the Borrowing Base Test, the Interest Coverage Ratio and the Overcollateralization Ratio as of the relevant payment date.

Reserve Account. The Credit Facility requires the Company to set aside an amount equal to the sum of accrued interest, commitment fees and administrative agent fees due and payable on the next succeeding three payment dates (or corresponding to three payment periods). If for any monthly period during which fees and other payments accrue, the aggregate Adjusted Borrowing Value of “eligible” pledged loan assets which do not pay cash interest at least quarterly exceeds 15.0% of the aggregate Adjusted Borrowing Value of “eligible” pledged loan assets, the Company is required to set aside such interest and fees due and payable on the next succeeding six payment dates. Amounts in the reserve account can be applied solely to the payment of administrative agent fees, commitment fees, accrued and unpaid interest and any breakage costs payable to the lenders.

Unfunded Exposure Account. With respect to revolver or delayed draw loan assets, the Company is required to set aside in a designated account (the “Unfunded Exposure Account”) 100.0% of its outstanding and undrawn funding commitments with respect to such loan assets. The Unfunded Exposure Account is funded at the time the Company acquires a revolver or delayed draw loan asset and requests a related borrowing under the Credit Facility. The Unfunded Exposure Account is funded through a combination of proceeds of the requested borrowing and other Company funds, and if for any reason such amounts are insufficient, through application of the priority of payment provisions described above.

Operating Expenses. The priority of payments provision of the Credit Facility provides for the payment of certain operating expenses of the Company out of collections on principal and interest during the Revolving Period and out of collections on interest following the termination of the Revolving Period in accordance with the priority established in such provision. The operating expenses payable pursuant to the priority of payment provisions is limited to $350,000 for each monthly payment date or $2.5 million for the immediately preceding period of twelve consecutive monthly payment dates. This ceiling can be increased by the lesser of 5.0% or the percentage increase in the fair market value of all the Company’s assets only on the first monthly payment date to occur after each one-year anniversary following the closing of the Credit Facility. Upon the occurrence of a Manager Event (described below), the consent of the administrative agent is required in order to pay operating expenses through the priority of payments provision.

Events of Default. The Credit Facility contains certain negative covenants, customary representations and warranties and affirmative covenants and events of default. The Credit Facility does not contain grace periods for breach by the Company of certain covenants, including, without limitation, preservation of existence, negative pledge, change of name or jurisdiction and separate legal entity status of the Company covenants and certain other customary covenants. Other events of default under the Credit Facility include, among other things, the following:

 

    an Interest Coverage Ratio of less than 150.0%;

 

    an Overcollateralization Ratio of less than 175.0%;

 

    the filing of certain ERISA or tax liens;

 

    the occurrence of certain “Manager Events” such as:

 

    failure by Saratoga Investment Advisors and its affiliates to maintain collectively, directly or indirectly, a cash equity investment in the Company in an amount equal to at least $5,000,000 at any time prior to the third anniversary of the closing date;

 

S-51


Table of Contents
    failure of the Management Agreement between Saratoga Investment Advisors and the Company to be in full force and effect;

 

    indictment or conviction of Saratoga Investment Advisors or any “key person” for a felony offense, or any fraud, embezzlement or misappropriation of funds by Saratoga Investment Advisors or any “key person” and, in the case of “key persons,” without a reputable, experienced individual reasonably satisfactory to Madison Capital Funding appointed to replace such key person within 30 days;

 

    resignation, termination, disability or death of a “key person” or failure of any “key person” to provide active participation in Saratoga Investment Advisors’ daily activities, all without a reputable, experienced individual reasonably satisfactory to Madison Capital Funding appointed within 30 days; or

 

    occurrence of any event constituting “cause” under the Collateral Management Agreement between the Company and Saratoga CLO (the “CLO Management Agreement”), delivery of a notice under Section 12(c) of the CLO Management Agreement with respect to the removal of the Company as collateral manager or the Company ceases to act as collateral manager under the CLO Management Agreement.

Conditions to Acquisitions and Pledges of Loan Assets. The Credit Facility imposes certain additional conditions to the acquisition and pledge of additional loan assets. Among other things, the Company may not acquire additional loan assets without the prior written consent of the administrative agent until such time that the administrative agent indicates in writing its satisfaction with Saratoga Investment Advisors’ policies, personnel and processes relating to the loan assets.

Fees and Expenses. The Company paid certain fees and reimbursed Madison Capital Funding for the aggregate amount of all documented, out-of-pocket costs and expenses, including the reasonable fees and expenses of lawyers, incurred by Madison Capital Funding in connection with the Credit Facility and the carrying out of any and all acts contemplated thereunder up to and as of the date of closing of the stock purchase transaction with Saratoga Investment Advisors and certain of its affiliates. These amounts totaled $2.0 million.

On February 24, 2012, we amended our senior secured revolving credit facility with Madison Capital Funding LLC to, among other things:

 

    expand the borrowing capacity under the credit facility from $40.0 million to $45.0 million;

 

    extend the Revolving Period from July 30, 2013 to February 24, 2015; and

 

    remove the condition that we may not acquire additional loan assets without the prior written consent of the administrative agent.

On September 17, 2014, we entered into a second amendment to the Revolving Facility with Madison Capital Funding LLC to, among other things:

 

    extend the commitment termination date from February 24, 2015 to September 17, 2017;

 

    extend the maturity date of the Revolving Facility from February 24, 2020 to September 17, 2022 (unless terminated sooner upon certain events);

 

    reduce the applicable margin rate on base rate borrowings from 4.50% to 3.75%, and on LIBOR borrowings from 5.50% to 4.75%; and

 

    reduce the floor on base rate borrowings from 3.00% to 2.25%; and on LIBOR borrowings from 2.00% to 1.25%.

As of May 31, 2015, we had $11.8 million outstanding under the Credit Facility and $79.0 million SBA-guaranteed debentures outstanding (which are discussed below). As of February 28, 2015, we had $9.6 million

 

S-52


Table of Contents

outstanding under the Credit Facility and $79.0 million SBA-guaranteed debentures outstanding. Our borrowing base under the Credit Facility at May 31, 2015 and February 28, 2015 was $35.5 million and $36.3 million, respectively.

Our asset coverage ratio, as defined in the 1940 Act, was 313.8% as of May 31, 2015 and 321.1% as of February 28, 2015.

As of February 28, 2015, we had $9.6 million outstanding under the Credit Facility and $79.0 million SBA-guaranteed debentures outstanding (which are discussed below). As of February 28, 2014, we had no outstanding balance under the Credit Facility and $50.0 million SBA-guaranteed debentures outstanding. Our borrowing base under the Credit Facility at February 28, 2015 and February 28, 2014 was $36.3 million and $44.6 million, respectively.

Our asset coverage ratio, as defined in the 1940 Act, was 321.1% and 348.2% for the years ended February 28, 2015 and February 28, 2014, respectively.

SBA-guaranteed debentures

In addition, we, through a wholly-owned subsidiary, sought and obtained a license from the SBA to operate an SBIC. In this regard, on March 28, 2012, our wholly-owned subsidiary, Saratoga Investment Corp. SBIC, LP, received a license from the SBA to operate as an SBIC under Section 301(c) of the Small Business Investment Act of 1958. SBICs are designated to stimulate the flow of private equity capital to eligible small businesses. Under SBA regulations, SBICs may make loans to eligible small businesses and invest in the equity securities of small businesses.

The SBIC license allows our SBIC subsidiary to obtain leverage by issuing SBA-guaranteed debentures. SBA-guaranteed debentures are non-recourse, interest only debentures with interest payable semi-annually and have a ten year maturity. The principal amount of SBA-guaranteed debentures is not required to be paid prior to maturity but may be prepaid at any time without penalty. The interest rate of SBA-guaranteed debentures is fixed on a semi-annual basis at a market-driven spread over U.S. Treasury Notes with 10-year maturities.

SBA regulations currently limit the amount that our SBIC subsidiary may borrow to a maximum of $150 million when it has at least $75 million in regulatory capital, receives a capital commitment from the SBA and has been through an examination by the SBA subsequent to licensing. As of February 28, 2015, our SBIC subsidiary had $59.3 million in regulatory capital and $79.0 million SBA-guaranteed debentures outstanding.

We received exemptive relief from the Securities and Exchange Commission to permit us to exclude the debt of our SBIC subsidiary guaranteed by the SBA from the definition of senior securities in the 200% asset coverage test under the 1940 Act. This allows us increased flexibility under the 200% asset coverage test by permitting us to borrow up to $150 million more than we would otherwise be able to absent the receipt of this exemptive relief.

On April 3, 2015, the SBA issued a “green light” or “go forth” letter inviting us to continue our application process to obtain a license to form and operate a second SBIC subsidiary. If approved, a second SBIC license would provide us an incremental source of long-term capital by permitting us to issue $75 million of additional SBA-guaranteed debentures in addition to the $150 million already approved under the first license. Receipt of a green light letter from the SBA does not assure an applicant that the SBA will ultimately issue an SBIC license and we have received no assurance or indication from the SBA that we will receive an SBIC license, or of the timeframe in which it would receive a license, should one be granted.

Unsecured notes

In May 2013, we issued $48.3 million in aggregate principal amount of our 7.50% unsecured notes due 2020 for net proceeds of $46.1 million after deducting underwriting commissions of $1.9 million and offering

 

S-53


Table of Contents

costs of $0.3 million. The proceeds included the underwriters’ full exercise of their overallotment option. Interest on these notes is paid quarterly in arrears on February 15, May 15, August 15 and November 15 of each year, at a rate of 7.50% per year, beginning August 15, 2013. The notes mature on May 31, 2020 and may be redeemed in whole or in part at any time or from time to time at our option on or after May 31, 2016. In connection with the issuance of the notes, we agreed to the following covenants for the period of time during which the notes are outstanding:

 

    we will not violate (whether or not we are subject to) Section 18(a)(1)(A) as modified by Section 61(a)(1) of the 1940 Act or any successor provisions, but giving effect to any exemptive relief granted to us by the SEC. Currently, these provisions generally prohibit us from making additional borrowings, including through the issuance of additional debt or the sale of additional debt securities, unless our asset coverage, as defined in the 1940 Act, equals at least 200% after such borrowings.

 

    we will not violate (regardless of whether we are subject to) Section 18(a)(1)(B) as modified by Section 61(a)(1) of the 1940 Act or any successor provisions, but giving effect to (i) any exemptive relief granted to us by the SEC and (ii) no-action relief granted by the SEC to another BDC (or to the Company if it determines to seek such similar no-action or other relief) permitting the BDC to declare any cash dividend or distribution notwithstanding the prohibition contained in Section 18(a)(1)(B) as modified by Section 61(a)(1) of the 1940 Act in order to maintain the BDC’s status as a regulated investment company under Subchapter M of the Internal Revenue Code of 1986. Currently these provisions generally prohibit us from declaring any cash dividend or distribution upon any class of our capital stock, or purchasing any such capital stock if our asset coverage, as defined in the 1940 Act, is below 200% at the time of the declaration of the dividend or distribution or the purchase and after deducting the amount of such dividend, distribution or purchase.

The Notes are listed on the NYSE under the trading symbol “SAQ” with a par value of $25.00 per note.

From May 29, 2015 through July 16, 2015, the Company sold 227,863 Notes in an aggregate principal amount of $5,696,575 at an average price of $25.32 for aggregate net proceeds of $5,653,305 (net of transaction costs).

At May 31, 2015 and February 28, 2015, the fair value of investments, cash and cash equivalents and cash and cash equivalents, securitization accounts were as follows:

 

     At May 31, 2015     At February 28, 2015  
     Fair Value      Percent
of
Total
    Fair Value      Percent
of
Total
 
     ($ in thousands)  

Cash and cash equivalents

   $ 699         0.3   $ 1,888         0.7

Cash and cash equivalents, securitization accounts

     5,864         2.2        18,175         7.0   

Syndicated loans

     17,794         6.6        18,302         7.0   

First lien term loans

     157,072         58.3        145,207         55.7   

Second lien term loans

     40,551         15.1        35,603         13.7   

Unsecured notes

     5,861         2.2        4,230         1.7   

Structured finance securities

     16,860         6.2        17,031         6.5   

Equity Interest

     24,606         9.1        20,165         7.7   
  

 

 

    

 

 

   

 

 

    

 

 

 

Total

$ 269,307      100.0 $ 260,601      100.0
  

 

 

    

 

 

   

 

 

    

 

 

 

 

S-54


Table of Contents

At February 28, 2015 and February 28, 2014, the fair value of investments, cash and cash equivalents and cash and cash equivalents, securitization accounts were as follows:

 

     At February 28,
2015
    At February 28,
2014
 
     Fair Value      Percent
of
Total
    Fair Value      Percent
of
Total
 
     ($ in thousands)  

Cash and cash equivalents

   $ 1,888         0.7   $ 3,294         1.6

Cash and cash equivalents, securitization accounts

     18,175         7.0        3,293         1.6   

Syndicated loans

     18,302         7.0        32,390         15.2   

First lien term loans

     145,207         55.7        110,278         51.9   

Second lien term loans

     35,603         13.7        27,804         13.1   

Unsecured notes

     4,230         1.7        5,471         2.6   

Structured finance securities

     17,031         6.5        19,570         9.2   

Equity Interest

     20,165         7.7        10,332         4.8   
  

 

 

    

 

 

   

 

 

    

 

 

 

Total

$ 260,601      100.0 $ 212,432      100.0
  

 

 

    

 

 

   

 

 

    

 

 

 

On July 8, 2015 the Company declared a dividend of $0.33 per share payable for the fiscal quarter ended May 31, 2015 to all stockholders of record at the close of business on August 3, 2015. Shareholders will have the option to receive payment of the dividend in cash, or receive shares of common stock pursuant to the Company’s dividend reinvestment plan.

On May 14, 2015, the Company declared a dividend of $1.00 per share payable on June 5, 2015. Shareholders have the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant our dividend reinvestment plan. Based on shareholder elections, the dividend consisted of approximately $3.4 million in cash and 126,230 newly issued shares of common stock.

On April 9, 2015, the Company declared a dividend of $0.27 per share payable for the fiscal quarter ended February 28, 2015, payable on May 29, 2015 to all stockholders of record at the close of business on May 4, 2015. Shareholders will have the option to receive payment of the dividend in cash, or receive shares of common stock pursuant to the Company’s dividend reinvestment plan.

On September 24, 2014, the Company declared a dividend of $0.22 per share payable on February 27, 2015. Shareholders have the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant our DRIP. Based on shareholder elections, the dividend consisted of approximately $0.8 million in cash and 26,858 newly issued shares of common stock, or 0.5% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $14.97 per share, which equaled the volume weighted average trading price per share of the common stock on February 13, 17, 18, 19, 20, 23, 24, 25, 26 and 27, 2015.

Also on September 24, 2014, the Company declared a dividend of $0.18 per share payable on November 28, 2014. Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock pursuant to our DRIP. Based on shareholder elections, the dividend consisted of approximately $0.6 million in cash and 22,283 newly issued shares of common stock, or 0.4% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $14.37 per share, which equaled the volume weighted average trading price per share of the common stock on November 14, 17, 18, 19, 20, 21, 24, 25, 26 and 28, 2014.

On October 30, 2013, our board of directors declared a dividend of $2.65 per share payable on December 27, 2013, to common stockholders of record on November 13, 2013. Shareholders had the option to receive payment of the dividend in cash, shares of common stock, or a combination of cash and shares of common stock, provided that the aggregate cash payable to all shareholders was limited to approximately

 

S-55


Table of Contents

$2.5 million or $0.53 per share. This dividend was declared in reliance on certain private letter rulings issued by the IRS concluding that a RIC may treat a distribution of its own stock as fulfilling its RIC distribution requirements if each stockholder may elect to receive his or her entire distribution in either cash or stock of the RIC subject to a limitation on the aggregate amount of cash to be distributed to all stockholders, which limitation must be at least 20.0% of the aggregate declared distribution.

Based on shareholder elections, the dividend consisted of approximately $2.5 million in cash and 649,500 shares of common stock, or 13.7% of our outstanding common stock prior to the dividend payment. The amount of cash elected to be received was greater than the cash limit of 20.0% of the aggregate dividend amount, thus resulting in the payment of a combination of cash and stock to shareholders who elected to receive cash. The number of shares of common stock comprising the stock portion was calculated based on a price of $15.439 per share, which equaled the volume weighted average trading price per share of the common stock on December 11, 13, and 16, 2013.

On November 9, 2012, our board of directors declared a dividend of $4.25 per share payable on December 31, 2012, to common stockholders of record on November 20, 2012. Shareholders had the option to receive payment of the dividend in cash, shares of common stock, or a combination of cash and shares of common stock, provided that the aggregate cash payable to all shareholders was limited to approximately $3.3 million or $0.85 per share.

Based on shareholder elections, the dividend consisted of $3.3 million in cash and 853,455 shares of common stock, or 22.0% of our outstanding common stock prior to the dividend payment. The amount of cash elected to be received was greater than the cash limit of 20.0% of the aggregate dividend amount, thus resulting in the payment of a combination of cash and stock to shareholders who elected to receive cash. The number of shares of common stock comprising the stock portion was calculated based on a price of $15.444 per share, which equaled the volume weighted average trading price per share of the common stock on December 14, 17 and 19, 2012.

On November 15, 2011, our board of directors declared a dividend of $3.00 per share payable on December 30, 2011, to common stockholders of record on November 25, 2011. Shareholders had the option to receive payment of the dividend in cash, shares of common stock, or a combination of cash and shares of common stock, provided that the aggregate cash payable to all shareholders was limited to $2.0 million or $0.60 per share.

Based on shareholder elections, the dividend consisted of $2.0 million in cash and 599,584 shares of common stock, or 18.0% of our outstanding common stock prior to the dividend payment. The amount of cash elected to be received was greater than the cash limit of 20.0% of the aggregate dividend amount, thus resulting in the payment of a combination of cash and stock to shareholders who elected to receive cash. The number of shares of common stock comprising the stock portion was calculated based on a price of $13.117067 per share, which equaled the volume weighted average trading price per share of the common stock on December 20, 21 and 22, 2011.

On November 12, 2010, our board of directors declared a dividend of $4.40 per share to shareholders payable in cash or shares of our common stock, in accordance with the provisions of the IRS Revenue Procedure 2010-12, which allows a publicly-traded regulated investment company to satisfy its distribution requirements with a distribution paid partly in common stock provided that at least 10.0% of the distribution is payable in cash. The dividend was paid on December 29, 2010 to common shareholders of record on November 19, 2010.

Based on shareholder elections, the dividend consisted of $1.2 million in cash and 596,235 shares of common stock, or 22.0% of our outstanding common stock prior to the dividend payment. The amount of cash elected to be received was greater than the cash limit of 10.0% of the aggregate dividend amount, thus resulting in the payment of a combination of cash and stock to shareholders who elected to receive cash. The number of

 

S-56


Table of Contents

shares of common stock comprising the stock portion was calculated based on a price of $17.8049 per share, which equaled the volume weighted average trading price per share of the common stock on December 20, 21 and 22, 2010.

On November 13, 2009, our board of directors declared a dividend of $18.25 per share payable on December 31, 2009, to common stockholders of record on November 25, 2009. Shareholders had the option to receive payment of the dividend in cash, shares of common stock, or a combination of cash and shares of common stock, provided that the aggregate cash payable to all shareholders was limited to $2.1 million or $0.25 per share.

Based on shareholder elections, the dividend consisted of $2.1 million in cash and 8,648,725 shares of common stock, or 104.0% of our outstanding common stock prior to the dividend payment. The amount of cash elected to be received was greater than the cash limit of 13.7% of the aggregate dividend amount, thus resulting in the payment of a combination of cash and stock to shareholders who elected to receive cash. The number of shares of common stock comprising the stock portion was calculated based on a price of $1.5099 per share, which equaled the volume weighted average trading price per share of the common stock on December 24 and 28, 2009.

We cannot provide any assurance that these measures will provide sufficient sources of liquidity to support our operations and growth.

Contractual obligations

The following table shows our payment obligations for repayment of debt and other contractual obligations at May 31, 2015:

 

            Payment Due by Period  
     Total      Less Than
1 Year
     1 -3
Years
     3 -5
Years
     More Than
5 Years
 
     ($ in thousands)  

Long-Term Debt Obligations

   $ 139,100       $   —        $   —        $ 48,300       $ 90,800   
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

The following table shows our payment obligations for repayment of debt and other contractual obligations at February 28, 2015:

 

            Payment Due by Period  
     Total      Less Than
1 Year
     1 -3
Years
     3 -5
Years
     More Than
5 Years
 
     ($ in thousands)  

Long-Term Debt Obligations

   $ 136,900       $ —         $ —         $ —         $ 136,900   
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Off-balance sheet arrangements

The Company’s off-balance sheet arrangements consisted of $11.2 million and $11.2 million of unfunded commitments to provide debt financing to its portfolio companies or to fund limited partnership interests as of May 31, 2015 and February 28, 2015, respectively. Such commitments are generally up to the Company’s discretion to approve, or the satisfaction of certain financial and nonfinancial covenants and involve, to varying degrees, elements of credit risk in excess of the amount recognized in the Company’s Consolidated Statement of Assets and Liabilities and are not reflected in the Company’s Consolidated Statements of Assets and Liabilities.

 

S-57


Table of Contents

A summary of the composition of the unfunded commitments as of May 31, 2015 and February 28, 2015 is shown in the table below (dollars in thousands):

 

     As of  
     May 31,
2015
     February 28,
2015
 

Bristol Hospice, LLC

   $ 7,500       $ 7,500   

HMN Holdco, LLC

     2,400         2,400   

Avionte Holdings, LLC

     1,000         1,000   

Knowland Technology Holdings, L.L.C

     300         300   
  

 

 

    

 

 

 

Total

$ 11,200    $ 11,200   
  

 

 

    

 

 

 

The Company’s off-balance sheet arrangements consisted of $11.2 million and $12.2 million of unfunded commitments to provide debt financing to its portfolio companies or to fund limited partnership interests as of February 28, 2015 and 2014, respectively. Such commitments are generally up to the Company’s discretion to approve, or the satisfaction of certain financial and nonfinancial covenants and involve, to varying degrees, elements of credit risk in excess of the amount recognized in the Company’s Consolidated Statement of Assets and Liabilities and are not reflected in the Company’s Consolidated Statements of Assets and Liabilities.

A summary of the composition of the unfunded commitments as of February 28, 2015 and 2014 is shown in the table below (dollars in thousands):

 

     As of  
     February 28,
2015
     February 28,
2014
 

Bristol Hospice, LLC

   $ 7,500       $ 7,500   

HMN Holdco, LLC

     2,400         —     

Avionte Holdings, LLC

     1,000         1,000   

Knowland Technology Holdings, L.L.C.

     300         —     

Easy Ice, LLC

     —           3,000   

Oceans Acquisition, Inc.

     —           500   

Community Investors, Inc.

     —           167   
  

 

 

    

 

 

 

Total

$ 11,200    $ 12,167   
  

 

 

    

 

 

 

On July 10, 2014, our board of directors appointed Henri J. Steenkamp to serve as our Chief Financial Officer and Chief Compliance Officer. As previously disclosed, Mr. Steenkamp was previously appointed to serve as our Interim Chief Financial Officer and Interim Chief Compliance Officer on March 4, 2014.

On July 10, 2014, our board of directors, including a majority of the independent directors, approved the annual continuation of our investment advisory and management agreement with Saratoga Investment Advisors, LLC. Our board of directors also approved the renewal of the administration agreement with Saratoga Investment Advisors, LLC for an additional one-year term and determined to maintain the cap on the payment or reimbursement of expenses by us thereunder to $1.0 million for the additional one-year term.

 

S-58


Table of Contents

SENIOR SECURITIES

(dollar amounts in thousands, except per share data)

Information about our senior securities is shown in the following table as of February 28/29 for the fiscal years indicated in the table, unless otherwise noted. Ernst & Young LLP’s report on the table, as of February 28, 2015, is attached as an exhibit to the registration statement of which this prospectus is a part. See “Management’s Discussion and Analysis of Financial Condition and Results of Operations—Financial condition, liquidity and capital resources” for more detailed information regarding the senior securities.

 

Class and Year(1)(2)

   Total
Amount
Outstanding
Exclusive of
Treasury
Securities(3)
     Asset
Coverage
per Unit(4)
     Involuntary
Liquidating
Preference
per Share(5)
     Average
Market
Value per
Share(6)
 
     (in thousands)  

Credit Facility with Madison Capital Funding

           

Fiscal year 2016 (as of May 31, 2015, unaudited)(7)

   $ 11,800       $ 3,138         —           N/A   

Fiscal year 2015

   $ 9,600       $ 3,211         —           N/A   

Fiscal year 2014

   $ —         $ 3,482         —           N/A   

Fiscal year 2013

   $ 24,300       $ 5,571         —           N/A   

Fiscal year 2012 (as of February 29, 2012)

   $ 20,000       $ 6,143         —           N/A   

Fiscal year 2011 (as of February 28, 2011)

   $ 4,500       $ 31,003         —           N/A   

Fiscal year 2010 (as of February 28, 2010)

   $ —         $ —           —           N/A   

Fiscal year 2009 (as of February 28, 2009)

   $ —         $ —           —           N/A   

Fiscal year 2008 (as of February 29, 2008)

   $ —         $ —           —           N/A   

Fiscal year 2007 (as of February 28, 2007)

   $ —         $ —           —           —     

7.50% Notes due 2020

           

Fiscal year 2016 (as of May 31, 2015, unaudited)(7)

   $ 48,300         3,138          $ 25.81 (8) 

Fiscal year 2015

   $ 48,300       $ 3,211         —         $ 25.46 (8) 

Fiscal year 2014

   $ 48,300       $ 3,482         —         $ 25.18 (8) 

Fiscal year 2013

   $ —         $ —           —           N/A   

Fiscal year 2012 (as of February 29, 2012)

   $ —         $ —           —           N/A   

Fiscal year 2011 (as of February 28, 2011)

   $ —         $ —           —           N/A   

Fiscal year 2010 (as of February 28, 2010)

   $ —         $ —           —           N/A   

Fiscal year 2009 (as of February 28, 2009)

   $ —         $ —           —           N/A   

Fiscal year 2008 (as of February 29, 2008)

   $ —         $ —           —           N/A   

Fiscal year 2007 (as of February 28, 2007)

   $ —         $ —           —           —     

 

(1) We have excluded our SBA-guaranteed debentures from this table because the SEC has granted us exemptive relief that permits us to exclude such debentures from the definition of senior securities in the 200% asset coverage ratio we are required to maintain under the 1940 Act. See “Management’s Discussion and Analysis of Financial Condition and Results of Operations—Financial Condition, Liquidity and Capital Resources.”
(2) This table does not include the senior securities of our predecessor entity, GSC Investment Corp., relating to a revolving securitized credit facility with Deutsche Bank, in light of the fact that the Company was under different management during the time that such credit facility was outstanding.
(3) Total amount of senior securities outstanding at the end of the period presented.
(4) Asset coverage per unit is the ratio of our total assets, less all liabilities and indebtedness not represented by senior securities, to the aggregate amount of senior securities representing indebtedness. Asset coverage per unit is expressed in terms of dollar amounts per $1,000 of indebtedness, calculated on a total basis.
(5) The amount to which such class of senior security would be entitled upon the involuntary liquidation of the issuer in preference to any security junior to it. The “—” indicates information which the Securities and Exchange Commission expressly does not require to be disclosed for certain types of senior securities.
(6) Not applicable for credit facility because not registered for public trading.
(7) Total amount outstanding as of July 16, 2015, including our Credit Facility, Notes and SBA-guaranteed debentures, was $139.0 million (Unaudited).
(8) Based on the average daily trading price of the Notes on the NYSE.

 

S-59


Table of Contents

MATERIAL U.S. FEDERAL INCOME TAX CONSEQUENCES

The following discussion is a general summary of the material United States federal income tax considerations (and, in the case of a non-U.S. holder (as defined below), the material United States federal estate tax consequences) applicable to an investment in the Notes. This summary does not purport to be a complete description of the income and estate tax considerations applicable to such an investment. The discussion is based upon the Internal Revenue Code of 1986, as amended (the “Code”), Treasury Regulations, and administrative and judicial interpretations, each as of the date of this prospectus and all of which are subject to change, potentially with retroactive effect. You should consult your own tax advisor with respect to tax considerations that pertain to your purchase, ownership and disposition of our Notes.

This discussion deals only with Notes held as capital assets within the meaning of Section 1221 of the Code and does not purport to deal with persons in special tax situations, such as financial institutions, insurance companies, controlled foreign corporations, passive foreign investment companies and regulated investment companies (and shareholders of such corporations), dealers in securities or currencies, traders in securities, former citizens of the United States, persons holding the Notes as a hedge against currency risks or as a position in a “straddle,” “hedge,” “constructive sale transaction” or “conversion transaction” for tax purposes, entities that are tax-exempt for United States federal income tax purposes, retirement plans, individual retirement accounts, tax-deferred accounts, persons subject to the alternative minimum tax, pass-through entities (including partnerships and entities and arrangements classified as partnerships for United States federal income tax purposes) and beneficial owners of pass-through entities, or persons whose functional currency is not the U.S. dollar. It also does not deal with beneficial owners of the Notes other than original purchasers of the Notes who acquire the Notes in this offering for a price equal to their original issue price (i.e., the first price at which a substantial amount of the notes is sold other than to bond houses, brokers, or similar persons or organizations acting in the capacity of underwriters, placement agents or wholesalers). If you are considering purchasing the Notes, you should consult your own tax advisor concerning the application of the United States federal tax laws to you in light of your particular situation, as well as any consequences to you of purchasing, owning and disposing of the Notes under the laws of any other taxing jurisdiction.

For purposes of this discussion, the term “U.S. holder” means a beneficial owner of a Note that is, for United States federal income tax purposes, (i) an individual citizen or resident of the United States, (ii) a corporation or other entity treated as a corporation for United States federal income tax purposes, created or organized in or under the laws of the United States or of any political subdivision thereof, (iii) a trust (a) subject to the control of one or more United States persons and the primary supervision of a court in the United States, or (b) that existed on August 20, 1996 and has made a valid election (under applicable Treasury Regulations) to be treated as a domestic trust, or (iv) an estate the income of which is subject to United States federal income taxation regardless of its source. The term “non-U.S. holder” means a beneficial owner of a Note that is neither a U.S. holder nor a partnership (including an entity or arrangement treated as a partnership for U.S. federal income tax purposes). An individual may, subject to exceptions, be deemed to be a resident alien, as opposed to a non-resident alien, by, among other ways, being present in the United States (i) on at least 31 days in the calendar year, and (ii) for an aggregate of at least 183 days during a three-year period ending in the current calendar year, counting for such purposes all of the days present in the current year, one-third of the days present in the immediately preceding year, and one-sixth of the days present in the second preceding year. Resident aliens are subject to United States federal income tax as if they were United States citizens.

If a partnership (including an entity or arrangement treated as a partnership for U.S. federal income tax purposes) holds any Notes, the United States federal income tax treatment of a partner of the partnership generally will depend upon the status of the partner, the activities of the partnership and certain determinations made at the partner level. Partners of partnerships holding Notes should consult their own tax advisors.

 

S-60


Table of Contents

Taxation of Note Holders

Under present law, we are of the opinion that the Notes will constitute indebtedness of us for United States federal income tax purposes, which the below discussion assumes. We intend to treat all payments made with respect to the Notes consistent with this characterization.

Taxation of U.S. Holders. Payments or accruals of interest on a Note generally will be taxable to a U.S. holder as ordinary interest income at the time they are received (actually or constructively) or accrued, in accordance with the U.S. holder’s regular method of tax accounting.

Upon the sale, exchange, redemption, retirement or other taxable disposition of a Note, a U.S. holder generally will recognize capital gain or loss equal to the difference between the amount realized on the sale, exchange, redemption, retirement or other taxable disposition (excluding amounts representing accrued and unpaid interest, which are treated as ordinary income to the extent not previously included in income) and the U.S. holder’s adjusted tax basis in the Note. A U.S. holder’s adjusted tax basis in a Note generally will equal the U.S. holder’s initial investment in the Note. Capital gain or loss generally will be long-term capital gain or loss if the Note was held for more than one year. Long-term capital gains recognized by individuals and certain other non-corporate U.S. holders generally are eligible for reduced rates of taxation. The distinction between capital gain or loss and ordinary income or loss is also important in other contexts; for example, for purposes of the limitations on a U.S. holder’s ability to offset capital losses against ordinary income.

Unearned Income Medicare Contribution

A tax of 3.8% will be imposed on certain “net investment income” (or “undistributed net investment income”, in the case of estates and trusts) received by taxpayers other than corporations with adjusted gross income above certain threshold amounts. “Net investment income” as defined for United States federal Medicare contribution purposes generally includes interest payments and gain recognized from the sale or other disposition of the Notes. Tax-exempt trusts, which are not subject to income taxes generally, and foreign individuals will not be subject to this tax. U.S. holders should consult their own tax advisors regarding the effect, if any, of this tax on their ownership and disposition of the Notes.

Taxation of Non-U.S. Holders. A non-U.S. holder generally will not be subject to United States federal income or withholding taxes on payments of principal or interest on a Note provided that (i) income on the Note is not effectively connected with the conduct by the non-U.S. holder of a trade or business within the United States, (ii) the non-U.S. holder is not a controlled foreign corporation related to the Company through stock ownership, (iii) the non-U.S. holder is not a bank receiving interest described in Section 881(c)(3)(A) of the Code, (iv) the non-U.S. holder does not own (directly or indirectly, actually or constructively) 10% or more of the total combined voting power of all classes of stock of the Company, and (v) the non-U.S. holder has provided a statement in the year in which a payment occurs or in the preceding 3 years, on an Internal Revenue Service (IRS) Form W-8BEN (or other applicable form) signed under penalties of perjury that includes its name and address and certifies that the non-U.S. holder is the beneficial owner and is not a United States person in compliance with applicable requirements, or satisfies documentary evidence requirements for establishing that it is a non-U.S. holder.

A non-U.S. holder that is not exempt from tax under these rules generally will be subject to United States federal income tax withholding on payments of interest on the Notes at a rate of 30% unless (i) the income is effectively connected with the conduct of a United States trade or business (and, under certain income tax treaties, is attributable to a permanent establishment maintained in the U.S. by the non-U.S. holder), so long as the non-U.S. holder has provided an IRS Form W-8ECI or substantially similar substitute form stating that the interest on the Notes is effectively connected with the non-U.S. holder’s conduct of a trade or business in the U.S. in which case the interest will be subject to United States federal income tax on a net income basis as applicable to U.S. holders generally (unless an applicable income tax treaty provides otherwise), or (ii) an applicable income tax treaty provides for a lower rate of, or exemption from, withholding tax.

 

S-61


Table of Contents

In the case of a non-U.S. holder that is a corporation and that receives income that is effectively connected with the conduct of a United States trade or business, such income may also be subject to a branch profits tax (which is generally imposed on a non-U.S. corporation on the actual or deemed repatriation from the United States of earnings and profits attributable to a United States trade or business) at a 30% rate. The branch profits tax may not apply (or may apply at a reduced rate) if the non-U.S. holder is a qualified resident of a country with which the United States has an income tax treaty.

To claim the benefit of an income tax treaty or to claim exemption from withholding because income is effectively connected with a United States trade or business, the non-U.S. holder must timely provide the appropriate, properly executed IRS forms. The non-U.S. holder must inform the recipient of any changes on these forms within 30 days of such change. These forms may be required to be periodically updated. Also, a non-U.S. holder who is claiming the benefits of a treaty may be required to obtain a United States taxpayer identification number and to provide certain documentary evidence issued by foreign governmental authorities to prove residence in the foreign country.

Generally, a non-U.S. holder will not be subject to United States federal income or withholding taxes on any amount that constitutes capital gain upon the sale, exchange, redemption, retirement or other taxable disposition of a Note, provided that (i) the gain is not effectively connected with the conduct of a trade or business in the United States by the non-U.S. holder (or, if required by an applicable income tax treaty, is not attributable to a United States “permanent establishment” maintained by the non-U.S. holder) and (ii) that the non-U.S. holder is not an individual who is present in the U.S. for 183 days or more in the taxable year of the sale, exchange, or other taxable disposition and meets certain other conditions (unless such holder is eligible for relief under an applicable income tax treaty). Certain other exceptions may be applicable, and a non-U.S. holder should consult its tax advisor in this regard.

A Note that is held by an individual who, at the time of death, is not a citizen or resident of the United States (as specially defined for United States federal estate tax purposes) generally will not be subject to the United States federal estate tax, unless, at the time of death, (i) such individual directly or indirectly, actually or constructively, owns ten percent or more of the total combined voting power of all classes of our stock entitled to vote within the meaning of Section 871(h)(3) of the Code and the Treasury Regulations thereunder or (ii) such individual’s interest in the Notes is effectively connected with the individual’s conduct of a United States trade or business.

Information Reporting and Backup Withholding. A U.S. holder (other than an “exempt recipient,” including a corporation and certain other persons who, when required, demonstrate their exempt status) may be subject to backup withholding at a rate of 28% on, and to information reporting requirements with respect to, payments of principal and interest on, and proceeds from the sale, exchange, redemption or retirement of, the Notes. In general, if a non-corporate U.S. holder subject to information reporting fails to furnish a correct taxpayer identification number or otherwise fails to comply with applicable backup withholding requirements, backup withholding at the applicable rate may apply.

The amount of interest we pay to a non-U.S. holder on the Notes will be reported to such non-U.S. Holder and to the IRS annually on an IRS Form 1042-S even if the non-U.S. holder is exempt from the 30% withholding tax described above. Copies of the information returns reporting those payments and the amounts withheld, if any, may also be made available to the tax authorities in the country where the non-U.S. holder is resident under provisions of an applicable income tax treaty or agreement.

In addition, backup withholding tax and certain other information reporting requirements apply to payments of principal and interest on, and proceeds from the sale, exchange, redemption or retirement of, the Notes, unless an exemption applies. Backup withholding and information reporting will not apply to payments we make to a non-U.S. holder if such non-U.S. holder has provided to the applicable withholding agent under penalties of perjury the required certification of their non-U.S. person status as discussed above (and the applicable withholding agent does not have actual knowledge or reason to know that they are a U.S. person) or if the non-U.S. holder is an exempt recipient.

 

S-62


Table of Contents

If a non-U.S. holder sells or redeems a Note through a U.S. broker or the U.S. office of a foreign broker, the proceeds from such sale or redemption will be subject to information reporting and backup withholding unless such non-U.S. holder provides a withholding certificate or other appropriate documentary evidence establishing that such non-U.S. holder is not a United States person to the broker and such broker does not have actual knowledge or reason to know that such non-U.S. holder is a United States person, or the non-U.S. holder is an exempt recipient eligible for an exemption from information reporting and backup withholding. If a non-U.S. holder sells or redeems a note through the foreign office of a broker who is a United States person or has certain enumerated connections with the U.S., the proceeds from such sale or redemption will be subject to information reporting unless the non-U.S. holder provides to such broker a withholding certificate or other appropriate documentary evidence establishing that the non-U.S. holder is not a United States person and such broker does not have actual knowledge or reason to know that such evidence is false, or the non-U.S. holder is an exempt recipient eligible for an exemption from information reporting. In circumstances where information reporting by the foreign office of such a broker is required, backup withholding will be required only if the broker has actual knowledge that the non-U.S. holder is a United States person.

You should consult your tax advisor regarding the qualification for an exemption from backup withholding and information reporting and the procedures for obtaining such an exemption, if applicable. Any amounts withheld under the backup withholding rules from a payment to a beneficial owner generally would be allowed as a refund or a credit against such beneficial owner’s United States federal income tax provided the required information is timely furnished to the IRS.

Foreign Account Tax Compliance Act

A United States federal withholding tax of 30% will be imposed on payments of interest or gross proceeds from the disposition of a debt instrument paid to certain non-U.S. entities, including certain foreign financial institutions and investment funds, unless such non-U.S. entity complies with certain reporting requirements regarding its United States account holders and its United States owners. Pursuant to Treasury Regulations and other Treasury guidance, these rules generally are not effective for payments of gross proceeds, until January 1, 2017. Prospective purchasers of the Notes should consult their own tax advisors regarding the new withholding and reporting provisions.

You should consult your own tax advisor with respect to the particular tax consequences to you of an investment in the Notes, including the possible effect of any pending legislation or proposed regulations.

Our Taxation as a Regulated Investment Company

As a regulated investment company (“RIC”), we generally will not have to pay corporate-level federal income taxes on any net ordinary income or realized capital gains that we distribute to our stockholders as dividends. To qualify as a RIC, we must, among other things, meet certain source-of-income and asset diversification requirements (as described below). In addition, in order to maintain our qualification as a RIC, we must distribute to our stockholders, for each taxable year, at least 90% of our “investment company taxable income,” which is generally our net ordinary income plus the excess of realized net short-term capital gains over realized net long-term capital losses (the “Annual Distribution Requirement”).

Taxation as a Regulated Investment Company

If we:

 

    Qualify as a RIC; and

 

    Satisfy the Annual Distribution Requirement

 

S-63


Table of Contents

then we will not be subject to U.S. federal income tax on the portion of our income we distribute (or are deemed to distribute) to stockholders. We will be subject to U.S. federal income tax at the regular corporate rates on any income or capital gains not distributed (or deemed distributed) to our stockholders.

We will be subject to a 4% nondeductible U.S. federal excise tax on certain undistributed income unless we distribute in a timely manner an amount at least equal to the sum of (1) 98% of our net ordinary income for each calendar year, (2) 98.2% of our capital gain net income for the one-year period ending October 31 in that calendar year and (3) any income recognized, but not distributed, in preceding years (the “Excise Tax Avoidance Requirement”). We generally will endeavor in each taxable year to make sufficient distributions to our stockholders to avoid the 4% excise tax on our income. However, depending on the level of taxable income earned in a tax year, we may choose to carry forward taxable income in excess of current year distributions into the next tax year and pay the 4% excise tax on such income. Any such carryover taxable income must be distributed through a dividend declared prior to filing the final tax return related to the year which generated such taxable income. We may, in the future, make actual distributions to our stockholders of our net capital gains.

In order to qualify as a RIC for U.S. federal income tax purposes, we must, among other things:

 

    continue to qualify as a business development company under the 1940 Act at all times during each taxable year;

 

    derive in each taxable year at least 90% of our gross income from dividends, interest, payments with respect to loans of certain securities, gains from the sale of stock or other securities, net income from certain “qualified publicly traded partnerships,” or other income derived with respect to our business of investing in such stock or securities (the “90% Income Test”); and

 

    diversify our holdings so that at the end of each quarter of the taxable year:

 

    at least 50% of the value of our assets consists of cash, cash equivalents, U.S. Government securities, securities of other RICs, and other securities if such other securities of any one issuer do not represent more than 5% of the value of our assets or more than 10% of the outstanding voting securities of the issuer; and

 

    no more than 25% of the value of our assets is invested in the securities, other than U.S. government securities or securities of other RICs, of one issuer, of two or more issuers that are controlled, as determined under applicable Code rules, by us and that are engaged in the same or similar or related trades or businesses or of certain “qualified publicly traded partnerships” (the “Diversification Tests”).

We may be required to recognize taxable income in circumstances in which we do not receive cash. For example, if we hold debt obligations that are treated under applicable tax rules as having original issue discount (such as debt instruments with PIK interest or, in certain cases, increasing interest rates or issued with warrants), we must include in income each year a portion of the original issue discount that accrues over the life of the obligation, regardless of whether cash representing such income is received by us in the same taxable year. We may also have to include in income other amounts that we have not yet received in cash, such as PIK interest and deferred loan origination fees that are paid after origination of the loan or are paid in non-cash compensation such as warrants or stock. Because any original issue discount or other amounts accrued will be included in our net ordinary income for the year of accrual, we may be required to make a distribution to our stockholders in order to satisfy the Annual Distribution Requirement, even though we will not have received any corresponding cash amount. If the IRS should adopt a position that a distribution of 20% cash and the balance in stock is not a distribution satisfying the Annual Distribution Requirement, we may find it more difficult to meet such requirement.

Although we do not presently expect to do so, we are authorized to borrow funds, to sell assets and to make taxable distributions of our stock and debt securities in order to satisfy distribution requirements. Our ability to dispose of assets to meet our distribution requirements may be limited by (1) the illiquid nature of our portfolio

 

S-64


Table of Contents

and/or (2) other requirements relating to our status as a RIC, including the Diversification Tests. If we dispose of assets in order to meet the Annual Distribution Requirement or the Excise Tax Avoidance Requirement, we may make such dispositions at times that, from an investment standpoint, are not advantageous. If we are unable to obtain cash from other sources to satisfy the Annual Distribution Requirement, we may fail to qualify as a RIC and become subject to tax as an ordinary corporation.

Under the 1940 Act, we are not permitted to make distributions to our stockholders while our debt obligations and other senior securities are outstanding unless certain “asset coverage” tests are met. If we are prohibited to make distributions, we may fail to qualify as a RIC and become subject to tax as an ordinary corporation.

Certain of our investment practices may be subject to special and complex U.S. federal income tax provisions that may, among other things: (i) disallow, suspend or otherwise limit the allowance of certain losses or deductions; (ii) convert lower taxed long-term capital gain into higher taxed short-term capital gain or ordinary income; (iii) convert an ordinary loss or a deduction into a capital loss (the deductibility of which is more limited); (iv) cause us to recognize income or gain without a corresponding receipt of cash; (v) adversely affect the time as to when a purchase or sale of securities is deemed to occur; (vi) adversely alter the characterization of certain complex financial transactions; and (vii) produce income that will not be qualifying income for purposes of the 90% Income Test described above. We will monitor our transactions and may make certain tax decisions in order to mitigate the potential adverse effect of these provisions.

If we fail to satisfy the Annual Distribution Requirement or otherwise fail to qualify as a RIC in any taxable year, we will be subject to tax in that year on all of our taxable income, regardless of whether we make any distributions to our stockholders. If we fail to maintain RIC tax treatment for any reason and are subject to corporate income tax, the resulting corporate taxes could substantially reduce our net assets and the amount of income available to make interest and principal payments on the Notes. In contrast, assuming we qualify as a RIC, our corporate-level federal income tax should be substantially reduced or eliminated.

 

S-65


Table of Contents

DESCRIPTION OF THE NOTES

On May 10, 2013, we and U.S. Bank National Association, or the “Trustee,” entered into the first supplemental indenture, or the “first supplemental indenture,” to the indenture, or the “base indenture,” between us and the Trustee, dated May 10, 2013, relating to our issuance, offer and sale of approximately $48.3 million aggregate principal amount of 7.5% fixed-rate notes due 2020, or the “Existing Notes.” We refer to the base indenture, along with the first supplemental indenture thereto, as the “indenture.” We will issue the Notes offered hereby under the same first supplemental indenture. The Notes offered hereby will be a further issuance of, rank equally in right of payment with, and form a single series for all purposes under the Indenture, including, without limitation, waivers, amendments, consents, redemptions and other offers to purchase and voting, with the Existing Notes. Unless otherwise indicated, the Notes offered hereby and the Existing Notes are collectively referred to herein as the “Notes.”

The Notes are governed by the indenture, as required by federal law for all bonds and notes of companies that are publicly offered. An indenture is a contract between us and the financial institution acting as trustee on your behalf, and is subject to and governed by the Trust Indenture Act of 1939, as amended. The trustee has two main roles. First, the trustee can enforce your rights against us if we default. There are some limitations on the extent to which the trustee acts on your behalf, described in the second paragraph under “—Events of Default—Remedies if an Event of Default Occurs.” Second, the trustee performs certain administrative duties for us with respect to our Notes.

This section includes a description of the material terms of the Notes and the indenture. Because this section is a summary, however, it does not describe every aspect of the Notes and the indenture. We urge you to read the indenture because it, and not this description, defines your rights as a holder of the Notes. The indenture has been attached as an exhibit to the registration statement of which this prospectus is a part and filed with the SEC. See “Available Information” for information on how to obtain a copy of the indenture.

General

The Notes will mature on May 31, 2020. The principal payable at maturity will be 100% of the aggregate principal amount. The interest rate of the Notes is 7.50% per year and will be paid every February 15, May 15, August 15 and November 15 of each year, beginning on the first applicable interest payment date following a given purchase of the Notes under this prospectus, and the regular record dates for interest payments will be February 1, May 1, August 1, and November 1 of each year, commencing with the first such date to follow a given purchase of the Notes under this prospectus. The interest payable on each interest payment date will be paid only to holders of record of the Notes at the close of business on the record date immediately preceding the applicable interest payment date. If an interest payment date falls on a non-business day, the applicable interest payment will be made on the next business day and no additional interest will accrue as a result of such delayed payment. Interest on the Notes will accrue from the most recent interest payment date immediately preceding the date of issuance of the Notes from time to time, except that, if you purchase Notes after the record dates noted above (or your settlement of a purchase of Notes otherwise occurs after such record date), your Notes will not accrue interest for the period from such purchase date to the interest payment date immediately following such record date. Subsequent interest periods will be the periods from and including an interest payment date to, but excluding, the next interest payment date or the stated maturity date, as the case may be.

We will issue the Notes in denominations of $25 and integral multiples of $25 in excess thereof. If any of the Notes are sold at prices above the par value of $25 per Note, the effective yield on such Notes to the purchasers may be less than 7.50%. The Notes will not be subject to any sinking fund and holders of the Notes will not have the option to have the Notes repaid prior to the stated maturity date.

The indenture does not contain any provisions that give you protection in the event we issue a large amount of debt or we are acquired by another entity.

We have the ability to issue indenture securities with terms different from the Notes and, without the consent of the holders thereof, to reopen the Notes and issue additional Notes.

 

S-66


Table of Contents

Optional Redemption

The Notes may be redeemed in whole or in part at any time or from time to time at our option on or after May 31, 2016 upon not less than 30 days nor more than 60 days written notice by mail prior to the date fixed for redemption thereof, at a redemption price of 100% of the outstanding principal amount of the Notes to be redeemed plus accrued and unpaid interest payments otherwise payable thereon for the then-current quarterly interest period accrued to the date fixed for redemption.

You may be prevented from exchanging or transferring the Notes when they are subject to redemption. In case any Notes are to be redeemed in part only, the redemption notice will provide that, upon surrender of such Note, you will receive, without a charge, a new Note or Notes of authorized denominations representing the principal amount of your remaining unredeemed Notes. Any exercise of our option to redeem the Notes will be done in compliance with the 1940 Act.

If we redeem only some of the Notes, the trustee will determine the method for selection of the particular Notes to be redeemed, in accordance with the indenture and the 1940 Act and in accordance with the rules of any national securities exchange or quotation system on which the Notes are listed. Unless we default in payment of the redemption price, on and after the date of redemption, interest will cease to accrue on the Notes called for redemption.

Global Securities

Each Note will be issued in book-entry form and represented by a global security that we deposit with and register in the name of The Depository Trust Company, New York, New York, known as DTC, or its nominee. A global security may not be transferred to or registered in the name of anyone other than the depositary or its nominee, unless special termination situations arise. As a result of these arrangements, the depositary, or its nominee, will be the sole registered owner and holder of all the Notes represented by a global security, and investors will be permitted to own only beneficial interests in a global security. For more information about these arrangements, see “—Book-Entry Procedures” below.

Termination of a Global Security

If a global security is terminated for any reason, interests in it will be exchanged for certificates in non-book-entry form (certificated securities). After that exchange, the choice of whether to hold the certificated Notes directly or in street name will be up to the investor. Investors must consult their own banks or brokers to find out how to have their interests in a global security transferred on termination to their own names, so that they will be holders.

Payment and Paying Agents

We will pay interest to the person listed in the trustee’s records as the owner of the Notes at the close of business on a particular day in advance of each due date for interest, even if that person no longer owns the Note on the interest due date. That day, usually about two weeks in advance of the interest due date, is called the “record date.” Because we will pay all the interest for an interest period to the holders on the record date, holders buying and selling the Notes must work out between themselves the appropriate purchase price. The most common manner is to adjust the sales price of the Notes to prorate interest fairly between buyer and seller based on their respective ownership periods within the particular interest period. This prorated interest amount is called “accrued interest.”

Payments on Global Securities

We will make payments on the Notes so long as they are represented by a global security in accordance with the applicable policies of the depositary as in effect from time to time. Under those policies, we will make payments directly to the depositary, or its nominee, and not to any indirect holders who own beneficial interests in the global security. An indirect holder’s right to those payments will be governed by the rules and practices of the depositary and its participants, as described under “—Book-Entry Procedures.”

 

S-67


Table of Contents

Payments on Certificated Securities

In the event the Notes become represented by certificated securities, we will make payments on the Notes as follows. We will pay interest that is due on an interest payment date to the holder of the Notes as shown on the trustee’s records as of the close of business on the regular record date at our office in New York, New York. We will make all payments of principal and premium, if any, by check at the office of the applicable trustee in New York, New York and/or at other offices that may be specified in a notice to holders against surrender of the Note.

Alternatively, at our option, we may pay any cash interest that becomes due on the Notes by mailing a check to the holder at his, her or its address shown on the trustee’s records as of the close of business on the regular record date or by transfer to an account at a bank in the United States, in either case, on the due date.

Payment When Offices Are Closed

If any payment is due on the Notes on a day that is not a business day, we will make the payment on the next day that is a business day. Payments made on the next business day in this situation will be treated under the indenture as if they were made on the original due date. Such payment will not result in a default under the Notes or the indenture, and no interest will accrue on the payment amount from the original due date to the next day that is a business day.

Book-entry and other indirect holders should consult their banks or brokers for information on how they will receive payments on the Notes.

Events of Default

You will have rights if an Event of Default occurs in respect of the Notes, as described later in this subsection.

The term “Event of Default” in respect of the Notes means any of the following:

 

    we do not pay the principal (or premium, if any) of any Note when due;

 

    we do not pay interest on any Note when due, and such default is not cured within 30 days;

 

    we remain in breach of a covenant in respect of the Notes for 60 days after we receive a written notice of default stating we are in breach (the notice must be sent by either the trustee or holders of at least 25% of the principal amount of the Notes);

 

    a final judgment for the payment of $15 million or more (excluding any amounts covered by insurance) rendered against us or any significant subsidiary, which judgment is not discharged or stayed within 60 days after (i) the date on which the right to appeal thereof has expired if no such appeal has commenced, or (ii) the date on which all rights to appeal have been extinguished;

 

    we file for bankruptcy or certain other events of bankruptcy, insolvency or reorganization occur and in the case of certain orders or decrees entered against us under bankruptcy law, such order or decree remains undischarged or unstayed for a period of 60 days;

 

    on the last business day of each of twenty-four consecutive calendar months, the Notes have the asset coverage, as defined in the 1940 Act, of less than 100% after giving effect to any exemptive relief granted to us by the SEC; or

 

    a default by us or any of our significant subsidiaries, which is not cured within 30 days, under any agreement or instrument relating to indebtedness for borrowed money in excess of $10 million, which default (i) results in such indebtedness becoming or being declared due and payable or (ii) constitutes a failure to pay the principal or interest of any such debt when due and payable at its stated maturity, upon required repurchase, upon declaration of acceleration or otherwise.

 

S-68


Table of Contents

An Event of Default for the Notes does not necessarily constitute an Event of Default for any other series of debt securities issued under the same or any other indenture. The trustee may withhold notice to the holders of the Notes of any default, except in the payment of principal or interest, if it in good faith considers the withholding of notice to be in the best interests of the holders.

Remedies if an Event of Default Occurs

If an Event of Default has occurred and is continuing, the trustee or the holders of not less than 25% in principal amount of the Notes may declare the entire principal amount of all the Notes to be due and immediately payable. If an Event of Default referred to in the second to last bullet point above with respect to us has occurred, the entire principal amount of all the Notes will automatically become due and immediately payable. This is called a declaration of acceleration of maturity. In certain circumstances, a declaration of acceleration of maturity may be canceled by the holders of a majority in principal amount of the Notes if (1) we have deposited with the trustee all amounts due and owing with respect to the Notes (other than principal that has become due solely by reason of such acceleration) and certain other amounts, and (2) any other Events of Default have been cured or waived.

Except in cases of default, where the trustee has some special duties, the trustee is not required to take any action under the indenture at the request of any holders unless the holders offer the trustee reasonable protection from expenses and liability (called an “indemnity”). If reasonable indemnity is provided, the holders of a majority in principal amount of the Notes may direct the time, method and place of conducting any lawsuit or other formal legal action seeking any remedy available to the trustee. The trustee may refuse to follow those directions in certain circumstances. No delay or omission in exercising any right or remedy will be treated as a waiver of that right, remedy or Event of Default.

Before you are allowed to bypass the trustee and bring your own lawsuit or other formal legal action or take other steps to enforce your rights or protect your interests relating to the Notes, the following must occur:

 

    you must give the trustee written notice that an Event of Default has occurred and remains uncured;

 

    the holders of at least 25% in principal amount of all the Notes must make a written request that the trustee take action because of the default and must offer reasonable indemnity to the trustee against the cost and other liabilities of taking that action;

 

    the trustee must not have taken action for 60 days after receipt of the above notice and offer of indemnity; and

 

    the holders of a majority in principal amount of the Notes must not have given the trustee a direction inconsistent with the above notice during that 60-day period.

However, you are entitled at any time to bring a lawsuit for the payment of money due on your Notes on or after the due date.

Book-entry and other indirect holders should consult their banks or brokers for information on how to give notice or direction to or make a request of the trustee and how to declare or cancel an acceleration of maturity.

Each year, we will furnish to the trustee a written statement of certain of our officers certifying that to their knowledge we are in compliance with the indenture and the Notes, or else specifying any default.

 

S-69


Table of Contents

Waiver of Default

The holders of a majority in principal amount of the Notes may waive any past defaults other than other than:

 

    the payment of principal or interest; or

 

    in respect of a covenant that cannot be modified or amended without the consent of each holder.

Merger or Consolidation

Under the terms of the indenture, we are generally permitted to consolidate or merge with another entity. We are also permitted to sell all or substantially all of our assets to another entity. However, we may not take any of these actions unless all the following conditions are met:

 

    where we merge out of existence or convey or transfer our assets substantially as an entirety, the resulting entity must agree to be legally responsible for our obligations under the Notes;

 

    the merger or sale of assets must not cause a default on the Notes and we must not already be in default (unless the merger or sale would cure the default). For purposes of this no-default test, a default would include an Event of Default that has occurred and has not been cured, as described under “Events of Default” above. A default for this purpose would also include any event that would be an Event of Default if the requirements for giving us a notice of default or our default having to exist for a specific period of time were disregarded; and

 

    we must deliver certain certificates and documents to the trustee.

Modification or Waiver

There are three types of changes we can make to the indenture and the Notes issued thereunder.

Changes Requiring Your Approval

First, there are changes that we cannot make to your Notes without your specific approval. The following is a list of those types of changes:

 

    change the stated maturity of the principal of or interest on the Notes;

 

    reduce any amounts due on the Notes;

 

    reduce the amount of principal payable upon acceleration of the maturity of a Note following a default;

 

    change the place or currency of payment on a Note;

 

    impair your right to sue for payment;

 

    reduce the percentage of holders of Notes whose consent is needed to modify or amend the indenture; and

 

    reduce the percentage of holders of Notes whose consent is needed to waive compliance with certain provisions of the indenture or to waive certain defaults.

Changes Not Requiring Approval

The second type of change does not require any vote by the holders of the Notes. This type is limited to clarifications and certain other changes that would not adversely affect holders of the Notes in any material respect.

 

S-70


Table of Contents

Changes Requiring Majority Approval

Any other change to the indenture and the Notes would require the following approval:

 

    if the change affects only the Notes, it must be approved by the holders of a majority in principal amount of the Notes; and

 

    if the change affects more than one series of debt securities issued under the same indenture, it must be approved by the holders of a majority in principal amount of all of the series affected by the change, with all affected series voting together as one class for this purpose.

In each case, the required approval must be given by written consent.

The holders of a majority in principal amount of all of the series of debt securities issued under an indenture, voting together as one class for this purpose, may waive our compliance with some of our covenants in that indenture. However, we cannot obtain a waiver of a payment default or of any of the matters covered by the bullet points included above under “—Changes Requiring Your Approval.”

Further Details Concerning Voting

When taking a vote, we will use the following rules to decide how much principal to attribute to the Notes:

The Notes will not be considered outstanding, and therefore not eligible to vote, if we have deposited or set aside in trust money for their payment or redemption. The Notes will also not be eligible to vote if they have been fully defeased as described later under “—Defeasance—Full Defeasance.”

We will generally be entitled to set any day as a record date for the purpose of determining the holders of the Notes that are entitled to vote or take other action under the indenture. However, the record date may not be more than 30 days before the date of the first solicitation of holders to vote on or take such action. If we set a record date for a vote or other action to be taken by holders of the Notes, that vote or action may be taken only by persons who are holders of the Notes on the record date and must be taken within eleven months following the record date.

Book-entry and other indirect holders should consult their banks or brokers for information on how approval may be granted or denied if we seek to change the indenture or the Notes or request a waiver.

Defeasance

The following defeasance provisions will be applicable to the Notes. “Defeasance” means that, by depositing with a trustee an amount of cash and/or government securities sufficient to pay all principal and interest, if any, on the Notes when due and satisfying any additional conditions noted below, we will be deemed to have been discharged from our obligations under the Notes. In the event of a “covenant defeasance,” upon depositing such funds and satisfying similar conditions discussed below we would be released from the restrictive covenants under the indenture relating to the Notes. The consequences to the holders of the Notes is that, while they no longer benefit from the restrictive covenants under the indenture, and while the Notes may not be accelerated for any reason, the holders of Notes nonetheless are guaranteed to receive the principal and interest owed to them. We are under no obligation to exercise any such rights of defeasance.

Covenant Defeasance

Under current U.S. federal tax law and the indenture, we can make the deposit described below and be released from some of the restrictive covenants in the indenture under which the Notes were issued. This is called “covenant defeasance.” In that event, you would lose the protection of those restrictive covenants but would gain the protection of having money and government securities set aside in trust to repay your Notes. If we achieve covenant defeasance and your Notes were subordinated as described under “Indenture Provisions—Ranking” below, such

 

S-71


Table of Contents

subordination would not prevent the trustee under the indenture from applying the funds available to it from the deposit described in the first bullet to the payment of amounts due in respect of such debt securities for the benefit of the subordinated debtholders. In order to achieve covenant defeasance, we must do the following:

 

    Since the Notes are denominated in U.S. dollars, we must deposit in trust for the benefit of all holders of the Notes a combination of cash and U.S. government or U.S. government agency notes or bonds that will generate enough cash to make interest, principal and any other payments on the Notes on their various due dates;

 

    we must deliver to the trustee a legal opinion of our counsel confirming that, under current U.S. federal income tax law, we may make the above deposit without causing you to be taxed on the Notes any differently than if we did not make the deposit;

 

    we must deliver to the trustee a legal opinion of our counsel stating that the above deposit does not require registration by us under the 1940 Act, and a legal opinion and officers’ certificate stating that all conditions precedent to covenant defeasance have been complied with;

 

    defeasance must not result in a breach or violation of, or result in a default under, the indenture or any of our other material agreements or instruments; and

 

    no default or event of default with respect to the Notes shall have occurred and be continuing and no defaults or events of default related to bankruptcy, insolvency or reorganization shall occur during the next 90 days.

If we accomplish covenant defeasance, you can still look to us for repayment of the Notes if there were a shortfall in the trust deposit or the trustee is prevented from making payment. In fact, if one of the remaining Events of Default occurred (such as our bankruptcy) and the Notes became immediately due and payable, there might be a shortfall. Depending on the event causing the default, you may not be able to obtain payment of the shortfall.

Full Defeasance

If there is a change in U.S. federal tax law, as described below, we can legally release ourselves from all payment and other obligations on the Notes (called “full defeasance”) if we put in place the following other arrangements for you to be repaid:

 

    Since the Notes are denominated in U.S. dollars, we must deposit in trust for the benefit of all holders of the Notes a combination of money and U.S. government or U.S. government agency notes or bonds that will generate enough cash to make interest, principal and any other payments on the Notes on their various due dates;

 

    we must deliver to the trustee a legal opinion confirming that there has been a change in current U.S. federal tax law or an IRS ruling that allows us to make the above deposit without causing you to be taxed on the Notes any differently than if we did not make the deposit. Under current U.S. federal tax law the deposit and our legal release from the Notes would be treated as though we paid you your share of the cash and notes or bonds at the time the cash and notes or bonds were deposited in trust in exchange for your Notes and you would recognize gain or loss on the Notes at the time of the deposit;

 

    we must deliver to the trustee a legal opinion of our counsel stating that the above deposit does not require registration by us under the 1940 Act, and a legal opinion and officers’ certificate stating that all conditions precedent to defeasance have been complied with;

 

    defeasance must not result in a breach or violation of, or constitute a default under, of the indenture or any of our other material agreements or instruments; and

 

    no default or event of default with respect to the Notes shall have occurred and be continuing and no defaults or events of default related to bankruptcy, insolvency or reorganization shall occur during the next 90 days.

 

S-72


Table of Contents

If we ever did accomplish full defeasance, as described above, you would have to rely solely on the trust deposit for repayment of the Notes. You could not look to us for repayment in the unlikely event of any shortfall. Conversely, the trust deposit would most likely be protected from claims of our lenders and other creditors if we ever became bankrupt or insolvent. If your Notes were subordinated as described later under “—Indenture Provisions—Ranking,” such subordination would not prevent the trustee under the Indenture from applying the funds available to it from the deposit referred to in the first bullet of the preceding paragraph to the payment of amounts due in respect of such Notes for the benefit of the subordinated debtholders.

Other Covenants

In addition to any other covenants described in this prospectus, as well as standard covenants relating to payment of principal and interest, maintaining an office where payments may be made or securities can be surrendered for payment, payment of taxes by the Company and related matters, the following covenants will apply to the Notes:

 

    We agree that for the period of time during which the Notes are outstanding, we will not violate (whether or not we are subject thereto) Section 18(a)(1)(A) as modified by Section 61(a)(1) of the 1940 Act or any successor provisions, but giving effect to any exemptive relief granted to us by the SEC. Currently, these provisions generally prohibit us from making additional borrowings, including through the issuance of additional debt securities, unless our asset coverage, as defined in the 1940 Act, equals at least 200% after such borrowings. See the accompanying prospectus, “Risk Factors—Pending legislation may allow us to incur additional leverage.”

 

    We agree that for the period of time during which the Notes are outstanding, we will not violate (regardless of whether we are subject to) Section 18(a)(1)(B) as modified by Section 61(a)(1) of the 1940 Act or any successor provisions, but giving effect to (i) any exemptive relief granted to us by the SEC and (ii) no-action relief granted by the SEC to another BDC (or to the Company if it determines to seek such similar no-action or other relief) permitting the BDC to declare any cash dividend or distribution notwithstanding the prohibition contained in Section 18(a)(1)(B) as modified by Section 61(a)(1) of the 1940 Act in order to maintain the BDC’s status as a regulated investment company under Subchapter M of the Internal Revenue Code of 1986. Currently, these provisions generally prohibit us from declaring any cash dividend or distribution upon any class of our capital stock, or purchasing any such capital stock if our asset coverage, as defined in the 1940 Act, is below 200% at the time of the declaration of the dividend or distribution or the purchase and after deducting the amount of such dividend, distribution or purchase.

 

    If, at any time, we are not subject to the reporting requirements of Sections 13 or 15(d) of the Exchange Act to file any periodic reports with the SEC, we agree to furnish to holders of the Notes and the Trustee, for the period of time during which the Notes are outstanding, our audited annual consolidated financial statements, within 90 days of our fiscal year end, and unaudited interim consolidated financial statements, within 45 days of our fiscal quarter end (other than our fourth fiscal quarter). All such financial statements will be prepared, in all material respects, in accordance with applicable United States generally accepted accounting principles.

Form, Exchange and Transfer of Certificated Registered Securities

If registered Notes cease to be issued in book-entry form, they will be issued:

 

    only in fully registered certificated form;

 

    without interest coupons; and

 

    unless we indicate otherwise, in denominations of $25 and amounts that are multiples of $25.

 

S-73


Table of Contents

Holders may exchange their certificated securities for Notes of smaller denominations or combined into fewer Notes of larger denominations, as long as the total principal amount is not changed and as long as the denomination is equal to or greater than $25.

Holders may exchange or transfer their certificated securities at the office of the trustee. We have appointed the trustee to act as our agent for registering Notes in the names of holders transferring Notes. We may appoint another entity to perform these functions or perform them ourselves.

Holders will not be required to pay a service charge to transfer or exchange their certificated securities, but they may be required to pay any tax or other governmental charge associated with the transfer or exchange. The transfer or exchange will be made only if our transfer agent is satisfied with the holder’s proof of legal ownership.

We may appoint additional transfer agents or cancel the appointment of any particular transfer agent. We may also approve a change in the office through which any transfer agent acts.

If any certificated securities of a particular series are redeemable and we redeem less than all the debt securities of that series, we may block the transfer or exchange of those debt securities during the period beginning 15 days before the day we mail the notice of redemption and ending on the day of that mailing, in order to freeze the list of holders to prepare the mailing. We may also refuse to register transfers or exchanges of any certificated securities selected for redemption, except that we will continue to permit transfers and exchanges of the unredeemed portion of any debt security that will be partially redeemed.

If a registered debt security is issued in book-entry form, only the depositary will be entitled to transfer and exchange the debt security as described in this subsection, since it will be the sole holder of the debt security.

Resignation of Trustee

The trustee may resign or be removed with respect to the Notes provided that a successor trustee is appointed to act with respect to the Notes. In the event that two or more persons are acting as trustee with respect to different series of indenture securities under the indenture, each of the trustees will be a trustee of a trust separate and apart from the trust administered by any other trustee.

Indenture Provisions—Ranking

The Notes will be our direct unsecured obligations and will rank:

 

    pari passu, or equal in right of payment, with our existing and future unsecured indebtedness;

 

    senior to any of our future indebtedness that expressly provides it is subordinated to the Notes;

 

    effectively subordinated to all of our existing and future secured indebtedness (including indebtedness that is initially unsecured to which we subsequently grant security), to the extent of the value of the assets securing such indebtedness; and

 

    structurally subordinated to all existing and future indebtedness and other obligations of any of our subsidiaries, including without limitation, borrowings under the Credit Facility and borrowings by Saratoga Investment Corp SBIC LP.

Upon any distribution of our assets upon our dissolution, winding up, liquidation or reorganization, the payment of the principal of (and premium if any) and interest, if any, on any indenture securities denominated as subordinated debt securities is to be subordinated to the extent provided in the indenture in right of payment to the prior payment in full of all Senior Indebtedness (as defined below). In addition, no payment on account of principal (or premium, if any), sinking fund or interest, if any, may be made on such subordinated debt securities at any time unless full payment of all amounts due in respect of the principal (and premium, if any), sinking fund and interest on Senior Indebtedness has been made or duly provided for in money or money’s worth.

 

S-74


Table of Contents

In the event that, notwithstanding the foregoing, any payment by us is received by the trustee in respect of subordinated debt securities or by the holders of any of such subordinated debt securities, upon our dissolution, winding up, liquidation or reorganization before all Senior Indebtedness is paid in full, the payment or distribution must be paid over to the holders of the Senior Indebtedness or on their behalf for application to the payment of all the Senior Indebtedness remaining unpaid until all the Senior Indebtedness has been paid in full, after giving effect to any concurrent payment or distribution to the holders of the Senior Indebtedness. Subject to the payment in full of all Senior Indebtedness upon this distribution by us, the holders of such subordinated debt securities will be subrogated to the rights of the holders of the Senior Indebtedness to the extent of payments made to the holders of the Senior Indebtedness out of the distributive share of such subordinated debt securities.

By reason of this subordination, in the event of a distribution of our assets upon our insolvency, certain of our senior creditors may recover more, ratably, than holders of any subordinated debt securities or the holders of any indenture securities that are not Senior Indebtedness or subordinated debt securities. The Indenture provides that these subordination provisions will not apply to money and securities held in trust under the defeasance provisions of the Indenture.

Senior Indebtedness is defined in the Indenture as the principal of (and premium, if any) and unpaid interest on:

 

    our indebtedness (including indebtedness of others guaranteed by us), whenever created, incurred, assumed or guaranteed, for money borrowed, that we have designated as “Senior Indebtedness” for purposes of the Indenture and in accordance with the terms of the Indenture (including any indenture securities designated as Senior Indebtedness), and

 

    renewals, extensions, modifications and refinancings of any of this indebtedness.

Book-Entry Procedures

The Notes will be represented by global securities that will be deposited and registered in the name of The Depository Trust Company (“DTC”) or its nominee. This means that, except in limited circumstances, you will not receive certificates for the Notes. Beneficial interests in the Notes will be represented through book-entry accounts of financial institutions acting on behalf of beneficial owners as direct and indirect participants in DTC. Investors may elect to hold interests in the Notes through either DTC, if they are a participant, or indirectly through organizations that are participants in DTC.

The Notes will be issued as fully registered securities registered in the name of Cede & Co. (DTC’s partnership nominee) or such other name as may be requested by an authorized representative of DTC. One fully-registered certificate will be issued for each issuance of the Notes, in the aggregate principal amount of such issue, and will be deposited with DTC. Interests in the Notes will trade in DTC’s Same Day Funds Settlement System, and any permitted secondary market trading activity in such Notes will, therefore, be required by DTC to be settled in immediately available funds. None of the Company, the Trustee or the Paying Agent will have any responsibility for the performance by DTC or its participants or indirect participants of their respective obligations under the rules and procedures governing their operations.

DTC is a limited-purpose trust company organized under the New York Banking Law, a “banking organization” within the meaning of the New York Banking Law, a member of the Federal Reserve System, a “clearing corporation” within the meaning of the New York Uniform Commercial Code, and a “clearing agency” registered pursuant to the provisions of Section 17A of the Exchange Act. DTC holds and provides asset servicing for over 3.5 million issues of U.S. and non-U.S. equity, corporate and municipal debt issues, and money market instruments from over 100 countries that DTC’s participants (“Direct Participants”) deposit with DTC. DTC also facilitates the post-trade settlement among Direct Participants of sales and other securities transactions in deposited securities through electronic computerized book-entry transfers and pledges between Direct Participants’ accounts. This eliminates the need for physical movement of securities certificates. Direct

 

S-75


Table of Contents

Participants include both U.S. and non-U.S. securities brokers and dealers, banks, trust companies, clearing corporations, and certain other organizations. DTC is a wholly owned subsidiary of The Depository Trust & Clearing Corporation (“DTCC”).

DTCC is the holding company for DTC, National Securities Clearing Corporation and Fixed Income Clearing Corporation, all of which are registered clearing agencies. DTCC is owned by the users of its regulated subsidiaries. Access to the DTC system is also available to others such as both U.S. and non-U.S. securities brokers and dealers, banks, trust companies and clearing corporations that clear through or maintain a custodial relationship with a Direct Participant, either directly or indirectly (“Indirect Participants”). DTC has Standard & Poor’s Ratings Services’ highest rating: AAA. The DTC Rules applicable to its participants are on file with the SEC. More information about DTC can be found at www.dtcc.com and www.dtc.org.

Purchases of the Notes under the DTC system must be made by or through Direct Participants, which will receive a credit for the Notes on DTC’s records. The ownership interest of each actual purchaser of each security, or the “Beneficial Owner,” is in turn to be recorded on the Direct and Indirect Participants’ records. Beneficial Owners will not receive written confirmation from DTC of their purchase. Beneficial Owners are, however, expected to receive written confirmations providing details of the transaction, as well as periodic statements of their holdings, from the Direct or Indirect Participant through which the Beneficial Owner entered into the transaction. Transfers of ownership interests in the Notes are to be accomplished by entries made on the books of Direct and Indirect Participants acting on behalf of Beneficial Owners. Beneficial Owners will not receive certificates representing their ownership interests in the Notes, except in the event that use of the book-entry system for the Notes is discontinued.

To facilitate subsequent transfers, all Notes deposited by Direct Participants with DTC are registered in the name of DTC’s partnership nominee, Cede & Co. or such other name as may be requested by an authorized representative of DTC. The deposit of the Notes with DTC and their registration in the name of Cede & Co. or such other DTC nominee do not effect any change in beneficial ownership. DTC has no knowledge of the actual Beneficial Owners of the Notes; DTC’s records reflect only the identity of the Direct Participants to whose accounts the Notes are credited, which may or may not be the Beneficial Owners. The Direct and Indirect Participants will remain responsible for keeping account of their holdings on behalf of their customers.

Conveyance of notices and other communications by DTC to Direct Participants, by Direct Participants to Indirect Participants, and by Direct Participants and Indirect Participants to Beneficial Owners will be governed by arrangements among them, subject to any statutory or regulatory requirements as may be in effect from time to time.

Redemption notices shall be sent to DTC. If less than all of the Notes within an issue are being redeemed, DTC’s practice is to determine by lot the amount of the interest of each Direct Participant in such issue to be redeemed.

Redemption proceeds, distributions, and interest payments on the Notes will be made to Cede & Co., or such other nominee as may be requested by an authorized representative of DTC. DTC’s practice is to credit Direct Participants’ accounts upon DTC’s receipt of funds and corresponding detail information from us or the Trustee on the payment date in accordance with their respective holdings shown on DTC’s records. Payments by Participants to Beneficial Owners will be governed by standing instructions and customary practices, as is the case with securities held for the accounts of customers in bearer form or registered in “street name,” and will be the responsibility of such Participant and not of DTC nor its nominee, the Trustee, or us, subject to any statutory or regulatory requirements as may be in effect from time to time. Payment of redemption proceeds, distributions, and interest payments to Cede & Co. (or such other nominee as may be requested by an authorized representative of DTC) is the responsibility of us or the Trustee, but disbursement of such payments to Direct Participants will be the responsibility of DTC, and disbursement of such payments to the Beneficial Owners will be the responsibility of Direct and Indirect Participants.

 

S-76


Table of Contents

DTC may discontinue providing its services as securities depository with respect to the Notes at any time by giving reasonable notice to us or to the Trustee. Under such circumstances, in the event that a successor securities depository is not obtained, certificates are required to be printed and delivered. We may decide to discontinue use of the system of book-entry-only transfers through DTC (or a successor securities depository). In that event, certificates will be printed and delivered to DTC.

The information in this section concerning DTC and DTC’s book-entry system has been obtained from sources that we believe to be reliable, but we take no responsibility for the accuracy thereof.

 

S-77


Table of Contents

PLAN OF DISTRIBUTION

Ladenburg Thalmann & Co. Inc. is acting as our sales agent in connection with the offer and sale of the Notes pursuant to this prospectus supplement and the accompanying prospectus. Upon written instructions from us, Ladenburg Thalmann & Co. Inc. will use its commercially reasonable efforts consistent with its sales and trading practices to sell, as our sales agent, the Notes under the terms and subject to the conditions set forth in our Debt Distribution Agreement with Ladenburg Thalmann & Co. Inc. dated May 29, 2015. We will instruct Ladenburg Thalmann & Co. Inc. as to the amount of the Notes to be sold by it. We may instruct Ladenburg Thalmann & Co. Inc. not to sell the Notes if the sales cannot be effected at or above the price designated by us in any instruction. We will not instruct the Ladenburg Thalmann & Co. Inc. to sell the Notes if the sales cannot be effected at or above prices that will allow the Notes to be treated as “fungible” with the Existing Notes for U.S. federal income tax purposes. We or Ladenburg Thalmann & Co. Inc. may suspend the offering of Notes upon proper notice and subject to other conditions.

Sales of the Notes, if any, under this prospectus supplement and the accompanying prospectus may be made in negotiated transactions or transactions that are deemed to be “at the market,” as defined in Rule 415 under the Securities Act, including sales made directly on the NYSE or similar securities exchange or sales made to or through a market maker other than on an exchange at prices related to the prevailing market prices or at negotiated prices. If any of the Notes are sold at prices above par, the effective yield on such Notes to the purchasers may be less than 7.50%.

Ladenburg Thalmann & Co. Inc. will provide written confirmation of a sale to us no later than the opening of the trading day on the NYSE following each trading day in which the Notes are sold under the Debt Distribution Agreement. Each confirmation will include the amount of Notes sold on the preceding day, the net proceeds to us and the compensation payable by us to Ladenburg Thalmann & Co. Inc. in connection with the sales.

Ladenburg Thalmann & Co. Inc. will receive a commission from us equal to 2.0% of the gross sales price of any of the Notes sold through Ladenburg Thalmann & Co. Inc. under the Debt Distribution Agreement. We estimate that the total expenses for the offering, excluding compensation payable to Ladenburg Thalmann & Co. Inc. under the terms of the Debt Distribution Agreement, will be approximately $135,000.

Settlement for sales of the Notes will occur on the third trading day following the date on which such sales are made, or on some other date that is agreed upon by us and Ladenburg Thalmann & Co. Inc. in connection with a particular transaction, in return for payment of the net proceeds to us. There is no arrangement for funds to be received in an escrow, trust or similar arrangement.

We will report at least quarterly the number of the Notes sold through Ladenburg Thalmann & Co. Inc. under the Debt Distribution Agreement, the net proceeds to us and the compensation paid by us to Ladenburg Thalmann & Co. Inc., if any.

From May 29, 2015, the date that we commenced this offering, through July 16, 2015, the Company sold 227,863 Notes in an aggregate principal amount of $5,696,575 at an average price of $25.32 for aggregate net proceeds of $5,653,305 (net of transaction costs). Ladenburg Thalmann & Co. Inc. received compensation of $115,375 in connection with such sales.

In connection with the sale of the Notes on our behalf, Ladenburg Thalmann & Co. Inc. may be deemed to be an “underwriter” within the meaning of the Securities Act, and the compensation of Ladenburg Thalmann & Co. Inc. may be deemed to be underwriting commissions or discounts. We have agreed to provide indemnification and contribution to Ladenburg Thalmann & Co. Inc. against certain civil liabilities, including liabilities under the Securities Act.

 

S-78


Table of Contents

The offering of the Notes pursuant to the Debt Distribution Agreement will terminate upon the earlier of (i) the sale of the dollar amount of Notes subject to the Debt Distribution Agreement or (ii) the termination of the Debt Distribution Agreement. The Debt Distribution Agreement may be terminated by us in our sole discretion under the circumstances specified in the Debt Distribution Agreement by giving notice to Ladenburg Thalmann & Co. Inc. In addition, Ladenburg Thalmann & Co. Inc. may terminate the Debt Distribution Agreement under the circumstances specified in the Debt Distribution Agreement by giving notice to us.

Potential Conflicts of Interest

Ladenburg Thalmann & Co. Inc. and its affiliates have provided, or may in the future provide, various investment banking, commercial banking, financial advisory, brokerage and other services to us and our affiliates for which services they have received, and may in the future receive, customary fees and expense reimbursement. Specifically, pursuant to an underwriting agreement dated May 2, 2013, for which Ladenburg Thalmann & Co. Inc. acted as representative of the underwriters, on May 10, 2013, we issued $42.0 million in aggregate principal amount of the Existing Notes. In addition, on May 17, 2013, we closed an additional $6.3 million in aggregate principal amount of the Existing Notes, pursuant to the full exercise of the underwriters’ option to purchase additional Existing Notes. In connection with the foregoing, we paid underwriting discounts and commissions of $1,932,000 to the underwriters.

Ladenburg Thalmann & Co. Inc. and its affiliates may, from time to time, engage in transactions with and perform services for us in the ordinary course of their business for which they may receive customary fees and reimbursement of expenses. In the ordinary course of their various business activities, Ladenburg Thalmann & Co. Inc. and its affiliates may make or hold a broad array of investments and actively trade debt and equity securities (or related derivative securities) and financial instruments (including bank loans) for their own account and for the accounts of their customers and such investment and securities activities may involve securities and/or instruments of our company. Ladenburg Thalmann & Co. Inc. and its affiliates may also make investment recommendations and/or publish or express independent research views in respect of such securities or instruments and may at any time hold, or recommend to clients that they acquire, long and/or short positions in such securities and instruments.

The principal business address of Ladenburg Thalmann & Co. Inc. is 570 Lexington Avenue, 12th Floor, New York, NY 10022.

 

S-79


Table of Contents

LEGAL MATTERS

Certain legal matters in connection with the securities offered hereby will be passed upon for us by Sutherland Asbill & Brennan LLP, Washington, DC. Certain legal matters in connection with the offering will be passed upon for the sales agent by Blank Rome LLP, New York, New York.

 

S-80


Table of Contents

INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

Ernst & Young LLP, our independent registered public accounting firm, has audited our consolidated financial statements as of February 28, 2015 and February 28, 2014 and the three years ended February 28, 2015, February 2014 and February 28, 2013 and the related senior securities table, as set forth in their reports. We have included our consolidated financial statements and our senior securities table in this prospectus and elsewhere in the registration statement in reliance on Ernst & Young LLP’s report, given on their authority as experts in accounting and auditing. Ernst & Young LLP’s principal business address is 5 Times Square, New York, New York 10036.

 

S-81


Table of Contents

AVAILABLE INFORMATION

We have filed with the SEC a registration statement on Form N-2 together with all amendments and related exhibits under the Securities Act. The registration statement contains additional information about us and the securities being offered by this prospectus supplement and the accompanying prospectus.

We file annual, quarterly and current reports, proxy statements and other information with the SEC under the Securities Exchange Act of 1934, as amended. You can inspect any materials we file with the SEC, without charge, at the SEC’s Public Reference Room at 100 F Street, N.E., Washington, D.C. 20549. Please call the SEC at 1-800-SEC-0330 for further information on the Public Reference Room. The information we file with the SEC is available free of charge by contacting us at Saratoga Investment Corp., 535 Madison Avenue, New York, New York 10022, by telephone at (212) 906-7800, or on our website at http://www.saratogainvestmentcorp.com. The SEC also maintains a website that contains reports, proxy statements and other information regarding registrants, including us, that file such information electronically with the SEC. The address of the SEC’s web site is http://www.sec.gov. Information contained on our website or on the SEC’s web site about us is not incorporated into this prospectus supplement or the accompanying prospectus and you should not consider information contained on our website or on the SEC’s website to be part of this prospectus supplement or the accompanying prospectus.

 

S-82


Table of Contents

INDEX TO CONSOLIDATED FINANACIAL STATEMENTS

 

 

 

         Page  
    UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS       
  Consolidated Statements of Assets and Liabilities as of May 31, 2015 (unaudited) and February 28, 2015      S-84   
  Consolidated Statements of Operations for the three months ended May 31, 2015 and May 31, 2014 (unaudited)      S-85   
  Consolidated Schedules of Investments as of May 31, 2015 (unaudited) and February 28, 2015      S-86   
  Consolidated Statements of Changes in Net Assets for the three months ended May 31, 2015 and May 31, 2014 (unaudited)      S-94   
  Consolidated Statements of Cash Flows for the three months ended May 31, 2015 and May 31, 2014 (unaudited)      S-95   
  Notes to Consolidated Financial Statements as of May 31, 2015 (unaudited)      S-96   
  AUDITED CONSOLIDATED FINANCIAL STATEMENTS   
  Report of Independent Registered Public Accounting Firm      S-134   
  Consolidated Statements of Assets and Liabilities as of February 28, 2015 and February 28, 2014      S-135   
  Consolidated Statements of Operations for the years ended February 28, 2015 and February 28, 2014      S-136   
  Consolidated Schedules of Investments as of February 28, 2015 and February 28, 2014      S-137   
  Consolidated Statements of Changes in Net Assets for the years ended February 28, 2015, February 28, 2014 and February 28, 2013      S-145   
  Consolidated Statements of Cash Flows for the years ended February 28, 2015, February 28, 2014 and February 28, 2013      S-146   
  Notes to Consolidated Financial Statements as of February 28, 2015      S-147   

 

S-83


Table of Contents

PART I FINANCIAL INFORMATION

Item 1. Financial Statements

Saratoga Investment Corp.

Consolidated Statements of Assets and Liabilities

 

     As of  
     May 31, 2015     February 28, 2015  
     (unaudited)        

ASSETS

    

Investments at fair value

    

Non-control/non-affiliate investments (amortized cost of $239,950,830 and $222,505,383, respectively)

   $ 245,883,731      $ 223,506,589   

Control investments (cost of $15,172,837 and $15,953,001, respectively)

     16,860,256        17,031,146   
  

 

 

   

 

 

 

Total investments at fair value (amortized cost of $255,123,667 and $238,458,384, respectively)

  262,743,987      240,537,735   

Cash and cash equivalents

  699,127      1,888,158   

Cash and cash equivalents, reserve accounts

  5,863,893      18,175,214   

Interest receivable, (net of reserve of $354,144 and $309,498, respectively)

  2,793,526      2,469,398   

Management fee receivable

  174,527      171,913   

Other assets

  475,257      317,637   
  

 

 

   

 

 

 

Total assets

$ 272,750,317    $ 263,560,055   
  

 

 

   

 

 

 

LIABILITIES

Revolving credit facility

$ 11,800,000    $ 9,600,000   

Deferred debt financing costs, revolving credit facility

  (575,002   (594,845

SBA debentures payable

  79,000,000      79,000,000   

Deferred debt financing costs, SBA debentures payable

  (2,231,653   (2,340,894

Notes payable

  48,300,000      48,300,000   

Deferred debt financing costs, notes payable

  (1,758,989   (1,847,564

Dividend payable

  5,995,489      402,200   

Base management and incentive fees payable

  6,765,317      5,835,941   

Accounts payable and accrued expenses

  675,383      835,189   

Interest and debt fees payable

  912,628      1,405,466   

Due to manager

  375,820      365,820   
  

 

 

   

 

 

 

Total liabilities

$ 149,258,993    $ 140,961,313   
  

 

 

   

 

 

 

Commitments and contingencies (See Note 7)

NET ASSETS

Common stock, par value $.001, 100,000,000 common shares authorized, 5,428,758 and 5,401,899 common shares issued and outstanding, respectively

$ 5,429    $ 5,402   

Capital in excess of par value

  185,279,853      184,877,680   

Distribution in excess of net investment income

  (29,029,436   (23,905,603

Accumulated net realized loss from investments and derivatives

  (40,384,842   (40,458,088

Accumulated net unrealized appreciation on investments and derivatives

  7,620,320      2,079,351   
  

 

 

   

 

 

 

Total net assets

  123,491,324      122,598,742   
  

 

 

   

 

 

 

Total liabilities and net assets

$ 272,750,317    $ 263,560,055   
  

 

 

   

 

 

 

NET ASSET VALUE PER SHARE

$ 22.75    $ 22.70   
  

 

 

   

 

 

 

See accompanying notes to consolidated financial statements.

 

S-84


Table of Contents

Saratoga Investment Corp.

Consolidated Statements of Operations

(unaudited)

 

     For the three months
ended May 31, 2015
     For the three months
ended May 31, 2014
 

INVESTMENT INCOME

     

Interest from investments

     

Non-control/Non-affiliate investments

   $ 5,648,979       $ 4,707,894   

Payment-in-kind interest income from Non-control/Non-affiliate investments

     691,152         252,928   

Control investments

     590,990         641,338   
  

 

 

    

 

 

 

Total interest income

  6,931,121      5,602,160   

Interest from cash and cash equivalents

  736      594   

Management fee income

  378,746      392,034   

Other income

  250,564      149,335   
  

 

 

    

 

 

 

Total investment income

  7,561,167      6,144,123   
  

 

 

    

 

 

 

EXPENSES

Interest and debt financing expenses

  1,963,865      1,787,587   

Base management fees

  1,124,098      968,479   

Professional fees

  333,444      435,374   

Administrator expenses

  250,000      250,000   

Incentive management fees

  1,797,833      378,489   

Insurance

  87,317      84,487   

Directors fees and expenses

  51,000      53,175   

General & administrative

  182,920      123,626   
  

 

 

    

 

 

 

Total expenses

  5,790,477      4,081,217   
  

 

 

    

 

 

 

NET INVESTMENT INCOME

  1,770,690      2,062,906   
  

 

 

    

 

 

 

REALIZED AND UNREALIZED GAIN (LOSS) ON INVESTMENTS:

Net realized gain from investments

  73,246      81,680   

Net unrealized appreciation/(depreciation) on investments

  5,540,969      (384,697
  

 

 

    

 

 

 

Net gain/(loss) on investments

  5,614,215      (303,017
  

 

 

    

 

 

 

NET INCREASE IN NET ASSETS RESULTING FROM OPERATIONS

$ 7,384,905    $ 1,759,889   
  

 

 

    

 

 

 

WEIGHTED AVERAGE—BASIC AND DILUTED EARNINGS PER COMMON SHARE

$ 1.36    $ 0.33   

WEIGHTED AVERAGE COMMON STOCK OUTSTANDING—BASIC AND DILUTED

  5,422,491      5,379,616   

See accompanying notes to consolidated financial statements.

 

S-85


Table of Contents

Saratoga Investment Corp.

Consolidated Schedule of Investments

May 31, 2015

(unaudited)

 

Company

 

Industry

 

Investment

Interest Rate /

Maturity

  Principal/
Number of
Shares
    Cost     Fair
Value(c)
    % of
Net Assets
 

Non-control/Non-affiliated investments—199.1%(b)

           

National Truck Protection Co., Inc.(d),(g)

  Automotive Aftermarket   Common Stock     1,116      $ 1,000,000      $ 1,430,192        1.2

National Truck Protection Co., Inc.(d)

  Automotive Aftermarket  

First Lien Term Loan 15.50%

Cash, 9/13/2018

  $ 7,326,770        7,326,770        7,326,770        5.9

Take 5 Oil Change, L.L.C.(d),(g)

  Automotive Aftermarket   Common Stock     7,128        480,535        1,782,855        1.4
       

 

 

   

 

 

   

 

 

 
    Total Automotive Aftermarket       8,807,305        10,539,817        8.5
       

 

 

   

 

 

   

 

 

 

Legacy Cabinets Holdings(d),(g)

  Building Products   Common Stock Voting A-1     2,535        220,900        1,701,441        1.4

Legacy Cabinets Holdings(d),(g)

  Building Products   Common Stock Voting B-1     1,600        139,424        1,073,888        0.9

Polar Holding Company, Ltd.(a),(i)

  Building Products  

First Lien Term Loan 10.00%

Cash, 8/13/2016

  $ 1,000,000        1,000,000        1,000,000        0.8
       

 

 

   

 

 

   

 

 

 
    Total Building Products       1,360,324        3,775,329        3.1
       

 

 

   

 

 

   

 

 

 

BMC Software, Inc.(d)

  Business Services  

First Lien Term Loan 5.00%

Cash, 9/10/2020

  $ 5,716,667        5,673,479        5,610,337        4.5

Dispensing Dynamics International(d)

  Business Services  

Senior Secured Note 12.50%

Cash, 1/1/2018

  $ 7,000,000        6,916,888        7,350,000        6.0

Easy Ice, LLC(d)

  Business Services  

First Lien Term Loan 9.50%

Cash, 1/15/2020

  $ 12,000,000        11,876,875        12,000,000        9.6

Emily Street Enterprises, L.L.C.

  Business Services  

Senior Secured Note 10.00%

Cash, 1/23/2020

  $ 8,400,000        8,271,383        8,400,000        6.8

Emily Street Enterprises, L.L.C.(g)

  Business Services   Warrant Membership Interests     49,318        400,000        452,056        0.4

Help/Systems Holdings, Inc.(Help/Systems, LLC)(d)

  Business Services  

First Lien Term Loan 5.50%

Cash, 6/28/2019

  $ 1,950,101        1,937,220        1,940,351        1.6

Help/Systems Holdings, Inc.(Help/Systems, LLC)(d)

  Business Services   Second Lien Term Loan 9.50% Cash, 6/28/2020   $ 2,000,000        1,976,757        1,965,000        1.6

Knowland Technology Holdings, L.L.C.

  Business Services  

First Lien Term Loan 11.00%

Cash, 11/29/2017

  $ 5,259,171        5,209,053        5,259,171        4.3

Knowland Technology Holdings, L.L.C.(j),(k),(l)

  Business Services   Delayed Draw Term Loan 11.00% Cash, 11/29/2017   $ —          —          —          0.0

Vector Controls Holding Co., LLC(d)

  Business Services   First Lien Term Loan, 14.00% (12.00% Cash/2.00% PIK), 3/6/2018   $ 9,482,677        9,366,186        9,482,677        7.7

Vector Controls Holding Co., LLC(d),(g)

  Business Services   Warrants to Purchase Limited Liability Company Interests     101        —          34,939        0.0
       

 

 

   

 

 

   

 

 

 
    Total Business Services       51,627,841        52,494,531        42.5
       

 

 

   

 

 

   

 

 

 

Targus Group International, Inc.(d)

  Consumer Products   First Lien Term Loan, 14.75% (13.75% Cash/1.00% PIK), 5/24/2016   $ 3,577,302        3,551,526        3,035,341        2.5

Targus Holdings, Inc.(d),(g)

  Consumer Products   Common Stock     62,413        566,765        —          0.0

Targus Holdings, Inc.(d),(m)

  Consumer Products   Unsecured Note 10.00% PIK, 6/14/2019   $ 2,054,158        2,054,158        —          0.0

Targus Holdings, Inc.(d),(m)

  Consumer Products   Unsecured Note 16.00% PIK, 10/26/2018   $ 429,797        425,459        —          0.0
       

 

 

   

 

 

   

 

 

 
    Total Consumer Products       6,597,908        3,035,341        2.5
       

 

 

   

 

 

   

 

 

 

 

S-86


Table of Contents

Company

 

Industry

 

Investment

Interest Rate /

Maturity

  Principal/
Number of
Shares
    Cost     Fair
Value(c)
    % of
Net Assets
 

Avionte Holdings, LLC(g)

 

Consumer

Services

  Common Stock     100,000        100,000        164,000        0.1

Avionte Holdings, LLC

 

Consumer

Services

  First Lien Term Loan 9.75% Cash, 1/8/2019   $ 2,406,342        2,370,166        2,406,342        1.9

Avionte Holdings, LLC(j),(l)

 

Consumer

Services

  Delayed Draw Term Loan A 9.75% Cash, 1/8/2019   $ —          —          —          0.0

CFF Acquisition L.L.C.(d)

 

Consumer

Services

  First Lien Term Loan 7.50% Cash, 7/31/2015   $ 582,304        581,685        582,304        0.5

Expedited Travel L.L.C.(g)

 

Consumer

Services

  Common Stock     1,000,000        1,000,000        1,180,000        1.0

Expedited Travel L.L.C.

 

Consumer

Services

  First Lien Term Loan 10.00% Cash, 10/10/2019   $ 13,018,475        12,898,361        13,018,475        10.6

PrePaid Legal Services, Inc.(d)

 

Consumer

Services

  First Lien Term Loan 6.50% Cash, 7/1/2019   $ 1,629,032        1,617,017        1,625,448        1.3

PrePaid Legal Services, Inc.(d)

 

Consumer

Services

  Second Lien Term Loan 9.75% Cash, 7/1/2020   $ 10,000,000        9,958,335        10,000,000        8.1
       

 

 

   

 

 

   

 

 

 
    Total Consumer Services       28,525,564        28,976,569        23.5
       

 

 

   

 

 

   

 

 

 

M/C Acquisition Corp., L.L.C.(d),(g)

  Education   Class A Common Stock     544,761        30,241        —          0.0

M/C Acquisition Corp., L.L.C.(d)

  Education   First Lien Term Loan 1.00% Cash, 3/31/2016   $ 2,362,978        1,235,695        102,983        0.1
       

 

 

   

 

 

   

 

 

 
    Total Education       1,265,936        102,983        0.1
       

 

 

   

 

 

   

 

 

 

Group Dekko, Inc.(d)

  Electronics   Second Lien Term Loan 11.00% (10.00% Cash/1.00% PIK), 5/1/2016   $ 6,880,696        6,880,696        6,575,881        5.3
       

 

 

   

 

 

   

 

 

 
    Total Electronics       6,880,696        6,575,881        5.3
       

 

 

   

 

 

   

 

 

 

TB Corp.(d)

 

Food and

Beverage

  First Lien Term Loan 5.50% Cash, 6/19/2018   $ 4,992,403        4,981,077        4,973,931        4.0

TB Corp.(d)

 

Food and

Beverage

  Unsecured Note 13.50% (12.00% Cash/1.50% PIK), 12/20/2018   $ 2,546,121        2,513,305        2,546,121        2.1

TM Restaurant Group L.L.C.

 

Food and

Beverage

  First Lien Term Loan 9.75% Cash, 7/16/2017   $ 9,783,298        9,649,729        9,764,709        7.9
       

 

 

   

 

 

   

 

 

 
    Total Food and Beverage       17,144,111        17,284,761        14.0
       

 

 

   

 

 

   

 

 

 

Bristol Hospice, LLC

 

Healthcare

Services

  Senior Secured Note 11.00% (10.00% Cash/1.00% PIK), 11/29/2018   $ 5,445,486        5,365,513        5,445,486        4.5

Bristol Hospice, LLC(j),(l)

 

Healthcare

Services

  Delayed Draw Term Loan 11.00% (10.00% Cash/1.00% PIK), 11/29/2018   $ —          —          —          0.0

Roscoe Medical, Inc.(d),(g)

 

Healthcare

Services

  Common Stock     5,000        500,000        328,400        0.3

Roscoe Medical, Inc.

 

Healthcare

Services

  Second Lien Term Loan 11.25% Cash, 9/26/2019   $ 4,200,000        4,132,667        4,009,740        3.2

Smile Brands Group Inc.(d)

 

Healthcare

Services

  First Lien Term Loan 7.50% Cash, 8/16/2019   $ 4,432,500        4,365,682        3,745,463        3.0

Surgical Specialties Corporation (US), Inc.(d)

 

Healthcare

Services

  First Lien Term Loan 7.25% Cash, 8/22/2018   $ 2,263,197        2,247,736        2,240,565        1.8

Zest Holdings, LLC(d)

 

Healthcare

Services

  First Lien Term Loan 5.25% Cash, 8/16/2020   $ 4,241,318        4,166,205        4,257,435        3.4
       

 

 

   

 

 

   

 

 

 
    Total Healthcare Services       20,777,803        20,027,089        16.2
       

 

 

   

 

 

   

 

 

 

HMN Holdco, LLC

  Media   First Lien Term Loan 12.00% Cash, 5/16/2019   $ 9,294,607        9,141,763        9,410,790        7.7

HMN Holdco, LLC(j),(k)

  Media   Deferred Draw Term Loan 12.00% Cash, 5/16/2020   $ 1,600,000        1,569,588        1,620,000        1.3

HMN Holdco, LLC(g)

  Media   Class A Series     4,264        61,647        247,525        0.2

HMN Holdco, LLC(g)

  Media   Class A Warrant     30,320        438,353        1,415,034        1.1

 

S-87


Table of Contents

Company

 

Industry

 

Investment

Interest Rate /

Maturity

  Principal/
Number of
Shares
    Cost     Fair
Value(c)
    % of
Net Assets
 

HMN Holdco, LLC(g)

  Media   Warrants to Purchase Limited Liability Company Interests (Common)     57,872        —          2,404,582        1.9

HMN Holdco, LLC(g)

  Media   Warrants to Purchase Limited Liability Company Interests     8,139        —          395,637        0.3
       

 

 

   

 

 

   

 

 

 
    Total Media       11,211,351        15,493,568        12.5
       

 

 

   

 

 

   

 

 

 

Elyria Foundry Company, L.L.C.(d),(g)

  Metals   Common Stock     35,000        9,217,563        6,762,000        5.5

Elyria Foundry Company, L.L.C.(d)

  Metals   Revolver 9.50% Cash, 12/31/2020   $ 8,500,000        8,500,000        8,500,000        6.9
       

 

 

   

 

 

   

 

 

 
    Total Metals       17,717,563        15,262,000        12.4
       

 

 

   

 

 

   

 

 

 

Network Communications, Inc.(d),(g)

  Publishing   Common Stock     380,572        —          3,206,314        2.6

Network Communications, Inc.(d)

  Publishing   Unsecured Notes 8.60% PIK, 1/14/2020   $ 3,214,368        2,867,573        3,214,368        2.6
       

 

 

   

 

 

   

 

 

 
    Total Publishing       2,867,573        6,420,682        5.2
       

 

 

   

 

 

   

 

 

 

Censis Technologies, Inc.

  Software as a Service   First Lien Term Loan B 11.00% Cash, 7/24/2019   $ 11,775,000        11,570,813        11,775,000        9.5

Censis Technologies, Inc.(g),(h)

  Software as a Service   Limited Partner Interests     999        999,000        988,011        0.8

Community Investors, Inc.(g)

  Software as a Service   Common Stock     1,282        1,282        2,546        0.0

Community Investors, Inc.

  Software as a Service   First Lien, Last Out Term Loan 11.73% Cash, 9/30/2019   $ 12,000,000        12,000,000        12,000,000        9.7

Community Investors, Inc.

  Software as a Service   First Lien Term Loan B 12.20% Cash, 12/31/2020   $ 2,500,000        2,500,000        2,500,000        2.0

Community Investors, Inc.(g)

  Software as a Service   Preferred Stock     63,463        149,138        126,056        0.1

Community Investors, Inc.(g)

  Software as a Service   Preferred Stock - A Shares     135,584        135,584        269,309        0.2

Community Investors, Inc.

  Software as a Service   Unsecured Note 10.00% PIK, 3/20/2020   $ 100,853        100,853        100,853        0.1

Finalsite Holdings, Inc.

  Software as a Service   Second Lien Term Loan 10.25% Cash, 11/21/2019   $ 7,500,000        7,435,282        7,500,000        6.1

Identity Automation Systems(g)

  Software as a Service   Common Stock Class A Units     232,616        232,616        227,964        0.2

Identity Automation Systems

  Software as a Service   First Lien Term Loan 10.25% Cash, 8/25/2019   $ 4,450,000        4,410,898        4,450,000        3.6

Mercury Network, LLC

  Software as a Service   First Lien Term Loan 10.25% Cash, 4/20/2020   $ 9,086,957        8,998,663        9,086,957        7.4

Mercury Network, LLC(g)

  Software as a Service   Common Stock     413,043        413,043        413,043        0.3

Pen-Link, Ltd.(d)

  Software as a Service   Second Lien Term Loan 12.50% Cash, 5/26/2019   $ 10,500,000        10,334,109        10,500,000        8.5
       

 

 

   

 

 

   

 

 

 
    Total Software as a Service       59,281,281        59,939,739        48.5
       

 

 

   

 

 

   

 

 

 

Advanced Air & Heat of Florida, LLC

  Utilities   First Lien Term Loan 10.00% Cash, 1/31/2019   $ 5,955,441        5,885,574        5,955,441        4.8
       

 

 

   

 

 

   

 

 

 
    Total Utilities       5,885,574        5,955,441        4.8
       

 

 

   

 

 

   

 

 

 

Sub Total Non-control/Non-affiliated investments

          239,950,830        245,883,731        199.1
       

 

 

   

 

 

   

 

 

 

Control investments—13.7%(b)

           

Saratoga Investment Corp. CLO 2013-1, Ltd.(a),(d),(e),(f)

  Structured Finance Securities   Other/Structured Finance Securities 16.21%, 10/17/2023   $ 30,000,000        15,172,837        16,860,256        13.7
       

 

 

   

 

 

   

 

 

 

Sub Total Control investments

          15,172,837        16,860,256        13.7
       

 

 

   

 

 

   

 

 

 

TOTAL INVESTMENTS—212.8%(b)

        $ 255,123,667      $ 262,743,987        212.8
       

 

 

   

 

 

   

 

 

 

 

S-88


Table of Contents

 

(a) Represents a non-qualifying investment as defined under Section 55 (a) of the Investment Company Act of 1940, as amended. Non-qualifying assets represent 6.8% of the Company’s portfolio at fair value. As a BDC, the Company can only invest 30% of its portfolio in non-qualifying assets.
(b) Percentages are based on net assets of $123,491,324 as of May 31, 2015.
(c) Because there is no readily available market value for these investments, the fair value of these investments is approved in good faith by our board of directors (see Note 3 to the consolidated financial statements).
(d) These securities are pledged as collateral under a senior secured revolving credit facility (see Note 6 to the consolidated financial statements).
(e) This investment does not have a stated interest rate that is payable thereon. As a result, the 16.21% interest rate in the table above represents the interest rate currently earned on the investment cost and is based on the current cash interest and other income generated by the investment.
(f) As defined in the Investment Company Act, we “Control” this portfolio company because we own more than 25% of the portfolio company’s outstanding voting securities. Transactions during the period in which the issuer was both an Affiliate and a portfolio company that we Control are as follows:

 

Company

   Purchases      Redemptions      Sales
(cost)
     Interest
Income
     Management
fee income
     Net
Realized
gains/(losses)
     Net
Unrealized
gains
 

Saratoga Investment Corp. CLO
2013-1, Ltd.

   $ —         $ —         $ —         $ 590,990       $ 378,746       $ —         $ 1,687,419   
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

 

(g) Non-income producing at May 31, 2015.
(h) Includes securities issued by an affiliate of the company.
(i) Non-U.S. company. The principal place of business for Polar Holding Company, Ltd. is Canada.
(j) The investment has an unfunded commitment as of May 31, 2015 (See note 7).
(k) Includes an analysis of the fair value of any unfunded loan commitments.
(l) The entire commitment was unfunded at May 31, 2015. As such, no interest is being earned on this investment.
(m) The investment was on non-accrual status as of May 31, 2015.

 

S-89


Table of Contents

Saratoga Investment Corp.

Consolidated Schedule of Investments

February 28, 2015

 

Company

 

Industry

 

Investment

Interest Rate /

Maturity

  Principal/
Number of
Shares
    Cost     Fair Value(c)     % of
Net Assets
 

Non-control/Non-affiliated investments—182.3% (b)

           

National Truck Protection Co., Inc.(d),(g)

  Automotive Aftermarket   Common Stock     1,116      $ 1,000,000      $ 1,769,432        1.4

National Truck Protection Co., Inc.(d)

  Automotive Aftermarket   First Lien Term Loan 15.50% Cash, 9/13/2018   $ 7,737,848        7,737,848        7,737,848        6.3

Take 5 Oil Change, L.L.C.(d),(g)

  Automotive Aftermarket   Common Stock     7,128        480,535        1,472,502        1.2
       

 

 

   

 

 

   

 

 

 
    Total Automotive Aftermarket       9,218,383        10,979,782        8.9
       

 

 

   

 

 

   

 

 

 

Legacy Cabinets Holdings(d),(g)

  Building Products   Common Stock Voting A-1     2,535        220,900        1,493,470        1.2

Legacy Cabinets Holdings(d),(g)

  Building Products   Common Stock Voting B-1     1,600        139,424        942,624        0.8

Polar Holding Company, Ltd.(a),(i)

  Building Products   First Lien Term Loan 10.00% Cash, 8/13/2016   $ 1,000,000        1,000,000        1,000,000        0.8
       

 

 

   

 

 

   

 

 

 
    Total Building Products       1,360,324        3,436,094        2.8
       

 

 

   

 

 

   

 

 

 

BMC Software, Inc.(d)

  Business Services   First Lien Term Loan 5.00% Cash, 9/10/2020   $ 5,731,667        5,686,622        5,478,327        4.5

Dispensing Dynamics International(d)

  Business Services   Senior Secured Note 12.50% Cash, 1/1/2018   $ 7,000,000        6,910,112        7,350,000        6.0

Easy Ice, LLC(d)

  Business Services   First Lien Term Loan 9.50% Cash, 1/15/2020   $ 12,000,000        11,872,639        12,000,000        9.6

Emily Street Enterprises, L.L.C.

  Business Services   Senior Secured Note 10.00% Cash, 1/23/2020   $ 8,400,000        8,260,787        8,400,000        6.9

Emily Street Enterprises, L.L.C.(g)

  Business Services   Warrant Membership Interests     49,318        400,000        391,584        0.3

Help/Systems Holdings, Inc.(Help/Systems, LLC)(d)

  Business Services   First Lien Term Loan 5.50% Cash, 6/28/2019   $ 1,955,051        1,941,417        1,925,725        1.6

Help/Systems Holdings, Inc.(Help/Systems, LLC)(d)

  Business Services   Second Lien Term Loan 9.50% Cash, 6/28/2020   $ 2,000,000        1,975,767        1,965,000        1.6

Knowland Technology Holdings, L.L.C.

  Business Services   First Lien Term Loan 11.00% Cash, 11/29/2017   $ 5,259,171        5,205,142        5,259,171        4.3

Knowland Technology Holdings, L.L.C.(j),(k),(l)

  Business Services   Delayed Draw Term Loan 11.00% Cash, 11/29/2017   $ —          —          —          0.0

Vector Controls Holding Co., LLC(d)

  Business Services   First Lien Term Loan, 14.00% (12.00% Cash/2.00% PIK), 3/6/2018   $ 9,436,991        9,312,095        9,295,437        7.6

Vector Controls Holding Co., LLC(d),(g)

  Business Services   Warrants to Purchase Limited Liability Company Interests     101        —          62,341        0.1
       

 

 

   

 

 

   

 

 

 
    Total Business Services       51,564,581        52,127,585        42.5
       

 

 

   

 

 

   

 

 

 

Targus Group International, Inc.(d)

  Consumer Products   First Lien Term Loan, 12.00% (11.00% Cash/1.00% PIK), 5/24/2016   $ 3,569,127        3,537,732        3,283,597        2.7

Targus Holdings, Inc.(d),(g)

  Consumer Products   Common Stock     62,413        566,765        —          0.0

Targus Holdings, Inc.(d),(g)

  Consumer Products   Unsecured Note 10.00% PIK, 6/14/2019   $ 2,054,158        2,054,158        —          0.0

Targus Holdings, Inc.(d),(g)

  Consumer Products   Unsecured Note 16.00% PIK, 10/26/2018   $ 429,797        425,227        —          0.0
       

 

 

   

 

 

   

 

 

 
    Total Consumer Products       6,583,882        3,283,597        2.7
       

 

 

   

 

 

   

 

 

 

 

S-90


Table of Contents

Company

 

Industry

 

Investment

Interest Rate /

Maturity

  Principal/
Number of
Shares
    Cost     Fair Value(c)     % of
Net Assets
 

Avionte Holdings, LLC(g)

  Consumer Services   Common Stock     100,000        100,000        163,000        0.1

Avionte Holdings, LLC

  Consumer Services   First Lien Term Loan 9.75% Cash, 1/8/2019   $ 3,000,000        2,951,759        3,000,000        2.4

Avionte Holdings, LLC(j),(l)

  Consumer Services   Delayed Draw Term Loan A 9.75% Cash, 1/8/2019   $ —          —          —          0.0

CFF Acquisition L.L.C.(d)

  Consumer Services   First Lien Term Loan 7.50% Cash, 7/31/2015   $ 716,179        714,270        716,179        0.6

Expedited Travel L.L.C.(g)

  Consumer Services   Common Stock     1,000,000        1,000,000        1,069,157        0.9

Expedited Travel L.L.C.

  Consumer Services   First Lien Term Loan 10.00% Cash, 10/10/2019   $ 13,750,000        13,609,579        13,750,000        11.2

PrePaid Legal Services, Inc.(d)

  Consumer Services   First Lien Term Loan 6.25% Cash, 7/1/2019   $ 3,709,677        3,680,863        3,652,919        3.0

PrePaid Legal Services, Inc.(d)

  Consumer Services   Second Lien Term Loan 9.75% Cash, 7/1/2020   $ 5,000,000        4,937,212        4,981,000        4.1
       

 

 

   

 

 

   

 

 

 
    Total Consumer Services       26,993,683        27,332,255        22.3
       

 

 

   

 

 

   

 

 

 

M/C Acquisition Corp., L.L.C.(d),(g)

  Education   Class A Common Stock     544,761        30,241        —          0.0

M/C Acquisition Corp., L.L.C.(d)

  Education   First Lien Term Loan 1.00% Cash, 3/31/2015   $ 2,362,978        1,235,695        100,951        0.1
       

 

 

   

 

 

   

 

 

 
    Total Education       1,265,936        100,951        0.1
       

 

 

   

 

 

   

 

 

 

Group Dekko, Inc.(d)

  Electronics   Second Lien Term Loan 11.00% (10.00% Cash/1.00% PIK), 5/1/2016   $ 6,950,048        6,950,048        6,667,181        5.4
       

 

 

   

 

 

   

 

 

 
    Total Electronics       6,950,048        6,667,181        5.4
       

 

 

   

 

 

   

 

 

 

TB Corp.(d)

  Food and Beverage   First Lien Term Loan 5.76% Cash, 6/19/2018   $ 5,050,436        5,038,131        5,037,810        4.0

TB Corp.(d)

  Food and Beverage   Unsecured Note 13.50% (12.00% Cash/1.50% PIK), 12/20/2018   $ 2,546,121        2,512,732        2,546,121        2.1

TM Restaurant Group L.L.C.

  Food and Beverage   First Lien Term Loan 7.75% Cash, 7/16/2017   $ 2,791,595        2,791,595        2,763,679        2.3
       

 

 

   

 

 

   

 

 

 
    Total Food and Beverage       10,342,458        10,347,610        8.4
       

 

 

   

 

 

   

 

 

 

Bristol Hospice, LLC

  Healthcare Services   Senior Secured Note 11.00% (10.00% Cash/1.00% PIK), 11/29/2018   $ 5,459,134        5,374,249        5,459,134        4.4

Bristol Hospice, LLC(j),(l)

  Healthcare Services   Delayed Draw Term Loan 11.00% (10.00% Cash/1.00% PIK), 11/29/2018   $ —          —          —          0.0

Roscoe Medical, Inc.(d),(g)

  Healthcare Services   Common Stock     5,000        500,000        294,500        0.2

Roscoe Medical, Inc.

  Healthcare Services   Second Lien Term Loan 11.25% Cash, 9/26/2019   $ 4,200,000        4,129,704        3,990,000        3.3

Smile Brands Group Inc.(d)

  Healthcare Services   First Lien Term Loan 7.50% Cash, 8/16/2019   $ 4,443,750        4,373,369        4,159,350        3.4

Surgical Specialties Corporation (US), Inc.(d)

  Healthcare Services   First Lien Term Loan 7.25% Cash, 8/22/2018   $ 2,312,500        2,295,234        2,277,813        1.9

Zest Holdings, LLC(d)

  Healthcare Services   First Lien Term Loan 5.25% Cash, 8/16/2020   $ 4,443,919        4,361,438        4,460,806        3.6
       

 

 

   

 

 

   

 

 

 
    Total Healthcare Services       21,033,994        20,641,603        16.8
       

 

 

   

 

 

   

 

 

 

HMN Holdco, LLC

  Media   First Lien Term Loan 14.00% (12.00% Cash/2.00% PIK), 5/16/2019   $ 9,368,327        9,206,438        9,579,115        7.9

HMN Holdco, LLC

  Media   First Lien Term Loan 12.00% Cash, 5/16/2020   $ 1,600,000        1,569,149        1,576,000        1.3

 

S-91


Table of Contents

Company

 

Industry

 

Investment

Interest Rate /

Maturity

  Principal/
Number of
Shares
    Cost     Fair Value(c)     % of
Net Assets
 

HMN Holdco, LLC(j),(k)

  Media   Deferred Draw Term Loan 12.00% Cash, 5/16/2020   $ —          —          (36,000     0.0

HMN Holdco, LLC(g)

  Media   Class A Series     4,264        61,647        223,604        0.2

HMN Holdco, LLC(g)

  Media   Class A Warrant     30,320        438,353        1,247,365        1.0

HMN Holdco, LLC(g)

  Media   Warrants to Purchase Limited Liability Company Interests (Common)     57,872        —          2,085,128        1.7

HMN Holdco, LLC(g)

  Media   Warrants to Purchase Limited Liability Company Interests     8,139        —          350,464        0.3
       

 

 

   

 

 

   

 

 

 
    Total Media       11,275,587        15,025,676        12.4
       

 

 

   

 

 

   

 

 

 

Elyria Foundry Company, L.L.C.(d),(g)

  Metals   Common Stock     35,000        9,217,563        6,762,000        5.5

Elyria Foundry Company, L.L.C.(d)

  Metals   Revolver 9.00% Cash, 12/31/2020   $ 8,500,000        8,500,000        8,500,000        6.8
       

 

 

   

 

 

   

 

 

 
    Total Metals       17,717,563        15,262,000        12.3
       

 

 

   

 

 

   

 

 

 

Network Communications, Inc.(d),(g)

  Publishing   Common Stock     380,572        —          300,652        0.2

Network Communications, Inc.(d)

  Publishing   Unsecured Notes 8.60% PIK, 1/14/2020   $ 2,732,976        2,374,260        1,684,118        1.4
       

 

 

   

 

 

   

 

 

 
    Total Publishing       2,374,260        1,984,770        1.6
       

 

 

   

 

 

   

 

 

 

Censis Technologies, Inc.

  Software as a Service   First Lien Term Loan B 11.00% Cash, 7/24/2019   $ 11,850,000        11,634,939        11,850,000        9.7

Censis Technologies, Inc.(g),(h)

  Software as a Service   Limited Partner Interests     999        999,000        981,627        0.8

Community Investors, Inc.(g)

  Software as a Service   Common Stock     1,282        1,282        1,769        0.0

Community Investors, Inc.

  Software as a Service   First Lien, Last Out Term Loan 11.78% Cash, 9/30/2019   $ 12,000,000        12,000,000        12,000,000        9.7

Community Investors, Inc.

  Software as a Service   First Lien Term Loan B 12.25% Cash, 12/31/2020   $ 2,500,000        2,500,000        2,500,000        2.0

Community Investors, Inc.(g)

  Software as a Service   Preferred Stock     63,463        149,138        87,579        0.1

Community Investors, Inc.

  Software as a Service   Preferred Stock - A2     38,641        100,853        53,325        0.0

Community Investors, Inc.(g)

  Software as a Service   Preferred Stock - A Shares     135,584        135,584        187,106        0.2

Finalsite Holdings, Inc.

  Software as a Service   Second Lien Term Loan 10.25% Cash, 11/21/2019   $ 7,500,000        7,429,305        7,500,000        6.1

Identity Automation Systems(g)

  Software as a Service   Common Stock Class A Units     232,616        232,616        225,638        0.2

Identity Automation Systems

  Software as a Service   First Lien Term Loan 10.25% Cash, 8/25/2019   $ 4,475,000        4,433,897        4,475,000        3.7

Pen-Link, Ltd.(d)

  Software as a Service   Second Lien Term Loan 12.50% Cash, 5/26/2019   $ 10,500,000        10,326,376        10,500,000        8.6
       

 

 

   

 

 

   

 

 

 
    Total Software as a Service       49,942,990        50,362,044        41.1
       

 

 

   

 

 

   

 

 

 

Advanced Air & Heat of Florida, LLC

  Utilities   First Lien Term Loan 10.00% Cash, 1/31/2019   $ 5,955,441        5,881,694        5,955,441        5.0
       

 

 

   

 

 

   

 

 

 
    Total Utilities       5,881,694        5,955,441        5.0
       

 

 

   

 

 

   

 

 

 

Sub Total Non-control/Non-affiliated investments

          222,505,383        223,506,589        182.3
       

 

 

   

 

 

   

 

 

 

 

S-92


Table of Contents

Company

 

Industry

 

Investment

Interest Rate /

Maturity

  Principal/
Number of
Shares
    Cost     Fair Value(c)     % of
Net Assets
 

Control investments—13.9%(b)

           

Saratoga Investment Corp. CLO 2013-1, Ltd.(a),(d),(e),(f)

  Structured Finance Securities   Other/Structured Finance Securities 14.32%, 10/17/2023   $ 30,000,000        15,953,001        17,031,146        13.9
       

 

 

   

 

 

   

 

 

 

Sub Total Control investments

          15,953,001        17,031,146        13.9
       

 

 

   

 

 

   

 

 

 

TOTAL INVESTMENTS—196.2%(b)

        $ 238,458,384      $ 240,537,735        196.2
       

 

 

   

 

 

   

 

 

 

 

(a) Represents a non-qualifyng investment as defined under Section 55 (a) of the Investment Company Act of 1940, as amended. Non-qualifying assets represent 7.5% of the Company’s portfolio at fair value. As a BDC, the Company can only invest 30% of its portfolio in non-qualifying assets.
(b) Percentages are based on net assets of $122,598,742, as of February 28, 2015.
(c) Because there is no readily available market value for these investments, the fair value of these investments is approved in good faith by our board of directors. (see Note 3 to the consolidated financial statements).
(d) These securities are pledged as collateral under a senior secured revolving credit facility (see Note 6 to the consolidated financial statements).
(e) This investment does not have a stated interest rate that is payable thereon. As a result, the 14.32% interest rate in the table above represents the interest rate currently earned on the investment cost and is based on the current cash interest and other income generated by the investment.
(f) As defined in the Investment Company Act, we “Control” this portfolio company because we own more than 25% of the portfolio company’s outstanding voting securities. Transactions during the period in which the issuer was both an Affiliate and a portfolio company that we Control are as follows:

 

Company

   Purchases      Redemptions      Sales
(cost)
     Interest
Income
     Management
fee income
     Net
Realized
gains/(losses)
     Net
Unrealized
gains
 

Saratoga Investment Corp. CLO 2013-1, Ltd.

   $ —         $ —         $ —         $ 2,707,230       $ 1,520,205       $ —         $ 1,078,145   
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

 

(g) Non-income producing at February 28, 2015.
(h) Includes securities issued by an affiliate of the company.
(i) Non-U.S. company. The principal place of business for Polar Holding Company, Ltd. is Canada.
(j) The investment has an unfunded commitment as of February 28, 2015 (See note 7).
(k) Includes an analysis of the value of any unfunded loan commitments.
(l) The entire commitment was unfunded at February 28, 2015. As such, no interest is being earned on this investment.

 

S-93


Table of Contents

Saratoga Investment Corp.

Consolidated Statements of Changes in Net Assets

(unaudited)

 

     For the three months
ended May 31, 2015
    For the three months
ended May 31, 2014
 

INCREASE FROM OPERATIONS:

    

Net investment income

   $ 1,770,690      $ 2,062,906   

Net realized gain from investments

     73,246        81,680   

Net unrealized appreciation (depreciation) on investments

     5,540,969        (384,697
  

 

 

   

 

 

 

Net increase in net assets from operations

     7,384,905        1,759,889   
  

 

 

   

 

 

 

DECREASE FROM SHAREHOLDER DISTRIBUTIONS:

    

Distributions declared

     (6,894,523     —     
  

 

 

   

 

 

 

Net decrease in net assets from shareholder distributions

     (6,894,523     —     
  

 

 

   

 

 

 

CAPITAL SHARE TRANSACTIONS:

    

Stock dividend distribution

     402,200        —     
  

 

 

   

 

 

 

Net increase in net assets from capital share transactions

     402,200        —     
  

 

 

   

 

 

 

Total increase in net assets

     892,582        1,759,889   

Net assets at beginning of period

     122,598,742        113,427,929   
  

 

 

   

 

 

 

Net assets at end of period

   $ 123,491,324      $ 115,187,818   
  

 

 

   

 

 

 

Net asset value per common share

   $ 22.75      $ 21.41   

Common shares outstanding at end of period

     5,428,758        5,379,616   

Distribution in excess of net investment income

   $ (29,029,436   $ (29,060,761

See accompanying notes to consolidated financial statements.

 

S-94


Table of Contents

Saratoga Investment Corp.

Consolidated Statements of Cash Flows

(unaudited)

 

     For the three months
ended May 31, 2015
    For the three months
ended May 31, 2014
 

Operating activities

    

NET INCREASE IN NET ASSETS FROM OPERATIONS

   $ 7,384,905      $ 1,759,889   

ADJUSTMENTS TO RECONCILE NET INCREASE IN NET ASSETS FROM OPERATIONS TO NET CASH USED BY OPERATING ACTIVITIES:

    

Paid-in-kind interest income

     (597,336     (110,592

Net accretion of discount on investments

     (143,205     (177,191

Amortization of deferred debt financing costs

     217,658        252,299   

Net realized gain from investments

     (73,246     (81,680

Net unrealized (appreciation) depreciation on investments

     (5,540,969     384,697   

Proceeds from sale and redemption of investments

     7,323,338        8,689,899   

Purchase of investments

     (23,174,833     (21,574,435

(Increase) decrease in operating assets:

    

Cash and cash equivalents, reserve accounts

     12,311,321        (6,432,500

Interest receivable

     (324,128     (934,623

Management fee receivable

     (2,614     (16,770

Other assets

     (4,847     (6,875

Increase (decrease) in operating liabilities:

    

Management and incentive fees payable

     929,376        (209,637

Accounts payable and accrued expenses

     (159,806     71,538   

Interest and debt fees payable

     (492,838     (214,866

Due to manager

     10,000        (50,000
  

 

 

   

 

 

 

NET CASH USED BY OPERATING ACTIVITIES

     (2,337,224     (18,650,847
  

 

 

   

 

 

 

Financing activities

    

Borrowings on debt

     3,200,000        18,700,000   

Paydowns on debt

     (1,000,000     —     

Debt financing cost

     (152,773     (368,940

Payments of cash dividends

     (899,034     —     
  

 

 

   

 

 

 

NET CASH PROVIDED BY FINANCING ACTIVITIES

     1,148,193        18,331,060   
  

 

 

   

 

 

 

NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS

     (1,189,031     (319,787

CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD

     1,888,158        3,293,898   
  

 

 

   

 

 

 

CASH AND CASH EQUIVALENTS, END OF PERIOD

   $ 699,127      $ 2,974,111   
  

 

 

   

 

 

 

Supplemental information:

    

Interest paid during the period

   $ 2,239,045      $ 1,750,155   

Supplemental non-cash information:

    

Paid-in-kind interest income

   $ 597,336      $ 110,592   

Net accretion of discount on investments

   $ 143,205      $ 177,191   

Amortization of deferred debt financing costs

   $ 217,658      $ 252,299   

Stock dividend distribution

   $ 402,200      $ —     

See accompanying notes to consolidated financial statements.

 

S-95


Table of Contents

SARATOGA INVESTMENT CORP.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

May 31, 2015

(unaudited)

Note 1. Organization

Saratoga Investment Corp. (the “Company”, “we”, “our” and “us”) is a non-diversified closed end management investment company incorporated in Maryland that has elected to be treated and is regulated as a business development company (“BDC”) under the Investment Company Act of 1940 (the “1940 Act”). We commenced operations on March 23, 2007 as GSC Investment Corp. and completed our initial public offering (“IPO”) on March 28, 2007. We have elected to be treated as a regulated investment company (“RIC”) under subchapter M of the Internal Revenue Code (the “Code”). We expect to continue to qualify and to elect to be treated for tax purposes as a RIC. Our investment objective is to generate current income and, to a lesser extent, capital appreciation from our investments.

GSC Investment, LLC (the “LLC”) was organized in May 2006 as a Maryland limited liability company. As of February 28, 2007, the LLC had not yet commenced its operations and investment activities.

On March 21, 2007, the Company was incorporated and concurrently therewith the LLC was merged with and into the Company, with the Company as the surviving entity, in accordance with the procedure for such merger in the LLC’s limited liability company agreement and Maryland law. In connection with such merger, each outstanding limited liability company interest of the LLC was converted into a share of common stock of the Company.

On July 30, 2010, the Company changed its name from “GSC Investment Corp.” to “Saratoga Investment Corp.”.

We are externally managed and advised by our investment adviser, Saratoga Investment Advisors, LLC (the “Manager”), pursuant to the Management Agreement. Prior to July 30, 2010, we were managed and advised by GSCP (NJ), L.P.

On March 28, 2012, our wholly-owned subsidiary, Saratoga Investment Corp. SBIC, LP (“SBIC LP”), received a Small Business Investment Company (“SBIC”) license from the Small Business Administration (“SBA”).

On April 2, 2015, the SBA issued a “green light” or “go forth” letter inviting us to continue our application process to obtain a license to form and operate its second SBIC subsidiary. If approved, a second SBIC license would provide us an incremental source of long-term capital by permitting us to issue $75 million of additional SBA-guaranteed debentures in addition to the $150 million already approved under the first license. Receipt of a green light letter from the SBA does not assure an applicant that the SBA will ultimately issue an SBIC license and we have received no assurance or indication from the SBA that it will receive an SBIC license, or of the timeframe in which it would receive a license, should one be granted.

Note 2. Summary of Significant Accounting Policies

Basis of Presentation

The accompanying consolidated financial statements have been prepared on the accrual basis of accounting in conformity with U.S. generally accepted accounting principles (“U.S. GAAP”) and include the accounts of the Company and its special purpose financing subsidiary, Saratoga Investment Funding, LLC (previously known as

 

S-96


Table of Contents

GSC Investment Funding LLC). All intercompany accounts and transactions have been eliminated in consolidation. All references made to the “Company,” “we,” and “us” herein include Saratoga Investment Corp. and its consolidated subsidiary, except as stated otherwise.

The Company and SBIC are both considered to be investment companies for financial reporting purposes and have applied the guidance in Topic 946, “Financial Services—Investment Companies”. There have been no changes to the Company or SBIC’s status as investment companies during the three months ended May 31, 2015.

Use of Estimates in the Preparation of Financial Statements

The preparation of the accompanying consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, and disclosure of contingent assets and liabilities at the date of the financial statements, and income, gains (losses) and expenses during the period reported. Actual results could differ materially from those estimates.

Cash and Cash Equivalents

Cash and cash equivalents include short-term, liquid investments in a money market fund. Cash and cash equivalents are carried at cost which approximates fair value. Per section 12(d)(1)(A) of the 1940 Act, the Company may not invest in another registered investment company such as a money market fund, if such investment would cause the Company to exceed any of the following limitations:

 

    we were to own more than 3.0% of the total outstanding voting stock of the money market fund;

 

    we were to hold securities in the money market fund having an aggregate value in excess of 5.0% of the value of our total assets; or

 

    we were to hold securities in money market funds and other registered investment companies and BDCs having an aggregate value in excess of 10.0% of the value of our total assets.

Cash and Cash Equivalents, Reserve Accounts

Cash and cash equivalents, reserve accounts include amounts held in designated bank accounts in the form of cash and short-term liquid investments in money market funds representing payments received on secured investments or other reserved amounts associated with our $45.0 million senior secured revolving credit facility with Madison Capital Funding LLC. The Company is required to use these amounts to pay interest expense, reduce borrowings, or pay other amounts in accordance with the terms of the senior secured revolving credit facility.

Investment Classification

The Company classifies its investments in accordance with the requirements of the 1940 Act. Under the 1940 Act, “Control Investments” are defined as investments in companies in which we own more than 25.0% of the voting securities or maintain greater than 50.0% of the board representation. Under the 1940 Act, “Affiliated Investments” are defined as those non-control investments in companies in which we own between 5.0% and 25.0% of the voting securities. Under the 1940 Act, “Non-affiliated Investments” are defined as investments that are neither Control Investments nor Affiliated Investments.

Investment Valuation

The Company accounts for its investments at fair value in accordance with the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 820, Fair Value Measurements and Disclosures (“ASC 820”). ASC 820 defines fair value, establishes a framework for measuring fair value, establishes a fair value hierarchy based on the quality of inputs used to measure fair value and enhances disclosure requirements for fair value measurements. ASC 820 requires the Company to assume that its

 

S-97


Table of Contents

investments are to be sold at the statement of assets and liabilities date in the principal market to independent market participants, or in the absence of a principal market, in the most advantageous market, which may be a hypothetical market. Market participants are defined as buyers and sellers in the principal or most advantageous market that are independent, knowledgeable, and willing and able to transact.

Investments for which market quotations are readily available are fair valued at such market quotations obtained from independent third party pricing services and market makers subject to any decision by our board of directors to approve a fair value determination to reflect significant events affecting the value of these investments. We value investments for which market quotations are not readily available at fair value as approved, in good faith, by our board of directors based on input from our Manager, the audit committee of our board of directors and a third party independent valuation firm. Determinations of fair value may involve subjective judgments and estimates. The types of factors that may be considered in determining the fair value of our investments include the nature and realizable value of any collateral, the portfolio company’s ability to make payments, market yield trend analysis, the markets in which the portfolio company does business, comparison to publicly traded companies, discounted cash flow and other relevant factors.

We undertake a multi-step valuation process each quarter when valuing investments for which market quotations are not readily available, as described below:

 

    Each investment is initially valued by the responsible investment professionals of our Manager and preliminary valuation conclusions are documented and discussed with the senior management of our Manager; and

 

    An independent valuation firm engaged by our board of directors reviews approximately one quarter of these preliminary valuations each quarter so that the valuation of each investment for which market quotes are not readily available is reviewed by the independent valuation firm at least annually.

In addition, all our investments are subject to the following valuation process:

 

    The audit committee of our board of directors reviews each preliminary valuation and our Manager and independent valuation firm (if applicable) will supplement the preliminary valuation to reflect any comments provided by the audit committee; and

 

    Our board of directors discusses the valuations and approves the fair value of each investment, in good faith, based on the input of our Manager, independent valuation firm (to the extent applicable) and the audit committee of our board of directors.

Our investment in Saratoga Investment Corp. CLO 2013-1, Ltd. (“Saratoga CLO”) is carried at fair value, which is based on a discounted cash flow model that utilizes prepayment, re-investment and loss assumptions based on historical experience and projected performance, economic factors, the characteristics of the underlying cash flow, and comparable yields for equity interests in collateralized loan obligation funds similar to Saratoga CLO, when available, as determined by our Manager and recommended to our board of directors. Specifically, we use Intex cash flow models, or an appropriate substitute, to form the basis for the valuation of our investment in Saratoga CLO. The models use a set of assumptions including projected default rates, recovery rates, reinvestment rate and prepayment rates in order to arrive at estimated valuations. The assumptions are based on available market data and projections provided by third parties as well as management estimates. We use the output from the Intex models (i.e., the estimated cash flows) to perform a discounted cash flows analysis on expected future cash flows to determine a valuation for our investment in Saratoga CLO.

Because such valuations, and particularly valuations of private investments and private companies, are inherently uncertain, they may fluctuate over short periods of time and may be based on estimates. The determination of fair value may differ materially from the values that would have been used if a ready market for these investments existed. Our net asset value could be materially affected if the determinations regarding the fair value of our investments were materially higher or lower than the values that we ultimately realize upon the disposal of such investments.

 

S-98


Table of Contents

Derivative Financial Instruments

We account for derivative financial instruments in accordance with ASC Topic 815, Derivatives and Hedging (“ASC 815”). ASC 815 requires recognizing all derivative instruments as either assets or liabilities on the consolidated statements of assets and liabilities at fair value. The Company values derivative contracts at the closing fair value provided by the counterparty. Changes in the values of derivative contracts are included in the consolidated statements of operations.

Investment Transactions and Income Recognition

Purchases and sales of investments and the related realized gains or losses are recorded on a trade-date basis. Interest income, adjusted for amortization of premium and accretion of discount, is recorded on an accrual basis to the extent that such amounts are expected to be collected. The Company stops accruing interest on its investments when it is determined that interest is no longer collectible. Discounts and premiums on investments purchased are accreted/amortized over the life of the respective investment using the effective yield method. The amortized cost of investments represents the original cost adjusted for the accretion of discounts and amortizations of premium on investments.

Loans are generally placed on non-accrual status when there is reasonable doubt that principal or interest will be collected. Accrued interest is generally reserved when a loan is placed on non-accrual status. Interest payments received on non-accrual loans may be recognized as a reduction in principal depending upon management’s judgment regarding collectability. Non-accrual loans are restored to accrual status when past due principal and interest is paid and, in management’s judgment, are likely to remain current, although we may make exceptions to this general rule if the loan has sufficient collateral value and is in the process of collection.

Interest income on our investment in Saratoga CLO is recorded using the effective interest method in accordance with the provisions of ASC Topic 325-40, Investments-Other, Beneficial Interests in Securitized Financial Assets, (“ASC 325-40”), based on the anticipated yield and the estimated cash flows over the projected life of the investment. Yields are revised when there are changes in actual or estimated cash flows due to changes in prepayments and/or re-investments, credit losses or asset pricing. Changes in estimated yield are recognized as an adjustment to the estimated yield over the remaining life of the investment from the date the estimated yield was changed.

Other Income

Other income includes dividends received, origination fees, structuring fees and advisory fees, and is recorded in income when earned.

Paid-in-Kind Interest

The Company holds debt investments in its portfolio that contain a payment-in-kind (“PIK”) interest provision. The PIK interest, which represents contractually deferred interest added to the investment balance that is generally due at maturity, is generally recorded on the accrual basis to the extent such amounts are expected to be collected. We stop accruing PIK interest if we do not expect the issuer to be able to pay all principal and interest when due.

Deferred Debt Financing Costs

Financing costs incurred in connection with our credit facility are deferred and amortized using the straight line method over the life of their respective facilities. Financing costs incurred in connection with our SBA debentures are deferred and amortized using the effective yield method over the life of the debentures.

 

S-99


Table of Contents

In April 2015, the FASB issued Accounting Standards Update (“ASU”) No. 2015-03, Interest—Imputation of Interest (Subtopic 835-30): Simplifying the Presentation of Debt Issuance Costs (“ASU 2015-03”). The amendments in this ASU require that debt issuance costs related to a recognized debt liability be presented in the balance sheet as a direct deduction from the carrying amount of that debt liability, consistent with debt discounts. The recognition and measurement guidance for debt issuance costs are not affected by the amendments in this ASU. The guidance is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2015, and early adoption is allowed, and is to be applied on a retrospective basis. The Company has adopted the provisions of ASU 2015-03 as of February 28, 2015, by reclassifying deferred debt financing costs from within total assets to within total liabilities as a contra-liability. The adoption of the provisions of ASU 2015-03 did not materially impact the Company’s consolidated financial position or results of operations. Prior period amounts were reclassified to conform to the current period presentation.

Contingencies

In the ordinary course of its business, the Company may enter into contracts or agreements that contain indemnifications or warranties. Future events could occur that lead to the execution of these provisions against the Company. Based on its history and experience, management feels that the likelihood of such an event is remote.

In the ordinary course of business, the Company may directly or indirectly be a defendant or plaintiff in legal actions with respect to bankruptcy, insolvency or other types of proceedings. Such lawsuits may involve claims that could adversely affect the value of certain financial instruments owned by the Company.

Income Taxes

The Company has filed an election to be treated for tax purposes as a RIC under Subchapter M of the Code and, among other things, intends to make the requisite distributions to its stockholders which will relieve the Company from federal income taxes. Therefore, no provision has been recorded for federal income taxes.

In order to qualify as a RIC, among other requirements, the Company is required to timely distribute to its stockholders at least 90.0% of its investment company taxable income, as defined by the Code, for each fiscal tax year. The Company will be subject to a nondeductible U.S. federal excise tax of 4.0% on undistributed income if it does not distribute at least 98.0% of its ordinary income in any calendar year and 98.2% of its capital gain net income for each one-year period ending on October 31.

Depending on the level of taxable income earned in a tax year, the Company may choose to carry forward taxable income in excess of current year dividend distributions into the next tax year and pay a 4.0% excise tax on such income, as required. To the extent that the Company determines that its estimated current year annual taxable income will be in excess of estimated current year dividend distributions for excise tax purposes, the Company accrues excise tax, if any, on estimated excess taxable income as taxable income is earned.

In accordance with certain applicable Treasury regulations and private letter rulings issued by the Internal Revenue Service, a RIC may treat a distribution of its own stock as fulfilling its RIC distribution requirements if each stockholder may elect to receive his or her entire distribution in either cash or stock of the RIC subject to a limitation on the aggregate amount of cash to be distributed to all stockholders, which limitation must be at least 20.0% of the aggregate declared distribution. If too many stockholders elect to receive cash, each stockholder electing to receive cash will receive a pro rata amount of cash (with the balance of the distribution paid in stock). In no event will any stockholder, electing to receive cash, receive less than 20.0% of his or her entire distribution in cash. If these and certain other requirements are met, for U.S federal income tax purposes, the amount of the dividend paid in stock will be equal to the amount of cash that could have been received instead of stock.

ASC 740, Income Taxes, (“ASC 740”), provides guidance for how uncertain tax positions should be recognized, measured, presented and disclosed in the financial statements. ASC 740 requires the evaluation of

 

S-100


Table of Contents

tax positions taken or expected to be taken in the course of preparing the Company’s tax returns to determine whether the tax positions are “more-likely-than-not” of being sustained by the applicable tax authority. Tax positions deemed to meet a “more-likely-than-not” threshold would be recorded as a tax benefit or expense in the current period. The Company recognizes interest and penalties, if any, related to unrecognized tax benefits as income tax expense in the consolidated statements of operations. During the fiscal year ended February 28, 2015, the Company did not incur any interest or penalties. Although we file federal and state tax returns, our major tax jurisdiction is federal. The 2012, 2013 and 2014 federal tax years for the Company remain subject to examination by the IRS. As of May 31, 2015 and May 31, 2014, there were no uncertain tax positions.

Dividends

Dividends to common stockholders are recorded on the ex-dividend date. The amount to be paid out as a dividend is determined by the board of directors. Net realized capital gains, if any, are generally distributed at least annually, although we may decide to retain such capital gains for reinvestment.

We have adopted a dividend reinvestment plan (“DRIP”) that provides for reinvestment of our dividend distributions on behalf of our stockholders unless a stockholder elects to receive cash. As a result, if our board of directors authorizes, and we declare, a cash dividend, then our stockholders who have not “opted out” of the DRIP by the dividend record date will have their cash dividends automatically reinvested into additional shares of our common stock, rather than receiving the cash dividends. We have the option to satisfy the share requirements of the DRIP through the issuance of new shares of common stock or through open market purchases of common stock by the DRIP plan administrator.

Capital Gains Incentive Fee

The Company records an expense accrual on the consolidated statements of operations, relating to the capital gains incentive fee payable on the consolidated statements of assets and liabilities, by the Company to its investment adviser when the net realized and unrealized gain on its investments exceed all net realized and unrealized capital losses on its investments given the fact that a capital gains incentive fee would be owed to the investment adviser if the Company were to liquidate its investment portfolio at such time. The actual incentive fee payable to the Company’s investment adviser related to capital gains will be determined and payable in arrears at the end of each fiscal year and will include only realized capital gains net of realized and unrealized losses for the period.

New Accounting Pronouncements

In February 2015, the FASB issued ASU 2015-02, Consolidation (ASC Topic 810): Amendments to the Consolidation Analysis (“ASU 2015-02”). ASU 2015-02 significantly changes the consolidation analysis required under GAAP and ends the deferral granted to investment companies from applying the variable interest entity guidance. ASU 2015-02 is effective for interim and annual reporting periods in fiscal years that begin after December 15, 2015 and early adoption is permitted. Management is currently evaluating the impact these changes will have on the Company’s consolidated financial statements and disclosures.

In August 2014, the FASB issued new accounting guidance that requires management to assess an entity’s ability to continue as a going concern by incorporating and expanding upon certain principles that are currently in U.S. auditing standards. The amendments provide a definition of the term “substantial doubt” and include principles for considering the mitigating effect of management’s plans. The amendments also require an evaluation every reporting period, including interim periods for a period of one year after the date that the financial statements are issued (or available to be issued), and certain disclosures when substantial doubt is alleviated or not alleviated. The amendments in this update are effective for reporting periods ending after December 15, 2016. Management is currently evaluating the impact of adopting this new accounting guidance update on the company’s consolidated financial statement.

 

S-101


Table of Contents

In May 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2014-09, Revenue from Contracts with Customers (Topic 606), which supersedes the revenue recognition requirements in Revenue Recognition (Topic 605). Under the new guidance, an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. This guidance is effective for annual and interim reporting periods beginning after December 15, 2016, and early application is not permitted. The Company is currently evaluating the impact this ASU will have on its consolidated financial statements.

Risk Management

In the ordinary course of its business, the Company manages a variety of risks, including market risk and credit risk. Market risk is the risk of potential adverse changes to the value of investments because of changes in market conditions such as interest rate movements and volatility in investment prices.

Credit risk is the risk of default or non-performance by portfolio companies, equivalent to the investment’s carrying amount.

The Company is also exposed to credit risk related to maintaining all of its cash and cash equivalents, including those in reserve accounts, at a major financial institution and credit risk related to any of its derivative counterparties.

The Company has investments in lower rated and comparable quality unrated high yield bonds and bank loans. Investments in high yield investments are accompanied by a greater degree of credit risk. The risk of loss due to default by the issuer is significantly greater for holders of high yield securities, because such investments are generally unsecured and are often subordinated to other creditors of the issuer.

Note 3. Investments

As noted above, the Company values all investments in accordance with ASC 820. ASC 820 requires enhanced disclosures about assets and liabilities that are measured and reported at fair value. As defined in ASC 820, fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date.

ASC 820 establishes a hierarchal disclosure framework which prioritizes and ranks the level of market price observability of inputs used in measuring investments at fair value. Market price observability is affected by a number of factors, including the type of investment and the characteristics specific to the investment. Investments with readily available active quoted prices or for which fair value can be measured from actively quoted prices generally will have a higher degree of market price observability and a lesser degree of judgment used in measuring fair value.

Based on the observability of the inputs used in the valuation techniques, the Company is required to provide disclosures on fair value measurements according to the fair value hierarchy. The fair value hierarchy ranks the observability of the inputs used to determine fair values. Investments carried at fair value are classified and disclosed in one of the following three categories:

 

    Level 1—Valuations based on quoted prices in active markets for identical assets or liabilities that the Company has the ability to access.

 

    Level 2—Valuations based on inputs other than quoted prices in active markets, which are either directly or indirectly observable.

 

   

Level 3—Valuations based on inputs that are unobservable and significant to the overall fair value measurement. The inputs used in the determination of fair value may require significant management

 

S-102


Table of Contents
 

judgment or estimation. Such information may be the result of consensus pricing information or broker quotes which include a disclaimer that the broker would not be held to such a price in an actual transaction. The non-binding nature of consensus pricing and/or quotes accompanied by disclaimer would result in classification as Level 3 asset, assuming no additional corroborating evidence.

In addition to using the above inputs in investment valuations, the Company continues to employ the valuation policy approved by the board of directors that is consistent with ASC 820 and the 1940 Act (see Note 2). Consistent with our Company’s valuation policy, we evaluate the source of inputs, including any markets in which our investments are trading, in determining fair value.

The following table presents fair value measurements of investments, by major class, as of May 31, 2015 (dollars in thousands), according to the fair value hierarchy:

 

     Fair Value Measurements  
     Level 1      Level 2      Level 3      Total  

Syndicated loans

   $ —        $ —        $ 17,794       $ 17,794   

First lien term loans

     —          —          157,072         157,072   

Second lien term loans

     —          —          40,551         40,551   

Unsecured notes

     —          —          5,861         5,861   

Structured finance securities

     —          —          16,860         16,860   

Equity interest

     —          —          24,606         24,606   
  

 

 

    

 

 

    

 

 

    

 

 

 

Total

$ —     $ —     $ 262,744    $ 262,744   
  

 

 

    

 

 

    

 

 

    

 

 

 

The following table presents fair value measurements of investments, by major class, as of February 28, 2015 (dollars in thousands), according to the fair value hierarchy:

 

     Fair Value Measurements  
     Level 1      Level 2      Level 3      Total  

Syndicated loans

   $ —        $ —        $ 18,302       $ 18,302   

First lien term loans

     —          —          145,207         145,207   

Second lien term loans

     —          —          35,603         35,603   

Unsecured notes

     —          —          4,230         4,230   

Structured finance securities

     —          —          17,031         17,031   

Equity interest

     —          —          20,165         20,165   
  

 

 

    

 

 

    

 

 

    

 

 

 

Total

$ —     $ —     $ 240,538    $ 240,538   
  

 

 

    

 

 

    

 

 

    

 

 

 

The following table provides a reconciliation of the beginning and ending balances for investments that use Level 3 inputs for the three months ended May 31, 2015 (dollars in thousands):

 

    Syndicated
loans
    First lien
term loans
    Second
lien
term loans
    Unsecured
notes
    Structured
finance
securities
    Common
stock/
equities
    Total  

Balance as of February 28, 2015

  $ 18,302      $ 145,207      $ 35,603      $ 4,230      $ 17,031      $ 20,165      $ 240,538   

Net unrealized gains (losses)

    (240     29        (22     1,036        609        4,129        5,541   

Purchases and other adjustments to cost

    11        17,941        5,056        494        —         413        23,915   

Sales and redemptions

    (283     (6,174     (86     —         (780     —          (7,323

Net realized gain from investments

    4        69        —          —         —         —          73   

Transfers in/out

    —         —          —         101       —         (101     —    
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Balance as of May 31, 2015

$ 17,794    $ 157,072    $ 40,551    $ 5,861    $ 16,860    $ 24,606    $ 262,744   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

S-103


Table of Contents

Purchases and other adjustments to cost include purchases of new investments at cost, effects of refinancing/restructuring, accretion/amortization of income from discount/premium on debt securities, and PIK.

Sales and redemptions represent net proceeds received from investments sold, and principal paydowns received, during the period.

The net change in unrealized gain/(loss) for the three months ended May 31, 2015 on investments held as of May 31, 2015 is $5,493,439 and is included in net unrealized appreciation (depreciation) on investments in the consolidated statements of operations.

The following table provides a reconciliation of the beginning and ending balances for investments that use Level 3 inputs for the three months ended May 31, 2014 (dollars in thousands):

 

    Syndicated
loans
    First lien
term loans
    Second
lien
term loans
    Unsecured
notes
    Structured
finance
securities
    Common
stock/
equities
    Total  

Balance as of February 28, 2014

  $ 32,390      $ 110,278      $ 27,804      $ 5,471      $ 19,570      $ 10,332      $ 205,845   

Net unrealized gains (losses)

    (181     (342     (210     8        549        (209     (385

Purchases and other adjustments to cost

    16        9,605        11,134        76        —         1,031        21,862   

Sales and redemptions

    (106     (2,584     (6,000     —         —          —          (8,690

Net realized gain (loss) from investments

    1        35        46        —         —         —         82   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Balance as of May 31, 2014

$ 32,120    $ 116,992    $ 32,774    $ 5,555    $ 20,119    $ 11,154    $ 218,714   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Purchases and other adjustments to cost include purchases of new investments at cost, effects of refinancing/restructuring, accretion/amortization of income from discount/premium on debt securities, and PIK.

Sales and redemptions represent net proceeds received from investments sold, and principal paydowns received, during the period.

The net change in unrealized gain/(loss) for the three months ended May 31, 2014 on investments held as of May 31, 2014 is ($319,092) and is included in net unrealized appreciation (depreciation) on investments in the consolidated statements of operations.

The valuation techniques and significant unobservable inputs used in recurring Level 3 fair value measurements of assets as of May 31, 2015 were as follows (dollars in thousands):

 

     Fair Value     

Valuation Technique

  

Unobservable Input

  

Range

Syndicated loans

     17,794       Market Comparables    Third-Party Bid    84.5% - 100.4%

First lien term loans

     157,072       Market Comparables    Market Yield (%)    6.2% - 15.5%
         EBITDA Multiples (x)    0.1x - 3.0x
         Third-Party Bid    81.5% - 105.0%

Second lien term loans

     40,551       Market Comparables    Market Yield (%)    8.5% - 16.9%
         Third-Party Bid    99.5% - 100.0%

Unsecured notes

     5,861       Market Comparables    Market Yield (%)    8.6% - 13.2%

Structured finance securities

     16,860       Discounted Cash Flow    Discount Rate (%)    11.0%

Equity interests

     24,606       Market Comparables    EBITDA Multiples (x)    5.0x - 11.0x

 

S-104


Table of Contents

The valuation techniques and significant unobservable inputs used in recurring Level 3 fair value measurements of assets as of February 28, 2015 were as follows (dollars in thousands):

 

     Fair Value     

Valuation Technique

  

Unobservable Input

  

Range

Syndicated loans

     18,302       Market Comparables    Third-Party Bid    93.6% -100.4%

First lien term loans

     145,207       Market Comparables    Market Yield (%)    5.8% - 17.7%
         EBITDA Multiples (x)    3.0x
         Third-Party Bid    79.3 - 105.0

Second lien term loans

     35,603       Market Comparables    Market Yield (%)    8.5% - 15.0%
         Third-Party Bid    98.3% - 98.3%

Unsecured notes

     4,230       Market Comparables    Market Yield (%)    13.2% - 20.3%

Structured finance securities

     17,031       Discounted Cash Flow    Discount Rate (%)    12.0%

Equity interests

     20,165       Market Comparables    EBITDA Multiples (x)    5.0x - 12.1x

For investments utilizing a market comparables valuation technique, a significant increase (decrease) in the market yield, in isolation, would result in a significantly lower (higher) fair value measurement, and a significant increase (decrease) in any of the EBITDA valuation multiples, in isolation, would result in a significantly higher (lower) fair value measurement. For investments utilizing a discounted cash flow valuation technique, a significant increase (decrease) in the discount rate, in isolation, would result in a significantly lower (higher) fair value measurement.

The composition of our investments as of May 31, 2015, at amortized cost and fair value were as follows (dollars in thousands):

 

     Investments at
Amortized Cost
     Amortized Cost
Percentage of
Total Portfolio
    Investments at
Fair Value
     Fair Value
Percentage of
Total Portfolio
 

Syndicated loans

   $ 18,390         7.2   $ 17,794         6.8

First lien term loans

     156,795         61.4        157,072         59.8   

Second lien term loans

     40,718         16.0        40,551         15.4   

Unsecured notes

     7,962         3.1        5,861         2.2   

Structured finance securities

     15,173         6.0        16,860         6.4   

Equity interest

     16,086         6.3        24,606         9.4   
  

 

 

    

 

 

   

 

 

    

 

 

 

Total

$ 255,124      100.0 $ 262,744      100.0
  

 

 

    

 

 

   

 

 

    

 

 

 

The composition of our investments as of February 28, 2015, at amortized cost and fair value were as follows (dollars in thousands):

 

     Investments at
Amortized Cost
     Amortized Cost
Percentage of
Total Portfolio
    Investments at
Fair Value
     Fair Value
Percentage of
Total Portfolio
 

Syndicated loans

   $ 18,658         7.8   $ 18,302         7.6

First lien term loans

     144,959         60.8        145,207         60.3   

Second lien term loans

     35,748         15.0        35,603         14.8   

Unsecured notes

     7,366         3.1        4,230         1.8   

Structured finance securities

     15,953         6.7        17,031         7.1   

Equity interest

     15,774         6.6        20,165         8.4   
  

 

 

    

 

 

   

 

 

    

 

 

 

Total

$ 238,458      100.0 $ 240,538      100.0
  

 

 

    

 

 

   

 

 

    

 

 

 

For loans and debt securities for which market quotations are not available, we determine their fair value based on third party indicative broker quotes, where available, or the assumptions that a hypothetical market participant would use to value the security in a current hypothetical sale using a market yield valuation

 

S-105


Table of Contents

methodology. In applying the market yield valuation methodology, we determine the fair value based on such factors as market participant assumptions including synthetic credit ratings, estimated remaining life, current market yield and interest rate spreads of similar securities as of the measurement date. If, in our judgment, the market yield methodology is not sufficient or appropriate, we may use additional methodologies such as an asset liquidation or expected recovery model.

For equity securities of portfolio companies and partnership interests, we determine the fair value based on the market approach with value then attributed to equity or equity like securities using the enterprise value waterfall valuation methodology. Under the enterprise value waterfall valuation methodology, we determine the enterprise fair value of the portfolio company and then waterfall the enterprise value over the portfolio company’s securities in order of their preference relative to one another. To estimate the enterprise value of the portfolio company, we weigh some or all of the traditional market valuation methods and factors based on the individual circumstances of the portfolio company in order to estimate the enterprise value. The methodologies for performing investments may be based on, among other things: valuations of comparable public companies, recent sales of private and public comparable companies, discounting the forecasted cash flows of the portfolio company, third party valuations of the portfolio company, considering offers from third parties to buy the company, estimating the value to potential strategic buyers and considering the value of recent investments in the equity securities of the portfolio company. For non-performing investments, we may estimate the liquidation or collateral value of the portfolio company’s assets and liabilities. We also take into account historical and anticipated financial results.

Our investment in Saratoga Investment Corp. CLO 2013-1, Ltd. (“Saratoga CLO”) is carried at fair value, which is based on a discounted cash flow model that utilizes prepayment, re-investment and loss assumptions based on historical experience and projected performance, economic factors, the characteristics of the underlying cash flow, and comparable yields for equity interests in collateralized loan obligation funds similar to Saratoga CLO, when available, as determined by our Manager and recommended to our board of directors. Specifically, we use Intex cash flow models, or an appropriate substitute, to form the basis for the valuation of our investment in Saratoga CLO. The models use a set of assumptions including projected default rates, recovery rates, reinvestment rate and prepayment rates in order to arrive at estimated valuations. The assumptions are based on available market data and projections provided by third parties as well as management estimates. For the quarter ended November 30, 2013, in connection with the refinancing of the Saratoga CLO liabilities, we ran Intex models based on assumptions about the refinanced Saratoga CLO’s structure, including capital structure, cost of liabilities and reinvestment period. We use the output from the Intex models (i.e., the estimated cash flows) to perform a discounted cash flows analysis on expected future cash flows to determine a valuation for our investment in Saratoga CLO at May 31, 2015. The significant inputs for the valuation model include:

 

    Default rates: 2.0%

 

    Recovery rates: 35-75%

 

    Prepayment rate: 25.0%

 

    Reinvestment rate / price: L+375bps / $99.75

Note 4. Investment in Saratoga Investment Corp. CLO 2013-1, Ltd. (“Saratoga CLO”)

On January 22, 2008, we invested $30 million in all of the outstanding subordinated notes of GSC Investment Corp. CLO 2007, Ltd., a collateralized loan obligation fund managed by us that invests primarily in senior secured loans. Additionally, we entered into a collateral management agreement with GSC Investment Corp. CLO 2007, Ltd. pursuant to which we act as collateral manager to it. The Saratoga CLO was refinanced in October 2013 and its reinvestment period ends in October 2016. The Saratoga CLO remains 100% owned and managed by Saratoga Investment Corp. We receive a base management fee of 0.25% and a subordinated management fee of 0.25% of the Fee Basis Amount at the beginning of the Collection Period, paid quarterly to the extent of available proceeds. We are also entitled to an incentive management fee equal to 20.0% of the

 

S-106


Table of Contents

remaining interest proceeds and principal proceeds, if any, after the subordinated notes have realized the incentive management fee target return of 12.0%, in accordance with the Priority of Payments after making the prior distributions on the relevant payment date. For the three months ended May 31, 2015 and May 31, 2014, we accrued $0.4 million and $0.4 million in management fee income, respectively, and $0.6 million and $0.6 million in interest income, respectively, from Saratoga CLO. We did not accrue any amounts related to the incentive management fee as the 12.0% hurdle rate has not yet been achieved.

At May 31, 2015, the Company determined that the fair value of its investment in the subordinated notes of Saratoga CLO was $16.9 million. The Company determines the fair value of its investment in the subordinated notes of Saratoga CLO based on the present value of the projected future cash flows of the subordinated notes over the life of Saratoga CLO. At May 31, 2015, Saratoga CLO had investments with a principal balance of $306.6 million and a weighted average spread over LIBOR of 4.2%, and had debt with a principal balance of $282.4 million with a weighted average spread over LIBOR of 1.8%. As a result, Saratoga CLO earns a “spread” between the interest income it receives on its investments and the interest expense it pays on its debt and other operating expenses, which is distributed quarterly to the Company as the holder of its subordinated notes. At May 31, 2015, the total “spread”, or projected future cash flows of the subordinated notes, over the life of Saratoga CLO was $17.1 million, which had a present value of approximately $16.9 million, using an 11.0% discount rate.

Below is certain financial information from the separate unaudited financial statements of Saratoga CLO as of May 31, 2015 and February 28, 2015 and for the three months ended May 31, 2015 and May 31, 2014.

 

S-107


Table of Contents

Saratoga Investment Corp. CLO 2013-1, Ltd.

Statements of Assets and Liabilities

 

     As of  
     May 31, 2015     February 28, 2015  
     (unaudited)        

ASSETS

    

Investments

    

Fair Value Loans (amortized cost of $304,723,108, and $295,193,588, respectively)

   $ 304,192,066      $ 294,621,817   

Fair Value Other/Structured finance securities (amortized cost of $2,566,752 and $2,566,752, respectively)

     490,890        617,451   
  

 

 

   

 

 

 

Total investments at fair value (amortized cost of $307,289,860 and $297,760,340, respectively)

  304,682,956      295,239,268   

Cash and cash equivalents

  2,565,671      5,831,797   

Receivable from open trades

  745,005      2,119,687   

Interest receivable

  1,361,040      1,290,637   
  

 

 

   

 

 

 

Total assets

$ 309,354,672    $ 304,481,389   
  

 

 

   

 

 

 

LIABILITIES

Interest payable

$ 644,098    $ 631,886   

Payable from open trades

  9,759,881      5,214,331   

Accrued base management fee

  87,263      85,957   

Accrued subordinated management fee

  87,263      85,957   

Class A-1 Notes—SIC CLO 2013-1, Ltd.

  170,000,000      170,000,000   

Discount on Class A-1 Notes—SIC CLO 2013-1, Ltd.

  (1,451,425   (1,495,802

Class A-2 Notes—SIC CLO 2013-1, Ltd.

  20,000,000      20,000,000   

Discount on Class A-2 Notes—SIC CLO 2013-1, Ltd.

  (150,450   (155,050

Class B Notes—SIC CLO 2013-1, Ltd.

  44,800,000      44,800,000   

Discount on Class B Notes—SIC CLO 2013-1, Ltd.

  (977,323   (1,007,205

Class C Notes—SIC CLO 2013-1, Ltd.

  16,000,000      16,000,000   

Discount on Class C Notes—SIC CLO 2013-1, Ltd.

  (608,487   (627,091

Class D Notes—SIC CLO 2013-1, Ltd.

  14,000,000      14,000,000   

Discount on Class D Notes—SIC CLO 2013-1, Ltd.

  (789,863   (814,013

Class E Notes—SIC CLO 2013-1, Ltd.

  13,100,000      13,100,000   

Discount on Class E Notes—SIC CLO 2013-1, Ltd.

  (1,489,121   (1,534,650

Class F Notes—SIC CLO 2013-1, Ltd.

  4,500,000      4,500,000   

Discount on Class F Notes—SIC CLO 2013-1, Ltd.

  (541,620   (558,180

Deferred debt financing costs, SIC CLO 2013-1, Ltd. Notes

  (1,885,333   (1,941,595

Subordinated Notes

  30,000,000      30,000,000   
  

 

 

   

 

 

 

Total liabilities

$ 315,084,883    $ 310,284,545   
  

 

 

   

 

 

 

Commitments and contingencies

NET ASSETS

Ordinary equity, par value $1.00, 250 ordinary shares authorized, 250 and 250 issued and outstanding, respectively

$ 250    $ 250   

Accumulated loss

  (5,803,406   (3,343,488

Net gain/(loss)

  72,945      (2,459,918
  

 

 

   

 

 

 

Total net assets

  (5,730,211   (5,803,156
  

 

 

   

 

 

 

Total liabilities and net assets

$ 309,354,672    $ 304,481,389   
  

 

 

   

 

 

 

 

S-108


Table of Contents

Saratoga Investment Corp. CLO 2013-1, Ltd.

Statements of Operations

(unaudited)

 

     For the three months
ended May 31, 2015
    For the three months
ended May 31, 2014
 

INVESTMENT INCOME

    

Interest from investments

   $ 3,512,587      $ 3,157,518   

Interest from cash and cash equivalents

     290        276   

Other income

     164,115        98,923   
  

 

 

   

 

 

 

Total investment income

  3,676,992      3,256,717   
  

 

 

   

 

 

 

EXPENSES

Interest expense

  2,846,636      2,126,984   

Professional fees

  59,222      70,218   

Miscellaneous fee expense

  4,925      23,133   

Base management fee

  189,373      196,017   

Subordinated management fee

  189,373      196,017   

Trustee expenses

  31,284      26,615   

Amortization expense

  239,963      239,963   
  

 

 

   

 

 

 

Total expenses

  3,560,776      2,878,947   
  

 

 

   

 

 

 

NET INVESTMENT INCOME

  116,216      377,770   
  

 

 

   

 

 

 

REALIZED AND UNREALIZED GAIN (LOSS) ON INVESTMENTS:

Net realized gain on investments

  42,561      380,619   

Net unrealized depreciation on investments

  (85,832   (1,453,349
  

 

 

   

 

 

 

Net loss on investments

  (43,271   (1,072,730
  

 

 

   

 

 

 

NET INCREASE (DECREASE) IN NET ASSETS RESULTING FROM OPERATIONS

$ 72,945    $ (694,960
  

 

 

   

 

 

 

 

S-109


Table of Contents

Saratoga Investment Corp. CLO 2013-1 Ltd.

Schedule of Investments

May 31, 2015

(unaudited)

 

Issuer Name

 

Industry

 

Asset Name

  Asset
Type
  Current
Rate
    Maturity
Date
    Principal/
Number
of Shares
    Cost     Fair
Value
 

Education Management II LLC

  Leisure Goods/Activities/ Movies   A-1 Preferred Shares   Equity     0.00       6,692      $ 669,214      $ 301,140   

Education Management II LLC

  Leisure Goods/Activities/ Movies   A-2 Preferred Shares   Equity     0.00       18,975        1,897,538        189,750   

24 Hour Holdings III LLC

  Leisure Goods/Activities/ Movies   Term Loan   Loan     4.75     5/28/2021      $ 496,250        491,913        476,400   

Acosta Holdco Inc.

  Media   Term Loan B1   Loan     4.25     9/27/2021      $ 1,990,000        1,975,220        1,992,806   

Aderant North America, Inc.

  Services: Business   Term Loan (First Lien)   Loan     5.25     12/20/2018      $ 3,260,898        3,260,898        3,260,898   

Aspen Dental Management, Inc.

  Healthcare & Pharmaceuticals   Term Loan Initial   Loan     5.50     4/27/2022      $ 500,000        497,525        504,375   

Advantage Sales & Marketing Inc.

  Services: Business   Delayed Draw Term Loan   Loan     4.25     7/25/2021      $ 2,490,000        2,486,539        2,485,344   

AECOM Technology Corporation

  Services: Business   Term Loan B   Loan     3.75     10/15/2021      $ 319,103        317,635        320,900   

Aegis Toxicology Science Corporation

  Healthcare & Pharmaceuticals   Term B Loan   Loan     5.50     2/24/2021      $ 992,500        992,500        967,687   

Akorn, Inc.

  Healthcare & Pharmaceuticals   Term Loan B   Loan     4.50     4/16/2021      $ 497,500        495,530        498,276   

Albertson’s LLC

  Retailers (Except Food and Drugs)   Term Loan B-4   Loan     5.50     8/25/2021      $ 3,410,000        3,390,923        3,427,971   

Alere Inc. (fka IM US Holdings, LLC)

  Healthcare & Pharmaceuticals   Incremental B-1 Term Loan   Loan     4.25     6/30/2017      $ 1,524,604        1,524,604        1,526,830   

Alvogen Pharma US, Inc

  Healthcare & Pharmaceuticals   Term Loan   Loan     5.00     4/2/2022      $ 500,000        497,572        502,915   

American Tire Distributors Inc

  Automotive   Term Loan B   Loan     4.25     9/1/2021      $ 496,487        495,668        501,040   

Aramark Corporation

  Food Products   LC-2 Facility   Loan     3.74     7/26/2016      $ 79,187        79,177        78,593   

Aramark Corporation

  Food Products   LC-3 Facility   Loan     3.74     7/26/2016      $ 43,961        43,961        43,631   

Aramark Corporation

  Food Products   U.S. Term F Loan   Loan     3.25     2/24/2021      $ 3,174,472        3,174,472        3,170,504   

ARG IH Corp

  Food Services   Term Loan   Loan     4.75     11/15/2020      $ 483,163        482,308        484,975   

American Beacon Advisors, Inc.

  Financial Intermediaries   Term Loan (First Lien)   Loan     5.50     4/30/2022      $ 250,000        248,759        252,812   

Asurion, LLC (fka Asurion Corporation)

  Insurance   Incremental Tranche B-1 Term Loan   Loan     5.00     5/24/2019      $ 5,397,939        5,358,755        5,414,834   

Avantor Performance Materials Holdings, Inc.

  Chemicals/Plastics   Term Loan   Loan     5.25     6/24/2017      $ 3,913,710        3,905,683        3,913,710   

Avast Software

  Electronics/Electric   Term Loan   Loan     4.75     3/20/2020      $ 1,900,000        1,898,425        1,911,077   

AZ Chem US Inc.

  Chemicals/Plastics   Term Loan   Loan     5.25     6/12/2021      $ 460,274        458,212        460,274   

Bass Pro Group, LLC

  Retailers (Except Food and Drugs)   New Term Loan   Loan     3.75     11/20/2019      $ 492,348        491,947        492,348   

Bass Pro Group, LLC

  Retailers (Except Food and Drugs)   Term Loan   Loan     3.75     11/20/2019      $ 1,007,652        1,005,133        1,007,652   

Bayonne Energy Center

  Oil & Gas   Term Loan B   Loan     5.00     8/19/2021      $ 533,481        531,096        536,148   

Belmond Interfin Ltd.

  Lodging & Casinos   Term Loan   Loan     4.00     3/19/2021      $ 495,000        492,889        494,381   

Berry Plastics Corporation

  Chemicals/Plastics   Term E Loan   Loan     3.75     1/6/2021      $ 1,814,499        1,802,988        1,814,499   

 

S-110


Table of Contents

Issuer Name

 

Industry

 

Asset Name

  Asset
Type
  Current
Rate
    Maturity
Date
    Principal/
Number
of Shares
    Cost     Fair
Value
 

Biomet, Inc.

  Healthcare & Pharmaceuticals   Dollar Term B-2 Loan   Loan     3.65     7/25/2017      $ 1,840,718        1,840,718        1,838,325   

BJ’s Wholesale Club, Inc.

 

Food/Drug Retailers

 

  New 2013 (November) Replacement Loan (First Lien)   Loan     4.50     9/26/2019      $ 1,486,212        1,485,225        1,489,304   

Blue Coat Systems

  Technology   Term Loan B   Loan     4.50     5/19/2022      $ 1,000,000        997,500        1,001,250   

BMC Software

  Technology   Term Loan   Loan     5.00     9/10/2020      $ 1,994,950        1,933,227        1,948,407   

Bombardier Recreational Products Inc.

  Leisure Goods/Activities/Movies   Term B Loan   Loan     4.00     1/30/2019      $ 754,286        750,526        753,516   

Brickman Group Holdings, Inc.

  Brokers/Dealers/Investment Houses   Initial Term Loan (First Lien)   Loan     4.00     12/18/2020      $ 1,487,481        1,475,540        1,484,699   

Brock Holdings III, Inc.

  Industrial Equipment   Term Loan (First Lien)   Loan     6.00     3/16/2017      $ 1,933,169        1,945,346        1,921,087   

Burlington Coat Factory Warehouse Corporation

  Retailers (Except Food and Drugs)   Term B-2 Loan   Loan     4.25     8/13/2021      $ 1,861,667        1,853,261        1,865,800   

BWAY Holding Company

  Leisure Goods/Activities/Movies   Term Loan B   Loan     5.50     8/14/2020      $ 992,500        983,770        995,805   

Caesars Entertainment Corp.

  Lodging & Casinos   Term B-7 Loan   Loan     9.75     1/28/2018      $ 995,000        989,683        900,167   

Camp International Holding Company

 

Aerospace and Defense

  2013 Replacement Term Loan (First Lien)   Loan     4.75     5/31/2019      $ 1,955,057        1,960,381        1,958,107   

Capital Automotive L.P.

  Conglomerate   Tranche B-1 Term Loan Facility   Loan     4.00     4/10/2019      $ 2,073,747        2,077,935        2,081,523   

Catalent Pharma Solutions, Inc

  Drugs   Initial Term B Loan   Loan     4.25     5/20/2021      $ 496,250        494,094        497,804   

Celanese US Holdings LLC

  Chemicals/Plastics   Dollar Term C-2 Commitment   Loan     2.49     10/31/2018      $ 2,149,147        2,173,337        2,156,905   

Cengage Learning Acquisitions, Inc.

  Publishing   Term Loan   Loan     7.00     3/31/2020      $ 2,724,987        2,753,442        2,730,328   

Charter Communications Operating, LLC

  Cable and Satellite Television   Term F Loan   Loan     3.00     12/31/2020      $ 2,649,005        2,640,702        2,632,078   

CHS/Community Health Systems, Inc.

  Healthcare & Pharmaceuticals   Term F Loan   Loan     3.25     12/31/2018      $ 1,097,819        1,077,865        1,099,653   

CHS/Community Health Systems, Inc.

  Healthcare & Pharmaceuticals   Term G Loan   Loan     3.75     12/31/2019      $ 1,027,707        1,000,275        1,029,568   

CHS/Community Health Systems, Inc.

  Healthcare & Pharmaceuticals   Term H Loan   Loan     4.00     1/27/2021      $ 1,890,955        1,840,450        1,894,377   

Cinedigm Digital Funding I, LLC

  Services: Business   Term Loan   Loan     3.75     2/28/2018      $ 490,397        487,081        490,397   

CITGO Petroleum Corporation

  Oil & Gas   Term Loan B   Loan     4.50     7/29/2021      $ 995,000        991,770        997,070   

ClubCorp Club Operations, Inc.

  Lodging & Casinos   Term Loan B   Loan     4.50     7/24/2020      $ 500,000        496,250        501,125   

Communications Sales & Leasing, Inc.

  Telecommunications   Term Loan B (First Lien)   Loan     5.00     10/24/2022      $ 2,000,000        1,987,560        1,990,500   

CommScope, Inc.

  Telecommunications   Term Loan B   Loan     4.00     5/27/2022      $ 500,000        498,750        500,625   

Concordia Healthcare Corp

  Healthcare & Pharmaceuticals   Term Loan B   Loan     4.75     4/21/2022      $ 250,000        248,764        251,875   

CPI International Acquisition, Inc.
(f/k/a Catalyst Holdings, Inc.)

  Electronics/Electric   Term B Loan   Loan     4.25     11/17/2017      $ 3,586,275        3,586,275        3,568,344   

Crosby US Acquisition Corp.

  Industrial Equipment   Initial Term Loan (First Lien)   Loan     3.75     11/23/2020      $ 740,625        739,888        700,816   

Crown Castle Operating Company

  Telecommunications/Cellular   Extended Incremental Tranche B-2 Term Loan   Loan     3.00     1/31/2021      $ 2,429,443        2,427,500        2,424,536   

 

S-111


Table of Contents

Issuer Name

 

Industry

 

Asset Name

  Asset
Type
  Current
Rate
    Maturity
Date
    Principal/
Number
of Shares
    Cost     Fair
Value
 

CT Technologies Intermediate Hldgs, Inc

  Healthcare & Pharmaceuticals   Term Loan (First Lien)   Loan     6.00     12/1/2021      $ 1,496,250        1,482,153        1,499,362   

Culligan International Company

  Conglomerate   Dollar Loan (First Lien)   Loan     6.25     12/19/2017      $ 777,637        738,020        764,029   

Culligan International Company

  Conglomerate   Dollar Loan (Second Lien)   Loan     9.50     6/19/2018      $ 783,162        742,154        744,333   

Cumulus Media Holdings Inc.

  Broadcast Radio and Television   Term Loan   Loan     4.25     12/23/2020      $ 470,093        466,256        445,413   

Custom Sensors & Technologies, Inc.

  Industrial Equipment   Term Loan   Loan     4.50     9/30/2021      $ 497,500        496,476        497,500   

DaVita HealthCare Partners Inc. (fka DaVita Inc.)

  Healthcare & Pharmaceuticals   Tranche B Term Loan   Loan     3.50     6/24/2021      $ 496,250        494,065        496,994   

DCS Business Services, Inc.

  Financial Intermediaries   Term B Loan   Loan     7.25     3/19/2018      $ 3,231,044        3,210,653        3,191,432   

Dealertrack Technologies, Inc.

  Leisure Goods/Activities/Movies   Term B Loan   Loan     3.25     2/26/2021      $ 477,011        476,070        476,214   

Dell International LLC

  Retailers (Except Food and Drugs)   Term B Loan   Loan     4.50     4/29/2020      $ 2,926,941        2,915,287        2,928,170   

Delos Finance SARL

  Financial Intermediaries   Term Loan   Loan     3.50     3/6/2021      $ 500,000        497,909        500,000   

Delta 2 (Lux) S.a.r.l.

  Lodging & Casinos   Term Loan B-3   Loan     4.75     7/30/2021      $ 1,000,000        995,563        999,310   

Deluxe Entertainment Service Group, Inc.

  Leisure Goods/Activities/Movies   Term Loan (First Lien)   Loan     6.50     2/28/2020      $ 1,882,982        1,884,624        1,835,908   

Devix US, Inc.

  Chemicals/Plastics   Term Loan   Loan     4.25     5/2/2021      $ 250,000        247,779        249,688   

Devix US, Inc.

  Chemicals/Plastics   Term Loan (Second Lien)   Loan     8.00     5/2/2022      $ 496,250        494,151        497,024   

Diamond Resorts International

  Lodging & Casinos   Term Loan   Loan     5.50     5/9/2021      $ 926,971        922,892        926,971   

DJO Finance LLC

  Healthcare & Pharmaceuticals   Term Loan   Loan     4.25     6/8/2020      $ 500,000        497,921        500,750   

Dollar Tree Stores Inc.

  Retail   Term Loan B (3950MM)   Loan     4.25     3/9/2022      $ 1,000,000        995,086        1,009,030   

DPX Holdings B.V.

  Healthcare & Pharmaceuticals   Term Loan 2015 Incr Dollar   Loan     4.25     3/11/2021      $ 2,977,500        2,971,293        2,959,814   

Drew Marine Group Inc.

  Chemicals/Plastics   Term Loan (First Lien)   Loan     4.50     11/19/2020      $ 1,472,161        1,477,822        1,469,408   

Education Management LLC

  Leisure Goods/Activities/Movies   Term Loan A   Loan     5.50     7/2/2020      $ 501,970        482,966        422,910   

Education Management LLC

  Leisure Goods/Activities/Movies   Term Loan B   Loan    

 

 

8.50

(2.00% Cash/

6.50% PIK)


  

  

    7/2/2020      $ 850,514        820,457        634,696   

Emerald Performance Materials, LLC

  Chemicals/Plastics   Term Loan (First Lien)   Loan     4.50     8/1/2021      $ 497,500        495,276        498,122   

Emerald Performance Materials, LLC

  Chemicals/Plastics   Term Loan (Second Lien)   Loan     7.75     8/1/2022      $ 500,000        497,728        498,440   

Emerald Performance Materials, LLC

  Chemicals/Plastics   Term Loan B1A   Loan     4.50     7/30/2021      $ 1,000,000        990,354        988,330   

EnergySolutions, LLC

  Oil & Gas   Term Loan B   Loan     6.75     5/29/2020      $ 937,857        921,782        941,374   

Evergreen Acqco 1 LP

  Retailers (Except Food and Drugs)   New Term Loan   Loan     5.00     7/9/2019      $ 972,562        970,551        948,248   

EWT Holdings III Corp. (fka WTG Holdings III Corp.)

  Industrial Equipment   Term Loan (First Lien)   Loan     4.75     1/15/2021      $ 1,982,462        1,977,634        1,979,984   

Federal-Mogul Corporation

  Automotive   Tranche C Term Loan   Loan     4.75     4/15/2021      $ 2,977,500        2,964,818        2,966,811   

First Data Corporation

  Financial Intermediaries   2017 Second New Dollar Term Loan   Loan     3.74     3/23/2018      $ 2,790,451        2,734,063        2,788,944   

First Data Corporation

  Financial Intermediaries   2018 Dollar Term Loan   Loan     4.24     3/24/2021      $ 2,111,028        2,024,645        2,116,833   

Fitness International, LLC

  Leisure Goods/Activities/Movies   Term Loan B   Loan     5.50     7/1/2020      $ 1,488,750        1,479,155        1,455,253   

 

S-112


Table of Contents

Issuer Name

 

Industry

 

Asset Name

  Asset
Type
  Current
Rate
    Maturity
Date
    Principal/
Number
of Shares
    Cost     Fair
Value
 

FMG Resources (August 2006) Pty LTD (FMG America Finance, Inc.)

  Nonferrous Metals/Minerals   Loan   Loan     3.75     6/28/2019      $ 1,977,443        1,977,366        1,790,199   

Four Seasons Holdings Inc.

  Lodging & Casinos   Term Loan (First Lien)   Loan     3.50     6/27/2020      $ 489,865        489,865        490,271   

Garda World Security Corporation

  Services: Business   Term B Delayed Draw Loan   Loan     4.00     11/6/2020      $ 200,648        199,825        199,896   

Garda World Security Corporation

  Services: Business   Term B Loan   Loan     4.00     11/6/2020      $ 784,352        781,392        781,411   

Gardner Denver, Inc.

 

Oil & Gas

  Initial Dollar Term Loan   Loan     4.25     7/30/2020      $ 2,469,943        2,461,740        2,412,690   

Gates Global LLC

  Leisure Goods/Activities/Movies   Term Loan (First Lien)   Loan     4.25     7/3/2021      $ 497,500        492,525        494,888   

Generac Power Systems, Inc.

  Industrial Equipment   Term Loan B   Loan     3.25     5/29/2020      $ 693,858        683,135        690,680   

General Nutrition Centers, Inc.

  Retailers (Except Food and Drugs)   Amended Tranche B Term Loan   Loan     3.25     3/4/2019      $ 4,720,142        4,706,492        4,667,041   

Global Tel*Link Corporation

  Services: Business   Term Loan (First Lien)   Loan     5.00     5/26/2020      $ 2,747,966        2,740,001        2,706,746   

Goodyear Tire & Rubber Company, The

  Chemicals/Plastics   Loan (Second Lien)   Loan     4.75     4/30/2019      $ 3,333,333        3,298,766        3,355,000   

Grosvenor Capital Management Holdings, LP

  Brokers/Dealers/Investment Houses   Initial Term Loan   Loan     3.75     1/4/2021      $ 3,395,892        3,381,806        3,381,052   

GTCR Valor Companies, Inc.

  Services: Business   Term Loan (First Lien)   Loan     6.00     6/1/2021      $ 1,989,995        1,950,196        1,987,508   

Harland Clarke Holdings Corp. (fka Clarke American Corp.)

  Publishing   Tranche B-4 Term Loan   Loan     6.00     8/2/2019      $ 484,375        482,452        485,184   

HCA Inc.

  Healthcare & Pharmaceuticals   Tranche B-4 Term Loan   Loan     2.99     5/1/2018      $ 5,648,670        5,415,004        5,648,105   

Headwaters Incorporated

  Building & Development   Term Loan   Loan     4.50     3/24/2022      $ 250,000        248,764        250,625   

Hertz Corporation, The

  Automotive   Tranche B-1 Term Loan   Loan     4.00     3/12/2018      $ 2,932,500        2,964,832        2,933,556   

Hoffmaster Group, Inc.

  Containers/Glass Products   Term Loan   Loan     5.25     5/8/2020      $ 1,985,000        1,968,036        1,994,925   

Huntsman International LLC

  Chemicals/Plastics   Extended Term B Loan   Loan     2.69     4/19/2017      $ 3,840,541        3,813,492        3,840,541   

Husky Injection Molding Systems Ltd.

  Services: Business   Term Loan B   Loan     4.25     6/30/2021      $ 491,797        489,720        492,761   

Infor (US), Inc. (fka Lawson Software Inc.)

  Services: Business   Tranche B-5 Term Loan   Loan     3.75     6/3/2020      $ 2,205,351        2,189,132        2,195,361   

Insight Global

  Services: Business   Term Loan   Loan     6.00     10/29/2021      $ 1,994,898        1,986,758        1,998,229   

J. Crew Group, Inc.

  Retailers (Except Food and Drugs)   Term B-1 Loan Retired 03/05/2014   Loan     4.00     3/5/2021      $ 962,775        962,775        872,188   

Jazz Acquisition, Inc

  Aerospace and Defense   First Lien 6/14   Loan     4.50     6/19/2021      $ 496,364        495,123        492,641   

J.Jill Group, Inc.

  Retail   Term Loan (First Lien)   Loan     6.00     5/9/2022      $ 1,000,000        995,018        1,001,250   

Kinetic Concepts, Inc.

  Healthcare & Pharmaceuticals   Dollar Term D-1 Loan   Loan     4.00     5/4/2018      $ 2,471,356        2,449,511        2,486,802   

Koosharem, LLC

  Services: Business   Term Loan   Loan     7.50     5/15/2020      $ 2,987,513        2,962,552        2,970,095   

La Quinta Holdings, Inc.

  Lodging & Casinos   Term Loan (First Lien)   Loan     4.00     4/14/2021      $ 434,717        433,214        435,586   

Level 3 Financing, Inc.

  Telecommunications   Term Loan B2   Loan     4.50     1/31/2022      $ 500,000        496,648        499,688   

Mauser Holdings, Inc.

  Containers/Glass Products   Term Loan   Loan     4.50     7/31/2021      $ 497,500        495,281        497,813   

Michaels Stores, Inc.

  Retailers (Except Food and Drugs)   Term B Loan   Loan     3.75     1/28/2020      $ 490,000        490,000        490,186   

 

S-113


Table of Contents

Issuer Name

 

Industry

 

Asset Name

  Asset
Type
  Current
Rate
    Maturity
Date
    Principal/
Number
of Shares
    Cost     Fair
Value
 

Michaels Stores, Inc.

  Retailers (Except Food and Drugs)   Term Loan B-2   Loan     4.00     1/28/2020      $ 1,488,750        1,482,222        1,493,469   

Microsemi Corporation

  Electronics/Electric   Incremental Term Loan   Loan     3.50     2/19/2020      $ 2,122,318        2,118,346        2,124,313   

Midas Intermediate Holdco II, LLC

  Automotive   Delayed Draw Term Loan   Loan     4.75     8/18/2021      $ 25,190        25,190        25,324   

Midas Intermediate Holdco II, LLC

  Automotive   Term Loan B   Loan     4.75     8/18/2021      $ 223,560        222,539        224,747   

Millenium Laboratories, LLC

  Drugs   Term Loan   Loan     5.25     4/16/2021      $ 1,488,750        1,475,773        1,001,929   

MPH Acquisition Holdings LLC

  Healthcare & Pharmaceuticals   Term Loan   Loan     3.75     3/31/2021      $ 431,818        430,910        430,739   

MSC Software Corp.

  Services: Business   Term Loan   Loan     5.00     5/29/2020      $ 992,500        984,127        985,056   

National CineMedia, LLC

  Leisure Goods/Activities/Movies   Term Loan (2013)   Loan     2.95     11/26/2019      $ 1,086,207        1,060,272        1,072,238   

National Veterinary Associates, Inc

  Healthcare & Pharmaceuticals   Term Loan B   Loan     4.75     8/14/2021      $ 995,006        991,489        995,832   

National Vision, Inc.

  Retailers (Except Food and Drugs)   Term Loan (Second Lien)   Loan     6.75     3/11/2022      $ 250,000        249,731        243,125   

Newsday, LLC

  Publishing   Term Loan   Loan     3.69     10/12/2016      $ 2,215,385        2,214,480        2,209,846   

Nortek, Inc.

  Electronics/Electric   Term B Loan   Loan     3.75     10/30/2020      $ 992,500        980,651        988,778   

Novelis, Inc.

  Conglomerate   Initial Term Loan   Loan     3.75     3/10/2017      $ 4,795,033        4,803,880        4,790,142   

Novelis, Inc.

  Conglomerate   Term Loan B   Loan     3.75     3/10/2017      $ 4,795,033        4,771,058        4,790,142   

NPC International, Inc.

  Food Services   Term Loan (2013)   Loan     4.00     12/28/2018      $ 485,000        485,000        480,756   

NRG Energy, Inc.

  Utilities   Term Loan (2013)   Loan     2.75     7/2/2018      $ 3,851,400        3,833,925        3,825,095   

NuSil Technology LLC.

  Chemicals/Plastics   Term Loan   Loan     5.25     4/7/2017      $ 795,751        795,751        790,284   

Ollie’s Bargain Outlet, Inc

  Retailers (Except Food and Drugs)   Term Loan   Loan     4.75     9/30/2019      $ 974,527        970,576        969,654   

On Assignment, Inc.

  Services: Business   Initial Term B Loan   Loan     3.50     5/15/2020      $ 1,311,364        1,303,800        1,310,957   

Onex Carestream Finance LP

  Healthcare & Pharmaceuticals   Term Loan (First Lien 2013)   Loan     5.00     6/7/2019      $ 3,996,811        3,982,808        3,993,054   

OnexYork Acquisition Co

  Healthcare & Pharmaceuticals   Delayed Draw Term Loan   Loan     4.75     10/1/2021      $ 48,537        48,182        48,294   

OnexYork Acquisition Co

  Healthcare & Pharmaceuticals   Term Loan B   Loan     4.75     10/1/2021      $ 448,963        445,914        446,719   

OpenLink International LLC

  Services: Business   Term B Loan   Loan     6.25     10/28/2017      $ 2,967,500        2,965,974        2,952,663   

Orbitz Worldwide, Inc.

  Services: Business   Term Loan (First Lien)   Loan     4.50     4/15/2021      $ 1,408,613        1,406,579        1,409,500   

P.F. Chang’s China Bistro, Inc. (Wok Acquisition Corp.)

  Food/Drug Retailers   Term Borrowing   Loan     4.25     6/24/2019      $ 1,444,113        1,437,299        1,427,867   

P2 Upstream Acquisition Co. (P2 Upstream Canada BC ULC)

  Services: Business   Term Loan (First Lien)   Loan     5.00     10/30/2020      $ 987,500        983,132        966,516   

Par Pharmaceutical Companies, Inc.

  Healthcare & Pharmaceuticals   Term Loan B3   Loan     4.25     9/28/2019      $ 498,750        496,360        499,583   

Penn Products Terminal, LLC

  Chemicals/Plastics   Term Loan B   Loan     4.75     4/13/2022      $ 250,000        248,773        251,875   

PetCo Animal Supplies Stores, Inc.

  Retailers (Except Food and Drugs)   New Loans   Loan     4.00     11/24/2017      $ 1,465,561        1,464,910        1,467,584   

Petsmart, Inc. (Argos Merger Sub, Inc.)

  Retail   Term Loan B1   Loan     4.25     3/11/2022      $ 1,000,000        995,088        1,002,140   

PGX Holdings, Inc.

  Financial Intermediaries   Term Loan   Loan     6.25     9/29/2020      $ 987,500        978,766        990,788   

Pharmaceutical Product Development, Inc. (Jaguar Holdings, LLC)

  Conglomerate   2013 Term Loan   Loan     4.00     12/5/2018      $ 1,935,450        1,914,850        1,937,521   

Phillips-Medisize Corporation

  Healthcare & Pharmaceuticals   Term Loan   Loan     4.75     6/16/2021      $ 496,250        494,073        495,942   

 

S-114


Table of Contents

Issuer Name

 

Industry

 

Asset Name

  Asset
Type
  Current
Rate
    Maturity
Date
    Principal/
Number
of Shares
    Cost     Fair
Value
 

Physio-Control International, Inc.

  Healthcare & Pharmaceuticals   Term Loan B   Loan     5.50     5/19/2022      $ 500,000        497,500        501,875   

Pinnacle Foods Finance LLC

  Food Products   New Term Loan G   Loan     3.00     4/29/2020      $ 2,581,332        2,576,895        2,572,813   

Planet Fitness Holdings LLC

  Leisure Goods/Activities/Movies   Term Loan   Loan     4.75     3/31/2021      $ 2,485,000        2,477,540        2,478,788   

Polymer Group, Inc.

  Chemicals/Plastics   Initial Loan   Loan     5.25     12/19/2019      $ 493,750        491,694        495,394   

Post Holdings, Inc.

  Consumer Goods: Non-Durable   Term Loan Series A   Loan     3.75     6/2/2021      $ 1,000,000        994,500        995,180   

PrePaid Legal Services, Inc.

  Services: Business   Term Loan B   Loan     6.50     7/1/2019      $ 750,000        746,250        750,623   

Presidio, Inc.

  Services: Business   Term Loan   Loan     5.25     2/2/2022      $ 1,916,667        1,861,770        1,920,270   

Prestige Brands, Inc.

  Consumer Goods: Durable   Term B-3 Loan   Loan     3.50     9/3/2021      $ 2,112,374        2,104,893        2,114,127   

Quintiles Transnational Corp.

  Services: Business   Term Loan B   Loan     3.25     5/6/2022      $ 1,000,000        997,510        1,002,190   

Ranpak Holdings, Inc.

  Services: Business   Term Loan   Loan     4.25     10/1/2021      $ 995,000        992,728        995,000   

Ranpak Holdings, Inc.

  Services: Business   Term Loan (Second Lien)   Loan     8.25     9/30/2022      $ 500,000        497,726        499,585   

Redtop Acquisitions Limited

  Electronics/Electric   Initial Dollar Term Loan (First Lien)   Loan     4.50     12/3/2020      $ 493,750        490,848        493,133   

Regal Cinemas Corporation

  Services: Consumer   Term Loan   Loan     3.75     4/1/2022      $ 500,000        498,780        501,640   

Research Now Group, Inc

  Media   Term Loan B   Loan     5.50     3/18/2021      $ 500,000        497,544        501,875   

Rexnord LLC/RBS Global, Inc.

  Industrial Equipment   Term B Loan   Loan     4.00     8/21/2020      $ 1,642,630        1,644,003        1,639,690   

Reynolds Group Holdings Inc.

  Industrial Equipment   Incremental U.S. Term Loan   Loan     4.00     12/1/2018      $ 1,910,551        1,910,551        1,916,531   

Riverbed Technology, Inc.

  Technology   Term Loan B   Loan     6.00     2/25/2022      $ 1,000,000        995,138        1,009,380   

Rocket Software, Inc.

  Services: Business   Term Loan (First Lien)   Loan     5.75     2/8/2018      $ 1,916,674        1,900,419        1,916,674   

Rovi Solutions Corporation / Rovi Guides, Inc.

  Electronics/Electric   Tranche B-3 Term Loan   Loan     3.75     7/2/2021      $ 1,488,750        1,482,202        1,481,306   

RPI Finance Trust

  Financial Intermediaries   Term B-4 Term Loan   Loan     3.50     11/9/2020      $ 5,194,247        5,194,247        5,194,247   

SBP Holdings LP

 

Industrial Equipment

  Term Loan (First Lien)   Loan     5.00     3/27/2021      $ 990,000        985,714        891,000   

Scientific Games International, Inc.

  Electronics/Electric   Term Loan B2   Loan     6.00     10/1/2021      $ 997,500        988,352        996,440   

Seadrill Operating LP

  Oil & Gas   Term Loan B   Loan     4.00     2/21/2021      $ 994,962        918,242        811,929   

Sensata Technologies B.V./Sensata Technology Finance Company, LLC

  Industrial Equipment   Term Loan   Loan     3.00     10/11/2021      $ 1,264,400        1,264,400        1,266,878   

Sensus USA Inc. (fka Sensus Metering Systems)

  Utilities   Term Loan (First Lien)   Loan     4.50     5/9/2017      $ 1,920,081        1,916,275        1,912,880   

ServiceMaster Company, The

  Conglomerate   Tranche B Term Loan   Loan     4.25     7/1/2021      $ 1,990,000        1,972,330        1,994,657   

Shearers Foods LLC

 

Food Services

  Term Loan (First Lien)   Loan     4.50     6/30/2021      $ 995,000        992,823        994,383   

Sonneborn, LLC

 

Chemicals/Plastics

  Term Loan (First Lien)   Loan     5.50     12/10/2020      $ 224,437        223,922        224,999   

Sonneborn, LLC

  Chemicals/Plastics   Initial US Term Loan   Loan     5.50     12/10/2020      $ 1,271,813        1,268,891        1,274,992   

Sophia, L.P.

  Electronics/Electric   Term B Loan   Loan     4.00     7/19/2018      $ 883,715        875,972        884,599   

SourceHOV LLC

 

Services: Business

  Term Loan B (First Lien)   Loan     7.75     10/31/2019      $ 1,987,500        1,932,692        1,828,500   

SRAM, LLC

 

Industrial Equipment

  Term Loan (First Lien)   Loan     4.00     4/10/2020      $ 2,935,089        2,926,129        2,930,187   

 

S-115


Table of Contents

Issuer Name

 

Industry

 

Asset Name

  Asset
Type
  Current
Rate
    Maturity
Date
    Principal/
Number
of Shares
    Cost     Fair
Value
 

Staples, Inc.

  Retail   Term Loan B   Loan     3.50     4/23/2021      $ 1,000,000        995,000        1,000,940   

Steak ‘n Shake Operations, Inc.

  Food Services   Term Loan   Loan     4.75     3/19/2021      $ 990,000        981,539        985,050   

SunGard Data Systems Inc. (Solar Capital Corp.)

  Conglomerate   Tranche C Term Loan   Loan     3.90     2/28/2017      $ 285,352        283,389        285,472   

SunGard Data Systems Inc. (Solar Capital Corp.)

  Conglomerate   Tranche E Term Loan   Loan     4.00     3/9/2020      $ 3,707,953        3,622,675        3,714,924   

SuperMedia Inc. (fka Idearc Inc.)

  Publishing   Loan   Loan     11.60     12/30/2016      $ 235,379        230,025        158,528   

Syniverse Holdings, Inc.

  Telecommunications   Initial Term Loan   Loan     4.00     4/23/2019      $ 479,913        476,313        458,917   

TGI Friday’s Inc

  Food Services   Term Loan B   Loan     5.25     7/15/2020      $ 1,761,386        1,756,571        1,761,386   

Townsquare Media, Inc.

  Media   Term Loan B   Loan     4.25     4/1/2022      $ 1,000,000        995,060        1,005,420   

TPF II Power LLC and TPF II Covert Midco LLC

  Utilities   Term Loan B   Loan     5.50     10/2/2021      $ 498,750        495,598        504,516   

TransDigm, Inc.

  Aerospace and Defense   Tranche C Term Loan   Loan     3.75     2/28/2020      $ 4,310,366        4,318,132        4,297,435   

TransDigm, Inc.

  Aerospace and Defense   Tranche E Term Loan   Loan     3.50     5/13/2022      $ 2,000,000        1,990,600        1,985,000   

TransFirst Holdings, Inc.

  Financial Intermediaries   Term Loan   Loan     5.50     11/12/2021      $ 498,750        494,148        498,022   

Trans Union LLC

  Financial Intermediaries   Term Loan   Loan     4.00     4/9/2021      $ 495,000        493,963        493,322   

Travel Leaders Group, LLC

  Hotel, Gaming and Leisure   Term Loan B   Loan     7.00     12/7/2020      $ 1,000,000        995,055        1,010,000   

Tricorbraun, Inc. (fka Kranson Industries, Inc.)

  Containers/Glass Products   Term Loan   Loan     4.00     5/3/2018      $ 1,836,625        1,830,188        1,827,442   

Truven Health Analytics Inc. (fka Thomson Reuters (Healthcare) Inc.)

  Healthcare & Pharmaceuticals   New Tranche B Term Loan   Loan     4.50     6/6/2019      $ 486,325        479,056        486,529   

Twin River Management Group, Inc.

  Lodging & Casinos   Term Loan B   Loan     5.25     7/10/2020      $ 956,192        958,419        953,801   

U.S. Security Associates Holdings, Inc.

  Services: Business   Delayed Draw Loan   Loan     6.25     7/28/2017      $ 158,110        157,308        157,814   

U.S. Security Associates Holdings, Inc.

  Services: Business   Term B Loan   Loan     6.25     7/28/2017      $ 928,641        924,314        926,905   

United Surgical Partners International, Inc.

  Healthcare & Pharmaceuticals   New Tranche B Term Loan   Loan     4.75     4/3/2019      $ 2,425,561        2,403,697        2,425,561   

Univar Inc.

  Chemicals/Plastics   Term B Loan   Loan     5.00     6/30/2017      $ 3,834,969        3,834,775        3,830,175   

Univision Communications Inc.

  Telecommunications   Replacement First-Lien Term Loan   Loan     4.00     3/1/2020      $ 2,939,724        2,924,949        2,934,667   

Valeant Pharmaceuticals International, Inc.

  Drugs   Series D2 Term Loan B   Loan     3.50     2/13/2019      $ 2,545,588        2,537,897        2,543,272   

Verint Systems Inc.

  Services: Business   Term Loan   Loan     3.50     9/6/2019      $ 1,014,058        1,010,683        1,015,325   

Vertafore, Inc.

  Services: Business   Term Loan (2013)   Loan     4.25     10/3/2019      $ 2,484,603        2,484,603        2,490,815   

Vouvray US Finance

  Industrial Equipment   Term Loan   Loan     5.00     6/28/2021      $ 496,250        494,080        498,319   

Washington Inventory Service

  Services: Business   U.S. Term Loan (First Lien)   Loan     5.75     12/20/2018      $ 1,832,875        1,850,149        1,800,800   

Waste Industries

  Environmental   Term Loan B   Loan     4.25     2/27/2020      $ 250,000        249,405        251,145   

Wendy’s International, Inc

  Food Services   Term B Loan   Loan     3.25     5/15/2019      $ 671,921        666,709        671,753   

West Corporation

  Telecommunications   Term B-10 Loan   Loan     3.25     6/30/2018      $ 2,571,560        2,603,429        2,565,490   
             

 

 

   

 

 

 
$ 307,289,860    $ 304,682,956   
             

 

 

   

 

 

 

 

S-116


Table of Contents

Saratoga Investment Corp. CLO 2013-1 Ltd.

Schedule of Investments

February 28, 2015

 

Issuer Name

 

Industry

 

Asset Name

  Asset
Type
  Current
Rate
    Maturity
Date
    Principal/
Number
of Shares
    Cost     Fair
Value
 

Education Management II LLC

 

Leisure Goods/Activities/

Movies

  A-1 Preferred Shares   Equity     0.00       6,692      $ 669,214      $ 437,188   

Education Management II LLC

 

Leisure Goods/Activities/

Movies

  A-2 Preferred Shares   Equity     0.00       18,975        1,897,538        180,263   

24 Hour Holdings III LLC

 

Leisure Goods/Activities/

Movies

  Term Loan   Loan     4.75     5/28/2021      $ 497,500        493,004        492,276   

Acosta Holdco Inc.

  Media   Term Loan B   Loan     5.00     9/27/2021      $ 1,995,000        1,981,328        2,004,416   

Aderant North America, Inc.

  Services: Business   Term Loan (First Lien)   Loan     5.25     12/20/2018      $ 3,260,898        3,260,898        3,240,517   

Advantage Sales & Marketing Inc.

  Services: Business   Delayed Draw Term Loan   Loan     4.25     7/25/2021      $ 1,995,000        1,993,940        1,984,287   

AECOM Technology Corporation

  Services: Business   Term Loan B   Loan     3.75     10/15/2021      $ 319,903        318,380        321,304   

Aegis Toxicology Science Corporation

  Healthcare & Pharmaceuticals   Term B Loan   Loan     5.50     2/24/2021      $ 995,000        995,000        997,488   

Akorn, Inc.

  Healthcare & Pharmaceuticals   Term Loan B   Loan     4.50     4/16/2021      $ 498,750        496,691        500,411   

Albertson’s LLC

  Retailers (Except Food and Drugs)   Term Loan B-4   Loan     5.50     8/25/2021      $ 3,410,000        3,389,632        3,437,723   

Alere Inc. (fka IM US Holdings, LLC)

  Healthcare & Pharmaceuticals   Incremental B-1 Term Loan   Loan     4.25     6/30/2017      $ 1,529,610        1,529,610        1,529,610   

American Tire Distributors Inc

  Automotive   Term Loan   Loan     5.75     6/1/2018      $ 496,487        496,486        497,108   

Aramark Corporation

  Food Products   LC-2 Facility   Loan     3.74     7/26/2016      $ 79,187        79,178        78,395   

Aramark Corporation

  Food Products   LC-3 Facility   Loan     3.74     7/26/2016      $ 43,961        43,961        43,521   

Aramark Corporation

  Food Products   U.S. Term F Loan   Loan     3.25     2/24/2021      $ 3,182,489        3,182,489        3,168,581   

ARG IH Corp

  Food Services   Term Loan   Loan     4.75     11/15/2020      $ 495,000        494,038        495,312   

Asurion, LLC (fka Asurion Corporation)

  Insurance   Incremental Tranche B-1 Term Loan   Loan     5.00     5/24/2019      $ 5,412,086        5,370,590        5,424,642   

Auction.Com, LLC

  Services: Business   Term Loan A-4   Loan     4.40     2/28/2017      $ 914,567        914,567        905,422   

Avantor Performance Materials Holdings, Inc.

  Chemicals/Plastics   Term Loan   Loan     5.25     6/24/2017      $ 4,319,115        4,309,242        4,297,520   

Avast Software

  Electronics/Electric   Term Loan   Loan     4.75     3/20/2020      $ 1,925,000        1,923,275        1,937,031   

AZ Chem US Inc.

  Chemicals/Plastics   Term Loan   Loan     5.25     6/12/2021      $ 467,123        464,958        466,614   

Bass Pro Group, LLC

  Retailers (Except Food and Drugs)   New Term Loan   Loan     3.75     11/20/2019      $ 493,623        493,111        492,236   

Bayonne Energy Center

  Oil & Gas   Term Loan B   Loan     5.00     8/19/2021      $ 969,671        965,093        964,416   

Belmond Hotels

  Lodging & Casinos   Term Loan   Loan     4.00     3/19/2021      $ 496,250        494,055        495,009   

Berry Plastics Corporation

  Chemicals/Plastics   Term E Loan   Loan     3.75     1/6/2021      $ 1,814,499        1,802,403        1,812,648   

Big Heart Pet Brands (fka Del Monte Corporation)

  Food/Drug Retailers   Initial Term Loan   Loan     3.50     3/9/2020      $ 2,977,500        2,996,769        2,971,307   

Biomet, Inc.

  Healthcare & Pharmaceuticals   Dollar Term B-2 Loan   Loan     3.65     7/25/2017      $ 1,840,718        1,840,718        1,838,601   

BJ’s Wholesale Club, Inc.

 

Food/Drug Retailers

 

  New 2013 (November) Replacement Loan (First Lien)   Loan     4.50     9/26/2019      $ 1,489,975        1,488,922        1,483,374   

 

S-117


Table of Contents

Issuer Name

 

Industry

 

Asset Name

  Asset
Type
  Current
Rate
    Maturity
Date
    Principal/
Number
of Shares
    Cost     Fair
Value
 

Bombardier Recreational Products Inc.

  Leisure Goods/Activities/Movies   Term B Loan   Loan     4.00     1/30/2019      $ 754,286        750,287        747,120   

Brickman Group Holdings, Inc.

  Brokers/Dealers/Investment Houses   Initial Term Loan (First Lien)   Loan     4.00     12/18/2020      $ 1,491,237        1,478,800        1,478,935   

Brock Holdings III, Inc.

  Industrial Equipment   Term Loan (First Lien)   Loan     6.00     3/16/2017      $ 1,938,503        1,952,391        1,904,580   

Burlington Coat Factory Warehouse Corporation

  Retailers (Except Food and Drugs)   Term B-2 Loan   Loan     4.25     8/13/2021      $ 1,945,000        1,935,814        1,942,219   

BWAY

  Leisure Goods/Activities/Movies   Term Loan B   Loan     5.50     8/14/2020      $ 995,000        985,881        998,423   

Caesars Entertainment Corp.

  Lodging & Casinos   Term B-7 Loan   Loan     9.75     1/28/2018      $ 995,000        989,028        917,141   

Camp International Holding Company

  Aerospace and Defense   2013 Replacement Term Loan (First Lien)   Loan     4.75     5/31/2019      $ 1,960,046        1,965,495        1,969,846   

Capital Automotive L.P.

  Conglomerate   Tranche B-1 Term Loan Facility   Loan     4.00     4/10/2019      $ 2,079,313        2,083,783        2,084,511   

Catalent Pharma Solutions, Inc

  Drugs   Initial Term B Loan   Loan     4.25     5/20/2021      $ 497,500        495,170        498,401   

Celanese US Holdings LLC

  Chemicals/Plastics   Dollar Term C-2 Commitment   Loan     2.49     10/31/2018      $ 2,154,560        2,180,598        2,157,533   

Cengage Learning

  Publishing   Term Loan   Loan     7.00     3/31/2020      $ 2,731,869        2,761,735        2,733,235   

Charter Communications Operating, LLC

  Cable and Satellite Television   Term F Loan   Loan     3.00     12/31/2020      $ 2,655,745        2,646,932        2,646,344   

CHS/Community Health Systems, Inc.

  Healthcare & Pharmaceuticals   2017 Term E Loan   Loan     3.49     1/25/2017      $ 1,097,818        1,074,945        1,097,193   

CHS/Community Health Systems, Inc.

  Healthcare & Pharmaceuticals   2021 Term D Loan   Loan     4.25     1/27/2021      $ 2,926,052        2,844,886        2,935,210   

Cinedigm Digital Funding I, LLC

  Services: Business   Term Loan   Loan     3.75     2/28/2018      $ 562,001        557,872        561,298   

CITGO Petroleum

  Oil & Gas   Term Loan B   Loan     4.50     7/29/2021      $ 997,500        994,095        979,106   

ClubCorp Club Operations, Inc.

  Lodging & Casinos   Term Loan B   Loan     4.50     7/24/2020      $ 500,000        496,250        500,315   

CPI International Acquisition, Inc. (f/k/a Catalyst Holdings, Inc.)

  Electronics/Electric   Term B Loan   Loan     4.25     11/17/2017      $ 3,595,331        3,595,331        3,570,631   

Crosby US Acquisition Corp.

  Industrial Equipment   Initial Term Loan (First Lien)   Loan     3.75     11/23/2020      $ 742,500        741,718        681,244   

Crown Castle Operating Company

  Telecommunications/Cellular   Extended Incremental Tranche B-2 Term Loan   Loan     3.00     1/31/2021      $ 2,435,594        2,433,546        2,430,723   

CT Technologies Intermediate Hldgs, Inc

  Healthcare & Pharmaceuticals   Term Loan (First Lien)   Loan     6.00     12/1/2021      $ 1,500,000        1,485,423        1,505,625   

Culligan International Company

  Conglomerate   Dollar Loan (First Lien)   Loan     6.25     12/19/2017      $ 779,642        736,275        765,998   

Culligan International Company

  Conglomerate   Dollar Loan (Second Lien)   Loan     9.50     6/19/2018      $ 783,162        739,367        727,033   

Cumulus Media Holdings Inc.

  Broadcast Radio and Television   Term Loan   Loan     4.25     12/23/2020      $ 470,093        466,100        466,863   

Custom Sensors

  Industrial Equipment   Term Loan   Loan     4.50     9/30/2021      $ 498,750        497,651        498,750   

DaVita HealthCare Partners Inc. (fka DaVita Inc.)

  Healthcare & Pharmaceuticals   Tranche B Term Loan   Loan     3.50     6/24/2021      $ 497,500        495,228        498,062   

DCS Business Services, Inc.

  Financial Intermediaries   Term B Loan   Loan     7.25     3/19/2018      $ 3,460,027        3,436,485        3,413,835   

 

S-118


Table of Contents

Issuer Name

 

Industry

 

Asset Name

  Asset
Type
  Current
Rate
    Maturity
Date
    Principal/
Number
of Shares
    Cost     Fair
Value
 

Dealertrack Technologies, Inc.

  Leisure Goods/Activities/Movies   Term B Loan   Loan     3.25     2/26/2021      $ 477,011        475,991        474,230   

Dell International LLC

  Retailers (Except Food and Drugs)   Term B Loan   Loan     4.50     4/29/2020      $ 2,969,962        2,957,576        2,980,684   

Delos Finance SARL

  Financial Intermediaries   Term Loan   Loan     3.50     3/6/2021      $ 500,000        497,835        499,790   

Delta 2 (Lux) S.a.r.l.

  Lodging & Casinos   Term Loan B-3   Loan     4.75     7/30/2021      $ 1,000,000        995,314        995,630   

Deluxe Entertainment Service Group, Inc.

  Leisure Goods/Activities/Movies   Term Loan (First Lien)   Loan     6.50     2/28/2020      $ 1,882,983        1,884,624        1,835,908   

Devix US, Inc.

  Chemicals/Plastics   Term Loan   Loan     4.25     5/2/2021      $ 250,000        247,710        250,938   

Devix US, Inc.

  Chemicals/Plastics   Term Loan (Second Lien)   Loan     8.00     5/2/2022      $ 497,500        495,324        497,500   

Diamond Resorts International

  Lodging & Casinos   Term Loan   Loan     5.50     5/9/2021      $ 995,000        990,370        999,975   

Dollar Tree

  Retail   Term Loan B (3950MM)   Loan     4.25     3/9/2022      $ 1,000,000        995,000        1,007,500   

DPX Holdings B.V.

  Healthcare & Pharmaceuticals   Term Loan   Loan     4.25     3/11/2021      $ 2,985,000        2,978,605        2,962,075   

Drew Marine Group Inc.

  Chemicals/Plastics   Term Loan (First Lien)   Loan     4.50     11/19/2020      $ 1,489,975        1,495,721        1,473,213   

Education Management LLC

  Leisure Goods/Activities/Movies   Term Loan A   Loan     5.50     7/2/2020      $ 501,970        482,120        457,295   

Education Management LLC

  Leisure Goods/Activities/Movies   Term Loan B   Loan    
 

 

8.50%
(2.00% Cash/

6.50% PIK)

  
  

  

    7/2/2020      $ 836,617        805,283        672,882   

EIG Investors Corp.

  Services: Business   Term Loan   Loan     5.00     11/8/2019      $ 987,500        983,552        989,969   

Emerald Performance Materials, LLC

  Chemicals/Plastics   Term Loan (First Lien)   Loan     4.50     8/1/2021      $ 498,750        496,403        496,102   

Emerald Performance Materials, LLC

  Chemicals/Plastics   Term Loan (Second Lien)   Loan     7.75     8/1/2022      $ 500,000        497,553        484,845   

EnergySolutions, LLC

  Oil & Gas   Term Loan B   Loan     6.75     5/29/2020      $ 937,857        921,126        942,546   

Enviromental Resources Management

  Services: Business   Term Loan   Loan     5.00     5/14/2021      $ 1,000,000        990,000        985,000   

Evergreen Acqco 1 LP

  Retailers (Except Food and Drugs)   New Term Loan   Loan     5.00     7/9/2019      $ 975,056        972,887        955,555   

EWT Holdings III Corp. (fka WTG Holdings III Corp.)

  Industrial Equipment   Term Loan (First Lien)   Loan     4.75     1/15/2021      $ 1,987,481        1,982,274        1,972,575   

Federal-Mogul Corporation

  Automotive   Tranche C Term Loan   Loan     4.75     4/15/2021      $ 2,985,000        2,971,883        2,975,687   

First Data Corporation

  Financial Intermediaries   2017 Second New Dollar Term Loan   Loan     3.74     3/23/2018      $ 2,790,451        2,729,399        2,785,568   

First Data Corporation

  Financial Intermediaries   2018 Dollar Term Loan   Loan     4.24     3/24/2021      $ 2,111,028        2,021,476        2,115,777   

Fitness International, LLC

  Leisure Goods/Activities/Movies   Term Loan B   Loan     5.50     7/1/2020      $ 1,492,500        1,482,322        1,421,606   

FMG Resources (August 2006) Pty LTD (FMG America Finance, Inc.)

  Nonferrous Metals/Minerals   Loan   Loan     3.75     6/28/2019      $ 1,982,462        1,982,212        1,835,423   

Four Seasons Holdings Inc.

  Lodging & Casinos   Term Loan (First Lien)   Loan     3.50     6/27/2020      $ 493,750        493,750        491,281   

Garda World Security Corporation

  Services: Business   Term B Delayed Draw Loan   Loan     4.00     11/6/2020      $ 201,157        200,308        199,146   

Garda World Security Corporation

  Services: Business   Term B Loan   Loan     4.00     11/6/2020      $ 786,343        783,060        778,479   

Gardner Denver, Inc.

  Oil & Gas   Initial Dollar Term Loan   Loan     4.25     7/30/2020      $ 2,476,212        2,467,608        2,377,164   

 

S-119


Table of Contents

Issuer Name

 

Industry

 

Asset Name

  Asset
Type
  Current
Rate
    Maturity
Date
    Principal/
Number
of Shares
    Cost     Fair
Value
 

Gates Global LLC

  Leisure Goods/Activities/Movies   Term Loan (First Lien)   Loan     4.25     7/3/2021      $ 498,750        493,763        494,885   

Generac Power Systems, Inc.

  Industrial Equipment   Term Loan B   Loan     3.25     5/29/2020      $ 802,956        789,932        797,182   

General Nutrition Centers, Inc.

  Retailers (Except Food and Drugs)   Amended Tranche B Term Loan   Loan     3.25     3/4/2019      $ 4,724,136        4,709,712        4,649,353   

Global Tel*Link Corporation

  Services: Business   Term Loan (First Lien)   Loan     5.00     5/26/2020      $ 2,755,515        2,747,025        2,719,914   

Goodyear Tire & Rubber Company, The

  Chemicals/Plastics   Loan (Second Lien)   Loan     4.75     4/30/2019      $ 3,333,333        3,296,753        3,347,933   

Grosvenor Capital Management Holdings, LP

  Brokers/Dealers/Investment Houses   Initial Term Loan   Loan     3.75     1/4/2021      $ 3,395,892        3,381,240        3,353,443   

GTCR Valor Companies, Inc.

  Services: Business   Term Loan (First Lien)   Loan     6.00     6/1/2021      $ 1,995,000        1,981,582        1,965,075   

Harland Clarke Holdings Corp. (fka Clarke American Corp.)

  Publishing   Tranche B-4 Term Loan   Loan     6.00     8/2/2019      $ 487,500        485,460        488,963   

HCA Inc.

  Healthcare & Pharmaceuticals   Tranche B-4 Term Loan   Loan     2.99     5/1/2018      $ 5,663,006        5,409,534        5,658,872   

Hertz Corporation, The

  Automotive   Tranche B-1 Term Loan   Loan     4.00     3/12/2018      $ 2,940,000        2,975,234        2,927,152   

Hoffmaster Group, Inc.

  Containers/Glass Products   Term Loan   Loan     5.25     5/8/2020      $ 1,990,000        1,972,040        1,999,950   

Huntsman International LLC

  Chemicals/Plastics   Extended Term B Loan   Loan     2.69     4/19/2017      $ 3,880,270        3,866,113        3,872,199   

Husky Injection

  Services: Business   Term Loan B   Loan     4.25     6/30/2021      $ 498,099        495,886        495,818   

Ikaria, Inc.

  Healthcare & Pharmaceuticals   Initial Term Loan (First Lien)   Loan     5.00     2/12/2021      $ 435,702        433,809        434,251   

Infor (US), Inc. (fka Lawson Software Inc.)

  Services: Business   Tranche B-5 Term Loan   Loan     3.75     6/3/2020      $ 2,211,036        2,194,068        2,190,650   

Insight Global

  Services: Business   Term Loan   Loan     6.00     10/29/2021      $ 2,000,000        1,990,539        1,993,760   

J. Crew Group, Inc.

  Retailers (Except Food and Drugs)   Term B-1 Loan Retired 03/05/2014   Loan     4.00     3/5/2021      $ 965,206        965,206        906,493   

Jazz Acquisition, Inc

  Aerospace and Defense   First Lien 6/14   Loan     4.50     6/19/2021      $ 497,576        496,332        492,913   

Kinetic Concepts, Inc.

  Healthcare & Pharmaceuticals   Dollar Term D-1 Loan   Loan     4.00     5/4/2018      $ 2,477,613        2,453,687        2,477,167   

Koosharem, LLC

  Services: Business   Term Loan   Loan     7.50     5/15/2020      $ 2,995,000        2,968,450        2,961,306   

La Quinta Holdings, Inc.

  Lodging & Casinos   Term Loan (First Lien)   Loan     4.00     4/14/2021      $ 451,283        449,626        450,719   

Level 3 Financing, Inc.

  Telecommunications   Term Loan B   Loan     4.50     1/31/2022      $ 500,000        496,541        502,085   

Mauser Holdings, Inc.

  Containers/Glass Products   Term Loan   Loan     4.50     7/31/2021      $ 498,750        496,409        491,269   

Michaels Stores, Inc.

  Retailers (Except Food and Drugs)   Term B Loan   Loan     3.75     1/28/2020      $ 491,250        491,250        488,258   

Michaels Stores, Inc.

  Retailers (Except Food and Drugs)   Term Loan B-2   Loan     4.00     1/28/2020      $ 1,492,500        1,485,638        1,488,769   

Microsemi Corporation

  Electronics/Electric   Incremental Term Loan   Loan     3.50     2/19/2020      $ 2,393,981        2,389,500        2,381,509   

Microsemi Corporation

  Electronics/Electric   Term Loan   Loan     3.75     2/19/2020      $ 172,170        172,170        171,309   

Midas Intermediate Holdco II, LLC

  Automotive   Delayed Draw Term Loan   Loan     4.75     8/18/2021      $ 25,253        25,253        25,364   

Midas Intermediate Holdco II, LLC

  Automotive   Term Loan B   Loan     4.75     8/18/2021      $ 224,122        223,063        225,103   

Millenium Laboratories, LLC

  Drugs   Term Loan   Loan     5.25     4/16/2021      $ 1,492,500        1,479,041        1,489,396   

 

S-120


Table of Contents

Issuer Name

 

Industry

 

Asset Name

  Asset
Type
  Current
Rate
    Maturity
Date
    Principal/
Number
of Shares
    Cost     Fair
Value
 

Mitel US Holdings, Inc.

  Telecommunications   Term Loan   Loan     5.25     1/31/2020      $ 196,558        195,710        196,411   

MPH Acquisition Holdings LLC

  Healthcare & Pharmaceuticals   Term Loan   Loan     3.75     3/31/2021      $ 445,455        444,453        442,033   

MSC Software Corp.

  Services: Business   Term Loan   Loan     5.00     5/29/2020      $ 995,000        986,186        996,244   

National CineMedia, LLC

  Leisure Goods/Activities/Movies   Term Loan (2013)   Loan     2.95     11/26/2019      $ 1,086,207        1,058,933        1,067,198   

National Veterinary Associates, Inc

  Healthcare & Pharmaceuticals   Term Loan B   Loan     4.75     8/14/2021      $ 997,500        992,907        996,253   

National Vision, Inc.

  Retailers (Except Food and Drugs)   Term Loan (Second Lien)   Loan     6.75     3/11/2022      $ 250,000        249,730        240,418   

Newsday, LLC

  Publishing   Term Loan   Loan     3.69     10/12/2016      $ 2,215,385        2,214,305        2,201,538   

Nortek, Inc.

  Electronics/Electric   Term B Loan   Loan     3.75     10/30/2020      $ 995,000        992,803        986,921   

Novelis, Inc.

  Conglomerate   Initial Term Loan   Loan     3.75     3/10/2017      $ 4,807,530        4,817,740        4,799,502   

NPC International, Inc.

  Food Services   Term Loan (2013)   Loan     4.00     12/28/2018      $ 486,250        486,250        480,780   

NRG Energy, Inc.

  Utilities   Term Loan (2013)   Loan     2.75     7/2/2018      $ 3,861,225        3,842,164        3,850,761   

NuSil Technology LLC.

  Chemicals/Plastics   Term Loan   Loan     5.25     4/7/2017      $ 797,986        797,986        791,004   

Ollie’s Bargain Outlet, Inc

  Retailers (Except Food and Drugs)   Term Loan   Loan     4.75     9/30/2019      $ 977,052        972,882        962,396   

On Assignment, Inc.

  Services: Business   Initial Term B Loan   Loan     3.50     5/15/2020      $ 1,311,364        1,303,451        1,301,528   

Onex Carestream Finance LP

  Healthcare & Pharmaceuticals   Term Loan (First Lien 2013)   Loan     5.00     6/7/2019      $ 4,074,401        4,059,378        4,078,842   

OnexYork Acquisition Co

  Healthcare & Pharmaceuticals   Delayed Draw Term Loan   Loan     4.75     10/1/2021      $ —          —          —     

OnexYork Acquisition Co

  Healthcare & Pharmaceuticals   Term Loan B   Loan     4.75     10/1/2021      $ 498,750        495,208        496,466   

OpenLink International LLC

  Services: Business   Term B Loan   Loan     6.25     10/28/2017      $ 970,000        970,000        957,875   

Orbitz Worldwide, Inc.

  Services: Business   Term Loan (First Lien)   Loan     4.50     4/15/2021      $ 1,494,994        1,492,711        1,494,755   

P.F. Chang’s China Bistro, Inc. (Wok Acquisition Corp.)

  Food/Drug Retailers   Term Borrowing   Loan     4.25     6/24/2019      $ 1,447,901        1,440,712        1,406,274   

P2 Upstream Acquisition Co. (P2 Upstream Canada BC ULC)

  Services: Business   Term Loan (First Lien)   Loan     5.00     10/30/2020      $ 990,000        985,444        947,925   

Par Pharmaceutical

  Healthcare & Pharmaceuticals   Term Loan B3   Loan     4.25     9/28/2019      $ 500,000        497,502        499,065   

PetCo Animal Supplies Stores, Inc.

  Retailers (Except Food and Drugs)   New Loans   Loan     4.00     11/24/2017      $ 1,469,388        1,468,520        1,467,066   

PetSmart

  Retail   Term Loan B   Loan     5.00     3/11/2022      $ 1,000,000        995,000        1,007,050   

PGX Holdings, Inc.

  Financial Intermediaries   Term Loan   Loan     6.25     9/29/2020      $ 993,750        984,482        993,750   

Pharmaceutical Product Development, Inc. (Jaguar Holdings, LLC)

  Conglomerate   2013 Term Loan   Loan     4.00     12/5/2018      $ 1,940,400        1,918,409        1,935,898   

Phillips-Medisize Corporation

  Healthcare & Pharmaceuticals   Term Loan   Loan     4.75     6/16/2021      $ 497,500        495,245        495,948   

Pinnacle Foods Finance LLC

  Food Products   New Term Loan G   Loan     3.00     4/29/2020      $ 2,581,332        2,576,466        2,565,560   

Planet Fitness Holdings LLC

  Leisure Goods/Activities/Movies   Term Loan   Loan     4.75     3/31/2021      $ 1,488,750        1,482,052        1,488,750   

Polymer Group, Inc.

  Chemicals/Plastics   Initial Loan   Loan     5.25     12/19/2019      $ 495,000        492,860        495,619   

Presidio

  Services: Business   Term Loan B   Loan     6.25     2/2/2022      $ 2,000,000        1,940,655        1,973,760   

Prestige Brands, Inc.

  Drugs   Term B-1 Loan   Loan     4.13     1/31/2019      $ 344,697        341,112        344,697   

Prestige Brands, Inc.

  Leisure Goods/Activities/Movies   Term Loan   Loan     4.50     9/3/2021      $ 1,861,111        1,858,280        1,860,534   

 

S-121


Table of Contents

Issuer Name

 

Industry

 

Asset Name

  Asset
Type
  Current
Rate
    Maturity
Date
    Principal/
Number
of Shares
    Cost     Fair
Value
 

QoL Meds, LLC

  Healthcare & Pharmaceuticals   Term Loan B   Loan     5.50     7/15/2020      $ 1,995,000        1,985,909        1,990,013   

Quintiles Transnational Corp.

  Conglomerate   Term B-3 Loan   Loan     3.75     6/8/2018      $ 3,627,678        3,600,425        3,628,802   

Ranpak Holdings, Inc.

  Services: Business   Term Loan   Loan     4.75     10/1/2021      $ 997,500        995,145        996,882   

Ranpak Holdings, Inc.

  Services: Business   Term Loan (Second Lien)   Loan     8.25     9/30/2022      $ 500,000        497,672        496,250   

Redtop Acquisitions Limited

  Electronics/Electric   Initial Dollar Term Loan (First Lien)   Loan     4.50     12/3/2020      $ 495,000        491,974        494,381   

Rexnord LLC/RBS Global, Inc.

  Industrial Equipment   Term B Loan   Loan     4.00     8/21/2020      $ 1,646,799        1,648,172        1,642,172   

Reynolds Group Holdings Inc.

  Industrial Equipment   Incremental U.S. Term Loan   Loan     4.00     12/1/2018      $ 1,960,200        1,960,200        1,965,767   

Riverbed Technology

  Technology   Term Loan B   Loan     6.00     2/25/2022      $ 1,000,000        995,000        1,007,500   

Rocket Software, Inc.

  Services: Business   Term Loan (First Lien)   Loan     5.75     2/8/2018      $ 1,916,674        1,898,764        1,906,285   

Rovi Solutions Corporation / Rovi Guides, Inc.

  Electronics/Electric   Tranche B-3 Term Loan   Loan     3.75     7/2/2021      $ 1,492,500        1,485,607        1,479,441   

RPI Finance Trust

  Drugs   Term B-2 Term Loan   Loan     3.25     5/9/2018      $ 5,207,431        5,188,396        5,219,147   

SBP Holdings LP

 

Industrial Equipment

  Term Loan (First Lien)   Loan     5.00     3/27/2021      $ 992,500        988,065        863,475   

Scientific Games International, Inc.

  Electronics/Electric   Term Loan B2   Loan     6.00     10/1/2021      $ 1,000,000        990,433        998,040   

Scitor Corporation

  Services: Business   Term Loan   Loan     5.00     2/15/2017      $ 463,977        462,387        461,077   

Seadrill

  Oil & Gas   Term Loan B   Loan     4.00     2/21/2021      $ 997,481        917,590        806,294   

Sensata Technologies B.V./Sensata Technology Finance Company, LLC

  Industrial Equipment   Term Loan   Loan     3.25     5/13/2019      $ 1,509,445        1,509,445        1,511,603   

Sensus USA Inc. (fka Sensus Metering Systems)

  Utilities   Term Loan (First Lien)   Loan     4.50     5/9/2017      $ 1,925,067        1,920,548        1,925,067   

ServiceMaster Company, The

  Conglomerate   Tranche B Term Loan   Loan     4.25     7/1/2021      $ 1,995,000        1,976,650        1,994,641   

Shearers Foods LLC

 

Food Services

  Term Loan (First Lien)   Loan     4.50     6/30/2021      $ 997,500        995,166        996,253   

Sonneborn, LLC

 

Chemicals/Plastics

  Term Loan (First Lien)   Loan     5.50     12/10/2020      $ 225,000        224,471        225,000   

Sonneborn, LLC

  Chemicals/Plastics   Initial US Term Loan   Loan     5.50     12/10/2020      $ 1,275,000        1,272,004        1,275,000   

Sophia, L.P.

  Electronics/Electric   Term B Loan   Loan     4.00     7/19/2018      $ 886,138        877,732        884,756   

SourceHOV LLC

 

Services: Business

  Term Loan B (First Lien)   Loan     7.75     10/31/2019      $ 2,000,000        1,942,284        1,915,000   

Southwire Company, LLC (f.k.a Southwire Company)

  Building and Development   Initial Term Loan   Loan     3.25     2/10/2021      $ 496,250        495,181        485,084   

SRAM, LLC

 

Industrial Equipment

  Term Loan (First Lien)   Loan     4.00     4/10/2020      $ 2,967,681        2,957,888        2,952,842   

Steak ‘n Shake Operations, Inc.

  Food Services   Term Loan   Loan     4.75     3/19/2021      $ 992,500        983,723        975,131   

STHI Holding

  Healthcare & Pharmaceuticals   Term Loan   Loan     4.50     8/6/2021      $ 997,500        997,500        994,388   

SunGard Data Systems Inc. (Solar Capital Corp.)

  Conglomerate   Tranche C Term Loan   Loan     3.90     2/28/2017      $ 285,352        283,117        285,084   

SunGard Data Systems Inc. (Solar Capital Corp.)

  Conglomerate   Tranche E Term Loan   Loan     4.00     3/9/2020      $ 3,707,953        3,618,899        3,706,804   

SuperMedia Inc. (fka Idearc Inc.)

  Publishing   Loan   Loan     11.60     12/30/2016      $ 238,660        232,462        203,756   

 

S-122


Table of Contents

Issuer Name

 

Industry

 

Asset Name

  Asset
Type
  Current
Rate
    Maturity
Date
    Principal/
Number
of Shares
    Cost     Fair
Value
 

Syniverse Holdings, Inc.

  Telecommunications   Initial Term Loan   Loan     4.00     4/23/2019      $ 479,913        476,105        473,314   

TGI Friday’s

  Food Services   Term Loan B   Loan     5.25     7/15/2020      $ 267,977        266,768        267,642   

TGI Friday’s

 

Food Services

  Term Loan (Second Lien)   Loan     9.25     7/15/2021      $ 2,000,000        2,016,250        2,000,000   

TPF II Power LLC and TPF II Covert Midco LLC

  Utilities   Term Loan B   Loan     5.50     10/2/2021      $ 500,000        496,689        504,790   

TransDigm, Inc.

  Aerospace and Defense   Tranche C Term Loan   Loan     3.75     2/28/2020      $ 4,847,054        4,856,484        4,824,661   

TransFirst

  Financial Intermediaries   Term Loan   Loan     5.50     11/12/2021      $ 500,000        495,182        502,815   

TransUnion

  Financial Intermediaries   Term Loan   Loan     4.00     4/9/2021      $ 496,250        495,138        493,977   

Tricorbraun, Inc. (fka Kranson Industries, Inc.)

  Containers/Glass Products   Term Loan   Loan     4.00     5/3/2018      $ 1,850,000        1,843,008        1,822,250   

Truven Health Analytics Inc. (fka Thomson Reuters (Healthcare) Inc.)

  Healthcare & Pharmaceuticals   New Tranche B Term Loan   Loan     4.50     6/6/2019      $ 487,566        479,874        481,471   

Twin River Management Group, Inc.

  Lodging & Casinos   Term Loan B   Loan     5.25     7/10/2020      $ 974,167        976,455        975,998   

U.S. Security Associates Holdings, Inc.

  Services: Business   Delayed Draw Loan   Loan     6.25     7/28/2017      $ 158,518        157,610        156,734   

U.S. Security Associates Holdings, Inc.

  Services: Business   Term B Loan   Loan     6.25     7/28/2017      $ 931,046        926,144        920,572   

United Surgical Partners International, Inc.

  Healthcare & Pharmaceuticals   New Tranche B Term Loan   Loan     4.75     4/3/2019      $ 2,431,749        2,408,580        2,431,749   

Univar Inc.

  Chemicals/Plastics   Term B Loan   Loan     5.00     6/30/2017      $ 3,844,964        3,844,749        3,813,935   

Univision Communications Inc.

  Telecommunications   Replacement First-Lien Term Loan   Loan     4.00     3/1/2020      $ 2,947,446        2,931,982        2,940,549   

Valeant Pharmaceuticals International, Inc.

  Drugs   Series D2 Term Loan B   Loan     3.50     2/13/2019      $ 2,545,588        2,537,415        2,539,683   

Verint Systems Inc.

  Services: Business   Term Loan   Loan     3.50     9/6/2019      $ 1,264,058        1,259,623        1,259,634   

Vertafore, Inc.

  Services: Business   Term Loan (2013)   Loan     4.25     10/3/2019      $ 2,881,003        2,881,003        2,878,294   

Vouvray US Finance

  Industrial Equipment   Term Loan   Loan     5.00     6/28/2021      $ 497,500        495,243        499,366   

Washington Inventory Service

  Services: Business   U.S. Term Loan (First Lien)   Loan     5.75     12/20/2018      $ 1,832,876        1,851,978        1,796,218   

Waste Industries

  Environmental   Term Loan B   Loan     4.25     2/27/2020      $ 250,000        249,375        250,520   

Wendy’s International, Inc

  Food Services   Term B Loan   Loan     3.25     5/15/2019      $ 673,630        668,099        670,545   

West Corporation

  Telecommunications   Term B-10 Loan   Loan     3.25     6/30/2018      $ 2,571,560        2,605,923        2,562,998   
             

 

 

   

 

 

 
$ 297,760,340    $ 295,239,268   
             

 

 

   

 

 

 

 

S-123


Table of Contents

Note 5. Agreements and-Related Party Transactions

On July 30, 2010, the Company entered into the Management Agreement with our Manager. The initial term of the Management Agreement is two years, with automatic, one-year renewals at the end of each year subject to certain approvals by our board of directors and/or our stockholders. On July 8, 2015, our board of directors approved the renewal of the Management Agreement for an additional one-year term. Pursuant to the Management Agreement, our Manager implements our business strategy on a day-to-day basis and performs certain services for us, subject to oversight by our board of directors. Our Manager is responsible for, among other duties, determining investment criteria, sourcing, analyzing and executing investments transactions, asset sales, financings and performing asset management duties. Under the Management Agreement, we have agreed to pay our Manager a management fee for investment advisory and management services consisting of a base management fee and an incentive fee.

The base management fee of 1.75% is calculated based on the average value of our gross assets (other than cash or cash equivalents, but including assets purchased with borrowed funds) at the end of the two most recently completed fiscal quarters, and appropriately adjusted for any share issuances or repurchases during the applicable fiscal quarter.

The incentive fee consists of the following two parts:

The first, payable quarterly in arrears, equals 20.0% of our pre-incentive fee net investment income, expressed as a rate of return on the value of our net assets at the end of the immediately preceding quarter, that exceeds a 1.875% quarterly (7.5% annualized) hurdle rate measured as of the end of each fiscal quarter, subject to a “catch-up” provision. Under this provision, in any fiscal quarter, our Manager receives no incentive fee unless our pre-incentive fee net investment income exceeds the hurdle rate of 1.875%. Our Manager will receive 100.0% of pre-incentive fee net investment income, if any, that exceeds the hurdle rate but is less than or equal to 2.344% in any fiscal quarter (9.376% annualized); and 20.0% of the amount of the our pre-incentive fee net investment income, if any, that exceeds 2.344% in any fiscal quarter (9.376% annualized).

The second part of the incentive fee is determined and payable in arrears as of the end of each fiscal year (or upon termination of the Management Agreement) and equals 20.0% of our “incentive fee capital gains,” which equals our realized capital gains on a cumulative basis from May 31, 2010 through the end of the year, if any, computed net of all realized capital losses and unrealized capital depreciation on a cumulative basis, less the aggregate amount of any previously paid capital gain incentive fee. Importantly, the capital gains portion of the incentive fee is based on realized gains and realized and unrealized losses from May 31, 2010. Therefore, realized and unrealized losses incurred prior to such time will not be taken into account when calculating the capital gains portion of the incentive fee, and our Manager will be entitled to 20.0% of incentive fee capital gains that arise after May 31, 2010. In addition, for the purpose of the “incentive fee capital gains” calculations, the cost basis for computing realized gains and losses on investments held by us as of May 31, 2010 will equal the fair value of such investments as of such date.

For the three months ended May 31, 2015 and May 31, 2014, we incurred $1.1 million and $1.0 million in base management fees, respectively. For the three months ended May 31, 2015 and May 31, 2014, we incurred $0.7 million and $0.3 million in incentive fees related to pre-incentive fee net investment income, respectively. For the three months ended May 31, 2015 and May 31, 2014, we accrued of $1.1 million and $0.1 million in incentive fees related to capital gains, respectively. The accrual is calculated using both realized and unrealized capital gains for the period. The actual incentive fee related to capital gains will be determined and payable in arrears at the end of the fiscal year and will include only realized capital gains for the period. As of May 31, 2015, the base management fees accrual was $1.1 million and the incentive fees accrual was $5.7 million and is included in base management and incentive fees payable in the accompanying consolidated statements of assets and liabilities. As of February 28, 2015, the base management fees accrual was $1.0 million and the incentive fees accrual was $4.8 million and is included in base management and incentive fees payable in the accompanying consolidated statements of assets and liabilities.

 

S-124


Table of Contents

On July 30, 2010, the Company entered into a separate administration agreement (the “Administration Agreement”) with our Manager, pursuant to which our Manager, as our administrator, has agreed to furnish us with the facilities and administrative services necessary to conduct our day-to-day operations and provide managerial assistance on our behalf to those portfolio companies to which we are required to provide such assistance. The initial term of the Administration Agreement was two years, with automatic, one-year renewals at the end of each year subject to certain approvals by our board of directors and/or our stockholders. The amount of expenses payable or reimbursable thereunder by the Company was capped at $1.0 million for the initial two year term of the administration agreement and subsequent renewals. On July 8, 2015, our board of directors approved the renewal of the Administration Agreement for an additional one-year term and determined to increase the cap on the payment or reimbursement of expenses by the Company thereunder, which had not been increased since the inception of the agreement, to $1.3 million. In addition, our board of directors intends to review the new cap in the next three to six months to determine whether it should be further adjusted in light of differences between our projected and actual expenses and other similar factors.

For the three months ended May 31, 2015 and May 31, 2014, we recognized $0.3 million and $0.3 million in administrator expenses for the periods, respectively, pertaining to bookkeeping, record keeping and other administrative services provided to us in addition to our allocable portion of rent and other overhead related expenses. As of May 31, 2015 and February 28, 2015, $0.4 million and $0.4 million, respectively, of administrator expenses were accrued and included in due to manager in the accompanying consolidated statements of assets and liabilities. For the three months ended May 31, 2015 and May 31, 2014, the Company neither bought nor sold any investments from the Saratoga CLO.

Note 6. Borrowings

Credit Facility

As a BDC, we are only allowed to employ leverage to the extent that our asset coverage, as defined in the 1940 Act, equals at least 200.0% after giving effect to such leverage. The amount of leverage that we employ at any time depends on our assessment of the market and other factors at the time of any proposed borrowing.

On April 11, 2007, we entered into a $100.0 million revolving securitized credit facility (the “Revolving Facility”). On May 1, 2007, we entered into a $25.7 million term securitized credit facility (the “Term Facility” and, together with the Revolving Facility, the “Facilities”), which was fully drawn at closing. In December 2007, we consolidated the Facilities by using a draw under the Revolving Facility to repay the Term Facility. In response to the market wide decline in financial asset prices, which negatively affected the value of our portfolio, we terminated the revolving period of the Revolving Facility effective January 14, 2009 and commenced a two-year amortization period during which all principal proceeds from the collateral was used to repay outstanding borrowings. A significant percentage of our total assets had been pledged under the Revolving Facility to secure our obligations thereunder. Under the Revolving Facility, funds were borrowed from or through certain lenders and interest was payable monthly at the greater of the commercial paper rate and our lender’s prime rate plus 4.00% plus a default rate of 2.00% or, if the commercial paper market was unavailable, the greater of the prevailing LIBOR rates and our lender’s prime rate plus 6.00% plus a default rate of 3.00%.

In March 2009, we amended the Revolving Facility to increase the portion of the portfolio that could be invested in “CCC” rated investments in return for an increased interest rate and expedited amortization. As a result of these transactions, we expected to have additional cushion under our borrowing base under the Revolving Facility that would allow us to better manage our capital in times of declining asset prices and market dislocation.

On July 30, 2009, we exceeded the permissible borrowing limit under the Revolving Facility for 30 consecutive days, resulting in an event of default under the Revolving Facility. As a result of this event of default, our lender had the right to accelerate repayment of the outstanding indebtedness under the Revolving Facility and to foreclose and liquidate the collateral pledged thereunder. Acceleration of the outstanding indebtedness and/or liquidation of the collateral could have had a material adverse effect on our liquidity, financial condition and operations.

 

S-125


Table of Contents

On July 30, 2010, we used the net proceeds from (i) the stock purchase transaction and (ii) a portion of the funds available to us under the $45.0 million senior secured revolving credit facility (the “Credit Facility”) with Madison Capital Funding LLC, in each case, to pay the full amount of principal and accrued interest, including default interest, outstanding under the Revolving Facility. As a result, the Revolving Facility was terminated in connection therewith. Substantially all of our total assets, other than those held by SBIC LP, have been pledged under the Credit Facility to secure our obligations thereunder.

On February 24, 2012, we amended our senior secured revolving credit facility with Madison Capital Funding LLC to, among other things:

 

    expand the borrowing capacity under the credit facility from $40.0 million to $45.0 million;

 

    extend the period during which we may make and repay borrowings under the credit facility from July 30, 2013 to February 24, 2015 (the “Revolving Period”). The Revolving Period may upon the occurrence of an event of default, by action of the lenders or automatically. All borrowings and other amounts payable under the credit facility are due and payable five years after the end of the Revolving Period; and

 

    remove the condition that we may not acquire additional loan assets without the prior written consent of Madison Capital Funding LLC.

On September 17, 2014, we entered into a second amendment to the Revolving Facility with Madison Capital Funding LLC to, among other things:

 

    extend the commitment termination date from February 24, 2015 to September 17, 2017;

 

    extend the maturity date of the Revolving Facility from February 24, 2020 to September 17, 2022 (unless terminated sooner upon certain events);

 

    reduce the applicable margin rate on base rate borrowings from 4.50% to 3.75%, and on LIBOR borrowings from 5.50% to 4.75%; and

 

    reduce the floor on base rate borrowings from 3.00% to 2.25%; and on LIBOR borrowings from 2.00% to 1.25%.

As of May 31, 2015 and February 28, 2015, there was $11.8 million and $9.6 million outstanding under the Credit Facility, respectively, and the Company was in compliance with all of the limitations and requirements of the Credit Facility. Financing costs of $2.7 million related to the Credit Facility have been capitalized and are being amortized over the term of the facility. For the three months ended May 31, 2015 and May 31, 2014, we recorded $0.2 million and $0.2 million of interest expense, respectively. For the three months ended May 31, 2015 and May 31, 2014, we recorded $0.02 million and $0.1 million of amortization of deferred financing costs related to the Credit Facility and Revolving Facility, respectively. The interest rates during the three months ended May 31, 2015 and May 31, 2014 on the outstanding borrowings under the Credit Facility were 6.00% and 7.50%, respectively.

The Credit Facility contains limitations as to how borrowed funds may be used, such as restrictions on industry concentrations, asset size, weighted average life, currency denomination and collateral interests. The Credit Facility also includes certain requirements relating to portfolio performance, the violation of which could result in the limit of further advances and, in some cases, result in an event of default, allowing the lenders to accelerate repayment of amounts owed thereunder. The Credit Facility has an eight year term, consisting of a three year period (the “Revolving Period”), under which the Company may make and repay borrowings, and a final maturity five years from the end of the Revolving Period. Availability on the Credit Facility will be subject to a borrowing base calculation, based on, among other things, applicable advance rates (which vary from 50.0% to 75.0% of par or fair value depending on the type of loan asset) and the value of certain “eligible” loan assets included as part of the Borrowing Base. Funds may be borrowed at the greater of the prevailing LIBOR rate and 2.00%, plus an applicable margin of 5.50%. At the Company’s option, funds may be borrowed based on an

 

S-126


Table of Contents

alternative base rate, which in no event will be less than 3.00%, and the applicable margin over such alternative base rate is 4.50%. In addition, the Company will pay the lenders a commitment fee of 0.75% per year on the unused amount of the Credit Facility for the duration of the Revolving Period.

Our borrowing base under the Credit Facility was $35.5 million subject to the Credit Facility cap of $45.0 million at May 31, 2015. For purposes of determining the borrowing base, most assets are assigned the values set forth in our most recent Annual Report on Form 10-K or Quarterly Report on Form 10-Q filed with the SEC. Accordingly, the May 31, 2015 borrowing base relies upon the valuations set forth in the Annual Report on Form 10-K for the year ended February 28, 2015. The valuations presented in this Quarterly Report on Form 10-Q will not be incorporated into the borrowing base until after this Quarterly Report on Form 10-Q is filed with the SEC.

SBA Debentures

SBIC LP is able to borrow funds from the SBA against regulatory capital (which approximates equity capital) that is paid in and is subject to customary regulatory requirements including but not limited to an examination by the SBA. As of May 31, 2015, we have funded SBIC LP with $59.3 million of equity capital, and have $79.0 million of SBA-guaranteed debentures outstanding. SBA debentures are non-recourse to us, have a 10-year maturity, and may be prepaid at any time without penalty. The interest rate of SBA debentures is fixed at the time of issuance, often referred to as pooling, at a market-driven spread over 10-year U.S. Treasury Notes. SBA current regulations limit the amount that SBIC LP may borrow to a maximum of $150.0 million, which is up to twice its potential regulatory capital.

SBICs are designed to stimulate the flow of private equity capital to eligible small businesses. Under SBA regulations, SBICs may make loans to eligible small businesses and invest in the equity securities of small businesses. Under present SBA regulations, eligible small businesses include businesses that have a tangible net worth not exceeding $19.5 million and have average annual fully taxed net income not exceeding $6.5 million for the two most recent fiscal years. In addition, an SBIC must devote 25.0% of its investment activity to ‘‘smaller’’ concerns as defined by the SBA. A smaller concern is one that has a tangible net worth not exceeding $6.0 million and has average annual fully taxed net income not exceeding $2.0 million for the two most recent fiscal years. SBA regulations also provide alternative size standard criteria to determine eligibility, which depend on the industry in which the business is engaged and are based on such factors as the number of employees and gross sales. According to SBA regulations, SBICs may make long-term loans to small businesses, invest in the equity securities of such businesses and provide them with consulting and advisory services.

SBIC LP is subject to regulation and oversight by the SBA, including requirements with respect to maintaining certain minimum financial ratios and other covenants. Receipt of an SBIC license does not assure that SBIC LP will receive SBA guaranteed debenture funding, which is dependent upon SBIC LP continuing to be in compliance with SBA regulations and policies. The SBA, as a creditor, will have a superior claim to SBIC LP’s assets over our stockholders and debtholders in the event we liquidate SBIC LP or the SBA exercises its remedies under the SBA-guaranteed debentures issued by SBIC LP upon an event of default.

The Company received exemptive relief from the Securities and Exchange Commission to permit it to exclude the debt of SBIC LP guaranteed by the SBA from the definition of senior securities in the 200.0% asset coverage test under the 1940 Act. This allows the Company increased flexibility under the 200.0% asset coverage test by permitting it to borrow up to $150.0 million more than it would otherwise be able to absent the receipt of this exemptive relief.

As of May 31, 2015 and February 28, 2015, there was $79.0 million and $79.0 million outstanding of SBA debentures, respectively. The carrying amount of the amount outstanding of SBA debentures approximates its fair value. Financing costs of $3.0 million related to the SBA debentures have been capitalized and are being amortized over the term of the commitment and drawdown. For the three months ended May 31, 2015 and May 31, 2014, we recorded $0.6 million and $0.4 million of interest expense related to the SBA debentures,

 

S-127


Table of Contents

respectively. For the three months ended May 31, 2015 and May 31, 2014, we recorded $0.1 million and $0.1 million of amortization of deferred financing costs related to the SBA debentures, respectively. The weighted average interest rate during the three months ended May 31, 2015 and May 31, 2014 on the outstanding borrowings of the SBA debentures was 3.25% and 3.06%, respectively.

On April 2, 2015, the SBA issued a “green light” or “go forth” letter inviting us to continue our application process to obtain a license to form and operate its second SBIC subsidiary. If approved, a second SBIC license would provide us an incremental source of long-term capital by permitting us to issue $75 million of additional SBA-guaranteed debentures in addition to the $150 million already approved under the first license. Receipt of a green light letter from the SBA does not assure an applicant that the SBA will ultimately issue an SBIC license and we have received no assurance or indication from the SBA that it will receive an SBIC license, or of the timeframe in which it would receive a license, should one be granted.

Notes

On May 10, 2013, the Company issued $42.0 million in aggregate principal amount of 7.50% fixed-rate notes due 2020 (the “Notes”). The Notes will mature on May 31, 2020, and may be redeemed in whole or in part at any time or from time to time at the Company’s option on or after May 31, 2016. Interest will be payable quarterly beginning August 15, 2013.

On May 17, 2013, the Company closed an additional $6.3 million in aggregate principal amount of the Notes, pursuant to the full exercise of the underwriters’ option to purchase additional Notes.

As of May 31, 2015, the carrying amount and fair value of the Notes was $48.3 million and $49.7 million, respectively. The fair value of the Notes, which are publicly traded, is based upon closing market quotes as of the measurement date and would be classified as a level 1 liability within the fair value hierarchy. As of May 31, 2015, $2.5 million of financing costs related to the Notes have been capitalized and are being amortized over the term of the Notes. For the three months ended May 31, 2015, we recorded $0.9 million of interest expense and $0.1 million of amortization of deferred financing costs related to the Notes. For the three months ended May 31, 2014, we recorded $0.9 million of interest expense and $0.1 million of amortization of deferred financing costs related to the Notes.

Note 7. Commitments and contingencies

Contractual obligations

The following table shows our payment obligations for repayment of debt and other contractual obligations at May 31, 2015:

 

            Payment Due by Period  
     Total      Less Than
1 Year
     1 - 3
Years
     3 - 5
Years
     More Than
5 Years
 
     ($ in thousands)  

Long-Term Debt Obligations

   $ 139,100       $ —        $ —        $ 48,300       $ 90,800   
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Off-balance sheet arrangements

The Company’s off-balance sheet arrangements consisted of $11.2 million and $11.2 million of unfunded commitments to provide debt financing to its portfolio companies or to fund limited partnership interests as of May 31, 2015 and February 28, 2015, respectively. Such commitments are generally up to the Company’s discretion to approve, or the satisfaction of certain financial and nonfinancial covenants and involve, to varying degrees, elements of credit risk in excess of the amount recognized in the Company’s Consolidated Statement of Assets and Liabilities and are not reflected in the Company’s Consolidated Statements of Assets and Liabilities.

 

S-128


Table of Contents

A summary of the composition of the unfunded commitments as of May 31, 2015 and February 28, 2015 are shown in the table below (dollars in thousands):

 

     As of  
     May 31, 2015      February 28, 2015  

Bristol Hospice, LLC

   $ 7,500       $ 7,500   

HMN Holdco, LLC

     2,400         2,400   

Avionte Holdings, LLC

     1,000         1,000   

Knowland Technology Holdings, L.L.C

     300         300   
  

 

 

    

 

 

 

Total

$ 11,200    $ 11,200   
  

 

 

    

 

 

 

Note 8. Directors Fees

The independent directors receive an annual fee of $40,000. They also receive $2,500 plus reimbursement of reasonable out-of-pocket expenses incurred in connection with attending each board meeting and receive $1,000 plus reimbursement of reasonable out-of-pocket expenses incurred in connection with attending each committee meeting. In addition, the chairman of the Audit Committee receives an annual fee of $5,000 and the chairman of each other committee receives an annual fee of $2,000 for their additional services in these capacities. In addition, we have purchased directors’ and officers’ liability insurance on behalf of our directors and officers. Independent directors have the option to receive their directors’ fees in the form of our common stock issued at a price per share equal to the greater of net asset value or the market price at the time of payment. No compensation is paid to directors who are “interested persons” of the Company (as such term is defined in the 1940 Act). For the three months ended May 31, 2015 and May 31, 2014, we accrued $0.05 million and $0.05 million for directors’ fees expense, respectively. As of May 31, 2015 and February 28, 2015, $0.04 million and $0.03 million in directors’ fees expense were unpaid and included in accounts payable and accrued expenses in the consolidated statements of assets and liabilities. As of May 31, 2015, we had not issued any common stock to our directors as compensation for their services.

Note 9. Stockholders’ Equity

On May 16, 2006, GSC Group, Inc. capitalized the LLC, by contributing $1,000 in exchange for 67 shares, constituting all of the issued and outstanding shares of the LLC.

On March 20, 2007, the Company issued 95,995.5 and 8,136.2 shares of common stock, priced at $150.00 per share, to GSC Group and certain individual employees of GSC Group, respectively, in exchange for the general partnership interest and a limited partnership interest in GSC Partners CDO III GP, LP, collectively valued at $15.6 million. At this time, the 6.7 shares owned by GSC Group in the LLC were exchanged for 6.7 shares of the Company.

On March 28, 2007, the Company completed its IPO of 725,000 shares of common stock, priced at $150.00 per share, before underwriting discounts and commissions. Total proceeds received from the IPO, net of $7.1 million in underwriter’s discount and commissions, and $1.0 million in offering costs, were $100.7 million.

On November 13, 2009, we declared a dividend of $18.25 per share payable on December 31, 2009. Shareholders had the option to receive payment of the dividend in cash, shares of common stock, or a combination of cash and shares of common stock, provided that the aggregate cash payable to all shareholders was limited to $2.1 million or $2.50 per share. Based on shareholder elections, the dividend consisted of $2.1 million in cash and 864,872.5 of newly issued shares of common stock.

On July 30, 2010, our Manager and its affiliates purchased 986,842 shares of common stock at $15.20 per share. Total proceeds received from this sale were $15.0 million.

 

S-129


Table of Contents

On August 12, 2010, we effected a one-for-ten reverse stock split of our outstanding common stock. As a result of the reverse stock split, every ten shares of our common stock were converted into one share of our common stock. Any fractional shares received as a result of the reverse stock split were redeemed for cash. The total cash payment in lieu of shares was $230. Immediately after the reverse stock split, we had 2,680,842 shares of our common stock outstanding.

On November 12, 2010, we declared a dividend of $4.40 per share payable on December 29, 2010. Shareholders had the option to receive payment of the dividend in cash, shares of common stock, or a combination of cash and shares of common stock, provided that the aggregate cash payable to all shareholders was limited to approximately $1.2 million or $0.44 per share. Based on shareholder elections, the dividend consisted of approximately $1.2 million in cash and 596,235 shares of common stock.

On November 15, 2011, we declared a dividend of $3.00 per share payable on December 30, 2011. Shareholders had the option to receive payment of the dividend in cash, shares of common stock, or a combination of cash and shares of common stock, provided that the aggregate cash payable to all shareholders was limited to approximately $2.0 million or $0.60 per share. Based on shareholder elections, the dividend consisted of approximately $2.0 million in cash and 599,584 shares of common stock.

On November 9, 2012, the Company declared a dividend of $4.25 per share payable on December 31, 2012. Shareholders had the option to receive payment of the dividend in cash, shares of common stock, or a combination of cash and shares of common stock, provided that the aggregate cash payable to all shareholders was limited to approximately $3.3 million or $0.85 per share. Based on shareholder elections, the dividend consisted of approximately $3.3 million in cash and 853,455 shares of common stock.

On October 30, 2013, the Company declared a dividend of $2.65 per share payable on December 27, 2013. Shareholders had the option to receive payment of the dividend in cash, shares of common stock, or a combination of cash and shares of common stock, provided that the aggregate cash payable to all shareholders was limited to approximately $2.5 million or $0.53 per share. Based on shareholder elections, the dividend consisted of approximately $2.5 million in cash and 649,500 shares of common stock.

On September 24, 2014, the Company declared a dividend of $0.18 per share payable on November 28, 2014. Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock pursuant to the Company’s DRIP. Based on shareholder elections, the dividend consisted of approximately $0.6 million in cash and 22,283 newly issued shares of common stock.

On September 24, 2014, the Company declared a dividend of $0.22 per share payable on February 27, 2015. Shareholders have the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant our DRIP. Based on shareholder elections, the dividend consisted of approximately $0.8 million in cash and 26,858 newly issued shares of common stock.

On September 24, 2014, the Company announced the approval of an open market share repurchase plan that allows it to repurchase up to 200,000 shares of its common stock at prices below its NAV as reported in its then most recently published financial statements. As of February 28, 2015, the Company had not purchased any shares of common stock pursuant to this repurchase plan.

On April 9, 2015, the Company declared a dividend of $0.27 per share payable on May 29, 2015. Shareholders have the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant our DRIP. Based on shareholder elections, the dividend consisted of approximately $0.9 million in cash and 33,766 newly issued shares of common stock.

On May 14, 2015, the Company declared a dividend of $1.00 per share payable on June 5, 2015. Shareholders have the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant our DRIP. Based on shareholder elections, the dividend consisted of approximately $3.4 million in cash and 126,230 newly issued shares of common stock.

 

S-130


Table of Contents

Note 10. Earnings Per Share

In accordance with the provisions of FASB ASC 260, “Earnings per Share” (“ASC 260”), basic earnings per share is computed by dividing earnings available to common shareholders by the weighted average number of shares outstanding during the period. Other potentially dilutive common shares, and the related impact to earnings, are considered when calculating earnings per share on a diluted basis.

The following information sets forth the computation of the weighted average basic and diluted net decrease in net assets per share from operations for the three months ended May 31, 2015 and May 31, 2014 (dollars in thousands except share and per share amounts):

 

     For the three months ended  

Basic and diluted

   May 31,
2015
     May 31,
2014
 

Net increase in net assets from operations

   $ 7,385       $ 1,760   

Weighted average common shares outstanding

     5,422,491         5,379,616   

Earnings per common share-basic and diluted

   $ 1.36       $ 0.33   

Note 11. Dividend

On May 14, 2015, the Company declared a dividend of $1.00 per share payable on June 5, 2015. Shareholders have the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant our DRIP. Based on shareholder elections, the dividend consisted of approximately $3.4 million in cash and 126,230 newly issued shares of common stock.

On April 9, 2015, the Company declared a dividend of $0.27 per share payable on May 29, 2015. Shareholders have the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant our DRIP. Based on shareholder elections, the dividend consisted of approximately $0.9 million in cash and 33,766 newly issued shares of common stock.

The following tables summarize dividends declared during the three months ended May 31, 2015 (dollars in thousands except per share amounts):

 

Date Declared

   Record Date    Payment Date    Amount
Per Share*
     Total
Amount
 

May 14, 2015

   May 26, 2015    June 5, 2015    $ 1.00       $ 5,429   

April 9, 2015

   May 4, 2015    May 29, 2015    $ 0.27       $ 1,466   
        

 

 

    

 

 

 

Total dividends declared

$ 1.27    $ 6,895   
        

 

 

    

 

 

 

 

* Amount per share is calculated based on the number of shares outstanding at the date of declaration.

The Company did not declare any dividend payments during the quarter ended May 31, 2014.

 

S-131


Table of Contents

Note 12. Financial Highlights

The following is a schedule of financial highlights for the three months ended May 31, 2015 and May 31, 2014:

 

     May 31, 2015     May 31, 2014  

Per share data:

  

Net asset value at beginning of period

   $ 22.70      $ 21.08   

Net investment income(1)

     0.33        0.38   

Net realized and unrealized gains and losses on investments and derivatives

     1.03        (0.05
  

 

 

   

 

 

 

Net increase in net assets from operations

  1.36      0.33   

Distributions declared from net investment income

  (1.27   —     
  

 

 

   

 

 

 

Total distributions to stockholders

  (1.27   —     

Other(4)

  (0.04   —     

Net asset value at end of period

$ 22.75    $ 21.41   

Net assets at end of period

$ 123,491,324    $ 115,187,818   

Shares outstanding at end of period

  5,428,758      5,379,616   

Per share market value at end of period

$ 17.42    $ 15.15   

Total return based on market value(2)

  10.86   (4.62 )% 

Total return based on net asset value(3)

  1.68   1.57

Ratio/Supplemental data:

Ratio of net investment income to average net assets

  5.80   7.28

Ratio of operating expenses to average net assets

  6.65   6.76

Ratio of incentive management fees to average net assets

  5.89   1.34

Ratio of credit facility related expenses to average net assets

  6.43   6.31

Ratio of total expenses to average net assets

  18.97   14.40

Portfolio turnover rate(5)

  2.99   4.29

As described in Note 2 to the consolidated financial statements and notes thereto, we identified errors that impacted the three months ended May 31, 2014. The corrections for the errors, which we have concluded are immaterial to all prior period consolidated financial statements, are reflected in the consolidated financial statements included in this Form 10-Q.

 

(1) Net investment income per share is calculated using the weighted average shares outstanding during the period.
(2) Total investment return is calculated assuming a purchase of common shares at the current market value on the first day and a sale at the current market value on the last day of the periods reported. Dividends and distributions, if any, are assumed for purposes of this calculation to be reinvested at prices obtained under the Company’s dividend reinvestment plan. Total investment return does not reflect brokerage commissions. Total investment returns covering less than a full period are not annualized.
(3) Total investment return is calculated assuming a purchase of common shares at the current net asset value on the first day and a sale at the current net asset value on the last day of the periods reported. Dividends and distributions, if any, are assumed for purposes of this calculation to be reinvested at prices obtained under the Company’s dividend reinvestment plan. Total investment return does not reflect brokerage commissions.
(4) Represents the dilutive effect of issuing common stock below net asset value per share during the period in connection with the satisfaction of the Company’s annual RIC distribution requirement. See Note 11, Dividend.
(5) Portfolio turnover rate is calculated using the lesser of year-to-date sales or year-to-date purchases over the average of the invested assets at fair value.

 

S-132


Table of Contents

Note 13. Subsequent Events

On May 29, 2015, the Company entered into a Debt Distribution Agreement with Ladenburg Thalmann & Co. Inc. through which the Company may offer for sale, from time to time, up to $20.0 million in aggregate principal amount of the Notes through an At-the-Market (“ATM”) offering. As of July 14, 2015, the Company sold 227,863 Notes in an aggregate principal amount of $5,696,575 at an average price of $25.32 for aggregate net proceeds of $5,653,305 (net of transaction costs).

On July 8, 2015 the Company declared a dividend of $0.33 per share payable for the fiscal quarter ended May 31, 2015 to all stockholders of record at the close of business on August 3, 2015. Shareholders will have the option to receive payment of the dividend in cash, or receive shares of common stock pursuant to the Company’s dividend reinvestment plan.

 

S-133


Table of Contents

Report of Independent Registered Public Accounting Firm

The Board of Directors and Stockholders of Saratoga Investment Corp.

We have audited the accompanying consolidated statement of assets and liabilities of Saratoga Investment Corp. (the “Company”) as of February 28, 2015 and February 28, 2014, including the consolidated schedule of investments, and the related consolidated statements of operations, cash flows and changes in net assets for the years ended February 28, 2015, February 28, 2014 and February 28, 2013. These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on these financial statements based on our audits.

We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. We were not engaged to perform an audit of the entity’s internal control over financial reporting. Our audits included consideration of internal control over financial reporting as a basis for designing audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the entity’s internal control over financial reporting. Accordingly, we express no such opinion. An audit also includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements, assessing the accounting principles used and significant estimates made by management, and evaluating the overall financial statement presentation. Our procedures included confirmation of securities owned as of February 28, 2015, by correspondence with the custodian, debt agents and lenders. We believe that our audits provide a reasonable basis for our opinion.

In our opinion, the financial statements referred to above present fairly, in all material respects, the consolidated financial position of Saratoga Investment Corp. at February 28, 2015 and February 28, 2014, and the consolidated results of its operations, changes in its net assets and its cash flows for the years ended February 28, 2015, February 28, 2014 and February 28, 2013, in conformity with U.S. generally accepted accounting principles.

/s/ Ernst & Young

May 20, 2015

 

S-134


Table of Contents

PART I FINANCIAL INFORMATION

Item 1. Financial Statements

Saratoga Investment Corp.

Consolidated Statements of Assets and Liabilities

 

     As of  
     February 28, 2015     February 28, 2014  

ASSETS

    

Investments at fair value

    

Non-control/non-affiliate investments (amortized cost of $222,505,383 and $185,266,607, respectively)

   $ 223,506,589      $ 186,275,106   

Control investments (cost of $15,953,001 and $16,555,808, respectively)

     17,031,146        19,569,596   
  

 

 

   

 

 

 

Total investments at fair value (amortized cost of $238,458,384 and $201,822,415, respectively)

  240,537,735      205,844,702   

Cash and cash equivalents

  1,888,158      3,293,898   

Cash and cash equivalents, reserve accounts

  18,175,214      3,293,113   

Interest receivable, (net of reserve of $309,498 and $150,058, respectively)

  2,469,398      2,571,853   

Management fee receivable

  171,913      150,106   

Other assets

  317,637      14,461   
  

 

 

   

 

 

 

Total assets

$ 263,560,055    $ 215,168,133   
  

 

 

   

 

 

 

LIABILITIES

Revolving credit facility

$ 9,600,000    $ —     

Deferred debt financing costs, revolving credit facility

  (594,845   (396,898

SBA debentures payable

  79,000,000      50,000,000   

Deferred debt financing costs, SBA debentures payable

  (2,340,894   (1,412,829

Notes payable

  48,300,000      48,300,000   

Deferred debt financing costs, notes payable

  (1,847,564   (2,198,977

Dividend payable

  402,200      —     

Base management and incentive fees payable

  5,835,941      5,353,051   

Accounts payable and accrued expenses

  835,189      824,568   

Interest and debt fees payable

  1,405,466      873,135   

Due to manager

  365,820      398,154   
  

 

 

   

 

 

 

Total liabilities

$ 140,961,313    $ 101,740,204   
  

 

 

   

 

 

 

Commitments and contingencies (See Note 8)

NET ASSETS

Common stock, par value $.001, 100,000,000 common shares authorized, 5,401,899 and 5,379,616 common shares issued and outstanding, respectively

$ 5,402    $ 5,380   

Capital in excess of par value

  184,877,680      184,851,154   

Distribution in excess of net investment income

  (23,905,603   (31,123,667

Accumulated net realized loss from investments and derivatives

  (40,458,088   (44,327,225

Accumulated net unrealized appreciation on investments and derivatives

  2,079,351      4,022,287   
  

 

 

   

 

 

 

Total net assets

  122,598,742      113,427,929   
  

 

 

   

 

 

 

Total liabilities and net assets

$ 263,560,055    $ 215,168,133   
  

 

 

   

 

 

 

NET ASSET VALUE PER SHARE

$ 22.70    $ 21.08   
  

 

 

   

 

 

 

See accompanying notes to consolidated financial statements.

 

S-135


Table of Contents

Saratoga Investment Corp.

Consolidated Statements of Operations

 

     For the year ended
February 28, 2015
    For the year ended
February 28, 2014
    For the year ended
February 28, 2013
 

INVESTMENT INCOME

      

Interest from investments

      

Non-control/Non-affiliate investments

   $ 20,790,324      $ 15,832,083      $ 9,176,156   

Payment-in-kind interest income from Non-control/Non-affiliate investments

     1,186,657        936,208        1,062,687   

Control investments

     2,707,230        3,410,868        4,205,509   
  

 

 

   

 

 

   

 

 

 

Total interest income

  24,684,211      20,179,159      14,444,352   

Interest from cash and cash equivalents

  3,801      7,932      5,956   

Management fee income

  1,520,205      1,775,141      2,000,072   

Other income

  1,167,144      931,513      556,427   
  

 

 

   

 

 

   

 

 

 

Total investment income

  27,375,361      22,893,745      17,006,807   
  

 

 

   

 

 

   

 

 

 

EXPENSES

Interest and debt financing expenses

  7,375,022      6,083,891      2,540,413   

Base management fees

  4,156,955      3,326,879      2,107,378   

Professional fees

  1,301,713      1,211,836      1,190,587   

Administrator expenses

  1,000,000      1,000,000      1,000,000   

Incentive management fees

  2,547,773      938,694      2,602,647   

Insurance

  337,335      442,977      516,121   

Directors fees and expenses

  210,761      204,607      206,705   

General & administrative

  478,299      789,208      368,815   

Excise tax expense

  293,653      —        —     

Other expense

  —        21,207      4,434   
  

 

 

   

 

 

   

 

 

 

Total expenses

  17,701,511      14,019,299      10,537,100   
  

 

 

   

 

 

   

 

 

 

NET INVESTMENT INCOME

  9,673,850      8,874,446      6,469,707   
  

 

 

   

 

 

   

 

 

 

REALIZED AND UNREALIZED GAIN/(LOSS) ON INVESTMENTS:

Net realized gain from investments

  3,276,450      1,270,765      561,700   

Net realized loss from derivatives

  —        —        (131,000

Net unrealized appreciation/(depreciation) on investments

  (1,942,936   (1,648,046   7,012,726   

Net unrealized appreciation on derivatives

  —        —        130,925   
  

 

 

   

 

 

   

 

 

 

Net gain/(loss) on investments

  1,333,514      (377,281   7,574,351   
  

 

 

   

 

 

   

 

 

 

NET INCREASE IN NET ASSETS RESULTING FROM OPERATIONS

$ 11,007,364    $ 8,497,165    $ 14,044,058   
  

 

 

   

 

 

   

 

 

 

WEIGHTED AVERAGE—BASIC AND DILUTED EARNINGS PER COMMON SHARE

$ 2.04    $ 1.73    $ 3.42   

WEIGHTED AVERAGE COMMON STOCK OUTSTANDING—BASIC AND DILUTED

  5,385,049      4,920,517      4,110,484   

See accompanying notes to consolidated financial statements.

 

S-136


Table of Contents

Saratoga Investment Corp.

Consolidated Schedule of Investments

February 28, 2015

 

Company

 

Industry

 

Investment

Interest Rate /

Maturity

  Principal/
Number of
Shares
    Cost     Fair
Value(c)
    % of
Net Assets
 

Non-control/Non-affiliated investments—182.3%(b)

           

National Truck Protection Co., Inc.(d),(g)

  Automotive Aftermarket   Common Stock     1,116      $ 1,000,000      $ 1,769,432        1.4

National Truck Protection Co., Inc.(d)

  Automotive Aftermarket   First Lien Term Loan 15.50% Cash, 9/13/2018   $ 7,737,848        7,737,848        7,737,848        6.3

Take 5 Oil Change, L.L.C.(d),(g)

  Automotive Aftermarket   Common Stock     7,128        480,535        1,472,502        1.2
       

 

 

   

 

 

   

 

 

 
    Total Automotive Aftermarket       9,218,383        10,979,782        8.9
       

 

 

   

 

 

   

 

 

 

Legacy Cabinets Holdings(d),(g)

  Building Products   Common Stock Voting A-1     2,535        220,900        1,493,470        1.2

Legacy Cabinets Holdings(d),(g)

  Building Products   Common Stock Voting B-1     1,600        139,424        942,624        0.8

Polar Holding Company, Ltd.(a),(i)

  Building Products   First Lien Term Loan 10.00% Cash, 8/13/2016   $ 1,000,000        1,000,000        1,000,000        0.8
       

 

 

   

 

 

   

 

 

 
    Total Building Products       1,360,324        3,436,094        2.8
       

 

 

   

 

 

   

 

 

 

BMC Software, Inc.(d)

  Business Services   First Lien Term Loan 5.00% Cash, 9/10/2020   $ 5,731,667        5,686,622        5,478,327        4.4

Dispensing Dynamics International(d)

  Business Services   Senior Secured Note 12.50% Cash, 1/1/2018   $ 7,000,000        6,910,112        7,350,000        6.0

Easy Ice, LLC(d)

  Business Services   First Lien Term Loan 9.50% Cash, 1/15/2020   $ 12,000,000        11,872,639        12,000,000        9.7

Easy Ice, LLC(m)

  Business Services   Delayed Draw Term Loan 9.50% Cash, 1/15/2020   $ —          —          —          0.0

Emily Street Enterprises, L.L.C.

  Business Services   Senior Secured Note 10.00% Cash, 1/23/2020   $ 8,400,000        8,260,787        8,400,000        6.9

Emily Street Enterprises, L.L.C.(g)

  Business Services   Warrant Membership Interests     49,318        400,000        391,584        0.3

Help/Systems Holdings, Inc.(Help/Systems, LLC)(d)

  Business Services   First Lien Term Loan 5.50% Cash, 6/28/2019   $ 1,955,051        1,941,417        1,925,725        1.6

Help/Systems Holdings, Inc.(Help/Systems, LLC)(d)

  Business Services   Second Lien Term Loan 9.50% Cash, 6/28/2020   $ 2,000,000        1,975,767        1,965,000        1.6

Knowland Technology Holdings, L.L.C.

  Business Services   First Lien Term Loan 11.00% Cash, 11/29/2017   $ 5,259,171        5,205,142        5,259,171        4.3

Knowland Technology Holdings, L.L.C.(j),(k),(l)

  Business Services   Delayed Draw Term Loan 11.00% Cash, 11/29/2017   $ —          —          —          0.0

Vector Controls Holding Co., LLC(d)

  Business Services   First Lien Term Loan, 14.00% (12.00% Cash/2.00% PIK), 3/6/2018   $ 9,436,991        9,312,095        9,295,437        7.6

Vector Controls Holding Co., LLC(d),(g)

  Business Services   Warrants to Purchase Limited Liability Company Interests     101        —          62,341        0.1
       

 

 

   

 

 

   

 

 

 
    Total Business Services       51,564,581        52,127,585        42.5
       

 

 

   

 

 

   

 

 

 

Targus Group International, Inc.(d)

  Consumer Products   First Lien Term Loan, 12.00% (11.00% Cash/1.00 PIK), 5/24/2016   $ 3,569,127        3,537,732        3,283,597        2.7

Targus Holdings, Inc.(d),(g)

  Consumer Products   Common Stock     62,413        566,765        —          0.0

Targus Holdings, Inc.(d),(g)

  Consumer Products   Unsecured Note 10.00% PIK, 6/14/2019   $ 2,054,158        2,054,158        —          0.0

 

S-137


Table of Contents

Company

 

Industry

 

Investment

Interest Rate /

Maturity

  Principal/
Number of
Shares
    Cost     Fair
Value(c)
    % of
Net Assets
 

Targus Holdings, Inc.(d),(g)

  Consumer Products   Unsecured Note 16.00% PIK, 10/26/2018   $ 429,797        425,227        —          0.0
       

 

 

   

 

 

   

 

 

 
    Total Consumer Products       6,583,882        3,283,597        2.7
       

 

 

   

 

 

   

 

 

 

Avionte Holdings, LLC(g)

  Consumer Services   Common Stock     100,000        100,000        163,000        0.1

Avionte Holdings, LLC

  Consumer Services   First Lien Term Loan 9.75% Cash, 1/8/2019   $ 3,000,000        2,951,759        3,000,000        2.4

Avionte Holdings, LLC(j),(l)

  Consumer Services   Delayed Draw Term Loan A 9.75% Cash, 1/8/2019   $ —          —          —          0.0

CFF Acquisition L.L.C.(d)

  Consumer Services   First Lien Term Loan 7.50% Cash, 7/31/2015   $ 716,179        714,270        716,179        0.6

Expedited Travel L.L.C.(g)

  Consumer Services   Common Stock     1,000,000        1,000,000        1,069,157        0.9

Expedited Travel L.L.C.

  Consumer Services   First Lien Term Loan 10.00% Cash, 10/10/2019   $ 13,750,000        13,609,579        13,750,000        11.2

PrePaid Legal Services, Inc.(d)

  Consumer Services   First Lien Term Loan 6.25% Cash, 7/1/2019   $ 3,709,677        3,680,863        3,652,919        3.0

PrePaid Legal Services, Inc.(d)

  Consumer Services   Second Lien Term Loan 9.75% Cash, 7/1/2020   $ 5,000,000        4,937,212        4,981,000        4.1
       

 

 

   

 

 

   

 

 

 
    Total Consumer Services       26,993,683        27,332,255        22.3
       

 

 

   

 

 

   

 

 

 

M/C Acquisition Corp., L.L.C.(d),(g)

  Education   Class A Common Stock     544,761        30,241        —          0.0

M/C Acquisition Corp., L.L.C.(d)

  Education   First Lien Term Loan 1.00% Cash, 3/31/2015   $ 2,362,978        1,235,695        100,951        0.1
       

 

 

   

 

 

   

 

 

 
    Total Education       1,265,936        100,951        0.1
       

 

 

   

 

 

   

 

 

 

Group Dekko, Inc.(d)

  Electronics   Second Lien Term Loan 11.00% (10.00% Cash/1.00% PIK), 5/1/2016   $ 6,950,048        6,950,048        6,667,181        5.4
       

 

 

   

 

 

   

 

 

 
    Total Electronics       6,950,048        6,667,181        5.4
       

 

 

   

 

 

   

 

 

 

TB Corp.(d)

  Food and Beverage   First Lien Term Loan 5.76% Cash, 6/19/2018   $ 5,050,436        5,038,131        5,037,810        4.0

TB Corp.(d)

  Food and Beverage   Unsecured Note 13.50% (12.00% Cash/1.50% PIK), 12/20/2018   $ 2,546,121        2,512,732        2,546,121        2.1

TM Restaurant Group L.L.C.

  Food and Beverage   First Lien Term Loan 7.75% Cash, 7/16/2017   $ 2,791,595        2,791,595        2,763,679        2.3
       

 

 

   

 

 

   

 

 

 
    Total Food and Beverage       10,342,458        10,347,610        8.4
       

 

 

   

 

 

   

 

 

 

Bristol Hospice, LLC

  Healthcare Services   Senior Secured Note 11.00% (10.00% Cash/1.00% PIK), 11/29/2018   $ 5,459,134        5,374,249        5,459,134        4.5

Bristol Hospice, LLC(j),(l)

  Healthcare Services   Delayed Draw Term Loan 11.00% (10.00% Cash/1.00% PIK), 11/29/2018   $ —          —          —          0.0

Roscoe Medical, Inc.(d),(g)

  Healthcare Services   Common Stock     5,000        500,000        294,500        0.1

Roscoe Medical, Inc.

  Healthcare Services   Second Lien Term Loan 11.25% Cash, 9/26/2019   $ 4,200,000        4,129,704        3,990,000        3.3

Smile Brands Group Inc.(d)

  Healthcare Services   First Lien Term Loan 7.50% Cash, 8/16/2019   $ 4,443,750        4,373,369        4,159,350        3.4

Surgical Specialties Corporation (US), Inc.(d)

  Healthcare Services   First Lien Term Loan 7.25% Cash, 8/22/2018   $ 2,312,500        2,295,234        2,277,813        1.9

Zest Holdings, LLC(d)

  Healthcare Services   First Lien Term Loan 5.25% Cash, 8/16/2020   $ 4,443,919        4,361,438        4,460,806        3.6
       

 

 

   

 

 

   

 

 

 
    Total Healthcare Services       21,033,994        20,641,603        16.8
       

 

 

   

 

 

   

 

 

 

 

S-138


Table of Contents

Company

 

Industry

 

Investment

Interest Rate /

Maturity

  Principal/
Number of
Shares
    Cost     Fair
Value(c)
    % of
Net Assets
 

HMN Holdco, LLC

  Media   First Lien Term Loan 14.00% (12.00% Cash/2.00% PIK), 5/16/2019   $ 9,368,327        9,206,438        9,579,115        7.9

HMN Holdco, LLC

  Media   First Lien Term Loan 12.00% Cash, 5/16/2020     1,600,000        1,569,149        1,576,000        1.3

HMN Holdco, LLC(j),(k)

  Media   Deferred Draw Term Loan 12.00% Cash, 5/16/2020     —          —          (36,000     0.0

HMN Holdco, LLC

  Media   Class A Series     4,264        61,647        223,604        0.2

HMN Holdco, LLC

  Media   Class A Warrant     30,320        438,353        1,247,365        1.0

HMN Holdco, LLC(g)

  Media   Warrants to Purchase Limited Liability Company Interests (Common)     57,872        —          2,085,128        1.7

HMN Holdco, LLC(g)

  Media   Warrants to Purchase Limited Liability Company Interests     8,139        —          350,464        0.3
       

 

 

   

 

 

   

 

 

 
    Total Media       11,275,587        15,025,676        12.4
       

 

 

   

 

 

   

 

 

 

Elyria Foundry Company, L.L.C.

  Metals   Common Stock     35,000        9,217,563        6,762,000        5.5

Elyria Foundry Company, L.L.C.

  Metals   Revolver 9.00% Cash, 12/31/2020   $ 8,500,000        8,500,000        8,500,000        6.8
       

 

 

   

 

 

   

 

 

 
    Total Metals       17,717,563        15,262,000        12.3
       

 

 

   

 

 

   

 

 

 

Network Communications, Inc.(d),(g)

  Publishing   Common Stock     380,572        —          300,652        0.2

Network Communications, Inc.(d)

  Publishing   Unsecured Notes 8.60% PIK, 1/14/2020   $ 2,732,976        2,374,260        1,684,118        1.4
       

 

 

   

 

 

   

 

 

 
    Total Publishing       2,374,260        1,984,770        1.6
       

 

 

   

 

 

   

 

 

 

Censis Technologies, Inc.

  Software   First Lien Term Loan B 11.00% Cash, 7/24/2019   $ 11,850,000        11,634,939        11,850,000        9.7

Censis Technologies, Inc.(g),(h)

  Software   Limited Partner Interests     999        999,000        981,627        0.8

Community Investors, Inc.(g)

  Software   Common Stock     1,282        1,282        1,769        0.0

Community Investors, Inc.

  Software   First Lien, Last Out Term Loan 11.78% Cash, 9/30/2019   $ 12,000,000        12,000,000        12,000,000        9.7

Community Investors, Inc.

  Software   First Lien Term Loan B 12.25% Cash, 12/31/2020   $ 2,500,000        2,500,000        2,500,000        2.0

Community Investors, Inc.(g)

  Software   Preferred Stock     63,463        149,138        87,579        0.1

Community Investors, Inc.

  Software   Preferred Stock—A2     38,641        100,853        53,325        0.0

Community Investors, Inc.(g)

  Software   Preferred Stock—A Shares     135,584        135,584        187,106        0.2

Finalsite Holdings, Inc.

  Software   Second Lien Term Loan 10.25% Cash, 5/21/2020   $ 7,500,000        7,429,305        7,500,000        6.1

Identity Automation Systems(g)

  Software   Common Stock Class A Units     232,616        232,616        225,638        0.2

Identity Automation Systems

  Software   First Lien Term Loan 10.25% Cash, 8/25/2019   $ 4,475,000        4,433,897        4,475,000        3.7

Pen-Link, Ltd.(d)

  Software   Second Lien Term Loan 12.50% Cash, 5/26/2019   $ 10,500,000        10,326,376        10,500,000        8.6
       

 

 

   

 

 

   

 

 

 
    Total Software       49,942,990        50,362,044        41.1
       

 

 

   

 

 

   

 

 

 

Advanced Air & Heat of Florida, LLC

  Utilities   First Lien Term Loan 10.00% Cash, 1/31/2019   $ 5,955,441        5,881,694        5,955,441        5.0
       

 

 

   

 

 

   

 

 

 
    Total Utilities       5,881,694        5,955,441        5.0
       

 

 

   

 

 

   

 

 

 

Sub Total Non-control/Non-affiliated investments

          222,505,383        223,506,589        182.3
       

 

 

   

 

 

   

 

 

 

Control investments—13.9%(b)

           

Saratoga Investment Corp. CLO 2013-1, Ltd.(a),(d),(e),(f)

 

Structured Finance Securities

  Other/Structured Finance Securities 14.32%, 10/17/2023   $ 30,000,000        15,953,001        17,031,146        13.9
       

 

 

   

 

 

   

 

 

 

Sub Total Control investments

          15,953,001        17,031,146        13.9
       

 

 

   

 

 

   

 

 

 

TOTAL INVESTMENTS—196.2%(b)

        $ 238,458,384      $ 240,537,735        196.2
       

 

 

   

 

 

   

 

 

 

 

S-139


Table of Contents

 

(a) Represents a non-qualifyng investment as defined under Section 55 (a) of the Investment Company Act of 1940, as amended. Non-qualifying assets represent 7.5% of the Company's portfolio at fair value. As a BDC, the Company can only invest 30% of its portfolio in non-qualifying assets.
(b) Percentages are based on net assets of $122,598,742, as of February 28, 2015.
(c) Because there is no readily available market value for these investments, the fair value of these investments is approved in good faith by our board of directors. (see Note 3 to the consolidated financial statements).
(d) These securities are pledged as collateral under a senior secured revolving credit facility (see Note 6 to the consolidated financial statements).
(e) This investment does not have a stated interest rate that is payable thereon. As a result, the 14.32% interest rate in the table above represents the interest rate currently earned on the investment cost and is based on the current cash interest and other income generated by the investment.
(f) As defined in the Investment Company Act, we "Control" this portfolio company because we own more than 25% of the portfolio company's outstanding voting securities. Transactions during the period in which the issuer was both an Affiliate and a portfolio company that we Control are as follows:

 

Company

   Purchases      Redemptions      Sales
(cost)
     Interest
Income
     Management
fee income
     Net
Realized
gains/(losses)
     Net
Unrealized
gains
 

Saratoga Investment Corp. CLO 2013-1, Ltd.

   $ —         $ —         $ —         $ 2,707,230       $ 1,520,205       $ —         $ 1,078,145   

 

(g) Non-income producing at February 28, 2015.
(h) Includes securities issued by an affiliate of the company.
(i) Non-U.S. company. The principal place of business for Polar Holding Company, Ltd. is Canada.
(j) The investment has an unfunded commitment as of February 28, 2015 (See note 8).
(k) Includes an analysis of the value of any unfunded loan commitments.
(l) The entire commitment was unfunded at February 28, 2015. As such, no interest is being earned on this investment.
(m) The entire commitment was funded at February 28, 2015.

 

S-140


Table of Contents

Saratoga Investment Corp.

Consolidated Schedule of Investments

February 28, 2014

 

Company

 

Industry

 

Investment

Interest Rate /

Maturity

  Principal/
Number
of Shares
    Cost     Fair Value(c)     % of
Net Assets
 

Non-control/Non-affiliated investments—164.2%(b)

           

PATS Aircraft, LLC

  Aerospace   Common Stock     51,813        89,636        89,636        0.1

PATS Aircraft, LLC

  Aerospace   First Lien Term Loan 8.50% Cash, 10/6/2016   $ 254,598        254,598        254,598        0.2
       

 

 

   

 

 

   

 

 

 
    Total Aerospace       344,234        344,234        0.3
       

 

 

   

 

 

   

 

 

 

National Truck Protection Co., Inc.(d,g)

  Automotive Aftermarket   Common Stock     1,116        1,000,000        1,152,531        1.0

National Truck Protection Co., Inc.(d)

  Automotive Aftermarket   First Lien Term Loan 15.50% (13.50% Cash/2.00% PIK), 9/13/2018   $ 8,250,000        8,250,000        8,250,000        7.3

Take 5 Oil Change, L.L.C.(d,g)

  Automotive Aftermarket   Common Stock     7,128        712,800        1,217,747        1.1
       

 

 

   

 

 

   

 

 

 
    Total Automotive Aftermarket       9,962,800        10,620,278        9.4
       

 

 

   

 

 

   

 

 

 

Legacy Cabinets Holdings(d,g)

  Building Products   Common Stock Voting A-1     2,535        220,900        552,351        0.5

Legacy Cabinets Holdings(d,g)

  Building Products   Common Stock Voting B-1     1,600        139,424        348,624        0.3
       

 

 

   

 

 

   

 

 

 
    Total Building Products       360,324        900,975        0.8
       

 

 

   

 

 

   

 

 

 

ARSloane Acquistion, LLC

  Business Services   First Lien Term Loan 7.50% Cash, 10/1/2019   $ 997,500        988,200        1,004,981        0.9

BMC Software, Inc.(d)

  Business Services   First Lien Term Loan 5.00% Cash, 9/10/2020   $ 6,000,000        5,943,801        6,013,800        5.3

Dispensing Dynamics International(d)

  Business Services   Senior Secured Note 12.50% Cash, 1/1/2018   $ 7,000,000        6,882,278        7,525,000        6.6

Easy Ice, LLC(d)

  Business Services   First Lien Term Loan 14.00% (11.00% Cash/3.00% PIK), 3/29/2018   $ 7,507,024        7,387,970        7,507,024        6.6

Easy Ice, LLC(i),(j)

  Business Services   Delayed Draw Term Loan 14.00% (11.00% Cash/3.00% PIK), 3/29/2018   $ —          —          —          0.0

Emily Street Enterprises, L.L.C.(d)

  Business Services   Senior Secured Note 12.00% (11.00% Cash/1.00% PIK), 12/28/2017   $ 5,767,983        5,680,703        5,767,983        5.1

Emily Street Enterprises, L.L.C.(d,g)

  Business Services   Warrant Membership Interests     49,318        400,000        601,679        0.5

Help/Systems Holdings, Inc.(Help/Systems, LLC)(d)

  Business Services   First Lien Term Loan 5.50% Cash, 6/28/2019   $ 3,990,000        3,954,385        3,960,075        3.5

Help/Systems Holdings, Inc.(Help/Systems, LLC)(d)

  Business Services   Second Lien Term Loan 9.50% Cash, 6/28/2020   $ 2,000,000        1,972,758        2,000,000        1.8

Knowland Technology Holdings, L.L.C.(d)

  Business Services   First Lien Term Loan 11.00% Cash, 11/29/2017   $ 6,200,000        6,107,034        6,200,000        5.5

Trinet HR Corporation (SOI Holdings, Inc.)(d)

  Business Services   First Lien Term Loan 5.00% Cash, 8/20/2020   $ 4,987,500        4,941,335        5,018,921        4.4

Trinet HR Corporation (SOI Holdings, Inc.)(d)

  Business Services   Second Lien Term Loan 8.75% Cash, 2/20/2021   $ 2,500,000        2,453,145        2,518,750        2.2

Vector Controls Holding Co., LLC(d)

  Business Services   First Lien Term Loan, 14.00% (12.00% Cash/2.00% PIK), 3/6/2018   $ 9,261,074        9,115,415        9,075,853        8.0

 

S-141


Table of Contents

Company

 

Industry

 

Investment

Interest Rate /

Maturity

  Principal/
Number
of Shares
    Cost     Fair Value(c)     % of
Net Assets
 

Vector Controls Holding Co., LLC(d,g)

  Business Services   Warrants to Purchase Limited Liability Company Interests     101        —          136,217        0.1
       

 

 

   

 

 

   

 

 

 
    Total Business Services       55,827,024        57,330,283        50.5
       

 

 

   

 

 

   

 

 

 

Targus Group International, Inc.(d)

  Consumer Products   First Lien Term Loan 11.00% Cash, 5/24/2016   $ 3,738,369        3,704,766        3,663,602        3.3

Targus Holdings, Inc.(d,g)

  Consumer Products   Common Stock     62,413        566,765        730,232        0.6

Targus Holdings, Inc.(d)

  Consumer Products   Unsecured Note 10.00% PIK, 6/14/2019   $ 2,054,158        2,054,158        1,387,848        1.2

Targus Holdings, Inc.(d)

  Consumer Products   Unsecured Note 16.00% Cash, 10/26/2018   $ 384,577        379,471        336,505        0.3
       

 

 

   

 

 

   

 

 

 
    Total Consumer Products       6,705,160        6,118,187        5.4
       

 

 

   

 

 

   

 

 

 

Avionte Holdings, LLC

  Consumer Services   Common Stock   $ 100,000        100,000        100,000        0.1

Avionte Holdings, LLC

  Consumer Services   First Lien Term Loan 9.75% Cash, 1/8/2019   $ 3,000,000        2,940,000        3,000,000        2.6

Avionte Holdings, LLC(i),(j)

  Consumer Services   Delayed Draw Term Loan A 9.75% Cash, 1/8/2019   $ —          —          —          0.0

CFF Acquisition L.L.C.(d)

  Consumer Services   First Lien Term Loan 7.50% Cash, 7/31/2015   $ 1,319,891        1,273,596        1,319,891        1.2

Expedited Travel L.L.C.(d)

  Consumer Services   First Lien Term Loan 9.00% Cash, 12/28/2017   $ 4,580,000        4,501,104        4,580,000        4.0

PrePaid Legal Services, Inc.(d)

  Consumer Services   First Lien Term Loan 6.25% Cash, 12/31/2016   $ 4,274,194        4,236,035        4,247,694        3.7

PrePaid Legal Services, Inc.(d)

  Consumer Services   Second Lien Term Loan 9.75% Cash, 7/1/2020   $ 5,000,000        4,931,888        5,044,000        4.5
       

 

 

   

 

 

   

 

 

 
    Total Consumer Services       17,982,623        18,291,585        16.1
       

 

 

   

 

 

   

 

 

 

M/C Acquisition Corp., L.L.C.(d,g)

  Education   Class A Common Stock     544,761        30,241        —          0.0

M/C Acquisition Corp., L.L.C.(d)

  Education   First Lien Term Loan 1.00% Cash, 3/13/14   $ 2,512,184        1,358,250        90,128        0.1
       

 

 

   

 

 

   

 

 

 
    Total Education       1,388,491        90,128        0.1
       

 

 

   

 

 

   

 

 

 

Group Dekko, Inc.(d)

  Electronics   Second Lien Term Loan 11.00% (10.00% Cash/1.00% PIK), 5/1/2016   $ 6,901,547        6,901,547        6,741,431        5.9
       

 

 

   

 

 

   

 

 

 
    Total Electronics       6,901,547        6,741,431        5.9
       

 

 

   

 

 

   

 

 

 

USS Parent Holding Corp.(d,g)

  Environmental   Non Voting Common Stock     765        133,002        220,992        0.2

USS Parent Holding Corp.(d,g)

  Environmental   Voting Common Stock     17,396        3,025,798        5,027,574        4.4
       

 

 

   

 

 

   

 

 

 
    Total Environmental       3,158,800        5,248,566        4.6
       

 

 

   

 

 

   

 

 

 

DS Waters of America, Inc.(d)

  Food and Beverage   First Lien Term Loan 5.25% Cash, 8/30/2020   $ 2,493,750        2,470,506        2,531,156        2.2

HOA Restaurant Group, L.L.C.(d)

  Food and Beverage   Senior Secured Note 11.25% Cash, 4/1/2017   $ 4,000,000        3,918,437        4,240,000        3.7

TB Corp.(d)

  Food and Beverage   First Lien Term Loan 5.75% Cash, 6/19/2018   $ 5,101,971        5,082,013        5,127,481        4.5

TB Corp.(d)

  Food and Beverage   Unsecured Note 13.50% (12.00% Cash/1.50% PIK), 12/20/2018   $ 2,543,154        2,513,130        2,555,870        2.3

TM Restaurant Group L.L.C.(d)

  Food and Beverage   First Lien Term Loan 7.75% Cash, 7/16/2017   $ 2,845,690        2,831,271        2,831,462        2.5
       

 

 

   

 

 

   

 

 

 
    Total Food and Beverage       16,815,357        17,285,969        15.2
       

 

 

   

 

 

   

 

 

 

 

S-142


Table of Contents

Company

 

Industry

 

Investment

Interest Rate /

Maturity

  Principal/
Number of
Shares
    Cost     Fair Value(c)     % of
Net Assets
 

Bristol Hospice, LLC

  Healthcare Services   Senior Secured Note 11.00%(10.00% Cash/1.00% PIK), 11/29/2018   $ 5,509,782        5,405,325        5,509,782        4.9

Bristol Hospice, LLC(i),(j)

  Healthcare Services   Delayed Draw Term Loan 11.00%(10.00% Cash/1.00% PIK), 11/29/2018   $ —          —          —          0.0

Oceans Acquisition, Inc.(d)

  Healthcare Services   First Lien Term A Loan 10.75% Cash, 12/27/2017   $ 6,373,113        6,273,020        6,373,113        5.5

Oceans Acquisition, Inc.(d)

  Healthcare Services   First Lien Term B Loan 10.75% Cash, 12/27/2017   $ 500,000        490,224        500,000        0.4

Oceans Acquisition, Inc.(i)

  Healthcare Services   Delayed Draw Term Loan 10.75% Cash, 12/27/2017   $ —          —          —          0.0

Smile Brands Group Inc.(d)

  Healthcare Services   First Lien Term Loan 7.50% Cash, 8/16/2019   $ 4,488,750        4,406,559        4,488,750        4.0

Surgical Specialties Corporation (US), Inc.(d)

  Healthcare Services   First Lien Term Loan 7.25% Cash, 8/22/2018   $ 2,437,500        2,415,591        2,449,688        2.2

Zest Holdings, LLC(d)

  Healthcare Services   First Lien Term Loan 6.50% Cash, 8/16/2020   $ 4,488,750        4,405,073        4,488,750        4.0
       

 

 

   

 

 

   

 

 

 
    Total Healthcare Services       23,395,792        23,810,083        21.0
       

 

 

   

 

 

   

 

 

 

McMillin Companies L.L.C.(d,g,h)

  Homebuilding   Senior Secured Note 0% Cash, 12/31/2013   $ 550,000        558,434        344,355        0.3
       

 

 

   

 

 

   

 

 

 
    Total Homebuilding       558,434        344,355        0.3
       

 

 

   

 

 

   

 

 

 

Distribution International, Inc.(d)

  Manufacturing   First Lien Term Loan 7.50% Cash, 7/16/2019   $ 5,970,000        5,916,094        5,970,000        5.3
       

 

 

   

 

 

   

 

 

 
    Total Manufacturing       5,916,094        5,970,000        5.3
       

 

 

   

 

 

   

 

 

 

Elyria Foundry Company, L.L.C.(d)

  Metals   Senior Secured Note 17.00% (13.00% Cash/4.00% PIK), 9/14/2014   $ 8,859,614        8,859,614        6,644,711        5.9

Elyria Foundry Company, L.L.C.(d,g)

  Metals   Warrants to Purchase Limited Liability Company Interests (2008)     7,000        20        —          0.0

Elyria Foundry Company, L.L.C.(d,g)

  Metals   Warrants to Purchase Limited Liability Company Interests (2013)     18,227        —          —          0.0
       

 

 

   

 

 

   

 

 

 
    Total Metals       8,859,634        6,644,711        5.9
       

 

 

   

 

 

   

 

 

 

Network Communications, Inc.(d,g)

  Publishing   Common Stock     380,572        —          —          0.0

Network Communications, Inc.(d)

  Publishing   Unsecured Notes 8.60% PIK, 1/14/2020   $ 2,601,736        2,202,168        1,190,888        1.0
       

 

 

   

 

 

   

 

 

 
    Total Publishing       2,202,168        1,190,888        1.0
       

 

 

   

 

 

   

 

 

 

Community Investors, Inc.(d,g)

  Software   Common Stock     1,282        1,282        1,449        0.0

Community Investors, Inc.(d)

  Software   First Lien Term Loan 9.75% Cash, 5/9/2018   $ 6,983,333        6,863,915        6,983,333        6.2

Community Investors, Inc.(d),(i),(j)

  Software   Revolver   $ 166,667        —          —          0.0

Community Investors, Inc.(d,g)

  Software   Preferred Stock     135,584        135,584        153,210        0.1

Pen-Link, Ltd.

  Software   Second Lien Term Loan 12.50% Cash, 5/26/2019   $ 11,500,000        11,280,887        11,500,000        10.2
       

 

 

   

 

 

   

 

 

 
    Total Software       18,281,668        18,637,992        16.5
       

 

 

   

 

 

   

 

 

 

Advanced Air & Heat of Florida, LLC

  Utilities   First Lien Term Loan 10.00% Cash, 1/31/2019   $ 6,705,441        6,606,457        6,705,441        5.9
       

 

 

   

 

 

   

 

 

 
    Total Utilities       6,606,457        6,705,441        5.9
       

 

 

   

 

 

   

 

 

 

 

S-143


Table of Contents

Company

 

Industry

 

Investment

Interest Rate /

Maturity

  Principal/
Number of
Shares
    Cost     Fair Value(c)     % of
Net Assets
 

Sub Total Non-control/Non-affiliated investments

          185,266,607        186,275,106        164.2
       

 

 

   

 

 

   

 

 

 

Control investments—
17.3%(b)

           

Saratoga Investment Corp. CLO 2013-1, Ltd.(a),(d),(e),(f)

  Structured Finance Securities   Other/Structured Finance Securities 15.16%, 10/17/2023   $ 30,000,000        16,555,808        19,569,596        17.3
       

 

 

   

 

 

   

 

 

 

Sub Total Control investments

          16,555,808        19,569,596        17.3
       

 

 

   

 

 

   

 

 

 

TOTAL INVESTMENTS—181.5%(b)

        $ 201,822,415      $ 205,844,702        181.5
       

 

 

   

 

 

   

 

 

 

 

(a) Represents a non-qualifyng investment as defined under Section 55 (a) of the Investment Company Act of 1940, as amended. Non-qualifying assets represent 9.5% of the Company's portfolio at fair value. As a BDC, the Company can only invest 30% of its portfolio in non-qualifying assets.
(b) Percentages are based on net assets of $113,427,929 as of February 28, 2014.
(c) Because there is no readily available market value for these investments, the fair value of these investments is approved in good faith by our board of directors. (see Note 3 to the consolidated financial statements).
(d) These securities are pledged as collateral under a senior secured revolving credit facility (see Note 6 to the consolidated financial statements).
(e) This investment does not have a stated interest rate that is payable thereon. As a result, the 15.16% interest rate in the table above represents the interest rate currently earned on the investment cost and is based on the current cash interest and other income generated by the investment.
(f) As defined in the Investment Company Act, we "Control" this portfolio company because we own more than 25% of the portfolio company's outstanding voting securities. Transactions during the period in which the issuer was both an Affiliate and a portfolio company that we Control are as follows:

 

Company

   Purchases      Redemptions      Sales (cost)      Interest
Income
     Management
fee income
     Net Realized
gains/(losses)
     Net Unrealized
gains/(losses)
 

Saratoga Investment Corp. CLO 2013-1, Ltd.

   $ —         $ —         $ —         $ 3,410,868       $ 1,775,141       $ —         $ 3,013,788   

 

(g) Non-income producing at February 28, 2014.
(h) In connection with the restructuring of this investment, the Company agreed to forego the receipt of any interest payments thereon.
(i) The investment has an unfunded commitment as of February 28, 2015 (See note 8).
(j) The entire commitment was unfunded at February 28, 2015. As such, no interest is being earned on this investment.

 

S-144


Table of Contents

Saratoga Investment Corp.

Consolidated Statements of Changes in Net Assets

 

     For the year ended
February 28, 2015
    For the year ended
February 28, 2014
    For the year ended
February 28, 2013
 

INCREASE FROM OPERATIONS:

      

Net investment income

   $ 9,673,850      $ 8,874,446      $ 6,469,707   

Net realized gain from investments

     3,276,450        1,270,765        561,700   

Net realized loss from derivatives

     —          —          (131,000

Net unrealized appreciation (depreciation) on investments

     (1,942,936     (1,648,046     7,012,726   

Net unrealized appreciation on derivatives

     —          —          130,925   
  

 

 

   

 

 

   

 

 

 

Net increase in net assets from operations

  11,007,364      8,497,165      14,044,058   
  

 

 

   

 

 

   

 

 

 

DECREASE FROM SHAREHOLDER DISTRIBUTIONS:

Distributions declared

  (2,156,740   (12,534,807   (16,475,809
  

 

 

   

 

 

   

 

 

 

Net decrease in net assets from shareholder distributions

  (2,156,740   (12,534,807   (16,475,809
  

 

 

   

 

 

   

 

 

 

CAPITAL SHARE TRANSACTIONS:

Stock dividend distribution

  320,189      10,027,697      13,180,503   
  

 

 

   

 

 

   

 

 

 

Net increase in net assets from capital share transactions

  320,189      10,027,697      13,180,503   
  

 

 

   

 

 

   

 

 

 

Total increase in net assets

  9,170,813      5,990,055      10,748,752   

Net assets at beginning of period

  113,427,929      107,437,874      96,689,122   
  

 

 

   

 

 

   

 

 

 

Net assets at end of period

$ 122,598,742    $ 113,427,929    $ 107,437,874   
  

 

 

   

 

 

   

 

 

 

Net asset value per common share

$ 22.70    $ 21.08    $ 22.71   

Common shares outstanding at end of period

  5,401,899      5,379,616      4,730,116   

Distribution in excess of net investment income

$ (23,905,603 $ (31,123,667 $ (25,771,838

See accompanying notes to consolidated financial statements.

 

S-145


Table of Contents

Saratoga Investment Corp.

Consolidated Statements of Cash Flows

 

     For the year ended
February 28, 2015
    For the year ended
February 28, 2014
    For the year ended
February 28, 2013
 

Operating activities

      

NET INCREASE IN NET ASSETS FROM OPERATIONS

   $ 11,007,364      $ 8,497,165      $ 14,044,058   

ADJUSTMENTS TO RECONCILE NET INCREASE IN NET ASSETS FROM OPERATIONS TO NET CASH USED BY OPERATING ACTIVITIES:

      

Paid-in-kind interest income

     (1,204,458     (1,007,494     (1,062,687

Net accretion of discount on investments

     (540,069     (666,849     (975,475

Amortization of deferred debt financing costs

     929,773        903,289        482,306   

Net realized gain from investments

     (3,276,450     (1,270,765     (561,700

Net realized loss from derivatives

     —          —          131,000   

Net unrealized (appreciation) depreciation on investments

     1,942,936        1,648,046        (7,012,726

Net unrealized appreciation on derivatives

     —          —          (130,925

Proceeds from sale and redemption of investments

     73,257,332        71,606,736        21,487,698   

Purchase of investments

     (104,872,326     (121,073,990     (71,595,649

(Increase) decrease in operating assets:

      

Cash and cash equivalents, reserve accounts

     (14,882,101     8,793,029        13,448,053   

Interest receivable

     102,455        317,505        (1,199,954

Management fee receivable

     (21,807     65,747        11,728   

Other assets

     (34,930     68,946        11,416   

Receivable from unsettled trades

     —          1,817,074        (1,757,563

Increase (decrease) in operating liabilities:

      

Payable for unsettled trades

     —          —          (4,072,500

Management and incentive fees payable

     482,890        (405,158     2,181,511   

Accounts payable and accrued expenses

     10,621        389,530        (269,911

Interest and debt fees payable

     532,331        615,339        204,534   

Due to manager

     (32,334     175,641        (171,581
  

 

 

   

 

 

   

 

 

 

NET CASH USED BY OPERATING ACTIVITIES

     (36,598,773     (29,526,209     (36,808,367
  

 

 

   

 

 

   

 

 

 

Financing activities

      

Borrowings on debt

     52,300,000        18,000,000        55,550,000   

Paydowns on debt

     (13,700,000     (28,300,000     (15,250,000

Issuance of notes

     —          48,300,000        —     

Debt financing cost

     (1,972,618     (2,821,806     (1,373,000

Payments of cash dividends

     (1,434,349     (2,507,112     (3,295,306
  

 

 

   

 

 

   

 

 

 

NET CASH PROVIDED BY FINANCING ACTIVITIES

     35,193,033        32,671,082        35,631,694   
  

 

 

   

 

 

   

 

 

 

NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS

     (1,405,740     3,144,873        (1,176,673

CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD

     3,293,898        149,025        1,325,698   
  

 

 

   

 

 

   

 

 

 

CASH AND CASH EQUIVALENTS, END OF PERIOD

   $ 1,888,158      $ 3,293,898      $ 149,025   
  

 

 

   

 

 

   

 

 

 

Supplemental information:

      

Interest paid during the period

   $ 5,912,862      $ 4,565,262      $ 1,853,573   

Supplemental non-cash information:

      

Paid-in-kind interest income

   $ 1,204,458      $ 1,007,494      $ 1,062,687   

Net accretion of discount on investments

   $ 540,069      $ 666,849      $ 975,475   

Amortization of deferred debt financing costs

   $ 929,773      $ 903,289      $ 482,306   

Stock dividend distribution

   $ 320,189      $ 10,027,697      $ 13,180,503   

See accompanying notes to consolidated financial statements.

 

S-146


Table of Contents

SARATOGA INVESTMENT CORP.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

February 28, 2015

Note 1. Organization

Saratoga Investment Corp. (the “Company”, “we”, “our” and “us”) is a non-diversified closed end management investment company incorporated in Maryland that has elected to be treated and is regulated as a business development company (“BDC”) under the Investment Company Act of 1940 (the “1940 Act”). We commenced operations on March 23, 2007 as GSC Investment Corp. and completed our initial public offering (“IPO”) on March 28, 2007. We have elected to be treated as a regulated investment company (“RIC”) under subchapter M of the Internal Revenue Code (the “Code”). We expect to continue to qualify and to elect to be treated for tax purposes as a RIC. Our investment objective is to generate current income and, to a lesser extent, capital appreciation from our investments.

GSC Investment, LLC (the “LLC”) was organized in May 2006 as a Maryland limited liability company. As of February 28, 2007, the LLC had not yet commenced its operations and investment activities.

On March 21, 2007, the Company was incorporated and concurrently therewith the LLC was merged with and into the Company, with the Company as the surviving entity, in accordance with the procedure for such merger in the LLC’s limited liability company agreement and Maryland law. In connection with such merger, each outstanding limited liability company interest of the LLC was converted into a share of common stock of the Company.

On July 30, 2010, the Company changed its name from “GSC Investment Corp.” to “Saratoga Investment Corp.”.

We are externally managed and advised by our investment adviser, Saratoga Investment Advisors, LLC (the “Manager”), pursuant to the Management Agreement. Prior to July 30, 2010, we were managed and advised by GSCP (NJ), L.P.

On March 28, 2012, our wholly-owned subsidiary, Saratoga Investment Corp. SBIC, LP (“SBIC LP”), received a Small Business Investment Company (“SBIC”) license from the Small Business Administration (“SBA”).

Note 2. Summary of Significant Accounting Policies

Basis of Presentation

The accompanying consolidated financial statements have been prepared on the accrual basis of accounting in conformity with U.S. generally accepted accounting principles (“U.S. GAAP”) and include the accounts of the Company and its special purpose financing subsidiary, Saratoga Investment Funding, LLC (previously known as GSC Investment Funding LLC). All intercompany accounts and transactions have been eliminated in consolidation. All references made to the “Company,” “we,” and “us” herein include Saratoga Investment Corp. and its consolidated subsidiary, except as stated otherwise.

The Company and SBIC are both considered to be investment companies for financial reporting purposes and have applied the guidance in Topic 946, “Financial Services—Investment Companies”. There have been no changes to the Company or SBIC’s status as investment companies during the year ended February 28, 2015.

Use of Estimates in the Preparation of Financial Statements

The preparation of the accompanying consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities,

 

S-147


Table of Contents

and disclosure of contingent assets and liabilities at the date of the financial statements, and income, gains (losses) and expenses during the period reported. Actual results could differ materially from those estimates.

Correction of Immaterial Errors Related to Prior Period

During the year ended February 28, 2015, the Company identified errors related to the accounting for the capital gains portion of the incentive fee for the years ended February 28, 2014, February 28, 2013, February 29, 2012 and February 28, 2011, as well as the cumulative impact of these errors as of February 28, 2014.

The Company assessed the materiality of these errors and concluded they were not material to any prior annual periods, but the cumulative impact of correcting them in the current period would be quantitatively material to the results of operations of the Company for the year ended February 28, 2015, if the entire adjustment was recorded in that period. Therefore, the consolidated financial statements as of and for the years ended February 28, 2014 and 2013 have been corrected.

The effects of these prior period errors on the consolidated financial statements are as follows (in thousands, except per share amounts):

Revised Consolidated Statement of Assets and Liabilities

 

     As of February 28, 2014  
     As
Previously
Reported
     Adjustments      As
Revised
 

LIABILITIES

        

Management and incentive fees payable

   $ 3,857       $ 1,496       $ 5,353   

Total liabilities

     104,253         1,496         105,749   

NET ASSETS

        

Distribution in excess of net investment income

     (29,628      (1,496      (31,124

Total Net Assets

   $ 114,924       $ (1,496    $ 113,428   
  

 

 

    

 

 

    

 

 

 

NET ASSET VALUE PER SHARE

$ 21.36    $ (0.28 $ 21.08   
  

 

 

    

 

 

    

 

 

 

 

     As of November 30, 2014  
     As
Previously
Reported
     Adjustments      As
Revised
 

LIABILITIES

        

Management and incentive fees payable

   $ 4,551       $ 1,554       $ 6,105   

Total liabilities

     138,684         1,554         140,238   

NET ASSETS

        

Distribution in excess of net investment income

     (23,753      (1,554      (25,307

Total Net Assets

   $ 122,316       $ (1,554    $ 120,762   
  

 

 

    

 

 

    

 

 

 

NET ASSET VALUE PER SHARE

$ 22.74    $ (0.29 $ 22.45   
  

 

 

    

 

 

    

 

 

 

 

     As of August 31, 2014  
     As
Previously
Reported
     Adjustments      As
Revised
 

LIABILITIES

        

Management and incentive fees payable

   $ 4,221       $ 1,473       $ 5,694   

Total liabilities

     127,412         1,473         128,885   

NET ASSETS

        

Distribution in excess of net investment income

     (25,494      (1,473      (26,967

Total Net Assets

   $ 119,818       $ (1,473    $ 118,345   
  

 

 

    

 

 

    

 

 

 

NET ASSET VALUE PER SHARE

$ 22.27    $ (0.27 $ 22.00   
  

 

 

    

 

 

    

 

 

 

 

S-148


Table of Contents
     As of May 31, 2014  
     As
Previously
Reported
     Adjustments      As
Revised
 

LIABILITIES

        

Management and incentive fees payable

   $ 3,649       $ 1,494       $ 5,143   

Total liabilities

     122,552         1,494         124,046   

NET ASSETS

        

Distribution in excess of net investment income

     (27,567      (1,494      (29,061

Total Net Assets

   $ 116,682       $ (1,494    $ 115,188   
  

 

 

    

 

 

    

 

 

 

NET ASSET VALUE PER SHARE

$ 21.69    $ (0.28 $ 21.41   
  

 

 

    

 

 

    

 

 

 

Revised Consolidated Statements of Operations

 

    Year Ended February 28, 2014     Year Ended February 28, 2013  
    As
Previously
Reported
    Adjustments     As
Revised
    As
Previously
Reported
    Adjustments     As
Revised
 

EXPENSES

           

Incentive management fees

  $ 692      $ 247      $ 939      $ 2,045      $ 558      $ 2,603   

Total expenses

    13,772        247        14,019        9,979        558        10,537   

NET INVESTMENT INCOME

    9,121        (247     8,874        7,028        (558     6,470   

NET INCREASE IN NET ASSETS RESULTING FROM OPERATIONS

  $ 8,744      $ (247   $ 8,497      $ 14,602      $ (558   $ 14,044   

WEIGHTED AVERAGE—BASIC AND DILUTED EARNINGS PER COMMON SHARE

  $ 1.78      $ (0.05   $ 1.73      $ 3.55      $ (0.13   $ 3.42   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

    Three Months Ended November 30,
2014
    Nine Months Ended November 30,
2014
 
    As
Previously
Reported
    Adjustments     As
Revised
    As
Previously
Reported
    Adjustments     As
Revised
 

EXPENSES

           

Incentive management fees

  $ 852      $ 81      $ 933      $ 2,022      $ 58      $ 2,080   

Total expenses

    4,595        81        4,676        13,081        58        13,139   

NET INVESTMENT INCOME

    2,710        (81     2,629        6,843        (58     6,785   

NET INCREASE IN NET ASSETS RESULTING FROM OPERATIONS

  $ 3,466      $ (81   $ 3,385      $ 8,360      $ (58   $ 8,302   

WEIGHTED AVERAGE—BASIC AND DILUTED EARNINGS PER COMMON SHARE

  $ 0.64      $ (0.01   $ 0.63      $ 1.55      $ (0.01   $ 1.54   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

S-149


Table of Contents
    Three Months Ended August 31,
2014
    Six Months Ended August 31, 2014  
    As
Previously
Reported
    Adjustments     As
Revised
    As
Previously
Reported
    Adjustments     As
Revised
 

EXPENSES

           

Incentive management fees

  $ 790      $ (21   $ 769      $ 1,170      $ (23   $ 1,147   

Total expenses

    4,403        (21     4,382        8,486        (23     8,463   

NET INVESTMENT INCOME

    2,072        21        2,093        4,133        23        4,156   

NET INCREASE IN NET ASSETS RESULTING FROM OPERATIONS

  $ 3,136      $ 21      $ 3,157      $ 4,894      $ 23      $ 4,917   

WEIGHTED AVERAGE—BASIC AND DILUTED EARNINGS PER COMMON SHARE

  $ 0.58      $ 0.01      $ 0.59      $ 0.91      $ —        $ 0.91   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

     Three Months Ended May 31, 2014  
     As
Previously
Reported
     Adjustments      As
Revised
 

EXPENSES

        

Incentive management fees

   $ 380       $ (2    $ 378   

Total expenses

     4,083         (2      4,081   

NET INVESTMENT INCOME

     2,061         2         2,063   

NET INCREASE IN NET ASSETS RESULTING FROM OPERATIONS

   $ 1,758       $ 2       $ 1,760   

WEIGHTED AVERAGE—BASIC AND DILUTED EARNINGS PER COMMON SHARE

   $ 0.33       $ —         $ 0.33   
  

 

 

    

 

 

    

 

 

 

Revised Consolidated Statements of Changes in Net Assets

 

     Year Ended February 28, 2014     Year Ended February 28, 2013  
     As
Previously
Reported
    Adjustments     As
Revised
    As
Previously
Reported
    Adjustments     As
Revised
 

INCREASE FROM OPERATIONS

            

Net investment income

   $ 9,121      $ (247   $ 8,874      $ 7,028      $ (558   $ 6,470   

Net increase in net assets from operations

     8,744        (247     8,497        14,602        (558     14,044   

Total increase in net assets

     6,237        (247     5,990        11,307        (558     10,749   

Net assets at beginning of period

     108,687        (1,249     107,438        97,380        (691     96,689   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net assets at end of period

$ 114,924    $ (1,496 $ 113,428    $ 108,687    $ (1,249 $ 107,438   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net asset value per common share

$ 21.36    $ (0.28 $ 21.08    $ 22.98    $ (0.27 $ 22.71   

Distribution in excess of net investment income

$ (29,628 $ (1,496 $ (31,124 $ (24,523 $ (1,249 $ (25,772

 

S-150


Table of Contents
     Nine Months Ended November 30, 2014  
     As
Previously
Reported
     Adjustments      As
Revised
 

INCREASE FROM OPERATIONS

        

Net investment income

   $ 6,843       $ (58    $ 6,785   

Net increase in net assets from operations

     8,360         (58      8,302   

Total increase in net assets

     7,392         (58      7,334   

Net assets at beginning of period

     114,924         (1,496      113,428   
  

 

 

    

 

 

    

 

 

 

Net assets at end of period

$ 122,316    $ (1,554 $ 120,762   
  

 

 

    

 

 

    

 

 

 

Net asset value per common share

$ 22.74    $ (0.29 $ 22.45   

Distribution in excess of net investment income

$ (23,753 $ (1,554 $ (25,307

 

     Six Months Ended August 31, 2014  
     As
Previously
Reported
     Adjustments      As
Revised
 

INCREASE FROM OPERATIONS

        

Net investment income

   $ 4,133       $ 23       $ 4,156   

Net increase in net assets from operations

     4,894         23         4,917   

Total increase in net assets

     4,894         23         4,917   

Net assets at beginning of period

     114,924         (1,496      113,428   
  

 

 

    

 

 

    

 

 

 

Net assets at end of period

$ 119,818    $ (1,473 $ 118,345   
  

 

 

    

 

 

    

 

 

 

Net asset value per common share

$ 22.27    $ (0.27 $ 22.00   

Distribution in excess of net investment income

$ (25,494 $ (1,473 $ (26,967

 

     Three Months Ended May 31, 2014  
     As
Previously
Reported
     Adjustments      As
Revised
 

INCREASE FROM OPERATIONS

        

Net investment income

   $ 2,061       $ 2       $ 2,063   

Net increase in net assets from operations

     1,758         2         1,760   

Total increase in net assets

     1,758         2         1,760   

Net assets at beginning of period

     114,924         (1,496      113,428   
  

 

 

    

 

 

    

 

 

 

Net assets at end of period

$ 116,682    $ (1,494 $ 115,188   
  

 

 

    

 

 

    

 

 

 

Net asset value per common share

$ 21.69    $ (0.28 $ 21.41   

Distribution in excess of net investment income

$ (27,567 $ (1,494 $ (29,061

Revised Consolidated Statements of Cash Flows

 

    Year Ended February 28, 2014     Year Ended February 28, 2013  
    As
Previously
Reported
    Adjustments     As
Revised
    As
Previously
Reported
    Adjustments     As
Revised
 

Operating activities

           

NET INCREASE IN NET ASSETS FROM OPERATIONS

  $ 8,744      $ (247   $ 8,497      $ 14,602      $ (558   $ 14,044   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Increase (decrease) in operating liabilities:

Management and incentive fees payable

  (652   247      (405   1,624      558      2,182   

 

S-151


Table of Contents
     Nine Months Ended November 30, 2014  
     As
Previously
Reported
     Adjustments      As
Revised
 

Operating activities

        

NET INCREASE IN NET ASSETS FROM OPERATIONS

   $ 8,360       $ (58    $ 8,302   
  

 

 

    

 

 

    

 

 

 

Increase (decrease) in operating liabilities:

Management and incentive fees payable

  694      58      752   

 

     Six Months Ended August 31, 2014  
     As
Previously
Reported
     Adjustments      As
Revised
 

Operating activities

        

NET INCREASE IN NET ASSETS FROM OPERATIONS

   $ 4,894       $ 23       $ 4,917   
  

 

 

    

 

 

    

 

 

 

Increase (decrease) in operating liabilities:

Management and incentive fees payable

  364      (23   341   

 

     Three Months Ended May 31, 2014  
     As
Previously
Reported
     Adjustments      As
Revised
 

Operating activities

        

NET INCREASE IN NET ASSETS FROM OPERATIONS

   $ 1,758       $ 2       $ 1,760   
  

 

 

    

 

 

    

 

 

 

Increase (decrease) in operating liabilities:

Management and incentive fees payable

  (208   (2   (210

Cash and Cash Equivalents

Cash and cash equivalents include short-term, liquid investments in a money market fund. Cash and cash equivalents are carried at cost which approximates fair value. Per section 12(d)(1)(A) of the 1940 Act, the Company may not invest in another registered investment company such as, a money market fund if such investment would cause the Company to exceed any of the following limitations:

 

    we were to own more than 3.0% of the total outstanding voting stock of the money market fund;

 

    we were to hold securities in the money market fund having an aggregate value in excess of 5.0% of the value of our total assets; or

 

    we were to hold securities in money market funds and other registered investment companies and BDCs having an aggregate value in excess of 10.0% of the value of our total assets.

Cash and Cash Equivalents, Reserve Accounts

Cash and cash equivalents, reserve accounts include amounts held in designated bank accounts in the form of cash and short-term liquid investments in money market funds representing payments received on secured investments or other reserved amounts associated with our $45.0 million senior secured revolving credit facility with Madison Capital Funding LLC. The Company is required to use these amounts to pay interest expense, reduce borrowings, or pay other amounts in accordance with the terms of the senior secured revolving credit facility.

 

S-152


Table of Contents

Investment Classification

The Company classifies its investments in accordance with the requirements of the 1940 Act. Under the 1940 Act, “Control Investments” are defined as investments in companies in which we own more than 25.0% of the voting securities or maintain greater than 50.0% of the board representation. Under the 1940 Act, “Affiliated Investments” are defined as those non-control investments in companies in which we own between 5.0% and 25.0% of the voting securities. Under the 1940 Act, “Non-affiliated Investments” are defined as investments that are neither Control Investments nor Affiliated Investments.

Investment Valuation

The Company accounts for its investments at fair value in accordance with the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 820, Fair Value Measurements and Disclosures (“ASC 820”). ASC 820 defines fair value, establishes a framework for measuring fair value, establishes a fair value hierarchy based on the quality of inputs used to measure fair value and enhances disclosure requirements for fair value measurements. ASC 820 requires the Company to assume that its investments are to be sold at the statement of assets and liabilities date in the principal market to independent market participants, or in the absence of a principal market, in the most advantageous market, which may be a hypothetical market. Market participants are defined as buyers and sellers in the principal or most advantageous market that are independent, knowledgeable, and willing and able to transact.

Investments for which market quotations are readily available are fair valued at such market quotations obtained from independent third party pricing services and market makers subject to any decision by our board of directors to approve a fair value determination to reflect significant events affecting the value of these investments. We value investments for which market quotations are not readily available at fair value as approved, in good faith, by our board of directors based on input from our Manager, the audit committee of our board of directors and a third party independent valuation firm. Determinations of fair value may involve subjective judgments and estimates. The types of factors that may be considered in determining the fair value of our investments include the nature and realizable value of any collateral, the portfolio company’s ability to make payments, market yield trend analysis, the markets in which the portfolio company does business, comparison to publicly traded companies, discounted cash flow and other relevant factors.

We undertake a multi-step valuation process each quarter when valuing investments for which market quotations are not readily available, as described below:

 

    Each investment is initially valued by the responsible investment professionals of our Manager and preliminary valuation conclusions are documented and discussed with the senior management of our Manager; and

 

    An independent valuation firm engaged by our board of directors reviews approximately one quarter of these preliminary valuations each quarter so that the valuation of each investment for which market quotes are not readily available is reviewed by the independent valuation firm at least annually.

In addition, all our investments are subject to the following valuation process:

 

    The audit committee of our board of directors reviews each preliminary valuation and our Manager and independent valuation firm (if applicable) will supplement the preliminary valuation to reflect any comments provided by the audit committee; and

 

    Our board of directors discusses the valuations and approves the fair value of each investment, in good faith, based on the input of our Manager, independent valuation firm (to the extent applicable) and the audit committee of our board of directors.

Our investment in Saratoga Investment Corp. CLO 2013-1, Ltd. (“Saratoga CLO”) is carried at fair value, which is based on a discounted cash flow model that utilizes prepayment, re-investment and loss assumptions

 

S-153


Table of Contents

based on historical experience and projected performance, economic factors, the characteristics of the underlying cash flow, and comparable yields for equity interests in collateralized loan obligation funds similar to Saratoga CLO, when available, as determined by our Manager and recommended to our board of directors. Specifically, we use Intex cash flow models, or an appropriate substitute, to form the basis for the valuation of our investment in Saratoga CLO. The models use a set of assumptions including projected default rates, recovery rates, reinvestment rate and prepayment rates in order to arrive at estimated valuations. The assumptions are based on available market data and projections provided by third parties as well as management estimates. We use the output from the Intex models (i.e., the estimated cash flows) to perform a discounted cash flows analysis on expected future cash flows to determine a valuation for our investment in Saratoga CLO.

Because such valuations, and particularly valuations of private investments and private companies, are inherently uncertain, they may fluctuate over short periods of time and may be based on estimates. The determination of fair value may differ materially from the values that would have been used if a ready market for these investments existed. Our net asset value could be materially affected if the determinations regarding the fair value of our investments were materially higher or lower than the values that we ultimately realize upon the disposal of such investments.

Derivative Financial Instruments

We account for derivative financial instruments in accordance with ASC Topic 815, Derivatives and Hedging (“ASC 815”). ASC 815 requires recognizing all derivative instruments as either assets or liabilities on the consolidated statements of assets and liabilities at fair value. The Company values derivative contracts at the closing fair value provided by the counterparty. Changes in the values of derivative contracts are included in the consolidated statements of operations.

Investment Transactions and Income Recognition

Purchases and sales of investments and the related realized gains or losses are recorded on a trade-date basis. Interest income, adjusted for amortization of premium and accretion of discount, is recorded on an accrual basis to the extent that such amounts are expected to be collected. The Company stops accruing interest on its investments when it is determined that interest is no longer collectible. Discounts and premiums on investments purchased are accreted/amortized over the life of the respective investment using the effective yield method. The amortized cost of investments represents the original cost adjusted for the accretion of discounts and amortizations of premium on investments.

Loans are generally placed on non-accrual status when there is reasonable doubt that principal or interest will be collected. Accrued interest is generally reserved when a loan is placed on non-accrual status. Interest payments received on non-accrual loans may be recognized as a reduction in principal depending upon management’s judgment regarding collectability. Non-accrual loans are restored to accrual status when past due principal and interest is paid and, in management’s judgment, are likely to remain current, although we may make exceptions to this general rule if the loan has sufficient collateral value and is in the process of collection.

Interest income on our investment in Saratoga CLO is recorded using the effective interest method in accordance with the provisions of ASC Topic 325-40, Investments-Other, Beneficial Interests in Securitized Financial Assets, (“ASC 325-40”), based on the anticipated yield and the estimated cash flows over the projected life of the investment. Yields are revised when there are changes in actual or estimated cash flows due to changes in prepayments and/or re-investments, credit losses or asset pricing. Changes in estimated yield are recognized as an adjustment to the estimated yield over the remaining life of the investment from the date the estimated yield was changed.

Other Income

Other income includes dividends received, origination fees, structuring fees and advisory fees, and is recorded in income when earned.

 

S-154


Table of Contents

Paid-in-Kind Interest

The Company holds debt investments in its portfolio that contain a payment-in-kind (“PIK”) interest provision. The PIK interest, which represents contractually deferred interest added to the investment balance that is generally due at maturity, is generally recorded on the accrual basis to the extent such amounts are expected to be collected. We stop accruing PIK interest if we do not expect the issuer to be able to pay all principal and interest when due.

Deferred Debt Financing Costs

Financing costs incurred in connection with our credit facility are deferred and amortized using the straight line method over the life of their respective facilities. Financing costs incurred in connection with our SBA debentures are deferred and amortized using the effective yield method over the life of the debentures.

In April 2015, the FASB has issued Accounting Standards Update (“ASU”) No. 2015-03, Interest—Imputation of Interest (Subtopic 835-30): Simplifying the Presentation of Debt Issuance Costs (“ASU 2015-03”). The amendments in this ASU require that debt issuance costs related to a recognized debt liability be presented in the balance sheet as a direct deduction from the carrying amount of that debt liability, consistent with debt discounts. The recognition and measurement guidance for debt issuance costs are not affected by the amendments in this ASU. The guidance is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2015, and early adoption is allowed, and is to be applied on a retrospective basis. The Company has adopted the provisions of ASU 2015-03 as of February 28, 2015, by reclassifying deferred debt financing costs from within total assets to within total liabilities as a contra-liability. The adoption of the provisions of ASU 2015-03 did not materially impact the Company’s consolidated financial position or results of operations. Prior period amounts were reclassified to conform to the current period presentation.

Contingencies

In the ordinary course of its business, the Company may enter into contracts or agreements that contain indemnifications or warranties. Future events could occur that lead to the execution of these provisions against the Company. Based on its history and experience, management feels that the likelihood of such an event is remote.

In the ordinary course of business, the Company may directly or indirectly be a defendant or plaintiff in legal actions with respect to bankruptcy, insolvency or other types of proceedings. Such lawsuits may involve claims that could adversely affect the value of certain financial instruments owned by the Company.

Income Taxes

The Company has filed an election to be treated for tax purposes as a RIC under Subchapter M of the Code and, among other things, intends to make the requisite distributions to its stockholders which will relieve the Company from federal income taxes. Therefore, no provision has been recorded for federal income taxes.

In order to qualify as a RIC, among other requirements, the Company is required to timely distribute to its stockholders at least 90.0% of its investment company taxable income, as defined by the Code, for each fiscal tax year. The Company will be subject to a nondeductible U.S. federal excise tax of 4.0% on undistributed income if it does not distribute at least 98.0% of its ordinary income in any calendar year and 98.2% of its capital gain net income for each one-year period ending on October 31.

Depending on the level of taxable income earned in a tax year, the Company may choose to carry forward taxable income in excess of current year dividend distributions into the next tax year and pay a 4.0% excise tax on such income, as required. To the extent that the Company determines that its estimated current year annual taxable income will be in excess of estimated current year dividend distributions for excise tax purposes, the Company accrues excise tax, if any, on estimated excess taxable income as taxable income is earned.

 

S-155


Table of Contents

In accordance with certain applicable Treasury regulations and private letter rulings issued by the Internal Revenue Service, a RIC may treat a distribution of its own stock as fulfilling its RIC distribution requirements if each stockholder may elect to receive his or her entire distribution in either cash or stock of the RIC subject to a limitation on the aggregate amount of cash to be distributed to all stockholders, which limitation must be at least 20.0% of the aggregate declared distribution. If too many stockholders elect to receive cash, each stockholder electing to receive cash will receive a pro rata amount of cash (with the balance of the distribution paid in stock). In no event will any stockholder, electing to receive cash, receive less than 20.0% of his or her entire distribution in cash. If these and certain other requirements are met, for U.S federal income tax purposes, the amount of the dividend paid in stock will be equal to the amount of cash that could have been received instead of stock.

ASC 740, Income Taxes, (“ASC 740”), provides guidance for how uncertain tax positions should be recognized, measured, presented and disclosed in the financial statements. ASC 740 requires the evaluation of tax positions taken or expected to be taken in the course of preparing the Company’s tax returns to determine whether the tax positions are “more-likely-than-not” of being sustained by the applicable tax authority. Tax positions deemed to meet a “more-likely-than-not” threshold would be recorded as a tax benefit or expense in the current period. The Company recognizes interest and penalties, if any, related to unrecognized tax benefits as income tax expense in the consolidated statements of operations. During the fiscal year ended February 28, 2015, the Company did not incur any interest or penalties. Although we file federal and state tax returns, our major tax jurisdiction is federal. The 2012, 2013 and 2014 federal tax years for the Company remain subject to examination by the IRS. As of February 28, 2015 and February 28, 2014, there were no uncertain tax positions.

Dividends

Dividends to common stockholders are recorded on the ex-dividend date. The amount to be paid out as a dividend is determined by the board of directors. Net realized capital gains, if any, are generally distributed at least annually, although we may decide to retain such capital gains for reinvestment.

We have adopted a dividend reinvestment plan (“DRIP”) that provides for reinvestment of our dividend distributions on behalf of our stockholders unless a stockholder elects to receive cash. As a result, if our board of directors authorizes, and we declare, a cash dividend, then our stockholders who have not “opted out” of the DRIP by the dividend record date will have their cash dividends automatically reinvested into additional shares of our common stock, rather than receiving the cash dividends. We have the option to satisfy the share requirements of the DRIP through the issuance of new shares of common stock or through open market purchases of common stock by the DRIP plan administrator.

Capital Gains Incentive Fee

The Company records an expense accrual on the consolidated statements of operations, relating to the capital gains incentive fee payable on the consolidated statements of assets and liabilities, by the Company to its investment adviser when the unrealized gains on its investments exceed all realized capital losses on its investments given the fact that a capital gains incentive fee would be owed to the investment adviser if the Company were to liquidate its investment portfolio at such time. The actual incentive fee payable to the Company’s investment adviser related to capital gains will be determined and payable in arrears at the end of each fiscal year and will include only realized capital gains for the period.

New Accounting Pronouncements

In February 2015, the FASB issued ASU 2015-02, Consolidation (ASC Topic 810): Amendments to the Consolidation Analysis (“ASU 2015-02”). ASU 2015-02 significantly changes the consolidation analysis required under GAAP and ends the deferral granted to investment companies from applying the variable interest entity guidance. ASU 2015-02 is effective for interim and annual reporting periods in fiscal years that begin after December 15, 2015 and early adoption is permitted. Management is currently evaluating the impact these changes will have on the Company’s consolidated financial statements and disclosures.

 

S-156


Table of Contents

In August 2014, the FASB issued new accounting guidance that requires management to assess an entity’s ability to continue as a going concern by incorporating and expanding upon certain principles that are currently in U.S. auditing standards. The amendments provide a definition of the term “substantial doubt” and include principles for considering the mitigating effect of management’s plans. The amendments also require an evaluation every reporting period, including interim periods for a period of one year after the date that the financial statements are issued (or available to be issued), and certain disclosures when substantial doubt is alleviated or not alleviated. The amendments in this update are effective for reporting periods ending after December 15, 2016. Management is currently evaluating the impact of adopting this new accounting guidance update on the company’s consolidated financial statement.

In June 2014, the FASB issued ASU 2014-11, Repurchase-to-Maturity Transactions, Repurchase Financings, and Disclosures, (“ASU 2014-11”). ASU 2014-11 makes limited changes to the accounting for repurchase agreements, clarifies when repurchase agreements and securities lending transactions should be accounted for as secured borrowings, and requires additional disclosures regarding these types of transactions. The guidance is effective for fiscal years beginning on or after December 15, 2014, and for interim periods within those fiscal years. Management is currently evaluating the impact these changes will have on the Company’s consolidated financial statement disclosures.

In May 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2014-09, Revenue from Contracts with Customers (Topic 606), which supersedes the revenue recognition requirements in Revenue Recognition (Topic 605). Under the new guidance, an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. This guidance is effective for annual and interim reporting periods beginning after December 15, 2016, and early application is not permitted. The Company is currently evaluating the impact this ASU will have on its consolidated financial statements.

Risk Management

In the ordinary course of its business, the Company manages a variety of risks, including market risk and credit risk. Market risk is the risk of potential adverse changes to the value of investments because of changes in market conditions such as interest rate movements and volatility in investment prices.

Credit risk is the risk of default or non-performance by portfolio companies, equivalent to the investment’s carrying amount.

The Company is also exposed to credit risk related to maintaining all of its cash and cash equivalents, including those in reserve accounts, at a major financial institution and credit risk related to any of its derivative counterparties.

The Company has investments in lower rated and comparable quality unrated high yield bonds and bank loans. Investments in high yield investments are accompanied by a greater degree of credit risk. The risk of loss due to default by the issuer is significantly greater for holders of high yield securities, because such investments are generally unsecured and are often subordinated to other creditors of the issuer.

Note 3. Investments

As noted above, the Company values all investments in accordance with ASC 820. ASC 820 requires enhanced disclosures about assets and liabilities that are measured and reported at fair value. As defined in ASC 820, fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date.

 

S-157


Table of Contents

ASC 820 establishes a hierarchal disclosure framework which prioritizes and ranks the level of market price observability of inputs used in measuring investments at fair value. Market price observability is affected by a number of factors, including the type of investment and the characteristics specific to the investment. Investments with readily available active quoted prices or for which fair value can be measured from actively quoted prices generally will have a higher degree of market price observability and a lesser degree of judgment used in measuring fair value.

Based on the observability of the inputs used in the valuation techniques, the Company is required to provide disclosures on fair value measurements according to the fair value hierarchy. The fair value hierarchy ranks the observability of the inputs used to determine fair values. Investments carried at fair value are classified and disclosed in one of the following three categories:

 

    Level 1—Valuations based on quoted prices in active markets for identical assets or liabilities that the Company has the ability to access.

 

    Level 2—Valuations based on inputs other than quoted prices in active markets, which are either directly or indirectly observable.

 

    Level 3—Valuations based on inputs that are unobservable and significant to the overall fair value measurement. The inputs used in the determination of fair value may require significant management judgment or estimation. Such information may be the result of consensus pricing information or broker quotes which include a disclaimer that the broker would not be held to such a price in an actual transaction. The non-binding nature of consensus pricing and/or quotes accompanied by disclaimer would result in classification as Level 3 asset, assuming no additional corroborating evidence.

In addition to using the above inputs in investment valuations, the Company continues to employ the valuation policy approved by the board of directors that is consistent with ASC 820 and the 1940 Act (see Note 2). Consistent with our Company’s valuation policy, we evaluate the source of inputs, including any markets in which our investments are trading, in determining fair value.

The following table presents fair value measurements of investments, by major class, as of February 28, 2015 (dollars in thousands), according to the fair value hierarchy:

 

     Fair Value Measurements  
     Level 1      Level 2      Level 3      Total  

Syndicated loans

   $ —         $ —         $ 18,302       $ 18,302   

First lien term loans

     —           —           145,207         145,207   

Second lien term loans

     —           —           35,603         35,603   

Unsecured notes

     —           —           4,230         4,230   

Structured finance securities

     —           —           17,031         17,031   

Equity interest

     —           —           20,165         20,165   
  

 

 

    

 

 

    

 

 

    

 

 

 

Total

$ —      $ —      $ 240,538    $ 240,538   
  

 

 

    

 

 

    

 

 

    

 

 

 

The following table presents fair value measurements of investments, by major class, as of February 28, 2014 (dollars in thousands), according to the fair value hierarchy:

 

     Fair Value Measurements  
     Level 1      Level 2      Level 3      Total  

Syndicated loans

   $ —         $ —         $ 32,390       $ 32,390   

First lien term loans

     —           —           110,278         110,278   

Second lien term loans

     —           —           27,804         27,804   

Unsecured notes

     —           —           5,471         5,471   

Structured finance securities

     —           —           19,570         19,570   

Equity interest

     —           —           10,332         10,332   
  

 

 

    

 

 

    

 

 

    

 

 

 

Total

$ —      $ —      $ 205,845    $ 205,845   
  

 

 

    

 

 

    

 

 

    

 

 

 

 

S-158


Table of Contents

The following table provides a reconciliation of the beginning and ending balances for investments that use Level 3 inputs for the year ended February 28, 2015 (dollars in thousands):

 

    Syndicated
loans
    First lien
term loans
    Second
lien
term loans
    Unsecured
notes
    Structured
finance
securities
    Common
stock/equities
    Total  

Balance as of February 28, 2014

  $ 32,390      $ 110,278      $ 27,804      $ 5,471      $ 19,570      $ 10,332      $ 205,845   

Net unrealized gains (losses)

    (763     (206     (409     (1,458     (1,936     2,829        (1,943

Purchases and other
adjustments to cost

    56        83,456        18,667        217        —          4,221        106,617   

Sales and redemptions

    (13,461     (42,445     (10,522     —          (603     (6,226     (73,257

Net realized gain from investments

    80        387        63        —          —          2,746        3,276   

Transfers In/Out

    —          (6,263     —          —          —          6,263        —     
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Balance as of February 28, 2015

$ 18,302    $ 145,207    $ 35,603    $ 4,230    $ 17,031    $ 20,165    $ 240,538   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Purchases and other adjustments to cost include purchases of new investments at cost, effects of refinancing/restructuring, accretion/amortization of income from discount/premium on debt securities, and PIK.

Sales and redemptions represent net proceeds received from investments sold, and principal paydowns received, during the period.

The net change in unrealized gain/(loss) for the year ended February 28, 2015 on investments held as of February 28, 2015 is ($1,456,791) and is included in net unrealized appreciation (depreciation) on investments in the consolidated statements of operations.

The following table provides a reconciliation of the beginning and ending balances for investments that use Level 3 inputs for the year ended February 28, 2014 (dollars in thousands):

 

    Syndicated
loans
    First lien
term loans
    Second
lien
term loans
    Unsecured
notes
    Structured
finance
securities
    Common
stock/equities
    Total  

Balance as of February 28, 2013

  $ —        $ 107,097      $ 9,571      $ 4,874      $ 25,517      $ 8,021      $ 155,080   

Net unrealized gains (losses)

    407        (354     165        207        (3,558     1,485        (1,648

Purchases and other adjustments
to cost

    37,048        63,743        20,727        390        —          841        122,749   

Sales and redemptions

    (5,138     (60,890     (3,030     —          (2,389     (160     (71,607

Net realized gain (loss) from investments

    73        682        371        —          —          145        1,271   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Balance as of February 28, 2014

$ 32,390    $ 110,278    $ 27,804    $ 5,471    $ 19,570    $ 10,332    $ 205,845   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Purchases and other adjustments to cost include purchases of new investments at cost, effects of refinancing/restructuring, accretion/amortization of income from discount/premium on debt securities, and PIK.

Sales and redemptions represent net proceeds received from investments sold, and principal paydowns received, during the period.

The net change in unrealized gain/(loss) for the year ended February 28, 2014 on investments held as of February 28, 2014 is $(1,767,285) and is included in net unrealized appreciation (depreciation) on investments in the consolidated statements of operations.

 

S-159


Table of Contents

The valuation techniques and significant unobservable inputs used in recurring Level 3 fair value measurements of assets as of February 28, 2015 were as follows (dollars in thousands):

 

     Fair Value     

Valuation Technique

  

Unobservable Input

  

Range

Syndicated loans

     18,302       Market Comparables    Third-Party Bid    93.6% - 100.4%

First lien term loans

     145,206       Market Comparables    Market Yield (%)    5.8% - 17.7%
         EBITDA Multiples (x)    3.0x
         Third-Party Bid    79.3 - 105.0

Second lien term loans

     35,603       Market Comparables    Market Yield (%)    8.5% - 15.0%
         Third-Party Bid    98.3% - 98.3%

Unsecured notes

     4,230       Market Comparables    Market Yield (%)    13.2% - 20.3%

Structured finance securities

     17,031       Discounted Cash Flow    Discount Rate (%)    12.0%

Equity interests

     20,165       Market Comparables    EBITDA Multiples (x)    5.0x - 12.1x

The valuation techniques and significant unobservable inputs used in recurring Level 3 fair value measurements of assets as of February 28, 2014 were as follows (dollars in thousands):

 

     Fair Value     

Valuation Technique

  

Unobservable Input

  

Range

Syndicated loans

   $ 32,390       Market Comparables    Third-Party Bid    99.5 - 100.6

First lien term loans

     110,278       Market Comparables    Market Yield (%)    5.1% - 42.5%
         EBITDA Multiples (x)    3.0x - 5.0x
         Third-Party Bid    83.3 - 107.5

Second lien term loans

     27,804       Market Comparables    Market Yield (%)    9.6% - 12.5%
         Third-Party Bid    100.0 - 101.8

Unsecured notes

     5,471       Market Comparables    Market Yield (%)    12.8% - 20.3%

Structured finance securities

     19,570       Discounted Cash Flow    Discount Rate (%)    9.0%

Equity interests

     10,332       Market Comparables    EBITDA Multiples (x)    6.3x - 12.0x

For investments utilizing a market comparables valuation technique, a significant increase (decrease) in the market yield, in isolation, would result in a significantly lower (higher) fair value measurement, and a significant increase (decrease) in any of the EBITDA valuation multiples, in isolation, would result in a significantly higher (lower) fair value measurement. For investments utilizing a discounted cash flow valuation technique, a significant increase (decrease) in the discount rate, in isolation, would result in a significantly lower (higher) fair value measurement.

The composition of our investments as of February 28, 2015, at amortized cost and fair value were as follows (dollars in thousands):

 

     Investments at
Amortized Cost
     Amortized Cost
Percentage of
Total Portfolio
    Investments at
Fair Value
     Fair Value
Percentage of
Total Portfolio
 

Syndicated loans

   $ 18,658         7.8   $ 18,302         7.6

First lien term loans

     144,959         60.8        145,207         60.3   

Second lien term loans

     35,748         15.0        35,603         14.8   

Unsecured notes

     7,366         3.1        4,230         1.8   

Structured finance securities

     15,953         6.7        17,031         7.1   

Equity interest

     15,774         6.6        20,165         8.4   
  

 

 

    

 

 

   

 

 

    

 

 

 

Total

$ 238,458      100.0 $ 240,538      100.0
  

 

 

    

 

 

   

 

 

    

 

 

 

 

S-160


Table of Contents

The composition of our investments as of February 28, 2014, at amortized cost and fair value were as follows (dollars in thousands):

 

     Investments at
Amortized Cost
     Amortized Cost
Percentage of
Total Portfolio
    Investments at
Fair Value
     Fair Value
Percentage of
Total Portfolio
 

Syndicated loans

   $ 31,982         15.8   $ 32,390         15.7

First lien term loans

     112,039         55.6        110,278         53.6   

Second lien term loans

     27,540         13.6        27,804         13.5   

Unsecured notes

     7,149         3.5        5,471         2.7   

Structured finance securities

     16,556         8.2        19,570         9.5   

Equity interest

     6,556         3.3        10,332         5.0   
  

 

 

    

 

 

   

 

 

    

 

 

 

Total

$ 201,822      100.0 $ 205,845      100.0
  

 

 

    

 

 

   

 

 

    

 

 

 

For loans and debt securities for which market quotations are not available, we determine their fair value based on third party indicative broker quotes, where available, or the assumptions that a hypothetical market participant would use to value the security in a current hypothetical sale using a market yield valuation methodology. In applying the market yield valuation methodology, we determine the fair value based on such factors as market participant assumptions including synthetic credit ratings, estimated remaining life, current market yield and interest rate spreads of similar securities as of the measurement date. If, in our judgment, the market yield methodology is not sufficient or appropriate, we may use additional methodologies such as an asset liquidation or expected recovery model.

For equity securities of portfolio companies and partnership interests, we determine the fair value based on the market approach with value then attributed to equity or equity like securities using the enterprise value waterfall valuation methodology. Under the enterprise value waterfall valuation methodology, we determine the enterprise fair value of the portfolio company and then waterfall the enterprise value over the portfolio company’s securities in order of their preference relative to one another. To estimate the enterprise value of the portfolio company, we weigh some or all of the traditional market valuation methods and factors based on the individual circumstances of the portfolio company in order to estimate the enterprise value. The methodologies for performing investments may be based on, among other things: valuations of comparable public companies, recent sales of private and public comparable companies, discounting the forecasted cash flows of the portfolio company, third party valuations of the portfolio company, considering offers from third parties to buy the company, estimating the value to potential strategic buyers and considering the value of recent investments in the equity securities of the portfolio company. For non-performing investments, we may estimate the liquidation or collateral value of the portfolio company’s assets and liabilities. We also take into account historical and anticipated financial results.

Our investment in Saratoga Investment Corp. CLO 2013-1, Ltd. (“Saratoga CLO”) is carried at fair value, which is based on a discounted cash flow model that utilizes prepayment, re-investment and loss assumptions based on historical experience and projected performance, economic factors, the characteristics of the underlying cash flow, and comparable yields for equity interests in collateralized loan obligation funds similar to Saratoga CLO, when available, as determined by our Manager and recommended to our board of directors. Specifically, we use Intex cash flow models, or an appropriate substitute, to form the basis for the valuation of our investment in Saratoga CLO. The models use a set of assumptions including projected default rates, recovery rates, reinvestment rate and prepayment rates in order to arrive at estimated valuations. The assumptions are based on available market data and projections provided by third parties as well as management estimates. For the quarter ended November 30, 2013, in connection with the refinancing of the Saratoga CLO liabilities, we ran Intex models based on assumptions about the refinanced Saratoga CLO’s structure, including capital structure, cost of liabilities and reinvestment period. We use the output from the Intex models (i.e., the estimated cash flows) to perform a discounted cash flows analysis on expected future cash flows to determine a valuation for our investment in Saratoga CLO at February 28, 2015. The significant inputs for the valuation model include:

 

    Default rates: 2.0%

 

S-161


Table of Contents
    Recovery rates: 35-75%

 

    Prepayment rate: 25.0%

 

    Reinvestment rate / price: L+375bps / $99.75

Note 4. Investment in Saratoga Investment Corp. CLO 2013-1, Ltd. (“Saratoga CLO”)

On January 22, 2008, we invested $30 million in all of the outstanding subordinated notes of GSC Investment Corp. CLO 2007, Ltd., a collateralized loan obligation fund managed by us that invests primarily in senior secured loans. Additionally, we entered into a collateral management agreement with GSC Investment Corp. CLO 2007, Ltd. pursuant to which we act as collateral manager to it. The Saratoga CLO was refinanced in October 2013 and its reinvestment period ends in October 2016. The Saratoga CLO remains 100% owned and managed by Saratoga Investment Corp. We receive a base management fee of 0.25% and a subordinated management fee of 0.25% of the Fee Basis Amount at the beginning of the Collection Period, paid quarterly to the extent of available proceeds. We are also entitled to an incentive management fee equal to 20.0% of the remaining interest proceeds and principal proceeds, if any, after the subordinated notes have realized the incentive management fee target return of 12.0%, in accordance with the Priority of Payments after making the prior distributions on the relevant payment date. For the years ended February 28, 2015, February 28, 2014 and February 28, 2013, we accrued $1.5 million, $1.8 million, and $2.0 million in management fee income, respectively, and $2.7 million, $3.4 million, and $4.2 million in interest income, respectively, from Saratoga CLO. We did not accrue any amounts related to the incentive management fee as the 12.0% hurdle rate has not yet been achieved.

At February 28, 2015, the Company determined that the fair value of its investment in the subordinated notes of Saratoga CLO was $17.0 million. The Company determines the fair value of its investment in the subordinated notes of Saratoga CLO based on the present value of the projected future cash flows of the subordinated notes over the life of Saratoga CLO. At February 28, 2015, Saratoga CLO had investments with a principal balance of $296.9 million and a weighted average spread over LIBOR of 4.3%, and had debt with a principal balance of $282.4 million with a weighted average spread over LIBOR of 1.8%. As a result, Saratoga CLO earns a “spread” between the interest income it receives on its investments and the interest expense it pays on its debt and other operating expenses, which is distributed quarterly to the Company as the holder of its subordinated notes. At February 28, 2015, the total “spread”, or projected future cash flows of the subordinated notes, over the life of Saratoga CLO was $17.3 million, which had a present value of approximately $17.0 million, using a 12.0% discount rate.

At February 28, 2014, the Company determined that the fair value of its investment in the subordinated notes of Saratoga CLO was $19.6 million. The Company determines the fair value of its investment in the subordinated notes of Saratoga CLO based on the present value of the projected future cash flows of the subordinated notes over the life of Saratoga CLO. At February 28, 2014, Saratoga CLO had investments with a principal balance of $301.1 million and a weighted average spread over LIBOR of 1.8%, and had debt with a principal balance of $284.1 million with a weighted average spread over LIBOR of 1.8%. As a result, Saratoga CLO earns a “spread” between the interest income it receives on its investments and the interest expense it pays on its debt and other operating expenses, which is distributed quarterly to the Company as the holder of its subordinated notes. At February 28, 2014, the total “spread”, or projected future cash flows of the subordinated notes, over the life of Saratoga CLO was $24.9 million, which had a present value of approximately $20.2 million, using a 9.0% discount rate.

The separate audited financial statements of Saratoga CLO as of February 28, 2015 and 2014, pursuant to Rule 3-09 of SEC rules Regulation S-X, and for the twelve months ended February 28, 2015, 2014 and 2013, are presented on page S-1.

 

S-162


Table of Contents

Note 5. Income Taxes

The Company intends to operate so as to qualify to be taxed as a RIC under Subchapter M of the Code and, as such, will not be subject to federal income tax on the portion of taxable income and gains distributed to stockholders.

The Company owns 100.0% of Saratoga CLO, an exempted company incorporated in the Cayman Islands. For financial reporting purposes, the Saratoga CLO is not included as part of the consolidated financial statements. For federal income tax purposes, the Company has requested and received approval from the Internal Revenue Service to treat the Saratoga CLO as a disregarded entity. As such, for federal income tax purposes and for purposes of meeting the RIC qualification and diversification tests, the results of operations of the Saratoga CLO are included with those of the Company.

To qualify as a RIC, the Company is required to meet certain income and asset diversification tests in addition to distributing at least 90.0% of its investment company taxable income, as defined by the Code. Because federal income tax regulations differ from U.S. GAAP, distributions in accordance with tax regulations may differ from net investment income and realized gains recognized for financial reporting purposes. Differences may be permanent or temporary in nature. Permanent differences are reclassified among capital accounts in the financial statements to reflect their tax character. Differences in classification may also result from the treatment of short-term gains as ordinary income for tax purposes. As of February 28, 2015 and February 28, 2014, the Company reclassified for book purposes amounts arising from permanent book/tax differences primarily related to nondeductible excise tax, meals & entertainment, market discount, interest income with respect to the Saratoga CLO which is consolidated for tax purposes, and the tax character of distributions as follows (dollars in thousands):

 

     February 28,
2015
     February 28,
2014
 

Accumulated net investment income/(loss)

   $ (299    $ (1,691

Accumulated net realized gains (losses) on investments

     593         1,691   

Additional paid-in-capital

     (294      —     

For income tax purposes, distributions paid to shareholders are reported as ordinary income, return of capital, long term capital gains or a combination thereof. The tax character of distributions paid for the years ended February 28, 2015 and February 28, 2014 was as follows (dollars in thousands):

 

     February 28,
2015
     February 28,
2014
 

Ordinary Income

   $ 2,157       $ 12,535   

Capital gains

     —           —     

Return of capital

     —           —     
  

 

 

    

 

 

 

Total

$ 2,157    $ 12,535   
  

 

 

    

 

 

 

For federal income tax purposes, as of February 28, 2015, the aggregate net unrealized depreciation for all securities is $3.6 million. The aggregate cost of securities for federal income tax purposes is $522.4 million.

For federal income tax purposes, as of February 28, 2014, the aggregate net unrealized depreciation for all securities is $0.04 million. The aggregate cost of securities for federal income tax purposes is $486.8 million.

 

S-163


Table of Contents

At February 28, 2015 and February 28, 2014, the components of accumulated losses on a tax basis as detailed below differ from the amounts reflected per the Company’s consolidated statements of assets and liabilities by temporary book/tax differences primarily arising from the consolidation of the Saratoga CLO for tax purposes, market discount and original issue discount income, interest income accrual on defaulted bonds, write-off of investments, and amortization of organizational expenditures (dollars in thousands).

 

     February 28,
2015
     February 28,
2014
 

Post October loss deferred

   $ (27,303    $ —     

Accumulated capital losses

     (32,308      (64,101

Other temporary differences

     (2,684      (304

Undistributed ordinary income

     10,578         963   

Unrealized appreciation/(depreciation)

     (3,662      (41
  

 

 

    

 

 

 

Total components of accumulated losses

$ (55,379 $ (63,483
  

 

 

    

 

 

 

Capital losses incurred after October 31 (“post-October losses”) within the taxable year are deemed to arise on the first business day of the Company’s next taxable year. For the year ended February 28, 2015, the Company will elect to defer $27.3 million of current year post-October losses.

The Company has incurred capital losses of $19.3, $13.0 million for the years ended February 28, 2011 and 2010. Such capital losses will be available to offset future capital gains if any and if unused, will expire on February 28, 2019, 2018.

The Company utilized $4.3 million of capital loss carryovers and $27.4 million of Post RIC-modernization act capital loss carryovers.

At February 28, 2015 and February 28, 2014, the Company had a short term capital loss of $0 million and $11.2 million, respectively, and a long-term capital loss of $0 million and $16.3 million, respectively, available to offset future capital gains. Post RIC-modernization act losses are deemed to arise on the first day of the fund’s following fiscal year and there is no expiration for these losses.

The Company is subject to a nondeductible U.S. federal excise tax of 4% on undistributed income if it does not distribute at least 98% of its ordinary income in any calendar year and 98.2% of its capital gain net income for each one-year period ending on October 31 of such calendar year. Depending on the level of Investment Company Taxable Income (“ICTI”) earned in a tax year, the Company may choose to carry forward ICTI in excess of current year dividend distributions into the next tax year and pay a 4% excise tax on such income, as required. To the extent that the Company determines that its estimated current year annual taxable income will be in excess of estimated current year dividend distributions for excise tax purposes, the Company accrues excise tax, if any, on estimated excess taxable income as taxable income is earned. Any such carryover ICTI must be distributed before the end of that next tax year through a dividend declared prior to filing the final tax return related to the year which generated such ICTI. For the calendar year ended December 31, 2014, the Company did not distribute at least 98% of its ordinary income and 98.2% of its capital gains and subsequently paid $293,653 in federal excise taxes.

Management has analyzed the Company’s tax positions taken on federal income tax returns for all open years (fiscal years 2011-2015), and has concluded that no provision for uncertain income tax positions is required in the Company’s financial statements.

On December 22, 2010, the Regulated Investment Company Modernization Act of 2010 (the “Modernization Act”) was enacted, and the provisions with the Modernization Act are effective for the Company

 

S-164


Table of Contents

for the year ended February 29, 2012. The Modernization Act is the first major piece of legislation affecting RICs since 1986 and it modernizes several of the federal income and excise tax provisions related to RICs. Some highlights of the enacted provisions are as follows:

New capital losses may now be carried forward indefinitely, and retain the character of the original loss. Under pre-enactment law, capital losses could be carried forward for eight years, and carried forward as short-term capital, irrespective of the character of the original loss.

The Modernization Act contains simplification provisions, which are aimed at preventing disqualification of a RIC for “inadvertent” failures of the asset diversification and/or qualifying income tests. Additionally, the Modernization Act exempts RICs from the preferential dividend rule, and repealed the 60-day designation requirement for certain types of pay-through income and gains.

Finally, the Modernization Act contains several provisions aimed at preserving the character of distributions made by a fiscal year RIC during the portion of its taxable year ending after October 31 or December 31, reducing the circumstances under which a RIC might be required to file amended Forms 1099 to restate previously reported distributions.

Note 6. Agreements and-Related Party Transactions

On July 30, 2010, the Company entered into the Management Agreement with our Manager. The initial term of the Management Agreement is two years, with automatic, one-year renewals at the end of each year subject to certain approvals by our board of directors and/or our stockholders. On July 10, 2014, our board of directors approved the renewal of the Management Agreement for an additional one-year term. Pursuant to the Management Agreement, our Manager implements our business strategy on a day-to-day basis and performs certain services for us, subject to oversight by our board of directors. Our Manager is responsible for, among other duties, determining investment criteria, sourcing, analyzing and executing investments transactions, asset sales, financings and performing asset management duties. Under the Management Agreement, we have agreed to pay our Manager a management fee for investment advisory and management services consisting of a base management fee and an incentive fee.

The base management fee of 1.75% is calculated based on the average value of our gross assets (other than cash or cash equivalents, but including assets purchased with borrowed funds) at the end of the two most recently completed fiscal quarters, and appropriately adjusted for any share issuances or repurchases during the applicable fiscal quarter.

The incentive fee consists of the following two parts:

The first, payable quarterly in arrears, equals 20.0% of our pre-incentive fee net investment income, expressed as a rate of return on the value of our net assets at the end of the immediately preceding quarter, that exceeds a 1.875% quarterly (7.5% annualized) hurdle rate measured as of the end of each fiscal quarter, subject to a “catch-up” provision. Under this provision, in any fiscal quarter, our Manager receives no incentive fee unless our pre-incentive fee net investment income exceeds the hurdle rate of 1.875%. Our Manager will receive 100.0% of pre-incentive fee net investment income, if any, that exceeds the hurdle rate but is less than or equal to 2.344% in any fiscal quarter (9.376% annualized); and 20.0% of the amount of the our pre-incentive fee net investment income, if any, that exceeds 2.344% in any fiscal quarter (9.376% annualized).

The second part of the incentive fee is determined and payable in arrears as of the end of each fiscal year (or upon termination of the Management Agreement) and equals 20.0% of our “incentive fee capital gains,” which equals our realized capital gains on a cumulative basis from May 31, 2010 through the end of the year, if any, computed net of all realized capital losses and unrealized capital depreciation on a cumulative basis, less the aggregate amount of any previously paid capital gain incentive fee. Importantly, the capital gains portion of the incentive fee is based on realized gains and realized and unrealized losses from May 31, 2010. Therefore,

 

S-165


Table of Contents

realized and unrealized losses incurred prior to such time will not be taken into account when calculating the capital gains portion of the incentive fee, and our Manager will be entitled to 20.0% of incentive fee capital gains that arise after May 31, 2010. In addition, for the purpose of the “incentive fee capital gains” calculations, the cost basis for computing realized gains and losses on investments held by us as of May 31, 2010 will equal the fair value of such investments as of such date.

For the years ended February 28, 2015, February 28, 2014 and February 28, 2013, we incurred $4.2 million, $3.3 million and $2.1 million in base management fees, respectively. For the years ended February 28, 2015, February 28, 2014 and February 28, 2013, we incurred $2.2 million, $1.0 million and $1.0 million in incentive fees related to pre-incentive fee net investment income. For the year ended February 28, 2015, we accrued of $0.3 million in incentive fees related to capital gains. For the year ended February 28, 2014, there was a reduction of $0.1 million in incentive fees related to capital gains. For the year ended February 28, 2013, we accrued $1.6 million in incentive management fees related to capital gains. The accrual is calculated using both realized and unrealized capital gains for the period. The actual incentive fee related to capital gains will be determined and payable in arrears at the end of the fiscal year and will include only realized capital gains for the period. As of February 28, 2015, the base management fees accrual was $1.0 million and the incentive fees accrual was $4.8 million and is included in base management and incentive fees payable in the accompanying consolidated statements of assets and liabilities. As of February 28, 2014, the base management fees accrual was $0.9 million and the incentive fees accrual was $4.5 million and is included in base management and incentive fees payable in the accompanying consolidated statements of assets and liabilities.

On July 30, 2010, the Company entered into a separate administration agreement (the “Administration Agreement”) with our Manager, pursuant to which our Manager, as our administrator, has agreed to furnish us with the facilities and administrative services necessary to conduct our day-to-day operations and provide managerial assistance on our behalf to those portfolio companies to which we are required to provide such assistance. The initial term of the Administration Agreement is two years, with automatic, one-year renewals at the end of each year subject to certain approvals by our board of directors and/or our stockholders. The amount of expenses payable or reimbursable thereunder by the Company is capped at $1.0 million for the initial two year term of the administration agreement. On July 10, 2014, our board of directors approved the renewal of the Administration Agreement for an additional one-year term and determined to maintain the cap on the payment or reimbursement of expenses by the Company thereunder to $1.0 million for the additional one-year term.

For the years ended February 28, 2015, February 28, 2014 and February 28, 2013, we recognized $1.0 million, $1.0 million and $1.0 million, in administrator expenses for the periods, respectively, pertaining to bookkeeping, record keeping and other administrative services provided to us in addition to our allocable portion of rent and other overhead related expenses. As of February 28, 2015, $0.4 million of administrator expenses were accrued and included in due to manager in the accompanying consolidated statements of assets and liabilities. As of February 28, 2014, $0.4 million of administrator expenses were accrued and included in due to manager in the accompanying consolidated statements of assets and liabilities. For the years ended February 28, 2015, 2014 and 2013, the Company bought investments fair valued at $0.0 million, $0.3 million, and $0.0 million, respectively, from the Saratoga CLO and sold no investments to related parties.

Note 7. Borrowings

Credit Facility

As a BDC, we are only allowed to employ leverage to the extent that our asset coverage, as defined in the 1940 Act, equals at least 200.0% after giving effect to such leverage. The amount of leverage that we employ at any time depends on our assessment of the market and other factors at the time of any proposed borrowing.

On April 11, 2007, we entered into a $100.0 million revolving securitized credit facility (the “Revolving Facility”). On May 1, 2007, we entered into a $25.7 million term securitized credit facility (the “Term Facility” and, together with the Revolving Facility, the “Facilities”), which was fully drawn at closing. In December 2007,

 

S-166


Table of Contents

we consolidated the Facilities by using a draw under the Revolving Facility to repay the Term Facility. In response to the market wide decline in financial asset prices, which negatively affected the value of our portfolio, we terminated the revolving period of the Revolving Facility effective January 14, 2009 and commenced a two-year amortization period during which all principal proceeds from the collateral was used to repay outstanding borrowings. A significant percentage of our total assets had been pledged under the Revolving Facility to secure our obligations thereunder. Under the Revolving Facility, funds were borrowed from or through certain lenders and interest was payable monthly at the greater of the commercial paper rate and our lender’s prime rate plus 4.00% plus a default rate of 2.00% or, if the commercial paper market was unavailable, the greater of the prevailing LIBOR rates and our lender’s prime rate plus 6.00% plus a default rate of 3.00%.

In March 2009, we amended the Revolving Facility to increase the portion of the portfolio that could be invested in “CCC” rated investments in return for an increased interest rate and expedited amortization. As a result of these transactions, we expected to have additional cushion under our borrowing base under the Revolving Facility that would allow us to better manage our capital in times of declining asset prices and market dislocation.

On July 30, 2009, we exceeded the permissible borrowing limit under the Revolving Facility for 30 consecutive days, resulting in an event of default under the Revolving Facility. As a result of this event of default, our lender had the right to accelerate repayment of the outstanding indebtedness under the Revolving Facility and to foreclose and liquidate the collateral pledged thereunder. Acceleration of the outstanding indebtedness and/or liquidation of the collateral could have had a material adverse effect on our liquidity, financial condition and operations.

On July 30, 2010, we used the net proceeds from (i) the stock purchase transaction and (ii) a portion of the funds available to us under the $45.0 million senior secured revolving credit facility (the “Credit Facility”) with Madison Capital Funding LLC, in each case, described in “Note 14. Recapitalization Transaction” below, to pay the full amount of principal and accrued interest, including default interest, outstanding under the Revolving Facility. As a result, the Revolving Facility was terminated in connection therewith. Substantially all of our total assets, other than those held by SBIC LP, have been pledged under the Credit Facility to secure our obligations thereunder.

On February 24, 2012, we amended our senior secured revolving credit facility with Madison Capital Funding LLC to, among other things:

 

    expand the borrowing capacity under the credit facility from $40.0 million to $45.0 million;

 

    extend the period during which we may make and repay borrowings under the credit facility from July 30, 2013 to February 24, 2015 (the “Revolving Period”). The Revolving Period may upon the occurrence of an event of default, by action of the lenders or automatically. All borrowings and other amounts payable under the credit facility are due and payable five years after the end of the Revolving Period; and

 

    remove the condition that we may not acquire additional loan assets without the prior written consent of Madison Capital Funding LLC.

On September 17, 2014, we entered into a second amendment to the Revolving Facility with Madison Capital Funding LLC to, among other things:

 

    extend the commitment termination date from February 24, 2015 to September 17, 2017;

 

    extend the maturity date of the Revolving Facility from February 24, 2020 to September 17, 2022 (unless terminated sooner upon certain events);

 

    reduce the applicable margin rate on base rate borrowings from 4.50% to 3.75%, and on LIBOR borrowings from 5.50% to 4.75%; and

 

    reduce the floor on base rate borrowings from 3.00% to 2.25%; and on LIBOR borrowings from 2.00% to 1.25%.

 

S-167


Table of Contents

As of February 28, 2015, there was $9.6 million outstanding under the Credit Facility and the Company was in compliance with all of the limitations and requirements of the Credit Facility. $2.7 million of financing costs related to the Credit Facility have been capitalized and are being amortized over the term of the facility. For the years ended February 28, 2015, February 28, 2014 and February 28, 2013, we recorded $0.9 million, $1.0 million and $2.0 million of interest expense, respectively. For the years ended February 28, 2015, February 28, 2014 and February 28, 2013, we recorded $0.3 million, $0.4 million and $0.4 million of amortization of deferred financing costs related to the Credit Facility and Revolving Facility, respectively. The interest rates during the years ended February 28, 2015, February 28, 2014 and February 28, 2013 on the outstanding borrowings under the Credit Facility were 6.00%, 7.50% and 7.50%, respectively.

The Credit Facility contains limitations as to how borrowed funds may be used, such as restrictions on industry concentrations, asset size, weighted average life, currency denomination and collateral interests. The Credit Facility also includes certain requirements relating to portfolio performance, the violation of which could result in the limit of further advances and, in some cases, result in an event of default, allowing the lenders to accelerate repayment of amounts owed thereunder. The Credit Facility has an eight year term, consisting of a three year period (the “Revolving Period”), under which the Company may make and repay borrowings, and a final maturity five years from the end of the Revolving Period. Availability on the Credit Facility will be subject to a borrowing base calculation, based on, among other things, applicable advance rates (which vary from 50.0% to 75.0% of par or fair value depending on the type of loan asset) and the value of certain “eligible” loan assets included as part of the Borrowing Base. Funds may be borrowed at the greater of the prevailing LIBOR rate and 2.00%, plus an applicable margin of 5.50%. At the Company’s option, funds may be borrowed based on an alternative base rate, which in no event will be less than 3.00%, and the applicable margin over such alternative base rate is 4.50%. In addition, the Company will pay the lenders a commitment fee of 0.75% per year on the unused amount of the Credit Facility for the duration of the Revolving Period.

Our borrowing base under the Credit Facility was $36.3 million subject to the Credit Facility cap of $45.0 million at February 28, 2015. For purposes of determining the borrowing base, most assets are assigned the values set forth in our most recent Annual Report on Form 10-K or Quarterly Report on Form 10-Q filed with the SEC. Accordingly, the February 28, 2015 borrowing base relies upon the valuations set forth in the Quarterly Report on Form 10-Q for the quarter ended November 30, 2014. The valuations presented in this Annual Report on Form 10-K will not be incorporated into the borrowing base until after this Annual Report on Form 10-K is filed with the SEC.

SBA Debentures

SBIC LP is able to borrow funds from the SBA against regulatory capital (which approximates equity capital) that is paid in and is subject to customary regulatory requirements including but not limited to an examination by the SBA. As of February 28, 2015, we have funded SBIC LP with $59.3 million of equity capital, and have $79.0 million of SBA-guaranteed debentures outstanding. SBA debentures are non-recourse to us, have a 10-year maturity, and may be prepaid at any time without penalty. The interest rate of SBA debentures is fixed at the time of issuance, often referred to as pooling, at a market-driven spread over 10-year U.S. Treasury Notes. SBA current regulations limit the amount that SBIC LP may borrow to a maximum of $150.0 million, which is up to twice its potential regulatory capital.

SBICs are designed to stimulate the flow of private equity capital to eligible small businesses. Under SBA regulations, SBICs may make loans to eligible small businesses and invest in the equity securities of small businesses. Under present SBA regulations, eligible small businesses include businesses that have a tangible net worth not exceeding $19.5 million and have average annual fully taxed net income not exceeding $6.5 million for the two most recent fiscal years. In addition, an SBIC must devote 25.0% of its investment activity to “smaller” concerns as defined by the SBA. A smaller concern is one that has a tangible net worth not exceeding $6.0 million and has average annual fully taxed net income not exceeding $2.0 million for the two most recent fiscal years. SBA regulations also provide alternative size standard criteria to determine eligibility, which depend

 

S-168


Table of Contents

on the industry in which the business is engaged and are based on such factors as the number of employees and gross sales. According to SBA regulations, SBICs may make long-term loans to small businesses, invest in the equity securities of such businesses and provide them with consulting and advisory services.

SBIC LP is subject to regulation and oversight by the SBA, including requirements with respect to maintaining certain minimum financial ratios and other covenants. Receipt of an SBIC license does not assure that SBIC LP will receive SBA guaranteed debenture funding, which is dependent upon SBIC LP continuing to be in compliance with SBA regulations and policies. The SBA, as a creditor, will have a superior claim to SBIC LP’s assets over our stockholders and debtholders in the event we liquidate SBIC LP or the SBA exercises its remedies under the SBA-guaranteed debentures issued by SBIC LP upon an event of default.

The Company received exemptive relief from the Securities and Exchange Commission to permit it to exclude the debt of SBIC LP guaranteed by the SBA from the definition of senior securities in the 200.0% asset coverage test under the 1940 Act. This allows the Company increased flexibility under the 200.0% asset coverage test by permitting it to borrow up to $150.0 million more than it would otherwise be able to absent the receipt of this exemptive relief.

As of February 28, 2015 and February 28, 2014, there was $79.0 million and $50.0 million outstanding of SBA debentures, respectively. The carrying amount of the amount outstanding of SBA debentures approximates its fair value. $3.0 million of financing costs related to the SBA debentures have been capitalized and are being amortized over the term of the commitment and drawdown. For the years ended February 28, 2015 and February 28, 2014, we recorded $2.0 million and $1.3 million of interest expense related to the SBA debentures, respectively. For the years ended February 28, 2015 and February 28, 2014, we recorded $0.3 million and $0.2 million of amortization of deferred financing costs related to the SBA debentures, respectively. The weighted average interest rate during the years ended February 28, 2015 and February 28, 2014 on the outstanding borrowings of the SBA debentures was 2.93% and 3.03%, respectively.

Notes

On May 10, 2013, the Company issued $42.0 million in aggregate principal amount of 7.50% fixed-rate notes due 2020 (the “Notes”). The Notes will mature on May 31, 2020, and may be redeemed in whole or in part at any time or from time to time at the Company’s option on or after May 31, 2016. Interest will be payable quarterly beginning August 15, 2013.

On May 17, 2013, the Company closed an additional $6.3 million in aggregate principal amount of the Notes, pursuant to the full exercise of the underwriters’ option to purchase additional Notes.

As of February 28, 2015, the carrying amount and fair value of the Notes was $48.3 million and $49.8 million, respectively. The fair value of the Notes, which are publicly traded, is based upon closing market quotes as of the measurement date and would be classified as a level 1 liability within the fair value hierarchy. As of February 28, 2015, $2.5 million of financing costs related to the Notes have been capitalized and are being amortized over the term of the Notes. For the year ended February 28, 2015, we recorded $3.6 million of interest expense and $0.3 million of amortization of deferred financing costs related to the Notes.

 

S-169


Table of Contents

Note 8. Commitments and contingencies

Contractual obligations

The following table shows our payment obligations for repayment of debt and other contractual obligations at February 28, 2015:

 

            Payment Due by Period  
     Total      Less Than
1 Year
     1 - 3
Years
     3 - 5
Years
     More Than
5 Years
 
($ in thousands)            

Long-Term Debt Obligations

   $ 136,900       $ —         $ —         $ —         $ 136,900   
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Off-balance sheet arrangements

The Company’s off-balance sheet arrangements consisted of $11.2 million and $12.2 million of unfunded commitments to provide debt financing to its portfolio companies or to fund limited partnership interests as of February 28, 2015 and 2014, respectively. Such commitments are generally up to the Company’s discretion to approve, or the satisfaction of certain financial and nonfinancial covenants and involve, to varying degrees, elements of credit risk in excess of the amount recognized in the Company’s Consolidated Statement of Assets and Liabilities and are not reflected in the Company’s Consolidated Statements of Assets and Liabilities.

A summary of the composition of the unfunded commitments as of February 28, 2015 and 2014 is shown in the table below (dollars in thousands):

 

     As of  
     February 28,
2015
     February 28,
2014
 

Bristol Hospice, LLC

   $ 7,500       $ 7,500   

HMN Holdco, LLC

     2,400         —     

Avionte Holdings, LLC

     1,000         1,000   

Knowland Technology Holdings, L.L.C.

     300         —     

Easy Ice, LLC

     —           3,000   

Oceans Acquisition, Inc.

     —           500   

Community Investors, Inc.

     —           167   
  

 

 

    

 

 

 

Total

$ 11,200    $ 12,167   
  

 

 

    

 

 

 

Note 9. Directors Fees

The independent directors receive an annual fee of $40,000. They also receive $2,500 plus reimbursement of reasonable out-of-pocket expenses incurred in connection with attending each board meeting and receive $1,000 plus reimbursement of reasonable out-of-pocket expenses incurred in connection with attending each committee meeting. In addition, the chairman of the Audit Committee receives an annual fee of $5,000 and the chairman of each other committee receives an annual fee of $2,000 for their additional services in these capacities. In addition, we have purchased directors’ and officers’ liability insurance on behalf of our directors and officers. Independent directors have the option to receive their directors’ fees in the form of our common stock issued at a price per share equal to the greater of net asset value or the market price at the time of payment. No compensation is paid to directors who are “interested persons” of the Company (as such term is defined in the 1940 Act). For the years ended February 28, 2015, February 28, 2014, and February 28, 2013, we accrued $0.2 million, $0.2 million, and $0.2 million for directors’ fees expense, respectively. As of February 28, 2015 and February 28, 2014, $0.02 million and $0.05 million in directors’ fees expense were unpaid and included in accounts payable and accrued expenses in the consolidated statements of assets and liabilities. As of February 28, 2015, we had not issued any common stock to our directors as compensation for their services.

 

S-170


Table of Contents

Note 10. Stockholders’ Equity

On May 16, 2006, GSC Group, Inc. capitalized the LLC, by contributing $1,000 in exchange for 67 shares, constituting all of the issued and outstanding shares of the LLC.

On March 20, 2007, the Company issued 95,995.5 and 8,136.2 shares of common stock, priced at $150.00 per share, to GSC Group and certain individual employees of GSC Group, respectively, in exchange for the general partnership interest and a limited partnership interest in GSC Partners CDO III GP, LP, collectively valued at $15.6 million. At this time, the 6.7 shares owned by GSC Group in the LLC were exchanged for 6.7 shares of the Company.

On March 28, 2007, the Company completed its IPO of 725,000 shares of common stock, priced at $150.00 per share, before underwriting discounts and commissions. Total proceeds received from the IPO, net of $7.1 million in underwriter’s discount and commissions, and $1.0 million in offering costs, were $100.7 million.

On November 13, 2009, we declared a dividend of $18.25 per share payable on December 31, 2009. Shareholders had the option to receive payment of the dividend in cash, shares of common stock, or a combination of cash and shares of common stock, provided that the aggregate cash payable to all shareholders was limited to $2.1 million or $2.50 per share. Based on shareholder elections, the dividend consisted of $2.1 million in cash and 864,872.5 of newly issued shares of common stock.

On July 30, 2010, our Manager and its affiliates purchased 986,842 shares of common stock at $15.20 per share. Total proceeds received from this sale were $15.0 million. See “Note 14. Recapitalization Transaction.”

On August 12, 2010, we effected a one-for-ten reverse stock split of our outstanding common stock. As a result of the reverse stock split, every ten shares of our common stock were converted into one share of our common stock. Any fractional shares received as a result of the reverse stock split were redeemed for cash. The total cash payment in lieu of shares was $230. Immediately after the reverse stock split, we had 2,680,842 shares of our common stock outstanding.

On November 12, 2010, we declared a dividend of $4.40 per share payable on December 29, 2010. Shareholders had the option to receive payment of the dividend in cash, shares of common stock, or a combination of cash and shares of common stock, provided that the aggregate cash payable to all shareholders was limited to approximately $1.2 million or $0.44 per share. Based on shareholder elections, the dividend consisted of approximately $1.2 million in cash and 596,235 shares of common stock.

On November 15, 2011, we declared a dividend of $3.00 per share payable on December 30, 2011. Shareholders had the option to receive payment of the dividend in cash, shares of common stock, or a combination of cash and shares of common stock, provided that the aggregate cash payable to all shareholders was limited to approximately $2.0 million or $0.60 per share. Based on shareholder elections, the dividend consisted of approximately $2.0 million in cash and 599,584 shares of common stock.

On November 9, 2012, the Company declared a dividend of $4.25 per share payable on December 31, 2012. Shareholders had the option to receive payment of the dividend in cash, shares of common stock, or a combination of cash and shares of common stock, provided that the aggregate cash payable to all shareholders was limited to approximately $3.3 million or $0.85 per share. Based on shareholder elections, the dividend consisted of approximately $3.3 million in cash and 853,455 shares of common stock.

On October 30, 2013, the Company declared a dividend of $2.65 per share payable on December 27, 2013. Shareholders had the option to receive payment of the dividend in cash, shares of common stock, or a combination of cash and shares of common stock, provided that the aggregate cash payable to all shareholders was limited to approximately $2.5 million or $0.53 per share. Based on shareholder elections, the dividend consisted of approximately $2.5 million in cash and 649,500 shares of common stock.

 

S-171


Table of Contents

On September 24, 2014, the Company declared a dividend of $0.18 per share payable on November 28, 2014. Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock pursuant to the Company’s DRIP. Based on shareholder elections, the dividend consisted of approximately $0.6 million in cash and 22,283 newly issued shares of common stock.

On September 24, 2014, the Company declared a dividend of $0.22 per share payable on February 27, 2015. Shareholders have the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant our DRIP. Based on shareholder elections, the dividend consisted of approximately $0.8 million in cash and 26,858 newly issued shares of common stock.

On September 24, 2014, the Company announced the approval of an open market share repurchase plan that allows it to repurchase up to 200,000 shares of its common stock at prices below its NAV as reported in its then most recently published financial statements. As of February 28, 2015, the Company had not purchased any shares of common stock pursuant to this repurchase plan.

Note 11. Earnings Per Share

In accordance with the provisions of FASB ASC 260, “Earnings per Share” (“ASC 260”), basic earnings per share is computed by dividing earnings available to common shareholders by the weighted average number of shares outstanding during the period. Other potentially dilutive common shares, and the related impact to earnings, are considered when calculating earnings per share on a diluted basis.

The following information sets forth the computation of the weighted average basic and diluted net decrease in net assets per share from operations for the years ended February 28, 2015, February 28, 2014, and February 28, 2013 (dollars in thousands except share and per share amounts):

 

Basic and diluted

   February 28,
2015
     February 28,
2014
     February 28,
2013
 

Net increase in net assets from operations

   $ 11,007       $ 8,497       $ 14,044   

Weighted average common shares outstanding

     5,385,049         4,920,517         4,110,484   

Earnings per common share-basic and diluted

   $ 2.04       $ 1.73       $ 3.42   

Note 12. Dividend

On September 24, 2014, the Company declared a dividend of $0.22 per share payable on February 27, 2015. Shareholders have the option to receive payment of the dividend in cash, or receive shares of common stock pursuant to the Company’s DRIP. Based on shareholder elections, the dividend consisted of approximately $0.8 million in cash and 26,858 newly issued shares of common stock, or 0.5% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $14.97 per share, which equaled the volume weighted average trading price per share of the common stock on February 13, 17, 18, 19, 20, 23, 24, 25, 26 and 27, 2015.

On September 24, 2014, the Company declared a dividend of $0.18 per share payable on November 28, 2014. Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock pursuant to the Company’s DRIP. Based on shareholder elections, the dividend consisted of approximately $0.6 million in cash and 22,283 newly issued shares of common stock, or 0.4% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $14.37 per share, which equaled the volume weighted average trading price per share of the common stock on November 14, 17, 18, 19, 20, 21, 24, 25, 26 and 28, 2014.

On October 30, 2013, the Company declared a dividend of $2.65 per share payable on December 27, 2013. Shareholders had the option to receive payment of the dividend in cash, shares of common stock, or a combination of cash and shares of common stock, provided that the aggregate cash payable to all shareholders

 

S-172


Table of Contents

was limited to approximately $2.5 million or $0.53 per share. This dividend was declared in reliance on certain private letter rulings issued by the IRS concluding that a RIC may treat a distribution of its own stock as fulfilling its RIC distribution requirements if each stockholder may elect to receive his or her entire distribution in either cash or stock of the RIC subject to a limitation on the aggregate amount of cash to be distributed to all stockholders, which limitation must be at least 20.0% of the aggregate declared distribution.

Based on shareholder elections, the dividend consisted of approximately $2.5 million in cash and 649,500 shares of common stock, or 13.7% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $15.439 per share, which equaled the volume weighted average trading price per share of the common stock on December 11, 13, and 16, 2013.

On November 9, 2012, the Company declared a dividend of $4.25 per share payable on December 31, 2012. Shareholders had the option to receive payment of the dividend in cash, shares of common stock, or a combination of cash and shares of common stock, provided that the aggregate cash payable to all shareholders was limited to approximately $3.3 million or $0.85 per share.

Based on shareholder elections, the dividend consisted of approximately $3.3 million in cash and 853,455 shares of common stock, or 22.0% of our outstanding common stock prior to the dividend payment. The amount of cash elected to be received was greater than the cash limit of 20.0% of the aggregate dividend amount, thus resulting in the payment of a combination of cash and stock to shareholders who elected to receive cash. The number of shares of common stock comprising the stock portion was calculated based on a price of $15.444 per share, which equaled the volume weighted average trading price per share of the common stock on December 14, 17, and 19, 2012.

On November 15, 2011, we declared a dividend of $3.00 per share payable on December 30, 2011. Shareholders had the option to receive payment of the dividend in cash, shares of common stock, or a combination of cash and shares of common stock, provided that the aggregate cash payable to all shareholders was limited to approximately $2.0 million or $0.60 per share.

Based on shareholder elections, the dividend consisted of approximately $2.0 million in cash and 599,584 shares of common stock, or 18.0% of our outstanding common stock prior to the dividend payment. The amount of cash elected to be received was greater than the cash limit of 20.0% of the aggregate dividend amount, thus resulting in the payment of a combination of cash and stock to shareholders who elected to receive cash. The number of shares of common stock comprising the stock portion was calculated based on a price of $13.1171 per share, which equaled the volume weighted average trading price per share of the common stock on December 20, 21 and 22, 2011.

On November 12, 2010, we declared a dividend of $4.40 per share payable on December 23, 2010. Shareholders had the option to receive payment of the dividend in cash, shares of common stock, or a combination of cash and shares of common stock, provided that the aggregate cash payable to all shareholders was limited to approximately $1.2 million or $0.44 per share.

Based on shareholder elections, the dividend consisted of approximately $1.2 million in cash and 596,235 shares of common stock, or 22.0% of our outstanding common stock prior to the dividend payment. The amount of cash elected to be received was greater than the cash limit of 10.0% of the aggregate dividend amount, thus resulting in the payment of a combination of cash and stock to shareholders who elected to receive cash. The number of shares of common stock comprising the stock portion was calculated based on a price of $17.8049 per share, which equaled the volume weighted average trading price per share of the common stock on December 20, 21 and 22, 2010. The financial statements for the period ended November 30, 2010 have been retroactively adjusted to reflect the increase in common stock as a result of the dividend in accordance with the provisions of ASC 505-20-S50 regarding disclosure of a capital structure change after the interim balance sheet but before the release of the financial statements.

 

S-173


Table of Contents

The following tables summarize dividends declared during the years ended February 28, 2015, February 28, 2014, February 28, 2013, February 29, 2012 and February 28, 2011 (dollars in thousands except per share amounts):

 

Date Declared

  

Record Date

  

Payment Date

   Amount
Per Share*
     Total
Amount
 

September 24, 2014

   October 30, 2014    November 28, 2014    $ 0.18       $ 968   

September 24, 2014

   January 29, 2015    February 27, 2015    $ 0.22       $ 1,189   
        

 

 

    

 

 

 

Total dividends declared

$ 0.40    $ 2,157   
        

 

 

    

 

 

 

 

Date Declared

  

Record Date

  

Payment Date

   Amount
Per Share*
     Total
Amount
 

October 30, 2013

   November 13, 2013    December 27, 2013    $ 2.65       $ 12,535   
        

 

 

    

 

 

 

Total dividends declared

$ 2.65    $ 12,535   
        

 

 

    

 

 

 

 

Date Declared

  

Record Date

  

Payment Date

   Amount
Per Share*
     Total
Amount
 

November 9, 2012

   November 20, 2012    December 31, 2012    $ 4.25       $ 16,476   
        

 

 

    

 

 

 

Total dividends declared

$ 4.25    $ 16,476   
        

 

 

    

 

 

 

 

Date Declared

  

Record Date

  

Payment Date

   Amount
Per Share*
     Total
Amount
 

November 15, 2011

   November 25, 2011    December 30, 2011    $ 3.00       $ 9,831   
        

 

 

    

 

 

 

Total dividends declared

$ 3.00    $ 9,831   
        

 

 

    

 

 

 

 

Date Declared

  

Record Date

  

Payment Date

   Amount
Per Share*
     Total
Amount
 

November 12, 2010

   November 19, 2010    December 29, 2010    $ 4.40       $ 11,796   
        

 

 

    

 

 

 

Total dividends declared

$ 4.40    $ 11,796   
        

 

 

    

 

 

 

 

* Amount per share is calculated based on the number of shares outstanding at the date of declaration.

 

S-174


Table of Contents

Note 13. Financial Highlights –

The following is a schedule of financial highlights for the years ended February 28, 2015, February 28, 2014, February 28, 2013, February 29, 2012, and February 28, 2011:

 

     February 28,
2015
    February 28,
2014
    February 28,
2013
    February 29,
2012
    February 28,
2011
 

Per share data:

        

Net asset value at beginning of period

   $ 21.08      $ 22.71      $ 24.94      $ 26.20      $ 32.75   

Net investment income(1)

     1.80        1.80        1.57        1.52        2.06   

Net realized and unrealized gains and losses on investments and derivatives

     0.24        (0.07     1.85        2.21        4.80   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase in net assets from operations

  2.04      1.73      3.42      3.73      6.86   

Distributions declared from net investment income

  (0.40   (2.65   (4.25   (3.00   (4.40

Distributions declared from net realized capital gains

  —        —        —        —        —     
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total distributions to stockholders

  (0.40   (2.65   (4.25   (3.00   (4.40

Other(5)

  (0.02   (0.71   (1.40   (1.99   (9.01

Net asset value at end of period

$ 22.70    $ 21. 08    $ 22.71    $ 24.94    $ 26.20   

Net assets at end of period

$ 122,598,742    $ 113,427,929    $ 107,437,874    $ 96,689,122    $ 85,844,605   

Shares outstanding at end of period

  5,401,899      5,379,616      4,730,116      3,876,661      3,277,077   

Per share market value at end of period

$ 15.76    $ 15.85    $ 17.02    $ 15.88    $ 17.58   

Total return based on market value(2)

  1.63   9.11   36.67   12.82   38.25

Total return based on net asset
value(3)

  10.09   8.75   16.12   16.98   (0.07 )% 

Ratio/Supplemental data:

Ratio of net investment income to average, net assets(4)

  8.11   7.97   6.26   5.64   6.58

Ratio of operating expenses to average net assets(4)

  6.52   6.28   5.22   5.66   12.02

Ratio of incentive management fees to average net assets

  2.14   0.84   2.52   1.85   2.75

Ratio of credit facility related expenses to average net assets

  6.19   5.46   2.46   1.40   3.42

Ratio of total expenses to average net assets(4)

  14.85   12.59   10.19   8.91   11.99

Portfolio turnover rate(6)

  31.28   37.82   17.30   36.34   10.14

As described in Note 2 to the consolidated financial statements and notes thereto, we identified errors that impacted the years ended February 28, 2014, February 28, 2013, February 29, 2012 and February 28, 2011. The corrections for the errors, which we have concluded are immaterial to all prior period consolidated financial statements, are reflected in the consolidated financial statements and selected financial data included in this Form 10-K.

 

S-175


Table of Contents

 

(1) Net investment income per share is calculated using the weighted average shares outstanding during the period. Net investment income excluding expense waiver and reimbursement equals $2.05 per share for the year ended February 28, 2011.
(2) Total investment return is calculated assuming a purchase of common shares at the current market value on the first day and a sale at the current market value on the last day of the periods reported. Dividends and distributions, if any, are assumed for purposes of this calculation to be reinvested at prices obtained under the Company’s dividend reinvestment plan. Total investment return does not reflect brokerage commissions. Total investment returns covering less than a full period are not annualized.
(3) Total investment return is calculated assuming a purchase of common shares at the current net asset value on the first day and a sale at the current net asset value on the last day of the periods reported. Dividends and distributions, if any, are assumed for purposes of this calculation to be reinvested at prices obtained under the Company’s dividend reinvestment plan. Total investment return does not reflect brokerage commissions.
(4) For the year ended February 28, 2011, net of the expense waiver and reimbursement arrangement, the ratio of net investment income, operating expenses, total expenses to average net assets is 6.24%, 12.36%, and 12.33%, respectively.
(5) Represents the dilutive effect of issuing common stock below net asset value per share during the period in connection with the satisfaction of the Company’s annual RIC distribution requirement. See Note 12, Dividend.
(6) Portfolio turnover rate is calculated using the lesser of year-to-date sales or year-to-date purchases over the average of the invested assets at fair value.

Note 14. Selected Quarterly Data (Unaudited)

 

     2015  

($ in thousands, except per share numbers)

   Qtr 4     Qtr 3      Qtr 2      Qtr 1  

Interest and related portfolio income

   $ 7,451      $ 7,305       $ 6,475       $ 6,144   

Net investment income

     2,889        2,629         2,093         2,063   

Net realized and unrealized gain (loss)

     (184     756         1,064         (303

Net increase in net assets resulting from operations

     2,705        3,385         3,157         1,760   

Net investment income per common share at end of each quarter

   $ 0.50      $ 0.49       $ 0.39       $ 0.38   

Net realized and unrealized gain (loss) per common share at end of each quarter

   $ (0.03   $ 0.14       $ 0.20       $ (0.06

Dividends declared per common share

   $ 0.22      $ 0.18       $ —         $ —     

Net asset value per common share

   $ 22.70      $ 22.45       $ 22.00       $ 21.41   

 

     2014  

($ in thousands, except per share numbers)

   Qtr 4      Qtr 3     Qtr 2     Qtr 1  

Interest and related portfolio income

   $ 5,687       $ 5,801      $ 5,388      $ 6,018   

Net investment income

     1,525         2,407        2,629        2,313   

Net realized and unrealized gain (loss)

     2,236         (1,630     (2,313     1,330   

Net increase (decrease) in net assets resulting from operations

     3,761         777        316        3,644   

Net investment income per common share at end of each quarter

   $ 0.28       $ 0.50      $ 0.56      $ 0.49   

Net realized and unrealized gain (loss) per common share at end of each quarter

   $ 0.42       $ (0.34   $ (0.49   $ 0.28   

Dividends declared per common share

   $ —         $ 2.65      $ —        $ —     

Net asset value per common share

   $ 21.08       $ 20.39      $ 23.55      $ 23.48   

 

S-176


Table of Contents
     2013  

($ in thousands, except per share numbers)

   Qtr 4      Qtr 3     Qtr 2      Qtr 1  

Interest and related portfolio income

   $ 5,191       $ 4,034      $ 4,163       $ 3,619   

Net investment income

     1,779         2,343        1,179         1,169   

Net realized and unrealized gain (loss)

     3,843         (1,744     3,557         1,918   

Net increase in net assets resulting from operations

     5,623         599        4,735         3,087   

Net investment income per common share at end of each quarter

   $ 0.38       $ 0.59      $ 0.30       $ 0.30   

Net realized and unrealized gain (loss) per common share at end of each quarter

   $ 0.81       $ (0.44   $ 0.92       $ 0.49   

Dividends declared per common share

   $ —         $ 4.25      $ —         $ —     

Net asset value per common share

   $ 22.71       $ 21.52      $ 26.96       $ 25.74   

As described in Note 2 to the consolidated financial statements and notes thereto, we identified errors that impacted the years ended February 28, 2014, February 28, 2013, February 29, 2012 and February 28, 2011. The corrections for the errors, which we have concluded are immaterial to all prior period consolidated financial statements, are reflected in the consolidated financial statements and selected financial data included in this Form 10-K.

Note 15. Subsequent Events

On May 14, 2015, the Company announced that its Board of Directors has declared a special dividend to shareholders of $1.00 per share, payable on June 5, 2015 to all stockholders of record at the close of business on May 26, 2015. Shareholders will have the option to receive payment of the dividend in cash, or receive shares of common stock pursuant to the Company’s DRIP.

On April 9, 2015, the Company declared a dividend of $0.27 per share payable for the fiscal quarter ended February 28, 2015, payable on May 29, 2015 to all stockholders of record at the close of business on May 4, 2015. Shareholders will have the option to receive payment of the dividend in cash, or receive shares of common stock pursuant to the Company’s dividend reinvestment plan.

On April 2, 2015, the SBA issued a “green light” or “go forth” letter inviting us to continue our application process to obtain a license to form and operate its second SBIC subsidiary. If approved, a second SBIC license would provide us an incremental source of long-term capital by permitting us to issue $75 million of additional SBA-guaranteed debentures in addition to the $150 million already approved under the first license. Receipt of a green light letter from the SBA does not assure an applicant that the SBA will ultimately issue an SBIC license and we have received no assurance or indication from the SBA that it will receive an SBIC license, or of the timeframe in which it would receive a license, should one be granted.

 

S-177


Table of Contents

INDEX TO OTHER FINANCIAL STATEMENTS

Saratoga Investment Corp. CLO 2013-1, Ltd.

 

Report of Independent Auditors

     S-179   

Statements of Assets and Liabilities as of February 28, 2015 and 2014

     S-180   

Statements of Operations for the years ended February 28, 2015, February 28, 2014, and February  28, 2013

     S-181   

Schedules of Investments as of February 28, 2015 and 2014

     S-182   

Statements of Changes in Net Assets for the years ended February 28, 2015, February  28, 2014 and February 28, 2013

     S-195   

Statements of Cash Flows for the years ended February 28, 2015, February 28, 2014 and February  28, 2013

     S-196   

Notes to Financial Statements

     S-197   

IMPORTANT NOTE

In accordance with certain SEC rules, Saratoga Investment Corp. (the “Company”) is providing additional information regarding one of its portfolio companies, Saratoga Investment Corp. CLO 2013-1, Ltd. (“Saratoga CLO”). The Company owns 100% of the subordinated notes of the Saratoga CLO. The additional financial information regarding the Saratoga CLO does not directly impact the Company’s financial position, results of operations or cash flows.

 

S-178


Table of Contents

Report of Independent Auditors

The Collateral Manager and Directors,

Saratoga Investment Corp. CLO 2013-1, Ltd.

We have audited the accompanying financial statements of Saratoga Investment Corp. CLO 2013-1, Ltd., which comprise the statements of assets and liabilities, as of February 28, 2015 and February 28, 2014, including the schedules of investments, and the statements of operations, changes in net assets and cash flows for the years ended February 28, 2015, February 28, 2014 and February 28, 2013, and the related notes to the financial statements.

Management’s Responsibility for the Financial Statements

Management is responsible for the preparation and fair presentation of these financial statements in conformity with U.S. generally accepted accounting principles; this includes the design, implementation, and maintenance of internal control relevant to the preparation and fair presentation of financial statements that are free of material misstatement, whether due to fraud or error.

Auditor’s Responsibility

Our responsibility is to express an opinion on these financial statements based on our audits. We conducted our audits in accordance with auditing standards generally accepted in the United States. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement.

An audit involves performing procedures to obtain audit evidence about the amounts and disclosures in the financial statements. The procedures selected depend on the auditor’s judgment, including the assessment of the risks of material misstatement of the financial statements, whether due to fraud or error. In making those risk assessments, the auditor considers internal control relevant to the entity’s preparation and fair presentation of the financial statements in order to design audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the entity’s internal control. Accordingly, we express no such opinion. An audit also includes evaluating the appropriateness of accounting policies used and the reasonableness of significant accounting estimates made by management, as well as evaluating the overall presentation of the financial statements.

We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our audit opinion.

Opinion

In our opinion, the financial statements referred to above present fairly, in all material respects, the financial position of Saratoga Investment Corp. CLO 2013-1, Ltd. at February 28, 2015 and February 28, 2014, and the results of its operations, changes in its net assets and its cash flows for the years ended February 28, 2015, February 28, 2014 and February 28, 2013, in conformity with U.S. generally accepted accounting principles.

/s/ Ernst & Young

May 20, 2015

 

S-179


Table of Contents

Saratoga Investment Corp. CLO 2013-1, Ltd.

Statements of Assets and Liabilities

 

     As of  
     February 28, 2015     February 28, 2014  

ASSETS

    

Investments

    

Fair value loans (amortized cost of $295,193,588 and $299,137,566, respectively)

   $ 294,621,817      $ 300,491,077   

Fair value other/structured finance securities (amortized cost of $2,566,752 and $0, respectively)

     617,451        —     
  

 

 

   

 

 

 

Total investments at fair value (amortized cost of $297,760,340 and $299,137,566, respectively)

  295,239,268      300,491,077   

Cash and cash equivalents

  5,831,797      8,018,933   

Receivable from open trades

  2,119,687      1,801,266   

Interest receivable

  1,290,637      1,450,952   

Other assets

  —        91,336   
  

 

 

   

 

 

 

Total assets

$ 304,481,389    $ 311,853,564   
  

 

 

   

 

 

 

LIABILITIES

Interest payable

$ 631,886    $ 622,476   

Payable from open trades

  5,214,331      9,445,000   

Accrued base management fee

  85,957      75,053   

Accrued subordinated management fee

  85,957      75,053   

Class X Notes—SIC CLO 2013-1, Ltd.

  —        1,666,666   

Class A-1 Notes—SIC CLO 2013-1, Ltd.

  170,000,000      170,000,000   

Discount on Class A-1 Notes—SIC CLO 2013-1, Ltd.

  (1,495,802   (1,671,864

Class A-2 Notes—SIC CLO 2013-1, Ltd.

  20,000,000      20,000,000   

Discount on Class A-2 Notes—SIC CLO 2013-1, Ltd.

  (155,050   (173,300

Class B Notes—SIC CLO 2013-1, Ltd.

  44,800,000      44,800,000   

Discount on Class B Notes — SIC CLO 2013-1, Ltd.

  (1,007,205   (1,125,757

Class C Notes—SIC CLO 2013-1, Ltd.

  16,000,000      16,000,000   

Discount on Class C Notes—SIC CLO 2013-1, Ltd.

  (627,091   (700,902

Class D Notes—SIC CLO 2013-1, Ltd.

  14,000,000      14,000,000   

Discount on Class D Notes — SIC CLO 2013-1, Ltd.

  (814,013   (909,825

Class E Notes—SIC CLO 2013-1, Ltd.

  13,100,000      13,100,000   

Discount on Class E Notes—SIC CLO 2013-1, Ltd.

  (1,534,650   (1,715,285

Class F Notes—SIC CLO 2013-1, Ltd.

  4,500,000      4,500,000   

Discount on Class F Notes—SIC CLO 2013-1, Ltd.

  (558,180   (623,880

Deferred debt financing costs, SIC CLO 2013-1, Ltd. Notes

  (1,941,595   (2,166,633

Subordinated Notes

  30,000,000      30,000,000   
  

 

 

   

 

 

 

Total liabilities

$ 310,284,545    $ 315,196,802   
  

 

 

   

 

 

 

Commitments and contingencies (See Note 6)

NET ASSETS

Ordinary equity, par value $1.00, 250 ordinary shares authorized, 250 and 250 issued and outstanding, respectively

$ 250    $ 250   

Accumulated gain/(loss)

  (3,343,488   838,567   

Net loss

  (2,459,918   (4,182,055
  

 

 

   

 

 

 

Total net assets

  (5,803,156   (3,343,238
  

 

 

   

 

 

 

Total liabilities and net assets

$ 304,481,389    $ 311,853,564   
  

 

 

   

 

 

 

See accompanying notes to financial statements.

 

S-180


Table of Contents

Saratoga Investment Corp. CLO 2013-1, Ltd.

Statements of Operations

 

     For the year ended
February 28, 2015
    For the year ended
February 28, 2014
    For the year ended
February 28, 2013
 

INVESTMENT INCOME

      

Interest from investments

   $ 13,091,019      $ 15,486,413      $ 19,328,855   

Interest from cash and cash equivalents

     1,446        6,792        16,587   

Other income

     188,180        945,441        967,991   
  

 

 

   

 

 

   

 

 

 

Total investment income

  13,280,645      16,438,646      20,313,433   
  

 

 

   

 

 

   

 

 

 

EXPENSES

Interest expense

  9,635,136      11,678,514      15,613,003   

Professional fees

  219,293      433,073      417,086   

Miscellaneous fee expense

  34,303      175,283      133,794   

Base management fee

  760,102      517,563      400,014   

Subordinated management fee

  760,102      1,257,578      1,600,057   

Trustee expenses

  123,999      83,221      100,820   

Amortization expense

  953,862      994,602      1,015,332   

Loss on extinguishment of debt

  —        3,442,442      —     
  

 

 

   

 

 

   

 

 

 

Total expenses

  12,486,797      18,582,276      19,280,106   
  

 

 

   

 

 

   

 

 

 

NET INVESTMENT INCOME (LOSS)

  793,848      (2,143,630   1,033,327   
  

 

 

   

 

 

   

 

 

 

REALIZED AND UNREALIZED GAIN (LOSS) ON INVESTMENTS:

Net realized gain (loss) on investments

  620,817      (8,815,296   2,532,558   

Net unrealized appreciation/(depreciation) on investments

  (3,874,583   6,776,871      3,235,774   
  

 

 

   

 

 

   

 

 

 

Net gain (loss) on investments

  (3,253,766   (2,038,425   5,768,332   
  

 

 

   

 

 

   

 

 

 

NET INCREASE (DECREASE) IN NET ASSETS RESULTING FROM OPERATIONS

$ (2,459,918 $ (4,182,055 $ 6,801,659   
  

 

 

   

 

 

   

 

 

 

See accompanying notes to financial statements.

 

S-181


Table of Contents

Saratoga Investment Corp. CLO 2013-1 Ltd.

Schedule of Investments

February 28, 2015

 

Issuer Name

  Industry   Asset Name   Asset
Type
  Current
Rate
    Maturity
Date
    Principal/
Number
of Shares
    Cost     Fair Value  

Education Management II LLC

  Leisure Goods/
Activities/Movies
  A-1 Preferred Shares   Equity     0.00       6,692      $ 669,214      $ 437,188   

Education Management II LLC

  Leisure Goods/
Activities/Movies
  A-2 Preferred Shares   Equity     0.00       18,975        1,897,538        180,263   

24 Hour Holdings III LLC

  Leisure Goods/
Activities/Movies
  Term Loan   Loan     4.75     5/28/2021      $ 497,500        493,004        492,276   

Acosta Holdco Inc.

  Media   Term Loan B   Loan     5.00     9/27/2021      $ 1,995,000        1,981,328        2,004,416   

Aderant North America, Inc.

  Business Equipment and
Services
  Term Loan
(First Lien)
  Loan     5.25     12/20/2018      $ 3,260,898        3,260,898        3,240,517   

Advantage Sales & Marketing Inc.

  Business Equipment and
Services
  Delayed Draw
Term Loan
  Loan     4.25     7/25/2021      $ 1,995,000        1,993,940        1,984,287   

AECOM Technology Corporation

  Business Equipment and
Services
  Term Loan B   Loan     3.75     10/15/2021      $ 319,903        318,380        321,304   

Aegis Toxicology Science Corporation

  Healthcare   Term B Loan   Loan     5.50     2/24/2021      $ 995,000        995,000        997,488   

Akorn, Inc.

  Healthcare   Term Loan B   Loan     4.50     4/16/2021      $ 498,750        496,691        500,411   

Albertson’s LLC

  Retailers (Except Food
and Drugs)
  Term Loan B-4   Loan     5.50     8/25/2021      $ 3,410,000        3,389,632        3,437,723   

Alere Inc. (fka IM US Holdings, LLC)

  Healthcare   Incremental B-1
Term Loan
  Loan     4.25     6/30/2017      $ 1,529,610        1,529,610        1,529,610   

American Tire Distributors Inc

  Automotive   Term Loan   Loan     5.75     6/1/2018      $ 496,487        496,486        497,108   

Aramark Corporation

  Food Products   LC-2 Facility   Loan     3.74     7/26/2016      $ 79,187        79,178        78,395   

Aramark Corporation

  Food Products   LC-3 Facility   Loan     3.74     7/26/2016      $ 43,961        43,961        43,521   

Aramark Corporation

  Food Products   U.S. Term F Loan   Loan     3.25     2/24/2021      $ 3,182,489        3,182,489        3,168,581   

ARG IH Corp

  Food Services   Term Loan   Loan     4.75     11/15/2020      $ 495,000        494,038        495,312   

Asurion, LLC (fka Asurion Corporation)

  Insurance   Incremental Tranche
B-1 Term Loan
  Loan     5.00     5/24/2019      $ 5,412,086        5,370,590        5,424,642   

Auction.Com, LLC

  Business Equipment and
Services
  Term Loan A-4   Loan     4.40     2/28/2017      $ 914,567        914,567        905,422   

Avantor Performance Materials Holdings, Inc.

  Chemicals/Plastics   Term Loan   Loan     5.25     6/24/2017      $ 4,319,115        4,309,242        4,297,520   

Avast Software

  Electronics/Electric   Term Loan   Loan     4.75     3/20/2020      $ 1,925,000        1,923,275        1,937,031   

AZ Chem US Inc.

  Chemicals/Plastics   Term Loan   Loan     5.25     6/12/2021      $ 467,123        464,958        466,614   

Bass Pro Group, LLC

  Retailers (Except Food
and Drugs)
  New Term Loan   Loan     3.75     11/20/2019      $ 493,623        493,111        492,236   

Bayonne Energy Center

  Oil & Gas   Term Loan B   Loan     5.00     8/19/2021      $ 969,671        965,093        964,416   

Belmond Hotels

  Lodging & Casinos   Term Loan   Loan     4.00     3/19/2021      $ 496,250        494,055        495,009   

Berry Plastics Corporation

  Chemicals/Plastics   Term E Loan   Loan     3.75     1/6/2021      $ 1,814,499        1,802,403        1,812,648   

Big Heart Pet Brands (fka Del Monte Corporation)

  Food/Drug Retailers   Initial Term Loan   Loan     3.50     3/9/2020      $ 2,977,500        2,996,769        2,971,307   

Biomet, Inc.

  Healthcare   Dollar Term B-2
Loan
  Loan     3.65     7/25/2017      $ 1,840,718        1,840,718        1,838,601   

BJ’s Wholesale Club, Inc.

 

Food/Drug Retailers

  New 2013
(November)
Replacement Loan
(First Lien)
  Loan     4.50     9/26/2019      $ 1,489,975        1,488,922        1,483,374   

Bombardier Recreational Products Inc.

  Leisure Goods/
Activities/Movies
  Term B Loan   Loan     4.00     1/30/2019      $ 754,286        750,287        747,120   

 

S-182


Table of Contents

Issuer Name

  Industry   Asset Name   Asset
Type
  Current
Rate
    Maturity
Date
    Principal/
Number
of Shares
    Cost     Fair Value  

Brickman Group Holdings, Inc.

  Brokers/Dealers/
Investment Houses
  Initial Term Loan
(First Lien)
  Loan     4.00     12/18/2020      $ 1,491,237        1,478,800        1,478,935   

Brock Holdings III, Inc.

  Industrial Equipment   Term Loan
(First Lien)
  Loan     6.00     3/16/2017      $ 1,938,503        1,952,391        1,904,580   

Burlington Coat Factory Warehouse Corporation

  Retailers (Except Food
and Drugs)
  Term B-2 Loan   Loan     4.25     8/13/2021      $ 1,945,000        1,935,814        1,942,219   

BWAY

  Leisure Goods/
Activities/Movies
  Term Loan B   Loan     5.50     8/14/2020      $ 995,000        985,881        998,423   

Caesars Entertainment Corp.

  Lodging & Casinos   Term B-7 Loan   Loan     9.75     1/28/2018      $ 995,000        989,028        917,141   

Camp International Holding Company

  Aerospace and
Defense
  2013 Replacement
Term Loan
(First Lien)
  Loan     4.75     5/31/2019      $ 1,960,046        1,965,495        1,969,846   

Capital Automotive L.P.

  Conglomerate   Tranche B-1 Term
Loan Facility
  Loan     4.00     4/10/2019      $ 2,079,313        2,083,783        2,084,511   

Catalent Pharma Solutions, Inc

  Drugs   Initial Term B Loan   Loan     4.25     5/20/2021      $ 497,500        495,170        498,401   

Celanese US Holdings LLC

  Chemicals/Plastics   Dollar Term C-2
Commitment
  Loan     2.49     10/31/2018      $ 2,154,560        2,180,598        2,157,533   

Cengage Learning

  Publishing   Term Loan   Loan     7.00     3/31/2020      $ 2,731,869        2,761,735        2,733,235   

Charter Communications Operating, LLC

  Cable and Satellite
Television
  Term F Loan   Loan     3.00     12/31/2020      $ 2,655,745        2,646,932        2,646,344   

CHS/Community Health Systems, Inc.

  Healthcare   2017 Term E Loan   Loan     3.49     1/25/2017      $ 1,097,818        1,074,945        1,097,193   

CHS/Community Health Systems, Inc.

  Healthcare   2021 Term D Loan   Loan     4.25     1/27/2021      $ 2,926,052        2,844,886        2,935,210   

Cinedigm Digital Funding I, LLC

  Business Equipment
and Services
  Term Loan   Loan     3.75     2/28/2018      $ 562,001        557,872        561,298   

CITGO Petroleum

  Oil & Gas   Term Loan B   Loan     4.50     7/29/2021      $ 997,500        994,095        979,106   

ClubCorp Club Operations, Inc.

  Lodging & Casinos   Term Loan B   Loan     4.50     7/24/2020      $ 500,000        496,250        500,315   

CPI International Acquisition, Inc. (f/k/a Catalyst Holdings, Inc.)

  Electronics/Electric   Term B Loan   Loan     4.25     11/17/2017      $ 3,595,331        3,595,331        3,570,631   

Crosby US Acquisition Corp.

  Industrial Equipment   Initial Term Loan
(First Lien)
  Loan     3.75     11/23/2020      $ 742,500        741,718        681,244   

Crown Castle Operating Company

 

Telecommunications/
Cellular

  Extended
Incremental
Tranche B-2 Term
Loan
  Loan     3.00     1/31/2021      $ 2,435,594        2,433,546        2,430,723   

CT Technologies Intermediate Hldgs, Inc

  Healthcare   Term Loan
(First Lien)
  Loan     6.00     12/1/2021      $ 1,500,000        1,485,423        1,505,625   

Culligan International Company

  Conglomerate   Dollar Loan
(First Lien)
  Loan     6.25     12/19/2017      $ 779,642        736,275        765,998   

Culligan International Company

  Conglomerate   Dollar Loan
(Second Lien)
  Loan     9.50     6/19/2018      $ 783,162        739,367        727,033   

Cumulus Media Holdings Inc.

  Broadcast Radio and
Television
  Term Loan   Loan     4.25     12/23/2020      $ 470,093        466,100        466,863   

Custom Sensors

  Industrial Equipment   Term Loan   Loan     4.50     9/30/2021      $ 498,750        497,651        498,750   

DaVita HealthCare Partners Inc. (fka DaVita Inc.)

  Healthcare   Tranche B Term
Loan
  Loan     3.50     6/24/2021      $ 497,500        495,228        498,062   

DCS Business Services, Inc.

  Financial
Intermediaries
  Term B Loan   Loan     7.25     3/19/2018      $ 3,460,027        3,436,485        3,413,835   

Dealertrack Technologies, Inc.

  Leisure Goods/
Activities/Movies
  Term B Loan   Loan     3.25     2/26/2021      $ 477,011        475,991        474,230   

Dell International LLC

  Retailers (Except Food
and Drugs)
  Term B Loan   Loan     4.50     4/29/2020      $ 2,969,962        2,957,576        2,980,684   

Delos Finance SARL

  Financial
Intermediaries
  Term Loan   Loan     3.50     3/6/2021      $ 500,000        497,835        499,790   

Delta 2 (Lux) S.a.r.l.

  Lodging & Casinos   Term Loan B-3   Loan     4.75     7/30/2021      $ 1,000,000        995,314        995,630   

Deluxe Entertainment Service Group, Inc.

  Leisure Goods/
Activities/Movies
  Term Loan
(First Lien)
  Loan     6.50     2/28/2020      $ 1,882,983        1,884,624        1,835,908   

 

S-183


Table of Contents

Issuer Name

  Industry   Asset Name   Asset
Type
  Current
Rate
    Maturity
Date
    Principal/
Number
of Shares
    Cost     Fair Value  

Devix US, Inc.

  Chemicals/Plastics   Term Loan   Loan     4.25     5/2/2021      $ 250,000        247,710        250,938   

Devix US, Inc.

  Chemicals/Plastics   Term Loan
(Second Lien)
  Loan     8.00     5/2/2022      $ 497,500        495,324        497,500   

Diamond Resorts International

  Lodging & Casinos   Term Loan   Loan     5.50     5/9/2021      $ 995,000        990,370        999,975   

Dollar Tree

  Retailers (Except Food
and Drugs)
  Term Loan B
(3950MM)
  Loan     4.25     3/9/2022      $ 1,000,000        995,000        1,007,500   

DPX Holdings B.V.

  Healthcare   Term Loan   Loan     4.25     3/11/2021      $ 2,985,000        2,978,605        2,962,075   

Drew Marine Group Inc.

  Chemicals/Plastics   Term Loan
(First Lien)
  Loan     4.50     11/19/2020      $ 1,489,975        1,495,721        1,473,213   

Education Management LLC

  Leisure Goods/
Activities/Movies
  Term Loan A   Loan     5.50     7/2/2020      $ 501,970        482,120        457,295   

Education Management LLC

  Leisure Goods/
Activities/Movies
  Term Loan B   Loan    

 
 

8.5

(2.00% Cash/
6.50% PIK)


  
  

    7/2/2020      $ 836,617        805,283        672,882   

EIG Investors Corp.

  Business Equipment and
Services
  Term Loan   Loan     5.00     11/8/2019      $ 987,500        983,552        989,969   

Emerald Performance Materials, LLC

  Chemicals/Plastics   Term Loan
(First Lien)
  Loan     4.50     8/1/2021      $ 498,750        496,403        496,102   

Emerald Performance Materials, LLC

  Chemicals/Plastics   Term Loan
(Second Lien)
  Loan     7.75     8/1/2022      $ 500,000        497,553        484,845   

EnergySolutions, LLC

  Oil & Gas   Term Loan B   Loan     6.75     5/29/2020      $ 937,857        921,126        942,546   

Enviromental Resources Management

  Business Equipment and
Services
  Term Loan   Loan     5.00     5/14/2021      $ 1,000,000        990,000        985,000   

Evergreen Acqco 1 LP

  Retailers (Except Food
and Drugs)
  New Term
Loan
  Loan     5.00     7/9/2019      $ 975,056        972,887        955,555   

EWT Holdings III Corp. (fka WTG Holdings III Corp.)

  Industrial Equipment   Term Loan
(First Lien)
  Loan     4.75     1/15/2021      $ 1,987,481        1,982,274        1,972,575   

Federal-Mogul Corporation

  Automotive   Tranche C
Term Loan
  Loan     4.75     4/15/2021      $ 2,985,000        2,971,883        2,975,687   

First Data Corporation

  Financial Intermediaries   2017 Second
New Dollar
Term Loan
  Loan     3.74     3/23/2018      $ 2,790,451        2,729,399        2,785,568   

First Data Corporation

  Financial Intermediaries   2018 Dollar
Term Loan
  Loan     4.24     3/24/2021      $ 2,111,028        2,021,476        2,115,777   

Fitness International, LLC

  Leisure Goods/
Activities/Movies
  Term Loan B   Loan     5.50     7/1/2020      $ 1,492,500        1,482,322        1,421,606   

FMG Resources (August 2006) Pty LTD (FMG America Finance, Inc.)

  Nonferrous Metals/
Minerals
  Loan   Loan     3.75     6/28/2019      $ 1,982,462        1,982,212        1,835,423   

Four Seasons Holdings Inc.

  Lodging & Casinos   Term Loan
(First Lien)
  Loan     3.50     6/27/2020      $ 493,750        493,750        491,281   

Garda World Security Corporation

  Business Equipment and
Services
  Term B
Delayed
Draw Loan
  Loan     4.00     11/6/2020      $ 201,157        200,308        199,146   

Garda World Security Corporation

  Business Equipment and
Services
  Term B Loan   Loan     4.00     11/6/2020      $ 786,343        783,060        778,479   

Gardner Denver, Inc.

  Oil & Gas   Initial Dollar
Term Loan
  Loan     4.25     7/30/2020      $ 2,476,212        2,467,608        2,377,164   

Gates Global LLC

  Leisure Goods/
Activities/Movies
  Term Loan
(First Lien)
  Loan     4.25     7/3/2021      $ 498,750        493,763        494,885   

Generac Power Systems, Inc.

  Industrial Equipment   Term Loan B   Loan     3.25     5/29/2020      $ 802,956        789,932        797,182   

General Nutrition Centers, Inc.

  Retailers (Except Food
and Drugs)
  Amended
Tranche B
Term Loan
  Loan     3.25     3/4/2019      $ 4,724,136        4,709,712        4,649,353   

Global Tel*Link Corporation

  Business Equipment and
Services
  Term Loan
(First Lien)
  Loan     5.00     5/26/2020      $ 2,755,515        2,747,025        2,719,914   

Goodyear Tire & Rubber Company, The

  Chemicals/Plastics   Loan (Second
Lien)
  Loan     4.75     4/30/2019      $ 3,333,333        3,296,753        3,347,933   

 

S-184


Table of Contents

Issuer Name

  Industry   Asset Name   Asset
Type
  Current
Rate
    Maturity
Date
    Principal/
Number
of Shares
    Cost     Fair Value  

Grosvenor Capital Management Holdings, LP

  Brokers/Dealers/
Investment Houses
  Initial Term Loan   Loan     3.75     1/4/2021      $ 3,395,892        3,381,240        3,353,443   

GTCR Valor Companies, Inc.

  Business Equipment and
Services
  Term Loan (First Lien)   Loan     6.00     6/1/2021      $ 1,995,000        1,981,582        1,965,075   

Harland Clarke Holdings Corp. (fka Clarke American Corp.)

  Publishing   Tranche B-4
Term Loan
  Loan     6.00     8/2/2019      $ 487,500        485,460        488,963   

HCA Inc.

  Healthcare   Tranche B-4
Term Loan
  Loan     2.99     5/1/2018      $ 5,663,006        5,409,534        5,658,872   

Hertz Corporation, The

  Automotive   Tranche B-1
Term Loan
  Loan     4.00     3/12/2018      $ 2,940,000        2,975,234        2,927,152   

Hoffmaster Group, Inc.

  Containers/Glass
Products
  Term Loan   Loan     5.25     5/8/2020      $ 1,990,000        1,972,040        1,999,950   

Huntsman International LLC

  Chemicals/Plastics   Extended Term B
Loan
  Loan     2.69     4/19/2017      $ 3,880,270        3,866,113        3,872,199   

Husky Injection

  Business Equipment and
Services
  Term Loan B   Loan     4.25     6/30/2021      $ 498,099        495,886        495,818   

Ikaria, Inc.

  Healthcare   Initial Term Loan
(First Lien)
  Loan     5.00     2/12/2021      $ 435,702        433,809        434,251   

Infor (US), Inc. (fka Lawson Software Inc.)

  Business Equipment and
Services
  Tranche B-5
Term Loan
  Loan     3.75     6/3/2020      $ 2,211,036        2,194,068        2,190,650   

Insight Global

  Business Equipment and
Services
  Term Loan   Loan     6.00     10/29/2021      $ 2,000,000        1,990,539        1,993,760   

J. Crew Group, Inc.

  Retailers (Except Food
and Drugs)
  Term B-1 Loan
Retired 03/05/2014
  Loan     4.00     3/5/2021      $ 965,206        965,206        906,493   

Jazz Acquisition, Inc

  Aerospace and Defense   First Lien 6/14   Loan     4.50     6/19/2021      $ 497,576        496,332        492,913   

Kinetic Concepts, Inc.

  Healthcare   Dollar Term D-1 Loan   Loan     4.00     5/4/2018      $ 2,477,613        2,453,687        2,477,167   

Koosharem, LLC

  Business Equipment and
Services
  Term Loan   Loan     7.50     5/15/2020      $ 2,995,000        2,968,450        2,961,306   

La Quinta Holdings, Inc.

  Lodging & Casinos   Term Loan (First Lien)   Loan     4.00     4/14/2021      $ 451,283        449,626        450,719   

Level 3 Financing, Inc.

  Telecommunications   Term Loan B   Loan     4.50     1/31/2022      $ 500,000        496,541        502,085   

Mauser Holdings, Inc.

  Containers/Glass
Products
  Term Loan   Loan     4.50     7/31/2021      $ 498,750        496,409        491,269   

Michaels Stores, Inc.

  Retailers (Except Food
and Drugs)
  Term B Loan   Loan     3.75     1/28/2020      $ 491,250        491,250        488,258   

Michaels Stores, Inc.

  Retailers (Except Food
and Drugs)
  Term Loan B-2   Loan     4.00     1/28/2020      $ 1,492,500        1,485,638        1,488,769   

Microsemi Corporation

  Electronics/Electric   Incremental Term
Loan
  Loan     3.50     2/19/2020      $ 2,393,981        2,389,500        2,381,509   

Microsemi Corporation

  Electronics/Electric   Term Loan   Loan     3.75     2/19/2020      $ 172,170        172,170        171,309   

Midas Intermediate Holdco II, LLC

  Automotive   Delayed Draw
Term Loan
  Loan     4.75     8/18/2021      $ 25,253        25,253        25,364   

Midas Intermediate Holdco II, LLC

  Automotive   Term Loan B   Loan     4.75     8/18/2021      $ 224,122        223,063        225,103   

Millenium Laboratories, LLC

  Drugs   Term Loan   Loan     5.25     4/16/2021      $ 1,492,500        1,479,041        1,489,396   

Mitel US Holdings, Inc.

  Telecommunications   Term Loan   Loan     5.25     1/31/2020      $ 196,558        195,710        196,411   

MPH Acquisition Holdings LLC

  Health Insurance   Term Loan   Loan     3.75     3/31/2021      $ 445,455        444,453        442,033   

MSC Software Corp.

  Business Equipment and
Services
  Term Loan   Loan     5.00     5/29/2020      $ 995,000        986,186        996,244   

National CineMedia, LLC

  Leisure Goods/
Activities/Movies
  Term Loan (2013)   Loan     2.95     11/26/2019      $ 1,086,207        1,058,933        1,067,198   

National Veterinary Associates, Inc

  Healthcare   Term Loan B   Loan     4.75     8/14/2021      $ 997,500        992,907        996,253   

National Vision, Inc.

  Retailers (Except Food
and Drugs)
  Term Loan (Second
Lien)
  Loan     6.75     3/11/2022      $ 250,000        249,730        240,418   

Newsday, LLC

  Publishing   Term Loan   Loan     3.69     10/12/2016      $ 2,215,385        2,214,305        2,201,538   

Nortek, Inc.

  Electronics/Electric   Term B Loan   Loan     3.75     10/30/2020      $ 995,000        992,803        986,921   

Novelis, Inc.

  Conglomerate   Initial Term Loan   Loan     3.75     3/10/2017      $ 4,807,530        4,817,740        4,799,502   

 

S-185


Table of Contents

Issuer Name

  Industry   Asset Name   Asset
Type
  Current
Rate
    Maturity
Date
    Principal/
Number
of Shares
    Cost     Fair Value  

NPC International, Inc.

  Food Services   Term Loan (2013)   Loan     4.00     12/28/2018      $ 486,250        486,250        480,780   

NRG Energy, Inc.

  Utilities   Term Loan (2013)   Loan     2.75     7/2/2018      $ 3,861,225        3,842,164        3,850,761   

NuSil Technology LLC.

  Chemicals/Plastics   Term Loan   Loan     5.25     4/7/2017      $ 797,986        797,986        791,004   

Ollie’s Bargain Outlet, Inc

  Retailers (Except Food and
Drugs)
  Term Loan   Loan     4.75     9/30/2019      $ 977,052        972,882        962,396   

On Assignment, Inc.

  Business Equipment and
Services
  Initial Term B
Loan
  Loan     3.50     5/15/2020      $ 1,311,364        1,303,451        1,301,528   

Onex Carestream Finance LP

  Healthcare   Term Loan (First
Lien 2013)
  Loan     5.00     6/7/2019      $ 4,074,401        4,059,378        4,078,842   

OnexYork Acquisition Co

  Healthcare   Delayed Draw
Term Loan
  Loan     4.75     10/1/2021      $ —          —          —     

OnexYork Acquisition Co

  Healthcare   Term Loan B   Loan     4.75     10/1/2021      $ 498,750        495,208        496,466   

OpenLink International LLC

  Business Equipment and
Services
  Term B Loan   Loan     6.25     10/28/2017      $ 970,000        970,000        957,875   

Orbitz Worldwide, Inc.

  Business Equipment and
Services
  Term Loan
(First Lien)
  Loan     4.50     4/15/2021      $ 1,494,994        1,492,711        1,494,755   

P.F. Chang’s China Bistro, Inc. (Wok Acquisition Corp.)

  Food/Drug Retailers   Term Borrowing   Loan     4.25     6/24/2019      $ 1,447,901        1,440,712        1,406,274   

P2 Upstream Acquisition Co. (P2 Upstream Canada BC ULC)

  Business Equipment and
Services
  Term Loan
(First Lien)
  Loan     5.00     10/30/2020      $ 990,000        985,444        947,925   

Par Pharmaceutical

  Healthcare &
Pharmaceuticals
  Term Loan B3   Loan     4.25     9/28/2019      $ 500,000        497,502        499,065   

PetCo Animal Supplies Stores, Inc.

  Retailers (Except Food and
Drugs)
  New Loans   Loan     4.00     11/24/2017      $ 1,469,388        1,468,520        1,467,066   

PetSmart

  Retailers (Except Food and
Drugs)
  Term Loan B   Loan     5.00     3/11/2022      $ 1,000,000        995,000        1,007,050   

PGX Holdings, Inc.

  Financial Intermediaries   Term Loan   Loan     6.25     9/29/2020      $ 993,750        984,482        993,750   

Pharmaceutical Product Development, Inc. (Jaguar Holdings, LLC)

  Conglomerate   2013 Term Loan   Loan     4.00     12/5/2018      $ 1,940,400        1,918,409        1,935,898   

Phillips-Medisize Corporation

  Healthcare   Term Loan   Loan     4.75     6/16/2021      $ 497,500        495,245        495,948   

Pinnacle Foods Finance LLC

  Food Products   New Term
Loan G
  Loan     3.00     4/29/2020      $ 2,581,332        2,576,466        2,565,560   

Planet Fitness Holdings LLC

  Leisure Goods/Activities/
Movies
  Term Loan   Loan     4.75     3/31/2021      $ 1,488,750        1,482,052        1,488,750   

Polymer Group, Inc.

  Chemicals/Plastics   Initial Loan   Loan     5.25     12/19/2019      $ 495,000        492,860        495,619   

Presidio

  Business Equipment and
Services
  Term Loan B   Loan     6.25     2/2/2022      $ 2,000,000        1,940,655        1,973,760   

Prestige Brands, Inc.

  Drugs   Term B-1 Loan   Loan     4.13     1/31/2019      $ 344,697        341,112        344,697   

Prestige Brands, Inc.

  Leisure Goods/Activities/
Movies
  Term Loan   Loan     4.50     9/3/2021      $ 1,861,111        1,858,280        1,860,534   

QoL Meds, LLC

  Healthcare   Term Loan B   Loan     5.50     7/15/2020      $ 1,995,000        1,985,909        1,990,013   

Quintiles Transnational Corp.

  Conglomerate   Term B-3 Loan   Loan     3.75     6/8/2018      $ 3,627,678        3,600,425        3,628,802   

Ranpak Holdings, Inc.

  Business Equipment and
Services
  Term Loan   Loan     4.75     10/1/2021      $ 997,500        995,145        996,882   

Ranpak Holdings, Inc.

  Business Equipment and
Services
  Term Loan
(Second Lien)
  Loan     8.25     9/30/2022      $ 500,000        497,672        496,250   

Redtop Acquisitions Limited

 

Electronics/Electric

  Initial Dollar
Term Loan
(First Lien)
  Loan     4.50     12/3/2020      $ 495,000        491,974        494,381   

Rexnord LLC/RBS Global, Inc.

  Industrial Equipment   Term B Loan   Loan     4.00     8/21/2020      $ 1,646,799        1,648,172        1,642,172   

Reynolds Group Holdings Inc.

  Industrial Equipment   Incremental U.S.
Term Loan
  Loan     4.00     12/1/2018      $ 1,960,200        1,960,200        1,965,767   

Riverbed Technology

  Technology   Term Loan B   Loan     6.00     2/25/2022      $ 1,000,000        995,000        1,007,500   

Rocket Software, Inc.

  Business Equipment and
Services
  Term Loan
(First Lien)
  Loan     5.75     2/8/2018      $ 1,916,674        1,898,764        1,906,285   

 

S-186


Table of Contents

Issuer Name

  Industry   Asset Name   Asset
Type
  Current
Rate
    Maturity
Date
    Principal/
Number
of Shares
    Cost     Fair Value  

Rovi Solutions Corporation / Rovi Guides, Inc.

  Electronics/Electric   Tranche B-3
Term Loan
  Loan     3.75     7/2/2021      $ 1,492,500        1,485,607        1,479,441   

RPI Finance Trust

  Drugs   Term B-2 Term
Loan
  Loan     3.25     5/9/2018      $ 5,207,431        5,188,396        5,219,147   

SBP Holdings LP

  Industrial Equipment   Term Loan
(First Lien)
  Loan     5.00     3/27/2021      $ 992,500        988,065        863,475   

Scientific Games International, Inc.

  Electronics/Electric   Term Loan B2   Loan     6.00     10/1/2021      $ 1,000,000        990,433        998,040   

Scitor Corporation

  Business Equipment and
Services
  Term Loan   Loan     5.00     2/15/2017      $ 463,977        462,387        461,077   

Seadrill

  Oil & Gas   Term Loan B   Loan     4.00     2/21/2021      $ 997,481        917,590        806,294   

Sensata Technologies B.V./Sensata Technology Finance Company, LLC

  Industrial Equipment   Term Loan   Loan     3.25     5/13/2019      $ 1,509,445        1,509,445        1,511,603   

Sensus USA Inc. (fka Sensus Metering Systems)

  Utilities   Term Loan
(First Lien)
  Loan     4.50     5/9/2017      $ 1,925,067        1,920,548        1,925,067   

ServiceMaster Company, The

  Conglomerate   Tranche B Term
Loan
  Loan     4.25     7/1/2021      $ 1,995,000        1,976,650        1,994,641   

Shearers Foods LLC

  Food Services   Term Loan
(First Lien)
  Loan     4.50     6/30/2021      $ 997,500        995,166        996,253   

Sonneborn, LLC

  Chemicals/Plastics   Term Loan
(First Lien)
  Loan     5.50     12/10/2020      $ 225,000        224,471        225,000   

Sonneborn, LLC

  Chemicals/Plastics   Initial US Term
Loan
  Loan     5.50     12/10/2020      $ 1,275,000        1,272,004        1,275,000   

Sophia, L.P.

  Electronics/Electric   Term B Loan   Loan     4.00     7/19/2018      $ 886,138        877,732        884,756   

SourceHOV LLC

  Business Equipment and
Services
  Term Loan B
(First Lien)
  Loan     7.75     10/31/2019      $ 2,000,000        1,942,284        1,915,000   

Southwire Company, LLC (f.k.a Southwire Company)

  Building and
Development
  Initial Term Loan   Loan     3.25     2/10/2021      $ 496,250        495,181        485,084   

SRAM, LLC

  Industrial Equipment   Term Loan
(First Lien)
  Loan     4.00     4/10/2020      $ 2,967,681        2,957,888        2,952,842   

Steak ‘n Shake Operations, Inc.

  Food Services   Term Loan   Loan     4.75     3/19/2021      $ 992,500        983,723        975,131   

STHI Holding

  Healthcare   Term Loan   Loan     4.50     8/6/2021      $ 997,500        997,500        994,388   

SunGard Data Systems Inc. (Solar Capital Corp.)

  Conglomerate   Tranche C
Term Loan
  Loan     3.90     2/28/2017      $ 285,352        283,117        285,084   

SunGard Data Systems Inc. (Solar Capital Corp.)

  Conglomerate   Tranche E
Term Loan
  Loan     4.00     3/9/2020      $ 3,707,953        3,618,899        3,706,804   

SuperMedia Inc. (fka Idearc Inc.)

  Publishing   Loan   Loan     11.60     12/30/2016      $ 238,660        232,462        203,756   

Syniverse Holdings, Inc.

  Telecommunications   Initial Term Loan   Loan     4.00     4/23/2019      $ 479,913        476,105        473,314   

TGI Friday’s

  Food Services   Term Loan B   Loan     5.25     7/15/2020      $ 267,977        266,768        267,642   

TGI Friday’s

  Food Services   Term Loan
(Second Lien)
  Loan     9.25     7/15/2021      $ 2,000,000        2,016,250        2,000,000   

TPF II Power LLC and TPF II Covert Midco LLC

  Utilities   Term Loan B   Loan     5.50     10/2/2021      $ 500,000        496,689        504,790   

TransDigm, Inc.

  Aerospace and Defense   Tranche C
Term Loan
  Loan     3.75     2/28/2020      $ 4,847,054        4,856,484        4,824,661   

TransFirst

  Financial Intermediaries   Term Loan   Loan     5.50     11/12/2021      $ 500,000        495,182        502,815   

TransUnion

  Financial Intermediaries   Term Loan   Loan     4.00     4/9/2021      $ 496,250        495,138        493,977   

Tricorbraun, Inc. (fka Kranson Industries, Inc.)

  Containers/Glass
Products
  Term Loan   Loan     4.00     5/3/2018      $ 1,850,000        1,843,008        1,822,250   

Truven Health Analytics Inc. (fka Thomson Reuters (Healthcare) Inc.)

  Healthcare   New Tranche B
Term Loan
  Loan     4.50     6/6/2019      $ 487,566        479,874        481,471   

Twin River Management Group, Inc.

  Lodging & Casinos   Term Loan B   Loan     5.25     7/10/2020      $ 974,167        976,455        975,998   

U.S. Security Associates Holdings, Inc.

  Business Equipment and
Services
  Delayed Draw
Loan
  Loan     6.25     7/28/2017      $ 158,518        157,610        156,734   

U.S. Security Associates Holdings, Inc.

  Business Equipment and
Services
  Term B Loan   Loan     6.25     7/28/2017      $ 931,046        926,144        920,572   

 

S-187


Table of Contents

Issuer Name

  Industry   Asset Name   Asset
Type
  Current
Rate
    Maturity
Date
    Principal/
Number
of Shares
    Cost     Fair Value  

United Surgical Partners International, Inc.

  Healthcare   New Tranche B
Term Loan
  Loan     4.75     4/3/2019      $ 2,431,749        2,408,580        2,431,749   

Univar Inc.

  Chemicals/Plastics   Term B Loan   Loan     5.00     6/30/2017      $ 3,844,964        3,844,749        3,813,935   

Univision Communications Inc.

 

Telecommunications

  Replacement
First-Lien
Term Loan
  Loan     4.00     3/1/2020      $ 2,947,446        2,931,982        2,940,549   

Valeant Pharmaceuticals International, Inc.

  Drugs   Series D2
Term Loan B
  Loan     3.50     2/13/2019      $ 2,545,588        2,537,415        2,539,683   

Verint Systems Inc.

  Business Equipment and
Services
  Term Loan   Loan     3.50     9/6/2019      $ 1,264,058        1,259,623        1,259,634   

Vertafore, Inc.

  Business Equipment and
Services
  Term Loan
(2013)
  Loan     4.25     10/3/2019      $ 2,881,003        2,881,003        2,878,294   

Vouvray US Finance

  Industrial Equipment   Term Loan   Loan     5.00     6/28/2021      $ 497,500        495,243        499,366   

Washington Inventory Service

  Business Equipment and
Services
  U.S. Term
Loan
(First Lien)
  Loan     5.75     12/20/2018      $ 1,832,876        1,851,978        1,796,218   

Waste Industries

  Environmental   Term Loan B   Loan     4.25     2/27/2020      $ 250,000        249,375        250,520   

Wendy’s International, Inc

  Food Services   Term B Loan   Loan     3.25     5/15/2019      $ 673,630        668,099        670,545   

West Corporation

  Telecommunications   Term B-10
Loan
  Loan     3.25     6/30/2018      $ 2,571,560        2,605,923        2,562,998   
             

 

 

   

 

 

 
              $ 297,760,340      $ 295,239,268   
             

 

 

   

 

 

 

See accompanying notes to financial statements.

 

S-188


Table of Contents

Saratoga Investment Corp. CLO 2013-1 Ltd.

Schedule of Investments

February 28, 2014

 

Issuer Name

  Industry   Asset Name   Asset
Type
  Current
Rate
    Maturity
Date
    Principal     Cost     Fair Value  

Academy, LTD.

  Retailers (Except
Food and Drugs)
  Initial Term Loan
(2012)
  Loan     4.50     8/3/2018      $ 1,960,187      $ 1,948,853      $ 1,969,969   

Acosta, Inc.

  Food Products   Term B Loan
(2013)
  Loan     4.25     3/2/2018        4,162,740        4,101,035        4,177,310   

Aderant North America, Inc.

  Business Equipment
and Services
  Term Loan (First
Lien)
  Loan     6.25     12/20/2018        3,473,750        3,470,186        3,482,434   

Aegis Toxicology Sciences Corporation

  Healthcare   Initial Term Loan
(First Lien)
  Loan     5.50     2/24/2021        1,000,000        990,000        990,000   

Aegis Toxicology Sciences Corporation

  Healthcare   Initial Term Loan
(Second Lien)
  Loan     9.50     8/24/2021        500,000        492,500        492,500   

Aeroflex Incorporated

  Aerospace and
Defense
  Tranche B-1
Term Loan
  Loan     4.50     11/9/2019        3,208,854        3,194,690        3,223,550   

Akorn, Inc.

  Healthcare   Term Loan B   Loan     4.50     11/13/2020        500,000        497,500        503,125   

Alere Inc. (fka IM US Holdings, LLC)

  Healthcare   Incremental B-1
Term Loan
  Loan     4.25     6/30/2017        1,960,000        1,930,566        1,968,173   

Applied Systems, Inc.

  Business Equipment
and Services
  Term Loan   Loan     4.25     12/8/2016        500,000        498,750        498,750   

Aramark Corporation

  Food Products   LC-2 Facility   Loan     3.69     7/26/2016        79,187        79,187        79,206   

Aramark Corporation

  Food Products   LC-3 Facility   Loan     3.69     7/26/2016        43,961        43,961        43,971   

Aramark Corporation

  Food Products   U.S. Term C
Loan
  Loan     3.25     7/26/2016        3,206,537        3,206,537        3,207,307   

Ardagh Holdings USA Inc. (Ardagh Packaging Finance S.A.)

  Containers/Glass
Products
  Dollar Term
Loan
  Loan     4.25     12/17/2019        1,000,000        995,109        1,002,500   

ARG IH Corporation

  Food Services   Term Loan   Loan     5.00     11/15/2020        500,000        498,797        502,500   

Asurion, LLC (fka Asurion Corporation)

  Insurance   Incremental
Tranche B-1
Term Loan
  Loan     4.50     5/24/2019        5,508,783        5,462,695        5,516,660   

Auction.Com, LLC

  Business Equipment
and Services
  Term Loan A-4   Loan     4.66     2/28/2017        980,651        979,812        970,845   

Autotrader.com, Inc.

  Automotive   Tranche B-1
Term Loan
  Loan     4.00     12/15/2016        3,791,778        3,791,778        3,805,997   

Avantor Performance Materials Holdings, Inc.

  Chemicals/Plastics   Term Loan   Loan     5.25     6/24/2017        4,875,000        4,861,403        4,875,000   

AZ Chem US Inc.

  Chemicals/Plastics   Term Loan   Loan     5.25     12/22/2017        1,355,941        1,329,859        1,362,720   

Bass Pro Group, LLC

  Retailers (Except
Food and Drugs)
  New Term Loan   Loan     3.75     11/20/2019        498,725        498,126        500,715   

Berry Plastics Corporation

  Chemicals/Plastics   Term E Loan   Loan     3.75     1/6/2021        1,500,000        1,496,250        1,495,500   

Big Heart Pet Brands (fka Del Monte Corporation)

  Food/Drug Retailers   Initial Term Loan   Loan     3.50     3/9/2020        3,000,000        3,022,866        2,999,250   

Biomet, Inc.

  Healthcare   Dollar Term B-2
Loan
  Loan     3.65     7/25/2017        1,970,137        1,970,137        1,972,797   

BJ's Wholesale Club, Inc.

  Food/Drug Retailers   New 2013
(November)
Replacement
Loan (First Lien)
  Loan     4.50     9/26/2019        500,000        497,592        502,750   

Bombardier Recreational Products Inc.

  Leisure Goods/
Activities/Movies
  Term B Loan   Loan     4.00     1/30/2019        754,286        748,080        756,647   

Brickman Group Ltd. LLC, The

  Brokers/Dealers/
Investment Houses
  Initial Term Loan
(First Lien)
  Loan     4.00     12/18/2020        250,000        248,750        250,937   

Brock Holdings III, Inc.

  Industrial Equipment   Term Loan (First
Lien)
  Loan     6.75     3/16/2017        1,959,839        1,976,826        1,967,188   

Burlington Coat Factory Warehouse Corporation

  Retailers (Except
Food and Drugs)
  Term B-2 Loan   Loan     4.25     2/23/2017        2,660,377        2,653,889        2,675,675   

 

S-189


Table of Contents

Issuer Name

  Industry   Asset Name   Asset
Type
  Current
Rate
    Maturity
Date
    Principal     Cost     Fair Value  

C.H.I. Overhead Doors, Inc.

  Building and
Development
  Term Loan (First
Lien)
  Loan     5.50     3/18/2019        2,739,013        2,692,934        2,745,861   

Camp International Holding Company

  Aerospace and
Defense
  2013
Replacement
Term Loan (First
Lien)
  Loan     4.75     5/31/2019        990,000        990,000        999,900   

Capital Automotive L.P.

  Conglomerate   Tranche B-1
Term Loan
Facility
  Loan     4.00     4/10/2019        2,137,369        2,141,920        2,142,712   

Capstone Logistics, LLC

  Business Equipment
and Services
  Term Note A   Loan     6.50     9/16/2016        2,658,626        2,637,550        2,618,899   

Capsugel Holdings US, Inc.

  Drugs   Initial Term Loan   Loan     3.50     8/1/2018        3,145,521        3,138,959        3,141,589   

Celanese US Holdings LLC

  Chemicals/Plastics   Dollar Term C-2
Commitment
  Loan     2.25     10/31/2016        2,176,323        2,201,894        2,192,254   

Charter Communications Operating, LLC

  Cable and Satellite
Television
  Term F Loan   Loan     3.00     12/31/2020        2,682,707        2,672,727        2,666,369   

CHS/Community Health Systems, Inc.

  Healthcare   2017 Term E
Loan
  Loan     3.48     1/25/2017        1,108,908        1,082,718        1,113,987   

CHS/Community Health Systems, Inc.

  Healthcare   2021 Term D
Loan
  Loan     4.25     1/27/2017        2,955,608        2,862,024        2,980,228   

Cinedigm Digital Funding I, LLC

  Business Equipment
and Services
  Term Loan   Loan     3.75     2/28/2018        825,121        820,892        825,121   

Covanta Energy Corporation

  Ecological Services
and Equipment
  Term Loan   Loan     3.50     3/28/2019        491,250        489,468        492,788   

CPI International Acquisition, Inc. (f/k/a Catalyst Holdings, Inc.)

  Electronics/Electric   Term B Loan   Loan     5.00     2/13/2017        4,622,500        4,611,092        4,622,500   

Crosby US Acquisition Corp.

  Industrial Equipment   Initial Term Loan
(First Lien)
  Loan     4.00     11/23/2020        750,000        749,094        748,312   

Crown Castle Operating Company

  Telecommunications
/Cellular
  Extended
Incremental
Tranche B-2
Term Loan
  Loan     3.25     1/31/2019        2,460,196        2,441,025        2,460,316   

Culligan International Company

  Conglomerate   Dollar Loan
(First Lien)
  Loan     6.25     12/19/2017        787,658        738,102        734,491   

Culligan International Company

  Conglomerate   Dollar Loan
(Second Lien)
  Loan     9.50     6/19/2018        783,162        732,061        657,856   

Cumulus Media Holdings Inc.

  Broadcast Radio and
Television
  Term Loan   Loan     4.25     12/23/2020        500,000        495,000        502,815   

DaVita HealthCare Partners Inc. (fka DaVita Inc.)

  Healthcare   Tranche B Term
Loan
  Loan     4.50     10/20/2016        3,909,320        3,909,320        3,927,655   

DCS Business Services, Inc.

  Financial
Intermediaries
  Term B Loan   Loan     7.25     3/19/2018        3,831,595        3,792,824        3,735,805   

DealerTrack Technologies, Inc.

  Computers &
Electronics
  Term Loan   Loan     3.50     2/28/2021        500,000        498,750        498,750   

Dell International LLC

  Retailers (Except
Food and Drugs)
  Term B Loan   Loan     4.50     4/29/2020        1,995,000        1,982,818        1,988,935   

Delos Finance

  Leasing   Loan   Loan     3.50     2/26/2021        500,000        497,500        497,500   

Deluxe Entertainment Services Group Inc.

  Media   Initial Term Loan   Loan     6.50     2/28/2020        1,000,000        1,000,000        1,000,000   

Digitalglobe, Inc.

  Ecological Services
and Equipment
  Term Loan   Loan     3.75     1/31/2020        248,125        248,125        247,815   

Drew Marine Group Inc.

  Chemicals/Plastics   Term Loan (First
Lien)
  Loan     4.50     11/19/2020        500,000        499,397        502,500   

Dunkin' Brands, Inc.

  Food Services   Term B-4 Loan   Loan     3.25     2/14/2020        3,956,731        3,946,925        3,936,948   

DynCorp International Inc.

  Aerospace and
Defense
  Term Loan   Loan     6.25     7/7/2016        486,442        482,619        488,573   

Education Management LLC

  Leisure Goods/
Activities/Movies
  Tranche C-2
Term Loan
  Loan     4.31     6/1/2016        3,882,152        3,746,734        3,544,405   

EIG Investors Corp.

  Business Equipment
and Services
  Term Loan   Loan     5.00     11/9/2019        997,500        992,713        1,003,734   

 

S-190


Table of Contents

Issuer Name

  Industry   Asset Name   Asset
Type
  Current
Rate
    Maturity
Date
    Principal     Cost     Fair Value  

Energy Transfer Equity, L.P.

  Oil & Gas   Loan   Loan     3.25     12/2/2019        1,000,000        997,599        998,750   

Evergreen Acqco 1 LP

  Retailers (Except
Food and Drugs)
  New Term Loan   Loan     5.00     7/9/2019        492,516        488,615        493,900   

EWT Holdings III Corp. (fka WTG Holdings III Corp.)

  Industrial Equipment   Term Loan (First
Lien)
  Loan     4.75     1/15/2021        1,000,000        995,084        1,002,500   

Federal-Mogul Corporation

  Automotive   Tranche B Term
Loan
  Loan     2.14     12/29/2014        2,220,981        2,187,068        2,202,747   

Federal-Mogul Corporation

  Automotive   Tranche C Term
Loan
  Loan     2.14     12/28/2015        1,307,032        1,270,847        1,296,301   

First Data Corporation

  Financial
Intermediaries
  2017 Second
New Dollar
Term Loan
  Loan     4.20     3/24/2017        2,111,028        2,010,799        2,109,276   

First Data Corporation

  Financial
Intermediaries
  2018 Dollar
Term Loan
  Loan     4.20     3/23/2018        2,290,451        2,231,370        2,292,741   

FMG Resources (August 2006) Pty LTD (FMG America Finance, Inc.)

  Nonferrous Metals/
Minerals
  Loan   Loan     4.25     6/28/2019        997,500        995,122        1,006,438   

Four Seasons Holdings Inc.

  Lodging & Casinos   Term Loan (First
Lien)
  Loan     3.50     6/27/2020        498,750        498,750        498,750   

Garda World Security Corporation

  Business Equipment
and Services
  Term B Delayed
Draw Loan
  Loan     4.00     11/6/2020        203,194        202,218        203,363   

Garda World Security Corporation

  Business Equipment
and Services
  Term B Loan   Loan     4.00     11/6/2020        794,306        790,489        794,965   

Gardner Denver, Inc.

  Oil & Gas   Initial Dollar
Term Loan
  Loan     4.25     7/30/2020        1,496,250        1,485,394        1,489,337   

Generac Power Systems, Inc.

  Industrial Equipment   Term Loan B   Loan     3.50     5/31/2020        868,414        852,908        868,258   

General Nutrition Centers, Inc.

  Retailers (Except
Food and Drugs)
  Amended
Tranche B Term
Loan
  Loan     3.25     3/4/2019        4,740,112        4,722,664        4,725,892   

Global Tel*Link Corporation

  Business Equipment
and Services
  Term Loan (First
Lien)
  Loan     5.00     5/23/2020        1,920,175        1,915,905        1,900,014   

Goodyear Tire & Rubber Company, The

  Chemicals/Plastics   Loan (Second
Lien)
  Loan     4.75     4/30/2019        4,000,000        3,941,039        4,037,000   

Grosvenor Capital Management Holdings, LP

  Brokers/Dealers/
Investment Houses
  Initial Term Loan   Loan     3.75     1/4/2021        3,500,000        3,482,803        3,489,080   

Harland Clarke Holdings Corp. (fka Clarke American Corp.)

  Publishing   Tranche B-4
Term Loan
  Loan     6.00     8/4/2019        500,000        497,500        500,780   

HCA Inc.

  Healthcare   Tranche B-4
Term Loan
  Loan     2.94     5/1/2018        5,720,353        5,390,148        5,713,947   

Hertz Corporation, The

  Automotive   Tranche B-1
Term Loan
  Loan     3.75     3/11/2018        2,970,000        3,005,791        2,973,683   

Hologic, Inc.

  Healthcare   Refinancing
Tranche A Term
Loan
  Loan     2.19     8/1/2017        2,312,500        2,307,973        2,313,425   

Hunter Defense Technologies, Inc.

  Aerospace and
Defense
  Term Loan   Loan     3.45     8/22/2014        3,470,285        3,460,723        3,262,068   

Huntsman International LLC

  Chemicals/Plastics   Extended Term
B Loan
  Loan     2.73     4/19/2017        3,920,000        3,892,467        3,919,020   

Ikaria, Inc.

  Healthcare   Initial Term Loan
(First Lien)
  Loan     5.00     2/12/2021        500,000        497,515        502,815   

Infor (US), Inc. (fka Lawson Software Inc.)

  Business Equipment
and Services
  Tranche B-5
Term Loan
  Loan     3.75     6/3/2020        1,776,183        1,758,861        1,772,488   

Inventiv Health, Inc. (fka Ventive Health, Inc)

  Conglomerate   Consolidated
Term Loan
  Loan     7.50     8/4/2016        492,090        492,090        491,105   

J. Crew Group, Inc.

  Retailers (Except
Food and Drugs)
  Term B-1 Loan
Retired
03/05/2014
  Loan     4.00     3/7/2018        972,500        972,500        972,656   

JFB Firth Rixson Inc.

  Industrial Equipment   2013
Replacement
Dollar Term
Facility Loan
  Loan     4.25     6/30/2017        2,564,311        2,554,534        2,568,054   

 

S-191


Table of Contents

Issuer Name

  Industry   Asset Name   Asset
Type
  Current
Rate
    Maturity
Date
    Principal     Cost     Fair Value  

Kinetic Concepts, Inc.

  Healthcare   Dollar Term
D-1 Loan
  Loan     4.00     5/4/2018        490,057        475,404        492,508   

La Quinta Intermediate Holdings L.L.C

 

Gaming and Hotels

  Initial Term
Loan
  Loan     4.00     2/19/2021        500,000        500,000        500,000   

Michaels Stores, Inc.

  Retailers (Except
Food and Drugs)
  Term B
Loan
  Loan     3.75     1/28/2020        496,250        496,250        497,302   

Microsemi Corporation

  Electronics/Electric   Incremental
Term Loan
  Loan     3.75     2/19/2020        498,750        498,750        499,373   

Microsemi Corporation

  Electronics/Electric   Term Loan   Loan     3.50     2/19/2020        2,393,981        2,389,463        2,398,482   

Mitel US Holdings, Inc.

  Telecommunications   Term Loan   Loan     5.25     1/31/2020        250,000        248,753        252,083   

National CineMedia, LLC

  Leisure Goods/
Activities/Movies
  Term Loan
(2013)
  Loan     2.95     11/26/2019        1,086,207        1,054,177        1,082,134   

Newsday, LLC

  Publishing   Term Loan   Loan     3.69     10/12/2016        2,215,385        2,213,416        2,215,385   

Novelis, Inc.

  Conglomerate   Initial Term
Loan
  Loan     3.75     3/10/2017        4,857,520        4,868,347        4,873,452   

NPC International, Inc.

  Food Services   Term Loan
(2013)
  Loan     4.00     12/28/2018        490,833        490,833        493,597   

NRG Energy, Inc.

  Utilities   Term Loan
(2013)
  Loan     2.75     7/1/2018        3,900,525        3,875,534        3,872,168   

NuSil Technology LLC.

  Chemicals/Plastics   Term Loan   Loan     5.25     4/7/2017        809,163        809,163        799,558   

OEP Pearl Dutch Acquisition B.V.

  Chemicals/Plastics   Initial BV
Term Loan
  Loan     6.50     3/30/2018        142,422        140,466        143,846   

On Assignment, Inc.

  Business Equipment
and Services
  Initial Term
B Loan
  Loan     3.50     5/15/2020        1,311,364        1,303,125        1,312,190   

Onex Carestream Finance LP

  Healthcare   Term Loan
(First Lien
2013)
  Loan     5.00     2/25/2017        4,531,159        4,511,264        4,582,135   

OpenLink International, Inc.

  Computers &
Electronics
  Replacement
Term Loan
  Loan     6.25     10/30/2017        980,000        980,000        980,000   

P.F. Chang's China Bistro, Inc. (Wok Acquisition Corp.)

  Food/Drug Retailers   Term
Borrowing
  Loan     5.50     6/22/2019        1,496,212        1,488,641        1,509,675   

P2 Upstream Acquisition Co. (P2 Upstream Canada BC ULC)

  Business Equipment
and Services
  Term Loan
(First Lien)
  Loan     5.00     10/30/2020        1,000,000        995,186        1,008,750   

Patheon Inc.

  Healthcare   Term Loan   Loan     4.25     3/11/2021        3,000,000        2,992,500        2,990,640   

PetCo Animal Supplies, Inc.

  Retailers (Except
Food and Drugs)
  New Loans   Loan     4.00     11/24/2017        1,484,694        1,483,250        1,489,103   

Pharmaceutical Product Development, Inc. (Jaguar Holdings, LLC)

  Conglomerate   2013 Term
Loan
  Loan     4.00     12/5/2018        1,960,200        1,936,226        1,967,845   

Pinnacle Foods Finance LLC

  Food Products   New Term
Loan G
  Loan     3.25     4/29/2020        4,962,500        4,951,514        4,942,352   

Polymer Group, Inc.

  Chemicals/Plastics   Initial Loan   Loan     5.25     12/19/2019        500,000        497,500        501,875   

Prestige Brands, Inc.

  Drugs   Term B-1
Loan
  Loan     3.75     1/31/2019        435,606        430,195        437,022   

Pro Mach, Inc.

  Industrial
Equipment
  Term Loan   Loan     4.50     7/6/2017        1,945,655        1,934,699        1,955,383   

Progressive Waste Solutions Ltd.

  Ecological Services
and Equipment
  Term B
Loan
  Loan     3.00     10/24/2019        498,741        498,741        500,486   

Quintiles Transnational Corp.

  Conglomerate   Term B-3
Loan
  Loan     3.75     6/8/2018        3,681,541        3,646,328        3,685,186   
Redtop Acquisitions Limited   Electronics/Electric   Initial Dollar
Term Loan
(First Lien)
  Loan     4.50     12/3/2020        500,000        496,369        502,915   
Rexnord LLC/RBS Global, Inc.   Industrial
Equipment
  Term B
Loan
  Loan     4.00     4/1/2018        1,663,476        1,663,476        1,667,035   
Reynolds Group Holdings Inc.   Industrial
Equipment
  Incremental
U.S. Term
Loan
  Loan     4.00     9/28/2018        1,980,000        1,980,000        1,993,365   
Rocket Software, Inc.   Business Equipment
and Services
  Term Loan
(First Lien)
  Loan     5.75     2/8/2018        1,960,025        1,934,083        1,960,515   

Rovi Solutions Corporation / Rovi Guides, Inc.

  Electronics/Electric   Tranche A-2
Loan
  Loan     2.45     3/29/2017        1,562,552        1,552,098        1,562,552   

 

S-192


Table of Contents

Issuer Name

  Industry   Asset Name   Asset
Type
  Current
Rate
    Maturity
Date
    Principal     Cost     Fair Value  

Rovi Solutions Corporation / Rovi Guides, Inc.

  Electronics/Electric   Tranche B-3
Term Loan
  Loan     3.50     3/29/2019        1,344,450        1,339,560        1,341,088   
RPI Finance Trust   Drugs   Term B-2
Term Loan
  Loan     3.25     5/9/2018        5,308,218        5,283,397        5,339,165   
Scitor Corporation   Business Equipment
and Services
  Term Loan   Loan     5.00     2/15/2017        463,977        462,831        460,354   

Sensata Technologies B.V./Sensata Technology Finance Company, LLC

  Industrial
Equipment
  Term Loan   Loan     3.25     5/12/2019        1,524,730        1,524,730        1,529,106   

Sensus USA Inc. (fka Sensus Metering Systems)

  Utilities   Term Loan
(First Lien)
  Loan     5.75     5/9/2017        1,945,013        1,939,821        1,957,987   
ServiceMaster Company, The   Conglomerate   Tranche B
Term Loan
  Loan     4.45     1/31/2017        2,822,729        2,830,165        2,825,552   
SI Organization, Inc., The   Aerospace and
Defense
  New
Tranche B
Term Loan
  Loan     5.50     11/22/2016        3,880,675        3,863,008        3,800,655   
Sonneborn, LLC   Chemicals/Plastics   Initial US
Term Loan
  Loan     6.50     3/30/2018        807,059        795,976        815,130   
Sophia, L.P.   Electronics/Electric   Term B
Loan
  Loan     4.50     7/19/2018        928,389        917,174        934,191   

Southwire Company, LLC (f.k.a Southwire Company)

  Building and
Development
  Initial Term
Loan
  Loan     3.25     2/10/2021        500,000        498,758        499,730   
SRA International Inc.   Aerospace and
Defense
  Term Loan   Loan     6.50     7/20/2018        3,268,571        3,184,532        3,276,743   
SRAM, LLC   Industrial
Equipment
  Term Loan
(First Lien)
  Loan     4.01     4/10/2020        3,304,614        3,278,551        3,304,614   

SS&C Technologies Holdings Europe S.A.R.L.

  Business Equipment
and Services
  2013
Replacement
Term B-2
Loan
  Loan     3.25     6/7/2019        64,638        64,070        64,839   

SS&C Technologies, Inc., /Sunshine Acquisition II, Inc.

  Business Equipment
and Services
  2013
Replacement
Term B-1
Loan
  Loan     3.25     6/7/2019        624,838        619,344        626,782   
SunCoke Energy, Inc.   Nonferrous Metals/
Minerals
  Tranche B
Term Loan
  Loan     4.00     7/26/2018        1,367,311        1,359,200        1,367,311   

SunGard Data Systems Inc (Solar Capital Corp.)

  Conglomerate   Tranche C
Term Loan
  Loan     3.95     2/28/2017        304,311        302,167        305,452   

SunGard Data Systems Inc (Solar Capital Corp.)

  Conglomerate   Tranche E
Term Loan
  Loan     4.00     3/8/2020        4,221,845        4,096,936        4,238,944   

SuperMedia Inc. (fka Idearc Inc.)

  Publishing   Loan   Loan     11.60     12/30/2016        264,330        257,131        196,762   
Syniverse Holdings, Inc.   Telecommunications   Initial Term
Loan
  Loan     4.00     4/23/2019        479,913        476,371        480,911   

Taminco Global Chemical Corporation

 

Chemicals/Plastics

  Initial
Tranche B-3
Dollar Term
Loan
  Loan     3.25     2/15/2019        1,473,863        1,464,165        1,473,406   
Team Health, Inc.   Healthcare   Tranche B
Term Loan
  Loan     3.75     6/29/2018        4,387,500        4,373,856        4,387,500   
TECTUM HOLDINGS INC   Industrial
Equipment
  Term Loan   Loan     6.50     12/3/2015        3,800,160        3,788,706        3,762,159   

Tomkins, LLC / Tomkins, Inc. (f/k/a Pinafore, LLC / Pinafore, Inc.)

  Conglomerate   Term B-2
Loan
  Loan     3.75     9/29/2016        2,356,680        2,360,795        2,361,982   

TransDigm Inc.

  Aerospace and
Defense
  Tranche C
Term Loan
  Loan     3.75     2/28/2020        4,896,514        4,904,843        4,914,876   

Tricorbraun Inc. (fka Kranson Industries, Inc.)

  Containers/Glass
Products
  Term Loan   Loan     4.00     5/3/2018        1,902,083        1,895,432        1,903,282   

Truven Health Analytics Inc. (fka Thomson Reuters (Healthcare) Inc.)

  Healthcare   New
Tranche B
Term Loan
  Loan     4.50     6/6/2019        492,528        484,755        493,513   

 

S-193


Table of Contents

Issuer Name

  Industry   Asset Name   Asset
Type
  Current
Rate
    Maturity
Date
    Principal     Cost     Fair Value  

U.S. Security Associates Holdings, Inc.

  Business Equipment
and Services
  Delayed
Draw Loan
  Loan     6.00     7/28/2017        160,148        159,235        160,348   

U.S. Security Associates Holdings, Inc.

  Business Equipment
and Services
  Term B
Loan
  Loan     6.00     7/28/2017        122,494        122,109        122,648   

U.S. Security Associates Holdings, Inc.

  Business Equipment
and Services
  Term B
Loan
  Loan     6.00     7/28/2017        818,172        813,513        819,195   

U.S. Silica Company

  Nonferrous Metals/
Minerals
  Term Loan   Loan     4.00     7/23/2020        1,950,200        1,941,292        1,954,256   

U.S. Xpress Enterprises, Inc.

  Industrial
Equipment
  Extended
Term Loan
  Loan     9.38     11/13/2016        2,805,278        2,766,405        2,777,225   

United Surgical Partners International, Inc.

 

Healthcare

  New
Tranche B
Term Loan
  Loan     4.75     4/3/2019        2,456,500        2,429,626        2,470,821   

Univar Inc.

  Chemicals/Plastics   Term B
Loan
  Loan     5.00     6/30/2017        3,884,944        3,884,238        3,859,225   

Univision Communications Inc.

 

Telecommunications

  Replacement
First-Lien
Term Loan
  Loan     4.00     3/1/2020        2,977,500        2,959,200        2,984,467   

UPC Financing Partnership

  Broadcast Radio and
Television
  Facility AF   Loan     4.00     1/31/2021        1,000,000        974,618        1,002,500   

Valeant Pharmaceuticals International, Inc.

  Drugs   Series D2
Term Loan
B
  Loan     3.75     2/13/2019        2,947,688        2,936,432        2,955,528   

Verint Systems Inc.

  Business Equipment
and Services
  Term Loan   Loan     4.00     9/6/2019        1,900,800        1,892,737        1,904,602   

Verint Systems Inc.

  Business Equipment
and Services
  Tranche B
Incremental
Term Loan
  Loan     3.50     9/6/2019        1,000,000        997,521        1,000,000   

Vertafore, Inc.

  Business Equipment
and Services
  Term Loan
(2013)
  Loan     4.25     10/3/2019        2,899,621        2,899,621        2,909,770   

Visant Corporation (fka Jostens)

  Leisure Goods/
Activities/Movies
  Tranche B
Term Loan
(2011)
  Loan     5.25     12/22/2016        3,658,446        3,658,446        3,607,008   

W.R. Grace & Co.-CONN

  Chemicals/Plastics   Delayed
Draw Term
Loan
  Loan     0.00     2/3/2021        —          (328     —     

W.R. Grace & Co.-CONN

  Chemicals/Plastics   U.S. Term
Loan
  Loan     3.00     2/3/2021        368,421        367,502        367,828   

Washington Inventory Service

  Business Equipment
and Services
  U.S. Term
Loan (First
Lien)
  Loan     6.75     12/20/2018        1,980,000        2,004,187        1,965,150   

Wendy's International, Inc

  Food Services   Term B
Loan
  Loan     3.25     5/15/2019        680,469        674,563        679,197   

Wesco Aircraft Hardware Corp.

  Aerospace and
Defense
  Tranche B
Term Loan
  Loan     4.75     2/28/2021        500,000        498,750        498,750   

West Corporation

  Telecommunications   Term B-10
Loan
  Loan     3.25     6/30/2018        2,926,111        2,976,179        2,909,666   
             

 

 

   

 

 

 
              $ 299,137,566      $ 300,491,077   
             

 

 

   

 

 

 

See accompanying notes to financial statements.

 

S-194


Table of Contents

Saratoga Investment Corp. CLO 2013-1, Ltd.

Statements of Changes in Net Assets

 

     For the year ended
February 28, 2015
    For the year ended
February 28, 2014
    For the year ended
February 28, 2013
 

INCREASE FROM OPERATIONS:

      

Net investment income (loss)

   $ 793,848      $ (2,143,630   $ 1,033,327   

Net realized gain (loss) from investments

     620,817        (8,815,296     2,532,558   

Net unrealized appreciation (depreciation) on investments

     (3,874,583     6,776,871        3,235,774   
  

 

 

   

 

 

   

 

 

 

Net increase (decrease) in net assets from operations

  (2,459,918   (4,182,055   6,801,659   
  

 

 

   

 

 

   

 

 

 

Total increase (decrease) in net assets

  (2,459,918   (4,182,055   6,801,659   

Net assets at beginning of period

  (3,343,238   838,817      (5,962,842
  

 

 

   

 

 

   

 

 

 

Net assets at end of period

$ (5,803,156 $ (3,343,238 $ 838,817   
  

 

 

   

 

 

   

 

 

 

See accompanying notes to financial statements.

 

S-195


Table of Contents

Saratoga Investment Corp. CLO 2013-1, Ltd.

Statements of Cash Flows

 

     For the year ended
February 28, 2015
    For the year ended
February 28, 2014
    For the year ended
February 28, 2013
 

Operating activities

      

NET INCREASE (DECREASE) IN NET ASSETS FROM OPERATIONS

   $ (2,459,918   $ (4,182,055   $ 6,801,659   

ADJUSTMENTS TO RECONCILE NET INCREASE (DECREASE) IN NET ASSETS FROM OPERATIONS TO NET CASH PROVIDED BY (USED BY) OPERATING ACTIVITIES:

      

Paid-in-kind interest income

     (167,097     (10,122     —     

Net accretion of discount on investments

     (454,809     (568,674     (1,383,978

Amortization of deferred debt financing costs

     953,862        994,602        1,015,332   

Loss on extinguishment of debt

     —          3,442,442        —     

Net realized (gain) loss from investments

     (620,817     8,815,296        (2,532,558

Net unrealized appreciation on investments

     3,874,583        (6,776,871     (3,235,774

Proceeds from sale and redemption of investments

     141,358,326        128,190,654        165,363,963   

Purchase of investments

     (138,738,379     (55,721,381     (151,267,166

(Increase) decrease in operating assets:

      

Interest receivable

     160,315        134,033        (3,547

Receivable from open trades

     (318,421     3,330,272        4,915,102   

Other Assets

     91,336        (91,336     —     

Increase (decrease) in operating liabilities:

      

Interest Payable

     9,410        (43,645     (160,620

Payable for open trades

     (4,230,669     (6,901,250     (8,510,897

Accrued base management fee

     10,904        31,882        (2,345

Accrued subordinated management fee

     10,904        (97,629     (9,382
  

 

 

   

 

 

   

 

 

 

NET CASH (USED BY) PROVIDED BY OPERATING ACTIVITIES

  (520,470   70,546,218      10,989,789   
  

 

 

   

 

 

   

 

 

 

Financing activities

Borrowings on debt

  —        277,711,620      —     

Paydowns on debt

  (1,666,666   (366,793,378   —     

Deferred debt financing costs

  —        (2,250,398   —     
  

 

 

   

 

 

   

 

 

 

NET CASH USED BY FINANCING ACTIVITIES

  (1,666,666   (91,332,156   —     
  

 

 

   

 

 

   

 

 

 

NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS

  (2,187,136   (20,785,938   10,989,789   

CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD

  8,018,933      28,804,871      17,815,082   
  

 

 

   

 

 

   

 

 

 

CASH AND CASH EQUIVALENTS, END OF PERIOD

$ 5,831,797    $ 8,018,933    $ 28,804,871   
  

 

 

   

 

 

   

 

 

 

Supplemental Information:

Interest paid during the period

$ 9,625,726    $ 11,722,159    $ 15,773,621   

Supplemental non-cash information:

Paid-in-kind interest income

$ 167,097    $ 10,122    $ —     

Net accretion of discount on investments

$ 454,809    $ 568,674    $ 1,383,978   

Amortization of deferred debt financing costs

$ 953,862    $ 994,602    $ 1,015,332   

See accompanying notes to financial statements.

 

S-196


Table of Contents

SARATOGA INVESTMENT CORP. CLO 2013-1, LTD.

NOTES TO FINANCIAL STATEMENTS

1. Organization and Purpose

Saratoga Investment Corp. CLO 2013-1, Ltd. (the “Issuer”, “we”, “our”, “us”, “CLO” and “Saratoga CLO”), an exempted company with limited liability incorporated under the laws of the Cayman Islands was formed on November 28, 2007 and commenced operations on January 22, 2008. The Issuer was established to acquire or participate in U.S. dollar-denominated corporate debt obligations.

On January 22, 2008, the Issuer issued $400.0 million of notes, consisting of Class A Floating Rate Senior Notes, Class B Floating Rate Senior Notes, Class C Deferrable Floating Rate Notes, Class D Deferrable Floating Rate Notes, Class E Deferrable Floating Rate Notes (collectively the “Secured Notes”), and Subordinated Notes. The notes were issued pursuant to an indenture, dated January 22, 2008 (the “Indenture”), with U.S. Bank National Association (the “Trustee”) servicing as the Trustee there under.

On October 17, 2013, in a refinancing transaction, the Issuer issued $284.9 million of notes (the “2013-1 CLO Notes”), consisting of Class X Floating Rate Senior Notes, Class A-1 Floating Rate Senior Notes, Class A-2 Floating Rate Senior Notes, Class B Floating Rate Senior Notes, Class C Deferrable Floating Rate Notes, Class D Deferrable Floating Rate Notes, Class E Deferrable Floating Rate Notes, and Class F Deferrable Floating Rate Notes. The 2013-1 CLO Notes were issued pursuant to the Indenture with the same Trustee. Proceeds of the issuance of the 2013-1 CLO Notes were used, along with existing assets held by the Trustee, to redeem all of the Secured Notes issued in 2008. As of February 28, 2015, Saratoga Investment Corp. owned 100% of the Subordinated Notes of the CLO.

Pursuant to an investment management agreement (the “Investment Management Agreement”), Saratoga Investment Corp. (the “Investment Manager”), provides investment management services to the Issuer, and makes day-to-day investment decisions concerning the assets of the Issuer. The Investment Manager also performs certain administrative services on behalf of the Issuer under the Investment Management Agreement.

2. Significant Accounting Policies

Basis of Presentation

The accompanying financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) and are stated in U.S. dollars. The following is a summary of the significant accounting policies followed by the Issuer in the preparation of its financial statements.

The Issuer is considered to be an investment company for financial reporting purposes and has applied the guidance in Topic 946, “Financial Services—Investment Companies.” There has been no change to the Issuer’s status as an investment company during the year ended February 28, 2015.

Use of Estimates

The preparation of the financial statements in conformity with U.S. GAAP requires the Investment Manager to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements, including the fair value of investments, and the amounts of income and expenses during the reporting period. Actual results could differ from these estimates and such differences could be material.

Cash and Cash Equivalents

The Issuer defines cash and cash equivalents as highly liquid financial instruments with original maturities of three months or less. Cash and cash equivalents may include investments in money market mutual funds,

 

S-197


Table of Contents

which are carried at fair value. At February 28, 2015 and February 28, 2014, cash and cash equivalents amounted to $5.8 million and $8.0 million, respectively, and are swept on an overnight basis into a money market deposit account and invested in shares of JP Morgan Liquidity Institutional fund held at the Trustee.

Valuation of Investments

The Issuer accounts for its investments at fair value in accordance with the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 820, Fair Value Measurements and Disclosures (“ASC 820”). ASC 820 defines fair value, establishes a framework for measuring fair value, establishes a fair value hierarchy based on the quality of inputs used to measure fair value and enhances disclosure requirements for fair value measurements. ASC 820 requires the Issuer to assume that its investments are to be sold at the Statement of Assets and Liabilities date in the principal market to independent market participants, or in the absence of a principal market, in the most advantageous market, which may be a hypothetical market. Market participants are defined as buyers and sellers in the principal or most advantageous market that are independent, knowledgeable, and willing and able to transact.

Investments for which market quotations are readily available are fair valued at such market quotations obtained from independent third party pricing services and market makers subject to any decision by the Investment Manager to approve a fair value determination to reflect significant events affecting the value of these investments. The Investment Manager values investments for which market quotations are not readily available at fair value. Determinations of fair value may involve significant judgments and estimates. The types of factors that may be considered in determining the fair value of investments include the nature and realizable value of any collateral, the portfolio company’s ability to make payments, market yield trend analysis, the markets in which the portfolio company does business, comparison to publicly traded companies, discounted cash flow and other relevant factors.

Because such valuations, and particularly valuations of private investments and private companies, are inherently uncertain, they may fluctuate over short periods of time and may be based on estimates. The determination of fair value may differ materially from the values that would have been used if a ready market for these investments existed. Our net asset value could be materially affected if the determinations regarding the fair value of our investments were materially higher or lower than the values that are ultimately realized upon the disposal of such investments.

Investment Transactions and Income Recognition

Purchases and sales of investments and the related realized gains or losses are recorded on a trade-date basis. Interest income, adjusted for amortization of premium and accretion of discount, is recorded on an accrual basis to the extent that such amounts are expected to be collected. The Issuer stops accruing interest on its investments when it is determined that interest is no longer collectible. Discounts and premiums on investments purchased are accreted/amortized over the life of the respective investment using the effective yield method. The amortized cost of investments represents the original cost adjusted for the accretion of discounts and amortizations of premium on investments.

Loans are generally placed on non-accrual status when there is reasonable doubt that principal or interest will be collected. Accrued interest is generally reserved when a loan is placed on non-accrual status. Interest payments received on non-accrual loans may be recognized as a reduction in principal depending upon the Investment Manager’s judgment regarding collectability. Non-accrual loans are restored to accrual status when past due principal and interest is paid and, in management’s judgment, are likely to remain current, although we may make exceptions to this general rule if the loan has sufficient collateral value and is in the process of collection.

 

S-198


Table of Contents

Paid-in-Kind Interest

The Issuer holds debt investments in its portfolio that contain a PIK interest provision. The PIK interest, which represents contractually deferred interest added to the investment balance that is generally due at maturity, is generally recorded on the accrual basis to the extent such amounts are expected to be collected. We stop accruing PIK interest if we do not expect the issuer to be able to pay all principal and interest when due.

Deferred Debt Financing Costs, net

In April 2015, the FASB has issued Accounting Standards Update (“ASU”) No. 2015-03, Interest—Imputation of Interest (Subtopic 835-30): Simplifying the Presentation of Debt Issuance Costs (“ASU 2015-03”). The amendments in this ASU require that debt issuance costs related to a recognized debt liability be presented in the balance sheet as a direct deduction from the carrying amount of that debt liability, consistent with debt discounts. The recognition and measurement guidance for debt issuance costs are not affected by the amendments in this ASU. The guidance is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2015, and early adoption is allowed, and is to be applied on a retrospective basis. Management has adopted the provisions of ASU 2015-03 as of February 28, 2015, by reclassifying deferred debt financing costs from within total assets to within total liabilities as a contra-liability. The adoption of the provisions of ASU 2015-03 did not materially impact the Issuer’s financial position or results of operations. Prior period amounts were reclassified to conform to the current period presentation.

Included in deferred debt financing costs of $1.9 million as of February 28, 2015 are structuring fees of the investment bank, rating agency fees and legal fees associated with the issuance of the 2013-1 CLO Notes on October 17, 2013. Such costs have been capitalized and amortized using an effective yield method, over the life of the related notes.

Included in deferred debt financing costs of $2.2 million as of February 28, 2014 are structuring fees of the investment bank, rating agency fees and legal fees associated with the issuance of the 2013-1 CLO Notes on October 17, 2013. Such costs have been capitalized and amortized using an effective yield method, over the life of the related notes.

Deferred debt financing costs of $1.6 million, incurred in connection with the issuance of the Secured Notes, were expensed when the Secured Notes were extinguished on October 17, 2013.

Management Fees

The Issuer is externally managed by the Investment Manager pursuant to the Investment Management Agreement. As compensation for the performance of its obligations under the Investment Management Agreement, the Investment Manager is entitled to receive from the Issuer a base management fee (the “Base Management Fee”), a subordinated management fee (the “Subordinated Management Fee”) and an incentive management fee (the “Incentive Management Fee”). The Base Management Fee is payable in arrears quarterly (subject to availability of funds and to the satisfaction of payment obligations on the debt obligations of the Issuer (the “Priority of Payments”) in an amount equal to 0.25% per annum of the Fee Basis Amount at the beginning of the Collection Period. The Subordinated Management Fee is payable in arrears quarterly (subject to availability of funds and to the Priority of Payments) in an amount equal to 0.25% per annum of the Fee Basis Amount at the beginning of the Collection Period. The Incentive Management Fee equals 20% of the remaining interest proceeds and principal proceeds, if any, after the Subordinated Notes have realized the incentive management fee target return of 12.0%, in accordance with the Priority of Payments after making the prior distributions on the relevant payment date. For the years ended February 28, 2015, 2014 and 2013, no Incentive Management Fee’s have been paid.

 

S-199


Table of Contents

Expenses

The Issuer bears its own organizational and offering expenses, all expenses related to its investment program and expenses incurred in connection with its operations including, but not limited to, external legal, administrative, trustee, accounting, tax and audit expenses, costs related to trading, acquiring, monitoring or disposing of investments of the Issuer, and interest and other borrowing expenses, expenses of preparing and distributing reports, financial statements, and litigation or other extraordinary expenses. The Issuer has retained the Trustee to provide trustee services. Additionally, the Trustee performs loan administration, debt covenant compliance calculations, and monitoring and reporting services. For the years ended February 28, 2015, 2014 and 2013, the Issuer paid $0.1 million, $0.1 million, $0.1 million, respectively, for trustee services provided and is included in other expenses in the Statement of Operations.

Interest Expense

The Issuer has issued rated and unrated notes to finance its operations. Interest on debt is calculated by the Trustee for the Issuer. Interest is accrued and generally paid quarterly. For the years ended February 28, 2015, 2014 and 2013, $3.7 million, $5.7 million, $8.8 million of payments to the Subordinated Notes were included in interest expense in the Statement of Operations, respectively.

Risk Management

In the ordinary course of its business, the Issuer manages a variety of risks, including market risk and credit risk. Market risk is the risk of potential adverse changes to the value of investments because of changes in market conditions such as interest rate movements and volatility in investment prices.

Credit risk is the risk of default or non-performance by portfolio companies, equivalent to the investment’s carrying amount.

The Issuer is also exposed to credit risk related to maintaining all of its cash and cash equivalents, including those in reserve accounts, at a major financial institution.

The Issuer has investments in lower rated and comparable quality unrated high yield bonds and bank loans. Investments in high yield investments are accompanied by a greater degree of credit risk. The risk of loss due to default by the issuer is significantly greater for holders of high yield securities, because such investments are generally unsecured and are often subordinated to other creditors of the issuer.

New Accounting Pronouncements

In February 2015, the FASB issued ASU 2015-02, Consolidation (ASC Topic 810): Amendments to the Consolidation Analysis (“ASU 2015-02”). ASU 2015-02 significantly changes the consolidation analysis required under GAAP and ends the deferral granted to investment companies from applying the variable interest entity guidance. ASU 2015-02 is effective for interim and annual reporting periods in fiscal years that begin after December 15, 2015 and early adoption is permitted. Management is currently evaluating the impact these changes will have on the Issuer’s financial statements and disclosures.

In August 2014, the FASB issued new accounting guidance that requires management to assess an entity’s ability to continue as a going concern by incorporating and expanding upon certain principles that are currently in U.S. auditing standards. The amendments provide a definition of the term “substantial doubt” and include principles for considering the mitigating effect of management’s plans. The amendments also require an evaluation every reporting period, including interim periods for a period of one year after the date that the financial statements are issued (or available to be issued), and certain disclosures when substantial doubt is alleviated or not alleviated. The amendments in this update are effective for reporting periods ending after December 15, 2016. Management is currently evaluating the impact of adopting this new accounting guidance update on the Issuer’s financial statements.

 

S-200


Table of Contents

In June 2014, the FASB issued ASU 2014-11, Repurchase-to-Maturity Transactions, Repurchase Financings, and Disclosures, (“ASU 2014-11”). ASU 2014-11 makes limited changes to the accounting for repurchase agreements, clarifies when repurchase agreements and securities lending transactions should be accounted for as secured borrowings, and requires additional disclosures regarding these types of transactions. The guidance is effective for fiscal years beginning on or after December 15, 2014, and for interim periods within those fiscal years. Management is currently evaluating the impact these changes will have on the Issuer’s financial statement disclosures.

In May 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2014-09, Revenue from Contracts with Customers (Topic 606), which supersedes the revenue recognition requirements in Revenue Recognition (Topic 605). Under the new guidance, an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. This guidance is effective for annual and interim reporting periods beginning after December 15, 2016, and early application is not permitted. The Issuer’s currently evaluating the impact this ASU will have on its consolidated financial statements.

3. Fair Value Measurements

As noted above, the Issuer values all investments in accordance with ASC 820. ASC 820 requires enhanced disclosures about assets and liabilities that are measured and reported at fair value. As defined in ASC 820, fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date.

ASC 820 establishes a hierarchal disclosure framework which prioritizes and ranks the level of market price observability of inputs used in measuring investments at fair value. Market price observability is affected by a number of factors, including the type of investment and the characteristics specific to the investment. Investments with readily available active quoted prices or for which fair value can be measured from actively quoted prices generally will have a higher degree of market price observability and a lesser degree of judgment used in measuring fair value.

Based on the observability of the inputs used in the valuation techniques, the Issuer is required to provide disclosures on fair value measurements according to the fair value hierarchy. The fair value hierarchy ranks the observability of the inputs used to determine fair values. Investments carried at fair value are classified and disclosed in one of the following three categories:

 

    Level 1—Valuations based on quoted prices in active markets for identical assets or liabilities that the Issuer has the ability to access.

 

    Level 2—Valuations based on inputs other than quoted prices in active markets, which are either directly or indirectly observable.

 

    Level 3—Valuations based on inputs that are unobservable and significant to the overall fair value measurement. The inputs used in the determination of fair value may require significant management judgment or estimation. Such information may be the result of consensus pricing information or broker quotes which include a disclaimer that the broker would not be held to such a price in an actual transaction. The non-binding nature of consensus pricing and/or quotes accompanied by disclaimer would result in classification as Level 3 asset, assuming no additional corroborating evidence.

In addition to using the above inputs in investment valuations, the Issuer continues to employ the valuation policy that is consistent with ASC 820 and the 1940 Act.

 

S-201


Table of Contents

The following table presents fair value measurements of investments, by major class, as of February 28, 2015, according to the fair value hierarchy:

 

     Fair Value Measurements  
         Level 1          Level 2          Level 3          Total  

Term loans

   $ —         $ 294,621,817       $ —         $ 294,621,817   

Structured finance securities

     —           —           —           —     

Equity interest

     —           617,451         —           617,451   
  

 

 

    

 

 

    

 

 

    

 

 

 

Total

$ —      $ 295,239,268    $           —      $ 295,239,268   
  

 

 

    

 

 

    

 

 

    

 

 

 

The following table presents fair value measurements of investments, by major class, as of February 28, 2014, according to the fair value hierarchy:

 

     Fair Value Measurements  
         Level 1          Level 2      Level 3      Total  

Term loans

   $ —         $ 297,872,178       $ 2,618,899       $ 300,491,077   

Structured finance securities

     —           —           —           —     

Equity interest

     —           —           —           —     
  

 

 

    

 

 

    

 

 

    

 

 

 

Total

$ —      $ 297,872,178    $ 2,618,899    $ 300,491,077   
  

 

 

    

 

 

    

 

 

    

 

 

 

Transfers into or out of Level 1, 2 or 3 are recognized at the reporting date.

The following table provides a reconciliation of the beginning and ending balances for investments that use Level 3 inputs for the year ended February 28, 2015:

 

     Term Loans      Structured Finance
Securities
     Equity Interest  

Balance as of February 28, 2014

   $ 2,618,899       $ —         $ —     

Net unrealized gains

     18,651         —           —     

Purchases and other adjustments to cost

     3,840         —           —     

Sales and redemptions

     (2,658,626      —           —     

Net realized gain from investments

     17,236         —           —     
  

 

 

    

 

 

    

 

 

 

Balance as of February 28, 2015

$ —      $ —      $ —     
  

 

 

    

 

 

    

 

 

 

The following table provides a reconciliation of the beginning and ending balances for investments that use Level 3 inputs for the year ended February 28, 2014:

 

     Term Loans      Structured Finance
Securities
     Equity Interest  

Balance as of February 28, 2013

   $ 4,256,932       $ 10,850,000       $ 1,070,563   

Net unrealized gains (losses)

     (45,982      2,189,036         (394,438

Purchases and other adjustments to cost

     34,872         203,167         —     

Sales and redemptions

     (408,133      (13,846,450      (181,476

Net realized gain (loss) from investments

     102,394         604,247         (494,649

Net transfers in and/or out of Level 3(1)

     (1,321,184      —           —     
  

 

 

    

 

 

    

 

 

 

Balance as of February 28, 2014

$ 2,618,899    $ —      $ —     
  

 

 

    

 

 

    

 

 

 

 

S-202


Table of Contents

 

(1) The Issuer’s investment in Tectum Holdings Inc. was transferred into Level 2 during the year ended February, 28, 2014, as the reliability of market quotes became available for this investment and have been subsequently used for valuation purposes.

Transfers into or out of Level 3 are recognized at the reporting date.

Purchases and other adjustments to cost include purchases of new investments at cost, effects of refinancing/restructuring, accretion/amortization of income from discount/premium on debt securities, and PIK.

Sales and redemptions represent net proceeds received from investments sold, and principal paydowns received, during the period.

There were no level 3 investments held as of February 28, 2015. The net unrealized loss on level 3 investments held as of February 28, 2014, was $0.02 million, and is included in net unrealized appreciation on investments in the Statements of Operations.

Significant unobservable inputs used in the fair value measurement of the Issuer’s term loans and structured finance securities include comparable market yields. For investments utilizing a yield analysis valuation technique, a significant increase (decrease) in the market yield, in isolation, would result in a significantly lower (higher) fair value measurement. Generally, a change in the assumption for comparable yields is accompanied by a directionally opposite change in the assumption used for pricing.

Significant unobservable inputs used in the fair value measurement of the Issuer’s equity interests include EBITDA multiples. For investments utilizing EBITDA multiples, a significant increase (decrease) in the EBITDA multiple, in isolation, would result in a significant higher (lower) fair value measurement.

4. Financing

On January 22, 2008, the Issuer issued $400.0 million of notes, consisting of Class A Floating Rate Senior Notes, Class B Floating Rate Senior Notes, Class C Deferrable Floating Rate Notes, Class D Deferrable Floating Rate Notes, Class E Deferrable Floating Rate Notes (collectively the “Secured Notes”), and Subordinated Notes. The notes were issued pursuant to the Indenture.

The Secured Notes are limited recourse obligations of the Issuer. The Subordinated Notes are unsecured, limited recourse debt obligations of the Issuer.

On October 17, 2013, the Issuer issued $284.9 million of notes (the “2013-1 CLO Notes”), consisting of Class X Floating Rate Senior Notes, Class A-1 Floating Rate Senior Notes, Class A-2 Floating Rate Senior Notes, Class B Floating Rate Senior Notes, Class C Deferrable Floating Rate Notes, Class D Deferrable Floating Rate Notes, Class E Deferrable Floating Rate Notes, and Class F Deferrable Floating Rate Notes. The 2013-1 CLO Notes were issued pursuant to the Indenture with the same Trustee. Proceeds of the issuance of the 2013-1 CLO Notes were used along with existing assets held by the Trustee to redeem all of the Secured Notes issued in 2008. The Subordinated Notes were not included in the refinancing transaction.

The 2013-1 CLO Notes are limited recourse obligations of the Issuer. The Subordinated Notes are unsecured, limited recourse debt obligations of the Issuer.

The relative order of seniority of payment of each class of securities is, as follows: first, Class X Notes, second, Class A-1 Notes, third, Class A-2 Notes, fourth, Class B Notes, fifth, Class C Notes, sixth, Class D Notes, seventh, Class E Notes, eighth, Class F Notes, and ninth, the Subordinated Notes, with (a) each class of securities (other than the Subordinated Notes) in such list being senior to each other class of securities that follows such class of securities in such list and (b) each class of securities (other than the Class X Notes) in such

 

S-203


Table of Contents

list being subordinate to each other class of securities that precedes such class of securities in such list. The Subordinated Notes are subordinated to the 2013-1 CLO Notes and are entitled to periodic payments from interest proceeds available in accordance with the Priority of Payments.

The table below sets forth certain information for each outstanding class of notes issued, pursuant to the Indenture on October 17, 2013, at February 28, 2015:

 

Debt Security

   Interest Rate     Maturity      Principal
Amount
     Amount
Outstanding
 

Class A-1 Floating Rate Senior Notes

     LIBOR + 1.30%        October 20, 2023       $ 170,000,000       $ 170,000,000   

Class A-2 Floating Rate Senior Notes

     LIBOR + 1.50%        October 20, 2023         20,000,000         20,000,000   

Class B Floating Rate Senior Notes

     LIBOR + 2.00%        October 20, 2023         44,800,000         44,800,000   

Class C Deferrable Floating Rate Notes

     LIBOR + 2.90%        October 20, 2023         16,000,000         16,000,000   

Class D Deferrable Floating Rate Notes

     LIBOR + 3.50%        October 20, 2023         14,000,000         14,000,000   

Class E Deferrable Floating Rate Notes

     LIBOR + 4.50%        October 20, 2023         13,100,000         13,100,000   

Class F Deferrable Floating Rate Notes

     LIBOR + 5.75%        October 20, 2023         4,500,000         4,500,000   

Subordinated Notes

     N/A        October 20, 2023         30,000,000         30,000,000   
       

 

 

    

 

 

 
$ 312,400,000    $ 312,400,000   
       

 

 

    

 

 

 

The table below sets forth certain information for each outstanding class of notes issued, pursuant to the Indenture on October 17, 2013, at February 28, 2014:

 

Debt Security

   Interest Rate     Maturity      Principal
Amount
     Amount
Outstanding
 

Class X Floating Rate Senior Notes

     LIBOR + 1.05%        October 20, 2023       $ 2,500,000       $ 1,666,666   

Class A-1 Floating Rate Senior Notes

     LIBOR + 1.30%        October 20, 2023         170,000,000         170,000,000   

Class A-2 Floating Rate Senior Notes

     LIBOR + 1.50%        October 20, 2023         20,000,000         20,000,000   

Class B Floating Rate Senior Notes

     LIBOR + 2.00%        October 20, 2023         44,800,000         44,800,000   

Class C Deferrable Floating Rate Notes

     LIBOR + 2.90%        October 20, 2023         16,000,000         16,000,000   

Class D Deferrable Floating Rate Notes

     LIBOR + 3.50%        October 20, 2023         14,000,000         14,000,000   

Class E Deferrable Floating Rate Notes

     LIBOR + 4.50%        October 20, 2023         13,100,000         13,100,000   

Class F Deferrable Floating Rate Notes

     LIBOR + 5.75%        October 20, 2023         4,500,000         4,500,000   

Subordinated Notes

     N/A        October 20, 2023         30,000,000         30,000,000   
       

 

 

    

 

 

 
$ 314,900,000    $ 314,066,666   
       

 

 

    

 

 

 

 

S-204


Table of Contents

The following table shows each outstanding class of notes issued, pursuant to the Indenture, at fair value at February 28, 2015:

 

Debt Security

   February 28, 2015  

Class A-1 Floating Rate Senior Notes

   $ 168,987,651   

Class A-2 Floating Rate Senior Notes

     19,973,973   

Class B Floating Rate Senior Notes

     44,569,451   

Class C Deferrable Floating Rate Notes

     15,898,369   

Class D Deferrable Floating Rate Notes

     13,737,672   

Class E Deferrable Floating Rate Notes

     12,404,616   

Class F Deferrable Floating Rate Notes

     4,234,225   

Subordinated Notes

     17,031,146   
  

 

 

 
$ 296,837,103   
  

 

 

 

The following table shows each outstanding class of notes issued, pursuant to the Indenture, at fair value at February 28, 2014:

 

Debt Security

   February 28, 2014  

Class X Floating Rate Senior Notes

   $ 1,664,666   

Class A-1 Floating Rate Senior Notes

     168,878,000   

Class A-2 Floating Rate Senior Notes

     20,000,000   

Class B Floating Rate Senior Notes

     44,679,040   

Class C Deferrable Floating Rate Notes

     15,944,000   

Class D Deferrable Floating Rate Notes

     13,766,200   

Class E Deferrable Floating Rate Notes

     12,481,680   

Class F Deferrable Floating Rate Notes

     4,398,300   

Subordinated Notes

     19,569,596   
  

 

 

 
$ 301,381,482   
  

 

 

 

These notes are fair valued based on a discounted cash flow model, specifically using Intex cash flow models, to form the basis for the valuation and would be classified as level 3 liabilities within the fair value hierarchy.

The following table provides the weighted average interest rate for the years ended February 28, 2015, February 28, 2014 and February 28, 2013:

 

           Weighted Average Interest Rate  

Debt Security

   Interest Rate     February 28,
2015
    February 28,
2014
    February 28,
2013
 

2013-1 CLO Notes

        

Class X Floating Rate Senior Notes

     LIBOR + 1.05%        1.28     1.29     N/A   

Class A-1 Floating Rate Senior Notes

     LIBOR + 1.30%        1.53     1.54     N/A   

Class A-2 Floating Rate Senior Notes

     LIBOR + 1.50%        1.73     1.74     N/A   

Class B Floating Rate Senior Notes

     LIBOR + 2.00%        2.23     2.24     N/A   

Class C Deferrable Floating Rate Notes

     LIBOR + 2.90%        3.13     3.14     N/A   

Class D Deferrable Floating Rate Notes

     LIBOR + 3.50%        3.73     3.74     N/A   

Class E Deferrable Floating Rate Notes

     LIBOR + 4.50%        4.73     4.74     N/A   

Class F Deferrable Floating Rate Notes

     LIBOR + 5.75%        5.98     5.99     N/A   

Subordinated Notes

     N/A        N/A        N/A        N/A   

 

S-205


Table of Contents
         Weighted Average Interest Rate  

Debt Security

   Interest Rate   February 28,
2015
     February 28,
2014
    February 28,
2013
 

Secured Notes

         

Class A Floating Rate Senior Notes

   LIBOR + 0.75%     N/A         1.03     1.15

Class B Floating Rate Senior Notes

   LIBOR + 2.50%     N/A         2.78     2.90

Class C Deferrable Floating Rate Notes

   LIBOR + 3.75%     N/A         4.03     4.15

Class D Deferrable Floating Rate Notes

   LIBOR + 4.70%     N/A         4.98     5.10

Class E Deferrable Floating Rate Notes

   LIBOR + 6.45%     N/A         6.73     6.85

The Indenture provides that payments on the Subordinated Notes shall rank subordinate in priority of payment to payments due on all classes of 2013-1 CLO Notes and subordinate in priority of payment to the payment of fees and expenses. Distributions on the Subordinated Notes are limited to the assets of the Issuer remaining after payment of all of the liabilities of the Issuer that rank senior in priority of payment to the Subordinated Notes. To the extent that the proceeds from the collateral are not sufficient to make distributions on the Subordinated Notes the Issuer will have no further obligation in respect of the Subordinated Notes.

Interest proceeds and, after the 2013-1 CLO Notes have been paid in full, principal proceeds, in each case will be distributed to the holders of the Subordinated Notes in accordance with the Indenture.

Distributions, if any, on the Subordinated Notes will be payable quarterly on the 20th day of each January, April, July and October of each calendar year or, if any such day is not a business day, on the next succeeding business day (each, a “Payment Date”), commencing on the first Payment Date, and on January 21, 2020 (or if any such day is not a business day, the next succeeding business day) (the “Stated Redemption Date”) (if not redeemed prior to such date) sequentially in order of seniority. At the Stated Redemption Date, the Subordinated Notes will be redeemed after payment in full of all of the 2013-1 CLO Notes and the payment of all administrative and other fees and expenses. The failure to pay interest proceeds or principal proceeds to the holders of the Subordinated Notes will not be an event of default under the Indenture.

In May of 2009, the Issuer defaulted on its Class E overcollateralization ratio of 105.10%, at which point, $4.0 million of interest proceeds were used to repay the Class E Notes through November 2009. Interest on the Class C, Class D, and Class E Notes was deferred and repaid in January of 2010 upon the Issuer’s return to compliance. Distributions to the Subordinated Notes resumed in April of 2010.

As of February 28, 2015, the remaining unamortized discount on the Class A-1 Notes, Class A-2 Notes, Class B Notes, Class C Notes, Class D Notes, Class E Notes, and Class F Notes were $1.5 million, $0.2 million, $1.0 million, $0.6 million, $0.8 million, $1.5 million, and $0.6 million, respectively.

As of February 28, 2014, the remaining unamortized discount on the Class X, Class A-1 Notes, Class A-2 Notes, Class B Notes, Class C Notes, Class D Notes, Class E Notes, and Class F Notes were $0.0 million, $1.7 million, $0.2 million, $1.1 million, $0.7 million, $0.9 million, $1.7 million and $0.6 million, respectively.

5. Income Tax

Under the current laws, the Issuer is not subject to net income taxation in the United States or the Cayman Islands. Accordingly, no provision for income taxes has been made in the accompanying financial statements.

Pursuant to ASC Topic 740, Accounting for Uncertainty in Income Taxes, the Issuer adopted the provisions of FASB relating to accounting for uncertainty in income taxes which clarifies the accounting for income taxes by prescribing the minimum recognition threshold a tax position must meet before being recognized in the

 

S-206


Table of Contents

financial statements and applies to all open tax years as of the effective date. The Investment Manager has analyzed such tax positions for uncertain tax positions for tax years that may be open (2011—2014). The Issuer identifies its major tax jurisdictions as U.S. Federal, state and foreign jurisdictions where the Issuer makes investments. As of February 28, 2015 and 2014, there was no impact to the financial statements as a result of the Issuer’s accounting for uncertainty in income taxes. The Issuer does not have any unrecognized tax benefits or liabilities for the years ended February 28, 2015, 2014, and 2013. Also, the Issuer recognizes interest and, if applicable, penalties for any uncertain tax positions, as a component of income tax expense. No interest or penalty expense was recorded by the Issuer for the years ended February 28, 2015, 2014, and 2013.

6. Commitments and Contingencies

In the ordinary course of its business, the Issuer may enter into contracts or agreements that contain indemnifications or warranties. Future events could occur that lead to the execution of these provisions against the Issuer. Based on its history and experience, the Investment Manager feels that the likelihood of such an event is remote.

In the ordinary course of business, the Issuer may directly or indirectly be a defendant or plaintiff in legal actions with respect to bankruptcy, insolvency or other types of proceedings. Such lawsuits may involve claims that could adversely affect the value of certain financial instruments owned by the Issuer. As of February 28, 2015 and 2014, the Issuer is not subject to any material legal proceedings.

The terms of Collateralized Debt Investments may require the Issuer to provide funding for any unfunded portion of a Collateralized Debt Investment at the request of the borrower. At February 28, 2015 and 2014, the Issuer had no unfunded commitments.

7. Related-Party Transactions

In the ordinary course of business and as permitted per the terms of the Indenture, the Issuer may acquire or sell investments to or from related parties at the fair value at such time. For the years ended February 28, 2015, 2014, and 2013, the Issuer bought no investments from related parties and sold investments fair valued at $0.0 million, $0.3 million, and $0.0 million, respectively, to the Investment Manager.

The Subordinated Notes are wholly owned by the Investment Manager. The Subordinated Notes do not have a stated coupon rates, but are entitled to residual cash flows from the CLO’s investments after all of the other tranches of debt and certain other fees and expenses are paid. For the years ended February 28, 2015, 2014 and 2013, $3.7 million, $5.7 million, and $8.8 million of payments to the Subordinated Notes were included in interest expense in the Statement of Operations, respectively.

8. Shareholders’ Capital

Capital contributions and distributions shall be made at such time and in such amounts as determined by the Investment Manager and the Indenture.

The majority holder of the Subordinated Notes has various control rights over the CLO, including the ability to call the CLO prior to its legal maturity, replace the Investment Manager under certain circumstances, and refinance any of the outstanding debt tranches. The voting structure of the Subordinated Notes may require either majority or unanimous approval depending upon the issue.

The authorized share capital of the Issuer consists of 50,000 ordinary shares, 250 of which are owned by Maples Finance Limited and are held under the terms of a declaration of trust.

As of February 28, 2015 and February 28, 2014, net assets were $(5.8) million and $(3.3) million, respectively. These amounts include accumulated losses of $(3.3) million and accumulated gains of $0.8 million,

 

S-207


Table of Contents

respectively, which includes cumulative net investment income or loss, cumulative amounts of gains and losses realized from investment transactions, net unrealized appreciation or depreciation of investments, as well as the cumulative effect of accounting mismatches between investments accounted for at fair value and amortized cost or accrual-basis assets and liabilities as discussed in Significant Accounting Policies, above. The Issuer’s investments continue to generate sufficient liquidity to satisfy its obligations on periodic payment dates as well as comply with all performance criteria as of the Statements of Assets and Liabilities date.

9. Financial Highlights

The following is a schedule of financial highlights for the years ended February 28, 2015, 2014, and 2013:

 

     February 28,
2015
    February 28,
2014
    February 28,
2013
 

Average subordinated notes’ capital balance(1)

   $ 25,077,372      $ 28,471,910      $ 27,165,497   

Ratio and supplemental data:

      

Total Return(2)

     5.34     4.65     73.51

Net investment income(3)

     3.17     (7.53 )%      3.80

Total expenses(3)

     49.79     65.27     70.97

Base management fee(3)

     3.03     1.82     1.47

Subordinated management fee(3)

     3.03     4.42     5.89

 

(1) Subordinated notes’ capital balance is calculated based on the sum of the subordinated notes outstanding amount and total net assets, net of ordinary equity.
(2) Total return is calculated based on a time-weighted rate of return methodology. Quarterly rates of return are compounded to derive the total return reflected above. Total return is calculated for the subordinated notes’ capital taken as a whole and assumes the purchase of the subordinated notes’ capital on the first day of the period and the sale of the last day of the period.
(3) Calculated based on the average subordinated notes’ capital balance.

10. Subsequent Events

The Investment Manager has evaluated events or transactions that have occurred since February 28, 2015 through May 20, 2015, the date the financial statements were available for issuance. The Investment Manager has determined that there are no material events that would require the disclosure in the financial statements.

 

S-208


Table of Contents

PROSPECTUS

$50,000,000

LOGO

Common Stock

Preferred Stock

Subscription Rights

Debt Securities

Warrants

We are a specialty finance company that invests primarily in leveraged loans and mezzanine debt issued by private U.S. middle-market companies, both through direct lending and through participation in loan syndicates. Our investment objective is to generate current income and, to a lesser extent, capital appreciation from our investments.

We are externally managed and advised by Saratoga Investment Advisors, LLC, a New York-based investment firm affiliated with Saratoga Partners, a middle market private equity investment firm.

We may offer, from time to time, in one or more offerings or series, up to $50,000,000 of our common stock, preferred stock, subscription rights to purchase shares of our common stock, debt securities, and warrants representing rights to purchase shares of our common stock, preferred stock or debt securities, which we refer to, collectively, as our “securities.” The preferred stock, subscription rights, warrants and debt securities offered hereby may be convertible or exchangeable into shares of our common stock. The securities may be offered at prices and on terms to be described in one or more supplements to this prospectus.

Absent approval by the majority of our common stockholders, the offering price per share of our common stock less any underwriting commissions or discounts will not be less than the net asset value per share of our common stock at the time we make the offering unless we issue shares in connection with a rights offering to our existing stockholders or under such other circumstances as the SEC may permit. On September 30, 2014, our common stockholders voted to allow us to sell or otherwise issue the Company’s common stock at an offering price per share to investors that is not less than 85% of the Company’s then current net asset value per share for a period ending on the earlier of our next annual meeting of shareholders or September 30, 2015. In addition, we cannot issue shares of our common stock below net asset value unless our Board of Directors determines that it would be in our and our stockholders’ best interests to do so. Sales of common stock at prices below net asset value per share dilute the interests of existing stockholders, have the effect of reducing our net asset value per share and may reduce our market price per share. In addition, continuous sales of common stock below net asset value may have a negative impact on total returns and could have a negative impact on the market price of our shares of common stock. See “Sales of Common Stock Below Net Asset Value.”

Our securities may be offered directly to one or more purchasers, or through agents designated from time to time by us, or to or through underwriters or dealers. The prospectus supplement relating to an offering will identify any agents or underwriters involved in the sale of our securities, and will disclose any applicable purchase price, fee, commission or discount arrangement between us and our agents or underwriters or among our underwriters or the basis upon which such amount may be calculated. See “Plan of Distribution.” We may not sell any of our securities through agents, underwriters or dealers without delivery of this prospectus and a prospectus supplement describing the method and terms of the offering of such securities.

Our common stock is traded on the New York Stock Exchange (“NYSE”) under the symbol “SAR.” On December 4, 2014, the last reported sales price on the NYSE for our common stock was $15.05 per share. We are required to determine the net asset value per share of our common stock on a quarterly basis. Our net asset value per share of our common stock as of August 31, 2014 was $22.27.


Table of Contents

Substantially all of the debt investments held in our portfolio hold a non-investment grade rating by one or more rating agencies (which non-investment grade debt is commonly referred to as “high yield” and “junk” debt) or, if not rated, would be rated below investment grade and “junk” if rated. A majority of our debt portfolio consists of debt securities for which issuers were not required to make principal payments until the maturity of such debt securities, which could result in a substantial loss to us if such issuers are unable to refinance or repay their debt at maturity. In addition, a majority of our debt investments had variable interest rates that reset periodically based on benchmarks such as LIBOR and the prime rate. As a result, significant increases in such benchmarks in the future may make it more difficult for these borrowers to service their obligations under the debt investments that we hold.

This prospectus and any accompanying prospectus supplement contain important information about us that a prospective investor should know before investing in our securities, and will collectively constitute the prospectus for each offering of our securities hereunder. We file annual, quarterly and current reports, proxy statements and other information about us with the Securities and Exchange Commission. This information is available free of charge by contacting us at 535 Madison Avenue, New York, New York 10022, by telephone at (212) 906-7800, or on our website at http://www.saratogainvestmentcorp.com. The information on our website is not incorporated by reference into this prospectus or any accompanying prospectus supplement, and you should not consider that information to be part of either. The SEC also maintains a website at www.sec.gov that contains such information.

As of June 3, 2014, the aggregate market value of our outstanding common stock held by non-affiliates, or the public float, was approximately $40 million which was calculated based on 2,653,227 shares of outstanding common stock held by non-affiliates and on a price per share of $15.16, the closing price of our common stock on June 3, 2014. Pursuant to certain SEC rules, in no event will we sell our securities in a public primary offering with a value exceeding more than one-third of our public float in any 12-month period so long as our public float remains below $75.0 million. We have not offered any securities pursuant to the SEC rules noted above during the 12 calendar months prior to and including the date of this prospectus.

Investing in our securities involves a high degree of risk and should be considered speculative. For more information regarding the risks you should consider, including the risk of leverage, please see “Risk Factors” beginning on page 22 of this prospectus. For example, our investment in the subordinated notes of one collateralized loan obligation fund, Saratoga Investment Corp. CLO 2013-1, Ltd., represents a first loss position in a portfolio that is composed predominantly of senior secured first lien term loans. A first loss position means that we will suffer the first economic losses if losses are incurred on loans held by the collateralized loan obligation fund or losses are otherwise incurred by the collateralized loan obligation fund, including its incurrence of operating expenses in excess of its operating income.

Neither the Securities and Exchange Commission nor any other regulatory body has approved or disapproved of these securities or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.

This prospectus may not be used to consummate sales of securities unless accompanied by a prospectus supplement.

The date of this prospectus is December 11, 2014


Table of Contents

You should rely only on the information contained in this prospectus. We have not authorized any dealer, salesperson or other person to provide you with different information or to make representations as to matters not stated in this prospectus. If anyone provides you with different or inconsistent information, you should not rely on it. This prospectus is not an offer to sell, or a solicitation of an offer to buy, any securities by any person in any jurisdiction where it is unlawful for that person to make such an offer or solicitation or to any person in any jurisdiction to whom it is unlawful to make such an offer or solicitation. The information in this prospectus is accurate only as of the date of this prospectus, and under no circumstances should the delivery of this prospectus or the sale of any securities imply that the information in this prospectus is accurate as of any later date or that the affairs of Saratoga Investment Corp., have not changed since the date hereof or thereof. Our business, financial condition, results of operations and prospectus may have changed since then. We will update the information in this prospectus to reflect material changes only as required by law.

Table of Contents

 

     Page  

Prospectus Summary

     1   

The Offering

     12   

Fees and Expenses

     16   

Selected Financial and Other Data

     19   

Risk Factors

     22   

Use of Proceeds

     43   

Ratio of Earnings to Fixed Charges

     43   

Note about Forward-Looking Statements

     44   

Price Range of Common Stock and Distributions

     45   

Dividend Reinvestment Plan

     49   

Management’s Discussion and Analysis of Financial Condition and Results of Operations

     51   

Senior Securities

     80   

Business

     81   

Our Portfolio Companies

     93   

Management Agreements

     97   

Management

     105   

Portfolio Management

     113   

Certain Relationships and Related Transactions

     114   

Control Persons and Principal Stockholders

     114   

Regulation

     117   

Material U.S. Federal Income Tax Considerations

     123   

Determination of Net Asset Value

     128   

Sales of Common Stock Below Net Asset Value

     131   

Description of Our Capital Stock

     137   

Description of Our Subscription Rights

     143   

Description of Our Debt Securities

     145   

Description of Our Warrants

     159   

Plan of Distribution

     161   

Brokerage Allocation and Other Practices

     163   

Custodian, Transfer and Dividend Paying Agent and Registrar

     163   

Legal Matters

     163   

Independent Registered Public Accounting Firm

     163   

Available Information

     163   

Privacy Notice

     164   

Index to Consolidated Financial Statements

     F-1   


Table of Contents

PROSPECTUS SUMMARY

This summary highlights some of the information in this prospectus. It is not complete and may not contain all of the information that is important to you. You should read carefully the more detailed information set forth under “Risk Factors” and the other information included in this prospectus. Unless otherwise noted, the terms “we,” “us,” “our,” the “Company” and “Saratoga” refer to Saratoga Investment Corp. and its wholly owned subsidiaries, Saratoga Investment Funding LLC and Saratoga Investment Corp. SBIC LP, and does not refer to Saratoga Investment Corp. CLO 2013-1 Ltd. In addition, the terms “Saratoga Investment Advisors” and “investment adviser” refer to Saratoga Investment Advisors, LLC, our external investment adviser.

Overview

We are a specialty finance company that invests primarily in leveraged loans and mezzanine debt issued by private U.S. middle-market companies, which we define as companies having annual EBITDA (earnings before interest, taxes, depreciation and amortization) of between $5 million and $50 million, both through direct lending and through participation in loan syndicates. Our investment objective is to generate current income and, to a lesser extent, capital appreciation from our investments. We are externally managed and advised by Saratoga Investment Advisors, LLC, a New York-based investment firm affiliated with Saratoga Partners, a middle market private equity investment firm.

Our portfolio is comprised primarily of investments in leveraged loans (both first and second lien term loans) issued by middle market companies. Term loans are loans that do not allow the borrowers to repay all or a portion of the loans prior to maturity and then re-borrow such repaid amounts under the loan again. Leveraged loans are generally senior debt instruments that rank ahead of subordinated debt which are issued by companies with below investment grade and “junk” ratings or, if not rated, would be rated below investment grade and “junk” and, as a result, carry a higher risk of default. Leveraged loans also have the benefit of first or second lien security interests on the assets of the portfolio company, which may rank ahead of, or be junior to, other security interests. We also purchase mezzanine debt and make equity investments in middle market companies. Mezzanine debt is typically unsecured and subordinated to senior debt of the portfolio company. As of August 31, 2014, 41.9% of our debt portfolio at fair value consisted of debt securities for which issuers were not required to make principal payments until the maturity of such debt securities, which could result in a substantial loss to us if such issuers are unable to refinance or repay their debt at maturity.

Substantially all of the debt investments held in our portfolio hold a non-investment grade rating by one or more rating agencies (which non-investment grade debt is commonly referred to as “high yield” and “junk” debt) or, if not rated, would be rated below investment grade and “junk” if rated. In addition, 62.2% of our debt investments at August 31, 2014 had variable interest rates that reset periodically based on benchmarks such as LIBOR and the prime rate. As a result, significant increases in such benchmarks in the future may make it more difficult for these borrowers to service their obligations under the debt investments that we hold.

While our primary focus is to generate current income and capital appreciation from our debt and equity investments in middle market companies, we may invest up to 30% of the portfolio in opportunistic investments in order to seek to enhance returns to stockholders. Such investments may include investments in distressed debt, including securities of companies in bankruptcy, foreign debt, private equity, securities of public companies that are not thinly traded and structured finance vehicles such as collateralized loan obligation funds.

As of August 31, 2014, we had total assets of $247.2 million and investments in 39 portfolio companies and an additional investment in the subordinated notes of one collateralized loan obligation fund, Saratoga Investment Corp. CLO 2013-1, Ltd. (“Saratoga CLO”), which investment had a fair value of $20.1 million as of August 31, 2014. Our overall portfolio composition as of August 31, 2014 consisted of 11.3% of syndicated loans, 48.9% of first lien term loans, 12.4% of second lien term loans, 10.6% of senior secured notes, 2.5% of

 

 

1


Table of Contents

unsecured notes, 8.5% of subordinated notes of Saratoga CLO and 5.8% of common equity. As of August 31, 2014, the weighted average yield on all of our debt investments, including our investment in the subordinated notes of Saratoga CLO, was approximately 12.2%. The weighted average yield of our debt investments is not the same as a return on investment for our stockholders and, among other things, is calculated before the payment of our fees and expenses. As of August 31, 2014, approximately 99% of our first lien debt investments, which comprises 48.9% of our portfolio, were fully collateralized in the sense that the portfolio companies in which we held such investments had an asset coverage equal to or greater than the principal amount of the related debt investment. Even though these loans are fully collateralized as is the case with all of the liens on our debt investments, there can be no assurance that the value of collateral will be sufficient to allow the portfolio company repay our first lien debt investments in the event of its default on our investment.

Saratoga CLO is an exempted company with limited liability incorporated under the laws of the Cayman Islands, which was established to acquire or participate in U.S. dollar-denominated corporate debt obligations. Saratoga CLO has issued various tranches of senior notes, held by numerous investors, and one tranche of subordinated notes, held entirely by us. As we own 100% of the subordinated notes issued by Saratoga CLO, which is junior to all of its other outstanding indebtedness, we are deemed to hold 100% of the equity interests in Saratoga CLO for tax purposes. Our investment in the subordinated notes of Saratoga CLO represents a first loss position in a portfolio that, at August 31, 2014, was composed of $304.4 million in aggregate principal amount of predominantly senior secured first lien term loans. A first loss position means that we will suffer the first economic losses if losses are incurred on loans held by the Saratoga CLO or losses otherwise incurred by Saratoga CLO, including its incurrence of operating expenses in excess of its operating income. As a result, this investment is subject to unique risks. See “Risk Factors—Our investment in Saratoga CLO constitutes a leveraged investment in a portfolio of predominantly senior secured first lien term loans and is subject to additional risks and volatility” for information regarding the general risks related to our investment in Saratoga CLO. Although we believe that we have observed and will observe certain formalities and operating procedures that are generally recognized requirements for maintaining our separate existence and that our assets and liabilities can be readily identified as distinct from those of Saratoga CLO, there can be no assurance that a bankruptcy court, in the exercise of its broad equitable powers, would not order that our assets and liabilities be substantively consolidated with those of Saratoga CLO in connection with a bankruptcy proceeding involving us or Saratoga CLO, including for the purposes of making distributions under a plan of reorganization or liquidation. Substantive consolidation means that our assets are placed in a single bankruptcy estate with those of Saratoga CLO, rather than kept separate, and that the creditors of Saratoga CLO have a claim against that single estate (including our assets), as opposed to retaining their claims against only Saratoga CLO. See “Risk Factors—In the event that a bankruptcy court orders the substantive consolidation of us with Saratoga CLO, the creditors of Saratoga CLO, including the holders of $304.4 million aggregate principal amount of debt, as of August 31, 2014, issued by Saratoga CLO, would have claims against the consolidated bankruptcy estate.”

We are an externally managed, closed-end, non-diversified management investment company that has elected to be regulated as a business development company (“BDC”) under the Investment Company Act of 1940 (“1940 Act”). As a BDC, we are required to comply with various regulatory requirements, including limitations on our use of debt. We finance our investments through borrowings. However, as a BDC, we are only generally allowed to borrow amounts such that our asset coverage, as defined in the 1940 Act, equals at least 200% after such borrowing.

We have elected to be treated for U.S. federal income tax purposes as a regulated investment company (“RIC”), under Subchapter M of the Internal Revenue Code of 1986 (the “Code”). As a RIC, we generally will not have to pay corporate-level federal income taxes on any net ordinary income or capital gains that we distribute to our stockholders if we meet certain source-of-income, distribution and asset diversification requirements.

 

 

2


Table of Contents

In addition, we have a wholly-owned subsidiary that is licensed as a small business investment company (“SBIC”) and regulated by the Small Business Administration (“SBA”). See “Regulation—Small Business Investment Company Regulations.” The SBIC license allows us, through our wholly-owned subsidiary, to issue SBA-guaranteed debentures. We received exemptive relief from the Securities and Exchange Commission to permit us to exclude the debt of our SBIC subsidiary guaranteed by the SBA from the definition of senior securities in the 200% asset coverage test under the 1940 Act. This allows us increased flexibility under the 200% asset coverage test by permitting us to borrow up to $150 million more than we would otherwise be able to absent the receipt of this exemptive relief.

Saratoga Investment Advisors

Our investment adviser was formed in 2010 as a Delaware limited liability company and became our investment adviser in July 2010. Our investment adviser is led by four principals, Christian L. Oberbeck, Michael J. Grisius, Thomas V. Inglesby, and Charles G. Phillips, with 26, 24, 27 and 17 years of experience in leveraged finance, respectively. Our investment adviser is affiliated with Saratoga Partners, a middle market private equity investment firm. Saratoga Partners was established in 1984 to be the middle market private investment arm of Dillon Read & Co. Inc. and has been independent of Dillon Read since 1998. Saratoga Partners has a 28-year history of private investments in middle market companies and focuses on public and private equity, preferred stock, and senior and mezzanine debt investments.

We utilize the personnel, infrastructure, relationships and experience of Saratoga Investment Advisors to enhance the growth of our business. We currently have no employees and each of our executive officers is also an officer of Saratoga Investment Advisors.

We have entered into an investment advisory and management agreement with Saratoga Investment Advisors. Pursuant to the investment advisory and management agreement, Saratoga Investment Advisors implements our business strategy on a day-to-day basis and performs certain services for us under the direction of our board of directors. Saratoga Investment Advisors is responsible for, among other duties, performing all of our day-to-day investment-related functions, determining investment criteria, sourcing, analyzing and executing investments, asset sales, financings and performing asset management duties.

Saratoga Investment Advisors has formed an investment committee to advise and consult with its senior management team with respect to our investment policies, investment portfolio holdings, financing and leveraging strategies and investment guidelines. We believe that the collective experience of the investment committee members across a variety of fixed income asset classes will benefit us. The investment committee must unanimously approve all investments in excess of $1 million made by us. In addition, all sales of our investments must be approved by three out of four investment committee members. The current members of the investment committee are Messrs. Oberbeck, Grisius, Inglesby, and Phillips.

Investments

Our portfolio is comprised primarily of investments in leveraged loans issued by middle market companies. Investments in middle market companies are generally less liquid than equivalent investments in companies with larger capitalizations. These investments are sourced in both the primary and secondary markets through a network of relationships with commercial and investment banks, commercial finance companies and financial sponsors. The leveraged loans that we purchase are generally used to finance buyouts, acquisitions, growth, recapitalizations and other types of transactions. Leveraged loans are generally senior debt instruments that rank ahead of subordinated debt which are issued by companies with below investment grade and “junk” ratings or, if not rated, would be rated below investment grade and “junk” and, as a result, carry a higher risk of default. Leveraged loans also have the benefit of security interests on the assets of the portfolio company, which may rank ahead of, or be junior to, other security interests. For a discussion risks pertaining to our secured investments, see “Risk Factors—Our investments may be risky, and you could lose all or part of our investment.”

 

 

3


Table of Contents

As part of our long-term strategy, we also purchase mezzanine debt and make equity investments in middle market companies. Mezzanine debt is typically unsecured and subordinated to senior debt of the portfolio company. See “Risk Factors—If we make unsecured debt investments, we may lack adequate protection in the event our portfolio companies become distressed or insolvent and will likely experience a lower recovery than more senior debtholders in the event our portfolio companies defaults on their indebtedness.”

In general, at least 70% of a BDC’s assets must be comprised of the type of assets that are listed in Section 55(a) of the 1940 Act, which are referred to as qualifying assets. Qualifying assets are generally securities of U.S. private operating companies, or listed operating companies with an aggregate market value of outstanding voting and non-voting common equity of less than $250 million. As of August 31, 2014, with the exception of our investment in the subordinated notes of Saratoga CLO, all of our equity and debt investments constituted qualifying assets under the 1940 Act. While our primary focus is to generate current income and capital appreciation from our debt and equity investments in middle market companies, we may invest up to 30% of the portfolio in opportunistic investments in order to seek to enhance returns to stockholders. Such investments may include investments in distressed debt, private equity, securities of public companies that are not thinly traded and structured finance vehicles such as collateralized loan obligation funds.

Prospective portfolio company characteristics

Our investment adviser generally selects portfolio companies with one or more of the following characteristics:

 

    a history of generating stable earnings and strong free cash flow;

 

    well-constructed balance sheets, including an established tangible liquidation value;

 

    reasonable debt-to-cash flow multiples;

 

    industry leadership with competitive advantages and sustainable market shares in attractive sectors; and

 

    capital structures that provide appropriate terms and reasonable covenants.

Investment selection

In managing us, Saratoga Investment Advisors employs the same investment philosophy and portfolio management methodologies used by Saratoga Partners. Through this investment selection process, based on quantitative and qualitative analysis, Saratoga Investment Advisors seeks to identify portfolio companies with superior fundamental risk-reward profiles and strong, defensible business franchises with the goal of minimizing principal losses while maximizing risk-adjusted returns. Saratoga Investment Advisors’ investment process emphasizes the following:

 

    bottoms-up, company-specific research and analysis;

 

    capital preservation, low volatility and minimization of downside risk; and

 

    investing with experienced management teams that hold meaningful equity ownership in their businesses.

Our investment adviser’s investment process generally includes the following steps:

 

    Initial screening. A brief analysis identifies the investment opportunity and reviews the merits of the transaction. The initial screening memorandum provides a brief description of the company, its industry, competitive position, capital structure, financials, equity sponsor and deal economics. If the deal is determined to be attractive by the senior members of the deal team, the opportunity is fully analyzed.

 

 

4


Table of Contents
    Comprehensive analysis. A comprehensive analysis includes:

 

    Business and Industry analysis—a review of the company’s business position, competitive dynamics within its industry, cost and growth drivers and technological and geographic factors. Business and industry research often includes meetings with industry experts, consultants, other investors, customers and competitors.

 

    Company analysis—a review of the company’s historical financial performance, future projections, cash flow characteristics, balance sheet strength, liquidation value, legal, financial and accounting risks, contingent liabilities, market share analysis and growth prospects. The Company considers the ability of each portfolio company to continue to make payments in an atmosphere of rising interest rates as a component of its overall diligence and monitoring process. In this regard, the Company regularly receives projections from its portfolio companies and models future performance for them in connection with its valuation process, taking into account changes in interest rates on the portfolio companies. Notwithstanding the foregoing, there can be no assurances that the portfolio companies will be able to meet their contractual obligations at any or all levels of increases in interest rates.

 

    Structural/security analysis—a thorough legal document analysis including but not limited to an assessment of financial and negative covenants, events of default, enforceability of liens and voting rights.

 

    Approval of the investment committee. The investment is then presented to the investment committee for approval. The investment committee must unanimously approve all investments in excess of $1 million made by us. In addition, all sales of our investments must be approved by four out of five investment committee members.

Investment structure

In general, our investment adviser intends to select investments with financial covenants and terms that reduce leverage over time, thereby enhancing credit quality. These methods include:

 

    maintenance leverage covenants requiring a decreasing ratio of debt to cash flow;

 

    maintenance cash flow covenants requiring an increasing ratio of cash flow to the sum of interest expense and capital expenditures; and

 

    debt incurrence prohibitions, limiting a company’s ability to re-lever.

In addition, limitations on asset sales and capital expenditures should prevent a company from changing the nature of its business or capitalization without our consent.

Our investment adviser seeks, where appropriate, to limit the downside potential of our investments by:

 

    requiring a total return on our investments (including both interest and potential equity appreciation) that compensates us for credit risk;

 

    requiring companies to use a portion of their excess cash flow to repay debt;

 

    selecting investments with covenants that incorporate call protection as part of the investment structure; and

 

    selecting investments with affirmative and negative covenants, default penalties, lien protection, change of control provisions and board rights, including either observation or participation rights.

 

 

5


Table of Contents

Valuation process

We carry our investments at fair value, as approved in good faith using written policies and procedures adopted by our board of directors. Investments for which market quotations are readily available are recorded in our financial statements at such market quotations subject to any decision by our board of directors to approve a fair value determination to reflect significant events affecting the value of these investments. We value investments for which market quotations are not readily available at fair value as approved in good faith by our board of directors based on input from Saratoga Investment Advisors, our audit committee and, on a selected basis, a third party independent valuation firm. Determinations of fair value may involve subjective judgments and estimates. The types of factors that may be considered in determining the fair value of our investments include the nature and realizable value of any collateral, the portfolio company’s ability to make payments, the markets in which the portfolio company does business, market yield trend analysis, comparison to publicly traded companies, discounted cash flow and other relevant factors.

Our investment in the subordinated notes of Saratoga CLO is carried at fair value, which is based on a discounted cash flow model that utilizes prepayment, re-investment and loss assumptions based on historical experience and projected performance, economic factors, the characteristics of the underlying cash flow, and comparable yields for similar collateralized loan obligation fund subordinated notes or equity, when available. Specifically, we use Intex cash flow models, or an appropriate substitute, to form the basis for Saratoga CLO’s valuation. The models use a set of assumptions including projected default rates, recovery rates, reinvestment rate and prepayment rates in order to arrive at estimated cash flows. The assumptions are based on available market data and projections provided by third parties as well as management estimates. We use the output from the Intex models (i.e., the estimated cash flows from our investment in Saratoga CLO) to perform a discounted cash flows analysis on expected future cash flows from our investment in Saratoga CLO to determine a valuation for the subordinated notes of Saratoga CLO held by us.

We undertake a multi-step valuation process each quarter when valuing investments for which market quotations are not readily available, as described below:

 

    each investment is initially valued by the responsible investment professionals of Saratoga Investment Advisors and preliminary valuation conclusions are documented and discussed with our senior management; and

 

    an independent valuation firm engaged by our board of directors independently values at least one quarter of our investments each quarter so that the valuation of each investment for which market quotes are not readily available is independently valued by an independent valuation firm at least annually.

In addition, all our investments are subject to the following valuation process:

 

    the audit committee of our board of directors reviews each preliminary valuation and our investment adviser and independent valuation firm (if applicable) will supplement the preliminary valuation to reflect any comments provided by the audit committee; and

 

    our board of directors discusses the valuations and approves the fair value of each investment in good faith based on the input of our investment adviser, independent valuation firm (if applicable) and audit committee.

Because such valuations, and particularly valuations of private investments and private companies, are inherently uncertain, they may fluctuate over short periods of time and may be based on estimates. The determination of fair value may differ materially from the values that would have been used if a ready market for these investments existed. Our net asset value could be materially affected if the determinations regarding the fair value of our investments were materially higher or lower than the values that we ultimately realize upon the disposal of such investments.

 

 

6


Table of Contents

Ongoing relationships with and monitoring of portfolio companies

Saratoga Investment Advisors closely monitors each investment we make and, when appropriate, conducts a regular dialogue with both the management team and other debtholders and seeks specifically tailored financial reporting. In addition, in certain circumstances, senior investment professionals of Saratoga Investment Advisors may take board seats or board observation seats.

Risk Factors

Investing in us involves significant risks. The following is a summary of certain risks that you should carefully consider before investing in us. For a further discussion of these risk factors, please see “Risk Factors” beginning on page 21.

Risks Related to Our Business and Structure

 

    The current state of the economy and financial markets increases the likelihood of adverse effects on our financial position and results of operations.

 

    Saratoga Investment Advisors has a limited history of managing a BDC or a RIC.

 

    We may be obligated to pay Saratoga Investment Advisors incentive fees even if we incur a net loss or there is a decline in the value of our portfolio.

 

    Under the terms of the investment advisory and management agreement, we may have to pay incentive fees to Saratoga Investment Advisors in connection with the sale of an investment that is sold at a price higher than the fair value of such investment on May 31, 2010, even if we incur a loss on the sale of such investment.

 

    The way in which the base management and incentive fees under the investment advisory and management agreement is determined may encourage Saratoga Investment Advisors to take actions that may not be in the best interests of the holders of our securities.

 

    The base management fee we pay to Saratoga Investment Advisors may cause it to increase our leverage contrary to our interest.

 

    We employ leverage, which magnifies the potential for gain or loss on amounts invested and may increase the risk of investing in our securities.

 

    Saratoga Investment Advisors’ liability is limited under the investment advisory and management agreement and we will indemnify Saratoga Investments Advisors against certain liabilities, which may lead it to act in a riskier manner on our behalf than it would when acting for its own account.

 

    Substantially all of our assets are subject to security interests under the Credit Facility, or claims of the SBA with respect to SBA-guaranteed debentures we may issue and if we default on our obligations thereunder, we may suffer adverse consequences, including Madison Capital Funding and/or the SBA foreclosing on our assets.

 

    We are exposed to risks associated with changes in interest rates, including potential effects on our cost of capital and net investment income.

 

    There are significant potential conflicts of interest which could adversely impact our investment returns.

 

    Changes in laws or regulations governing our operations, or changes in the interpretation thereof, and any failure by us to comply with laws or regulations governing our operations may adversely affect our business.

 

 

7


Table of Contents
    Regulations governing our operation as a BDC affect our ability to, and the way in which we, raise additional capital.

 

    Pending legislation may allow us to incur additional leverage.

 

    The agreement governing the Credit Facility contains various covenants that, among other things, limits our discretion in operating our business and provides for certain minimum financial covenants.

 

    A failure on our part to maintain our qualification as a BDC would significantly reduce our operating flexibility.

 

    We will be subject to corporate-level federal income tax if we fail to continue to qualify as a RIC.

 

    Because we intend to distribute between 90% and 100% of our income to our stockholders in connection with our election to be treated as a RIC, we will continue to need additional capital to finance our growth. If additional funds are unavailable or not available on favorable terms, our ability to grow will be impaired.

 

    We may have difficulty paying our required distributions if we recognize income before or without receiving cash in respect of such income.

 

    Our ability to enter into transactions with our affiliates is restricted.

 

    We operate in a highly competitive market for investment opportunities.

 

    Economic recessions or downturns could impair our portfolio companies and harm our operating results.

 

    We are a non-diversified investment company within the meaning of the 1940 Act, and therefore we are not limited with respect to the proportion of our assets that may be invested in securities of a single issuer.

 

    Our financial condition and results of operation depend on our ability to manage future investments effectively.

 

    We may experience fluctuations in our quarterly results.

 

    Substantially all of our portfolio investments are recorded at fair value as approved in good faith by our board of directors; such valuations are inherently uncertain and may be materially higher or lower than the values that we ultimately realize upon the disposal of such investments.

 

    If we make unsecured debt investments, we may lack adequate protection in the event our portfolio companies become distressed or insolvent and will likely experience a lower recovery than more senior debtholders in the event our portfolio companies default on their indebtedness.

 

    If we invest in the securities and other obligations of distressed or bankrupt companies, such investments may be subject to significant risks, including lack of income, extraordinary expenses, uncertainty with respect to satisfaction of debt, lower-than expected investment values or income potentials and resale restrictions.

 

    Second priority liens on collateral securing loans that we make to our portfolio companies may be subject to control by senior creditors with first priority liens. If there is a default, the value of the collateral may not be sufficient to repay in full both the first priority creditors and us.

 

    The lack of liquidity in our investments may adversely affect our business.

 

    The debt securities in which we invest are subject to credit risk and prepayment risk.

 

    Uncertainty relating to the LIBOR calculation process may adversely affect the value of our portfolio of the LIBOR-indexed, floating-rate debt securities.

 

 

8


Table of Contents
    Our investment in Saratoga CLO constitutes a leveraged investment in a portfolio of predominantly senior secured first lien term loans and is subject to additional risks and volatility.

 

    Available information about privately held companies is limited.

 

    When we are a debt or minority equity investor in a portfolio company, we may not be in a position to control the entity, and its management may make decisions that could decrease the value of our investment.

 

    Our portfolio companies may incur debt or issue equity securities that rank equally with, or senior to, our investments in such companies.

 

    There may be circumstances where our debt investments could be subordinated to claims of other creditors or we could be subject to lender liability claims.

 

    Investments in equity securities involve a substantial degree of risk.

 

    Our investments in foreign debt, including that of emerging market issuers, may involve significant risks in addition to the risks inherent in U.S. investments.

 

    We may expose ourselves to risks if we engage in hedging transactions.

 

    Our board of directors may change our investment objective, operating policies and strategies without prior notice or stockholder approval, the effects of which may be adverse.

 

    We have no prior experience managing an SBIC and any failure to comply with SBA regulations, resulting from our lack of experience or otherwise, could have an adverse effect on our operations.

 

    Our investments may be risky, and you could lose all or part of your investment.

 

    Our independent auditors have not assessed our internal control over financial reporting. If our internal control over financial reporting is not effective, it could have a material adverse effect on our stock price and our ability to raise capital.

Risks Related to Our Common Stock

 

    Investing in our common stock may involve an above average degree of risk.

 

    We may continue to choose to pay dividends in our own stock, in which case you may be required to pay tax in excess of the cash you receive.

 

    The market price of our common stock may fluctuate significantly.

 

    There is a risk that you may not receive distributions or that our distributions may not grow over time.

 

    Provisions of our governing documents and the Maryland General Corporation Law could deter future takeover attempts and have an adverse impact on the price of our common stock.

 

    Our common stock may trade at a discount to our net asset value per share.

 

    Stockholders may incur dilution if we sell shares of our common stock in one or more offerings at prices below the then current net asset value per share of our common stock.

 

    The issuance of subscription rights, warrants or convertible debt that are exchangeable for our common stock will cause your economic interest and voting power in us to be diluted as a result of our offering of any such securities.

 

    We may be unable to invest a significant portion of the net proceeds from this offering, which could harm our financial condition and operating results.

 

 

9


Table of Contents

Recent Developments

On September 17, 2014, we entered into a second amendment to our senior secured revolving credit facility with Madison Capital Funding LLC to, among other things, (1) extend the commitment termination date from February 24, 2015 to September 17, 2017; (2) extend the maturity date of the credit facility from February 24, 2020 to September 17, 2022 (unless terminated sooner upon certain events); (3) reduce the applicable margin rate on base rate borrowings from 4.50% to 3.75%; (4) reduce the applicable margin rate on LIBOR borrowings from 5.50% to 4.75%; (5) reduce the floor on base rate borrowings from 3.0% to 2.25%; and (6) reduce the floor on LIBOR borrowings from 2.0% to 1.25%.

On September 24, 2014, our board of directors adopted a new dividend policy pursuant to which the Company would begin to pay a regular quarterly cash dividend to shareholders. We declared our first dividend in the amount of $0.18 per share for the fiscal quarter ended August 31, 2014, and a dividend in the amount of $0.22 per share for the fiscal quarter ended November 30, 2014. The dividend for the fiscal quarter ended August 31, 2014 will be payable on November 28, 2014 to all stockholders of record at the close of business on November 3, 2014, and the dividend for the fiscal quarter ended November 30, 2014 will be payable on February 27, 2015 to all stockholders of record at the close of business on February 2, 2015.

Also on September 24, 2014, we adopted a new dividend reinvestment plan (“DRIP”) that provides for the reinvestment of dividends on behalf of our stockholders, unless a stockholder has elected to receive dividends in cash. As a result, if we declare a dividend, stockholders who have not “opted out” of the DRIP by the dividend record date will have their dividend automatically reinvested into additional shares of our common stock. We have the option to satisfy the share requirements of the DRIP through the issuance of new shares of common stock or through open market purchases of common stock by the DRIP plan administrator. Newly-issued shares will be issued at a price equal to 95% of the average of the market prices of our common stock at the close of trading on the 10 trading days immediately preceding and ending on the date fixed by our board of directors for the payment of the dividend. If shares are purchased in the open market to satisfy the DRIP requirements, they will be issued at a price based upon the average price of the applicable shares purchased by the DRIP plan administrator, before any associated brokerage or other costs. Stockholders who receive distributions in the form of our common stock will be subject to the same federal, state and local tax consequences as stockholders who elect to receive their distributions in cash, and will need to pay any such taxes from other sources in light of the fact that their distributions will be reinvested in additional shares of the Company’s common stock. See “Dividend Reinvestment Plan” for a description of the plan and information on how to “opt out” of the plan.

In addition, on September 24, 2014, our board of directors approved an open market share repurchase plan that allows us to repurchase up to 200,000 shares of our common stock at prices below net asset value per share as reported in our most recently filed financial statements. Shares may be purchased in the open market, including through block purchases, at the discretion of our management. The share repurchase plan does not obligate us to acquire any specific number of shares. Unless extended by our board of directors, the share repurchase plan will expire on October 15, 2015, and may be limited or terminated at any time without prior notice.

Corporate History and Information

We commenced operations on March 23, 2007 as GSC Investment Corp. and completed an initial public offering (“IPO”) of shares of our common stock on March 28, 2007. From the date we commenced operations until July 30, 2010, we were managed and advised by GSCP (NJ), L.P., an entity affiliated with GSC Group, Inc. In connection with the consummation of a recapitalization transaction on July 30, 2010, we engaged Saratoga Investment Advisors to replace GSCP (NJ), L.P. as our investment adviser and changed our name to Saratoga Investment Corp.

The recapitalization transaction consisted of (i) the private sale of 986,842 shares of our common stock for $15 million in aggregate purchase price to Saratoga Investment Advisors and certain of its affiliates and (ii) the

 

 

10


Table of Contents

entry into a senior secured revolving credit facility with Madison Capital Funding LLC (“Madison Capital Funding”). We used the net proceeds from the private sale of shares of our common stock and a portion of the funds available to us under the secured revolving credit facility with Madison Capital Funding to pay the full amount of principal and accrued interest, including default interest, outstanding under our revolving securitized credit facility with Deutsche Bank AG, New York Branch. Specifically, in July 2009, we had exceeded permissible borrowing limits under the revolving securitized credit facility with Deutsche Bank, which resulted in an event of default under the revolving securitized credit facility. As a result of the event of default, Deutsche Bank had the right to accelerate repayment of the outstanding indebtedness under the revolving securitized credit facility and to foreclose and liquidate the collateral pledged under the revolving securitized credit facility. The revolving securitized credit facility with Deutsche Bank was terminated in connection with our payment of all amounts outstanding thereunder on July 30, 2010. In January 2011, we registered for public resale by Saratoga Investment Advisors and certain of its affiliates the 986,842 shares of our common stock issued to them in the recapitalization.

On March 28, 2012, our wholly-owned subsidiary, Saratoga Investment Corp SBIC, LP, received an SBIC license from the SBA.

Our corporate offices are located at 535 Madison Avenue, New York, New York 10022. Our telephone number is (212) 906-7800. We maintain a website on the Internet at www.saratogainvestmentcorp.com. Information contained on our website is not incorporated by reference into this prospectus, and you should not consider that information to be part of this prospectus.

On August 31, 2012, a complaint was filed in the United States Bankruptcy Court for the Southern District of New York by GSC Acquisition Holdings, LLC against us to recover, among other things, approximately $2.6 million for the benefit of the estates and the general unsecured creditors of GSC Group, Inc. and its affiliates, including the Company’s former investment adviser, GSCP (NJ), L.P. The complaint alleges that the former investment adviser made a constructively fraudulent transfer of $2.6 million in deferred incentive fees by waiving them in connection with the termination of the Management Agreement with us, and that the termination of the Management Agreement was itself a fraudulent transfer. These transfers, the complaint alleges, were made without receipt of reasonably equivalent value and while the former investment adviser was insolvent. The complaint has not yet been served, and the plaintiff’s motion for authority to prosecute the case on behalf of the estates was taken under advisement by the court on October 1, 2012. We opposed that motion. We believe that the claims in this lawsuit are without merit and, if the plaintiff is authorized to proceed, intend to vigorously defend against this action.

 

 

11


Table of Contents

THE OFFERING

We may offer, from time to time, up to $50,000,000 of our securities, on terms to be determined at the time of the offering. Our securities may be offered at prices and on terms to be disclosed in one or more prospectus supplements.

Our securities may be offered directly to one or more purchasers by us or through agents designated from time to time by us, or to or through underwriters or dealers. The prospectus supplement relating to the offering will disclose the terms of the offering, including the name or names of any agents or underwriters involved in the sale of our securities by us, the purchase price, and any fee, commission or discount arrangement between us and our agents or underwriters or among our underwriters or the basis upon which such amount may be calculated. See “Plan of Distribution.” We may not sell any of our securities directly or through agents, underwriters or dealers without delivery of a prospectus supplement describing the method and terms of the offering of our securities.

Set forth below is additional information regarding the offering of our securities:

 

Use of proceeds

We intend to use substantially all of the net proceeds from the sale of our securities to make investments in middle-market companies in accordance with our investment objective and strategies described in this prospectus, and for general corporate purposes. We may also use a portion of the net proceeds to reduce any of our outstanding borrowings. Pending such use, we will invest the net proceeds primarily in high quality, short-term debt securities consistent with our business development company election and our election to be taxed as a RIC. Reducing our borrowings may include the repurchase of certain debt instruments that could provide us with a net gain on extinguishment of debt, and increase certain fees payable to our investment adviser. See “Use of Proceeds.”

Investment Advisory and Management Agreement

Saratoga Investment Advisors serves as our investment adviser. Our investment adviser was formed in 2010 as a Delaware limited liability company and became our investment advisor in July 2010. Subject to the overall supervision of our board of directors, Saratoga Investment Advisors manages our day-to-day operations and provides investment advisory and management services to us. Under the terms of an investment advisory and management agreement, Saratoga Investment Advisors:

 

    determines the composition of our portfolio, the nature and timing of the changes to our portfolio and the manner of implementing such changes;

 

    identifies, evaluates and negotiates the structure of the investments we make (including performing due diligence on our prospective portfolio companies);

 

    closes and monitors the investments we make; and

 

    determines the securities and other assets that we purchase, retain or sell.

 

 

12


Table of Contents
  Pursuant to the investment advisory and management agreement with Saratoga Investment Advisors, we pay Saratoga Investment Advisors a fee for investment advisory and management services consisting of two components—a base management fee and an incentive fee.

 

  The base management fee is paid quarterly in arrears, and equals 1.75% per annum of our gross assets (other than cash or cash equivalents but including assets purchased with borrowed funds) and calculated at the end of each fiscal quarter based on the average value of our gross assets (other than cash or cash equivalents but including assets purchased with borrowed funds) as of the end of such fiscal quarter and the end of the immediate prior fiscal quarter. Base management fees for any partial month or quarter are appropriately pro-rated.

 

  The incentive fee has the following two parts:

 

  The first part is calculated and payable quarterly in arrears based on our pre-incentive fee net investment income for the immediately preceding fiscal quarter. Pre-incentive fee net investment income means interest income, dividend income and any other income (including any other fees such as commitment, origination, structuring, diligence, managerial and consulting fees or other fees that we receive from portfolio companies) accrued during the fiscal quarter, minus our operating expenses for the quarter (including the base management fee, expenses payable under the administration agreement, and any interest expense and dividends paid on any issued and outstanding preferred stock or debt security, but excluding the incentive fee). Pre-incentive fee net investment income includes, in the case of investments with a deferred interest feature (such as market discount, debt instruments with payment-in-kind interest, preferred stock with payment-in-kind dividends and zero coupon securities), accrued income that we have not yet received in cash. Pre-incentive fee net investment income does not include any realized capital gains, realized capital losses or unrealized capital appreciation or depreciation. Pre-incentive fee net investment income, expressed as a rate of return on the value of our net assets (defined as total assets less liabilities) at the end of the immediately preceding fiscal quarter, is compared to a “hurdle rate” of 1.875% per quarter (7.5% annualized), subject to a “catch up” provision. The base management fee is calculated prior to giving effect to the payment of any incentive fees.

 

 

We pay Saratoga Investment Advisors an incentive fee with respect to our pre-incentive fee net investment income in each fiscal quarter as follows: (A) no incentive fee in any fiscal quarter in which our pre-incentive fee net investment income does not exceed the hurdle rate; (B) 100.0% of our pre-incentive fee net investment income with respect to that portion of such pre-incentive fee net investment income, if any, that exceeds the hurdle rate but is less than or equal to

 

 

13


Table of Contents
 

2.344% in any fiscal quarter (9.376% annualized) is payable to Saratoga Investment Advisors; and (C) 20.0% of the amount of our pre-incentive fee net investment income, if any, that exceeds 2.344% in any fiscal quarter (9.376% annualized). We refer to the amount specified in clause (B) as the “catch-up.” The “catch-up” provision is intended to provide Saratoga Investment Advisors with an incentive fee of 20.0% on all of our pre-incentive fee net investment income as if a hurdle rate did not apply when our pre-incentive fee net investment income exceeds 2.344% in any fiscal quarter. Notwithstanding the foregoing, with respect to any period ending on or prior to December 31, 2010, Saratoga Investment Advisors was only entitled to 20.0% of the amount of our pre-incentive fee net investment income, if any, that exceeded 1.875% in any fiscal quarter (7.5% annualized) without any catch-up provision. These calculations are appropriately pro-rated when such calculations are applicable for any period of less than three months. See “Management Agreements”.

 

Administration Agreement

Pursuant to a separate administration agreement, Saratoga Investment Advisors, who also serves as our administrator, furnishes us with office facilities, equipment and clerical, book-keeping and record keeping services. Under the administration agreement, our administrator also performs, or oversees the performance of, our required administrative services, which include, among other things, being responsible for the financial records which we are required to maintain, preparing reports for our stockholders and reports required to be filed with the SEC. In addition, our administrator assists us in determining and publishing our net asset value, oversees the preparation and filing of our tax returns and the printing and dissemination of reports to our stockholders, and generally oversees the payment of our expenses and the performance of administrative and professional services rendered to us by others. Payments under the administration agreement equal an amount based upon our allocable portion of our administrator’s overhead in performing its obligations under the administration agreement, including rent and our allocable portion of the cost of our officers and their respective staffs relating to the performance of services under this agreement (including travel expenses). Our allocable portion is based on the proportion that our total assets bears to the total assets administered or managed by our administrator. Under the administration agreement, our administrator also provides managerial assistance, on our behalf, to those portfolio companies who accept our offer of assistance. The administration agreement may be terminated by either party without penalty upon 60 days’ written notice to the other party. The amount payable by us under the administration agreement is currently capped at $1.0 million for each annual term of the agreement. On July 10, 2014, our board of directors approved the renewal of the administration agreement for an additional one-year term and determined to maintain the cap on the payment or reimbursement of expenses by us thereunder to $1.0 million for the additional one-year term. See “Management Agreements”.

 

 

14


Table of Contents

Distributions

Our distributions, if any, will be determined by our board of directors and paid out of assets legally available for distribution. Prior to January 2009, we paid quarterly dividends to our stockholders. However, in January 2009, we suspended the practice of paying quarterly dividends to our stockholders and only paid five dividend distributions (December 2013, 2012, 2011, 2010 and 2009) to our stockholders through December 2013, which distributions were made with a combination of cash and the issuance of shares of our common stock. On September 24, 2014, our board of directors adopted a new dividend policy pursuant to which we will begin to again pay a regular quarterly cash dividend to our shareholders. In this regard, our board of directors declared a dividend in the amount of $0.18 per share for the fiscal quarter ended August 31, 2014, and a dividend in the amount of $0.22 per share for the fiscal quarter ended November 30, 2014. The dividend for the fiscal quarter ended August 31, 2014 will be payable on November 28, 2014 to all stockholders of record at the close of business on November 3, 2014, and the dividend for the fiscal quarter ended November 30, 2014 will be payable on February 27, 2015 to all stockholders of record at the close of business on February 2, 2015.

 

Taxation

We elected to be treated for federal income tax purposes as a RIC under Subchapter M of the Code. Accordingly, we generally will not pay corporate-level federal income taxes on any net ordinary income or realized net capital gains that we distribute to our stockholders as dividends. To maintain our RIC tax treatment, we must meet specified source-of- income and asset diversification requirements and distribute annually at least 90% of our net ordinary income and realized net short-term capital gains in excess of realized net long-term capital losses, if any. Depending on the level of taxable income earned in a tax year, we may choose to carry forward taxable income in excess of current year distributions into the next tax year and pay a 4% excise tax on such income. Any such carryover taxable income must be distributed through a dividend declared prior to filing the final tax return related to the year which generated such taxable income. See “Material U.S. Federal Income Tax Considerations.”

 

Dividend reinvestment plan

We maintain an “opt out” dividend reinvestment plan for our common stockholders. As a result, if we declare a dividend, then stockholders’ cash dividends will be automatically reinvested in additional shares of our common stock, unless they specifically “opt out” of the dividend reinvestment plan so as to receive cash dividends. Stockholders who receive distributions in the form of our common stock will be subject to the same federal, state and local tax consequences as stockholders who elect to receive their distributions in cash, and will need to pay any such taxes from other sources in light of the fact that their distributions will be reinvested in additional shares of the Company’s common stock. See “Dividend Reinvestment Plan” for a description of the plan and information on how to “opt out” of the plan.

 

 

15


Table of Contents

FEES AND EXPENSES

The following table is intended to assist you in understanding the costs and expenses that an investor in this offering will bear directly or indirectly. We caution you that some of the percentages indicated in the table below are estimates and may vary. Moreover, the information set forth below does not include any transaction costs and expenses that investors will incur in connection with each offering of our securities pursuant to this prospectus. As a result, investors are urged to read the “Fees and Expenses” table contained in any corresponding prospectus supplement to fully understanding the actual transaction costs and expenses they will incur in connection with each such offering. Except where the context suggests otherwise, whenever this prospectus contains a reference to fees or expenses paid by “you,” “us” or “Saratoga Investment Corp.,” or that “we” will pay fees or expenses, stockholders will indirectly bear such fees or expenses as investors in Saratoga Investment Corp.

 

Stockholder transaction expenses (as a percentage of offering price):

  

Sales load paid

  —  % (1) 

Offering expenses borne by us

  —  % (2) 

Dividend reinvestment plan expenses

  None (3) 
   

 

 

 

Total stockholder transaction expenses paid

  —  %   

Annual estimated expenses (as a percentage of average net assets attributable to common stock):

Management fees

  3.2% (4) 

Incentive fees payable under the investment advisory and management agreement

  1.4% (5) 

Interest payments on borrowed funds

  6.0% (6) 

Other expenses

  3.3% (7) 
   

 

 

 

Total annual expenses

  13.9% (8) 

 

(1) In the event that the shares of common stock to which this prospectus relates are sold to or through underwriters, a corresponding prospectus supplement will disclose the applicable sales load.
(2) The prospectus supplement corresponding to each offering will disclose the applicable offering expenses and total stockholder transaction expenses.
(3) The expenses associated with the administration of our dividend reinvestment plan are included in “Other expenses.” The participants in the dividend reinvestment plan will pay a pro rata share of brokerage commissions incurred with respect to open market purchases, if any, made by the administrator under the plan. For more details about the plan, see “Dividend Reinvestment Plan.”
(4) Our base management fee under the investment advisory and management agreement with Saratoga Investment Advisors is based on our gross assets, which is defined as our total assets, including those acquired using borrowings for investment purposes, but excluding cash and cash equivalents. See “Investment Advisory and Management Agreement.” The fact that our base management fee is payable based upon our gross assets, rather than our net assets (i.e., total assets after deduction of any liabilities, including borrowings) means that our base management fee as a percentage of net assets attributable to common stock will increase when we utilize leverage.
(5) The incentive fee consists of two parts. The first part is calculated and payable quarterly in arrears and equals 20% of our “pre-incentive fee net investment income” for the immediately preceding quarter, subject to a preferred return, or “hurdle,” and a “catch up” feature. For this purpose, “pre-incentive fee net investment income” means interest income, dividend income and any other income (including any other fees, such as commitment, origination, structuring, diligence, managerial and consulting fees or other fees that we receive from portfolio companies) accrued by us during the fiscal quarter, minus our operating expenses for the quarter (including the base management fee, expenses payable under the administration agreement described below, and any interest expense and dividends paid on any issued and outstanding preferred stock, but excluding the incentive fee).

 

 

16


Table of Contents

The second part of the incentive fee is determined and payable in arrears as of the end of each fiscal year (or upon termination of the investment advisory and management agreement) and equals 20% of our “incentive fee capital gains,” which equals our realized capital gains on a cumulative basis from May 31, 2010 through the end of the year, if any, computed net of all realized capital losses and unrealized capital depreciation on a cumulative basis, less the aggregate amount of any previously paid capital gain incentive fee. Under the investment advisory and management agreement, the capital gains portion of the incentive fee is based on realized gains and realized and unrealized losses from May 31, 2010. Therefore, realized and unrealized losses incurred prior to such time will not be taken into account when calculating the capital gains portion of the incentive fee, and Saratoga Investment Advisors will be entitled to 20% of incentive fee capital gains that arise after May 31, 2010. In addition, the cost basis for computing realized gains and losses on investments held by us as of May 31, 2010 will equal the fair value of such investments as of such date. We estimate this as zero for purposes of this table as these fees are hard to predict, as they are based on capital gains and losses. See “Investment Advisory and Management Agreement.”

 

(6) We may borrow funds from time to time to make investments to the extent we determine that the economic situation is conducive to doing so. The 6.0% figure in the table includes all expected borrowing costs in connection with the secured revolving credit facility we have with Madison Capital Funding LLC. The costs associated with our outstanding borrowings are indirectly borne by our stockholders. We do not expect to issue any preferred stock during the next twelve months and, therefore, have not included the cost of issuing and servicing preferred stock in the table. In addition, all of the commitment fees, interest expense, amortized financing costs of our Credit Facility, SBA debentures, and the 7.50% Notes due 2020 issued by us in May 2013, and the fees and expenses of issuing and servicing any other borrowings or leverage that we expect to incur during the next twelve months are included in the table and expense example presentation below.
(7) “Other expenses” are based on estimated amounts for the current fiscal year and include our overhead expenses, including payments under our administration agreement based on our allocable portion of overhead and other expenses incurred by Saratoga Investment Advisors in performing its obligations under the administration agreement. See “Administration Agreement.”
(8) This figure includes all of the fees and expenses of our wholly-owned subsidiaries, Saratoga Investment Corp SBIC, LP and Saratoga Investment Funding LLC.

Example

The following example demonstrates the projected dollar amount of total cumulative expenses over various periods with respect to a hypothetical investment in our common stock. In calculating the following expense amounts, we have assumed that we would have no additional leverage and our annual operating expenses would remain at the levels set forth in the table above. In the event that shares to which this prospectus relates are sold to or through underwriters, a corresponding prospectus supplement will restate this example to reflect the applicable sales load and offering expenses.

 

     1 Year      3 Years      5 Years      10 Years  

You would pay the following expenses on a $1,000 investment, assuming a 5% annual return on portfolio

   $ 130       $ 390       $ 650       $ 1,300   

This example and the expenses in the table above should not be considered a representation of our future expenses, and actual expenses (including the cost of debt, if any, and other expenses) may be greater or less than those shown.

The foregoing table is to assist you in understanding the various costs and expenses that an investor in our common stock will bear directly or indirectly. While the example assumes, as required by the SEC, a 5% annual

 

 

17


Table of Contents

return, our performance will vary and may result in a return greater or less than 5%. The incentive fee under the investment advisory and management agreement, which, assuming a 5% annual return, would either not be payable or have an insignificant impact on the expense amounts shown above, is not included in the example. If we achieve sufficient returns on our investments, including through the realization of capital gains, to trigger an incentive fee of a material amount, our expenses, and returns to our investors, would be higher.

While the example assumes reinvestment of all dividends and distributions at net asset value, participants in our dividend reinvestment plan will receive a number of shares of our common stock, determined by dividing the total dollar amount of the dividend payable to a participant by either (i) the greater of (x) the net asset value of our common stock or (y) 95% of the market price per share of our common stock at the close of trading on the payment date fixed by our board of directors in the event that we use newly issued shares to satisfy the share requirements of the dividend reinvestment plan or (ii) the average purchase price, including any brokerage charges or other charges, of all shares of common stock purchased by the administrator of the dividend reinvestment plan in the event that shares are purchased in the open market to satisfy the share requirements of the dividend reinvestment plan, which may be at, above or below net asset value. See “Dividend Reinvestment Plan” for additional information regarding our dividend reinvestment plan.

 

 

18


Table of Contents

SELECTED FINANCIAL AND OTHER DATA

The following selected financial and other data reflects the consolidated financial condition and the consolidated statement of operations of Saratoga as of and for the years ended February 28, 2014, February 28, 2013, February 29, 2012, February 28, 2011, and February 28, 2010. The selected financial and other data have been derived from our consolidated financial statements which have been audited by Ernst & Young LLP, an independent registered public accounting firm, whose report thereon is included in this registration statement. The financial information as of and for the six months ended August 31, 2014 and 2013 was derived from our unaudited financial statements and related notes. In the opinion of management, all adjustments, consisting solely of normal recurring accruals, considered necessary for the fair presentation of financial statements for the interim periods, have been included. The data should be read in conjunction with our financial statements and notes thereto and “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” which are included in this prospectus. The historical data is not necessarily indicative of results to be expected for any future period.

 

    Six Months Ended
August 31,
2014
    Six Months Ended
August 31,
2013
    Year Ended
February 28,
2014
    Year Ended
February 28,
2013
    Year Ended
February 29,
2012
    Year Ended
February 28,
2011
    Year Ended
February 28,
2010
 
    (dollar amounts in
thousands, except
share and per
share numbers)
                                     

Income Statement Data:

             

Interest and related portfolio income:

             

Interest

  $ 11,639      $ 9,963      $ 20,187      $ 14,450      $ 11,262      $ 12,050      $ 13,324   

Management fee and other income

    980        1,443        2,706        2,557        2,250        2,123        2,293   
     

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total interest and related portfolio income

    12,619        11,406        22,893        17,007        13,512        14,173        15,617   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Expenses:

             

Interest and debt financing expenses

    3,597        2,731        6,084        2,540        1,298        2,612        4,096   

Base management and incentive management fees(1)

    3,176        2,329        4,018        4,152        2,875        3,514        2,278   

Administrator expenses

    500        500        1,000        1,000        1,000        810        671   

Administrative and other

    1,213        1,104        2,670        2,287        2,638        4,882        3,502   

Expense reimbursement

    —          —          —          —          —          (2,894     (671
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total operating expenses after reimbursements

    8,486        6,664        13,772        9,979        7,811        8,924        9,876   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income before income taxes

    4,133        4,742        9,121        7,028        5,701        5,249        5,741   

Income tax expenses, including excise tax

    —          —          —          —          —          —          (27
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income

  $ 4,133      $ 4,742      $ 9,121      $ 7,028      $ 5,701      $ 5,249      $ 5,714   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

 

19


Table of Contents
    Six Months Ended
August 31,
2014
    Six Months Ended
August 31,
2013
    Year Ended
February 28,
2014
    Year Ended
February 28,
2013
    Year Ended
February 29,
2012
    Year Ended
February 28,
2011
    Year Ended
February 28,
2010
 
    (dollar amounts in thousands, except share and per share numbers)  

Realized and unrealized gain (loss) on investments and derivatives:

             

Net realized gain (loss)

  $ 442      $ 1,074      $ 1,271      $ 431      $ (12,186   $ (24,684   $ (6,654

Net change in unrealized gain (loss)

    319        (2,057     (1,648     7,143        19,760        36,393        (9,523
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total net gain (loss)

    761        (983     (377     7,574        7,574        11,709        (16,177
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) in net assets resulting from operations

  $ 4,894      $ 3,759      $ 8,744      $ 14,602      $ 13,275      $ 16,958      $ (10,463
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Per Share:

             

Earnings (loss) per common share—basic and diluted(2)(5)

  $ 0.91      $ 0.79      $ 1.78      $ 3.55      $ 3.87      $ 6.96      $ (9.86

Net investment income per share—basic and
diluted(2)(5)

  $ 0.77      $ 1.00      $ 1.85      $ 1.71      $ 1.66      $ 2.15      $ 5.38   

Net realized and unrealized gain (loss) per share—basic and diluted(2)(5)

  $ 0.14      $ (0.21   $ (0.07   $ 1.84      $ 2.21      $ 4.81      $ (15.24

Dividends declared per common share(3)(5)

  $ —        $ —        $ 2.65      $ 4.25      $ 3.00      $ 4.40      $ 18.25   

Dilutive impact of dividends paid in stock on net asset value per share(4)

  $ —        $ —        $ (0.75   $ (1.44   $ (2.01   $ (9.05   $ (21.10

Net asset value per share

  $
22.27
  
  $
23.77
  
  $ 21.36      $ 22.98      $ 25.12      $ 26.26      $ 32.75   

Statement of Assets and Liabilities Data:

             

Investment assets at fair value

  $ 236,320      $ 187,800      $ 205,845      $ 155,080      $ 95,360      $ 80,025      $ 89,373   

Total assets

    247,230        224,057        219,177        174,411        125,491        98,769        96,935   

Total debt outstanding

    121,200        88,300        98,300        60,300        20,000        4,500        36,992   

Stockholders’ equity

    119,818        112,445        114,924        108,687        97,380        86,071        55,478   

Net asset value per common share(5)

  $ 22.27      $ 23.77      $ 21.36      $ 22.98      $ 25.12      $ 26.26      $ 32.75   

Common shares outstanding at end of period

    5,379,616        4,730,116        5,379,616        4,730,116        3,876,661        3,277,077        1,694,010   

Other Data:

             

Investments funded

  $ 53,348      $ 87,854      $ 121,074      $ 71,596      $ 38,679      $ 9,014      $ —     

Principal collections related to investment repayments or sales

  $ 24,387      $ 54,850      $ 71,607      $ 21,488      $ 33,568      $ 31,975      $ 15,185   

Number of investments at end of period

    65        55        60        47        33        37        41   

Weighted average yield of income producing debt investments—Non-control/ non-affiliate

    11.02     10.38     10.62     11.26     11.88     11.1     9.6

Weighted average yield on income producing debt investments—Control

    23.91     27.20     18.55     27.11     20.17     15.8     8.3

 

 

20


Table of Contents

 

(1) See note 6 in consolidated financial statements contained elsewhere herein.
(2) For the six months ended August 31, 2014 and August 31, 2013, amounts are calculated using weighted average common shares outstanding of 5,379,616 and 4,730,116, respectively. For the years ended February 28, 2014, February 28, 2013, February 29, 2012, February 28, 2011 and February 28, 2010 amounts are calculated using weighted average common shares outstanding of 4,920,517, 4,110,484, 3,434,345, 2,437,577, and 1,061,351, respectively.
(3) Calculated using the shares outstanding at ex-dividend date.
(4) Dilutive effect of the issuance of shares of common stock below net asset value per share in connection with the satisfaction of the Company’s annual RIC distribution requirement. See “Price Range of Common Stock and Distributions—Dividend Policy.”
(5) Earnings per share, dividend per share and net asset value per share figures for February 28, 2010 were updated and do not reflect historical figures.

 

 

21


Table of Contents

RISK FACTORS

Investing in our securities involves a high degree of risk. Before you invest in our securities, you should be aware of various significant risks, including those described below. You should carefully consider these risks, together with all of the other information included in this prospectus, before you decide whether to make an investment in our securities. The risks set forth below are the principal risks with respect to an investment in our securities generally and with respect to a business development company with investment objectives, investment policies, capital structures or trading markets similar to ours. However, they may not be the only risks we face. If any of the following risks occur, our business, financial condition and results of our operations could be materially adversely affected. In such case, you could lose all or part of your investment.

Risks Related to Our Business and Structure

The current state of the economy and financial markets increases the likelihood of adverse effects on our financial position and results of operations.

The broader economic fundamentals of the United States economy remain uncertain. Unemployment levels remain elevated and other economic fundamentals remain depressed. In the event that the United States economic performance contracts, it is likely that the financial results of middle market companies, like those in which we invest, could experience deterioration or limited growth, which could ultimately lead to difficulty in meeting their debt service requirements and an increase in defaults. Consequently, we can provide no assurance that the performance of certain of our portfolio companies will not be negatively impacted by economic or other conditions, which could also have a negative impact on our future results.

The current worldwide financial market situation, as well as various social and political tensions in the United States and around the world, may continue to contribute to increased market volatility, may have long-term effects on the United States and worldwide financial markets, and may cause further economic uncertainties or deterioration in the United States and worldwide. Since 2010, several European Union (“EU”) countries, including Greece, Ireland, Italy, Spain, and Portugal, have faced budget issues, some of which may have negative long-term effects for the economies of those countries and other EU countries. There is continued concern about national-level support for the Euro and the accompanying coordination of fiscal and wage policy among European Economic and Monetary Union member countries. In addition, the fiscal policy of foreign nations, such as China, may have a severe impact on the worldwide and United States financial markets. Moreover, there are concerns that the recent economic slowdown in China could have a negative impact on markets throughout the world. We do not know how long the financial markets will continue to be affected by these events and cannot predict the effects of these or similar events in the future on the United States economy and securities markets or on our investments. We monitor developments and seek to manage our investments in a manner consistent with achieving our investment objective, but there can be no assurance that we will be successful in doing so.

Although we have been able to secure access to additional liquidity, the potential for volatility in the debt and in the equity capital markets provides no assurance that debt or equity capital will be available to us in the future on favorable terms, or at all.

We may be obligated to pay Saratoga Investment Advisors incentive fees even if we incur a net loss, or there is a decline in the value of our portfolio.

Saratoga Investment Advisors is entitled to incentive fees for each fiscal quarter in an amount equal to a percentage of the excess of our investment income for that quarter (before deducting incentive compensation, but net of operating expenses and certain other items) above a threshold return for that quarter. Our pre-incentive fee net investment income, for incentive compensation purposes, excludes realized and unrealized capital gains or losses that we may incur in the fiscal quarter, even if such capital gains or losses result in a net gain or loss on

 

22


Table of Contents

our statement of operations for that quarter. Thus, we may be required to pay Saratoga Investment Advisors incentive fees for a fiscal quarter even if there is a decline in the value of our portfolio or we incur a net loss for that quarter.

Under the terms of the Management Agreement, we may have to pay incentive fees to Saratoga Investment Advisors in connection with the sale of an investment that is sold at a price higher than the fair value of such investment on May 31, 2010, even if we incur a loss on the sale of such investment.

Incentive fees on capital gains paid to Saratoga Investment Advisors under the Management Agreement equals 20.0% of our “incentive fee capital gains,” which equals our realized capital gains on a cumulative basis from May 31, 2010 through the end of the year, if any, computed net of all realized capital losses and unrealized capital depreciation on a cumulative basis, less the aggregate amount of any previously paid capital gain incentive fee. Under the Management Agreement, the capital gains portion of the incentive fee is based on realized gains and realized and unrealized losses from May 31, 2010. Therefore, realized and unrealized losses incurred prior to such time will not be taken into account when calculating the capital gains portion of the incentive fee, and Saratoga Investment Advisors will be entitled to 20.0% of the incentive fee capital gains that arise after May 31, 2010. In addition, the cost basis for computing realized gains and losses on investments held by us as of May 31, 2010 will equal the fair value of such investments as of such date. See our Form 10-Q for the quarter ended May 31, 2010 that was filed with the SEC on July 15, 2010 for the fair value and other information related to our investments as of such date. As a result, we may be required to pay incentive fees to Saratoga Investment Advisors on the sale of an investment even if we incur a realized loss on such investment, so long as the investment is sold for an amount greater than its fair value as of May 31, 2010.

The way in which the base management and incentive fees under the Management Agreement is determined may encourage Saratoga Investment Advisors to take actions that may not be in our best interests.

The incentive fee payable by us to our investment adviser may create an incentive for it to make investments on our behalf that are risky or more speculative than would be the case in the absence of such compensation arrangement, which could result in higher investment losses, particularly during cyclical economic downturns. The way in which the incentive fee payable to our investment adviser is determined, which is calculated separately in two components as a percentage of the income (subject to a hurdle rate) and as a percentage of the realized gain on invested capital, may encourage our investment adviser to use leverage to increase the return on our investments or otherwise manipulate our income so as to recognize income in quarters where the hurdle rate is exceeded. Moreover, we pay Saratoga Investment Advisors a base management fee based on our total assets, including any investments made with borrowings, which may create an incentive for it to cause us to incur more leverage than is prudent, or not to repay our outstanding indebtedness when it may be advantageous for us to do so, in order to maximize its compensation. Under certain circumstances, the use of leverage may increase the likelihood of default, which would disfavor the holders of our securities.

The incentive fee payable by us to our investment adviser also may create an incentive for our investment adviser to invest on our behalf in instruments that have a deferred interest feature. Under these investments, we would accrue the interest over the life of the investment but would not receive the cash income from the investment until the end of the investment’s term, if at all. Our net investment income used to calculate the income portion of our incentive fee, however, includes accrued interest. Thus, a portion of the incentive fee would be based on income that we have not yet received in cash and may never receive in cash if the portfolio company is unable to satisfy such interest payment obligation to us. Consequently, while we may make incentive fee payments on income accruals that we may not collect in the future and with respect to which we do not have a “claw back” right against our investment adviser per se, the amount of accrued income written off in any period will reduce the income in the period in which such write-off was taken and may thereby reduce such period’s incentive fee payment.

In addition, Saratoga Investment Advisors receives a quarterly income incentive fee based, in part, on our pre-incentive fee net investment income, if any, for the immediately preceding calendar quarter. This income

 

23


Table of Contents

incentive fee is subject to a fixed quarterly hurdle rate before providing an income incentive fee return to Saratoga Investment Advisors. This fixed hurdle rate was determined when then current interest rates were relatively low on a historical basis. Thus, if interest rates rise, it would become easier for our investment income to exceed the hurdle rate and, as a result, more likely that Saratoga Investment Advisors will receive an income incentive fee than if interest rates on our investments remained constant or decreased. In addition, if we repurchase our outstanding debt securities, including our 7.50% Notes due 2020 (the “Notes”) and such repurchase results in our recording a net gain on the extinguishment of debt for financial reporting and tax purposes, such net gain will be included in our pre-incentive fee net investment income for purposes of determining the income incentive fee payable to our investment adviser under the Management Agreement.

Moreover, our investment adviser receives the incentive fee based, in part, upon net capital gains realized on our investments. Unlike the portion of the incentive fee based on income, there is no performance threshold applicable to the portion of the incentive fee based on net capital gains. As a result, our investment adviser may have a tendency to invest more in investments that are likely to result in capital gains as compared to income producing securities. Such a practice could result in our investing in more speculative securities than would otherwise be the case, which could result in higher investment losses, particularly during economic downturns.

Our board of directors will seek to ensure that Saratoga Investment Advisors is acting in our best interests and that any conflict of interest faced by Saratoga Investment Advisors in its capacity as our investment adviser does not negatively impact us.

The base management fee we pay to Saratoga Investment Advisors may cause it to increase our leverage contrary to our interest.

We pay Saratoga Investment Advisors a quarterly base management fee based on the value of our total assets (including any assets acquired with leverage). Accordingly, Saratoga Investment Advisors has an economic incentive to increase our leverage. Our board of directors monitors the conflicts presented by this compensation structure by approving the amount of leverage that we incur. If our leverage is increased, we will be exposed to increased risk of loss, bear the increase cost of issuing and servicing such senior indebtedness, and will be subject to any additional covenant restrictions imposed on us in an indenture or other instrument or by the applicable lender.

We employ leverage, which magnifies the potential for gain or loss on amounts invested and may increase the risk of investing in us.

Borrowings, also known as leverage, magnify the potential for gain or loss on amounts invested and, therefore, increase the risks associated with investing in us. We borrow from and issue senior debt securities to banks and other lenders that is secured by a lien on our assets. Holders of these senior securities have fixed dollar claims on our assets that are superior to the claims of the holders of our securities, including the holders of our securities. Leverage is generally considered a speculative investment technique. Any increase in our income in excess of interest payable on our outstanding indebtedness would cause our net income to increase more than it would have had we not incurred leverage, while any decrease in our income would cause net income to decline more sharply than it would have had we not incurred leverage. Such a decline could negatively affect our ability to make common stock distributions or scheduled debt payments, including with respect to the Notes. There can be no assurance that our leveraging strategy will be successful.

Our outstanding indebtedness imposes, and additional debt we may incur in the future will likely impose, financial and operating covenants that restrict our business activities, including limitations that could hinder our ability to finance additional loans and investments or to make the distributions required to maintain our status as a RIC. A failure to add new debt facilities or issue additional debt securities or other evidences of indebtedness in lieu of or in addition to existing indebtedness could have a material adverse effect on our business, financial condition or results of operations.

 

24


Table of Contents

As of August 31, 2014, we had $64.0 million outstanding indebtedness guaranteed by the SBA and $48.3 million of outstanding Notes. This debt requires periodic payments of interest. The weighted average interest rate charged on our borrowings as of August 31, 2014 was 5.14% per annum (exclusive of deferred financing costs). We will need to generate sufficient cash flow to make these required interest payments. In order for us to cover our annual interest payments on indebtedness, we must achieve annual returns on our August 31, 2014 total assets of at least 2.4%.

Illustration. The following table illustrates the effect of leverage on returns from an investment in our common stock assuming various annual returns, net of expenses. The calculations in the table below are hypothetical and actual returns may be higher or lower than those appearing below:

Assumed Return on Our Portfolio(1)

(net of expenses)

 

     –10.0%     –5.0%     0.0%     5.0%     10.0%  

Corresponding net return to common stockholder

     –26.4     –16.2     –5.9     4.3     14.5

 

(1) Assumes $239.2 million in average total assets, $112.3 million in average debt outstanding, $117.0 million in average net assets and an average interest rate of 5.32%. Actual interest payments may be different.

Saratoga Investment Advisors’ liability is limited under the Management Agreement and we will indemnify Saratoga Investments Advisors against certain liabilities, which may lead it to act in a riskier manner on our behalf than it would when acting for its own account.

Saratoga Investment Advisors has not assumed any responsibility to us other than to render the services described in the Management Agreement. Pursuant to the Management Agreement, Saratoga Investment Advisors and its officers and employees are not liable to us for their acts under the Management Agreement absent willful misfeasance, bad faith, gross negligence or reckless disregard in the performance of their duties. We have agreed to indemnify, defend and protect Saratoga Investment Advisors and its officers and employees with respect to all damages, liabilities, costs and expenses resulting from acts of Saratoga Investment Advisors not arising out of willful misfeasance, bad faith, gross negligence or reckless disregard in the performance of their duties under the Management Agreement. These protections may lead Saratoga Investment Advisors to act in a riskier manner when acting on our behalf than it would when acting for its own account.

Substantially all of our assets are subject to security interests under our Credit Facility or claims of the SBA with respect to SBA-guaranteed debentures we may issue and if we default on our obligations thereunder, we may suffer adverse consequences, including the foreclosure on our assets.

Substantially all of our assets are pledged as collateral under the Credit Facility or are subject to a superior claim over the holders of our common stock or the Notes by the SBA pursuant to the SBA-guaranteed debentures. If we default on our obligations under the Credit Facility or the SBA-guaranteed debentures, Madison Capital Funding and/or the SBA may have the right to foreclose upon and sell, or otherwise transfer, the collateral subject to their security interests or superior claim. In such event, we may be forced to sell our investments to raise funds to repay our outstanding borrowings in order to avoid foreclosure and these forced sales may be at times and at prices we would not consider advantageous. Moreover, such deleveraging of our company could significantly impair our ability to effectively operate our business in the manner in which we have historically operated.

In addition, if Madison Capital Funding exercises its right to sell the assets pledged under the Credit Facility, such sales may be completed at distressed sale prices, thereby diminishing or potentially eliminating the amount of cash available to us after repayment of the amounts outstanding under the Credit Facility.

 

25


Table of Contents

We are exposed to risks associated with changes in interest rates including potential effects on our cost of capital and net investment income.

General interest rate fluctuations and changes in credit spreads on floating rate loans may have a substantial negative impact on our investments and investment opportunities and, accordingly, may have a material adverse effect on our rate of return on invested capital. In addition, an increase in interest rates would make it more expensive to use debt to finance our investments. Decreases in credit spreads on debt that pays a floating rate of return would have an impact on the income generation of our floating rate assets. Trading prices for debt that pays a fixed rate of return tend to fall as interest rates rise. Trading prices tend to fluctuate more for fixed rate securities that have longer maturities. Although we have no policy governing the maturities of our investments, under current market conditions we expect that we will invest in a portfolio of debt generally having maturities of up to ten years. This means that we will be subject to greater risk (other things being equal) than an entity investing solely in shorter-term securities.

Because we may borrow to fund our investments, a portion of our net investment income may be dependent upon the difference between the interest rate at which we borrow funds and the interest rate at which we invest these funds. A portion of our investments will have fixed interest rates, while a portion of our borrowings will likely have floating interest rates. As a result, a significant change in market interest rates could have a material adverse effect on our net investment income. In periods of rising interest rates, our cost of funds could increase, which would reduce our net investment income. We may hedge against such interest rate fluctuations by using standard hedging instruments such as futures, options and forward contracts, subject to applicable legal requirements, including without limitation, all necessary registrations (or exemptions from registration) with the Commodity Futures Trading Commission. These activities may limit our ability to participate in the benefits of lower interest rates with respect to the hedged borrowings. Adverse developments resulting from changes in interest rates or hedging transactions could have a material adverse effect on our business, financial condition and results of operations.

There are significant potential conflicts of interest which could adversely impact our investment returns.

Our executive officers and directors, and the members of our investment adviser, serve or may serve as officers, directors or principals of entities that operate in the same or a related line of business as we do or of investment funds managed by our affiliates. Accordingly, they may have obligations to investors in those entities, the fulfillment of which might not be in the best interests of us or our stockholders. For example, Christian L. Oberbeck, our chief executive officer and managing member of our investment adviser, is the managing partner of Saratoga Partners, a middle market private equity investment firm. In addition, the principals of our investment adviser may manage other funds which may from time to time have overlapping investment objectives with those of us and accordingly invest in, whether principally or secondarily, asset classes similar to those targeted by us. If this should occur, the principals of our investment adviser will face conflicts of interest in the allocation of investment opportunities to us and such other funds. Although our investment professionals will endeavor to allocate investment opportunities in a fair and equitable manner, we and our common stockholders could be adversely affected in the event investment opportunities are allocated among us and other investment vehicles managed or sponsored by, or affiliated with, our executive officers, directors and investment adviser, and the members of our investment adviser.

Changes in laws or regulations governing our operations, or changes in the interpretation thereof, and any failure by us to comply with laws or regulations governing our operations may adversely affect our business.

We are subject to regulation at the local, state and federal levels. These laws and regulations, as well as their interpretation, may be changed from time to time. Any change in these laws or regulations, or their interpretation, or any failure by us to comply with these laws or regulations may adversely affect our business.

Regulations governing our operation as a BDC will affect our ability to raise additional capital.

Our business requires a substantial amount of additional capital. We may acquire additional capital from the issuance of senior securities or other indebtedness or the issuance of additional shares of our common stock.

 

26


Table of Contents

However, we may not be able to raise additional capital in the future on favorable terms or at all. We may issue debt securities or preferred securities, which we refer to collectively as “senior securities,” and we may borrow money from banks or other financial institutions, up to the maximum amount permitted by the 1940 Act.

Under the provisions of the 1940 Act, we are permitted, as a BDC, to incur indebtedness or issue senior securities only in amounts such that our asset coverage, as defined in the 1940 Act, equals at least 200.0% after such incurrence or issuance. Our ability to issue different types of securities is also limited. Compliance with these requirements may unfavorably limit our investment opportunities and reduce our ability in comparison to other companies to profit from favorable spreads between the rates at which we can borrow and the rates at which we can lend. As a business development company, therefore, we may need to issue equity more frequently than our privately owned competitors, which may lead to greater stockholder dilution. With respect to certain types of senior securities, we must make provisions to prohibit any dividend distribution to our stockholders or the repurchase of certain of our securities, unless we meet the applicable asset coverage ratios at the time of the dividend distribution or repurchase. If the value of our assets declines, we may be unable to satisfy the asset coverage test. If that happens, we may be required to liquidate a portion of our investments and repay a portion of our indebtedness at a time when such sales may be disadvantageous in order to make dividend distributions or repurchase certain of our securities.

We are not generally able to issue and sell our common stock at a price below net asset value per share. We may, however, sell our common stock, or warrants, options or rights to acquire our common stock, at a price below the current net asset value of the common stock if our board of directors determines that such sale is in our best interests and the best interests of our stockholders, and our stockholders approve such sale. In any such case, the price at which our securities are to be issued and sold may not be less than a price which, in the determination of our board of directors, closely approximates the market value of such securities (less any commission or discount). If our common stock trades at a discount to net asset value, this restriction could adversely affect our ability to raise capital. At our 2014 annual meeting of stockholders, our stockholders approved a proposal that authorizes us to sell shares of our common stock below the then current net asset value per share of our common stock at an offering price per share that is not less than 85% of the then current net asset value per share in one or more offerings for a period of one year ending on the earlier of our next annual meeting of shareholders or September 30, 2015. Continued access to this exception will require approval of similar proposals at future stockholder meetings. If our common stock trades at a discount to net asset value, this restriction could adversely affect our ability to raise capital.

Pending legislation may allow us to incur additional leverage.

As a business development company, we are generally not permitted to incur indebtedness unless immediately after such borrowing we have an asset coverage for total borrowings of at least 200% (i.e., the amount of debt may not exceed 50% of the value of our assets). We have agreed in the covenant in the indenture governing the Notes not to violate this section of the 1940 Act, whether or not we continue to be subject to such provision, but giving effect, in either case, to any exemptive relief granted to us by the SEC. Recent legislation introduced in the U.S. House of Representatives, if passed, would modify this section of the 1940 Act and increase the amount of debt that business development companies may incur by modifying the percentage from 200% to 150%. As a result, we may be able to incur additional indebtedness in the future and therefore your risk of an investment in our securities may increase.

The agreement governing our Credit Facility contains various covenants that, among other things, limits our discretion in operating our business and provides for certain minimum financial covenants.

The agreement governing the Credit Facility contains customary default provisions such as the termination or departure of certain “key persons” of Saratoga Investment Advisors, a material adverse change in our business and the failure to maintain certain minimum loan quality and performance standards. An event of default under

 

27


Table of Contents

the facility would result, among other things, in termination of the availability of further funds under the facility and an accelerated maturity date for all amounts outstanding under the facility, which would likely disrupt our business and, potentially, the portfolio companies whose loans we financed through the facility. This could reduce our revenues and, by delaying any cash payment allowed to us under the facility until the lender has been paid in full, reduce our liquidity and cash flow and impair our ability to grow our business and maintain our status as a RIC.

Each loan origination under the facility is subject to the satisfaction of certain conditions. We cannot assure you that we will be able to borrow funds under the facility at any particular time or at all.

A failure on our part to maintain our qualification as a business development company would significantly reduce our operating flexibility.

If we fail to continuously qualify as a business development company, we might be subject to regulation as a registered closed-end investment company under the 1940 Act, which would significantly decrease our operating flexibility. In addition, failure to comply with the requirements imposed on business development companies by the 1940 Act could cause the SEC to bring an enforcement action against us. For additional information on the qualification requirements of a business development company, see the disclosure under the caption “Regulation—Business Development Company Regulations.”

We will be subject to corporate-level federal income tax if we fail to continue to qualify as a RIC.

We seek to maintain our qualification as a RIC under the Code, which requires us to qualify continuously as a BDC and meet certain source of income, distribution and asset diversification requirements.

The source of income requirement is satisfied if we derive at least 90.0% of our annual gross income from interest, dividends, payments with respect to certain securities loans, gains from the sale or other disposition of securities or options thereon or foreign currencies, or other income derived with respect to our business of investing in such securities or currencies, and net income from interests in “qualified publicly traded partnerships,” as defined in the Code.

The annual distribution requirement is satisfied if we distribute to our stockholders on an annual basis an amount equal to at least 90.0% of our ordinary net taxable income and realized net short-term capital gains in excess of realized net long-term capital losses, if any, reduced by deductible expenses. We are subject to certain asset coverage ratio requirements under the 1940 Act and covenants under our borrowing agreements that could, under certain circumstances, restrict us from making distributions necessary to qualify as a RIC. In such case, if we are unable to obtain cash from other sources, we may fail to qualify as a RIC and, thus, may be subject to corporate-level federal income tax.

The diversification requirements will be satisfied if we diversify our holdings so that at the end of each quarter of the taxable year: (i) at least 50.0% of the value of our assets consists of cash, cash equivalents, U.S. government securities, securities of other regulated investment companies, and other securities if such other securities of any one issuer do not represent more than 5.0% of the value of our assets or more than 10% of the outstanding voting securities of the issuer; and (ii) no more than 25.0% of the value of our assets is invested in the securities, other than U.S. government securities or securities of other regulated investment companies, of one issuer or of two or more issuers that are controlled, as determined under applicable tax rules, by us and that are engaged in the same or similar or related trades or businesses or in certain publicly traded partnerships.

Failure to meet these tests may result in our having to (i) dispose of certain investments quickly or (ii) raise additional capital to prevent the loss of our RIC qualification. Because most of our investments will be in private companies, any such dispositions could be made at disadvantageous prices and may result in substantial losses. If we raise additional capital to satisfy the asset diversification requirements, it could take us time to invest such

 

28


Table of Contents

capital. During this period, we will invest the additional capital in temporary investments, such as cash and cash equivalents, which we expect will earn yields substantially lower than the interest income that we anticipate receiving in respect of investments in leveraged loans and mezzanine debt.

If we fail to qualify as a RIC for any reason, all of our taxable income will be subject to U.S. federal income tax at regular corporate rates. The resulting corporate taxes could substantially reduce our net assets, the amount of income available for distribution to our common stockholders or payment of our outstanding indebtedness including the Notes. Such a failure would have a material adverse effect on us and the holders of our securities.

Because we intend to distribute between 90% and 100% of our income to our stockholders in connection with our election to be treated as a RIC, we will continue to need additional capital to finance our growth. If additional funds are unavailable or not available on favorable terms, our ability to grow will be impaired.

In order to qualify for the tax benefits available to RICs and to minimize corporate-level federal income tax, we intend to distribute to our stockholders between 90% and 100% of our annual taxable income, except that we may retain certain net capital gains for investment, and treat such amounts as deemed distributions to our stockholders. If we elect to treat any amounts as deemed distributions, we must pay income taxes at the corporate rate on such deemed distributions on behalf of our stockholders. As a result of these requirements, we will likely need to raise capital from other sources to grow our business. As a BDC, we generally are required to meet a coverage ratio of total assets, less liabilities and indebtedness not represented by senior securities, to total senior securities, which includes all of our borrowings and any outstanding preferred stock, of at least 200%. These requirements limit the amount that we may borrow. Because we will continue to need capital to grow our investment portfolio, these limitations may prevent us from incurring debt and require us to raise additional equity at a time when it may be disadvantageous to do so.

While we expect to be able to borrow and to issue additional debt and equity securities, we cannot assure you that debt and equity financing will be available to us on favorable terms, or at all. Also, as a BDC, we generally are not permitted to issue equity securities priced below net asset value without stockholder approval. If additional funds are not available to us, we could be forced to curtail or cease new investment activities, and our net asset value and share price could decline.

We may have difficulty paying our required distributions if we recognize income before or without receiving cash in respect of such income.

For federal income tax purposes, we may be required to recognize taxable income in circumstances in which we do not receive a corresponding payment in cash. For example, we may on occasion hold debt obligations that are treated under applicable tax rules as having original issue discount (such as debt instruments with payment-in-kind interest (“PIK”) or, in certain cases, increasing interest rates or issued with warrants) and we must include in income each year a portion of the original issue discount that accrues over the life of the obligation, regardless of whether cash representing such income is received by us in the same taxable year. We may also have to include in income other amounts that we have not yet received in cash, such as deferred loan origination fees that are paid after origination of the loan or are paid in non-cash compensation such as warrants or stock. In addition, we may be required to accrue for federal income tax purposes amounts attributable to our investment in Saratoga CLO, a collateralized loan obligation fund, that may differ from the distributions paid in respect of our investment in the subordinated notes of such collateralized loan obligation fund because of the factors set forth above or because distributions on the subordinated notes are contractually required to be diverted for reinvestment or to pay down outstanding indebtedness.

Because any original issue discount or other amounts accrued will be included in our investment company taxable income for the year of accrual, we may be required to make a distribution to our stockholders in order to satisfy the annual distribution requirement, even though we will not have received any corresponding cash amount. As a result, we may have difficulty meeting the annual distribution requirement necessary to obtain and

 

29


Table of Contents

maintain RIC tax treatment under the Code. We may have to sell some of our investments at times and/or at prices we would not consider advantageous, raise additional debt or equity capital or forgo new investment opportunities for this purpose. If we are not able to obtain cash from other sources, we may fail to qualify for RIC tax treatment and thus become subject to corporate-level federal income tax.

Our ability to enter into transactions with our affiliates is restricted.

We are prohibited under the 1940 Act from participating in certain transactions with certain of our affiliates without the prior approval of the members of our independent directors and, in some cases, the SEC. Any person that owns, directly or indirectly, 5.0% or more of our outstanding voting securities is our affiliate for purposes of the 1940 Act and we are generally prohibited from buying or selling any securities (other than our securities) from or to such affiliate, absent the prior approval of our independent directors. The 1940 Act also prohibits certain “joint” transactions with certain of our affiliates, which could include investments in the same portfolio company, without prior approval of our independent directors and, in some cases, the SEC. If a person acquires more than 25.0% of our voting securities, we are prohibited from buying or selling any security (other than any security of which we are the issuer) from or to such person or certain of that person’s affiliates, or entering into prohibited joint transactions with such person, absent the prior approval of the SEC. Similar restrictions limit our ability to transact business with our officers, directors or investment adviser or their affiliates. As a result of these restrictions, we may be prohibited from buying or selling any security (other than any security of which we are the issuer) from or to any portfolio company of a private equity fund managed by our investment adviser without the prior approval of the SEC, which may limit the scope of investment opportunities that would otherwise be available to us.

We operate in a highly competitive market for investment opportunities.

A number of entities compete with us to make the types of investments that we make in private middle market companies. We compete with other BDCs, public and private funds (including SBICs), commercial and investment banks, commercial financing companies, insurance companies, high-yield investors, hedge funds, and, to the extent they provide an alternative form of financing, private equity funds. Many of our competitors are substantially larger and have considerably greater financial, technical and marketing resources than us. Some competitors may have a lower cost of funds and access to funding sources that are not available to us. In addition, some of our competitors may have higher risk tolerances or different risk assessments that could allow them to consider a wider variety of investments and establish more relationships than us. Furthermore, many of our competitors are not subject to the regulatory restrictions that the 1940 Act imposes on us as a BDC. As a result of this competition, we may not be able to take advantage of attractive investment opportunities from time to time, and we cannot assure you that we will be able to identify and make investments that meet our investment objective.

We do not seek to compete primarily based on the interest rates we offer and we believe that some of our competitors may make loans with interest rates that are comparable to or lower than the rates we offer.

We may lose investment opportunities if we do not match our competitors’ pricing, terms and structure. If we match our competitors’ pricing, terms and structure, we may experience decreased net interest income and increased risk of credit loss. As a result of operating in such a competitive environment, we may make investments that are on better terms to our portfolio companies than we originally anticipated, which may impact our return on these investments.

Economic recessions or downturns could impair our portfolio companies and harm our operating results.

Many of our portfolio companies may be susceptible to economic slowdowns or recessions and may be unable to repay our debt investments during these periods. Therefore, our non-performing assets are likely to increase and the value of our portfolio is likely to decrease during these periods. Adverse economic conditions

 

30


Table of Contents

also may decrease the value of collateral securing some of our debt investments and the value of our equity investments. Economic slowdowns or recessions could lead to financial losses in our portfolio and a decrease in revenues, net income and assets. Unfavorable economic conditions also could increase our funding costs, limit our access to the capital markets or result in a decision by lenders not to extend credit to us. These events could prevent us from increasing investments and harm our operating results.

We are a non-diversified investment company within the meaning of the 1940 Act, and therefore we are not limited with respect to the proportion of our assets that may be invested in securities of a single issuer.

We are classified as a non-diversified investment company within the meaning of the 1940 Act, which means that we are not limited by the 1940 Act with respect to the proportion of our assets that we may invest in securities of a single issuer. Although we seek to maintain a diversified portfolio in accordance with our business strategies, to the extent that we assume large positions in the securities of a small number of issuers, our net asset value may fluctuate to a greater extent than that of a diversified investment company as a result of changes in the financial condition or the market’s assessment of the issuer. We may also be more susceptible to any single economic or regulatory occurrence than a diversified investment company. Beyond our RIC asset diversification requirements, we do not have fixed guidelines for diversification, and our investments could be concentrated in relatively few portfolio companies.

Our financial condition and results of operation depend on our ability to manage future investments effectively.

Our ability to achieve our investment objective depends on our ability to acquire suitable investments and monitor and administer those investments, which depends, in turn, on Saratoga Investment Advisors’ ability to identify, invest in and monitor companies that meet our investment criteria.

Accomplishing this result on a cost-effective basis is largely a function of Saratoga Investment Advisors’ structuring of the investment process and its ability to provide competent, attentive and efficient service to us. Our executive officers and the officers and employees of Saratoga Investment Advisors have substantial responsibilities in connection with their roles at Saratoga Partners as well as responsibilities under the Management Agreement. They may also be called upon to provide managerial assistance to our portfolio companies. These demands on their time, which will increase as the number of investments grow, may distract them or slow the rate of investment. In order to grow, Saratoga Investment Advisors may need to hire, train, supervise and manage new employees. However, we cannot assure you that any such employees will contribute to the work of Saratoga Investment Advisors. Any failure to manage our future growth effectively could have a material adverse effect on our business and financial condition.

We may experience fluctuations in our quarterly results.

We could experience fluctuations in our quarterly operating results due to a number of factors, including the interest rate payable on the debt investments we make, the default rate on such investments, the level of our expenses, variations in and the timing of the recognition of realized and unrealized gains or losses, the degree to which we encounter competition in our markets and general economic conditions. As a result of these factors, results for any period should not be relied upon as being indicative of performance in future periods.

Substantially all of our portfolio investments are recorded at fair value as approved in good faith by our board of directors; such valuations are inherently uncertain and may be materially higher or lower than the values that we ultimately realize upon the disposal of such investments.

Substantially all of our portfolio is, and we expect will continue to be, comprised of investments that are not publicly traded. The value of investments that are not publicly traded may not be readily determinable. We value these investments quarterly at fair value as approved in good faith by our board of directors. Where appropriate,

 

31


Table of Contents

Saratoga Investment Advisors may utilize the services of an independent valuation firm to aid it in determining fair value. The types of factors that may be considered in valuing our investments include the nature and realizable value of any collateral, the portfolio company’s ability to make payments and its earnings, the markets in which the portfolio company does business, market yield trend analysis, comparison to publicly traded companies, discounted cash flow and other relevant factors. Because such valuations, and particularly valuations of private investments and private companies, are inherently uncertain, may fluctuate over short periods of time and may be based on estimates, our determinations of fair value may differ materially from the values that would have been used if a ready market for these investments existed. Our net asset value could be materially affected if the determinations regarding the fair value of our investments were materially higher or lower than the values that we ultimately realize upon the disposal of such investments.

If we make unsecured debt investments, we may lack adequate protection in the event our portfolio companies become distressed or insolvent and will likely experience a lower recovery than more senior debtholders in the event our portfolio companies default on their indebtedness.

We make unsecured debt investments in portfolio companies. Unsecured debt investments are unsecured and junior to other indebtedness of the portfolio company. As a consequence, the holder of an unsecured debt investment may lack adequate protection in the event the portfolio company becomes distressed or insolvent and will likely experience a lower recovery than more senior debtholders in the event the portfolio company defaults on its indebtedness. In addition, unsecured debt investments of middle-market companies are often highly illiquid and in adverse market conditions may experience steep declines in valuation even if they are fully performing.

If we invest in the securities and other obligations of distressed or bankrupt companies, such investments may be subject to significant risks, including lack of income, extraordinary expenses, uncertainty with respect to satisfaction of debt, lower-than expected investment values or income potentials and resale restrictions.

We are authorized to invest in the securities and other obligations of distressed or bankrupt companies. At times, distressed debt obligations may not produce income and may require us to bear certain extraordinary expenses (including legal, accounting, valuation and transaction expenses) in order to protect and recover our investment. Therefore, to the extent we invest in distressed debt, our ability to achieve current income may be diminished which may affect our ability to make distributions on our common stock or make interest and principal payments of the Notes.

We also will be subject to significant uncertainty as to when and in what manner and for what value the distressed debt we invest in will eventually be satisfied (e.g., through a liquidation of the obligor’s assets, an exchange offer or plan of reorganization involving the distressed debt securities or a payment of some amount in satisfaction of the obligation). In addition, even if an exchange offer is made or plan of reorganization is adopted with respect to distressed debt held by us, there can be no assurance that the securities or other assets received by us in connection with such exchange offer or plan of reorganization will not have a lower value or income potential than may have been anticipated when the investment was made.

Moreover, any securities received by us upon completion of an exchange offer or plan of reorganization may be restricted as to resale. As a result of our participation in negotiations with respect to any exchange offer or plan of reorganization with respect to an issuer of distressed debt, we may be restricted from disposing of such securities if we are in possession of material non-public information relating to the issuer.

Second priority liens on collateral securing loans that we make to our portfolio companies may be subject to control by senior creditors with first priority liens. If there is a default, the value of the collateral may not be sufficient to repay in full both the first priority creditors and us.

Certain loans that we make to portfolio companies will be secured on a second priority basis by the same collateral securing senior secured debt of such companies. The first priority liens on the collateral will secure the

 

32


Table of Contents

portfolio company’s obligations under any outstanding senior debt and may secure certain other future debt that may be permitted to be incurred by the company under the agreements governing the loans. The holders of obligations secured by the first priority liens on the collateral will generally control the liquidation of and be entitled to receive proceeds from any realization of the collateral to repay their obligations in full before us. In addition, the value of the collateral in the event of liquidation will depend on market and economic conditions, the availability of buyers and other factors. There can be no assurance that the proceeds, if any, from the sale or sales of all of the collateral would be sufficient to satisfy the loan obligations secured by the second priority liens after payment in full of all obligations secured by the first priority liens on the collateral. If such proceeds are not sufficient to repay amounts outstanding under the loan obligations secured by the second priority liens, then we, to the extent not repaid from the proceeds of the sale of the collateral, will only have an unsecured claim against the company’s remaining assets, if any.

The rights we may have with respect to the collateral securing the loans we make to our portfolio companies with senior debt outstanding may also be limited pursuant to the terms of one or more intercreditor agreements that we enter into with the holders of senior debt. Under such an intercreditor agreement, at any time that obligations that have the benefit of the first priority liens are outstanding, any of the following actions that may be taken with respect to the collateral will be at the direction of the holders of the obligations secured by the first priority liens: the ability to cause the commencement of enforcement proceedings against the collateral; the ability to control the conduct of such proceedings; the approval of amendments to collateral documents; releases of liens on the collateral; and waivers of past defaults under collateral documents. We may not have the ability to control or direct such actions, even if our rights are adversely affected.

The lack of liquidity in our investments may adversely affect our business.

We primarily make investments in private companies. A portion of these securities may be subject to legal and other restrictions on resale, transfer, pledge or other disposition or will otherwise be less liquid than publicly traded securities. The illiquidity of our investments may make it difficult for us to sell such investments if the need arises. In addition, if we are required to liquidate all or a portion of our portfolio quickly, we may realize significantly less than the value at which we have previously recorded our investments. In addition, we may face other restrictions on our ability to liquidate an investment in a business entity to the extent that we or our investment adviser has or could be deemed to have material non-public information regarding such business entity.

The debt securities in which we invest are subject to credit risk and prepayment risk.

An issuer of a debt security may be unable to make interest payments and repay principal. We could lose money if the issuer of a debt obligation is, or is perceived to be, unable or unwilling to make timely principal and/or interest payments, or to otherwise honor its obligations. The downgrade of a security by rating agencies may further decrease its value.

Certain debt instruments may contain call or redemption provisions which would allow the issuer thereof to prepay principal prior to the debt instrument’s stated maturity. This is known as prepayment risk. Prepayment risk is greater during a falling interest rate environment as issuers can reduce their cost of capital by refinancing higher interest debt instruments with lower interest debt instruments. An issuer may also elect to refinance their debt instruments with lower interest debt instruments if the credit standing of the issuer improves. To the extent debt securities in our portfolio are called or redeemed, we may receive less than we paid for such security and we may be forced to reinvest in lower yielding securities or debt securities of issuers of lower credit quality.

Uncertainty relating to the LIBOR calculation process may adversely affect the value of our portfolio of the LIBOR-indexed, floating-rate debt securities.

Concerns have been publicized that some of the member banks surveyed by the British Bankers’ Association (“BBA”) in connection with the calculation of LIBOR across a range of maturities and currencies may have been under-reporting or otherwise manipulating the inter-bank lending rate applicable to them in order

 

33


Table of Contents

to profit on their derivatives positions or to avoid an appearance of capital insufficiency or adverse reputational or other consequences that may have resulted from reporting inter-bank lending rates higher than those they actually submitted. A number of BBA member banks have entered into settlements with their regulators and law enforcement agencies with respect to alleged manipulation of LIBOR, and investigations by regulators and governmental authorities in various jurisdictions are ongoing.

Actions by the BBA, regulators or law enforcement agencies may result in changes to the manner in which LIBOR is determined. Uncertainty as to the nature of such potential changes may adversely affect the market for LIBOR-based securities, including our portfolio of LIBOR-indexed, floating-rate debt securities. In addition, any further changes or reforms to the determination or supervision of LIBOR may result in a sudden or prolonged increase or decrease in reported LIBOR, which could have an adverse impact on the market for LIBOR-based securities or the value of our portfolio of LIBOR-indexed, floating-rate debt securities.

Our investment in Saratoga CLO constitutes a leveraged investment in a portfolio of predominantly senior secured first lien term loans and is subject to additional risks and volatility.

At February 28, 2014, our investment in the subordinated notes of Saratoga CLO, a collateralized loan obligation fund, had a fair value of $19.6 million and constituted 9.5% of our portfolio. This investment constitutes a first loss position in a portfolio that, as of February 28, 2014, was composed of $301.3 million in aggregate principal amount of primarily senior secured first lien term loans and $8.0 million in uninvested cash. A first loss position means that we will suffer the first economic losses if the value of Saratoga CLO decreases. First loss positions typically carry a higher risk and earn a higher yield. Interest payments generated from this portfolio will be used to pay the administrative expenses of Saratoga CLO and interest on the debt issued by Saratoga CLO before paying a return on the subordinated notes. Principal payments will be similarly applied to pay administrative expenses of Saratoga CLO and for reinvestment or repayment of Saratoga CLO debt before paying a return on, or repayment of, the subordinated notes. In addition, 80.0% of our fixed management fee and 100.0% our incentive management fee for acting as the collateral manager of Saratoga CLO is subordinated to the payment of interest and principal on Saratoga CLO debt. Any losses on the portfolio will accordingly reduce the cash flow available to pay these management fees and provide a return on, or repayment of, our investment. Depending on the amount and timing of such losses, we may experience smaller than expected returns and, potentially, the loss of our entire investment.

As the manager of the portfolio of Saratoga CLO we will have some ability to direct the composition of the portfolio, but our discretion is limited by the terms of the debt issued by Saratoga CLO which may limit our ability to make investments that we feel are in the best interests of the subordinated notes, and the availability of suitable investments. The performance of Saratoga CLO’s portfolio is also subject to many of the same risks sets forth in this prospectus with respect to portfolio investments in leveraged loans.

In the event that a bankruptcy court orders the substantive consolidation of us with Saratoga CLO, the creditors of Saratoga CLO, including the holders of $304.4 million aggregate principal amount of debt, as of August 31, 2014 issued by Saratoga CLO, would have claims against the consolidated bankruptcy estate, which would include our assets.

We believe that we have observed and will observe certain formalities and operating procedures that are generally recognized requirements for maintaining our separate existence and that our assets and liabilities can be readily identified as distinct from those of Saratoga CLO. However, we cannot assure you that a bankruptcy court would agree in the event that we or Saratoga CLO became a debtor in connection with a bankruptcy proceeding. If a bankruptcy court concludes that substantive consolidation of us with Saratoga CLO is warranted, the creditors of Saratoga CLO, including the holders of $304.4 million aggregate principal amount of debt, as of August 31, 2014 issued by Saratoga CLO, would have claims against the consolidated bankruptcy estate. Substantive consolidation means that our assets are placed in a single bankruptcy estate with those of Saratoga CLO, rather than kept separate, and that the creditors of Saratoga CLO have a claim against that single estate (including our assets), as opposed to retaining their claims against only Saratoga CLO.

 

34


Table of Contents

Available information about privately held companies is limited.

We invest primarily in privately-held companies. Generally, little public information exists about these companies, and we are required to rely on the ability of our investment adviser’s investment professionals to obtain adequate information to evaluate the potential returns from investing in these companies. These companies and their financial information are not subject to the Sarbanes-Oxley Act of 2002 and other rules that govern public companies. If we are unable to uncover all material information about these companies, we may not make a fully informed investment decision, and we may lose money on our investments.

When we are a debt or minority equity investor in a portfolio company, we may not be in a position to control the entity, and its management may make decisions that could decrease the value of our investment.

We make both debt and minority equity investments; therefore, we are subject to the risk that a portfolio company may make business decisions with which we disagree, and the stockholders and management of such company may take risks or otherwise act in ways that do not serve our interests. As a result, a portfolio company may make decisions that could decrease the value of our portfolio holdings.

Our portfolio companies may incur debt or issue equity securities that rank equally with, or senior to, our investments in such companies.

Our portfolio companies usually will have, or may be permitted to incur, other debt, or issue other equity securities that rank equally with, or senior to, our investments. By their terms, such instruments may provide that the holders are entitled to receive payment of dividends, interest or principal on or before the dates on which we are entitled to receive payments in respect of our investments. These debt instruments will usually prohibit the portfolio companies from paying interest on or repaying our investments in the event and during the continuance of a default under such debt. Also, in the event of insolvency, liquidation, dissolution, reorganization or bankruptcy of a portfolio company, holders of securities ranking senior to our investment in that portfolio company would typically be entitled to receive payment in full before we receive any distribution in respect of our investment. After repaying such holders, the portfolio company may not have any remaining assets to use for repaying its obligation to us. In the case of debtor ranking equally with our investments, we would have to share on an equal basis any distributions with other holders in the event of an insolvency, liquidation, dissolution, reorganization or bankruptcy of the relevant portfolio company.

There may be circumstances where our debt investments could be subordinated to claims of other creditors or we could be subject to lender liability claims.

If one of our portfolio companies were to go bankrupt, even though we may have structured our interest as senior debt, depending on the facts and circumstances, including the extent to which we actually provided managerial assistance to that portfolio company, a bankruptcy court might re-characterize our debt holding and subordinate all or a portion of our claim to that of other creditors. In addition, lenders can be subject to lender liability claims for actions taken by them where they become too involved in the borrower’s business or exercise control over the borrower. It is possible that we could become subject to a lender’s liability claim, including as a result of actions taken if we actually render significant managerial assistance.

Investments in equity securities involve a substantial degree of risk.

We purchase common stock and other equity securities. Although equity securities have historically generated higher average total returns than fixed-income securities over the long-term, equity securities also have experienced significantly more volatility in those returns and in recent years have significantly underperformed relative to fixed-income securities. The equity securities we acquire may fail to appreciate and may decline in value or become worthless and our ability to recover our investment will depend on our portfolio company’s success. Investments in equity securities involve a number of significant risks, including:

 

   

any equity investment we make in a portfolio company could be subject to further dilution as a result of the issuance of additional equity interests and to serious risks as a junior security that will be

 

35


Table of Contents
 

subordinate to all indebtedness or senior securities in the event that the issuer is unable to meet its obligations or becomes subject to a bankruptcy process;

 

    to the extent that the portfolio company requires additional capital and is unable to obtain it, we may not recover our investment in equity securities; and

 

    in some cases, equity securities in which we invest will not pay current dividends, and our ability to realize a return on our investment, as well as to recover our investment, will be dependent on the success of our portfolio companies. Even if the portfolio companies are successful, our ability to realize the value of our investment may be dependent on the occurrence of a liquidity event, such as a public offering or the sale of the portfolio company. It is likely to take a significant amount of time before a liquidity event occurs or we can sell our equity investments. In addition, the equity securities we receive or invest in may be subject to restrictions on resale during periods in which it could be advantageous to sell.

There are special risks associated with investing in preferred securities, including:

 

    preferred securities may include provisions that permit the issuer, at its discretion, to defer distributions for a stated period without any adverse consequences to the issuer. If we own a preferred security that is deferring its distributions, we may be required to report income for tax purposes even though we have not received any cash payments in respect of such income;

 

    preferred securities are subordinated with respect to corporate income and liquidation payments, and are therefore subject to greater risk than debt;

 

    preferred securities may be substantially less liquid than many other securities, such as common securities or U.S. government securities; and

 

    preferred security holders generally have no voting rights with respect to the issuing company, subject to limited exceptions.

Our investments in foreign debt, including that of emerging market issuers, may involve significant risks in addition to the risks inherent in U.S. investments.

Although there are limitations on our ability to invest in foreign debt, we may, from time to time, invest in debt of foreign companies, including the debt of emerging market issuers. Investing in foreign companies may expose us to additional risks not typically associated with investing in U.S. companies. These risks include changes in exchange control regulations, political and social instability, expropriation, imposition of foreign taxes, less liquid markets and less available information than is generally the case in the United States, higher transaction costs, less government supervision of exchanges, brokers and issuers, less developed bankruptcy laws, difficulty in enforcing contractual obligations, lack of uniform accounting and auditing standards and greater price volatility. Investments in the debt of emerging market issuers may subject us to additional risks such as inflation, wage and price controls, and the imposition of trade barriers. Furthermore, economic conditions in emerging market countries are, to some extent, influenced by economic and securities market conditions in other emerging market countries. Although economic conditions are different in each country, investors’ reaction to developments in one country can have effects on the debt of issuers in other countries.

Although most of our investments will be U.S. dollar-denominated, our investments that are denominated in a foreign currency will be subject to the risk that the value of a particular currency will change in relation to one or more other currencies. Among the factors that may affect currency values are trade balances, the level of short-term interest rates, differences in relative values of similar assets in different currencies, long-term opportunities for investment and capital appreciation, and political developments. We may employ hedging techniques to minimize these risks, but we cannot assure you that we will fully hedge against these risks or that such strategies will be effective.

 

36


Table of Contents

We may expose ourselves to risks if we engage in hedging transactions.

We may utilize instruments such as forward contracts, currency options and interest rate swaps, caps, collars and floors to seek to hedge against fluctuations in the relative values of our portfolio positions from changes in currency exchange rates and market interest rates. Use of these hedging instruments may expose us to counter-party credit risk. Hedging against a decline in the values of our portfolio positions does not eliminate the possibility of fluctuations in the values of such positions or prevent losses if the values of such positions decline. However, such hedging can establish other positions designed to gain from those same developments, thereby offsetting the decline in the value of such portfolio positions. Such hedging transactions may also limit the opportunity for gain if the values of the portfolio positions should increase. Moreover, it may not be possible to hedge against an exchange rate or interest rate fluctuation that is generally anticipated at an acceptable price.

Our board of directors may change our investment objective, operating policies and strategies without prior notice or stockholder approval, the effects of which may be adverse.

Our board of directors has the authority to modify or waive our current investment objective, operating policies and strategies without prior notice and without stockholder approval. We cannot predict the effect any changes to our current operating policies and strategies would have on our business, financial condition, and value of our common stock. However, the effects might be adverse, which could negatively impact our ability to pay dividends and cause you to lose all or part of your investment.

We have limited experience in managing an SBIC and any failure to comply with SBA regulations, resulting from our lack of experience or otherwise, could have an adverse effect on our operations.

On March 28, 2012, our wholly-owned subsidiary, Saratoga Investment Corp. SBIC, LP, received a license from the SBA to operate as an SBIC under Section 301(c) of the Small Business Investment Act of 1958 and is regulated by the SBA.

The SBA places certain limitations on the financing terms of investments by SBICs in portfolio companies and prohibits SBICs from providing funds for certain purposes or to businesses in a few prohibited industries. Compliance with SBIC requirements may cause our SBIC subsidiary to forego attractive investment opportunities that are not permitted under SBA regulations.

Further, SBA regulations require that an SBIC be periodically examined and audited by the SBA to determine its compliance with the relevant SBA regulations. The SBA prohibits, without prior SBA approval, a “change of control” of an SBIC or transfers that would result in any person (or a group of persons acting in concert) owning 10% or more of a class of capital stock of an SBIC. If our SBIC subsidiary fails to comply with applicable SBA regulations, the SBA could, depending on the severity of the violation, limit or prohibit its use of debentures, declare outstanding debentures immediately due and payable, and/or limit it from making new investments. In addition, the SBA can revoke or suspend a license for willful or repeated violation of, or willful or repeated failure to observe, any provision of the Small Business Investment Act of 1958 or any rule or regulation promulgated thereunder. These actions by the SBA would, in turn, negatively affect us because our SBIC subsidiary is our wholly-owned subsidiary. We do not have any prior experience managing an SBIC. Our lack of experience in complying with SBA regulations may hinder our ability to take advantage of our SBIC subsidiary’s access to SBA-guaranteed debentures.

Any failure to comply with SBA regulations could have an adverse effect on our operations.

Our investments may be risky, and you could lose all or part of your investment.

Substantially all of our debt investments hold a non-investment grade rating by one or more rating agencies (which non-investment grade debt is commonly referred to as “high yield” and “junk” debt) or, where not rated by any rating agency, would be below investment grade and “junk”, if rated. A below investment grade and

 

37


Table of Contents

“junk” rating means that, in the rating agency’s view, there is an increased risk that the obligor on such debt will be unable to pay interest and repay principal on its debt in full. We also invest in debt that defers or pays PIK interest. To the extent interest payments associated with such debt are deferred, such debt will be subject to greater fluctuations in value based on changes in interest rates, such debt could produce taxable income without a corresponding cash payment to us, and since we generally do not receive any cash prior to maturity of the debt, the investment will be of greater risk.

In addition, private middle market companies in which we invest are exposed to a number of significant risks, including:

 

    limited financial resources and an inability to meet their obligations, which may be accompanied by a deterioration in the value of any collateral and a reduction in the likelihood of us realizing any guarantees we may have obtained in connection with our investment;

 

    shorter operating histories, narrower product lines and smaller market shares than larger businesses, which tend to render them more vulnerable to competitors’ actions and market conditions, as well as general economic downturns;

 

    dependence on the management talents and efforts of a small group of persons; the death, disability, resignation or termination of one or more of which could have a material adverse impact on the company and, in turn, on us;

 

    less predictable operating results and, possibly, substantial additional capital requirements to support their operations, finance expansion or maintain their competitive position; and

 

    difficulty accessing the capital markets to meet future capital needs.

In addition, our executive officers, directors and our investment adviser may, in the ordinary course of business, be named as defendants in litigation arising from our investments in the portfolio companies.

Our independent auditors have not assessed our internal control over financial reporting. If our internal control over financial reporting is not effective, it could have a material adverse effect on our stock price and our ability to raise capital.

Because we are a “non-accelerated filer” within the meaning of Rule 12b-2 under the Securities Exchange Act of 1934, our independent auditors are not required to assess our internal control over financial reporting or to provide a report thereon. Although our management determined that our internal control over financial reporting was effective at February 28, 2014 (the last date that such determination was required to be made by us), there can be no assurance that our independent auditors would agree with our management’s conclusion. Furthermore, if our market capitalization, excluding affiliated stockholders, at August 31 of any fiscal year is greater than $75 million, then we will be required to obtain independent auditor certification on the adequacy of our internal control over financial reporting for that fiscal year. If our internal control over financial reporting is determined in the future to not be effective, whether by our management or by our independent auditors, there could be an adverse reaction in the financial markets due to a loss of confidence in the reliability of our financial statements, which could materially adversely affect our stock price and our ability to raise capital necessary to operate our business. In addition, we may be required to incur costs in improving our internal control system and hiring additional personnel.

Risks Related to Our Common Stock

Investing in our common stock may involve an above average degree of risk.

The investments we make in accordance with our investment objective may result in a higher amount of risk than alternative investment options and volatility or loss of principal. Our investments in portfolio companies may be highly speculative and aggressive, and therefore, an investment in our common stock may not be suitable for someone with lower risk tolerance.

 

38


Table of Contents

We may choose to pay dividends in our own stock, in which case you may be required to pay tax in excess of the cash you receive.

We have in the past, and may in the future, distribute taxable dividends that are payable to our stockholders in part through the issuance of shares of our stock. For example, on October 30, 2013, our board of directors declared a dividend of $2.65 per share to shareholders payable in cash or shares of our common stock. Under certain applicable provisions of the Code and the Treasury regulations, distributions payable in cash or in shares of stock at the election of stockholders are treated as taxable dividends. The Internal Revenue Service has issued private rulings indicating that this rule will apply even where the total amount of cash that may be distributed is limited to no more than 20.0% of the total distribution. Under these rulings, if too many stockholders elect to receive their distributions in cash, each such stockholder would receive a pro rata share of the total cash to be distributed and would receive the remainder of their distribution in shares of stock. If we decide to make any distributions consistent with these rulings that are payable in part in our stock, taxable stockholders receiving such dividends will be required to include the full amount of the dividend no matter how paid (whether received in cash, our stock, or a combination thereof) as ordinary income (or as long-term capital gain to the extent such distribution is properly reported as a capital gain dividend) to the extent of our current and accumulated earnings and profits for U.S. federal income tax purposes. As a result, a U.S. stockholder may be required to pay tax with respect to such dividends in excess of any cash received. If a U.S. stockholder sells the stock it receives as a dividend in order to pay this tax, the sales proceeds may be less than the amount included in income with respect to the dividend, depending on the market price of our stock at the time of the sale. Furthermore, with respect to non-U.S. stockholders, we may be required to withhold U.S. tax with respect to such dividends, including in respect of all or a portion of such dividend that is payable in stock. In addition, if a significant number of our stockholders determine to sell shares of our stock in order to pay taxes owed on dividends, it may put downward pressure on the trading price of our stock.

The market price of our common stock may fluctuate significantly.

The market price and liquidity of the market for our common stock may be significantly affected by numerous factors, some of which are beyond our control and may not be directly related to our operating performance. These factors include:

 

    significant volatility in the market price and trading volume of securities of BDCs or other companies in our sector, which are not necessarily related to the operating performance of these companies;

 

    changes in regulatory policies, accounting pronouncements or tax rules, particularly with respect to RICs, BDCs or SBICs;

 

    loss of RIC qualification;

 

    changes in the value of our portfolio of investments;

 

    any shortfall in revenue or net income or any increase in losses from levels expected by investors or securities analysts;

 

    departure of any of Saratoga Investment Advisors’ key personnel;

 

    operating performance of companies comparable to us;

 

    general economic trends and other external factors; and

 

    loss of a major funding source.

There is a risk that you may not receive distributions or that our distributions may not grow over time.

As a BDC for 1940 Act purposes and a RIC for U.S. federal income tax purposes, we intend to make distributions out of assets legally available for distribution to our stockholders once such distributions are authorized by our board of directors and declared by us. We cannot assure you that we will achieve investment

 

39


Table of Contents

results that will allow us to make a specified level of cash distributions or year-to-year increases in cash distributions. In addition, due to the asset coverage test that is applicable to us as a BDC, and provisions contained in the agreements governing our borrowings, we may be limited in our ability to make distributions. Further, if we invest a greater amount of assets in equity securities that do not pay current dividends, it could reduce the amount available for distribution.

Provisions of our governing documents and the Maryland General Corporation Law could deter future takeover attempts and have an adverse impact on the price of our common stock.

We are governed by our charter and bylaws, which we refer to as our “governing documents.”

Our governing documents and the Maryland General Corporation Law contain provisions that may have the effect of delaying, deferring or preventing a future transaction or change in control of us that might involve a premium price for our stockholders or otherwise be in their best interest.

Our charter provides for the classification of our board of directors into three classes of directors, serving staggered three-year terms, which may render a change of control of us or removal of our incumbent management more difficult. Furthermore, any and all vacancies on our board of directors will be filled generally only by the affirmative vote of a majority of the remaining directors in office, even if the remaining directors do not constitute a quorum, and any director elected to fill a vacancy will serve for the remainder of the full term until a successor is elected and qualifies.

Our board of directors is authorized to create and issue new series of shares, to classify or reclassify any unissued shares of stock into one or more classes or series, including preferred stock and, without stockholder approval, to amend our charter to increase or decrease the number of shares of stock that we have authority to issue, which could have the effect of diluting a stockholder’s ownership interest. Prior to the issuance of shares of stock of each class or series, including any reclassified series, our board of directors is required by our governing documents to set the terms, preferences, conversion or other rights, voting powers, restrictions, limitations as to dividends or other distributions, qualifications and terms or conditions of redemption for each class or series of shares of stock.

Our governing documents also provide that our board of directors has the exclusive power to adopt, alter or repeal any provision of our bylaws, and to make new bylaws. The Maryland General Corporation Law also contains certain provisions that may limit the ability of a third party to acquire control of us, such as:

 

    The Maryland Business Combination Act, which, subject to certain limitations, prohibits certain business combinations between us and an “interested stockholder” (defined generally as any person who beneficially owns 10% or more of the voting power of the common stock or an affiliate thereof) for five years after the most recent date on which the stockholder becomes an interested stockholder and, thereafter, imposes special minimum price provisions and special stockholder voting requirements on these combinations; and

 

    The Maryland Control Share Acquisition Act, which provides that “control shares” of a Maryland corporation (defined as shares of common stock which, when aggregated with other shares of common stock controlled by the stockholder, entitles the stockholder to exercise one of three increasing ranges of voting power in electing directors) acquired in a “control share acquisition” (defined as the direct or indirect acquisition of ownership or control of “control shares”) have no voting rights except to the extent approved by stockholders by the affirmative vote of at least two-thirds of all the votes entitled to be cast on the matter, excluding all interested shares of common stock.

In addition, the provisions of the Maryland Business Combination Act will not apply, however, if our board of directors adopts a resolution that any business combination between us and any other person will be exempt from the provisions of the Maryland Business Combination Act. Although our board of directors has adopted

 

40


Table of Contents

such a resolution, there can be no assurance that this resolution will not be altered or repealed in whole or in part at any time. If the resolution is altered or repealed, the provisions of the Maryland Business Combination Act may discourage others from trying to acquire control of us.

As permitted by Maryland law, our bylaws contain a provision exempting from the Maryland Control Share Acquisition Act any and all acquisitions by any person of our common stock. Although our bylaws include such a provision, such a provision may also be amended or eliminated by our board of directors at any time in the future, subject to obtaining confirmation from the SEC that it does not object to us being subject to the Maryland Control Share Acquisition Act.

Our common stock may trade at a discount to our net asset value per share.

Common stock of BDCs, as closed-end investment companies, frequently trade at a discount to net asset value. Our common stock has traded at a discount to our net asset value since shortly after our initial public offering. The risk that our common stock may continue to trade at a discount to our net asset value is separate and distinct from the risk that our net asset value per share may decline.

Stockholders may incur dilution if we sell shares of our common stock in one or more offerings at prices below the then current net asset value per share of our common stock.

The 1940 Act prohibits us from selling shares of our common stock at a price below the current net asset value per share of such stock, with certain exceptions. One such exception is prior stockholder approval of issuances below net asset value provided that our board of directors makes certain determinations. At our 2014 annual meeting of stockholders, our stockholders approved a proposal that authorizes us to sell shares of our common stock below the then current net asset value per share of our common stock at an offering price per share that is not less than 85% of the then current net asset value per share in one or more offerings for a period of one year ending on the earlier of our next annual meeting of shareholders or September 30, 2015. Continued access to this exception will require approval of similar proposals at future stockholder meetings.

If we were to sell shares of our common stock below net asset value per share, such sales would result in an immediate dilution to the net asset value per share. This dilution would occur as a result of the sale of shares at a price below the then current net asset value per share of our common stock and a proportionately greater decrease in a stockholder’s interest in our earnings and assets and voting interest in us than the increase in our assets resulting from such issuance.

Because the number of shares of common stock that could be so issued and the timing of any issuance is not currently known, the actual dilutive effect cannot be predicted.

The issuance of subscription rights, warrants or convertible debt that are exchangeable for our common stock, will cause your economic interest and voting power in us to be diluted as a result of our offering of any such securities.

Stockholders who do not fully exercise rights, warrants or convertible debt issued to them in any offering of subscription rights, warrants or convertible debt to purchase our common stock should expect that they will, at the completion of the offering, own a smaller proportional economic interest and have diminished voting power in us than would otherwise be the case if they fully exercised their rights, warrants or convertible debt. We cannot state precisely the amount of any such dilution in share ownership or voting power because we do not know what proportion of the common stock would be purchased as a result of any such offering.

In addition, if the subscription price, warrant price or convertible debt price is less than our net asset value per share of common stock at the time of such offering, then our stockholders would experience an immediate

 

41


Table of Contents

dilution of the aggregate net asset value of their shares as a result of the offering. The amount of any such decrease in net asset value is not predictable because it is not known at this time what the subscription price, warrant price, convertible debt price or net asset value per share will be on the expiration date of such offering or what proportion of our common stock will be purchased as a result of any such offering. The risk of dilution is greater if there are multiple rights offerings. However, our board of directors will make a good faith determination that any offering of subscription rights, warrants or convertible debt would result in a net benefit to existing stockholders.

Finally, our common stockholders will bear will all costs and expenses incurred by us in connection with any proposed offering of subscription rights, warrants or convertible debt that are exchangeable for our common stock, whether or not such offering is actually completed by us.

We may be unable to invest a significant portion of the net proceeds from this offering, which could harm our financial condition and operating results.

Delays in investing the net proceeds raised in this offering may cause our performance to be worse than that of other fully invested business development companies or other lenders or investors pursuing comparable investment strategies. We cannot assure you that we will be able to identify any investments that meet our investment objective or that any investment that we make will produce a positive return. We may be unable to invest the net proceeds of this offering on acceptable terms within the time period that we anticipate or at all, which could harm our financial condition and operating results. We anticipate that, depending on market conditions and the amount of the capital, it may take us a substantial period of time to invest substantially all of the net proceeds from this offering in investments meeting our investment objective. During this period, we will invest the capital primarily in cash, cash equivalents, U.S. government securities or high-quality debt securities maturing in one year or less from the time of investment. These securities may earn yields substantially lower than the income that we anticipate receiving once we are fully invested in accordance with our investment objective.

 

42


Table of Contents

USE OF PROCEEDS

We intend to use substantially all of the net proceeds from the sale of our securities to make investments in middle-market companies in accordance with our investment objective and strategies described in this prospectus, and for general corporate purposes. We may also use a portion of the net proceeds to reduce any of our outstanding borrowings. Reducing our borrowings may include the repurchase of certain debt instruments that could provide us with a net gain on extinguishment of debt, and increase certain fees payable to our investment adviser.

We anticipate that substantially all of the net proceeds from any offering of our securities will be used as described above within six to twelve months. Pending such use, we will invest the net proceeds primarily in high quality, short-term debt securities consistent with our business development company election and our election to be taxed as a RIC. See “Regulation—Business Development Company Regulations—Temporary Investments.” Our ability to achieve our investment objective may be limited to the extent that the net proceeds from an offering, pending full investment, are held in interest-bearing deposits or other short-term instruments. See “Risk Factors—Risks Relating to Our Business and Structure—We may be unable to invest a significant portion of the net proceeds from an offering of our securities on acceptable terms within an attractive timeframe” for additional information regarding this matter. The supplement to this prospectus relating to an offering will more fully identify the use of proceeds from such an offering.

RATIOS OF EARNINGS TO FIXED CHARGES

For the fiscal years ended February 28, 2014 and 2013, February 29, 2012 and February 28, 2011 and 2010 and the six months ended August 31, 2014, the ratios of earnings to fixed charges of the Company, computed as set forth below, were as follows:

 

    Six
months
ended
August 31,
2014
    Year ended
February 28,
2014
    Year ended
February 28,
2013
    Year ended
February 29,
2012
    Year ended
February 28,
2011
    Year ended
February 28,
2010
 

Earnings to Fixed Charges

    2.36        2.44        6.75        11.23        7.49        (1.55

For purposes of computing the ratios of earnings to fixed charges, earnings represent net increase in net assets resulting from operations plus (or minus) income tax provision (benefit) including excise tax expense plus fixed charges. Fixed charges include interest and credit facility fees and amortization of deferred financing fees.

 

43


Table of Contents

NOTE ABOUT FORWARD-LOOKING STATEMENTS

The following discussion should be read in conjunction with our financial statements and related notes and other financial information appearing elsewhere in this prospectus. In addition to historical information, the following discussion and other parts of this prospectus contain forward-looking information that involves risks and uncertainties. Our actual results could differ materially from those anticipated by such forward-looking information due to the factors discussed in the section entitled “Risk Factors.”

The forward-looking statements are based on our beliefs, assumptions and expectations of our future performance, taking into account all information currently available to us. These beliefs, assumptions and expectations can change as a result of many possible events or factors, not all of which are known to us or are within our control. If a change occurs, our business, financial condition, liquidity and results of operations may vary materially from those expressed in our forward-looking statements.

The forward-looking statements contained in this prospectus involve risks and uncertainties, including statements as to:

 

    our future operating results;

 

    our business prospects and the prospects of our portfolio companies;

 

    the impact of investments that we expect to make;

 

    our contractual arrangements and relationships with third parties;

 

    the dependence of our future success on the general economy and its impact on the industries in which we invest;

 

    the ability of our portfolio companies to achieve their objectives;

 

    our expected financings and investments;

 

    our regulatory structure and tax treatment, including our ability to operate as a business development company, a regulated investment company and a small business investment company;

 

    the adequacy of our cash resources and working capital;

 

    the timing of cash flows, if any, from the operations of our portfolio companies; and

 

    the ability of our investment adviser to locate suitable investments for us and to monitor and effectively administer our investments.

You should not place undue reliance on these forward-looking statements. The forward-looking statements made in this prospectus relate only to events as of the date on which the statements are made. We undertake no obligation to update any forward-looking statement to reflect events or circumstances occurring after the date of this prospectus.

You should understand that, under Sections 27A(b)(2)(B) of the Securities Act and Section 21E(b)(2)B of the Exchange Act, the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995 do not apply to statements made in connection with any offering of securities pursuant to this prospectus.

 

44


Table of Contents

PRICE RANGE OF COMMON STOCK AND DISTRIBUTIONS

Our common stock is traded on the New York Stock Exchange under the symbol “SAR.” Prior to July 30, 2010, our common stock traded on the New York Stock Exchange under the symbol “GNV.” The following table sets forth, for the two most recent fiscal years and the current fiscal year, the range of high and low sales prices of our common stock as reported on the New York Stock Exchange, the sales price as a percentage of our net asset value (“NAV”) and the dividends declared by us for each fiscal quarter. The net asset value per share and high and low sales prices listed below reflect the 1:10 reverse stock split that occurred on August 12, 2010.

 

Fiscal Year ended February 28, 2013

   NAV(1)      High      Low      Premium
(Discount) of
High Sales
Price to NAV(2)
    Premium
(Discount) of
Low Sales
Price to NAV(2)
 

First Quarter

   $ 25.94       $ 18.25       $ 15.15         (29.6 )%      (41.6 )% 

Second Quarter

   $ 27.20       $ 17.20       $ 16.50         (36.8 )%      (39.3 )% 

Third Quarter

   $ 21.75       $ 19.97       $ 15.17         (8.2 )%      (30.3 )% 

Fourth Quarter

   $ 22.98       $ 18.50       $ 15.07         (19.5 )%      (34.4 )% 

Fiscal Year ended February 28, 2014

   NAV(1)      High      Low      Premium
(Discount) of
High Sales
Price to NAV(2)
    Premium
(Discount) of
Low Sales
Price to NAV(2)
 

First Quarter

   $ 23.78       $ 19.08       $ 16.35         (19.8 )%      (31.2 )% 

Second Quarter

   $ 23.77       $ 18.70       $ 17.40         (21.3 )%      (26.8 )% 

Third Quarter

   $ 20.67       $ 19.55       $ 15.40         (5.4 )%      (25.5 )% 

Fourth Quarter

   $ 21.36       $ 16.56       $ 15.25         (22.5 )%      (28.7 )% 
            Price Range               

Fiscal Year ended February 28, 2015

   NAV(1)      High      Low      Premium
(Discount) of
High Sales
Price to NAV(2)
    Premium
(Discount) of
Low Sales
Price to NAV(2)
 

First Quarter

     21.69       $ 15.91       $ 15.05         (26.6 )%      (30.6 )% 

Second Quarter

     22.27         16.26         15.15         (27.0 )%      (32.0 )% 

Third Quarter

     *         16.67         14.69         *        *   

Fourth Quarter through December 4, 2014

     *         15.36         14.72         *        *   

 

* Not determinable at the time of filing.
(1) Net asset value per share is determined as of the last day in the relevant quarter and therefore may not reflect the net asset value per share on the date of the high and low closing sales prices. The net asset values shown are based on outstanding shares at the end of each period.
(2) Calculated as the respective high or low sales price less net asset value, divided by net asset value.

Holders

The last reported price for our common stock on December 4, 2014 was $15.05 per share. As of December 1, 2014, there were 19 holders of record of our common stock.

 

45


Table of Contents

Dividend Policy

The following table summarizes our dividends or distributions declared during fiscal 2009, 2010, 2011, 2012, 2013, 2014 and 2015:

 

Date Declared

   Record Date    Payment Date    Amount
per Share
 

May 22, 2008

   May 30, 2008    June 13, 2008    $ 3.90   

August 19, 2008

   August 29, 2008    September 15, 2008    $ 3.90   

December 8, 2008

   December 18, 2008    December 29, 2008    $ 2.50   
        

 

 

 

Total Dividends Declared for Fiscal 2009

$ 10.30   
        

 

 

 

November 13, 2009

November 25, 2009 December 31, 2009 $ 18.25 (1) 
        

 

 

 

Total Dividends Declared for Fiscal 2010

$ 18.25   
        

 

 

 

November 12, 2010

November 19, 2010 December 29, 2010 $ 4.40 (1) 
        

 

 

 

Total Dividends Declared for Fiscal 2011

$ 4.40   
        

 

 

 

November 15, 2011

November 25, 2011 December 30, 2011 $ 3.00 (1) 
        

 

 

 

Total Dividends Declared for Fiscal 2012

$ 3.00   
        

 

 

 

November 9, 2012

November 20, 2012 December 31, 2012 $ 4.25 (1) 
        

 

 

 

Total Dividends Declared for Fiscal 2013

$ 4.25   
        

 

 

 

October 30, 2013

November 13, 2013 December 27, 2013 $ 2.65 (1) 
        

 

 

 

Total Dividends Declared for Fiscal 2014

$ 2.65   
        

 

 

 

September 24, 2014

November 3, 2014 November 28, 2014 $ 0.18 (1) 

September 24, 2014

February 2, 2015 February 27, 2015 $ 0.22   
        

 

 

 

Total Dividends Declared for Fiscal 2015

$ 0.40   
        

 

 

 

 

(1) This dividend was paid by combination of shares of common stock and cash. Please see the discussion immediately following this table for more detail about the composition of this dividend.

Our distributions, if any, will be determined by our board of directors and paid out of assets legally available for distribution. Any such distributions will be taxable to our stockholders, including to those stockholders who receive additional shares of our common stock pursuant to our dividend reinvestment plan. The reinvested dividends under our dividend reinvestment plan increase our gross assets, which will result in higher management fees, and potentially income incentive fees and capital gains incentive fees payable to Saratoga Investment Advisors. Prior to January 2009, we paid quarterly dividends to our stockholders. However, in January 2009, we suspended the practice of paying quarterly dividends to our stockholders and made five dividend distributions (in December 2013, 2012, 2011, 2010 and 2009) to our stockholders in the form of a combination of cash and the issuance of shares of our common stock as discussed more fully below. On September 24, 2014, our board of directors adopted a new dividend policy pursuant to which we will begin to again pay a regular quarterly cash dividend to our shareholders. In this regard, our board of directors declared a dividend in the amount of $0.18 per share for the fiscal quarter ended August 31, 2014, and a dividend in the amount of $0.22 per share for the fiscal quarter ended November 30, 2014. The dividend for the fiscal quarter ended August 31, 2014 will be payable on November 28, 2014 to all stockholders of record at the close of business on November 3, 2014, and the dividend for the fiscal quarter ended November 30, 2014 will be payable on February 27, 2015 to all stockholders of record at the close of business on February 2, 2015.

We are prohibited from making distributions that cause us to fail to maintain the asset coverage ratios stipulated by the 1940 Act, subject to certain exceptions, or that violate our debt covenants.

 

46


Table of Contents

Prior to the adoption of our new dividend policy described above, our board of directors believed that using our capital resources to build and diversify our portfolio served our stockholders’ interests best by better positioning us to generate current income and capital appreciation on an increasing scale. Therefore, our board of directors determined to pay a 20.0% cash and 80.0% stock dividend with respect to a significant portion of our taxable income for our 2014, 2013, 2012, 2011 and 2010 fiscal years in accordance with an IRS revenue procedure or certain IRS private letter rulings. For more detailed information about these dividends, please see the discussion below.

In order to maintain our qualification as a RIC, we must for each fiscal year distribute an amount equal to at least 90.0% of our ordinary net taxable income and realized net short-term capital gains in excess of realized net long-term capital losses, if any, reduced by deductible expenses. In addition, we will be subject to federal excise taxes to the extent we do not distribute during the calendar year at least (1) 98.0% of our ordinary income for the calendar year, (2) 98.2% of our capital gains in excess of capital losses for the one year period ending on October 31 of the calendar year and (3) any ordinary income and net capital gains for preceding years that were not distributed during such years and on which we paid no federal income tax. For the 2013 calendar year, the Company made distributions sufficient such that we did not incur any federal excise taxes. We may elect to withhold from distribution a portion of our ordinary income for the 2014 calendar year and/or portion of the capital gains in excess of capital losses realized during the one year period ending October 31, 2014, if any, and, if we do so, we would expect to incur federal excise taxes as a result.

We maintain an “opt out” dividend reinvestment plan for our common stockholders. As a result, if we declare a dividend, then stockholders’ cash dividends will be automatically reinvested in additional shares of our common stock, unless they specifically “opt out” of the dividend reinvestment plan so as to receive cash dividends.

Pursuant to a revenue procedure (Revenue Procedure 2010-12), or the Revenue Procedure, issued by the Internal Revenue Service, or IRS, the IRS indicated that it would treat distributions from certain publicly traded RICs (including BDCs) that were paid part in cash and part in stock as dividends that would satisfy the RIC’s annual distribution requirements and qualify for the dividends paid deduction for federal income tax purposes. In order to qualify for such treatment, the Revenue Procedure required that at least 10.0% of the total distribution be payable in cash and that each stockholder have a right to elect to receive its entire distribution in cash. If too many stockholders elected to receive cash, each stockholder electing to receive cash must receive a proportionate share of the cash to be distributed (although no stockholder electing to receive cash may receive less than 10.0% of such stockholder’s distribution in cash). This Revenue Procedure applied to distributions declared on or before December 31, 2012 with respect to taxable years ending on or before December 31, 2011.

Although this Revenue Procedure is no longer available and did not apply to our distributions for our fiscal year ended February 28, 2014, the revenue procedure was based upon certain applicable provisions of the Code and the Treasury regulations pursuant to which distributions payable in cash or in shares of stock at the election of stockholders are treated as taxable dividends. Consistent with these provisions, the IRS has issued private letter rulings concluding that a RIC may treat a distribution of its own stock as fulfilling its RIC distribution requirements if each stockholder may elect to receive his or her entire distribution in either cash or stock of the RIC subject to a limitation on the aggregate amount of cash to be distributed to all stockholders, which limitation must be at least 20.0% of the aggregate declared distribution.

On October 30, 2013, our board of directors declared a dividend of $2.65 per share payable on December 27, 2013, to common stockholders of record on November 13, 2013. Shareholders had the option to receive payment of the dividend in cash, shares of common stock, or a combination of cash and shares of common stock, provided that the aggregate cash payable to all shareholders was limited to approximately $2.5 million or $0.53 per share.

Based on shareholder elections, the dividend consisted of approximately $2.5 million in cash and 649,500 shares of common stock, or 13.7% of our outstanding common stock prior to the dividend payment. The amount of cash elected to be received was greater than the cash limit of 20.0% of the aggregate dividend amount, thus resulting in the payment of a combination of cash and stock to shareholders who elected to receive cash. The number of shares of common stock comprising the stock portion was calculated based on a price of $15.439 per share, which equaled the volume weighted average trading price per share of the common stock on December 11, 13, and 16, 2013.

 

47


Table of Contents

On November 9, 2012, our board of directors declared a dividend of $4.25 per share payable on December 31, 2012, to common stockholders of record on November 20, 2012. Shareholders had the option to receive payment of the dividend in cash, shares of common stock, or a combination of cash and shares of common stock, provided that the aggregate cash payable to all shareholders was limited to approximately $3.3 million or $0.85 per share.

Based on shareholder elections, the dividend consisted of $3.3 million in cash and 853,455 shares of common stock, or 22.0% of our outstanding common stock prior to the dividend payment. The amount of cash elected to be received was greater than the cash limit of 20.0% of the aggregate dividend amount, thus resulting in the payment of a combination of cash and stock to shareholders who elected to receive cash. The number of shares of common stock comprising the stock portion was calculated based on a price of $15.444 per share, which equaled the volume weighted average trading price per share of the common stock on December 14, 17 and 19, 2012.

On November 15, 2011, our board of directors declared a dividend of $3.00 per share payable on December 30, 2011, to common stockholders of record on November 25, 2011. Shareholders had the option to receive payment of the dividend in cash, shares of common stock, or a combination of cash and shares of common stock, provided that the aggregate cash payable to all shareholders was limited to $2.0 million or $0.60 per share.

Based on shareholder elections, the dividend consisted of $2.0 million in cash and 599,584 shares of common stock, or 18.0% of our outstanding common stock prior to the dividend payment. The amount of cash elected to be received was greater than the cash limit of 20.0% of the aggregate dividend amount, thus resulting in the payment of a combination of cash and stock to shareholders who elected to receive cash. The number of shares of common stock comprising the stock portion was calculated based on a price of $13.12 per share, which equaled the volume weighted average trading price per share of the common stock on December 20, 21 and 22, 2011.

On November 12, 2010, we declared a dividend of $4.40 per share which was paid on December 29, 2010. Stockholders had the option to receive payment of the dividend in cash, shares of common stock, or a combination of cash and shares of common stock, provided that the aggregate cash payable to all shareholders was limited to $1.2 million or $0.44 per share.

Based on shareholder elections, the dividend consisted of $1.2 million in cash and 596,235 shares of common stock, or 22.0% of our outstanding common stock prior to the dividend payment. The amount of cash elected to be received was greater than the cash limit of 10.0% of the aggregate dividend amount, thus resulting in the payment of a combination of cash and stock to shareholders who elected to receive cash. The number of shares of common stock comprising the stock portion was calculated based on a price of $17.8049 per share, which equaled the volume weighted average trading price per share of the common stock on December 20, 21 and 22, 2010.

On November 13, 2009, we declared a dividend of $18.25 per share payable on December 31, 2009. Stockholders had the option to receive payment of the dividend in cash, shares of common stock, or a combination of cash and shares of common stock, provided that the aggregate cash payable to all stockholders was limited to $2.1 million or $0.25 per share.

Based on stockholder elections, the dividend consisted of $2.1 million in cash and 8,648,725 shares of common stock, or 104.0% of our outstanding common stock prior to the dividend payment. The amount of cash elected to be received was greater than the cash limit of 13.7% of the aggregate dividend amount, thus resulting in the payment of a combination of cash and stock to stockholders who elected to receive cash. The number of shares of common stock comprising the stock portion was calculated based on a price of $1.5099 per share, which equaled the volume weighted average trading price per share of the common stock on December 24 and 28, 2009.

 

48


Table of Contents

DIVIDEND REINVESTMENT PLAN

We have adopted a dividend reinvestment plan (the “Plan”) that provides that, unless you elect to receive your dividends or other distributions in cash, they will be automatically reinvested by the Plan Administrator, American Stock Transfer & Trust Company LLC, in additional shares of our common stock. If you elect to receive your dividends or other distributions in cash, you will receive them in cash paid by check mailed directly to you by the Plan Administrator. The reinvestment of our distributions does not relieve stockholders of any tax that may be payable on such distributions. For U.S. federal income tax purposes, stockholders will be treated as receiving the amount of the distributions made by us, which amount generally will be either equal to the amount of the cash distribution the stockholder would have received if the stockholder had elected to receive cash or, for shares issued by us, the fair market value of the shares issued to the stockholder.

No action is required on the part of a registered stockholder to have their cash dividend reinvested in shares of our common stock. When the share price of our common stock is trading above net asset value, we intend to primarily use newly issued shares to implement the plan. However, we reserve the right to purchase shares in the open market in connection with our implementation of the plan even if the share price of our common stock is trading below net asset value. Unless you or your brokerage firm decides to opt out of the Plan, the number of shares of common stock you will receive will be determined as follows:

(1) If we use newly issued shares under the Plan, we will issue the new shares at a price equal to 95% of the average of the market prices of our common stock at the close of trading on the ten trading days immediately preceding and ending on the date fixed by our board of directors for the payment of the dividend.

(2) If we use shares purchased in the open market under the Plan, the Plan Administrator will receive the dividend or distribution in cash and will purchase common stock in the open market, on the New York Stock Exchange or elsewhere, for the participants’ accounts. Shares purchased in the open market will be allocated to a participant based on the average purchase price, excluding any brokerage charges or other charges, of all shares purchased with respect to the dividend.

You may withdraw from the Plan at any time by giving written notice to the Plan Administrator, or by telephone in accordance with such reasonable requirements as we and the Plan Administrator may agree upon. If you withdraw or the Plan is terminated, you will receive a certificate for each whole share in your account under the Plan and you will receive a cash payment for any fraction of a share in your account. If you wish, the Plan Administrator will sell your shares and send you the proceeds, minus brokerage commissions.

The Plan Administrator maintains all common stockholders’ accounts in the Plan and gives written confirmation of all transactions in the accounts, including information you may need for tax records. Common stock in your account will be held by the Plan Administrator in non-certificated form. The Plan Administrator will forward to each participant any proxy solicitation material and will vote any shares so held only in accordance with proxies returned to us. Any proxy you receive will include all common stock you have received under the Plan.

There is no brokerage charge for reinvestment of your dividends or distributions in common stock.

Automatically reinvesting dividends and distributions does not mean that you do not have to pay income taxes due upon the reinvestment of such dividends and distributions. See “Material United States Federal Income Tax Considerations”.

If you hold your common stock with a brokerage firm that does not participate in the Plan, you will not be able to participate in the Plan and any dividend reinvestment may be effected on different terms than those described above. Consult your financial advisory for more information.

 

49


Table of Contents

Neither us nor the Plan Administrator nor its nominee or nominees shall be liable for any act done in good faith, or for any good faith omission to act, including without limitation, any claims of liability arising out of failure to terminate a participant’s account upon the participant’s death prior to receipt of notice in writing of such death, and with respect to the price at which shares are purchased or sold for the participant’s account.

The Plan Administrator’s fees under the Plan will be borne by us. There is no direct service charge to participants in the Plan; however, we reserve the right to amend or terminate the Plan, including amending the Plan to include a service charge payable by the participants, if in the judgment of the board of directors the change is warranted. Any amendment to the Plan, except amendments necessary or appropriate to comply with applicable law or the rules and policies of the SEC or any other regulatory authority, require us to provide at least 30 days written notice to each participant. Additional information about the Plan may be obtained from American Stock Transfer & Trust Company LLC, 59 Maiden Lane, New York, New York 10038.

 

50


Table of Contents

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF

OPERATIONS

The following discussion should be read in conjunction with our financial statements and related notes and other financial information appearing elsewhere in this prospectus. In addition to historical information, the following discussion and other parts of this prospectus contain forward-looking information that involves risks and uncertainties. Our actual results could differ materially from those anticipated by such forward-looking information due to the factors discussed under “Risk Factors” and “Note about Forward-Looking Statements” appearing elsewhere in this prospectus.

Overview

We are a Maryland corporation that has elected to be treated as a business development company (“BDC”) under the Investment Company Act of 1940 (the “1940 Act”). Our investment objective is to generate current income and, to a lesser extent, capital appreciation from our investments. We invest primarily in leveraged loans and mezzanine debt issued by private U.S. middle market companies, which we define as companies having EBITDA of between $5 million and $50 million, both through direct lending and through participation in loan syndicates. We may also invest up to 30.0% of the portfolio in opportunistic investments in order to seek to enhance returns to stockholders. Such investments may include investments in distressed debt, which may include securities of companies in bankruptcy, foreign debt, private equity, securities of public companies that are not thinly traded and structured finance vehicles such as collateralized loan obligation funds. We have elected and qualified to be treated as a regulated investment company (“RIC”) under Subchapter M of the Internal Revenue Code of 1986, as amended (the “Code”).

Corporate History

We commenced operations, at the time known as GSC Investment Corp., on March 23, 2007 and completed an initial public offering of shares of common stock on March 28, 2007. Prior to July 30, 2010, we were externally managed and advised by GSCP (NJ), L.P., an entity affiliated with GSC Group, Inc. In connection with the consummation of a recapitalization transaction on July 30, 2010, as described below we engaged Saratoga Investment Advisors (“SIA”) to replace GSCP (NJ), L.P. as our investment adviser and changed our name to Saratoga Investment Corp.

As a result of the event of default under a revolving securitized credit facility with Deutsche Bank we previously had in place, in December 2008 we engaged the investment banking firm of Stifel, Nicolaus & Company to evaluate strategic transaction opportunities and consider alternatives for us. On April 14, 2010, GSC Investment Corp. entered into a stock purchase agreement with Saratoga Investment Advisors and certain of its affiliates and an assignment, assumption and novation agreement with Saratoga Investment Advisors, pursuant to which GSC Investment Corp. assumed certain rights and obligations of Saratoga Investment Advisors under a debt commitment letter Saratoga Investment Advisors received from Madison Capital Funding LLC, which indicated Madison Capital Funding’s willingness to provide GSC Investment Corp. with a $40.0 million senior secured revolving credit facility, subject to the satisfaction of certain terms and conditions. In addition, GSC Investment Corp. and GSCP (NJ), L.P. entered into a termination and release agreement, to be effective as of the closing of the transaction contemplated by the stock purchase agreement, pursuant to which GSCP (NJ), L.P., among other things, agreed to waive any and all accrued and unpaid deferred incentive management fees up to and as of the closing of the transaction contemplated by the stock purchase agreement but continued to be entitled to receive the base management fees earned through the date of the closing of the transaction contemplated by the stock purchase agreement.

On July 30, 2010, the transactions contemplated by the stock purchase agreement with Saratoga Investment Advisors and certain of its affiliates were completed, the private sale of 986,842 shares of our common stock for $15.0 million in aggregate purchase price to Saratoga Investment Advisors and certain of its affiliates closed, the Company entered into the Credit Facility, and the Company began doing business as Saratoga Investment Corp.

 

51


Table of Contents

We used the net proceeds from the private sale transaction and a portion of the funds available to us under the Credit Facility to pay the full amount of principal and accrued interest, including default interest, outstanding under our revolving securitized credit facility with Deutsche Bank. The revolving securitized credit facility with Deutsche Bank was terminated in connection with our payment of all amounts outstanding thereunder on July 30, 2010.

On August 12, 2010, we effected a one-for-ten reverse stock split of our outstanding common stock. As a result of the reverse stock split, every ten shares of our common stock were converted into one share of our common stock. Any fractional shares received as a result of the reverse stock split were redeemed for cash. The total cash payment in lieu of shares was $230. Immediately after the reverse stock split, we had 2,680,842 shares of our common stock outstanding.

In January 2011, we registered for public resale the 982,842 shares of our common stock issued to Saratoga Investment Advisors and certain of its affiliates.

On March 28, 2012, our wholly-owned subsidiary, Saratoga Investment Corp. SBIC, LP (“SBIC LP”), received a Small Business Investment Company (“SBIC”) license from the Small Business Administration (“SBA”).

In May 2013, we issued $48.3 million in aggregate principal amount of our 7.50% unsecured notes due 2020 for net proceeds of $46.1 million after deducting underwriting commissions of $1.9 million and offering costs of $0.3 million. The proceeds included the underwriters’ full exercise of their overallotment option. Interest on these notes is paid quarterly in arrears on February 15, May 15, August 15 and November 15 of each year, at a rate of 7.50% per year, beginning August 15, 2013. The notes mature on May 31, 2020 and may be redeemed in whole or in part at any time or from time to time at our option on or after May 31, 2016. The notes are listed on the NYSE under the trading symbol “SAQ” with a par value of $25.00 per share.

Critical Accounting Policies

Basis of Presentation

The preparation of financial statements in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) requires management to make certain estimates and assumptions affecting amounts reported in the Company’s consolidated financial statements. We have identified investment valuation, revenue recognition and the recognition of capital gains incentive fee expense as our most critical accounting estimates. We continuously evaluate our estimates, including those related to the matters described below. These estimates are based on the information that is currently available to us and on various other assumptions that we believe to be reasonable under the circumstances. Actual results could differ materially from those estimates under different assumptions or conditions. A discussion of our critical accounting policies follows.

Investment Valuation

The Company accounts for its investments at fair value in accordance with the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 820, Fair Value Measurements and Disclosures (“ASC 820”). ASC 820 defines fair value, establishes a framework for measuring fair value, establishes a fair value hierarchy based on the quality of inputs used to measure fair value and enhances disclosure requirements for fair value measurements. ASC 820 requires the Company to assume that its investments are to be sold at the statement of assets and liabilities date in the principal market to independent market participants, or in the absence of a principal market, in the most advantageous market, which may be a hypothetical market. Market participants are defined as buyers and sellers in the principal or most advantageous market that are independent, knowledgeable, and willing and able to transact.

 

52


Table of Contents

Investments for which market quotations are readily available are fair valued at such market quotations obtained from independent third party pricing services and market makers subject to any decision by our board of directors to approve a fair value determination to reflect significant events affecting the value of these investments. We value investments for which market quotations are not readily available at fair value as approved, in good faith, by our board of directors based on input from Saratoga Investment Advisers, the audit committee of our board of directors and a third party independent valuation firm. Determinations of fair value may involve subjective judgments and estimates. The types of factors that may be considered in determining the fair value of our investments include the nature and realizable value of any collateral, the portfolio company’s ability to make payments, market yield trend analysis, the markets in which the portfolio company does business, comparison to publicly traded companies, discounted cash flow and other relevant factors. We undertake a multi-step valuation process each quarter when valuing investments for which market quotations are not readily available, as described below:

 

    Each investment is initially valued by the responsible investment professionals of Saratoga Investment Advisors and preliminary valuation conclusions are documented and discussed with our senior management; and

 

    An independent valuation firm engaged by our board of directors reviews approximately one quarter of these preliminary valuations each quarter so that the valuation of each investment for which market quotes are not readily available is reviewed by the independent valuation firm at least annually.

In addition, all our investments are subject to the following valuation process:

 

    The audit committee of our board of directors reviews each preliminary valuation and Saratoga Investment Advisors and independent valuation firm (if applicable) will supplement the preliminary valuation to reflect any comments provided by the audit committee; and

 

    Our board of directors discusses the valuations and approves the fair value of each investment, in good faith, based on the input of Saratoga Investment Advisors, independent valuation firm (to the extent applicable) and the audit committee of our board of directors.

Our investment in Saratoga Investment Corp. CLO 2013-1, Ltd. (“Saratoga CLO”) is carried at fair value, which is based on a discounted cash flow model that utilizes prepayment, re-investment and loss assumptions based on historical experience and projected performance, economic factors, the characteristics of the underlying cash flow, and comparable yields for equity interests in collateralized loan obligation funds similar to Saratoga CLO, when available, as determined by SIA and recommended to our board of directors. Specifically, we use Intex cash flow models, or an appropriate substitute, to form the basis for the valuation of our investment in Saratoga CLO. The models use a set of assumptions including projected default rates, recovery rates, reinvestment rate and prepayment rates in order to arrive at estimated valuations. The assumptions are based on available market data and projections provided by third parties as well as management estimates. We use the output from the Intex models (i.e., the estimated cash flows) to perform a discounted cash flows analysis on expected future cash flows to determine a valuation for our investment in Saratoga CLO.

Revenue Recognition

Income Recognition

Interest income, adjusted for amortization of premium and accretion of discount, is recorded on an accrual basis to the extent that such amounts are expected to be collected. The Company stops accruing interest on its investments when it is determined that interest is no longer collectible. Discounts and premiums on investments purchased are accreted/amortized over the life of the respective investment using the effective yield method. The amortized cost of investments represents the original cost adjusted for the accretion of discounts and amortizations of premium on investments.

 

53


Table of Contents

Loans are generally placed on non-accrual status when there is reasonable doubt that principal or interest will be collected. Accrued interest is generally reserved when a loan is placed on non-accrual status. Interest payments received on non-accrual loans may be recognized as a reduction in principal depending upon management’s judgment regarding collectability. Non-accrual loans are restored to accrual status when past due principal and interest is paid and, in management’s judgment, are likely to remain current, although we may make exceptions to this general rule if the loan has sufficient collateral value and is in the process of collection.

Interest income on our investment in Saratoga CLO is recorded using the effective interest method in accordance with the provisions of ASC Topic 325-40, Investments-Other, Beneficial Interests in Securitized Financial Assets, based on the anticipated yield and the estimated cash flows over the projected life of the investment. Yields are revised when there are changes in actual or estimated cash flows due to changes in prepayments and/or re-investments, credit losses or asset pricing. Changes in estimated yield are recognized as an adjustment to the estimated yield over the remaining life of the investment from the date the estimated yield was changed.

Paid-in-Kind Interest

The Company holds debt investments in its portfolio that contain a payment-in-kind (“PIK”) interest provision. The PIK interest, which represents contractually deferred interest added to the investment balance that is generally due at maturity, is generally recorded on the accrual basis to the extent such amounts are expected to be collected. We stop accruing PIK interest if we do not expect the issuer to be able to pay all principal and interest when due.

Capital Gains Incentive Fee

The Company records an expense accrual relating to the capital gains incentive fee payable by the Company to its investment adviser when the unrealized gains on its investments exceed all realized capital losses on its investments given the fact that a capital gains incentive fee would be owed to the investment adviser if the Company were to liquidate its investment portfolio at such time. The actual incentive fee payable to the Company’s investment adviser related to capital gains will be determined and payable in arrears at the end of each fiscal year and will include only realized capital gains for the period.

Revenues

We generate revenue in the form of interest income and capital gains on the debt investments that we hold and capital gains, if any, on equity interests that we may acquire. We expect our debt investments, whether in the form of leveraged loans or mezzanine debt, to have terms of up to ten years, and to bear interest at either a fixed or floating rate. Interest on debt will be payable generally either quarterly or semi-annually. In some cases, our debt investments may provide for a portion of the interest to be PIK. To the extent interest is paid-in-kind, it will be payable through the increase of the principal amount of the obligation by the amount of interest due on the then-outstanding aggregate principal amount of such obligation. The principal amount of the debt and any accrued but unpaid interest will generally become due at the maturity date. In addition, we may generate revenue in the form of commitment, origination, structuring or diligence fees, fees for providing managerial assistance or investment management services and possibly consulting fees. Any such fees will be generated in connection with our investments and recognized as earned. We may also invest in preferred equity securities that pay dividends on a current basis.

On January 22, 2008, we entered into a collateral management agreement with Saratoga CLO, pursuant to which we act as its collateral manager. The Saratoga CLO was refinanced in October 2013 and its reinvestment period ends in October 2016. The Saratoga CLO remains 100% owned and managed by Saratoga Investment Corp. We receive a senior collateral management fee of 0.25% and a subordinate collateral management fee of 0.25% of the outstanding principal amount of Saratoga CLO’s assets, paid quarterly to the extent of available proceeds. We are also entitled to an incentive management fee equal to 20.0% of excess cash flow to the extent the Saratoga CLO subordinated notes receive an internal rate of return equal to or greater than 12.0%.

 

54


Table of Contents

We recognize interest income on our investment in the subordinated notes of Saratoga CLO using the effective interest method, based on the anticipated yield and the estimated cash flows over the projected life of the investment. Yields are revised when there are changes in actual or estimated cash flows due to changes in prepayments and/or re-investments, credit losses or asset pricing. Changes in estimated yield are recognized as an adjustment to the estimated yield over the remaining life of the investment from the date the estimated yield was changed.

Expenses

Our primary operating expenses include the payment of investment advisory and management fees, professional fees, directors and officers insurance, fees paid to independent directors and administrator expenses, including our allocable portion of our administrator’s overhead. Our investment advisory and management fees compensate our investment adviser for its work in identifying, evaluating, negotiating, closing and monitoring our investments. We bear all other costs and expenses of our operations and transactions, including those relating to:

 

    organization;

 

    calculating our net asset value (including the cost and expenses of any independent valuation firm);

 

    expenses incurred by our investment adviser payable to third parties, including agents, consultants or other advisers, in monitoring our financial and legal affairs and in monitoring our investments and performing due diligence on our prospective portfolio companies;

 

    interest payable on debt, if any, incurred to finance our investments;

 

    offerings of our common stock and other securities;

 

    investment advisory and management fees;

 

    fees payable to third parties, including agents, consultants or other advisers, relating to, or associated with, evaluating and making investments;

 

    transfer agent and custodial fees;

 

    federal and state registration fees;

 

    all costs of registration and listing our common stock on any securities exchange;

 

    federal, state and local taxes;

 

    independent directors’ fees and expenses;

 

    costs of preparing and filing reports or other documents required by governmental bodies (including the SEC and the SBA);

 

    costs of any reports, proxy statements or other notices to common stockholders including printing costs;

 

    our fidelity bond, directors and officers errors and omissions liability insurance, and any other insurance premiums;

 

    direct costs and expenses of administration, including printing, mailing, long distance telephone, copying, secretarial and other staff, independent auditors and outside legal costs; and

 

    administration fees and all other expenses incurred by us or, if applicable, the administrator in connection with administering our business (including payments under the administration agreement based upon our allocable portion of the administrator’s overhead in performing its obligations under an administration agreement, including rent and the allocable portion of the cost of our officers and their respective staffs (including travel expenses)).

 

55


Table of Contents

Pursuant to the investment advisory and management agreement that we had with GSCP (NJ), L.P., our former investment adviser and administrator, we had agreed to pay GSCP (NJ), L.P. as investment adviser a quarterly base management fee of 1.75% of the average value of our total assets (other than cash or cash equivalents but including assets purchased with borrowed funds) at the end of the two most recently completed fiscal quarters, and appropriately adjusted for any share issuances or repurchases during the applicable fiscal quarter, and an incentive fee.

The incentive fee had two parts:

 

    A fee, payable quarterly in arrears, equal to 20.0% of our pre-incentive fee net investment income, expressed as a rate of return on the value of the net assets at the end of the immediately preceding quarter, that exceeded a 1.875% quarterly (7.5% annualized) hurdle rate measured as of the end of each fiscal quarter. Under this provision, in any fiscal quarter, our investment adviser received no incentive fee unless our pre-incentive fee net investment income exceeded the hurdle rate of 1.875%. Amounts received as a return of capital were not included in calculating this portion of the incentive fee. Since the hurdle rate was based on net assets, a return of less than the hurdle rate on total assets could still have resulted in an incentive fee.

 

    A fee, payable at the end of each fiscal year, equal to 20.0% of our net realized capital gains, if any, computed net of all realized capital losses and unrealized capital depreciation, in each case on a cumulative basis, less the aggregate amount of capital gains incentive fees paid to the investment adviser through such date.

We deferred cash payment of any incentive fee otherwise earned by our former investment adviser if, during the then most recent four full fiscal quarters ending on or prior to the date such payment was to be made, the sum of (a) our aggregate distributions to our stockholders and (b) our change in net assets (defined as total assets less liabilities) (before taking into account any incentive fees payable during that period) was less than 7.5% of our net assets at the beginning of such period. These calculations were appropriately pro-rated for the first three fiscal quarters of operation and adjusted for any share issuances or repurchases during the applicable period. Such incentive fee would become payable on the next date on which such test had been satisfied for the most recent four full fiscal quarters or upon certain terminations of the investment advisory and management agreement. We commenced deferring cash payment of incentive fees during the quarterly period ended August 31, 2007, and continued to defer such payments through the quarterly period ended May 31, 2010. As of July 30, 2010, the date on which GSCP (NJ), L.P. ceased to be our investment adviser and administrator, we owed GSCP (NJ), L.P. $2.9 million in fees for services previously provided to us; of which $0.3 million has been paid by us. GSCP (NJ), L.P. agreed to waive payment by us of the remaining $2.6 million in connection with the consummation of the stock purchase transaction with Saratoga Investment Advisors and certain of its affiliates described elsewhere in this Annual Report.

The terms of the investment advisory and management agreement with Saratoga Investment Advisors, our current investment adviser, are substantially similar to the terms of the investment advisory and management agreement we had entered into with GSCP (NJ), L.P., our former investment adviser, except for the following material distinctions in the fee terms:

 

    The capital gains portion of the incentive fee was reset with respect to gains and losses from May 31, 2010, and therefore losses and gains incurred prior to such time will not be taken into account when calculating the capital gains fee payable to Saratoga Investment Advisors and, as a result, Saratoga Investment Advisors will be entitled to 20.0% of net gains that arise after May 31, 2010. In addition, the cost basis for computing realized gains and losses on investments held by us as of May 31, 2010 equal the fair value of such investment as of such date. Under the investment advisory and management agreement with our former investment adviser, GSCP (NJ), L.P., the capital gains fee was calculated from March 21, 2007, and the gains were substantially outweighed by losses.

 

56


Table of Contents
    Under the “catch up” provision, 100.0% of our pre-incentive fee net investment income with respect to that portion of such pre-incentive fee net investment income that exceeds 1.875% (7.5% annualized) but is less than or equal to 2.344% in any fiscal quarter is payable to Saratoga Investment Advisors. This will enable Saratoga Investment Advisors to receive 20.0% of all net investment income as such amount approaches 2.344% in any quarter, and Saratoga Investment Advisors will receive 20.0% of any additional net investment income. Under the investment advisory and management agreement with our former investment adviser, GSCP (NJ), L.P. only received 20.0% of the excess net investment income over 1.875%.

 

    We will no longer have deferral rights regarding incentive fees in the event that the distributions to stockholders and change in net assets is less than 7.5% for the preceding four fiscal quarters.

To the extent that any of our leveraged loans are denominated in a currency other than U.S. dollars, we may enter into currency hedging contracts to reduce our exposure to fluctuations in currency exchange rates. We may also enter into interest rate hedging agreements. Such hedging activities, which will be subject to compliance with applicable legal requirements, may include the use of interest rate caps, futures, options and forward contracts. Costs incurred in entering into or settling such contracts will be borne by us.

Portfolio and investment activity

Corporate Debt Portfolio Overview

 

     At August 31,
2014
    At February 28,
2014
    At February 28,
2013
    At February 29,
2012
 
     ($ in millions)     ($ in millions)     ($ in millions)     ($ in millions)  

Number of investments(1)

     64        59        44        30   

Number of portfolio companies(1)

     39        37        28        21   

Average investment size(1)

   $ 3.4      $ 3.2      $ 2.9      $ 2.3   

Weighted average maturity(1)

     3.9yrs        4.3yrs        3.7yrs        3.0yrs   

Number of industries(1)

     18        16        15        15   

Average investment per portfolio company(1)

   $ 5.5      $ 5.0      $ 4.6      $ 3.3   

Non-performing or delinquent investments(1)

   $ 0.4      $ 0.3      $ 6.7      $ 0.0   

Fixed rate debt (% of interest bearing portfolio)(2)

   $ 76.6(37.8 )%    $ 70.6(40.1 )%    $ 53.4(43.9 )%    $ 18.7(29.3 )% 

Weighted average current coupon(2)

     13.0     12.5     12.6     13.0

Floating rate debt (% of interest bearing portfolio)(2)

   $ 126.0(62.2 )%    $ 105.4(59.9 )%    $ 68.2(56.1 )%    $ 45.1(70.7 )% 

Weighted average current spread over LIBOR(2)

     8.5     7.3     7.5     7.4

 

(1) Excludes our investment in the subordinated notes of Saratoga CLO.
(2) Excludes our investment in the subordinated notes of Saratoga CLO and investments in common stocks.

During the three months ended August 31, 2014, we made $31.8 million investments in new or existing portfolio companies and had $15.7 million in aggregate amount of exits and repayments resulting in net investments of $16.1 million for the period. During the three months ended August 31, 2013, we made $54.9 million investments in the new or existing portfolio companies and had $29.6 million in aggregate amount of exits and repayments resulting in net investments of $25.3 million for the period.

During the six months ended August 31, 2014, we made $53.3 million investments in new or existing portfolio companies and had $24.4 million in aggregate amount of exits and repayments resulting in net

 

57


Table of Contents

investments of $28.9 million for the period. During the six months ended August 31, 2013, we made $87.9 million investments in new or existing portfolio companies and had $54.9 million in aggregate amount of exits and repayments resulting in net investments of $33.0 million for the period.

During the fiscal year ended February 28, 2014, we invested $121.1 million in new or existing portfolio companies and had $71.6 million in aggregate amount of exits and repayments resulting in net investments of $49.5 million for the year.

During the fiscal year ended February 28, 2013, we invested $71.6 million in new or existing portfolio companies and had $21.5 million in aggregate amount of exits and repayments resulting in net investments of $50.1 million for the year.

During the fiscal year ended February 29, 2012, we invested $38.7 million in new or existing portfolio companies and had $33.6 million in aggregate amount of exits and repayments resulting in net investments of $5.1 million for the year.

Our portfolio composition at August 31, 2014, February 28, 2014, February 28, 2013, and February 29, 2012 at fair value was as follows:

Portfolio composition

 

    At August 31, 2014     At February 28, 2014     At February 28, 2013     At February 29, 2012  
    Percentage
of Total
Portfolio
    Weighted
Average
Current
Yield
    Percentage
of Total
Portfolio
    Weighted
Average
Current
Yield
    Percentage
of Total
Portfolio
    Weighted
Average
Current
Yield
    Percentage
of Total
Portfolio
    Weighted
Average
Current
Yield
 

Syndicated loans*

    11.3     6.5     15.7     6.2     —       —       —       —  

First lien term loans*

    48.9        11.0        39.0        10.7        54.0        10.0        38.0        10.1   

Second lien term loans

    12.4        11.5        13.5        11.1        6.2        11.1        9.3        10.3   

Senior secured notes*

    10.6        14.7        14.6        13.8        15.0        14.8        11.2        16.0   

Senior unsecured loans

    —          —          —          —          —          —          6.3        15.0   

Unsecured notes

    2.5        14.2        2.7        15.2        3.1        16.4        2.1        19.3   

Saratoga CLO subordinated notes

    8.5        23.9        9.5        18.6        16.5        27.1        27.1        20.2   

Equity interests

    5.8        N/A        5.0        N/A        5.2        N/A        6.0        N/A   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total

  100.0   12.2   100.0   11.8   100.0   14.0   100.0   13.4
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

* Syndicated loans, first lien term loans and senior secured debt instruments are all securities in which we hold a first lien position. The distinction between the two categories is that senior secured notes are bonds that are issued by investment banks and purchased by us, while all other debt instruments we hold are term loans.

Saratoga Investment Advisors normally grades all of our investments using a credit and monitoring rating system (“CMR”). The CMR consists of a single component: a color rating. The color rating is based on several criteria, including financial and operating strength, probability of default, and restructuring risk. The color ratings are characterized as follows: (Green)—strong credit; (Yellow)—satisfactory credit; (Red)—payment default risk, in payment default and/or significant restructuring activity.

 

58


Table of Contents

The CMR distribution of our investments at August 31, 2014, February 28, 2014 and February 28, 2013 was as follows:

Portfolio CMR distribution

 

     At August 31, 2014     At February 28, 2014     At February 28, 2013  

Color Score

   Investments
at
Fair Value
     Percentage
of Total
Portfolio
    Investments
at
Fair Value
     Percentage
of Total
Portfolio
    Investments
at
Fair Value
     Percentage
of Total
Portfolio
 
    

($ in thousands)

 

Green

   $ 179,293         75.9   $ 159,207         77.4   $ 100,170         64.6

Yellow

     15,531         6.6        8,466         4.1        8,143         5.3   

Red

     7,785         3.3        8,270         4.0        13,229         8.5   

N/A(1)

     33,711         14.2        29,902         14.5        33,538         21.6   
  

 

 

    

 

 

   

 

 

    

 

 

   

 

 

    

 

 

 

Total

$ 236,320      100.0 $ 205,845      100.0 $ 155,080      100.0
  

 

 

    

 

 

   

 

 

    

 

 

   

 

 

    

 

 

 

 

(1) Comprised of our investment in the subordinated notes of Saratoga CLO and equity interests.

The CMR distribution of Saratoga CLO investments at August 31, 2014, February 28, 2014 and February 28, 2013 was as follows:

Portfolio CMR distribution

 

     At August 31, 2014     At February 28, 2014     At February 28, 2013  

Color Score

   Investments
at
Fair Value
     Percentage
of Total
Portfolio
    Investments
at
Fair Value
     Percentage
of Total
Portfolio
    Investments
at
Fair Value
     Percentage
of Total
Portfolio
 
    

($ in thousands)

 

Green

   $ 289,563         96.2   $ 284,796         94.8   $ 318,181         85.0

Yellow

     8,068         2.7        14,106         4.7        50,677         13.5   

Red

     3,389         1.1        1,589         0.5        5,562         1.5   

N/A(1)

               
  

 

 

    

 

 

   

 

 

    

 

 

   

 

 

    

 

 

 

Total

$ 301,020      100.0 $ 300,491      100.0 $ 374,420      100.0
  

 

 

    

 

 

   

 

 

    

 

 

   

 

 

    

 

 

 

 

(1) Comprised of our investment in the subordinated notes of Saratoga CLO and equity interests.

Our investment in the subordinated notes of Saratoga CLO represents a first loss position in a portfolio that, at August 31, 2014 at February 28, 2014, February 28, 2013, and February 29, 2012, was composed of $304.4 million, $301.3 million, $383.3 million, and $380.2 million, respectively, in aggregate principal amount of predominantly senior secured first lien term loans. This investment is subject to unique risks. (See “Risk Factors—Our investment in Saratoga CLO 2013-1 LTD. constitutes a leveraged investment in a portfolio of predominantly senior secured first lien term loans and is subject to additional risks and volatility”). We do not consolidate the Saratoga CLO portfolio in our financial statements. Accordingly, the metrics above do not include the underlying Saratoga CLO portfolio investments. However, at August 31, 2014, $297.6 million or 98.9% of the Saratoga CLO portfolio investments in terms of market value had a CMR color rating of green or yellow and $3.4 million or 1.1% had a color rating of red. At February 28, 2014, $298.9 million or 99.5% of the Saratoga CLO portfolio investments in terms of market value had a CMR (as defined below) color rating of green or yellow and $1.6 million or 0.5% had a color rating of red. At February 28, 2013, $368.9 million or 98.5% of the Saratoga CLO portfolio investments in terms of market value had a CMR color rating of green or yellow and $5.6 million or 1.5% had a color rating of red.

 

59


Table of Contents

Portfolio composition by industry grouping at fair value

The following table shows our portfolio composition by industry grouping at fair value at August 31, 2014, February 28, 2014 and February 28, 2013:

 

     At August 31, 2014     At February 28, 2014     At February 28, 2013  
     Investments
at
Fair Value
     Percentage
of Total
Portfolio
    Investments
at
Fair Value
     Percentage
of Total
Portfolio
    Investments
at
Fair Value
     Percentage
of Total
Portfolio
 
    

($ in thousands)

 

Business Services

   $ 47,700         20.2   $ 57,330         27.9   $ 22,155         14.3

Healthcare Services

     42,227         17.9        23,810         11.6        12,400         8.0   

Consumer Services

     16,963         7.2        21,897         10.6        10,654         6.9   

Software

     24,011         10.2        21,738         10.5        —           —     

Structured Finance Securities(1)

     20,090         8.5        19,570         9.5        25,517         16.5   

Food and Beverage

     12,913         5.4        17,286         8.4        18,199         11.7   

Automotive

     10,672         4.5        10,621         5.2        14,805         9.5   

Electronics

     6,554         2.8        6,741         3.3        6,721         4.3   

Metals

     5,785         2.4        6,645         3.2        6,724         4.3   

Consumer Products

     5,378         2.3        6,118         3.0        13,727         8.9   

Manufacturing

     5,940         2.5        5,970         2.9        —           —     

Environmental

     5,812         2.5        5,249         2.5        2,992         1.9   

Publishing

     1,489         0.6        1,191         0.6        5,631         3.6   

Building Products

     1,956         0.8        901         0.4        267         0.2   

Aerospace

     —           —          344         0.2        3,500         2.3   

Homebuilding

     411         0.2        344         0.2        315         0.2   

Education

     101         0.0        90         0.0        292         0.2   

Logistics

     —           —          —           —          11,181         7.2   

Technology

     12,759         5.4             

Media

     9,454         4.0             

Utilities

     6,105         2.6             
  

 

 

    

 

 

   

 

 

    

 

 

   

 

 

    

 

 

 

Total

$ 236,320      100.0 $ 205,845      100.0 $ 155,080      100.0
  

 

 

    

 

 

   

 

 

    

 

 

   

 

 

    

 

 

 

 

(1) Comprised of our investment in the subordinated notes of Saratoga CLO.

The following table shows Saratoga CLO’s portfolio composition by industry grouping at fair value at August 31, 2014, February 28, 2014 and February 28, 2013:

 

     At August 31, 2014     At February 28, 2014     At February 28, 2013  
     Investments
at
Fair Value
     Percentage
of Total
Portfolio
    Investments
at
Fair Value
     Percentage
of Total
Portfolio
    Investments
at
Fair Value
     Percentage
of Total
Portfolio
 
    

($ in thousands)

 

Healthcare

   $ 34,718         11.5   $ 37,896         12.6   $ 40,502         10.8

Business Equipment and Services

     31,543         10.5        28,386         9.4        28,300         7.6   

Chemicals/Plastics

     27,214         9.0        26,345         8.8        28,817         7.7   

Conglomerate

     19,946         6.6        24,285         8.1        29,888         8.0   

Industrial Equipment

     19,160         6.4        24,143         8.0        21,864         5.8   

Aerospace and Defense

     10,491         3.5        20,465         6.8        20,914         5.6   

Retailers (Except Food and Drugs)

     17,670         5.9        15,314         5.1        19,050         5.1   

Food Products

     9,956         3.3        12,450         4.1        21,016         5.6   

Drugs

     13,260         4.4        11,873         4.0        18,226         4.9   

Electronics/Electric

     12,013         4.0        11,861         4.0        26,321         7.0   

 

60


Table of Contents
     At August 31, 2014     At February 28, 2014     At February 28, 2013  
     Investments
at
Fair Value
     Percentage
of Total
Portfolio
    Investments
at
Fair Value
     Percentage
of Total
Portfolio
    Investments
at
Fair Value
     Percentage
of Total
Portfolio
 
    

($ in thousands)

 

Automotive

   $ 6,424         2.1 %     $ 10,279         3.4 %     $ 10,625         2.8 %  

Leisure Goods/Activities/Movies

     16,271         5.4        8,990         3.0        8,879         2.4   

Financial Intermediaries

     8,731         2.9        8,138         2.7        20,199         5.4   

Telecommunications

     6,163         2.0        6,627         2.2        10,951         2.9   

Utilities

     5,754         1.9        5,830         1.9        9,932         2.6   

Food Services

     8,502         2.8        5,612         1.9        5,491         1.5   

Insurance

     5,482         1.8        5,517         1.8        6,648         1.8   

Food/Drug Retailers

     5,840         1.9        5,012         1.7        4,329         1.1   

Nonferrous Metals/Minerals

     1,973         0.7        4,328         1.4        5,187         1.4   

Brokers/Dealers/Investment Houses

     4,920         1.6        3,740         1.2        3,311         0.9   

Building and Development

     494         0.2        3,246         1.1        2,124         0.6   

Publishing

     5,185         1.7        2,913         1.0        5,657         1.5   

Containers/Glass Products

     6,387         2.1        2,906         1.0        2,009         0.5   

Cable and Satellite Television

     2,582         0.9        2,666         0.9        4,058         1.1   

Oil & Gas

     5,714         1.9        2,488         0.8        —           —     

Telecommunications/Cellular

     2,423         0.8        2,460         0.8        3,076         0.8   

Broadcast Radio and Television

     489         0.2        1,505         0.5        1,010         0.3   

Computers & Electronics

     —           —          1,479         0.5        —           —     

Ecological Services and Equipment

     826         0.3        1,241         0.4        753         0.2   

Media

     2,007         0.7        1,000         0.3        —           —     

Gaming And Hotels

     —           —          500         0.2        —           —     

Lodging and Casinos

     5,438         1.8        499         0.2        7,400         2.0   

Leasing

     —           —          497         0.2        —           —     

Beverage and Tobacco

     —           —          —           —          3,037         0.8   

Home Furnishings

     —           —          —           —          2,984         0.8   

Steel

     —           —          —           —          1,001         0.3   

Clothing/Textiles

     —           —          —           —          861         0.2   

Health Insurance

     483         0.2        —           —          —           —     

Healthcare and Pharmaceuticals

     2,961         1.0             
  

 

 

    

 

 

   

 

 

    

 

 

   

 

 

    

 

 

 

Total

$ 301,020      100.0 $ 300,491      100.0 $ 374,420      100.0
  

 

 

    

 

 

   

 

 

    

 

 

   

 

 

    

 

 

 

Portfolio composition by geographic location at fair value

The following table shows our portfolio composition by geographic location at fair value at August 31, 2014, February 28, 2014 and February 28, 2013. The geographic composition is determined by the location of the corporate headquarters of the portfolio company.

 

     At August 31, 2014     At February 28, 2014     At February 28, 2013  
     Investments
at
Fair Value
     Percentage
of Total
Portfolio
    Investments
at
Fair Value
     Percentage
of Total
Portfolio
    Investments
at
Fair Value
     Percentage
of Total
Portfolio
 
     ($ in thousands)  

Southeast

   $ 94,390         39.9   $ 83,161         40.4   $ 70,476         45.4

West

     35,943         15.2        44,470         21.6        26,573         17.1   

Midwest

     45,119         19.1        41,453         20.1        18,469         11.9   

Other(1)

     20,090         8.5        19,570         9.5        25,517         16.5   

Northeast

     40,778         17.3        17,191         8.4        14,045         9.1   
  

 

 

    

 

 

   

 

 

    

 

 

   

 

 

    

 

 

 

Total

$ 236,320      100.0 $ 205,845      100.0 $ 155,080      100.0
  

 

 

    

 

 

   

 

 

    

 

 

   

 

 

    

 

 

 

 

(1) Comprised of our investment in the subordinated notes of Saratoga CLO.

 

61


Table of Contents

Results of operations

Operating results for the three and six months ended August 31, 2014 and 2013 are as follows:

 

     For the three months ended  
     August 31, 2014      August 31, 2013  
     ($ in thousands)  

Total investment income

   $ 6,475       $ 5,388   

Total expenses, net

     4,403         3,116   
  

 

 

    

 

 

 

Net investment income

  2,072      2,272   

Net realized gains

  360      546   

Net unrealized gains (losses)

  704      (2,859
  

 

 

    

 

 

 

Net increase/(decrease) in net assets resulting from operations

$ 3,136    $ (41
  

 

 

    

 

 

 

 

     For the six months ended  
     August 31, 2014      August 31, 2013  
     ($ in thousands)  

Total investment income

   $ 12,619       $ 11,406   

Total expenses, net

     8,486         6,664   
  

 

 

    

 

 

 

Net investment income

  4,133      4,742   

Net realized gains

  442      1,074   

Net unrealized gains (losses)

  319      (2,057
  

 

 

    

 

 

 

Net increase in net assets resulting from operations

$ 4,894    $ 3,759   
  

 

 

    

 

 

 

Investment income

The composition of our investment income for the three and six months ended August 31, 2014 and 2013 was as follows:

 

     For the three months ended  
     August 31, 2014      August 31, 2013  
     ($ in thousands)  

Interest from investments

   $ 6,037       $ 4,792   

Management fee income from Saratoga CLO

     375         481   

Interest from cash and cash equivalents and other income

     63         115   
  

 

 

    

 

 

 

Total

$ 6,475    $ 5,388   
  

 

 

    

 

 

 

 

     For the six months ended  
     August 31, 2014      August 31, 2013  
     ($ in thousands)  

Interest from investments

   $ 11,639       $ 9,963   

Management fee income from Saratoga CLO

     767         979   

Interest from cash and cash equivalents and other income

     213         464   
  

 

 

    

 

 

 

Total

$ 12,619    $ 11,406   
  

 

 

    

 

 

 

 

62


Table of Contents

For the three months ended August 31, 2014, total investment income increased $1.1 million, or 20.2% compared to the three months ended August 31, 2013. Interest income from investments increased $1.2 million, or 26.0%, to $6.0 million for the three months ended August 31, 2014, from $4.8 million for the three months ended August 31, 2013. This reflects an increase of 25.8% in total investments to $236.3 million at August 31, 2014 from $187.8 million at August 31, 2013, with the weighted average yield also decreasing to 12.2% from 13.2%.

For the six months ended August 31, 2014, total investment income increased $1.2 million, or 10.6%, compared to the six months ended August 31, 2013. Interest income from investments increased $1.6 million, or 16.8%, to $11.6 million for the six months ended August 31, 2014, from $10.0 million for the six months ended August 31, 2013. This reflects an increase of 25.8% in total investments to $236.3 million at August 31, 2014 from $187.8 million at August 31, 2013, with the weighted average yield also decreasing to 12.2% from 13.2%.

For the three and six months ended August 31, 2014 and 2013, total PIK income was $0.3 million and $0.6 million, and $0.3 million and $0.5 million, respectively.

The Saratoga CLO was refinanced in October 2013. As a result, proceeds from principal payments in the loan portfolio of Saratoga CLO must now be used to paydown its outstanding notes. Thus, the management fee income and investment income that we receive from Saratoga CLO has declined from historical periods decreasing $0.1 million, or 21.9%, to $0.4 million and $0.2 million, or 21.6%, to $0.8 million, respectively, for the three and six months ended August 31, 2014 from $0.5 million and $1.0 million for the three and six months ended August 31, 2013, respectively.

Operating expenses

The composition of our expenses for the three and six months ended August 31, 2014 and 2013 was as follows:

Operating Expenses

 

     For the three months ended  
     August 31,
2014
     August 31,
2013
 
     ($ in thousands)  

Interest and debt financing expenses

   $ 1,809       $ 1,604   

Base management fees

     1,037         811   

Professional fees

     276         235   

Incentive management fees

     790         (40

Administrator expenses

     250         250   

Insurance

     84         119   

Directors fees and expenses

     56         45   

General and administrative and other expenses

     101         92   
  

 

 

    

 

 

 

Total expenses

$ 4,403    $ 3,116   
  

 

 

    

 

 

 

 

63


Table of Contents
     For the six months ended  
     August 31,
2014
     August 31,
2013
 
     ($ in thousands)  

Interest and debt financing expenses

   $ 3,597       $ 2,731   

Base management fees

     2,006         1,548   

Professional fees

     711         566   

Incentive management fees

     1,171         781   

Administrator expenses

     500         500   

Insurance

     168         239   

Directors fees and expenses

     109         96   

General and administrative and other expenses

     224         203   
  

 

 

    

 

 

 

Total expenses

$ 8,486    $ 6,664   
  

 

 

    

 

 

 

For the three months ended August 31, 2014, total operating expenses increased $1.3 million, or 41.3% compared to the three months ended August 31, 2013. For the six months ended August 31, 2014, total operating expenses increased $1.8 million or 27.3% compared to the six months ended August 31, 2013.

For the three months ended August 31, 2014 and 2013, the increase in interest and credit facility expense is primarily attributable to an increase in the amount of outstanding debt as compared to the prior periods, with higher levels of both the SBA debentures and the revolving credit facility outstanding. For the three months ended August 31, 2014, the weighted average interest rate on our outstanding indebtedness was 5.14% compared to 5.53% for the three months ended August 31, 2013. This decrease was primarily driven by an increase in SBA debentures that carry a lower interest rate.

For the six months ended August 31, 2014 and 2013, the increase in interest and credit facility expense is primarily attributable to an increase in the amount of outstanding debt as compared to the prior periods, with higher levels of both the SBA debentures and the revolving credit facility outstanding. For the six months ended August 31, 2014, the weighted average interest rate on our outstanding indebtedness was 5.22% compared to 4.85% for the six months ended August 31, 2013. This increase was primarily driven by the interest rate on the note issuance.

For the three months ended August 31, 2014, base management fees increased $0.2 million, or 27.9% compared to the three months ended August 31, 2013. For the six months ended August 31, 2014, base management fees increased $0.5 million, or 29.6% compared to the six months ended August 31, 2013. The increase in base management fees results from the increase in the average value of our total assets, less cash and cash equivalents, from $183.9 million to $235.1 million as of August 31, 2013 and 2014, respectively.

For the three and six months ended August 31, 2014, professional fees increased $0.04 million or 17.4%, and $0.1 million, or 25.6%, respectively, compared to the three and six months ended August 31, 2013.

For the three months ended August 31, 2014, incentive management fees increased $0.8 million to $0.8 million, compared to a reduction of $0.04 million for the three months ended August 31, 2013. For the six months ended August 31, 2014, incentive management fees increased $0.4 million or 49.9% compared to the six months ended August 31, 2013. The increase in incentive management fees is primarily attributable to an increase in accrued incentive fees related to higher net investment income and incentive fee capital gains.

As discussed above, the increase in interest and credit facility expense for the three and six months ended August 31, 2014 and 2013 is primarily attributable to an increase in the amount of outstanding debt as compared to the prior periods. For the six months ended August 31, 2014, the weighted average interest rate on the outstanding borrowings under the Credit Facility and notes payable was 7.50%, however the notes were only issued and outstanding from May 10, 2013, while they were outstanding for the full six months ended August 31, 2014. For the three months ended August 31, 2014 and 2013, the weighted average interest rate on the

 

64


Table of Contents

outstanding borrowings of the SBA debentures was 3.16% and 3.16%, respectively. For the six months ended August 31, 2014 and 2013, the weighted average interest rate on the outstanding borrowings of the SBA debentures was 3.16% and 2.90%, respectively.

Net realized gains/losses on sales of investments

For the three months ended August 31, 2014, the Company had $15.7 million of sales, repayments, exits or restructurings resulting in $0.4 million of net realized gains.

For the six months ended August 31, 2014, the Company had $24.4 million of sales, repayments, exits or restructurings resulting in $0.4 million of net realized gains.

For the three months ended August 31, 2013, the Company had $29.6 million of sales, repayments, exits or restructurings resulting in $0.5 million of net realized gains.

For the six months ended August 31, 2013, the Company had $54.9 million of sales, repayments, exits or restructurings resulting in $1.1 million of net realized gains.

Net unrealized appreciation/depreciation on investments

For the three months ended August 31, 2014, our investments had net unrealized appreciation of $0.7 million versus net unrealized depreciation of $2.9 million for the three months ended August 31, 2013. For the six months ended August 31, 2014, our investments had net unrealized appreciation of $0.3 million versus net unrealized depreciation of $2.1 million for the six months ended August 31, 2013. The most significant cumulative changes in unrealized appreciation and depreciation for the six months ended August 31, 2014, were the following:

Six Months ended August 31, 2014

 

Issuer

  

Asset Type

  Cost     Fair
Value
    Total
Unrealized
Appreciation/
(Depreciation)
    YTD Change
in Unrealized
Appreciation/
(Depreciation)
 
               ($ in thousands)        

Elyria Foundry Company, LLC

   Senior Secured Note   $ 8,860      $ 5,785      $ (3,075   $ (859

Saratoga CLO

   Other/Structured Finance Securities     16,556        20,090        3,534        520   

USS Parent Holding Corp.

   Voting Common Stock     3,026        5,567        2,541        539   

The $0.9 million of unrealized depreciation in our investment in Elyria Foundry Company, LLC was due to a decline in the company’s performance as a result of volume declines from key energy customers.

The $0.5 million of unrealized appreciation in our investment in the Saratoga CLO subordinated notes was due to a decrease in the discount rate from the previous year end.

The $0.5 million of unrealized appreciation in our investment in the common stock of USS Parent Holding Corp. was due to the sale of the company to a private equity firm.

 

65


Table of Contents

The most significant cumulative changes in unrealized appreciation and depreciation for the six months ended August 31, 2013, were the following:

Six months ended August 31, 2013

 

Issuer

  

Asset Type

  Cost     Fair
Value
    Total
Unrealized

Appreciation/
(Depreciation)
    YTD Change
in Unrealized
Appreciation/
(Depreciation)
 
               ($ in thousands)        

Elyria Foundry Company, LLC

   Senior Secured Note   $ 8,860      $ 7,147      $ (1,713   $ (1,713

Saratoga CLO

   Other/Structured Finance Securities     16,805        19,742        2,937        (3,635

USS Parent Holding Corp.

   Voting Common Stock     3,026        4,023        997        1,157   

The $1.7 million of unrealized depreciation in our investment in Elyria Foundry Company, LLC was due to lower operating performance as a result of weaker oil and gas demand.

The $3.6 million of unrealized depreciation in our investment in the Saratoga CLO subordinated notes was due to lower net present value of projected future cash flows partially offset by a reduction in the investment basis of the subordinated notes.

The $1.2 million of unrealized appreciation in our investment in the common stock of USS Parent Holding Corp. was due to improved operating performance.

Changes in net assets resulting from operations

For the three months ended August 31, 2014, we recorded a net increase in net assets resulting from operations of $3.1 million versus a net decrease in net assets resulting from operations of $0.04 million for the three months ended August 31, 2013. Based on 5,379,616 and 4,730,116 weighted average common shares outstanding for the three months ended August 31, 2014 and August 31, 2013, respectively, our per share net increase in net assets resulting from operations was $0.58 for the three months ended August 31, 2014 versus a per share net decrease in net assets from operations of $(0.01) for the three months ended August 31, 2013.

For the six months ended August 31, 2014, we recorded a net increase in net assets resulting from operations of $4.9 million versus a net increase in net assets resulting from operations of $3.8 million for the six months ended August 31, 2013. Based on 5,379,616 and 4,730,116 weighted average common shares outstanding for the six months ended August 31, 2014 and August 31, 2013, respectively, our per share net increase in net assets resulting from operations was $0.91 for the six months ended August 31, 2014 versus a per share net increase in net assets from operations of $0.79 for the six months ended August 31, 2013.

 

66


Table of Contents

Operating results for the fiscal years ended February 28, 2014, February 28, 2013 and February 29, 2012 are as follows:

 

     For the Year Ended  
     February 28,
2014
     February 28,
2013
     February 29,
2012
 
     ($ in thousands)  

Total investment income

   $ 22,893       $ 17,007       $ 13,512   

Total expenses, net

     13,772         9,979         7,811   
  

 

 

    

 

 

    

 

 

 

Net investment income

  9,121      7,028      5,701   

Net realized gains (losses)

  1,271      431      (12,186

Net unrealized gains

  (1,648   7,143      19,760   
  

 

 

    

 

 

    

 

 

 

Net increase in net assets resulting from operations

$ 8,744    $ 14,602    $ 13,275   
  

 

 

    

 

 

    

 

 

 

Investment income

The composition of our investment income for the fiscal years ended February 28, 2014, February 28, 2013 and February 29, 2012 are as follows:

 

     February 28,
2014
     February 28,
2013
     February 29,
2012
 
     ($ in thousands)  

Interest from investments

   $ 20,179       $ 14,444       $ 11,254   

Management fees from Saratoga CLO

     1,775         2,000         2,012   

Interest from cash and cash equivalents and other income

     939         563         246   
  

 

 

    

 

 

    

 

 

 

Total

$ 22,893    $ 17,007    $ 13,512   
  

 

 

    

 

 

    

 

 

 

For the fiscal year ended February 28, 2014, total investment income increased $5.9 million, or 34.6% compared to the fiscal year ended February 28, 2013. Interest income from investments increased $5.7 million, or 39.7%, to $20.2 million for the year ended February 28, 2014 from $14.4 million for the fiscal year ended February 28, 2013. This reflects an increase of 32.7% in total investments to $205.8 million at February 28, 2014 from $155.1 million at February 28, 2013, while the weighted average current coupon remained relatively unchanged at 12.5%.

For the fiscal year ended February 28, 2013, total investment income increased $3.5 million, or 25.9% compared to the fiscal year ended February 29, 2012. Interest income from investments increased $3.2 million, or 28.4%, to $14.4 million for the year ended February 28, 2013 from $11.2 million for the fiscal year ended February 29, 2012.

For the fiscal year ended February 29, 2012, total investment income decreased $0.6 million, or 4.7% compared to the fiscal year ended February 28, 2011. Interest income from our investment in the subordinated notes of Saratoga CLO increased $0.9 million, or 27.4%, to $4.2 million for the year ended February 29, 2012 from $3.3 million for the fiscal year ended February 28, 2011.

For the fiscal years ended February 28, 2014, February 28, 2013, and February 29, 2012, total PIK income was $0.9 million, $1.1 million, and $1.4 million, respectively.

The Saratoga CLO was refinanced in October 2013. As a result, proceeds from principal payments in the loan portfolio of Saratoga CLO must now be used to paydown its outstanding notes. Thus, the management fee income and investment income that we will receive from Saratoga CLO will decline in future periods.

 

67


Table of Contents

Operating expenses

The composition of our operating expenses for the years ended February 28, 2014, February 28, 2013 and February 29, 2012 are as follows:

Operating Expenses

 

     February 28,
2014
     February 28,
2013
     February 29,
2012
 
     ($ in thousands)  

Interest and credit facility expense

   $ 6,084       $ 2,540       $ 1,298   

Base management fees

     3,327         2,107         1,618   

Professional fees

     1,212         1,191         1,455   

Incentive management fees

     691         2,045         1,257   

Administrator expenses

     1,000         1,000         1,000   

Insurance expenses

     443         516         579   

Directors fees

     205         207         209   

General and administrative and other expenses

     810         373         395   
  

 

 

    

 

 

    

 

 

 

Total expenses

$ 13,772    $ 9,979    $ 7,811   
  

 

 

    

 

 

    

 

 

 

For the year ended February 28, 2014, total operating expenses before manager expense waiver and reimbursement increased $3.8 million, or 38.0% compared to the fiscal year ended February 28, 2013. For the year ended February 28, 2013, total operating expenses before manager expense waiver and reimbursement increased $2.2 million, or 27.8% compared to the fiscal year ended February 29, 2012.

For the years ended February 28, 2014 and 2013, the increase in interest and credit facility expense is primarily attributable to an increase in outstanding debt during the year from the issuance of $48.3 million notes during the year ended February 28, 2013, and the increase of our SBA debentures during both years, respectively. For the year ended February 28, 2014, the weighted average interest rate on our outstanding indebtedness was 5.35% compared to 6.35% for the fiscal year ended February 28, 2013 and 7.50% for the fiscal year ended February 29, 2012. This decrease was primarily driven by increased SBA debentures that have a lower interest rate.

For the year ended February 28, 2014, base management fees increased $1.2 million, or 57.9% compared to the fiscal year ended February 28, 2013. The increase in base management fees results from the increase in the average value of our total net assets from $108.7 million to $114.9 million as of February 28, 2013 and 2014, respectively. For the year ended February 28, 2013, base management fees increased $0.5 million, or 30.3% compared to the fiscal year ended February 29, 2012. The increase in base management fees results from the increase in the average value of our total net assets.

For the year ended February 28, 2014, professional fees increased $0.02 million, or 1.8% compared to the fiscal year ended February 28, 2013. For the year ended February 28, 2013, professional fees decreased $0.3 million, or 18.2% compared to the fiscal year ended February 29, 2012.

For the year ended February 28, 2014, incentive management fees decreased $1.4 million, or 66.2% compared to the fiscal year ended February 28, 2013. The decrease in incentive management fees is primarily attributable to the second part of the incentive fee accrual, with the year ending February 28, 2013 being an accrual of $1.0 million as compared to the year ending February 28, 2014 being a reversal of the accrual of $0.3 million. For the year ended February 28, 2013, incentive management fees increased $0.8 million, or 62.7% compared to the fiscal year ended February 29, 2012. The increase in incentive management fees is primarily attributable to an increase in accrued incentive fees related to net investment income.

As discussed above, the increase in interest and credit facility expense for the years ended February 28, 2014, February 28, 2013 and February 29, 2012 is primarily attributable to an increase in the amount of

 

68


Table of Contents

outstanding debt as compared to the prior periods. For the years ended February 28, 2014, February 28, 2013 and February 29, 2012, the weighted average interest rate on the outstanding borrowings under the Credit Facility was 7.50%, 7.50% and 7.50%, respectively. For the years ended February 28, 2014 and February 28, 2013, the weighted average interest rate on the outstanding borrowings of the SBA debentures was 3.03% and 1.42%, respectively. There were no outstanding borrowings for the year ended February 29, 2012.

Net realized gains/losses on sales of investments

For the fiscal year ended February 28, 2014, the Company had $71.6 million of sales, repayments, exits or restructurings resulting in $1.3 million of net realized gains. The most significant realized gains and losses during the year ended February 28, 2014 were as follows:

Fiscal year ended February 28, 2014

 

Issuer

   Asset Type    Gross
Proceeds
     Cost      Net
Realized
Gain/(Loss)
 
          ($ in thousands)  

Penton Media, Inc.

   First Lien Term Loan    $ 4,887       $ 4,681       $ 206   

Sourcehov, LLC.

   Second Lien Term Loan      3,030         2,659         371   

Worldwide Express Operations, LLC

   Warrants      128         —           128   

For the fiscal year ended February 28, 2013, the Company had $21.5 million of sales, repayments, exits or restructurings resulting in $0.6 million of net realized gains. The most significant realized gains and losses during the year ended February 28, 2013 were as follows:

Fiscal year ended February 28, 2013

 

Issuer

   Asset Type    Gross
Proceeds
     Cost      Net
Realized
Gain/(Loss)
 
          ($ in thousands)  

Grant US Holdings LLP

   Second Lien Term Loan    $ 183       $ —         $ 183   

Energy Alloys LLC

   Warrants      146         —           146   

For the fiscal year ended February 29, 2012, the Company had $33.6 million of sales, repayments, exits or restructurings resulting in $12.2 million of net realized losses. The most significant realized gains and losses during the year ended February 29, 2012 were as follows:

Fiscal year ended February 29, 2012

 

Issuer

   Asset Type      Gross
Proceeds
     Cost     Net
Realized
Gain/(Loss)
 
            ($ in thousands)  

Grant US Holdings LLP

     Second Lien Term Loan       $ —         $ (6,348   $ (6,348

Pracs Institute Ltd.

     Second Lien Term Loan         —           (4,078     (4,078

Bankruptcy Management Solutions, Inc.

     Second Lien Term Loan         223         (2,645     (2,422

 

69


Table of Contents

Net unrealized appreciation/depreciation on investments

For the year ended February 28, 2014, our investments had a decrease in net unrealized depreciation of $1.6 million versus an increase in net unrealized appreciation of $7.0 million for the year ended February 28, 2013. The most significant cumulative changes in unrealized appreciation and depreciation for the year ended February 28, 2014, were the following:

Fiscal year ended February 28, 2014

 

Issuer

   Asset Type    Cost      Fair
Value
     Total
Unrealized
Appreciation/
(Depreciation)
    YTD Change
in Unrealized
Appreciation/
(Depreciation)
 
          ($ in thousands)  

Saratoga CLO

   Other/Structured Finance
Securities
   $ 16,556       $ 19,570       $ 3,014      $ (3,558

Targus Holdings, Inc.

   Common Stock      567         730         163        (2,595

USS Parent Holding Corp.

   Voting Common Stock      3,026         5,028         2,002        2,162   

Group Dekko, Inc.

   Second Lien Term Loan      6,902         6,741         (161     (56

Elyria Foundry Company, LLC

   Senior Secured Notes      9,037         6,777         (2,260     (2,259

For the year ended February 28, 2013, our investments had an increase in net unrealized appreciation of $7.0 million versus an increase in net unrealized appreciation of $19.8 million for the year ended February 29, 2012. The most significant cumulative changes in unrealized appreciation and depreciation for the year ended February 28, 2013, were the following:

Fiscal year ended February 28, 2013

 

Issuer

   Asset Type    Cost      Fair
Value
     Total
Unrealized
Appreciation/
(Depreciation)
    YTD Change
in Unrealized
Appreciation/
(Depreciation)
 
          ($ in thousands)  

Saratoga CLO

   Other/Structured Finance
Securities
   $ 18,945       $ 25,517       $ 6,572      $ 4,266   

Targus Holdings, Inc.

   Common Stock      567         3,325         2,758        649   

USS Parent Holding Corp.

   Voting Common Stock      3,026         2,866         (160     641   

Group Dekko, Inc.

   Second Lien Term Loan      6,825         6,721         (104     464   

Worldwide Express Operations, LLC

   First Lien Term Loan      6,461         6,504         43        352   

Penton Media, Inc.

   First Lien Term Loan      4,497         4,670         173        798   

For the year ended February 29, 2012, our investments had an increase in net unrealized appreciation of $19.8 million versus an increase in net unrealized appreciation of $36.4 million for the year ended February 28, 2011. The most significant cumulative changes in unrealized appreciation and depreciation for the year ended February 29, 2012, were the following:

Fiscal year ended February 29, 2012

 

Issuer

  

Asset Type

   Cost      Fair
Value
     Total
Unrealized
Appreciation/
(Depreciation)
    YTD Change
in Unrealized
Appreciation/
(Depreciation)
 
          ($ in thousands)  

Saratoga CLO

   Other/Structured Finance Securities    $ 23,541       $ 25,846       $ 2,305      $ 6,938   

Targus Holdings, Inc.

   Common Stock      567         2,676         2,109        206   

USS Parent Holding Corp.

   Voting Common Stock      3,026         2,225         (801     603   

Penton Media, Inc.

   First Lien Term Loan      4,281         3,655         (626     (534

 

70


Table of Contents

The $6.9 million net unrealized appreciation in our investment in the Saratoga CLO subordinated notes was due to higher cash flow projections based on an increase in principal balance and an improvement in the overcollateralization ratios, a decrease in the assumed portfolio default rate (based on better than forecast actual default rates and improved default forecasts) and an improvement in reinvestment assumptions based on current market conditions and projections. In addition, for the year ended February 29, 2012 we had approximately $15.7 million of unrealized appreciation due to the reversal of prior period unrealized depreciation recorded upon the exit of certain investments including approximately $6.1 million related to Energy Alloys, L.L.C., $6.3 million related to Grant U.S. Holdings LLP., $2.3 million related to Bankruptcy Management Solutions and $1.1 million related to Pracs Institute, LTD.

Changes in net assets resulting from operations

For the fiscal years ended February 28, 2014, February 28, 2013 and February 29, 2012 we recorded a net increase in net assets resulting from operations of $8.7 million, $14.6 million, and $13.3 million, respectively. Based on 4,920,517 weighted average common shares outstanding as of February 28, 2014, our per share net increase in net assets resulting from operations was $1.78 for the fiscal year ended February 28, 2014. This compares to a per share net increase in net assets resulting from operations of $3.55 for the fiscal year ended February 28, 2013 (based on 4,110,484 weighted average common shares outstanding as of February 28, 2013), and a per share net increase in net assets resulting from operations of $3.87 for the fiscal year ended February 29, 2012 (based on 3,434,345 weighted average common shares outstanding as of February 29, 2012). These increases do not reflect the impact of the payment of any dividends.

FINANCIAL CONDITION, LIQUIDITY AND CAPITAL RESOURCES

We intend to continue to generate cash primarily from cash flows from operations, including interest earned from our investments in debt in middle market companies, interest earned from the temporary investment of cash in U.S. government securities and other high-quality debt investments that mature in one year or less, future borrowings and future offerings of securities.

Although we expect to fund the growth of our investment portfolio through the net proceeds from SBA debenture drawdowns and future equity offerings, including our dividend reinvestment plan, and issuances of senior securities or future borrowings, to the extent permitted by the 1940 Act, we cannot assure you that our plans to raise capital will be successful. In this regard, because our common stock has historically traded at a price below our current net asset value per share and we are limited in our ability to sell our common stock at a price below net asset value per share, we have been and may continue to be limited in our ability to raise equity capital. Our stockholders approved a proposal at our annual meeting of stockholders held on September 30, 2014 that authorizes us to sell shares of our common stock at an offering price per share to investors that is not less than 85% of our then current net asset value per share in one or more offerings for a period ending on the earlier of September 30, 2015 or the date of our next annual meeting of stockholders. We would need stockholder approval of a similar proposal to issue shares below net asset value per share at any time after the earlier of September 30, 2015 or our next annual meeting of stockholders.

In addition, we intend to distribute to our stockholders substantially all of our taxable income in order to satisfy the distribution requirement applicable to RICs under Subchapter M of the Code. In satisfying this distribution requirement, we have in the past relied on IRS issued private letter rulings concluding that a RIC may treat a distribution of its own stock as fulfilling its RIC distribution requirements if each stockholder may elect to receive his or her entire distribution in either cash or stock of the RIC subject to a limitation on the aggregate amount of cash to be distributed to all stockholders, which limitation must be at least 20% of the aggregate declared distribution. We may rely on these IRS private letter rulings in future periods to satisfy our RIC distribution requirement.

Also, as a BDC, we generally are required to meet a coverage ratio of total assets, less liabilities and indebtedness not represented by senior securities, to total senior securities, which include all of our borrowings

 

71


Table of Contents

and any outstanding preferred stock, of at least 200%. This requirement limits the amount that we may borrow. Our asset coverage ratio, as defined in the 1940 Act, was 309.5% as of August 31, 2014, 338.1% as of February 28, 2014 and 547.3% as of February 28, 2013. To fund growth in our investment portfolio in the future, we anticipate needing to raise additional capital from various sources, including the equity markets and other debt-related markets, which may or may not be available on favorable terms, if at all.

Consequently, we may not have the funds or the ability to fund new investments, to make additional investments in our portfolio companies, to fund our unfunded commitments to portfolio companies or to repay borrowings. Also, the illiquidity of our portfolio investments may make it difficult for us to sell these investments when desired and, if we are required to sell these investments, we may realize significantly less than their recorded value.

Madison revolving credit facility

Below is a summary of the terms of the senior secured revolving credit facility we entered into with Madison Capital Funding (the “Credit Facility”) on June 30, 2010.

Availability. The Company can draw up to the lesser of (i) $40.0 million (the “Facility Amount”) and (ii) the product of the applicable advance rate (which varies from 50.0% to 75.0% depending on the type of loan asset) and the value, determined in accordance with the Credit Facility (the “Adjusted Borrowing Value”), of certain “eligible” loan assets pledged as security for the loan (the “Borrowing Base”), in each case less (a) the amount of any undrawn funding commitments the Company has under any loan asset and which are not covered by amounts in the Unfunded Exposure Account referred to below (the “Unfunded Exposure Amount”) and (b) outstanding borrowings. Each loan asset held by the Company as of the date on which the Credit Facility was closed was valued as of that date and each loan asset that the Company acquires after such date will be valued at the lowest of its fair value, its face value (excluding accrued interest) and the purchase price paid for such loan asset. Adjustments to the value of a loan asset will be made to reflect, among other things, changes in its fair value, a default by the obligor on the loan asset, insolvency of the obligor, acceleration of the loan asset, and certain modifications to the terms of the loan asset.

The Credit Facility contains limitations on the type of loan assets that are “eligible” to be included in the Borrowing Base and as to the concentration level of certain categories of loan assets in the Borrowing Base such as restrictions on geographic and industry concentrations, asset size and quality, payment frequency, status and terms, average life, and collateral interests. In addition, if an asset is to remain an “eligible” loan asset, the Company may not make changes to the payment, amortization, collateral and certain other terms of the loan assets without the consent of the administrative agent that will either result in subordination of the loan asset or be materially adverse to the lenders.

Collateral. The Credit Facility is secured by substantially all of the assets of the Company (other than assets held by our SBIC subsidiary) and includes the subordinated notes (“CLO Notes”) issued by Saratoga CLO and the Company’s rights under the CLO Management Agreement (as defined below).

Interest Rate and Fees. Under the Credit Facility, funds are borrowed from or through certain lenders at the greater of the prevailing LIBOR rate and 2.00%, plus an applicable margin of 5.50%. At the Company’s option, funds may be borrowed based on an alternative base rate, which in no event will be less than 3.00%, and the applicable margin over such alternative base rate is 4.50%. In addition, the Company pays the lenders a commitment fee of 0.75% per year on the unused amount of the Credit Facility for the duration of the Revolving Period (defined below). Accrued interest and commitment fees are payable monthly. The Company was also obligated to pay certain other fees to the lenders in connection with the closing of the Credit Facility.

Revolving Period and Maturity Date. The Company may make and repay borrowings under the Credit Facility for a period of three years following the closing of the Credit Facility (the “Revolving Period”). The

 

72


Table of Contents

Revolving Period may be terminated at an earlier time by the Company or, upon the occurrence of an event of default, by action of the lenders or automatically. All borrowings and other amounts payable under the Credit Facility are due and payable in full five years after the end of the Revolving Period.

Collateral Tests. It is a condition precedent to any borrowing under the Credit Facility that the principal amount outstanding under the Credit Facility, after giving effect to the proposed borrowings, not exceed the lesser of the Borrowing Base or the Facility Amount (the “Borrowing Base Test”). In addition to satisfying the Borrowing Base Test, the following tests must also be satisfied (together with Borrowing Base Test, the “Collateral Tests”):

 

    Interest Coverage Ratio. The ratio (expressed as a percentage) of interest collections with respect to pledged loan assets, less certain fees and expenses relating to the Credit Facility, to accrued interest and commitment fees and any breakage costs payable to the lenders under the Credit Facility for the last 6 payment periods must equal at least 175.0%.

 

    Overcollateralization Ratio. The ratio (expressed as a percentage) of the aggregate Adjusted Borrowing Value of “eligible” pledged loan assets plus the fair value of certain ineligible pledged loan assets and the CLO Notes (in each case, subject to certain adjustments) to outstanding borrowings under the Credit Facility plus the Unfunded Exposure Amount must equal at least 200.0%.

 

    Weighted Average FMV Test. The aggregate adjusted or weighted value of “eligible” pledged loan assets as a percentage of the aggregate outstanding principal balance of “eligible” pledged loan assets must be equal to or greater than 72.0% and 80.0% during the one-year periods prior to the first and second anniversary of the closing date, respectively, and 85.0% at all times thereafter.

The Credit Facility also requires payment of outstanding borrowings or replacement of pledged loan assets upon the Company’s breach of its representation and warranty that pledged loan assets included in the Borrowing Base are “eligible” loan assets. Such payments or replacements must equal the lower of the amount by which the Borrowing Base is overstated as a result of such breach or any deficiency under the Collateral Tests at the time of repayment or replacement. Compliance with the Collateral Tests is also a condition to the discretionary sale of pledged loan assets by the Company.

Priority of Payments. During the Revolving Period, the priority of payments provisions of the Credit Facility require, after payment of specified fees and expenses and any necessary funding of the Unfunded Exposure Account, that collections of principal from the loan assets and, to the extent that these are insufficient, collections of interest from the loan assets, be applied on each payment date to payment of outstanding borrowings if the Borrowing Base Test, the Overcollateralization Ratio and the Interest Coverage Ratio would not otherwise be met. Similarly, following termination of the Revolving Period, collections of interest are required to be applied, after payment of certain fees and expenses, to cure any deficiencies in the Borrowing Base Test, the Interest Coverage Ratio and the Overcollateralization Ratio as of the relevant payment date.

Reserve Account. The Credit Facility requires the Company to set aside an amount equal to the sum of accrued interest, commitment fees and administrative agent fees due and payable on the next succeeding three payment dates (or corresponding to three payment periods). If for any monthly period during which fees and other payments accrue, the aggregate Adjusted Borrowing Value of “eligible” pledged loan assets which do not pay cash interest at least quarterly exceeds 15.0% of the aggregate Adjusted Borrowing Value of “eligible” pledged loan assets, the Company is required to set aside such interest and fees due and payable on the next succeeding six payment dates. Amounts in the reserve account can be applied solely to the payment of administrative agent fees, commitment fees, accrued and unpaid interest and any breakage costs payable to the lenders.

Unfunded Exposure Account. With respect to revolver or delayed draw loan assets, the Company is required to set aside in a designated account (the “Unfunded Exposure Account”) 100.0% of its outstanding and undrawn funding commitments with respect to such loan assets. The Unfunded Exposure Account is funded at the time the

 

73


Table of Contents

Company acquires a revolver or delayed draw loan asset and requests a related borrowing under the Credit Facility. The Unfunded Exposure Account is funded through a combination of proceeds of the requested borrowing and other Company funds, and if for any reason such amounts are insufficient, through application of the priority of payment provisions described above.

Operating Expenses. The priority of payments provision of the Credit Facility provides for the payment of certain operating expenses of the Company out of collections on principal and interest during the Revolving Period and out of collections on interest following the termination of the Revolving Period in accordance with the priority established in such provision. The operating expenses payable pursuant to the priority of payment provisions is limited to $350,000 for each monthly payment date or $2.5 million for the immediately preceding period of twelve consecutive monthly payment dates. This ceiling can be increased by the lesser of 5.0% or the percentage increase in the fair market value of all the Company’s assets only on the first monthly payment date to occur after each one-year anniversary following the closing of the Credit Facility. Upon the occurrence of a Manager Event (described below), the consent of the administrative agent is required in order to pay operating expenses through the priority of payments provision.

Events of Default. The Credit Facility contains certain negative covenants, customary representations and warranties and affirmative covenants and events of default. The Credit Facility does not contain grace periods for breach by the Company of certain covenants, including, without limitation, preservation of existence, negative pledge, change of name or jurisdiction and separate legal entity status of the Company covenants and certain other customary covenants. Other events of default under the Credit Facility include, among other things, the following:

 

    an Interest Coverage Ratio of less than 150.0%;

 

    an Overcollateralization Ratio of less than 175.0%;

 

    the filing of certain ERISA or tax liens;

 

    the occurrence of certain “Manager Events” such as:

 

    failure by Saratoga Investment Advisors and its affiliates to maintain collectively, directly or indirectly, a cash equity investment in the Company in an amount equal to at least $5,000,000 at any time prior to the third anniversary of the closing date;

 

    failure of the Management Agreement between Saratoga Investment Advisors and the Company to be in full force and effect;

 

    indictment or conviction of Saratoga Investment Advisors or any “key person” for a felony offense, or any fraud, embezzlement or misappropriation of funds by Saratoga Investment Advisors or any “key person” and, in the case of “key persons,” without a reputable, experienced individual reasonably satisfactory to Madison Capital Funding appointed to replace such key person within 30 days;

 

    resignation, termination, disability or death of a “key person” or failure of any “key person” to provide active participation in Saratoga Investment Advisors’ daily activities, all without a reputable, experienced individual reasonably satisfactory to Madison Capital Funding appointed within 30 days; or

 

    occurrence of any event constituting “cause” under the Collateral Management Agreement between the Company and Saratoga CLO (the “CLO Management Agreement”), delivery of a notice under Section 12(c) of the CLO Management Agreement with respect to the removal of the Company as collateral manager or the Company ceases to act as collateral manager under the CLO Management Agreement.

Conditions to Acquisitions and Pledges of Loan Assets. The Credit Facility imposes certain additional conditions to the acquisition and pledge of additional loan assets. Among other things, the Company may not

 

74


Table of Contents

acquire additional loan assets without the prior written consent of the administrative agent until such time that the administrative agent indicates in writing its satisfaction with Saratoga Investment Advisors’ policies, personnel and processes relating to the loan assets.

Fees and Expenses. The Company paid certain fees and reimbursed Madison Capital Funding for the aggregate amount of all documented, out-of-pocket costs and expenses, including the reasonable fees and expenses of lawyers, incurred by Madison Capital Funding in connection with the Credit Facility and the carrying out of any and all acts contemplated thereunder up to and as of the date of closing of the stock purchase transaction with Saratoga Investment Advisors and certain of its affiliates. These amounts totaled $2.0 million.

On February 24, 2012, we amended our senior secured revolving credit facility with Madison Capital Funding LLC to, among other things:

 

    expand the borrowing capacity under the credit facility from $40.0 million to $45.0 million;

 

    extend the Revolving Period from July 30, 2013 to February 24, 2015; and

 

    remove the condition that we may not acquire additional loan assets without the prior written consent of the administrative agent.

On September 17, 2014, we entered into a second amendment to the Revolving Facility with Madison Capital Funding LLC to, among other things:

 

    extend the commitment termination date from February 24, 2015 to September 17, 2017;

 

    extend the maturity date of the Revolving Facility from February 24, 2020 to September 17, 2022 (unless terminated sooner upon certain events);

 

    reduce the applicable margin rate on base rate borrowings from 4.50% to 3.75%, and on LIBOR borrowings from 5.50% to 4.75%; and

 

    reduce the floor on base rate borrowings from 3.00% to 2.25%; and on LIBOR borrowings from 2.00% to 1.25%.

As of August 31, 2014, we had $8.9 million outstanding under the Credit Facility and $64.0 million SBA-guaranteed debentures outstanding (which are discussed below). As of February 28, 2014 we had no outstanding balance under the Credit Facility and $50.0 million SBA-guaranteed debentures outstanding. Our borrowing base under the Credit Facility at August 31, 2014 and February 28, 2014 was $42.2 million, and $44.6 million, respectively.

Our asset coverage ratio, as defined in the 1940 Act, was 338.1% and 547.3% for the years ended February 28, 2014 and February 28, 2013, respectively.

SBA-guaranteed debentures

In addition, we, through a wholly-owned subsidiary, sought and obtained a license from the SBA to operate an SBIC. In this regard, on March 28, 2012, our wholly-owned subsidiary, Saratoga Investment Corp. SBIC, LP, received a license from the SBA to operate as an SBIC under Section 301(c) of the Small Business Investment Act of 1958. SBICs are designated to stimulate the flow of private equity capital to eligible small businesses. Under SBA regulations, SBICs may make loans to eligible small businesses and invest in the equity securities of small businesses.

The SBIC license allows our SBIC subsidiary to obtain leverage by issuing SBA-guaranteed debentures. SBA-guaranteed debentures are non-recourse, interest only debentures with interest payable semi-annually and have a ten year maturity. The principal amount of SBA-guaranteed debentures is not required to be paid prior to maturity but may be prepaid at any time without penalty. The interest rate of SBA-guaranteed debentures is fixed on a semi-annual basis at a market-driven spread over U.S. Treasury Notes with 10-year maturities.

 

75


Table of Contents

SBA regulations currently limit the amount that our SBIC subsidiary may borrow to a maximum of $150 million when it has at least $75 million in regulatory capital, receives a capital commitment from the SBA and has been through an examination by the SBA subsequent to licensing. As of August 31, 2014, our SBIC subsidiary had $45.5 million in regulatory capital and $64.0 million SBA-guaranteed debentures outstanding.

We received exemptive relief from the Securities and Exchange Commission to permit us to exclude the debt of our SBIC subsidiary guaranteed by the SBA from the definition of senior securities in the 200% asset coverage test under the 1940 Act. This allows us increased flexibility under the 200% asset coverage test by permitting us to borrow up to $150 million more than we would otherwise be able to absent the receipt of this exemptive relief.

Unsecured notes

In May 2013, we issued $48.3 million in aggregate principal amount of our 7.50% unsecured notes due 2020 for net proceeds of $46.1 million after deducting underwriting commissions of $1.9 million and offering costs of $0.3 million. The proceeds included the underwriters’ full exercise of their overallotment option. Interest on these notes is paid quarterly in arrears on February 15, May 15, August 15 and November 15 of each year, at a rate of 7.50% per year, beginning August 15, 2013. The notes mature on May 31, 2020 and may be redeemed in whole or in part at any time or from time to time at our option on or after May 31, 2016. In connection with the issuance of the notes, we agreed to the following covenants for the period of time during which the notes are outstanding:

 

    we will not violate (whether or not we are subject to) Section 18(a)(1)(A) as modified by Section 61(a)(1) of the 1940 Act or any successor provisions, but giving effect to any exemptive relief granted to us by the SEC. Currently, these provisions generally prohibit us from making additional borrowings, including through the issuance of additional debt or the sale of additional debt securities, unless our asset coverage, as defined in the 1940 Act, equals at least 200% after such borrowings.

 

    we will not violate (regardless of whether we are subject to) Section 18(a)(1)(B) as modified by Section 61(a)(1) of the 1940 Act or any successor provisions, but giving effect to (i) any exemptive relief granted to us by the SEC and (ii) no-action relief granted by the SEC to another BDC (or to the Company if it determines to seek such similar no-action or other relief) permitting the BDC to declare any cash dividend or distribution notwithstanding the prohibition contained in Section 18(a)(1)(B) as modified by Section 61(a)(1) of the 1940 Act in order to maintain the BDC’s status as a regulated investment company under Subchapter M of the Internal Revenue Code of 1986. Currently these provisions generally prohibit us from declaring any cash dividend or distribution upon any class of our capital stock, or purchasing any such capital stock if our asset coverage, as defined in the 1940 Act, is below 200% at the time of the declaration of the dividend or distribution or the purchase and after deducting the amount of such dividend, distribution or purchase.

The Notes are listed on the NYSE under the trading symbol “SAQ” with a par value of $25.00 per share.

 

76


Table of Contents

At August 31, 2014, February 28, 2014 and February 28, 2013, the fair value of investments, cash and cash equivalents and cash and cash equivalents, securitization accounts were as follows:

 

     At August 31,
2014
    At February 28,
2014
    At February 28,
2013
 
     Fair Value      Percent
of Total
    Fair Value      Percent
of Total
    Fair Value      Percent
of Total
 
     ($ in thousands)  

Cash and cash equivalents

   $ 271         0.1   $ 3,294         1.6   $ 149         0.1

Cash and cash equivalents, securitization accounts

     3,216         1.3        3,293         1.6        12,086         7.2   

Syndicated loans

     26,814         11.2        32,390         15.2        —           —     

First lien term loans

     115,589         48.2        80,246         37.8        83,792         50.1   

Second lien term loans

     29,262         12.2        27,804         13.1        9,571         5.7   

Senior secured notes

     25,035         10.4        30,032         14.1        23,305         13.9   

Unsecured notes

     5,909         2.5        5,471         2.6        4,874         2.9   

Structured finance securities

     20,090         8.4        19,570         9.2        25,517         15.3   

Equity Interest

     13,621         5.7        10,332         4.8        8,021         4.8   
  

 

 

    

 

 

   

 

 

    

 

 

   

 

 

    

 

 

 

Total

$ 239,807      100.0 $ 212,432      100.0 $ 167,315      100.0
  

 

 

    

 

 

   

 

 

    

 

 

   

 

 

    

 

 

 

On September 24, 2014, our board of directors adopted a new dividend policy pursuant to which we will begin to again pay a regular quarterly cash dividend to our shareholders. In this regard, our board of directors declared a dividend in the amount of $0.18 per share for the fiscal quarter ended August 31, 2014, and a dividend in the amount of $0.22 per share for the fiscal quarter ended November 30, 2014. The dividend for the fiscal quarter ended August 31, 2014 will be payable on November 28, 2014 to all stockholders of record at the close of business on November 3, 2014, and the dividend for the fiscal quarter ended November 30, 2014 will be payable on February 27, 2015 to all stockholders of record at the close of business on February 2, 2015.

On October 30, 2013, our board of directors declared a dividend of $2.65 per share payable on December 27, 2013, to common stockholders of record on November 13, 2013. Shareholders had the option to receive payment of the dividend in cash, shares of common stock, or a combination of cash and shares of common stock, provided that the aggregate cash payable to all shareholders was limited to approximately $2.5 million or $0.53 per share.

Based on shareholder elections, the dividend consisted of approximately $2.5 million in cash and 649,500 shares of common stock, or 13.7% of our outstanding common stock prior to the dividend payment. The amount of cash elected to be received was greater than the cash limit of 20.0% of the aggregate dividend amount, thus resulting in the payment of a combination of cash and stock to shareholders who elected to receive cash. The number of shares of common stock comprising the stock portion was calculated based on a price of $15.439 per share, which equaled the volume weighted average trading price per share of the common stock on December 11, 13, and 16, 2013.

On November 9, 2012, our board of directors declared a dividend of $4.25 per share payable on December 31, 2012, to common stockholders of record on November 20, 2012. Shareholders had the option to receive payment of the dividend in cash, shares of common stock, or a combination of cash and shares of common stock, provided that the aggregate cash payable to all shareholders was limited to approximately $3.3 million or $0.85 per share.

Based on shareholder elections, the dividend consisted of $3.3 million in cash and 853,455 shares of common stock, or 22.0% of our outstanding common stock prior to the dividend payment. The amount of cash elected to be received was greater than the cash limit of 20.0% of the aggregate dividend amount, thus resulting in the payment of a combination of cash and stock to shareholders who elected to receive cash. The number of shares of common stock comprising the stock portion was calculated based on a price of $15.444 per share, which equaled the volume weighted average trading price per share of the common stock on December 14, 17 and 19, 2012.

 

77


Table of Contents

On November 15, 2011, our board of directors declared a dividend of $3.00 per share payable on December 30, 2011, to common stockholders of record on November 25, 2011. Shareholders had the option to receive payment of the dividend in cash, shares of common stock, or a combination of cash and shares of common stock, provided that the aggregate cash payable to all shareholders was limited to $2.0 million or $0.60 per share.

Based on shareholder elections, the dividend consisted of $2.0 million in cash and 599,584 shares of common stock, or 18.0% of our outstanding common stock prior to the dividend payment. The amount of cash elected to be received was greater than the cash limit of 20.0% of the aggregate dividend amount, thus resulting in the payment of a combination of cash and stock to shareholders who elected to receive cash. The number of shares of common stock comprising the stock portion was calculated based on a price of $13.117067 per share, which equaled the volume weighted average trading price per share of the common stock on December 20, 21 and 22, 2011.

On November 12, 2010, our board of directors declared a dividend of $4.40 per share to shareholders payable in cash or shares of our common stock, in accordance with the provisions of the IRS Revenue Procedure 2010-12, which allows a publicly-traded regulated investment company to satisfy its distribution requirements with a distribution paid partly in common stock provided that at least 10.0% of the distribution is payable in cash. The dividend was paid on December 29, 2010 to common shareholders of record on November 19, 2010.

Based on shareholder elections, the dividend consisted of $1.2 million in cash and 596,235 shares of common stock, or 22.0% of our outstanding common stock prior to the dividend payment. The amount of cash elected to be received was greater than the cash limit of 10.0% of the aggregate dividend amount, thus resulting in the payment of a combination of cash and stock to shareholders who elected to receive cash. The number of shares of common stock comprising the stock portion was calculated based on a price of $17.8049 per share, which equaled the volume weighted average trading price per share of the common stock on December 20, 21 and 22, 2010.

On November 13, 2009, our board of directors declared a dividend of $18.25 per share payable on December 31, 2009, to common stockholders of record on November 25, 2009. Shareholders had the option to receive payment of the dividend in cash, shares of common stock, or a combination of cash and shares of common stock, provided that the aggregate cash payable to all shareholders was limited to $2.1 million or $0.25 per share.

Based on shareholder elections, the dividend consisted of $2.1 million in cash and 8,648,725 shares of common stock, or 104.0% of our outstanding common stock prior to the dividend payment. The amount of cash elected to be received was greater than the cash limit of 13.7% of the aggregate dividend amount, thus resulting in the payment of a combination of cash and stock to shareholders who elected to receive cash. The number of shares of common stock comprising the stock portion was calculated based on a price of $1.5099 per share, which equaled the volume weighted average trading price per share of the common stock on December 24 and 28, 2009.

We cannot provide any assurance that these measures will provide sufficient sources of liquidity to support our operations and growth.

Contractual obligations

The following table shows our payment obligations for repayment of debt and other contractual obligations at August 31, 2014:

 

            Payment Due by Period  
     Total      Less Than
1 Year
     1 - 3
Years
     3 - 5
Years
     More Than
5 Years
 
     ($ in thousands)                       

Long-Term Debt Obligations

   $ 121,200       $ 8,900       $       $       $ 112,300   
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

 

78


Table of Contents

Off-balance sheet arrangements

The Company’s off-balance sheet arrangements consisted of $13.1 million, $12.2 million and $0.0 million of unfunded commitments to provide debt financing to its portfolio companies or to fund limited partnership interests as of August 31, 2014, February 28, 2014 and 2013, respectively. Such commitments are generally up to the Company’s discretion to approve, or the satisfaction of certain financial and nonfinancial covenants and involve, to varying degrees, elements of credit risk in excess of the amount recognized in the Company’s Consolidated Statement of Assets and Liabilities and are not reflected in the Company’s Consolidated Statements of Assets and Liabilities.

Recent Developments

On July 10, 2014, our board of directors appointed Henri J. Steenkamp to serve as our Chief Financial Officer and Chief Compliance Officer. As previously disclosed, Mr. Steenkamp was previously appointed to serve as our Interim Chief Financial Officer and Interim Chief Compliance Officer on March 4, 2014.

On July 10, 2014, our board of directors, including a majority of the independent directors, approved the annual continuation of our investment advisory and management agreement with Saratoga Investment Advisors, LLC. Our board of directors also approved the renewal of the administration agreement with Saratoga Investment Advisors, LLC for an additional one-year term and determined to maintain the cap on the payment or reimbursement of expenses by us thereunder to $1.0 million for the additional one-year term.

On September 17, 2014, we entered into a second amendment to the Revolving Facility with Madison Capital Funding LLC to, among other things, (1) extend the commitment termination date from February 24, 2015 to September 17, 2017; (2) extend the maturity date of the Revolving Facility from February 24, 2020 to September 17, 2022 (unless terminated sooner upon certain events); (3) reduce the applicable margin rate on base rate borrowings from 4.50% to 3.75%; (4) reduce the applicable margin rate on LIBOR borrowings from 5.50% to 4.75%; (5) reduce the floor on base rate borrowings from 3.00% to 2.25%; and (6) reduce the floor on LIBOR borrowings from 2.00% to 1.25%.

On September 24, 2014, the Company announced that its Board of Directors adopted a new dividend policy to pay a regular quarterly cash dividend to shareholders. The Company will pay a quarterly dividend of $0.18 per share for the quarter ended August 31, 2014, which will be payable on November 28, 2014 to all stockholders of record at the close of business on November 3, 2014. The second dividend of $0.22 per share for the quarter ended November 30, 2014, will be payable on February 27, 2015 to all stockholders of record at the close of business on February 2, 2015.

On September 24, 2014, the Company also adopted a new dividend reinvestment plan (“DRIP”) that provides for the reinvestment of dividends on behalf of its stockholders, unless a stockholder has elected to receive dividends in cash. If the Company declares a dividend, its stockholders who have not “opted out” of the DRIP by the dividend record date will have their dividend automatically reinvested into additional shares of the Company’s common stock.

On the same day, the Company also announced the approval of an open market share repurchase plan that allows it to repurchase up to 200,000 shares of its common stock at prices below its NAV as reported in its then most recently published financial statements. Shares may be purchased in the open market, including through block purchases, at the discretion of our management. The share repurchase plan does not obligate us to acquire any specific number of shares. Unless extended by our board of directors, the share repurchase plan will expire on October 15, 2015, and may be limited or terminated at any time without prior notice.

 

79


Table of Contents

SENIOR SECURITIES

Information about our senior securities is shown in the following table as of February 28/29 for the fiscal years indicated in the table, unless otherwise noted. Ernst & Young LLP’s report on the table, as of February 28, 2014, is attached as an exhibit to the registration statement of which this prospectus is a part. See “Management’s Discussion and Analysis of Financial Condition and Results of Operations—Financial condition, liquidity and capital resources” for more detailed information regarding the senior securities.

 

Class and Year(1)(2)

   Total
Amount
Outstanding
Exclusive of
Treasury
Securities(3)
     Asset
Coverage
per Unit(4)
     Involuntary
Liquidating
Preference
per Share(5)
     Average
Market
Value per
Share(6)
 
     (in thousands)  

Credit Facility with Madison Capital Funding

           

Fiscal year 2014(7)

   $ —         $ —           —           N/A   

Fiscal year 2013

   $ 24,300       $ 5,473         —           N/A   

Fiscal year 2012 (as of February 29, 2012)

   $ 20,000       $ 5,869         —           N/A   

Fiscal year 2011 (as of February 28, 2011)

   $ 4,500       $ 20,127         —           N/A   

Fiscal year 2010 (as of February 28, 2010)

   $ —         $ —           —           N/A   

Fiscal year 2009 (as of February 28, 2009)

   $ —         $ —           —           N/A   

Fiscal year 2008 (as of February 29, 2008)

   $ —         $ —           —           N/A   

Fiscal year 2007 (as of February 28, 2007)

   $ —         $ —           —           —     

7.50% Notes due 2020

           

Fiscal year 2014(7)

   $ 48,300       $ 3,379         —         $ 25.18   

Fiscal year 2013

   $ —         $ —           —           N/A   

Fiscal year 2012 (as of February 29, 2012)

   $ —         $ —           —           N/A   

Fiscal year 2011 (as of February 28, 2011)

   $ —         $ —           —           N/A   

Fiscal year 2010 (as of February 28, 2010)

   $ —         $ —           —           N/A   

Fiscal year 2009 (as of February 28, 2009)

   $ —         $ —           —           N/A   

Fiscal year 2008 (as of February 29, 2008)

   $ —         $ —           —           N/A   

Fiscal year 2007 (as of February 28, 2007)

   $ —         $ —           —           —     

 

(1) We have excluded our SBA-guaranteed debentures from this table because the SEC has granted us exemptive relief that permits us to exclude such debentures from the definition of senior securities in the 200% asset coverage ratio we are required to maintain under the 1940 Act. See “Management’s Discussion and Analysis of Financial Condition and Results of Operations—Financial Condition, Liquidity and Capital Resources.”
(2) This table does not include the senior securities of our predecessor entity, GSC Investment Corp., relating to a revolving securitized credit facility with Deutsche Bank, in light of the fact that the Company was under different management during the time that such credit facility was outstanding.
(3) Total amount of senior securities outstanding at the end of the period presented.
(4) Asset coverage per unit is the ratio of our total assets, less all liabilities and indebtedness not represented by senior securities, to the aggregate amount of senior securities representing indebtedness. Asset coverage per unit is expressed in terms of dollar amounts per $1,000 of indebtedness, calculated on a total basis.
(5) The amount to which such class of senior security would be entitled upon the involuntary liquidation of the issuer in preference to any security junior to it. The “—” indicates information which the Securities and Exchange Commission expressly does not require to be disclosed for certain types of senior securities.
(6) Not applicable for credit facility because not registered for public trading.
(7) (Unaudited) Total amount outstanding as of August 31, 2014, including our Notes and SBA-guaranteed debentures, was $121.2 million.

 

80


Table of Contents

BUSINESS

General

We are a specialty finance company that invests primarily in leveraged loans and mezzanine debt issued by private U.S. middle-market companies, which we define as companies having annual EBITDA (earnings before interest, taxes, depreciation and amortization) of $5 million and $50 million, both through direct lending and through participation in loan syndicates. Our investment objective is to generate current income and, to a lesser extent, capital appreciation from our investments. We are externally managed and advised by Saratoga Investment Advisors, LLC, a New York-based investment firm affiliated with Saratoga Partners, a middle market private equity investment firm.

Our portfolio is comprised primarily of investments in leveraged loans (both first and second lien term loans) issued by middle market companies. Leveraged loans are generally senior debt instruments that rank ahead of subordinated debt which are issued by companies with below investment grade and “junk” ratings or, if not rated, would be rated below investment grade and “junk” and, as a result, carry a higher risk of default. Leveraged loans also have the benefit of security interests on the assets of the portfolio company, which may rank ahead of, or be junior to, other security interests. Term loans are loans that do not allow the borrowers to repay all or a portion of the loans prior to maturity and then re-borrow such repaid amounts under the loan again. We also purchase mezzanine debt and make equity investments in middle market companies. Mezzanine debt is typically unsecured and subordinated to senior debt of the portfolio company. As of August 31, 2014, 41.9% of our debt portfolio at fair value consisted of debt securities for which issuers were not required to make principal payments until the maturity of such debt securities, which could result in a substantial loss to us if such issuers are unable to refinance or repay their debt at maturity.

Substantially all of the debt investments held in our portfolio hold a non-investment grade rating by one or more rating agencies (which non-investment grade debt is commonly referred to as “high yield” and “junk” debt) or, if not rated, would be rated below investment grade and “junk” if rated. In addition, 62.2% of our debt investments at August 31, 2014, had variable interest rates that reset periodically based on benchmarks such as LIBOR and the prime rate. As a result, significant increases in such benchmarks in the future may make it more difficult for these borrowers to service their obligations under the debt investments that we hold.

While our primary focus is to generate current income and capital appreciation from our debt and equity investments in middle market companies, we may invest up to 30.0% of our portfolio in opportunistic investments in order to seek to enhance returns to stockholders. Such investments may include investments in distressed debt, including securities of companies in bankruptcy, foreign debt, private equity, securities of public companies that are not thinly traded and structured finance vehicles such as collateralized loan obligation funds.

As of August 31, 2014, we had total assets of $247.2 million and investments in 39 portfolio companies and an additional investment in the subordinated notes of one collateralized loan obligation fund, Saratoga Investment Corp. CLO 2013-1, Ltd. (“Saratoga CLO”), which investment had a fair value of $20.1 million as of August 31, 2014. Our overall portfolio composition as of August 31, 2014 consisted of 11.3% of syndicated loans, 48.9% of first lien term loans, 12.4% of second lien term loans, 10.6% of senior secured notes, 2.5% of unsecured notes, 8.5% of subordinated notes of Saratoga CLO and 5.8% of common equity. As of August 31, 2014 the weighted average yield on all of our debt investments, including our investment in the subordinated notes of Saratoga CLO, was approximately 12.2%. The weighted average yield of our debt investments is not the same as a return on investment for our stockholders and, among other things, is calculated before the payment of our fees and expenses. As of August 31, 2014, approximately 99% of our first lien debt investments, which comprises 48.9% of our portfolio, were fully collateralized in the sense that the portfolio companies in which we held such investments had an asset coverage equal to or greater than the principal amount of the related debt investment. Even though these loans are fully collateralized as is the case with the liens on our debt investments, there can be no assurance that the value of collateral will be sufficient to allow the portfolio company repay our

 

81


Table of Contents

first lien debt investments in the event of its default on our investment. Our investment in the subordinated notes of Saratoga CLO represents a first loss position in a portfolio that, at August 31, 2014, was composed of $304.4 million in aggregate principal amount of predominantly senior secured first lien term loans. A first loss position means that we will suffer the first economic losses if losses are incurred on loans held by the Saratoga CLO. As a result, this investment is subject to unique risks. See Part I, Item 1A. “Risk Factors—Our investment in Saratoga CLO constitutes a leveraged investment in a portfolio of predominantly senior secured first lien term loans and is subject to additional risks and volatility.”

We are an externally managed, closed-end, non-diversified management investment company that has elected to be regulated as a business development company (“BDC”) under the Investment Company Act of 1940 (“1940 Act”). As a BDC, we are required to comply with various regulatory requirements, including limitations on our use of debt. We finance our investments through borrowings. However, as a BDC, we are only generally allowed to borrow amounts such that our asset coverage, as defined in the 1940 Act, equals at least 200.0% after such borrowing. Pursuant to the 200.0% asset coverage ratio limitation, we are permitted to borrow one dollar to make investments for every dollar we have in assets less all liabilities and indebtedness not represented by preferred stock or debt securities issued by us or loans obtained by us so that for every one dollar of outstanding indebtedness we have two dollars of assets.

We have elected to be treated for U.S. federal income tax purposes as a regulated investment company (“RIC”), under Subchapter M of the Internal Revenue Code of 1986 (the “Code”). As a RIC, we generally will not have to pay corporate-level federal income taxes on any net ordinary income or capital gains that we distribute to our stockholders if we meet certain source-of-income, distribution and asset diversification requirements.

In addition, we have a wholly-owned subsidiary that is licensed as a small business investment company (“SBIC”) and regulated by the Small Business Administration (“SBA”). See “Item 1. Business—Regulation—Small Business Investment Company Regulations.” The SBIC license allows us, through our wholly-owned subsidiary, to issue SBA-guaranteed debentures. We received exemptive relief from the Securities and Exchange Commission (“SEC”) to permit us to exclude the debt of our SBIC subsidiary guaranteed by the SBA from the 200.0% asset coverage ratio we are required to maintain under the 1940 Act. This allows us increased flexibility under the 200.0% asset coverage test by permitting us to borrow up to $150.0 million more than we would otherwise be able to absent the receipt of this exemptive relief.

Corporate History and Information

We commenced operations, at the time known as GSC Investment Corp., on March 23, 2007 and completed an initial public offering of shares of common stock on March 28, 2007. Prior to July 30, 2010, we were externally managed and advised by GSCP (NJ), L.P., an entity affiliated with GSC Group, Inc. In connection with the consummation of a recapitalization transaction on July 30, 2010, we engaged Saratoga Investment Advisors (“SIA”) to replace GSCP (NJ), L.P. as our investment adviser and changed our name to Saratoga Investment Corp.

The recapitalization transaction consisted of (i) the private sale of 986,842 shares of our common stock for $15.0 million in aggregate purchase price to Saratoga Investment Advisors and certain of its affiliates and (ii) the entry into a $40.0 million senior secured revolving credit facility with Madison Capital Funding LLC (the “Credit Facility”). We used the net proceeds from the private sale of shares of our common stock and a portion of the funds available to us under the Credit Facility to pay the full amount of principal and accrued interest, including default interest, outstanding under our revolving securitized credit facility with Deutsche Bank AG, New York Branch. Specifically, in July 2009, we had exceeded permissible borrowing limits under the revolving securitized credit facility with Deutsche Bank, which resulted in an event of default under the revolving securitized credit facility. As a result of the event of default, Deutsche Bank had the right to accelerate repayment of the outstanding indebtedness under the revolving securitized credit facility and to foreclose and liquidate the

 

82


Table of Contents

collateral pledged under the revolving securitized credit facility. The revolving securitized credit facility with Deutsche Bank was terminated in connection with our payment of all amounts outstanding thereunder on July 30, 2010. In January 2011, we registered for public resale by Saratoga Investment Advisors and certain of its affiliates the 986,842 shares of our common stock issued to them in the recapitalization.

On March 28, 2012, our wholly-owned subsidiary, Saratoga Investment Corp. SBIC, LP, received an SBIC license from the SBA.

Our corporate offices are located at 535 Madison Avenue, New York, New York 10022. Our telephone number is (212) 906-7800. We maintain a website on the Internet at www.saratogainvestmentcorp.com. Information contained on our website is not incorporated by reference into this prospectus, and you should not consider that information to be part of this prospectus.

Saratoga Investment Advisors

General

Our investment adviser was formed in 2010 as a Delaware limited liability company and became our investment adviser in July 2010. Our investment adviser is led by four principals, Christian L. Oberbeck, Michael J. Grisius, Thomas V. Inglesby, and Charles G. Phillips, with 26, 24, 27 and 17 years of experience in leveraged finance, respectively. Our investment adviser is affiliated with Saratoga Partners, a middle market private equity investment firm. Saratoga Partners was established in 1984 to be the middle market private investment arm of Dillon Read & Co. Inc. and has been independent of Dillon Read since 1998. Saratoga Partners has a 28-year history of private investments in middle market companies and focuses on public and private equity, preferred stock, and senior and mezzanine debt investments.

Our Relationship with Saratoga Investment Advisors

We utilize the personnel, infrastructure, relationships and experience of Saratoga Investment Advisors to enhance the growth of our business. We currently have no employees and each of our executive officers is also an officer of Saratoga Investment Advisors.

We have entered into an investment advisory and management agreement (the “Management Agreement”) with Saratoga Investment Advisors. Pursuant to the 1940 Act, the initial term of the Management Agreement was for two years from its effective date of July 30, 2010, with automatic, one-year renewals, subject to approval by our board of directors, a majority of whom must be our independent directors. On July 10, 2014, our board of directors approved the renewal of the Management Agreement for an additional one-year term at an in-person meeting. Pursuant to the Management Agreement, Saratoga Investment Advisors implements our business strategy on a day-to-day basis and performs certain services for us under the direction of our board of directors. Saratoga Investment Advisors is responsible for, among other duties, performing all of our day-to-day functions, determining investment criteria, sourcing, analyzing and executing investments, asset sales, financings and performing asset management duties.

Saratoga Investment Advisors has formed an investment committee to advise and consult with its senior management team with respect to our investment policies, investment portfolio holdings, financing and leveraging strategies and investment guidelines. We believe that the collective experience of the investment committee members across a variety of fixed income asset classes will benefit us. The investment committee must unanimously approve all investments in excess of $1.0 million made by us. In addition, all sales of our investments must be approved by all four of our investment committee members. The current members of the investment committee are Messrs. Oberbeck, Grisius, Inglesby, and Phillips.

We pay Saratoga Investment Advisors a fee for investment advisory and management services consisting of two components—a base management fee and an incentive fee. The base management fee is calculated at an

 

83


Table of Contents

annual rate of 1.75% of our gross assets which includes assets purchased with borrowed funds but excludes cash and cash equivalents. As a result, Saratoga Investment Advisors will benefit as we incur debt or use leverage to purchase assets. Our board of directors will monitor the conflicts presented by this compensation structure by approving the amount of leverage that we may incur.

In addition to the base management fee, we pay Saratoga Investment Advisors an incentive fee which consists of two parts. First, we pay Saratoga Investment Advisors an incentive fee with respect to our pre-incentive fee net investment income in each calendar quarter as follows:

 

    no incentive fee in any calendar quarter in which our pre-incentive fee income does not exceed a fixed “hurdle rate” of 1.875% per quarter (7.5% annualized); and

 

    100.0% of our pre-incentive fee net investment income with respect to that portion of such pre-incentive fee net investment income, if any, that exceeds the hurdle rate but is less than or equal to 2.344% in any fiscal quarter (9.376% annualized) is payable to the investment adviser. We refer to this portion of our pre-incentive fee net investment income (which exceeds the hurdle rate but is less than or equal to 2.344%) as the “catch-up.” The “catch-up” provision is intended to provide our investment adviser with an incentive fee of 20.0% on all of our pre-incentive fee net investment income as if a hurdle rate did not apply when our pre-incentive fee net investment income exceeds 2.344% in any fiscal quarter. Notwithstanding the foregoing, with respect to any period ending on or prior to December 31, 2010, our investment adviser was only entitled to 20.0% of the amount of our pre-incentive fee net investment income, if any, that exceeded 1.875% in any fiscal quarter (7.5% annualized) without any catch-up provision; and

 

    20.0% of the amount of our pre-incentive fee net investment income, if any, that exceeds 2.344% in any fiscal quarter (9.376% annualized) is payable to the investment adviser (once the hurdle is reached and the catch-up is achieved, 20.0% of all pre-incentive fee net investment income thereafter is allocated to the investment adviser).

Pre-incentive fee net investment income means interest income, dividend income and other income (including any other fees, such as commitment, origination, structuring, diligence, managerial and consulting fees or other fees that we receive from portfolio companies) earned during the calendar quarter, minus our operating expenses for the quarter.

The second part of the incentive fee is determined and payable in arrears as of the end of each fiscal year (or upon termination of the Management Agreement) and equals 20.0% of our “incentive fee capital gains,” which equals our realized capital gains on a cumulative basis from May 31, 2010 through the end of the fiscal year, if any, computed net of all realized capital losses and unrealized capital depreciation on a cumulative basis, less the aggregate amount of any previously paid capital gain incentive fee. Importantly, the capital gains portion of the incentive fee is based on realized gains and realized and unrealized losses from May 31, 2010. Therefore, realized and unrealized losses incurred prior to such time will not be taken into account when calculating the capital gains portion of the incentive fee, and Saratoga Investment Advisors will be entitled to 20.0% of incentive fee capital gains that arise after May 31, 2010. In addition, for the purpose of the “incentive fee capital gains” calculations, the cost basis for computing realized gains and losses on investments held by us as of May 31, 2010 will equal the fair value of such investments as of such date.

We have also entered into a separate administration agreement with Saratoga Investment Advisors pursuant to which Saratoga Investment Advisors furnishes us with office facilities, equipment and clerical, bookkeeping and record keeping services. The administration agreement has an initial term of two years from its effective date of July 30, 2010, with automatic one-year renewals, subject to approval by our board of directors, a majority of whom must be our independent directors. On July 15, 2013, our board of directors approved the renewal of the Administration Agreement for an additional one-year term and determined to maintain the cap on the payment or reimbursement of expenses by us thereunder to $1.0 million for the additional one-year term. Under the

 

84


Table of Contents

administration agreement, Saratoga Investment Advisors also performs, or oversees the performance of our required administrative services, which include, among other things, being responsible for the financial records which we are required to maintain, preparing reports for our stockholders and reports required to be filed with the SEC. Payments under the administration agreement will be equal to an amount based upon the allocable portion of Saratoga Investment Advisors’ overhead in performing its obligations under the administration agreement, including rent and the allocable portion of the cost of our officers and their respective staffs relating to the performance of services under the administration agreement.

Investments

Our portfolio is comprised primarily of investments in leveraged loans (both first and second lien term loans) issued by middle market companies. Investments in middle market companies are generally less liquid than equivalent investments in companies with larger capitalizations. These investments are sourced in both the primary and secondary markets through a network of relationships with commercial and investment banks, commercial finance companies and financial sponsors. The leveraged loans that we purchase are generally used to finance buyouts, acquisitions, growth, recapitalizations and other types of transactions. Leveraged loans are generally senior debt instruments that rank ahead of subordinated debt which are issued by companies with below investment grade and “junk” ratings or, if not rated, would be rated below investment grade and “junk” and, as a result, carry a higher risk of default. Leveraged loans also have the benefit of security interests on the assets of the portfolio company, which may rank ahead of, or be junior to, other security interests. For a discussion of the risks pertaining to our secured investments, see Part I, Item 1A. “Risk Factors—Our investments may be risky, and you could lose all or part of your investment.”

As part of our long-term strategy, we also purchase mezzanine debt and make equity investments in middle market companies. Mezzanine debt is typically unsecured and subordinated to senior debt of the portfolio company. See Part I, Item 1A. “Risk Factors—If we make unsecured debt investments, we may lack adequate protection in the event our portfolio companies become distressed or insolvent and will likely experience a lower recovery than more senior debtholders in the event our portfolio companies defaults on their indebtedness.”

As a BDC, we are required to comply with certain regulatory requirements. For instance, we have to invest at least 70.0% of our total assets in assets of the type listed in section 55(a) of the 1940 Act, including securities of U.S. operating companies whose securities are not listed on a national securities exchange (i.e., New York Stock Exchange, NYSE MKT and The NASDAQ Stock Market), U.S. operating companies with listed securities that have market capitalizations of less than $250.0 million, cash, cash equivalents, U.S. government securities and high-quality debt investments that mature in one year or less, which we refer to as “qualifying assets.”

While our primary focus is to generate current income and capital appreciation from our debt and equity investments in middle market companies, we may invest up to 30.0% of the portfolio in opportunistic investments in order to seek to enhance returns to stockholders. Such investments may include investments in distressed debt, private equity, securities of public companies that are not thinly traded and structured finance vehicles such as collateralized loan obligation funds.

Leveraged loans

Our leveraged loan portfolio is comprised primarily of first lien and second lien term loans. First lien term loans are secured by a first priority perfected security interest on all or substantially all of the assets of the borrower and typically include a first priority pledge of the capital stock of the borrower. First lien term loans hold a first priority with regard to right of payment. Generally, first lien term loans offer floating rate interest payments, have a stated maturity of five to seven years, and have a fixed amortization schedule. First lien term loans generally have restrictive financial and negative covenants. Second lien term loans are secured by a second priority perfected security interest on all or substantially all of the assets of the borrower and typically include a second priority pledge of the capital stock of the borrower. Second lien term loans hold a second priority with

 

85


Table of Contents

regard to right of payment. Second lien term loans offer either floating rate or fixed rate interest payments, generally have a stated maturity of five to eight years, and may or may not have a fixed amortization schedule. Second lien term loans that do not have fixed amortization schedules require payment of the principal amount of the loan upon the maturity date of the loan. Second lien term loans have less restrictive financial and negative covenants than those that govern first lien term loans.

Mezzanine debt

Mezzanine debt usually ranks subordinate in priority of payment to senior debt and is often unsecured. However, mezzanine debt ranks senior to common and preferred equity in a borrowers’ capital structure. Mezzanine debt typically has fixed rate interest payments and a stated maturity of six to eight years and does not have fixed amortization schedules.

In some cases, our debt investments may provide for a portion of the interest payable to be paid-in-kind interest (“PIK”). To the extent interest is paid-in-kind, it will be payable through the increase of the principal amount of the obligation by the amount of interest due on the then-outstanding aggregate principal amount of such obligation.

Equity Investments

Equity investments may consist of preferred equity that is expected to pay dividends on a current basis or preferred equity that does not pay current dividends. Preferred equity generally has a preference over common equity as to distributions on liquidation and dividends. In some cases, we may acquire common equity. In general, our equity investments are not control-oriented investments and we expect that in many cases we will acquire equity securities as part of a group of private equity investors in which we are not the lead investor.

Opportunistic Investments

Opportunistic investments may include investments in distressed debt, which may include securities of companies in bankruptcy, debt and equity securities of public companies that are not thinly traded, emerging market debt, structured finance vehicles such as collateralized loan obligation funds and debt of middle market companies located outside the United States.

On January 22, 2008, GSC Group, Inc., as asset manager, with Lehman Brothers raising the financing, entered into a collateral management agreement with Saratoga CLO. Saratoga CLO was structured with five tranches of debt, plus residual notes. Saratoga CLO’s five tranches of debt was purchased by a wide variety of CLO debt market participants. In addition, we purchased for $30.0 million all of the outstanding subordinated notes of Saratoga CLO.

Pursuant to its terms, the investment period for Saratoga CLO ended in January 2013, and certain restrictions in such terms prevented portfolio reinvestment. As a result, the Company determined that it was in its best interest to refinance Saratoga CLO given the fee income it receives for managing Saratoga CLO. The Company did not originate any of the loan assets included in the formation of Saratoga CLO, nor has it done so since the subsequent refinancing transaction. Moreover, the Company does not expect to originate any of the loans in the Saratoga CLO portfolio prospectively. The Company has from time to time co-invested in loans with the Saratoga CLO. The Company currently has no co-investments between it and Saratoga CLO.

With respect to our advisory services to Saratoga CLO, and in particular the underwriting standards used when determining which investments qualify for inclusion in the Saratoga CLO, they are substantially similar to the process employed in selecting the Company’s investments. All of the credit metrics for a Saratoga CLO investment are reviewed and documented in the same manner as they would be for an investment for the Company, with some minor differences. For example, the Saratoga CLO investment process also includes the

 

86


Table of Contents

Standard & Poors and Moody’s review of the loan investment and the assigned corporate ratings, in addition to the Standard & Poors recovery rate analysis, which typically does not apply to a prospective investment of the Company. Lastly, a Saratoga CLO investment also considers the likely secondary liquidity of the loan in considering the investment, whereas the Company’s investments are generally illiquid.

Saratoga CLO was refinanced in October 2013 and its reinvestment period ends in October 2016. After the reinvestment period ends in October 2016, the Company will consider refinancing the Saratoga CLO, subject to market conditions. A refinancing transaction entails finding existing and new investors that are willing to provide debt financing to Saratoga CLO on terms that are acceptable to it and in an amount sufficient to allow it to repay all of its existing debt holders. If Saratoga CLO is unable to refinance its indebtedness by October 2016, then Saratoga CLO will be required to use investment repayments by portfolio companies received thereafter to repay its outstanding indebtedness and ultimately liquidate Saratoga CLO.

The terms of the subordinated notes of Saratoga CLO entitles the Company to the residual net interest income in Saratoga CLO, which are paid on a quarterly basis after payment of all expenses, assuming that the Saratoga CLO remains in compliance with its various debt and rating agency compliance tests. The Company’s investment in the subordinated notes of Saratoga CLO can be sold or transferred at any time. The Company has held 100% of the subordinated notes of Saratoga CLO since the inception of Saratoga CLO.

Generally, the interests of the holders of the various classes of securities issued by the Saratoga CLO are aligned with the interests of the Company as holder of the subordinated notes. The investors in the various debt tranches of the securities issued by the Saratoga CLO are interested in the regular payment of interest income from the Saratoga CLO and the overcollateralization of the underlying loan assets relative to the Saratoga CLO debt issued. On the other hand, the subordinated note holders might prefer purchasing higher yielding riskier assets that could increase returns while the returns of the holders of the debt securities remain unchanged.

With respect to the collateral management agreement that the Company has entered into with Saratoga CLO, while the agreement is similar to the investment advisory and management agreement between the Company and Saratoga Investment Advisors in that it is an asset management agreement, there are material differences between the two. For example, pursuant to Section 15 of the 1940 Act, the investment advisory and management agreement with Saratoga Investment Advisors has an initial term of two years, with annual renewals to be approved by the Company’s Board of Directors. The contract can be terminated by the Company’s Board of Directors or stockholders with 60 days’ notice, with no penalty for termination. The collateral management agreement that the Company has entered into with Saratoga CLO, on the other hand, has no renewal requirement, and can be terminated without cause with the approval of two-thirds of each of the class of CLO securities, excluding votes from interested noteholders. Furthermore, the Saratoga CLO collateral management agreement cannot be terminated with cause without the approval of a majority of all of the CLO security holders voting collectively, excluding votes from interested noteholders. If the Saratoga CLO collateral management agreement is terminated, the manager remains in place until a new manager is appointed by the issuer at the direction of a majority of the noteholders, and so long as such replacement is not rejected within 20 days by the most senior class of the Saratoga CLO securities. We receive a senior collateral management fee of 0.25% and a subordinate collateral management fee of 0.25% of the outstanding principal amount of Saratoga CLO’s assets, paid quarterly to the extent of available proceeds. We are also entitled to an incentive management fee equal to 20.0% of excess cash flow to the extent the Saratoga CLO subordinated notes receive an internal rate of return equal to or greater than 12.0%.

The securities issued by the Saratoga CLO do not have any external credit enhancement features that would minimize the potential losses to the subordinated notes. Saratoga CLO recognized a loss of approximately $2.8 million in October 2013 upon the refinancing as a result of the legal and accounting costs associated with the refinancing and the divestiture of certain Saratoga CLO loans not eligible for the refinanced Saratoga CLO. The cost of the refinancing was effectively borne by the Company as the holder of the subordinated notes in Saratoga CLO. The indenture for the Saratoga CLO does not contemplate the issuance of additional securities while the existing Saratoga CLO securities

 

87


Table of Contents

remain outstanding. The indenture could be amended to allow the issuance of additional securities, which would require consents of the holders of the Saratoga CLO debt securities and the approval of the rating agencies. The Saratoga CLO could issue additional securities pursuant to a refinancing of the existing securities. The costs of any such future refinancing would effectively be borne by us as the holder of the subordinated notes in Saratoga CLO.

The Company does not believe that any representations or warranties made by the Company as manager of Saratoga CLO or investor in the subordinated notes could materially affect the Company. However, because the Company acts as the collateral manager to Saratoga CLO, it may be subject to claims by third-party investors in Saratoga CLO for alleged or actual negligent acts, errors or omissions or breach of fiduciary duties committed in the scope of performing its services as the collateral manager.

As of August 31, 2014, the Saratoga CLO portfolio consisted of $304.4 million in aggregate principal amount of primarily senior secured first lien term loans, 98.3% of the Saratoga CLO portfolio consisted of such loans at August 31, 2014, to 177 borrowers with an average exposure to each borrower of $1.7 million. The weighted average maturity of the portfolio is 4.8 years. In addition, Saratoga CLO held $2.8 million in cash at August 31, 2014. Our investment in Saratoga CLO falls into our 30% “bucket” of non-qualifying assets under the 1940 Act and currently has a cost basis of approximately $16.6 million, which is net of all principal payments made by Saratoga CLO on the Company’s initial $30 million investment in Saratoga CLO.

Prospective portfolio company characteristics

Our investment adviser generally selects portfolio companies with one or more of the following characteristics:

 

    a history of generating stable earnings and strong free cash flow;

 

    well-constructed balance sheets, including an established tangible liquidation value;

 

    reasonable debt-to-cash flow multiples;

 

    industry leadership with competitive advantages and sustainable market shares in attractive sectors; and

 

    capital structures that provide appropriate terms and reasonable covenants.

Investment selection

In managing us, Saratoga Investment Advisors employs the same investment philosophy and portfolio management methodologies used by Saratoga Partners. Through this investment selection process, based on quantitative and qualitative analysis, Saratoga Investment Advisors seeks to identify portfolio companies with superior fundamental risk-reward profiles and strong, defensible business franchises with the goal of minimizing principal losses while maximizing risk-adjusted returns. Saratoga Investment Advisors’ investment process emphasizes the following:

 

    bottoms-up, company-specific research and analysis;

 

    capital preservation, low volatility and minimization of downside risk; and

 

    investing with experienced management teams that hold meaningful equity ownership in their businesses.

Our investment adviser’s investment process generally includes the following steps:

 

    Initial screening. A brief analysis identifies the investment opportunity and reviews the merits of the transaction. The initial screening memorandum provides a brief description of the company, its industry, competitive position, capital structure, financials, equity sponsor and deal economics. If the deal is determined to be attractive by the senior members of the deal team, the opportunity is fully analyzed.

 

88


Table of Contents
    Full analysis. A full analysis includes:

 

    Business and Industry analysis—a review of the company’s business position, competitive dynamics within its industry, cost and growth drivers and technological and geographic factors. Business and industry research often includes meetings with industry experts, consultants, other investors, customers and competitors.

 

    Company analysis—a review of the company’s historical financial performance, future projections, cash flow characteristics, balance sheet strength, liquidation value, legal, financial and accounting risks, contingent liabilities, market share analysis and growth prospects.

 

    Structural/security analysis—a thorough legal document analysis including but not limited to an assessment of financial and negative covenants, events of default, enforceability of liens and voting rights.

 

    Approval of the investment committee. The investment is then presented to the investment committee for approval. The investment committee must unanimously approve all investments in excess of $1 million made by us. In addition, all sales of our investments must be approved by all four of our investment committee members. The members of our investment committee are Christian L. Oberbeck, Michael J. Grisius, Thomas V. Inglesby, and Charles G. Phillips.

Investment structure

In general, our Investment Adviser intends to select investments with financial covenants and terms that reduce leverage over time, thereby enhancing credit quality. These methods include:

 

    maintenance leverage covenants requiring a decreasing ratio of debt to cash flow;

 

    maintenance cash flow covenants requiring an increasing ratio of cash flow to the sum of interest expense and capital expenditures; and

 

    debt incurrence prohibitions, limiting a company’s ability to re-lever.

In addition, limitations on asset sales and capital expenditures should prevent a company from changing the nature of its business or capitalization without our consent.

Our investment adviser seeks, where appropriate, to limit the downside potential of our investments by:

 

    requiring a total return on our investments (including both interest and potential equity appreciation) that compensates us for credit risk;

 

    requiring companies to use a portion of their excess cash flow to repay debt;

 

    selecting investments with covenants that incorporate call protection as part of the investment structure; and

 

    selecting investments with affirmative and negative covenants, default penalties, lien protection, change of control provisions and board rights, including either observation or participation rights.

Valuation process

We carry our investments at fair value in accordance with the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 820, Fair Value Measurements and Disclosures (“ASC 820”), as approved in good faith using written policies and procedures adopted by our board of directors. Investments for which market quotations are readily available are recorded in our financial statements at such market quotations subject to any decision by our board of directors to approve a fair value determination to

 

89


Table of Contents

reflect significant events affecting the value of these investments. We value investments for which market quotations are not readily available at fair value as approved in good faith by our board of directors based on input from Saratoga Investment Advisors, our audit committee and an independent valuation firm engaged by our board of directors that independently values approximately one quarter of these valuations each quarter. Determinations of fair value may involve subjective judgments and estimates. The types of factors that may be considered in determining the fair value of our investments include the nature and realizable value of any collateral, the portfolio company’s ability to make payments, the markets in which the portfolio company does business, market yield trend analysis, comparison to publicly traded companies, discounted cash flow and other relevant factors.

Our investment in the subordinated notes of Saratoga CLO is carried at fair value, which is based on a discounted cash flow model that utilizes prepayment, re-investment and loss assumptions based on historical experience and projected performance, economic factors, the characteristics of the underlying cash flow, and comparable yields for similar collateralized loan obligation fund subordinated notes or equity, when available. Specifically, we use Intex cash flow models, or an appropriate substitute, to form the basis for Saratoga CLO’s valuation. The Intex cash flow models use a set of assumptions including projected default rates, recovery rates, reinvestment rate and prepayment rates in order to arrive at estimated cash flows. The assumptions are based on available market data and projections provided by third parties as well as management estimates. We use the output from the Intex models (i.e., the estimated cash flows from our investment in Saratoga CLO) to perform a discounted cash flows analysis on expected future cash flows from our investment in Saratoga CLO to determine a valuation for the subordinated notes of Saratoga CLO held by us.

We undertake a multi-step valuation process each quarter when valuing investments for which market quotations are not readily available, as described below:

 

    each investment is initially valued by the responsible investment professionals of Saratoga Investment Advisors and preliminary valuation conclusions are documented and discussed with our senior management; and

 

    an independent valuation firm engaged by our board of directors independently values at least one quarter of our investments each quarter so that the valuation of each investment for which market quotes are not readily available is independently valued by an independent valuation firm at least annually.

In addition, all our investments are subject to the following valuation process:

 

    the audit committee of our board of directors reviews each preliminary valuation and our investment adviser and independent valuation firm (if applicable) will supplement the preliminary valuation to reflect any comments provided by the audit committee; and

 

    our board of directors discusses the valuations and approves the fair value of each investment in good faith based on the input of our investment adviser, independent valuation firm (if applicable) and audit committee.

Because such valuations, and particularly valuations of private investments and private companies, are inherently uncertain, they may fluctuate over short periods of time and may be based on estimates. The determination of fair value may differ materially from the values that would have been used if a ready market for these investments existed. Our net asset value could be materially affected if the determinations regarding the fair value of our investments were materially higher or lower than the values that we ultimately realize upon the disposal of such investments.

Ongoing relationships with and monitoring of portfolio companies

Saratoga Investment Advisors will closely monitor each investment we make and, when appropriate, will conduct a regular dialogue with both the management team and other debtholders and seek specifically tailored financial reporting. In addition, in certain circumstances, senior investment professionals of Saratoga Investment Advisors may take board seats or board observation seats.

 

90


Table of Contents

Distributions

Our distributions, if any, will be determined by our board of directors and paid out of assets legally available for distribution. Any such distributions generally will be taxable to our stockholders, including to those stockholders who receive additional shares of our common stock pursuant to our dividend reinvestment plan. Prior to January 2009, we paid quarterly dividends to our stockholders. However, in January 2009, we suspended the practice of paying quarterly dividends to our stockholders and only paid five dividend distributions (December 2013, 2012, 2011, 2010 and 2009) to our stockholders through December 2013, which distributions were made with a combination of cash and the issuance of shares of our common stock as discussed more fully below. On September 24, 2014, our board of directors adopted a new dividend policy pursuant to which we will begin to again pay a regular quarterly cash dividend to our shareholders. In this regard, our board of directors declared a dividend in the amount of $0.18 per share for the fiscal quarter ended August 31, 2014, and a dividend in the amount of $0.22 per share for the fiscal quarter ended November 30, 2014. The dividend for the fiscal quarter ended August 31, 2014 will be payable on November 28, 2014 to all stockholders of record at the close of business on November 3, 2014, and the dividend for the fiscal quarter ended November 30, 2014 will be payable on February 27, 2015 to all stockholders of record at the close of business on February 2, 2015.

In order to maintain our qualification as a RIC, we must for each fiscal year distribute an amount equal to at least 90.0% of our ordinary net taxable income and realized net short-term capital gains in excess of realized net long-term capital losses, if any, reduced by deductible expenses. In addition, we will be subject to federal excise taxes to the extent we do not distribute during the calendar year at least (1) 98.0% of our ordinary income for the calendar year, (2) 98.2% of our capital gains in excess of capital losses for the one year period ending on October 31 of the calendar year and (3) any ordinary income and net capital gains for preceding years that were not distributed during such years and on which we paid no federal income tax. For the 2013 calendar year, we made distributions sufficient such that we did not incur any federal excise taxes. We may elect to withhold from distribution a portion of our ordinary income for the 2014 calendar year and/or portion of the capital gains in excess of capital losses realized during the one year period ending October 31, 2014, if any, and, if we do so, we would expect to incur federal excise taxes as a result.

We maintain an “opt out” dividend reinvestment plan for our common stockholders. As a result, if we declare a dividend, then stockholders’ cash dividends will be automatically reinvested in additional shares of our common stock, unless they specifically “opt out” of the dividend reinvestment plan so as to receive cash dividends.

We may distribute taxable dividends that are payable in cash or shares of our common stock at the election of each stockholder. Under certain applicable provisions of the Code and the Treasury regulations, distributions payable in cash or in shares of stock at the election of stockholders are treated as taxable dividends. The Internal Revenue Service has issued private rulings indicating that this rule will apply even where the total amount of cash that may be distributed is limited to no more than 20.0% of the total distribution. Under these rulings, if too many stockholders elect to receive their distributions in cash, each such stockholder would receive a pro rata share of the total cash to be distributed and would receive the remainder of their distribution in shares of stock. If we decide to make any distributions consistent with these rulings that are payable in part in our stock, taxable stockholders receiving such dividends will be required to include the full amount of the dividend (whether received in cash, our stock, or a combination thereof) as ordinary income (or as long-term capital gain to the extent such distribution is properly reported as a capital gain dividend) to the extent of our current and accumulated earnings and profits for U.S. federal income tax purposes. As a result, a U.S. stockholder may be required to pay tax with respect to such dividends in excess of any cash received. If a U.S. stockholder sells the stock it receives as a dividend in order to pay this tax, the sales proceeds may be less than the amount included in income with respect to the dividend, depending on the market price of our stock at the time of the sale. Furthermore, with respect to non-U.S. stockholders, we may be required to withhold U.S. tax with respect to such dividends, including in respect of all or a portion of such dividend that is payable in stock. In addition, if a significant number of our stockholders determine to sell shares of our stock in order to pay taxes owed on dividends, it may put downward pressure on the trading price of our stock.

 

91


Table of Contents

Competition

Our primary competitors in providing financing to private middle market companies include public and private investment funds (including private equity funds, mezzanine funds, BDCs and SBICs), commercial and investment banks and commercial financing companies. Many of our competitors are substantially larger and have considerably greater financial and marketing resources than us. For example, some competitors may have access to funding sources that are not available to us. In addition, some of our competitors may have higher risk tolerances or different risk assessments, which may allow them to consider a wider variety of investments. Furthermore, many of our competitors are not subject to the regulatory restrictions that the 1940 Act imposes on us as a BDC. For additional information concerning the competitive risks we face, please see Part I, Item 1A, “Risk Factors—We operate in a highly competitive market for investment opportunities.”

Staffing

We do not currently have any employees and do not expect to have any employees in the future. Services necessary for our business are provided by individuals who are employees of Saratoga Investment Advisors, pursuant to the terms of the Management Agreement and the administration agreement. For a discussion of the Management Agreement, see “Business—Investment Advisory and Management Agreement” below. We reimburse Saratoga Investment Advisors for our allocable portion of expenses incurred by it in performing its obligations under the administration agreement, including rent and our allocable portion of the cost of our officers and their respective staffs, subject to certain limitations. For a discussion of the administration agreement, see “Business—Administration Agreement” below.

Derivatives

We may utilize hedging techniques such as interest rate swaps to mitigate potential interest rate risk on our indebtedness. Such interest rate swaps would principally be used to protect us against higher costs on our indebtedness resulting from increases in both short-term and long-term interest rates.

We also may use various hedging and other risk management strategies to seek to manage various risks, including changes in currency exchange rates and market interest rates. Such hedging strategies would be utilized to seek to protect the value of our portfolio investments, for example, against possible adverse changes in the market value of securities held in our portfolio.

 

92


Table of Contents

OUR PORTFOLIO COMPANIES

The following table sets forth certain information as of August 31, 2014 for each portfolio company in which we had a debt or equity investment. Other than these investments, our only relationships with our portfolio companies are the managerial assistance we may separately provide to our portfolio companies, which services would be ancillary to our investments, and the board observer or participation rights we may receive.

 

Company

 

Industry

 

Investment

Interest Rate /

Maturity

  Principal/
Number of
Shares
    Cost     Fair Value ( c )     % of
Net Assets
 

Non-control/Non-affiliated investments—180.5% (b)

           

National Truck Protection Co., Inc. (d), (g)

  Automotive   Common Stock     1,116      $ 1,000,000      $ 1,473,053        1.2

National Truck Protection Co., Inc. (d)

  Automotive  

First Lien Term Loan

15.50% Cash, 9/13/2018

  $ 7,737,848        7,737,848        7,737,848        6.5

Take 5 Oil Change, L.L.C. (d), (g)

  Automotive   Common Stock     7,128        712,800        1,460,954        1.2
       

 

 

   

 

 

   

 

 

 
   

Total Automotive

      9,450,648        10,671,855        8.9
       

 

 

   

 

 

   

 

 

 

Legacy Cabinets Holdings (d), (g)

  Building Products   Common Stock Voting A-1     2,535        220,900        1,199,055        1.0

Legacy Cabinets Holdings (d), (g)

  Building Products   Common Stock Voting B-1     1,600        139,424        756,800        0.6
       

 

 

   

 

 

   

 

 

 
   

Total Building Products

      360,324        1,955,855        1.6
       

 

 

   

 

 

   

 

 

 

BMC Software, Inc. (d)

  Business Services   First Lien Term Loan 5.00% Cash, 9/10/2020   $ 5,761,667        5,713,227        5,742,077        4.8

Dispensing Dynamics International (d)

  Business Services   Senior Secured Note 12.50% Cash, 1/1/2018   $ 7,000,000        6,897,469        7,560,000        6.3

Easy Ice, LLC (d)

  Business Services   First Lien Term Loan 14.00% (11.00% Cash/3.00% PIK), 3/29/2018   $ 7,603,228        7,603,231        7,603,228        6.3

Emily Street Enterprises, L.L.C.

  Business Services   Senior Secured Note 12.00% (11.00% Cash/1.00% PIK), 12/28/2017   $ 5,792,538        5,709,596        5,792,538        4.8

Emily Street Enterprises, L.L.C. (g)

  Business Services   Warrant Membership Interests     49,318        400,000        385,174        0.3

Help/Systems Holdings, Inc.(Help/Systems, LLC) (d)

  Business Services   First Lien Term Loan 5.50% Cash, 6/28/2019   $ 3,970,000        3,936,883        3,930,300        3.3

Help/Systems Holdings, Inc. (Help/Systems, LLC) (d)

  Business Services   Second Lien Term Loan 9.50% Cash, 6/28/2020   $ 2,000,000        1,973,818        2,000,000        1.7

Knowland Technology Holdings, L.L.C.

  Business Services   First Lien Term Loan 11.00% Cash, 11/29/2017   $ 5,259,171        5,215,608        5,259,171        4.4

Vector Controls Holding Co., LLC (d)

 


Business Services

  First Lien Term Loan, 14.00% (12.00% Cash/2.00% PIK), 3/6/2018   $ 9,340,061        9,195,124        9,340,061        7.8

Vector Controls Holding Co., LLC (d), (g)

 


Business Services

  Warrants to Purchase Limited Liability Company Interests     101        —          87,600        0.1
       

 

 

   

 

 

   

 

 

 
   

Total Business Services

      46,644,956        47,700,149        39.8
       

 

 

   

 

 

   

 

 

 

Targus Group International, Inc. (d)

  Consumer Products   First Lien Term Loan 11.00% Cash, 5/24/2016   $ 3,661,247        3,612,910        3,503,447        2.9

Targus Holdings, Inc. (d), (g)

  Consumer Products   Common Stock     62,413        566,765        —          0.0

Targus Holdings, Inc. (d)

  Consumer Products   Unsecured Note 10.00% PIK, 6/14/2019   $ 2,054,158        2,054,158        1,499,104        1.3

Targus Holdings, Inc. (d)

  Consumer Products   Unsecured Note 16.00% Cash, 10/26/2018   $ 399,152        394,283        375,489        0.3
       

 

 

   

 

 

   

 

 

 
   

Total Consumer Products

      6,628,116        5,378,040        4.5
       

 

 

   

 

 

   

 

 

 

 

93


Table of Contents

Company

 

Industry

 

Investment

Interest Rate /

Maturity

  Principal/
Number of
Shares
    Cost     Fair Value ( c )     % of
Net Assets
 

Avionte Holdings, LLC (g)

  Consumer Services   Common Stock     100,000        100,000        139,000        0.1

Avionte Holdings, LLC

  Consumer Services   First Lien Term Loan 8.25% Cash, 1/8/2019   $ 3,000,000        2,946,920        3,000,000        2.5

CFF Acquisition L.L.C. (d)

  Consumer Services   First Lien Term Loan 7.50% Cash, 7/31/2015   $ 996,679        990,974        996,679        0.9

Expedited Travel L.L.C.

  Consumer Services   First Lien Term Loan 9.00% Cash, 12/28/2017   $ 3,830,000        3,768,632        3,830,000        3.2

PrePaid Legal Services, Inc. (d)

  Consumer Services   First Lien Term Loan 6.25% Cash, 7/1/2019   $ 3,951,613        3,917,123        3,950,427        3.3

PrePaid Legal Services, Inc. (d)

  Consumer Services   Second Lien Term Loan 9.75% Cash, 7/1/2020   $ 5,000,000        4,933,418        5,047,000        4.2
       

 

 

   

 

 

   

 

 

 
   

Total Consumer Services

      16,657,067        16,963,106        14.2
       

 

 

   

 

 

   

 

 

 

M/C Acquisition Corp., L.L.C. (d), (g)

  Education   Class A Common Stock     544,761        30,241        —          0.0

M/C Acquisition Corp., L.L.C. (d)

  Education   First Lien Term Loan 1.00% Cash, 3/13/14   $ 2,444,027        1,295,285        100,597        0.1
       

 

 

   

 

 

   

 

 

 
   

Total Education

      1,325,526        100,597        0.1
       

 

 

   

 

 

   

 

 

 

Group Dekko, Inc. (d)

  Electronics   Second Lien Term Loan 11.00% (10.00% Cash/1.00% PIK), 5/1/2016   $ 6,935,934        6,935,934        6,554,458        5.5
       

 

 

   

 

 

   

 

 

 
   

Total Electronics

      6,935,934        6,554,458        5.5
       

 

 

   

 

 

   

 

 

 

USS Parent Holding Corp. (d), (g)

  Environmental   Non Voting Common Stock     765        133,002        244,698        0.2

USS Parent Holding
Corp. (d), (g)

  Environmental   Voting Common Stock     17,396        3,025,798        5,566,864        4.7
       

 

 

   

 

 

   

 

 

 
   

Total Environmental

      3,158,800        5,811,562        4.9
       

 

 

   

 

 

   

 

 

 

DS Waters of America, Inc. (d)

  Food and Beverage   First Lien Term Loan 5.25% Cash, 8/30/2020   $ 2,481,250        2,459,770        2,487,453        2.2

TB Corp. (d)

  Food and Beverage   First Lien Term Loan 5.75% Cash, 6/19/2018   $ 5,076,203        5,064,962        5,076,203        4.2

TB Corp. (d)

  Food and Beverage   Unsecured Note 13.50% (12.00% Cash/1.50% PIK), 12/20/2018   $ 2,546,121        2,517,122        2,546,121        2.1

TM Restaurant Group L.L.C.

  Food and Beverage   First Lien Term Loan 7.75% Cash, 7/16/2017   $ 2,808,190        2,808,190        2,802,855        2.3
       

 

 

   

 

 

   

 

 

 
   

Total Food and Beverage

      12,850,044        12,912,632        10.8
       

 

 

   

 

 

   

 

 

 

Bristol Hospice, LLC

  Healthcare Services   Senior Secured Note 11.00%(10.00% Cash/1.00% PIK), 11/29/2018   $ 5,486,532        5,390,528        5,486,532        4.6

IDOC, LLC

  Healthcare Services   First Lien Term Loan 9.75% Cash, 8/2/2017   $ 13,831,583        13,831,583        13,831,583        11.5

Oceans Acquisition, Inc.

  Healthcare Services   First Lien Term A Loan 10.75% Cash, 12/27/2017   $ 6,246,226        6,154,475        6,121,301        5.1

Oceans Acquisition, Inc.

  Healthcare Services   First Lien Term B Loan 10.75% Cash, 12/27/2017   $ 1,000,000        991,202        980,000        0.8

Roscoe Medical, Inc. (d), (g)

  Healthcare Services   Common Stock     5,000        500,000        446,800        0.4

Roscoe Medical, Inc.

  Healthcare Services   Second Lien Term Loan 11.25% Cash, 9/26/2019   $ 4,200,000        4,123,141        4,160,100        3.5

Smile Brands Group Inc. (d)

  Healthcare Services   First Lien Term Loan 7.50% Cash, 8/16/2019   $ 4,466,250        4,390,964        4,354,594        3.6

Surgical Specialties Corporation
(US), Inc. (d)

  Healthcare Services   First Lien Term Loan 7.25% Cash, 8/22/2018   $ 2,375,000        2,355,380        2,369,063        2.0

Zest Holdings, LLC (d)

  Healthcare Services   First Lien Term Loan 6.50% Cash, 8/16/2020   $ 4,466,250        4,377,323        4,477,416        3.7
       

 

 

   

 

 

   

 

 

 
   

Total Healthcare Services

      42,114,596        42,227,389        35.2
       

 

 

   

 

 

   

 

 

 

 

94


Table of Contents

Company

 

Industry

 

Investment

Interest Rate /

Maturity

  Principal/
Number of
Shares
    Cost     Fair Value ( c )     % of
Net Assets
 

McMillin Companies
L.L.C. (d), (g)

  Homebuilding   Senior Secured Note 0% Cash, 12/31/2013   $ 550,000        558,434        410,740        0.3
       

 

 

   

 

 

   

 

 

 
   

Total Homebuilding

      558,434        410,740        0.3
       

 

 

   

 

 

   

 

 

 

Distribution International,
Inc. (d)

  Manufacturing   First Lien Term Loan 7.50% Cash, 7/16/2019   $ 5,940,000        5,888,342        5,940,000        5.0
       

 

 

   

 

 

   

 

 

 
   

Total Manufacturing

      5,888,342        5,940,000        5.0
       

 

 

   

 

 

   

 

 

 

HMN Holdco, LLC

  Media   First Lien Term Loan 14.00% Cash, 5/16/2019   $ 9,540,696        9,360,503        9,206,771        7.7

HMN Holdco, LLC (g)

  Media   Warrants to Purchase Limited Liability Company Interests (Common)     57,783        —          179,127        0.1

HMN Holdco, LLC (g)

  Media   Warrants to Purchase Limited Liability Company Interests     8,139        —          67,798        0.1
       

 

 

   

 

 

   

 

 

 
   

Total Media

      9,360,503        9,453,696        7.9
       

 

 

   

 

 

   

 

 

 

Elyria Foundry Company,
L.L.C. (d)

 


Metals

  Senior Secured Note 17.00% (13.00% Cash/4.00% PIK), 9/14/2014   $ 8,859,616        8,859,614        5,785,311        4.8

Elyria Foundry Company, L.L.C. (d), (g)

  Metals   Warrants to Purchase Limited Liability Company Interests (2008)     7,000        20        —          0.0

Elyria Foundry Company, L.L.C. (d), (g)

  Metals   Warrants to Purchase Limited Liability Company Interests (2013)     18,227        —          —          0.0
       

 

 

   

 

 

   

 

 

 
   

Total Metals

      8,859,634        5,785,311        4.8
       

 

 

   

 

 

   

 

 

 

Network Communications,
Inc. (d), (g)

  Publishing   Common Stock     380,572        —          —          0.0

Network Communications,
Inc. (d)

  Publishing   Unsecured Notes 8.60% PIK, 1/14/2020   $ 2,657,971        2,299,254        1,488,510        1.2
       

 

 

   

 

 

   

 

 

 
   

Total Publishing

      2,299,254        1,488,510        1.2
       

 

 

   

 

 

   

 

 

 

Community Investors, Inc. (g)

  Software   Common Stock     1,282        1,282        2,449        0.0

Community Investors, Inc.

  Software   First Lien Term Loan 9.75% Cash, 5/9/2018   $ 6,896,042        6,784,964        6,896,042        5.8

Community Investors, Inc.

  Software   Revolver   $ 166,667        —          —          0.0

Community Investors, Inc. (g)

  Software   Preferred Stock     63,463        149,138        121,214        0.1

Community Investors, Inc. (g)

  Software   Preferred Stock - A Shares     135,584        135,584        258,965        0.2

Identity Automation
Systems (g)

  Software   Common Stock Class A Units     232,616        232,616        232,616        0.2

Identity Automation Systems

  Software   First Lien Term Loan 10.25% Cash, 8/25/2019   $ 5,000,000        4,950,321        5,000,000        4.2

Pen-Link, Ltd. (d)

  Software   Second Lien Term Loan 12.50% Cash, 5/26/2019   $ 11,500,000        11,294,269        11,500,000        9.6
       

 

 

   

 

 

   

 

 

 
   

Total Software

      23,548,174        24,011,286        20.1
       

 

 

   

 

 

   

 

 

 

Censis Technologies, Inc.

  Technology   First Lien Term Loan B 11.00% Cash, 7/24/2019   $  12,000,000        11,761,173        11,760,000        9.8

Censis Technologies,
Inc. (g), (h)

  Technology   Limited Partner Interests     999        999,000        999,000        0.8
       

 

 

   

 

 

   

 

 

 
   

Total Technology

      12,760,173        12,759,000        10.6
       

 

 

   

 

 

   

 

 

 

Advanced Air & Heat of Florida, LLC

  Utilities   First Lien Term Loan 10.00% Cash, 1/31/2019   $ 6,105,441        6,022,273        6,105,441        5.1
       

 

 

   

 

 

   

 

 

 
   

Total Utilities

      6,022,273        6,105,441        5.1
       

 

 

   

 

 

   

 

 

 

Sub Total Non-control/Non-affiliated investments

      215,422,798        216,229,627        180.5
       

 

 

   

 

 

   

 

 

 

 

95


Table of Contents

Company

 

Industry

 

Investment

Interest Rate /

Maturity

  Principal/
Number of
Shares
    Cost     Fair Value ( c )     % of
Net Assets
 

Control investments—16.8% (b)

           

Saratoga Investment Corp. CLO 2013-1, Ltd. (a), (d), (e), (f)

  Structured Finance Securities   Other/Structured Finance Securities 16.01%, 10/17/2023   $ 30,000,000        16,555,808        20,090,075        16.8
       

 

 

   

 

 

   

 

 

 

Sub Total Control investments

          16,555,808        20,090,075        16.8
       

 

 

   

 

 

   

 

 

 

TOTAL INVESTMENTS— 197.3% (b)

        $ 231,978,606      $ 236,319,702        197.3
       

 

 

   

 

 

   

 

 

 

 

(a) Represents a non-qualifyng investment as defined under Section 55 (a) of the Investment Company Act of 1940, as amended. Non-qualifying assets represent 9.2% of the Company’s portfolio at fair value. As a BDC, the Company can only invest 30% of its portfolio in non-qualifying assets.
(b) Percentages are based on net assets of $119,817,820 as of August 31, 2014.
(c) Because there is no readily available market value for these investments, the fair value of these investments is approved in good faith by our board of directors (see Note 3 to the consolidated financial statements).
(d) These securities are pledged as collateral under a senior secured revolving credit facility (see Note 6 to the consolidated financial statements).
(e) This investment does not have a stated interest rate that is payable thereon. As a result, the 16.01% interest rate in the table above represents the annualized interest rate currently earned on the investment cost and is based on the current cash interest and other income generated by the investment for the six months ended August 31, 2014 (which was approximately $1.3 million for the six-month period).
(f) As defined in the Investment Company Act, we “Control” this portfolio company because we own more than 25% of the portfolio company’s outstanding voting securities. Transactions during the period in which the issuer was both an Affiliate and a portfolio company that we Control are as follows:

 

Company

   Purchases      Redemptions      Sales
(cost)
     Interest
Income
     Management
fee income
     Net
Realized
gains/
(losses)
     Net
Unrealized
gains/
(losses)
 

Saratoga Investment Corp. CLO 2013-1, Ltd.

   $ —         $ —         $ —         $ 1,301,369       $ 767,493       $ —         $ 3,534,267   

 

(g) Non-income producing at August 31, 2014. All of the Company’s non-income producing investments at August 31, 2014 were equity investments that did not carry any stated dividend or interest rate payable thereon except with respect to the Company’s debt investment in McMillin Companies L.L.C., which was in default under the terms of the debt investment at August 31, 2014. Subsequently, a payment was received by McMillan Companies L.L.C. in excess of the August 31, 2014 fair value thereof.
(h) Includes securities issued by an affiliate of the company.

 

96


Table of Contents

MANAGEMENT AGREEMENTS

Saratoga Investment Advisors serves as our investment adviser. Our investment adviser was formed in 2010 as a Delaware limited liability company and became our investment adviser in July 2010. Subject to the overall supervision of our board of directors, Saratoga Investment Advisors manages our day-to-day operations and provides investment advisory and management services to us. Under the terms of an investment advisory and management agreement, Saratoga Investment Advisors:

 

    determines the composition of our portfolio, the nature and timing of the changes to our portfolio and the manner of implementing such changes;

 

    identifies, evaluates and negotiates the structure of the investments we make (including performing due diligence on our prospective portfolio companies);

 

    closes and monitors the investments we make;

 

    determines the securities and other assets that we purchase, retain or sell; and

 

    performs due diligence on prospective portfolio companies.

Saratoga Investment Advisors services under the investment advisory and management agreement are not exclusive, and it is free to furnish similar services to other entities.

Management Fee and Incentive Fee

Pursuant to the investment advisory and management agreement with Saratoga Investment Advisors, we pay Saratoga Investment Advisors a fee for investment advisory and management services consisting of two components—a base management fee and an incentive fee.

The base management fee is paid quarterly in arrears, and equals 1.75% per annum of our gross assets (other than cash or cash equivalents but including assets purchased with borrowed funds) and calculated at the end of each fiscal quarter based on the average value of our gross assets (i.e., total assets less cash or cash equivalents, as presented in the Company’s consolidated financial statements) as of the end of such fiscal quarter and the end of the immediate prior fiscal quarter. Any derivative contracts the Company may enter into will be factored into our gross assets on which a management fee is paid to Saratoga Investment Advisors to the extent and in the manner that it is treated as such under GAAP and set forth in our consolidated financial statements. Base management fees for any partial month or quarter are appropriately pro-rated.

The incentive fee has the following two parts:

The first part is calculated and payable quarterly in arrears based on our pre-incentive fee net investment income for the immediately preceding fiscal quarter. Pre-incentive fee net investment income means interest income, dividend income and any other income (including any other fees such as commitment, origination, structuring, diligence, managerial and consulting fees or other fees that we receive from portfolio companies) accrued during the fiscal quarter, minus our operating expenses for the quarter (including the base management fee, expenses payable under the administration agreement, and any interest expense and dividends paid on any issued and outstanding preferred stock or debt security, but excluding the incentive fee). Pre-incentive fee net investment income includes, in the case of investments with a deferred interest feature (such as market discount, debt instruments with payment-in-kind interest, preferred stock with payment-in-kind dividends and zero coupon securities), accrued income that we have not yet received in cash. Pre-incentive fee net investment income does not include any realized capital gains, realized capital losses or unrealized capital appreciation or depreciation. Pre-incentive fee net investment income, expressed as a rate of return on the value of our net assets (defined as total assets less liabilities) at the end of the immediately preceding fiscal quarter, is compared to a “hurdle rate” of 1.875% per quarter (7.5% annualized), subject to a “catch up” provision. The base management fee is calculated prior to giving effect to the payment of any incentive fees.

 

97


Table of Contents

We pay Saratoga Investment Advisors an incentive fee with respect to our pre-incentive fee net investment income in each fiscal quarter as follows: (A) no incentive fee in any fiscal quarter in which our pre-incentive fee net investment income does not exceed the hurdle rate; (B) 100% of our pre-incentive fee net investment income with respect to that portion of such pre-incentive fee net investment income, if any, that exceeds the hurdle rate but is less than or equal to 2.344% in any fiscal quarter (9.376% annualized) is payable to Saratoga Investment Advisors; and (C) 20% of the amount of our pre-incentive fee net investment income, if any, that exceeds 2.344% in any fiscal quarter (9.376% annualized). We refer to the amount specified in clause (B) as the “catch-up.” The “catch-up” provision is intended to provide Saratoga Investment Advisors with an incentive fee of 20% on all of our pre-incentive fee net investment income as if a hurdle rate did not apply when our pre-incentive fee net investment income exceeds 2.344% in any fiscal quarter. Notwithstanding the foregoing, with respect to any period ending on or prior to December 31, 2010, Saratoga Investment Advisors was only entitled to 20% of the amount of our pre-incentive fee net investment income, if any, that exceeded 1.875% in any fiscal quarter (7.5% annualized) without any catch-up provision. These calculations are appropriately pro-rated when such calculations are applicable for any period of less than three months.

The following is a graphical representation of the calculation of the income-related portion of the incentive fee subsequent to any period ending after December 31, 2010:

Quarterly Incentive Fee Based on “Pre-Incentive Fee Net Investment Income”

Pre-Incentive Fee Net Investment Income

(expressed as a percentage of the value of net assets)

 

LOGO

Percentage of Pre-Incentive Fee Net Investment

Income allocated to income-related portion of incentive fee

The second part of the incentive fee, the capital gains fee, is determined and payable in arrears as of the end of each fiscal year (or, upon termination of the investment advisory and management agreement), and is calculated at the end of each applicable year by subtracting (1) the sum of our cumulative aggregate realized capital losses and aggregate unrealized capital depreciation from (2) our cumulative aggregate realized capital gains, in each case calculated from May 31, 2010. If such amount is positive at the end of such year, then the capital gains fee for such year is equal to 20% of such amount, less the cumulative aggregate amount of capital gains fees paid in all prior years. If such amount is negative, then there is no capital gains fee for such year.

Under the investment advisory and management agreement, the capital gains portion of the incentive fee is based on realized gains and realized and unrealized losses from May 31, 2010. Therefore, realized and unrealized losses incurred prior to such time will not be taken into account when calculating the capital gains portion of the incentive fee, and Saratoga Investment Advisors will be entitled to 20% of net capital gains that arise after May 31, 2010. In addition, the cost basis for computing our realized gains and losses on investments held by us as of May 31, 2010 equals the fair value of such investments as of such date.

 

 

98


Table of Contents

Examples of Quarterly Incentive Fee Calculation

Example 1: Income Related Portion of Incentive Fee(1):

Assumptions

 

    Hurdle rate(2) = 1.875%

 

    Management fee(3) = 0.4375%

 

    Other expenses (legal, accounting, custodian, transfer agent, etc.)(4) = 0.33%

Alternative 1

Additional Assumptions

 

    Investment income (including interest, dividends, fees, etc.) = 1.25%

 

    Pre-incentive fee net investment income (investment income – (management fee + other expenses)) = 0.4825%

Pre-incentive fee net investment income does not exceed hurdle rate, therefore there is no incentive fee.

Alternative 2

Additional Assumptions

 

    Investment income (including interest, dividends, fees, etc.) = 3.0%

 

    Pre-incentive fee net investment income (investment income – (management fee + other expenses)) = 2.2325%

Pre-incentive fee net investment income exceeds hurdle rate, but does not fully satisfy the “catch-up” provision, therefore the income related portion of the incentive fee is 0.3575%.

 

Incentive Fee = (100% × (pre-incentive fee net investment income – 1.875%)
= 100%(2.2325% – 1.875%)
= 100%(0.3575%)
= 0.3575%

 

(1) The hypothetical amount of pre-incentive fee net investment income shown is based on a percentage of total net assets.
(2) Represents 7.5% annualized hurdle rate.
(3) Represents 1.75% annualized management fee. For the purposes of this example, we have assumed that we have not incurred any indebtedness and that we maintain no cash or cash equivalents.
(4) The “catch-up” provision is intended to provide our investment adviser with an incentive fee of 20% on all pre-incentive fee net investment income as if a hurdle rate did not apply when our net investment income exceeds 2.344% in any fiscal quarter.

Alternative 3

Additional Assumptions

 

    Investment income (including interest, dividends, fees, etc.) = 3.5%

 

    Pre-Incentive Fee Net Investment Income (investment income – (management fee + other expenses) = 2.7325%

 

99


Table of Contents

Pre-incentive fee net investment income exceeds the hurdle rate, and fully satisfies the “catch-up” provision, therefore the income related portion of the incentive fee is 0.5467%.

 

Incentive fee = 100% × pre-incentive fee net investment income (subject to “catch-up”)(4)
Incentive fee = 100% × “catch-up”+ (20% × (Pre-incentive fee net investment income – 2.344%))
Catch up = 2.344% – 1.875%
= 0.469%
Incentive fee = (100% × 0.469%)+(20% ×(2.7325% – 2.344%))
= 0.469% + (20% × 0.3885%)
= 0.469% + 0.0777%
= 0.5467%

Example 2: Capital Gains Portion of Incentive Fee:

Alternative 1:

Assumptions(1)

 

(1) The examples assume that Investment A and Investment B were acquired by us subsequent to May 31, 2010. If Investment A and B were acquired by us prior to May 31, 2010, then the cost basis for computing our realized gains and losses on such investments would equal the fair value of such investments as of May 31, 2010.

 

    Year 1: $20 million investment made in Company A (“Investment A”), and $30 million investment made in Company B (“Investment B”)

 

    Year 2: Investment A is sold for $50 million and fair market value (“FMV”) of Investment B determined to be $32 million

 

    Year 3: FMV of Investment B determined to be $25 million

 

    Year 4: Investment B sold for $31 million

The capital gains portion of the incentive fee, if any, calculated under the cumulative method would be:

 

    Year 1: None

 

    Year 2: $6 million (20% multiplied by $30 million realized capital gains on sale of Investment A)

 

    Year 3: None; $5 million (20% multiplied by ($30 million realized cumulative capital gains less $5 million cumulative capital depreciation)) less $6 million (capital gains incentive fee paid in Year 2)

 

    Year 4: $200,000; $6.2 million (20% multiplied by $31 million cumulative realized capital gains) less $6 million (capital gains incentive fee paid in Year 2)

Alternative 2

Assumptions(1)

 

    Year 1: $20 million investment made in Company A (“Investment A”), $30 million investment made in Company B (“Investment B”) and $25 million investment made in Company C (“Investment C”)

 

    Year 2: Investment A sold for $50 million, FMV of Investment B determined to be $25 million and FMV of Investment C determined to be $25 million

 

    Year 3: FMV of Investment B determined to be $27 million and Investment C sold for $30 million

 

    Year 4: FMV of Investment B determined to be $35 million

 

    Year 5: Investment B sold for $20 million

 

100


Table of Contents

The capital gains portion of the incentive fee, if any, calculated under the cumulative method would be:

 

    Year 1: None

 

    Year 2: $5 million (20% multiplied by $25 million ($30 million realized capital gains on Investment A less $5 million unrealized capital depreciation on Investment B))

 

    Year 3: $1.4 million ($6.4 million (20% multiplied by $32 million ($35 million cumulative realized capital gains less $3 million unrealized capital depreciation)) less $5 million (capital gains incentive fee paid in Year 2))

 

    Year 4: None

 

    Year 5: None ($5 million (20% multiplied by $25 million (cumulative realized capital gains of $35 million less realized capital losses of $10 million)) less $6.4 million (cumulative capital gains incentive fee paid in Year 2 and Year 3))

Board Approval of the Investment Advisory and Management Agreement

The investment advisory and management agreement with Saratoga Investment Advisors was initially approved by our board of directors at an in-person meeting of the directors, including a majority of our independent directors, and was approved by our stockholders at the special meeting of stockholders held on July 30, 2010.

In approving this agreement, the directors considered, among other things, (i) the nature, extent and quality of the advisory and other services to be provided to us by Saratoga Investment Advisors; (ii) our investment performance and the investment performance of Saratoga Investment Advisors; (iii) the expected costs of the services to be provided by Saratoga Investment Advisors (including management fees, advisory fees and expense ratios) and the profits expected to be realized by Saratoga Investment Advisors; (iv) the limited potential for economies of scale in investment management associated with managing us; and (v) Saratoga Investment Advisors estimated pro forma profitability with respect to managing us.

Pursuant to the 1940 Act, the initial term of the Management Agreement was for two years from its effective date of July 30, 2010, and will continue in effect for a successive period of 12 months thereafter, provided that each continuance is specifically approved at least annually by both (i) the vote of a majority of the board members or the vote of a majority of our outstanding voting securities (as such term is defined in the 1940 Act) and (ii) the vote of a majority of the board members who are not parties to the investment advisory and management agreement or interested persons (as such term is defined in the 1940 Act) of any such party, cast in person at a meeting called for the purpose of voting on such approval. Most recently, on July 10, 2014, our board of directors, including a majority of our independent directors, approved the renewal of the Management Agreement for an additional one-year term at an in-person meeting.

Payment of our expenses

The investment advisory and management agreement provides that all investment professionals of Saratoga Investment Advisors and its staff, when and to the extent engaged in providing investment advisory services required to be provided by Saratoga Investment Advisors, and the compensation and routine overhead expenses of such personnel allocable to such services, will be provided and paid for by Saratoga Investment Advisors and not by us.

We bear all costs and expenses of our operations and transactions, including those relating to:

 

    our organization;

 

    calculating our net asset value (including the cost and expenses of any independent valuation firm);

 

 

101


Table of Contents
    expenses incurred by Saratoga Investment Advisors payable to third parties, including agents, consultants or other advisors, in monitoring financial and legal affairs for us and in monitoring our investments and performing due diligence on our prospective portfolio companies;

 

    interest payable on debt, if any, incurred to finance our investments;

 

    offerings of our common stock and other securities;

 

    investment advisory and management fees;

 

    fees payable to third parties, including agents, consultants or other advisors, relating to, or associated with, evaluating and making investments;

 

    transfer agent and custodial fees;

 

    federal and state registration fees;

 

    all costs of registration and listing our common stock on any securities exchange;

 

    federal, state and local taxes;

 

    independent directors’ fees and expenses;

 

    costs of preparing and filing reports or other documents required by governmental bodies (including the SEC and the SBA);

 

    costs of any reports, proxy statements or other notices to common stockholders including printing costs;

 

    our fidelity bond, directors and officers errors and omissions liability insurance, and any other insurance premiums;

 

    direct costs and expenses of administration, including printing, mailing, long distance telephone, copying, secretarial and other staff, independent auditors and outside legal costs; and

 

    administration fees and all other expenses incurred by us or, if applicable, the administrator in connection with administering our business (including payments under the administration agreement based upon our allocable portion of the administrator’s overhead in performing its obligations under the administration agreement, including rent and the allocable portion of the cost of our officers and their respective staffs (including travel expenses)).

Duration and Termination

The investment advisory and management agreement will remain in effect continuously, unless terminated under the termination provisions of the agreement. The investment advisory and management agreement may be terminated as a whole at any time by us, without the payment of any penalty, upon the vote of a majority of the board members or a majority of our outstanding voting securities or by Saratoga Investment Advisors, on 60 days’ written notice by either party to the other, which notice may be waived by the non-terminating party.

Indemnification

Under the investment advisory and management agreement, Saratoga Investment Advisors and certain of its affiliates are not liable to us for any action taken or omitted to be taken by Saratoga Investment Advisors in connection with the performance of any of its duties or obligations under the agreement or otherwise as an investment adviser to us, except to the extent specified in Section 36(b) of the 1940 Act concerning loss resulting from a breach of fiduciary duty (as the same is finally determined by judicial proceedings) with respect to the receipt of compensation for services and except to the extent such action or omission constitutes gross negligence, willful misfeasance, bad faith or reckless disregard of its duties and obligations under the agreement.

 

 

102


Table of Contents

We also provide indemnification to Saratoga Investment Advisors and certain of its affiliates for damages, liabilities, costs and expenses incurred by them in or by reason of any pending, threatened or completed action, suit, investigation or other proceeding arising out of or otherwise based upon the performance of any of its duties or obligations under the agreement or otherwise as an investment adviser to us. However, we would not provide indemnification against any liability to us or our security holders to which Saratoga Investment Advisors or such affiliates would otherwise be subject by reason of willful misfeasance, bad faith or gross negligence in the performance of any such person’s duties or by reason of the reckless disregard of its duties and obligations under the agreement.

Organization of the Investment Adviser

Saratoga Investment Advisors is registered as an investment adviser under the Investment Advisers Act of 1940. The principal executive offices of Saratoga Investment Advisors are located at 535 Madison Avenue, New York, New York 10022.

Administration Agreement

Pursuant to a separate administration agreement, Saratoga Investment Advisors, who also serves as our administrator, furnishes us with office facilities, equipment and clerical, book-keeping and record keeping services. Under the administration agreement, our administrator also performs, or oversees the performance of, our required administrative services, which include, among other things, being responsible for the financial records which we are required to maintain, preparing reports for our stockholders and reports required to be filed with the SEC. In addition, our administrator assists us in determining and publishing our net asset value, oversees the preparation and filing of our tax returns and the printing and dissemination of reports to our stockholders, and generally oversees the payment of our expenses and the performance of administrative and professional services rendered to us by others. Payments under the administration agreement equal an amount based upon our allocable portion of our administrator’s overhead in performing its obligations under the administration agreement, including rent and our allocable portion of the cost of our officers and their respective staffs relating to the performance of services under this agreement (including travel expenses). Our allocable portion is based on the proportion that our total assets bears to the total assets administered or managed by our administrator. Under the administration agreement, our administrator also provides managerial assistance, on our behalf, to those portfolio companies who accept our offer of assistance. The amount payable under the administration agreement is currently capped at $1.0 million for each annual term of the agreement. The administration agreement had an initial term of two years from its effective date of July 30, 2010, with automatic one-year renewals, subject to approval by our board of directors, a majority of whom must be our independent directors. On July 10, 2014, our board of directors approved the renewal of the Administration Agreement for an additional one-year term and determined to maintain the cap on the payment or reimbursement of expenses by us thereunder to $1.0 million for the additional one-year term. The administration agreement may be terminated by either party without penalty upon 60 days written notice to the other party.

Indemnification

Under the administration agreement, Saratoga Investment Advisors and certain of its affiliates are not liable to us for any action taken or omitted to be taken by Saratoga Investment Advisors in connection with the performance of any of its duties or obligations under the agreement.

We also provide indemnification to Saratoga Investment Advisors and certain of its affiliates for damages, liabilities, costs and expenses incurred by them in or by reason of any pending, threatened or completed action, suit, investigation or other proceeding arising out of or otherwise based upon the performance of any of its duties or obligations under the agreement or otherwise as an administrator to us. However, we do not provide indemnification against any liability to us or our security holders to which Saratoga Investment Advisors or such affiliates would otherwise be subject by reason of willful misfeasance, bad faith or gross negligence in the performance of any such person’s duties or by reason of the reckless disregard of its duties and obligations under the agreement.

 

103


Table of Contents

License Agreement

We entered into a trademark license agreement with Saratoga Investment Advisors, pursuant to which Saratoga Investment Advisors grants us a non-exclusive, royalty-free license to use the name “Saratoga.” Under this agreement, we have a right to use the “Saratoga” name, for so long as Saratoga Investment Advisors or one of its affiliates remains our investment adviser. Other than with respect to this limited license, we have no legal right to the “Saratoga” name. Saratoga Investment Advisors has the right to terminate the license agreement if it is no longer acting as our investment adviser. In the event the investment advisory and management agreement is terminated, we would be required to change our name to eliminate the use of the name “Saratoga.”

 

104


Table of Contents

MANAGEMENT

Our business and affairs are managed under the direction of our Board of Directors. Our Board of Directors elects our officers who serve at its discretion. Our Board of Directors has five members, two of whom are “interested persons” as defined in Section 2(a)(19) of the 1940 Act and five of whom are not interested persons, whom we refer to as our independent directors.

Director and Executive Officer Information

As of June 3, 2014, our executive officers, directors and key employees and their positions are as set forth below. The address for each executive officer and director is c/o Saratoga Investment Corp., 535 Madison Avenue, New York, New York 10022.

 

Name

 

Age

  

Position

   Director
Since
     Expiration
of Term
 

Interested Directors

          

Christian L. Oberbeck

  53    Chairman of the Board and Chief Executive Officer      2010         2015   

Michael J. Grisius

  49    President and Director      2011         2014   

Independent Directors

          

Steven M. Looney

  63    Director      2007         2016   

Charles S. Whitman III

  70    Director      2007         2016   

G. Cabell Williams

  58    Director      2007         2014   

Name

 

Age

  

Position

             

Executive Officers

          

Christian L. Oberbeck

  53    Chief Executive Officer      

Michael J. Grisius

  49    President      

Henri J. Steenkamp

  38    Chief Financial Officer, Treasurer, Secretary and Chief Compliance Officer      

Biographical information regarding our Board and our executive officers is set forth below. We have divided the directors into two groups—independent directors and interested directors. Interested directors are “interested persons” of Saratoga Investment Corp., as defined in Section 2(a)(19) of the 1940 Act. We do not currently have any other executive officers who are not also directors.

Biographical Information

Independent Directors

Steven M. Looney—Mr. Looney is a Managing Director of Peale Davies & Co. Inc., a consulting firm with particular expertise in financial process and IT outsourcing, and is a CPA and an attorney. Mr. Looney has also served as Managing Director, Americas of Vayon Group, a strategic adviser for greentech electric and hybrid vehicle services, since June 2014. Mr. Looney also serves as a consultant and director to numerous companies in the healthcare, manufacturing and technology services industries, including FCL Graphics Inc., (since October 2009) Church Street Health Management (since June 2012), Sun Healthcare Group (May 2004 to November 2010) and WH Industries Inc. (January 1997 to December 2012). Between 2000 and 2005, he served as Senior Vice President and Chief Financial Officer of PCCI, Inc., a private IT staffing and outsourcing firm. Between 1992 and 2000, Mr. Looney worked at WH Industries as Chief Financial and Administrative Officer. Mr. Looney also serves as a director of Excellent Education for Everyone, a nonprofit organization. Mr. Looney graduated summa cum laude from the University of Washington with a B.A. degree in Accounting and received a J.D. from the University of Washington School of Law where he was a member of the law review. Mr. Looney’s

 

105


Table of Contents

qualifications as director include his experience as a Managing Director of Peale Davies & Co. Inc. and as Chief Financial and Administrative Officer of WH Industries, as well as his financial, accounting and legal expertise.

Charles S. Whitman III—Mr. Whitman is senior counsel (retired) at Davis Polk & Wardwell LLP. Mr. Whitman was a partner in Davis Polk’s Corporate Department for 28 years, representing clients in a broad range of corporate finance matters, including shelf registrations, securities compliance for financial institutions, foreign asset privatizations, and mergers and acquisitions. From 1971 to 1973, Mr. Whitman served as Executive Assistant to three successive Chairmen of the SEC. Mr. Whitman serves on the Legal Advisory Board of the National Association of Securities Dealers. Mr. Whitman graduated from Harvard College and graduated magna cum laude from Harvard Law School with a LL.B. Mr. Whitman also received an LL.M. from Cambridge University in England. Mr. Whitman’s qualifications as director include his 28 years of experience representing clients, including AT&T, Exxon Mobil, General Motors and BP, in securities matters as a partner in Davis Polk’s corporate department.

G. Cabell Williams—Mr. Williams has served as the Managing General Partner of Williams and Gallagher, a private equity partnership located in Chevy Chase, Maryland since 2004. Since March 2011, Mr. Williams has also served as a partner of Faragut Capital Partners, an investment firm based in Fairfax, VA. In 2004, Mr. Williams concluded a 23 year career at Allied Capital Corporation, a business development company based in Washington, DC, which was acquired by Ares Capital Corporation in 2010. While at Allied, Mr. Williams held a variety of positions, including President, COO and finally Managing Director following Allied’s merger with its affiliates in 1998. From 1991 to 2004, Mr. Williams either led or co-managed the firm’s Private Equity Group. For the nine years prior to 1999, Mr. Williams led Allied’s Mezzanine investment activities. For 15 years, Mr. Williams served on Allied’s Investment Committee where he was responsible for reviewing and approving all of the firm’s investments. Prior to 1991, Mr. Williams ran Allied’s Minority Small Business Investment Company. He also founded Allied Capital Commercial Corporation, a real estate investment vehicle. Mr. Williams has served on the Board of various public and private companies. Mr. Williams attended The Landon School, and graduated from Mercersburg Academy and Rollins College, receiving a B.S. in Business Administration from the latter. Mr. Williams’ qualifications as director include his over 25 years of experience managing investment activities at Williams and Gallagher and at Allied Capital, where he served in a variety of positions, including President, COO and Managing Director.

Interested Directors

Christian L. Oberbeck—Mr. Oberbeck has over 23 years of experience in leveraged finance, from distressed debt to private equity, and has been involved in originating, structuring, negotiating, consummating, managing and monitoring investments in these businesses. Mr. Oberbeck is the Managing Partner of Saratoga Partners, a middle market private equity investment firm, and has served on its investment committee since 1995. Mr. Oberbeck is also the Managing Member of Saratoga Investment Advisors, LLC, the Company’s investment adviser, and the Chief Executive Officer of the Company. Mr. Oberbeck also served as our President until February 2013.

Prior to assuming management responsibility for Saratoga Partners in 2008, Mr. Oberbeck has co-managed Saratoga Partners since 1995, when he joined Dillon Read and Saratoga Partners from Castle Harlan, Inc., a corporate buyout firm, which he had joined at its founding in 1987 and was a Managing Director, leading successful investments in manufacturing and financial services companies. Prior to joining that, he worked in the Corporate Development Group of Arthur Young and in corporate finance at Blyth Eastman Paine Webber. Mr. Oberbeck has been a director of numerous middle market companies.

Mr. Oberbeck graduated from Brown University in 1982 with a BS in Physics and a BA in Mathematics. In 1985, he earned an MBA from Columbia University. Mr. Oberbecks’s qualifications as a director include his extensive experience in the investment and finance industry, as well as his intimate knowledge of the Company’s operations, gained through his service as an executive officer.

 

106


Table of Contents

Michael J. Grisius—Mr. Grisius has over 22 years of experience in leveraged finance, investment management and financial services. He has originated, structured, negotiated, consummated, managed and monitored numerous successful investments in mezzanine debt, private equity, senior debt, structured products and commercial real estate debt. Mr. Grisius is Chief Investment Officer and a Managing Director of Saratoga Investment Advisors, LLC, the Company’s investment adviser and was appointed President of the Company in February 2013. Mr. Grisius joined Saratoga Investment Advisors, LLC in July 2011.

Prior to joining Saratoga Investment Advisors, Mr. Grisius served as Managing Director at Allied Capital Corporation, where he was an investment professional for 16 years. At Allied Capital Corporation, Mr. Grisius held several senior positions including co-head of Mezzanine Finance and member of its Management Committee and its Investment Committee. In 2008, Mr. Grisius was appointed co-chairman of the Allied Capital Corporation’s Investment Committee. He also had responsibility for structuring and managing Unitranche Fund, LLC. During his tenure at Allied, Mr. Grisius built and led teams that made investments in subordinated debt, control equity and real estate mortgage debt. Mr. Grisius has served on the board of directors of numerous middle market companies. Prior to joining Allied Capital Corp., Mr. Grisius worked in leveraged finance at Chemical Bank from 1989 to 1992 and held senior accountant and consultant positions with KPMG LLP from 1985 to 1988.

Mr. Grisius graduated with a BS from Georgetown University in 1985 and earned an MBA from Cornell University’s Johnson Graduate School of Management in 1990. Mr. Grisius’ qualifications as a director include his broad experience in leverage finance, investment management, private equity and financial services.

Executive Officers

For information regarding Mr. Oberbeck, the Chairman of the Board and our Chief Executive Officer and Mr. Grisius, our President, see “—Interested directors” above.

Henri J. Steenkamp. Mr. Steenkamp has over 15 years of experience in finance and accounting. On March 4, 2014, the Board of Directors appointed Mr. Steenkamp to serve as the Company’s Interim Chief Financial Officer, Treasurer, Secretary and Chief Compliance Officer. On July 10, 2014, our board of directors appointed Mr. Steenkamp to serve in all of the foregoing roles on a permanent basis. Prior to joining the Company, Mr. Steenkamp served as the Chief Financial Officer of MF Global Holdings Ltd., a broker in commodities and derivatives, from April 2011. Prior to that, Mr. Steenkamp held the position of Chief Accounting Officer and Global Controller at MF Global for four years. He joined MF Global, then Man Financial, in 2006 as Vice President of External Reporting and Accounting Policy. After MF Global filed for bankruptcy protection in October 2011, he continued to serve as Chief Financial Officer through January 2013. Before joining MF Global, Mr. Steenkamp spent eight years with PricewaterhouseCoopers (“PwC”), including four years in Transaction Services in its New York office, managing a variety of capital-raising transactions on a global basis. His focus was also on the SEC registration and public company filing process, including technical accounting. He spent four years with PwC in South Africa, where he served as an auditor primarily for SEC registrants and assisted South African companies as they went public in the U.S. Mr. Steenkamp is a chartered accountant and holds an honors degree in Finance.

Board Leadership and the Board’s Role in the Oversight of Risk Management

Our board of directors monitors and performs an oversight role with respect to the business and affairs of the Company, including with respect to investment practices and performance, compliance with regulatory requirements and the services, expenses and performance of service providers to the Company. Among other things, our board of directors approves the appointment of our investment adviser, administrator and officers; reviews and monitors the services and activities performed by our investment adviser, administrator and officers; and approves the engagement, and reviews the performance of, our independent public accounting firm.

 

107


Table of Contents

Under our bylaws, the Board may designate a chairman to preside over the meetings of the Board and meetings of the stockholders and to perform such other duties as may be assigned to him by the Board. The Company does not have a fixed policy as to whether the chairman of the Board should be an independent director and believes that its flexibility to select its chairman and reorganize its leadership structure from time to time is in the best interests of the Company and its stockholders.

Mr. Oberbeck, who is an “interested person” of the Company as defined in Section 2(a)(19) of the 1940 Act, serves as our chief executive officer and chairman of the Board. The Board believes that Mr. Oberbeck, as chief executive officer of the Company and as a principal of Saratoga Investment Advisors, is the director with the most knowledge of our business strategy and is best situated to serve as chairman of the Board. The Board does not currently have a lead independent director. We believe that our board leadership structure must be evaluated on a case-by-case basis and that our existing board leadership structure is appropriate. However, we continually re-examine our corporate governance policies on an ongoing basis to ensure that they continue to meet our needs.

The Board, directly and through the audit committee and other committees of the Board, takes an active role in the oversight of the Company’s policies with respect to the assessment and management of enterprise risk. Among other things, the Board has policies in place for identifying the senior executive responsible for key risks as well as the Board committees with oversight responsibility for particular key risks. In a number of cases, oversight is conducted by the full Board. Our Board also performs its risk oversight responsibilities with the assistance of the chief compliance officer. The chief compliance officer is designated to oversee compliance with the federal securities laws.

We believe that our Board and its committees’ role in risk oversight complements our Board’s leadership structure because it allows our independent directors, through three fully independent board committees, auditor and independent valuation providers, our chief compliance officer, and otherwise, to exercise oversight of risk without any conflict that might discourage critical review. We believe that our board leadership structure and the Board’s approach to risk oversight must be evaluated on a case-by-case basis and that the Board’s role in risk oversight is appropriate. However, we continually re-examine the manner in which the Board administers its oversight function on an ongoing basis to ensure that it continues to meet our needs.

Director Independence

In accordance with rules of the New York Stock Exchange (the “NYSE”), the Board annually determines the independence of each director. No director is considered independent unless the Board has determined that he or she has no material relationship with the Company. The Company monitors the status of its directors and officers through the activities of the Company’s Nominating and Corporate Governance Committee and through a questionnaire to be completed by each director no less frequently than annually, with updates periodically if information provided in the most recent questionnaire has changed.

In order to evaluate the materiality of any such relationship, the Board uses the definition of director independence set forth in the NYSE Listed Company Manual. Section 303A.00 of the NYSE Listed Company Manual provides that business development companies, or BDCs, such as the Company, are required to comply with all of the provisions of Section 303A applicable to domestic issuers other than Sections 303A.02, the section that defines director independence. Section 303A.00 provides that a director of a BDC shall be considered to be independent if he or she is not an “interested person” of the Company, as defined in Section 2(a)(19) of the 1940 Act. Section 2(a)(19) of the 1940 Act defines an “interested person” to include, among other things, any person who has, or within the last two years had, a material business or professional relationship with the Company.

The Board has determined that each of the directors is independent and has no relationship with the Company, except as a director and stockholder of the Company, with the exception of Messrs. Oberbeck and Grisius, who are interested persons of the Company due to their positions as officers of the Company and/or officers of Saratoga Investment Advisors, LLC, our external investment adviser.

 

108


Table of Contents

Corporate Governance

We maintain a corporate governance webpage at the “Corporate Governance” link under the “Investor Relations” link at http://saratogainvestmentcorp.com.

Our Corporate Governance Procedures, Code of Business Conduct and Ethics, Code of Ethics and Board committee charters are available at our corporate governance webpage at http://saratogainvestmentcorp.com and are also available to any stockholder who requests them by writing to our Interim Secretary, Henri J. Steenkamp, at Saratoga Investment Corp., 535 Madison Avenue, New York, New York 10022.

Annual Evaluation

Our directors perform an evaluation, at least annually, of the effectiveness of the Board and its committees. This evaluation includes an annual questionnaire and Board and Board committee discussion.

Board Meetings and Committees

Our Board met six times during fiscal year 2014. Each director attended at least 75% of the total number of meetings of the Board and committees on which the director served that were held while the director was a member. The Board’s standing committees are set forth below. We require each director to make a diligent effort to attend all Board and committee meetings, as well as each Annual Meeting of Stockholders. All of the five directors attended the 2014 Annual Meeting of Stockholders in person.

Communications with Directors

Stockholders and other interested parties may contact any member (or all members) of the Board by mail. To communicate with the Board, any individual directors or any group or committee of directors, correspondence should be addressed to the Board or any such individual directors or group or committee of directors by either name or title. All such correspondence should be sent to Saratoga Investment Corp., 535 Madison Avenue, New York, New York 10022, Attention: Secretary. Any communication to report potential issues regarding accounting, internal controls and other auditing matters will be directed to the Audit Committee. Appropriate personnel of the Company will review and sort through communications before forwarding them to the addressee(s).

Code of Business Conduct and Ethics

We have adopted a Code of Business Conduct and Ethics that applies to which applies to, among others, our executive officers, including our principal executive officer and principal financial officer, as well as every officer, director and employee of the Company. Requests for copies should be sent in writing to Saratoga Investment Corp., 535 Madison Avenue, New York, New York 10022. The Company’s Code of Business Conduct and Ethics is also available on our website at http://saratogainvestmentcorp.com.

If we make any substantive amendment to, or grant a waiver from, a provision of our Code of Business Conduct and Ethics, we will promptly disclose the nature of the amendment or waiver on our website at http://saratogainvestmentcorp.com.

Committees of the Board of Directors

Audit Committee

The current members of the audit committee are Steven M. Looney (Chairman), Charles S. Whitman III and G. Cabell Williams. The Board has determined that Mr. Looney is an “audit committee financial expert” as defined under Item 407 of Regulation S-K of the Securities Exchange Act of 1934 and that each of Messrs.

 

109


Table of Contents

Whitman and Williams are “financially literate” as required by NYSE corporate governance standards. All of these members are independent directors. The audit committee is responsible for approving our independent accountants, reviewing with our independent accountants the plans and results of the audit engagement, approving professional services provided by our independent accountants, reviewing the independence of our independent accountants and reviewing the adequacy of our internal accounting controls. The audit committee is also responsible for aiding our board of directors in determining the fair value of debt and equity investments that are not publicly traded or for which current market values are not readily available; where appropriate, the board of directors and audit committee may utilize the services of an independent valuation firm to assist them in determining the fair value of these investments. Finally, the audit committee also reviews our financial statements and the disclosure thereof and the adequacy of our disclosure controls and procedures.

Authority

The audit committee is authorized (without seeking Board approval) to retain special legal, accounting or other advisors and may request any officer or employee of the Company or the Company’s outside counsel or independent auditor to meet with any members of, or advisors to, the audit committee. The audit committee has available appropriate funding from the Company as determined by the audit committee for payment of: (i) compensation to any accounting firm engaged for the purpose of preparing or issuing an audit report or performing other audit, review or attest services for the Company, (ii) compensation to any advisers employed by the audit committee, and (iii) ordinary administrative expenses of the audit committee that are necessary or appropriate in carrying out its duties. The audit committee may delegate its authority to subcommittees or the chairman of the audit committee when it deems appropriate and in the best interests of the Company.

Procedures

The audit committee meets as often as it determines is appropriate to carry out its responsibilities under its charter, but not less frequently than quarterly. The chairman of the audit committee, in consultation with the other committee members, determines the frequency and length of the committee meetings and sets meeting agendas consistent with its charter. The audit committee meets separately, periodically, with management, with internal auditors or other personnel responsible for the internal audit function and with the independent auditor.

A charter of the audit committee is available in print to any stockholder who requests it and it is also available on the Company’s website at www.saratogainvestmentcorp.com.

Nominating and Corporate Governance Committee

The current members of the nominating and corporate governance committee are Charles S. Whitman III (Chairman), G. Cabell Williams and Steven M. Looney. All of these members are independent directors. The nominating and corporate governance committee is responsible for identifying individuals qualified to become board members, and recommending to the Board director nominees for election at the next annual or special meeting of shareholders at which directors are to be elected or to fill any vacancies or newly created directorships that may occur between such meetings, recommending directors for appointment to Board committees, making recommendations to the Board as to determinations of director independence, overseeing the evaluation of the Board, overseeing and setting compensation for the Company’s directors.

In making its recommendations for Board and committee membership, the nominating and corporate governance committee reviews candidates’ qualifications for membership on the Board or a committee of the Board (including making a specific determination as to the independence of each candidate) based on the criteria approved by the Board (and taking into account the enhanced independence, financial literacy and financial expertise standards required under law or the New York Stock Exchange rules for audit committee membership purposes). In evaluating current directors for re-nomination to the Board or re-appointment to any Board committees, the nominating and corporate governance committee assesses the performance of such directors, periodically reviews

 

110


Table of Contents

the composition of the Board and its committees in light of the current challenges and needs of the Board, the Company and each committee, and determines whether it may be appropriate to add or remove individuals after considering issues of judgment, diversity, age, skills, background and experience, considers rotation of committee members and committee chairmen and considers any other factors that are set forth in the Company’s corporate governance procedures or are deemed appropriate by the nominating and corporate governance committee or the Board. The nominating and corporate governance committee considers issues of judgment, diversity, age, skills, background and experience in evaluating candidates for membership on the Board.

The nominating and corporate governance committee does not have a formal policy on the consideration of director candidates recommended by stockholders. The board of directors believes that it is more appropriate to give the nominating and corporate governance committee flexibility in evaluating stockholder recommendations. In the event that a director nominee is recommended by a stockholder, the nominating and corporate governance committee will give due consideration to the director nominee and will use the same criteria used for evaluating board director nominees, in addition to considering the information relating to the director nominee provided by the stockholder.

Authority

The nominating and corporate governance committee has the sole authority to retain and terminate any search firm assisting the nominating and corporate governance committee in identifying director candidates, including sole authority to approve all such search firm’s fees and other retention terms. In addition, the nominating and corporate governance committee has the sole authority to retain and terminate any compensation consultant assisting the nominating and corporate governance committee in the evaluation of director compensation, including sole authority to approve all such compensation consultant’s fees and other retention terms. The nominating and corporate governance committee may delegate its authority to subcommittees or the chair of the nominating and corporate governance committee when it deems appropriate and in the best interests of the Company.

Procedures

The nominating and corporate governance committee meets as often as it determines is appropriate to carry out its responsibilities under its charter. The chair of the committee, in consultation with the other committee members, determines the frequency and length of the committee meetings and shall set meeting agendas consistent with its charter.

A charter of the nominating and corporate governance committee is available in print to any stockholder who requests it, and it is also available on the Company’s website at www.saratogainvestmentcorp.com.

Compensation Committee

The current members of the compensation committee are G. Cabell Williams (Chairman), Steven M. Looney and Charles S. Whitman III. All of these members are independent directors. The compensation committee is responsible for overseeing the Company’s compensation policies generally and making recommendations to the Board with respect to incentive compensation and equity-based plans of the Company that are subject to Board approval, evaluating executive officer performance and reviewing the Company’s management succession plan, overseeing and setting compensation for the Company’s directors and, as applicable, its executive officers and, as applicable, preparing the report on executive officer compensation that SEC rules require to be included in the Company’s annual proxy statement. Currently, none of our executive officers are compensated by the Company and as such the compensation committee is not required to produce a report on executive officer compensation for inclusion in our annual proxy statement.

The compensation committee has the sole authority to retain and terminate any compensation consultant assisting the compensation committee, including sole authority to approve all such compensation consultant’s

 

111


Table of Contents

fees and other retention terms. The compensation committee may delegate its authority to subcommittees or the chairman of the compensation committee when it deems appropriate and in the best interests of the Company.

Procedures

The compensation committee shall meet as often as it determines is appropriate to carry out its responsibilities under its charter. The chairman of the compensation committee, in consultation with the other committee members, shall determine the frequency and length of the committee meetings and shall set meeting agendas consistent with its charter. No executive officer should attend that portion of any meeting where such executive’s performance (or, as applicable, compensation) is discussed, unless specifically invited by the compensation committee.

A charter of the compensation committee is available in print to any stockholder who requests it and is also available on the Company’s website at www.saratogainvestmentcorp.com.

Compensation Committee Interlocks and Insider Participation

During fiscal year 2012, none of the Company’s executive officers served on the board of directors (or a compensation committee thereof or other board committee performing equivalent functions) of any entities that had one or more executive officers serve on the compensation committee or on the board of directors. No current or past executive officers or employees of the Company or its affiliates serve on the compensation committee.

Executive Compensation

Currently, none of our executive officers are compensated by us. We currently have no employees, and each of our executive officers is also an employee of Saratoga Investment Advisors. Services necessary for our business are provided by individuals who are employees of Saratoga Investment Advisors, pursuant to the terms of the investment advisory and management agreement and the administration agreement.

Director Compensation

Our independent directors receive an annual fee of $40,000. They also receive $2,500 plus reimbursement of reasonable out-of-pocket expenses incurred in connection with attending each board meeting and receive $1,000 plus reimbursement of reasonable out-of-pocket expenses incurred in connection with attending each committee meeting. In addition, the chairman of the audit committee receives an annual fee of $5,000 and the chairman of each other committee receives an annual fee of $2,000 for their additional services in these capacities. In addition, we have purchased directors’ and officers’ liability insurance on behalf of our directors and officers. Independent directors have the option to receive their directors’ fees in the form of our common stock issued at a price per share equal to the greater of net asset value or the market price at the time of payment. No compensation is paid to directors who are “interested persons.”

The following table sets forth information concerning total compensation earned by or paid to each of our directors during the fiscal year ended February 28, 2014:

 

Name

   Fees Earned or
Paid in Cash
     Total  

Interested Directors

     

Christian L. Oberbeck(1)

     —           —     

Michael J. Grisius(1)

     —           —     

Independent Directors

                     

Steven M. Looney

   $ 69,000       $ 69,000   

Charles S. Whitman III

   $ 66,000       $ 66,000   

G. Cabell Williams

   $ 66,000       $ 66,000   

 

(1) No compensation was paid to directors who are interested persons of us as defined in the 1940 Act.

 

112


Table of Contents

PORTFOLIO MANAGEMENT

The day-to-day management of our portfolio is the responsibility of Saratoga Investment Advisors and overseen by its investment committee.

Investment Committee

The members of Saratoga Investment Advisors’ investment committee include Christian L. Oberbeck, Michael J. Grisius, Thomas V. Inglesby and Charles G. Phillips. See the section of the prospectus entitled “Management” for biographies of Messrs. Oberbeck and Grisius. For biographical information for Messrs. Inglesby and Phillips, see “Investment Professionals” below.

Investment Professionals

Our investment adviser’s investment personnel, in addition to our investment adviser’s investment committee, are primarily responsible for the day-to-day management of our portfolio.

The members of our investment adviser’s investment committee and its investment personnel are not be employed by us, and receive no compensation from us in connection with their activities. However, they receive compensation from our investment adviser that includes an annual base salary, an annual individual performance bonus, contributions to 401(k) plans, and, in certain circumstances, a portion of the incentive fee or carried interest earned in connection with their services.

Below are the biographies for the members of our investment adviser’s investment committee whose biographies are not included elsewhere in this prospectus and the other investment professionals of our investment adviser.

Thomas V. Inglesby—Mr. Inglesby has over 25 years of investment experience including private equity and leveraged finance. Mr. Inglesby is a managing director at Saratoga Investment Advisors and is responsible for originating, structuring, negotiating, consummating, managing and monitoring middle market investments.

Prior to joining Saratoga Investment Advisors, Mr. Inglesby was a senior managing director at GSC Group, Inc. From September 2008 through July 2010, Mr. Inglesby was a senior managing director in the Recovery Investment Group at GSC Group, serving on the investment committee as an internal advisor on matters relating to GSC Group’s ongoing restructuring. From 2002 to 2008, Mr. Inglesby served as the Head of the U.S. Corporate Debt Group of GSC Group. During this period, GSC Group raised and managed $5.6 billion in capital across 12 corporate credit investment funds. From 1997 to 2002, he served as a managing director at GSC Group focused on middle market buyouts. Prior to joining GSC Group in 1997, Mr. Inglesby served as a managing director with Harbour Group from 1994 to 1997, where he focused on acquisitions of manufacturing companies in fragmented industries. From 1992 to 1994, Mr. Inglesby served as a managing director at the South Street Funds, a startup distressed debt investment fund founded by former partners at Goldman Sachs. From 1986 to 1990, Mr. Inglesby served as a vice president in the Merchant Banking Department at PaineWebber.

In September 2010, GSC Group filed for bankruptcy under Chapter 11 of the United States Bankruptcy Code.

Mr. Inglesby received a J.D. from the University of Virginia School of Law, an M.B.A. from the Darden Graduate School of Business Administration, and a B.S. in Accounting with General Honors from the University of Maryland.

Charles G. Phillips IV—Mr. Phillips has over 13 years of investment experience including private equity and leveraged finance. Mr. Phillips is a managing director at Saratoga Investment Advisors and Saratoga Partners

 

113


Table of Contents

and has been involved in originating, structuring, negotiating, consummating, managing and monitoring middle market investments. Mr. Phillips has extensive experience investing in middle-market manufacturing and service companies. He also has extensive experience in dealing with public financings and sales through his work with several portfolio companies of Saratoga Partners. Prior corporate finance experience includes mergers and acquisitions and capital markets experience in a variety of industries, including packaged foods, consumer products, cable television, energy and education. Mr. Phillips joined Saratoga Partners in 1997 after graduating from Harvard Business School. Prior to that, from 1993 to 1995, Mr. Phillips worked in Dillon Read’s corporate finance department, where he was involved in mergers and acquisitions and advisory assignments in a variety of industries. Prior experience includes McCown De Leeuw & Co., a corporate buyout firm. Mr. Phillips has served as a director of a number of Saratoga Partners’ portfolio companies.

CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS

Transactions with Related Persons

We have entered into an investment advisory and management agreement with Saratoga Investment Advisors, LLC. We have also entered into a license agreement with Saratoga Investment Advisors, LLC, pursuant to which Saratoga Investment Advisors has agreed to grant us a non-exclusive, royalty-free license to use the name “Saratoga.” In addition, pursuant to the terms of the administration agreement, Saratoga Investment Advisors, LLC provides us with the office facilities and administrative services necessary to conduct our day-to-day operations. Mr. Oberbeck, our chief executive officer, is the primary investor in and controls Saratoga Investment Advisors, LLC.

Review, Approval or Ratification of Transactions with Related Persons

The Audit Committee of our Board is required to review and approve any transactions with related persons (as such term is defined in Item 404 of Regulation S-K). Generally, a related person includes any director or officer of the Company or any immediate family member of a director or officer of the Company or any 5% holder of our common stock or any immediate family member of a 5% holder of our common stock.

CONTROL PERSONS AND PRINCIPAL STOCKHOLDERS

The following table sets forth, as of November 4, 2014, the beneficial ownership of each current director, the nominees for director, the Company’s executive officers, each person known to us to beneficially own 5.0% or more of the outstanding shares of our common stock, and the executive officers and directors as a group.

The percentage ownership is based on 5,379,616 shares of common stock outstanding as of November 4, 2014. Shares of common stock that are subject to warrants or other convertible securities currently exercisable or exercisable within 60 days thereof, are deemed outstanding for the purposes of computing the percentage ownership of the person holding these options or convertible securities, but are not deemed outstanding for computing the percentage ownership of any other person. Beneficial ownership is determined under the rules of the SEC and generally includes voting or investment power with respect to securities. To our knowledge, unless otherwise indicated in the footnotes to this table, the persons and entities named in the table have sole voting and sole investment power with respect to all shares beneficially owned. Unless otherwise indicated by footnote, the address for each listed individual is Saratoga Investment Corp., 535 Madison Avenue, New York, New York 10022.

 

Name of Beneficial Owners

   Number of
Shares of
Common Stock
Beneficially Owned
    Percent of
Class
 

Interested Directors

    

Christian L. Oberbeck

     1,539,564 (1)      28.6

Michael J. Grisius

     67,479        1.3

 

114


Table of Contents

Name of Beneficial Owners

   Number of
Shares of
Common Stock
Beneficially Owned
     Percent of
Class
 

Executive Officer

     

Henri J. Steenkamp

     1,400          

Independent Directors

     

Steven M. Looney

     1,547          

Charles S. Whitman III

     1,833          

G. Cabell Williams

     20,376          
  

 

 

    

All Directors and Executive Officers as a Group

  1,632,195      29.9

Owners of 5% or more of our common stock

Black Diamond Capital Management, L.L.C.(2)

  505,935      9.4

Elizabeth Oberbeck(3)

  744,183      13.8

Raging Capital Management, LLC(4)

  318,077      5.9

Thomas V. Inglesby(5)

  269,549      5.4

 

* Less than 1.0%

Mr. Oberbeck and Mr. Inglesby are affiliates who make up 30.0% of the ownership of SAR.

 

(1) Includes 473,373 shares of common stock directly held by Mr. Oberbeck, 180,738 shares of common stock held by Saratoga Investment Advisors, which Mr. Oberbeck controls, 174,035 shares of common stock held by CLO Partners LLC, an entity wholly owned by Mr. Oberbeck, and 744,183 shares of common stock directly held by Elizabeth Oberbeck. See footnote 3 below.
(2) Based on information included in Amendment No. 2 to Schedule 13G filed by Black Diamond Capital Management, L.L.C. with the SEC on February 14, 2014. The address of Black Diamond Capital Management, L.L.C. is One Sound Shore Drive, Suite 200, Greenwich, CT 06830.
(3) Based on information included in Amendment No. 3 to Schedule 13D filed jointly by Christian L. Oberbeck, Elizabeth Oberbeck, Saratoga Investment Advisors and CLO Partners LLC on November 4, 2014. Pursuant to an Agreement Relating to Shares of Common Stock of Saratoga Investment Corp. (the “Transfer Agreement”), Christian L. Oberbeck transferred 744,183 shares of common stock beneficially owned by him to Elizabeth Oberbeck. Elizabeth Oberbeck has full ownership rights with respect to the shares, including without limitation, the right to (A) receive any cash and/or stock dividends and distributions paid on or with respect to the shares and (B) sell the shares in accordance with the provisions of the Transfer Agreement and receive all proceeds therefrom. However, pursuant to the terms of the Transfer Agreement, Christian L. Oberbeck has retained the right to vote the shares, except that Elizabeth Oberbeck has retained the right to vote the shares on all matters submitted to shareholders with respect to any matter that could give rise to dissenters or other rights of an objecting shareholder under Maryland General Corporation Law. The Transfer Agreement also contains a right of first refusal that requires Elizabeth Oberbeck to offer Christian L. Oberbeck the opportunity to purchase any shares of Common Stock owned by her prior to her intended sale of the shares. Any such purchases may be made either directly by Mr. Oberbeck or through entities affiliated with him.
(4) Based on information included in Amendment No. 4 to Schedule 13G filed by Raging Capital Management, LLC with the SEC on February 14, 2014. The address of Raging Capital Master Fund, Ltd. is Ten Princeton Avenue, Rocky Hill, NJ 08553.
(5) Based on information included in Schedule 13D filed by Thomas V. Inglesby with the SEC on January 6, 2014.

 

115


Table of Contents

Set forth below is the dollar range of equity securities beneficially owned by each of our directors as of        , 2014. We are not part of a “family of investment companies” as that term is defined in the 1940 Act.

 

Name of Director

   Dollar Range of Equity Securities
Beneficially Owned(1)(2)

Interested Directors

  

Christian L. Oberbeck

   Over $1,000,000

Michael J. Grisius

   Over $1,000,000

Independent Directors

  

Steven M. Looney

   $10,001-$50,000

Charles S. Whitman

   $10,001-$50,000

G. Cabell Williams

   $100,001-$500,000

 

(1) The dollar ranges are as follows: None, $1-$10,000, $10,001-$50,000, $50,001-$100,000, $100,001-$500,000, $500,001-$1,000,000 or over $1,000,000.
(2) The dollar range of equity securities beneficially owned in us is based on the closing price for our common stock of $             on November     , 2014 on the New York Stock Exchange. Beneficial ownership has been determined in accordance with Rule 16a-1(a)(2) of the Exchange Act.

 

116


Table of Contents

REGULATION

Business Development Company Regulations

We have elected to be treated as a BDC under the 1940 Act. As with other companies regulated by the 1940 Act, a BDC must adhere to certain substantive regulatory requirements. The 1940 Act contains prohibitions and restrictions relating to transactions between BDCs and their affiliates (including any investment advisers or sub-advisers), principal underwriters and affiliates of those affiliates or underwriters, and requires that a majority of the directors be persons other than “interested persons,” as that term is defined in the 1940 Act. In addition, the 1940 Act provides that we may not change the nature of our business so as to cease to be, or to withdraw our election as, a BDC, unless approved by a majority of our outstanding voting securities. A majority of the outstanding voting securities of a company is defined under the 1940 Act as the lesser of: (i) 67% or more of such company’s stock present at a meeting if more than 50% of the outstanding stock of such company is present and represented by proxy or (ii) more than 50% of the outstanding stock of such company.

Qualifying Assets

Under the 1940 Act, a BDC may not acquire any asset other than assets of the type listed in Section 55(a) of the 1940 Act, which are referred to as qualifying assets, unless, at the time the acquisition is made, qualifying assets represent at least 70% of the company’s total assets. The principal categories of qualifying assets relevant to our business are the following:

 

  (1) Securities purchased in transactions not involving any public offering from the issuer of such securities, which issuer (subject to certain limited exceptions) is an eligible portfolio company, or from any person who is, or has been during the preceding 13 months, an affiliated person of an eligible portfolio company, or from any other person, subject to such rules as may be prescribed by the SEC. An eligible portfolio company is defined in the 1940 Act as any issuer which:

(a) is organized under the laws of, and has its principal place of business in, the United States;

(b) is not an investment company (other than a small business investment company wholly owned by the BDC) or a company that would be an investment company but for certain exclusions under the 1940 Act; and

(c) satisfies either of the following:

(i) does not have any class of securities listed on a national securities exchange;

(ii) has a class of securities listed on a national securities exchange but has an aggregate market value of outstanding voting and non-voting common equity of less than $250 million;

(iii) is controlled by a BDC or a group of companies including a BDC and the BDC has an affiliated person who is a director of the eligible portfolio company;

(iv) is a small and solvent company having total assets of not more than $4 million and capital and surplus of not less than $2 million; or

(v) meets such other criteria as may established by the SEC.

 

  (2) Securities of any eligible portfolio company which we control.

 

  (3) Securities purchased in a private transaction from a U.S. issuer that is not an investment company or from an affiliated person of the issuer, or in transactions incident thereto, if the issuer is in bankruptcy and subject to reorganization or if the issuer, immediately prior to the purchase of its securities was unable to meet its obligations as they came due without material assistance other than conventional lending or financing arrangements.

 

  (4) Securities of an eligible portfolio company purchased from any person in a private transaction if there is no ready market for such securities and we already own at least 60% of the outstanding equity of the eligible portfolio company.

 

117


Table of Contents
  (5) Securities received in exchange for or distributed on or with respect to securities described in (1) through (4) above, or pursuant to the exercise of options, warrants or rights relating to such securities.

 

  (6) Cash, cash equivalents, U.S. Government securities or high-quality debt securities maturing in one year or less from the time of investment.

Managerial Assistance to Portfolio Companies

As a BDC we offer, and must provide upon request, managerial assistance to our portfolio companies. This assistance could involve, among other things, monitoring the operations of our portfolio companies, participating in board and management meetings, consulting with and advising officers of portfolio companies and providing other organizational and financial guidance. Pursuant to a separate administration agreement, our investment adviser provides such managerial assistance on our behalf to portfolio companies that request this assistance, recognizing that our involvement with each investment will vary based on factors including the size of the company, the nature of our investment, the company’s overall stage of development and our relative position in the capital structure. We may receive fees for these services.

In addition, a BDC must have been organized and have its principal place of business in the United States and must be operated for the purpose of making investments in the types of securities described in (1), (2) or (3) above under “—Qualifying assets.” BDCs generally must offer to make available to the issuer of the securities significant managerial assistance, except in circumstances where either (i) the BDC controls such issuer of securities or (ii) the BDC purchases such securities in conjunction with one or more other persons acting together and one of the other persons in the group makes available such managerial assistance. Making available significant managerial assistance means, among other things, any arrangement whereby the BDC, through its directors, officers or employees, offers to provide, and, if accepted, does so provide, significant guidance and counsel concerning the management, operations or business objectives and policies of a portfolio company.

Temporary investments

As a BDC, pending investment in other types of “qualifying assets,” as described above, our investments may consist of cash, cash equivalents, U.S. Government securities or high-quality debt securities maturing in one year or less from the time of investment, which we refer to, collectively, as temporary investments, so that 70% of our assets are qualifying assets. Typically, we will invest in U.S. Treasury Bills or in repurchase agreements, provided that such agreements are fully collateralized by cash or securities issued by the U.S. Government or its agencies. A repurchase agreement involves the purchase by an investor, such as us, of a specified security and the simultaneous agreement by the seller to repurchase it at an agreed-upon future date and at a price which is greater than the purchase price by an amount that reflects an agreed-upon interest rate. There is no percentage restriction on the proportion of our assets that may be invested in such repurchase agreements. However, if more than 25% of our total assets constitute repurchase agreements from a single counterparty, we would not meet the asset diversification requirements in order to qualify as a RIC for U.S. federal income tax purposes. Thus, we do not intend to enter into repurchase agreements with a single counterparty in excess of this limit. Our investment adviser will monitor the creditworthiness of the counterparties with which we enter into repurchase agreement transactions.

Indebtedness and senior securities

As a BDC, we are permitted, under specified conditions, to issue multiple classes of indebtedness and one class of shares of stock senior to our common stock if our asset coverage, as defined in the 1940 Act, is at least equal to 200% immediately after each such issuance. In addition, while any indebtedness and senior securities

 

118


Table of Contents

remain outstanding, we must generally make provisions to prohibit any distribution to our stockholders or the repurchase of such securities or stock unless we meet the applicable asset coverage ratios at the time of the distribution or repurchase. We may also borrow amounts up to 5% of the value of our total assets for temporary or emergency purposes without regard to asset coverage.

Common stock

We are generally not able to issue and sell our common stock at a price below net asset value per share. We may, however, sell our common stock, warrants, options or rights to acquire our common stock, at a price below the current net asset value of the common stock if our board of directors determines that such sale is in our best interests and that of our stockholders, and our stockholders approve such sale. In any such case, the price at which our securities are to be issued and sold may not be less than a price which, in the determination of our board of directors, closely approximates the market value of such securities (less any distributing commission or discount). We may also make rights offerings to our stockholders at prices per share less than the net asset value per share, subject to applicable requirements of the 1940 Act.

Code of ethics

As a BDC, we and Saratoga Investment Advisors have each adopted a code of ethics pursuant to Rule 17j-1 under the 1940 Act that establishes procedures for personal investments and restricts certain personal securities transactions. Personnel subject to each code may invest in securities for their personal investment accounts, including securities that may be purchased or held by us, so long as such investments are made in accordance with the code’s requirements.

Proxy voting policies and procedures

SEC registered investment advisers that have the authority to vote (client) proxies (which authority may be implied from a general grant of investment discretion) are required to adopt policies and procedures reasonably designed to ensure that the adviser votes proxies in the best interests of its clients. Registered investment advisers also must maintain certain records on proxy voting. In most cases, we will invest in securities that do not generally entitle us to voting rights in our portfolio companies. When we do have voting rights, we will delegate the exercise of such rights to our investment adviser.

Saratoga Investment Advisors has particular proxy voting policies and procedures in place. In determining how to vote, officers of Saratoga Investment Advisors will consult with each other, taking into account our interests and the interests of our investors, as well as any potential conflicts of interest. Saratoga Investment Advisors will consult with legal counsel to identify potential conflicts of interest. Where a potential conflict of interest exists, Saratoga Investment Advisors may, if it so elects, resolve it by following the recommendation of a disinterested third party, by seeking the direction of our independent directors or, in extreme cases, by abstaining from voting. While Saratoga Investment Advisors may retain an outside service to provide voting recommendations and to assist in analyzing votes, it will not delegate its voting authority to any third party.

An officer of Saratoga Investment Advisors will keep a written record of how all such proxies are voted. It will retain records of (1) proxy voting policies and procedures, (2) all proxy statements received (or it may rely on proxy statements filed on the SEC’s EDGAR system in lieu thereof), (3) all votes cast, (4) investor requests for voting information, and (5) any specific documents prepared or received in connection with a decision on a proxy vote. If it uses an outside service, Saratoga Investment Advisors may rely on such service to maintain copies of proxy statements and records, so long as such service will provide a copy of such documents promptly upon request.

Saratoga Investment Advisors’ proxy voting policies are not exhaustive and are designed to be responsive to the wide range of issues that may be subject to a proxy vote. In general, Saratoga Investment Advisors will vote

 

119


Table of Contents

our proxies in accordance with these guidelines unless: (1) it has determined otherwise due to the specific and unusual facts and circumstances with respect to a particular vote, (2) the subject matter of the vote is not covered by these guidelines, (3) a material conflict of interest is present, or (4) it finds it necessary to vote contrary to its general guidelines to maximize stockholder value or our best interests.

In reviewing proxy issues, Saratoga Investment Advisors generally will use the following guidelines:

Elections of Directors: In general, Saratoga Investment Advisors will vote in favor of the management-proposed slate of directors. If there is a proxy fight for seats on a portfolio company’s board of directors, or Saratoga Investment Advisors determines that there are other compelling reasons for withholding our vote, it will determine the appropriate vote on the matter. It may withhold votes for directors that fail to act on key issues, such as failure to: (1) implement proposals to declassify a board, (2) implement a majority vote requirement, (3) submit a rights plan to a stockholder vote or (4) act on tender offers where a majority of stockholders have tendered their shares. Finally, Saratoga Investment Advisors may withhold votes for directors of non-U.S. issuers where there is insufficient information about the nominees disclosed in the proxy statement.

Appointment of Auditors: We believe that a portfolio company remains in the best position to choose its independent auditors and Saratoga Investment Advisors will generally support management’s recommendation in this regard.

Changes in Capital Structure: Changes in a portfolio company’s organizational documents may be required by state or federal regulation. In general, Saratoga Investment Advisors will cast our votes in accordance with the management on such proposals. However, Saratoga Investment Advisors will consider carefully any proposal regarding a change in corporate structure that is not required by state or federal regulation.

Corporate Restructurings, Mergers and Acquisitions: We believe proxy votes dealing with corporate reorganizations are an extension of the investment decision. Accordingly, Saratoga Investment Advisors will analyze such proposals on a case-by-case basis and vote in accordance with its perception of our interests.

Proposals Affecting Stockholder Rights: We will generally vote in favor of proposals that give stockholders a greater voice in the affairs of a portfolio company and oppose any measure that seeks to limit such rights. However, when analyzing such proposals, Saratoga Investment Advisors will balance the financial impact of the proposal against any impairment of stockholder rights as well as of our investment in the portfolio company.

Corporate Governance: We recognize the importance of good corporate governance. Accordingly, Saratoga Investment Advisors will generally favor proposals that promote transparency and accountability within a portfolio company.

Anti-Takeover Measures: Saratoga Investment Advisors will evaluate, on a case-by-case basis, any proposals regarding anti-takeover measures to determine the likely effect on stockholder value dilution.

Share Splits: Saratoga Investment Advisors will generally vote with management on share split matters.

Limited Liability of Directors: Saratoga Investment Advisors will generally vote with management on matters that could adversely affect the limited liability of directors.

Social and Corporate Responsibility: Saratoga Investment Advisors will review proposals related to social, political and environmental issues to determine whether they may adversely affect stockholder value. It may abstain from voting on such proposals where they do not have a readily determinable financial impact on stockholder value.

 

120


Table of Contents

Privacy principles

We are committed to protecting the privacy of our stockholders. The following explains the privacy policies of Saratoga Investment Corp., Saratoga Investment Advisors and their affiliated companies.

We will safeguard, according to strict standards of security and confidentiality, all information we receive about our stockholders. The only information we collect from stockholders is the holder’s name, address, number of shares and social security number. This information is used only so that we can send annual reports and other information about us to the stockholder, and send the stockholder proxy statements or other information required by law.

We do not share this information with any non-affiliated third party except as described below.

 

    Authorized Employees of Saratoga Investment Advisors. It is our policy that only authorized employees of Saratoga Investment Advisors who need to know a stockholder’s personal information will have access to it.

 

    Service Providers. We may disclose your personal information to companies that provide services on our behalf, such as recordkeeping, processing a stockholder’s trades, and mailing a stockholder information. These companies are required to protect our stockholders’ information and use it solely for the purpose for which they received it.

 

    Courts and Government Officials. If required by law, we may disclose a stockholder’s personal information in accordance with a court order or at the request of government regulators. Only that information required by law, subpoena, or court order will be disclosed.

Compliance with applicable laws

As a BDC, we will be subject to periodic examination by the SEC for compliance with the 1940 Act.

We are required to provide and maintain a bond issued by a reputable fidelity insurance company to protect us against larceny and embezzlement. Furthermore, as a BDC, we are prohibited from protecting any director or officer against any liability to us or our stockholders arising from willful misfeasance, bad faith, gross negligence or reckless disregard of the duties involved in the conduct of such person’s office.

We and Saratoga Investment Advisors are each required to adopt and implement written policies and procedures reasonably designed to prevent violation of the federal securities laws, review these policies and procedures annually for their adequacy and the effectiveness of their implementation, and designate a chief compliance officer to be responsible for administering the policies and procedures.

Co-investment

We may be prohibited under the 1940 Act from knowingly participating in certain transactions with our affiliates without the prior approval of our board of directors who are not interested persons and, in some cases, prior approval by the SEC. Thus, based on current SEC interpretations, co-investment transactions involving a BDC like us and an entity that is advised by Saratoga Investment Advisors or an affiliated adviser generally could not be effected without SEC relief. The staff of the SEC has, however, granted no-action relief to third parties permitting for purchases of a single class of privately-placed securities provided that the adviser negotiates no term other than price and certain other conditions are met. As a result, currently we only expect to co-invest on a concurrent basis with affiliates of Saratoga Investment Advisors when each of us will own the same securities of the issuer and when no term is negotiated other than price. Any such investment would be made, subject to compliance with existing regulatory guidance, applicable regulations and our allocation procedures.

We may in the future submit an exemptive application to the SEC to permit greater flexibility to negotiate the terms of co-investments because we believe that it will be advantageous for us to co-invest with affiliates of

 

121


Table of Contents

Saratoga Investment Advisors where such investment is consistent with the investment objective, investment positions, investment policies, investment strategies, investment restrictions, regulatory requirements and other pertinent factors applicable to us. However, there is no assurance that any application for exemptive relief, if made, would be granted by the SEC.

Small Business Investment Company Regulations

On March 28, 2012, our wholly-owned subsidiary, Saratoga Investment Corp. SBIC, LP, received an SBIC license from the SBA.

The SBIC license allows our SBIC subsidiary to obtain leverage by issuing SBA-guaranteed debentures, subject to the satisfaction of certain customary procedures. SBA-guaranteed debentures are non-recourse, interest only debentures with interest payable semi-annually and have a ten year maturity. The principal amount of SBA-guaranteed debentures is not required to be paid prior to maturity but may be prepaid at any time without penalty. The interest rate of SBA-guaranteed debentures is fixed at the time of issuance at a market-driven spread over U.S. Treasury Notes with 10-year maturities.

SBICs are designed to stimulate the flow of private equity capital to eligible small businesses. Under SBA regulations, SBICs may make loans to eligible small businesses and invest in the equity securities of small businesses. Under present SBA regulations, eligible small businesses include businesses that have a tangible net worth not exceeding $18 million and have average annual fully taxed net income not exceeding $6 million for the two most recent fiscal years. In addition, an SBIC must devote 25% of its investment activity to “smaller” concerns as defined by the SBA. A smaller concern is one that has a tangible net worth not exceeding $6 million and has average annual fully taxed net income not exceeding $2 million for the two most recent fiscal years. SBA regulations also provide alternative size standard criteria to determine eligibility, which depend on the industry in which the business is engaged and are based on such factors as the number of employees and gross sales. According to SBA regulations, SBICs may make long-term loans to small businesses, invest in the equity securities of such businesses and provide them with consulting and advisory services.

SBA regulations currently limit the amount of SBA-guaranteed debentures that an SBIC may issue to $150 million when it has at least $75 million in regulatory capital. Affiliated SBICs are permitted to issue up to a combined maximum amount of $225 million in SBA-guaranteed debentures when they have at least $112.5 million in combined regulatory capital. As of June 4, 2014, our SBIC subsidiary had $32 million in regulatory capital and $64 million of SBA-guaranteed debentures outstanding. The SBA restricts the ability of SBICs to repurchase their capital stock. SBA regulations also include restrictions on a “change of control” or transfer of an SBIC and require that SBICs invest idle funds in accordance with SBA regulations. In addition, our SBIC subsidiary may also be limited in its ability to make distributions to us if it does not have sufficient capital, in accordance with SBA regulations.

Our SBIC subsidiary is subject to regulation and oversight by the SBA, including requirements with respect to maintaining certain minimum financial ratios and other covenants. Receipt of an SBIC license does not assure that our SBIC subsidiary will receive SBA guaranteed debenture funding, which is dependent upon our SBIC subsidiary continuing to be in compliance with SBA regulations and policies. The SBA, as a creditor, will have a superior claim to our SBIC subsidiary’s assets over our stockholders in the event we liquidate our SBIC subsidiary or the SBA exercises its remedies under the SBA-guaranteed debentures issued by our SBIC subsidiary upon an event of default.

 

122


Table of Contents

MATERIAL U.S. FEDERAL INCOME TAX CONSIDERATIONS

The following discussion is a general summary of the material U.S. federal income tax considerations (and, in the case of a non-U.S. holder (as defined below), the material U.S. federal estate tax consequences) applicable to an investment in the Notes. This summary does not purport to be a complete description of the income and estate tax considerations applicable to such an investment. The discussion is based upon the Internal Revenue Code of 1986, as amended (the “Code”), Treasury Regulations, and administrative and judicial interpretations, each as of the date of this prospectus and all of which are subject to change, potentially with retroactive effect. You should consult your own tax advisor with respect to tax considerations that pertain to your purchase, ownership and disposition of our Notes.

This discussion deals only with Notes held as capital assets within the meaning of Section 1221 of the Code and does not purport to deal with persons in special tax situations, such as financial institutions, insurance companies, controlled foreign corporations, passive foreign investment companies and regulated investment companies (and shareholders of such corporations), dealers in securities or currencies, traders in securities, former citizens of the United States, persons holding the Notes as a hedge against currency risks or as a position in a “straddle,” “hedge,” “constructive sale transaction” or “conversion transaction” for tax purposes, entities that are tax-exempt for U.S. federal income tax purposes, retirement plans, individual retirement accounts, tax-deferred accounts, persons subject to the alternative minimum tax, pass-through entities (including partnerships and entities and arrangements classified as partnerships for U.S. federal income tax purposes) and beneficial owners of pass-through entities, or persons whose functional currency is not the U.S. dollar. It also does not deal with beneficial owners of the Notes other than original purchasers of the Notes who acquire the Notes in this offering for a price equal to their original issue price ( i.e., the first price at which a substantial amount of the notes is sold other than to bond houses, brokers, or similar persons or organizations acting in the capacity of underwriters, placement agents or wholesalers). If you are considering purchasing the Notes, you should consult your own tax advisor concerning the application of the U.S. federal tax laws to you in light of your particular situation, as well as any consequences to you of purchasing, owning and disposing of the Notes under the laws of any other taxing jurisdiction.

For purposes of this discussion, the term “U.S. holder” means a beneficial owner of a Note that is, for U.S. federal income tax purposes, (i) an individual citizen or resident of the United States, (ii) a corporation or other entity treated as a corporation for U.S. federal income tax purposes, created or organized in or under the laws of the United States or any State thereof or the District of Columbia, (iii) a trust (a) subject to the control of one or more U.S. persons and the primary supervision of a court in the United States, or (b) that existed on August 20, 1996 and has made a valid election (under applicable Treasury Regulations) to be treated as a domestic trust, or (iv) an estate the income of which is subject to U.S. federal income taxation regardless of its source. The term “non-U.S. holder” means a beneficial owner of a Note that is neither a U.S. holder nor a partnership (including an entity or arrangement treated as a partnership for U.S. federal income tax purposes). An individual may, subject to exceptions, be deemed to be a resident alien, as opposed to a non-resident alien, by, among other ways, being present in the United States (i) on at least 31 days in the calendar year, and (ii) for an aggregate of at least 183 days during a three-year period ending in the current calendar year, counting for such purposes all of the days present in the current year, one-third of the days present in the immediately preceding year, and one-sixth of the days present in the second preceding year. Resident aliens are subject to U.S. federal income tax as if they were U.S. citizens.

If a partnership (including an entity or arrangement treated as a partnership for U.S. federal income tax purposes) holds any Notes, the U.S. federal income tax treatment of a partner of the partnership generally will depend upon the status of the partner, the activities of the partnership and certain determinations made at the partner level. Partners of partnerships holding Notes should consult their own tax advisors.

 

123


Table of Contents

Taxation of Note Holders

Under present law, we are of the opinion that the Notes will constitute indebtedness of us for U.S. federal income tax purposes, which the below discussion assumes. We intend to treat all payments made with respect to the Notes consistent with this characterization.

Taxation of U.S. Holders. Payments or accruals of interest on a Note generally will be taxable to a U.S. holder as ordinary interest income at the time they are received (actually or constructively) or accrued, in accordance with the U.S. holder’s regular method of tax accounting.

Upon the sale, exchange, redemption, retirement or other taxable disposition of a Note, a U.S. holder generally will recognize capital gain or loss equal to the difference between the amount realized on the sale, exchange, redemption, retirement or other taxable disposition (excluding amounts representing accrued and unpaid interest, which are treated as ordinary income to the extent not previously included in income) and the U.S. holder’s adjusted tax basis in the Note. A U.S. holder’s adjusted tax basis in a Note generally will equal the U.S. holder’s initial investment in the Note. Capital gain or loss generally will be long-term capital gain or loss if the Note was held for more than one year. Long-term capital gains recognized by individuals and certain other non-corporate U.S. holders generally are eligible for reduced rates of taxation. The distinction between capital gain or loss and ordinary income or loss is also important in other contexts; for example, for purposes of the limitations on a U.S. holder’s ability to offset capital losses against ordinary income.

Unearned Income Medicare Contribution

After December 31, 2012, a tax of 3.8% will be imposed on certain “net investment income” (or “undistributed net investment income”, in the case of estates and trusts) received by taxpayers other than corporations with adjusted gross income above certain threshold amounts. “Net investment income” as defined for U.S. federal Medicare contribution purposes generally includes interest payments and gain recognized from the sale or other disposition of the Notes. Tax-exempt trusts, which are not subject to income taxes generally, and foreign individuals will not be subject to this tax. U.S. holders should consult their own tax advisors regarding the effect, if any, of this tax on their ownership and disposition of the Notes.

Taxation of Non-U.S. Holders. A non-U.S. holder generally will not be subject to U.S. federal income or withholding taxes on payments of principal or interest on a Note provided that (i) income on the Note is not effectively connected with the conduct by the non-U.S. holder of a trade or business within the United States, (ii) the non-U.S. holder is not a controlled foreign corporation related to the Company through stock ownership, (iii) the non-U.S. holder is not a bank receiving interest described in Section 881(c)(3)(A) of the Code, (iv) the non-U.S. holder does not own (directly or indirectly, actually or constructively) 10% or more of the total combined voting power of all classes of stock of the Company, and (v) the non-U.S. holder has provided a statement in the year in which a payment occurs or in the preceding 3 years, on an Internal Revenue Service (IRS) Form W-8BEN, Form W-8BEN-E, or other applicable form signed under penalties of perjury that includes its name and address and certifies that the non-U.S. holder is the beneficial owner and is not a U.S. person in compliance with applicable requirements, or satisfies documentary evidence requirements for establishing that it is a non-U.S. holder.

A non-U.S. holder that is not exempt from tax under these rules generally will be subject to U.S. federal income tax withholding on payments of interest on the Notes at a rate of 30% unless (i) the income is effectively connected with the conduct of a U.S. trade or business (and, under certain income tax treaties, is attributable to a permanent establishment maintained in the U.S. by the non-U.S. holder), so long as the non-U.S. holder has provided an IRS Form W-8ECI or substantially similar substitute form stating that the interest on the Notes is effectively connected with the non-U.S. holder’s conduct of a trade or business in the U.S. in which case the interest will be subject to U.S. federal income tax on a net income basis as applicable to U.S. holders generally (unless an applicable income tax treaty provides otherwise), or (ii) an applicable income tax treaty provides for a lower rate of, or exemption from, withholding tax.

 

124


Table of Contents

In the case of a non-U.S. holder that is a corporation and that receives income that is effectively connected with the conduct of a U.S. trade or business, such income may also be subject to a branch profits tax (which is generally imposed on a non-U.S. corporation on the actual or deemed repatriation from the United States of earnings and profits attributable to a U.S. trade or business) at a 30% rate. The branch profits tax may not apply (or may apply at a reduced rate) if the non-U.S. holder is a qualified resident of a country with which the United States has an income tax treaty.

To claim the benefit of an income tax treaty or to claim exemption from withholding because income is effectively connected with a U.S. trade or business, the non-U.S. holder must timely provide the appropriate, properly executed IRS forms. The non-U.S. holder must inform the recipient of any changes on these forms within 30 days of such change. These forms may be required to be periodically updated. Also, a non-U.S. holder who is claiming the benefits of a treaty may be required to obtain a United States taxpayer identification number and to provide certain documentary evidence issued by foreign governmental authorities to prove residence in the foreign country.

Generally, a non-U.S. holder will not be subject to U.S. federal income or withholding taxes on any amount that constitutes capital gain upon the sale, exchange, redemption, retirement or other taxable disposition of a Note, provided that (i) the gain is not effectively connected with the conduct of a trade or business in the United States by the non-U.S. holder (or, if required by an applicable income tax treaty, is not attributable to a U.S. “permanent establishment” maintained by the non-U.S. holder) and (ii) that the non-U.S. holder is not an individual who is present in the U.S. for 183 days or more in the taxable year of the sale, exchange, or other taxable disposition and meets certain other conditions (unless such holder is eligible for relief under an applicable income tax treaty). Certain other exceptions may be applicable, and a non-U.S. holder should consult its tax advisor in this regard.

A Note that is held by an individual who, at the time of death, is not a citizen or resident of the United States (as specially defined for U.S. federal estate tax purposes) generally will not be subject to the U.S. federal estate tax, unless, at the time of death, (i) such individual directly or indirectly, actually or constructively, owns ten percent or more of the total combined voting power of all classes of our stock entitled to vote within the meaning of Section 871(h)(3) of the Code and the Treasury Regulations thereunder or (ii) such individual’s interest in the Notes is effectively connected with the individual’s conduct of a U.S. trade or business.

Information Reporting and Backup Withholding. A U.S. holder (other than an “exempt recipient,” including a corporation and certain other persons who, when required, demonstrate their exempt status) may be subject to backup withholding on, and to information reporting requirements with respect to, payments of principal and interest on, and proceeds from the sale, exchange, redemption or retirement of, the Notes. In general, if a non-corporate U.S. holder subject to information reporting fails to furnish a correct taxpayer identification number or otherwise fails to comply with applicable backup withholding requirements, backup withholding at the applicable rate may apply.

The amount of interest we pay to a non-U.S. holder on the Notes will be reported to such non-U.S. Holder and to the IRS annually on an IRS Form 1042-S even if the non-U.S. holder is exempt from the 30% withholding tax described above. Copies of the information returns reporting those payments and the amounts withheld, if any, may also be made available to the tax authorities in the country where the non-U.S. holder is resident under provisions of an applicable income tax treaty or agreement.

In addition, backup withholding tax and certain other information reporting requirements apply to payments of principal and interest on, and proceeds from the sale, exchange, redemption or retirement of, the Notes, unless an exemption applies. Backup withholding and information reporting will not apply to payments we make to a non-U.S. holder if such non-U.S. holder has provided to the applicable withholding agent under penalties of perjury the required certification of their non-U.S. person status as discussed above (and the applicable withholding agent does not have actual knowledge or reason to know that they are a U.S. person) or if the non-U.S. holder is an exempt recipient.

 

125


Table of Contents

If a non-U.S. holder sells or redeems a Note through a U.S. broker or the U.S. office of a foreign broker, the proceeds from such sale or redemption will be subject to information reporting and backup withholding unless such non-U.S. holder provides a withholding certificate or other appropriate documentary evidence establishing that such non-U.S. holder is not a U.S. person to the broker and such broker does not have actual knowledge or reason to know that such non-U.S. holder is a U.S. person, or the non-U.S. holder is an exempt recipient eligible for an exemption from information reporting and backup withholding. If a non-U.S. holder sells or redeems a note through the foreign office of a broker who is a U.S. person or has certain enumerated connections with the U.S., the proceeds from such sale or redemption will be subject to information reporting unless the non-U.S. holder provides to such broker a withholding certificate or other appropriate documentary evidence establishing that the non-U.S. holder is not a U.S. person and such broker does not have actual knowledge or reason to know that such evidence is false, or the non-U.S. holder is an exempt recipient eligible for an exemption from information reporting. In circumstances where information reporting by the foreign office of such a broker is required, backup withholding will be required only if the broker has actual knowledge that the non-U.S. holder is a U.S. person.

You should consult your tax advisor regarding the qualification for an exemption from backup withholding and information reporting and the procedures for obtaining such an exemption, if applicable. Any amounts withheld under the backup withholding rules from a payment to a beneficial owner generally would be allowed as a refund or a credit against such beneficial owner’s U.S. federal income tax provided the required information is timely furnished to the IRS.

Foreign Account Tax Compliance Act

Legislation enacted in 2010 imposes a U.S. federal withholding tax of 30% on payments of interest or gross proceeds from the disposition of a debt instrument paid after December 31, 2012 to certain non-U.S. entities, including certain foreign financial institutions and investment funds, unless such non-U.S. entity complies with certain reporting requirements regarding its U.S. account holders and its U.S. owners. Pursuant to Treasury Regulations and other Treasury guidance, these rules generally are not effective for payments of gross proceeds, until January 1, 2017. In addition, Treasury Regulations state that even after the effective dates the new withholding obligations will not apply to payments on, or with respect to, to obligations that are outstanding on July 1, 2014. Prospective purchasers of the Notes should consult their own tax advisors regarding the new withholding and reporting provisions.

You should consult your own tax advisor with respect to the particular tax consequences to you of an investment in the Notes, including the possible effect of any pending legislation or proposed regulations.

Our Taxation as a Regulated Investment Company

As a regulated investment company (“RIC”), we generally will not have to pay corporate-level federal income taxes on any net ordinary income or realized capital gains that we distribute to our stockholders as dividends. To qualify as a RIC, we must, among other things, meet certain source-of-income and asset diversification requirements (as described below). In addition, in order to maintain our qualification as a RIC, we must distribute to our stockholders, for each taxable year, at least 90% of our “investment company taxable income,” which is generally our net ordinary income plus the excess of realized net short-term capital gains over realized net long-term capital losses (the “Annual Distribution Requirement”).

Taxation as a Regulated Investment Company

If we:

 

    Qualify as a RIC; and

 

    Satisfy the Annual Distribution Requirement

 

126


Table of Contents

then we will not be subject to U.S. federal income tax on the portion of our income we distribute (or are deemed to distribute) to stockholders. We will be subject to U.S. federal income tax at the regular corporate rates on any income or capital gains not distributed (or deemed distributed) to our stockholders.

We will be subject to a 4% nondeductible U.S. federal excise tax on certain undistributed income unless we distribute in a timely manner an amount at least equal to the sum of (1) 98% of our net ordinary income for each calendar year, (2) 98.2% of our capital gain net income for the one-year period ending October 31 in that calendar year and (3) any income recognized, but not distributed, in preceding years (the “Excise Tax Avoidance Requirement”). We generally will endeavor in each taxable year to make sufficient distributions to our stockholders to avoid the 4% excise tax on our income. However, depending on the level of taxable income earned in a tax year, we may choose to carry forward taxable income in excess of current year distributions into the next tax year and pay the 4% excise tax on such income. Any such carryover taxable income must be distributed through a dividend declared prior to filing the final tax return related to the year which generated such taxable income. We may, in the future, make actual distributions to our stockholders of our net capital gains.

In order to qualify as a RIC for U.S. federal income tax purposes, we must, among other things:

 

    continue to qualify as a business development company under the 1940 Act at all times during each taxable year;

 

    derive in each taxable year at least 90% of our gross income from dividends, interest, payments with respect to loans of certain securities, gains from the sale of stock or other securities, net income from certain “qualified publicly traded partnerships,” or other income derived with respect to our business of investing in such stock or securities (the “90% Income Test”); and

 

    diversify our holdings so that at the end of each quarter of the taxable year:

 

    at least 50% of the value of our assets consists of cash, cash equivalents, U.S. Government securities, securities of other RICs, and other securities if such other securities of any one issuer do not represent more than 5% of the value of our assets or more than 10% of the outstanding voting securities of the issuer; and

 

    no more than 25% of the value of our assets is invested in the securities, other than U.S. government securities or securities of other RICs, of one issuer, of two or more issuers that are controlled, as determined under applicable Code rules, by us and that are engaged in the same or similar or related trades or businesses or of certain “qualified publicly traded partnerships” (the “Diversification Tests”).

We may be required to recognize taxable income in circumstances in which we do not receive cash. For example, if we hold debt obligations that are treated under applicable tax rules as having original issue discount (such as debt instruments with PIK interest or, in certain cases, increasing interest rates or issued with warrants), we must include in income each year a portion of the original issue discount that accrues over the life of the obligation, regardless of whether cash representing such income is received by us in the same taxable year. We may also have to include in income other amounts that we have not yet received in cash, such as PIK interest and deferred loan origination fees that are paid after origination of the loan or are paid in non-cash compensation such as warrants or stock. Because any original issue discount or other amounts accrued will be included in our net ordinary income for the year of accrual, we may be required to make a distribution to our stockholders in order to satisfy the Annual Distribution Requirement, even though we will not have received any corresponding cash amount. If the IRS should adopt a position that a distribution of 20% cash and the balance in stock is not a distribution satisfying the Annual Distribution Requirement, we may find it more difficult to meet such requirement.

Although we do not presently expect to do so, we are authorized to borrow funds, to sell assets and to make taxable distributions of our stock and debt securities in order to satisfy distribution requirements. Our ability to dispose of assets to meet our distribution requirements may be limited by (1) the illiquid nature of our portfolio

 

127


Table of Contents

and/or (2) other requirements relating to our status as a RIC, including the Diversification Tests. If we dispose of assets in order to meet the Annual Distribution Requirement or the Excise Tax Avoidance Requirement, we may make such dispositions at times that, from an investment standpoint, are not advantageous. If we are unable to obtain cash from other sources to satisfy the Annual Distribution Requirement, we may fail to qualify as a RIC and become subject to tax as an ordinary corporation.

Under the 1940 Act, we are not permitted to make distributions to our stockholders while our debt obligations and other senior securities are outstanding unless certain “asset coverage” tests are met. If we are prohibited to make distributions, we may fail to qualify as a RIC and become subject to tax as an ordinary corporation.

Certain of our investment practices may be subject to special and complex U.S. federal income tax provisions that may, among other things: (i) disallow, suspend or otherwise limit the allowance of certain losses or deductions; (ii) convert lower taxed long-term capital gain into higher taxed short-term capital gain or ordinary income; (iii) convert an ordinary loss or a deduction into a capital loss (the deductibility of which is more limited); (iv) cause us to recognize income or gain without a corresponding receipt of cash; (v) adversely affect the time as to when a purchase or sale of securities is deemed to occur; (vi) adversely alter the characterization of certain complex financial transactions; and (vii) produce income that will not be qualifying income for purposes of the 90% Income Test described above. We will monitor our transactions and may make certain tax decisions in order to mitigate the potential adverse effect of these provisions.

If we fail to satisfy the Annual Distribution Requirement or otherwise fail to qualify as a RIC in any taxable year, we will be subject to U.S. federal income tax in that year on all of our taxable income, regardless of whether we make any distributions to our stockholders. If we fail to maintain RIC tax treatment for any reason and are subject to corporate-level federal income tax, the resulting corporate-level federal income tax could substantially reduce our net assets and the amount of income available to make interest and principal payments on the Notes. In contrast, assuming we qualify as a RIC, our corporate-level federal income tax should be substantially reduced or eliminated.

DETERMINATION OF NET ASSET VALUE

The NAV per share of our outstanding shares of common stock is determined quarterly by dividing the value of total assets minus liabilities by the total number of shares of common stock outstanding at the date as of which the determination is made.

We carry our investments at fair value, as approved in good faith using written policies and procedures adopted by our board of directors. In calculating the value of our total assets, investments for which market quotations are readily available are recorded in our financial statements at such market quotations subject to any decision by our board of directors to approve a fair value determination to reflect significant events affecting the value of these investments. We value investments for which market quotations are not readily available at fair value as approved in good faith by our board of directors based on input from Saratoga Investment Advisors, our audit committee and, on a selected basis, a third party independent valuation firm. Determinations of fair value may involve subjective judgments and estimates. The types of factors that may be considered in determining the fair value of our investments include the nature and realizable value of any collateral, the portfolio company’s ability to make payments, the markets in which the portfolio company does business, market yield trend analysis, comparison to publicly traded companies, discounted cash flow and other relevant factors.

Our investment in the subordinated notes of Saratoga CLO is carried at fair value, which is based on a discounted cash flow model that utilizes prepayment, re-investment and loss assumptions based on historical experience and projected performance, economic factors, the characteristics of the underlying cash flow, and comparable yields for similar collateralized loan obligation fund subordinated notes or equity, when available. Specifically, we use Intex cash flow models, or an appropriate substitute, to form the basis for Saratoga CLO’s

 

128


Table of Contents

valuation. The models use a set of assumptions including projected default rates, recovery rates, reinvestment rate and prepayment rates in order to arrive at estimated cash flows. The assumptions are based on available market data and projections provided by third parties as well as management estimates. We use the output from the Intex models (i.e., the estimated cash flows from our investment in Saratoga CLO) to perform a discounted cash flows analysis on expected future cash flows from our investment in Saratoga CLO to determine a valuation for the subordinated notes of Saratoga CLO held by us.

We undertake a multi-step valuation process each quarter when valuing investments for which market quotations are not readily available, as described below:

 

    each investment is initially valued by the responsible investment professionals of Saratoga Investment Advisors and preliminary valuation conclusions are documented and discussed with our senior management; and

 

    an independent valuation firm engaged by our board of directors independently values at least one quarter of our investments each quarter so that the valuation of each investment for which market quotes are not readily available is independently valued by an independent valuation firm at least annually.

In addition, all our investments are subject to the following valuation process:

 

    the audit committee of our board of directors reviews each preliminary valuation and our investment adviser and independent valuation firm (if applicable) will supplement the preliminary valuation to reflect any comments provided by the audit committee; and

 

    our board of directors discusses the valuations and approves the fair value of each investment in good faith based on the input of our investment adviser, independent valuation firm (if applicable) and audit committee.

Because such valuations, and particularly valuations of private investments and private companies, are inherently uncertain, they may fluctuate over short periods of time and may be based on estimates.

The determination of fair value may differ materially from the values that would have been used if a ready market for these investments existed. Our net asset value could be materially affected if the determinations regarding the fair value of our investments were materially higher or lower than the values that we ultimately realize upon the disposal of such investments.

In September 2006, the Financial Accounting Standards Board, (the “FASB”), issued Statement of Financial Accounting Standards No. 157, “Fair Value Measurements” (“FAS 157”). In conjunction with Accounting Standards Codification (“ASC”) 105 issued by the FASB in June 2009, FAS 157 has been codified in ASC 820, “Fair Value Measurement and Disclosures” (“ASC 820”). ASC 820 defines fair value, establishes a framework for measuring fair value in accordance with Generally Accepted Accounting Principles in the United Sates, or GAAP, and expands disclosures about fair value measurements.

ASC 820 classifies the inputs used to measure these fair values into the following hierarchy:

Level 1 : Quoted prices in active markets for identical assets or liabilities, accessible by the Company at the measurement date.

Level 2 : Quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in markets that are not active, or other observable inputs other than quoted prices.

Level 3 : Unobservable inputs for the asset or liability.

 

129


Table of Contents

In all cases, the level in the fair value hierarchy within which the fair value measurement in its entirety falls will be determined based on the lowest level of input that is significant to the fair value measurement. Our assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to each investment.

The changes to generally accepted accounting principles from the application of ASC 820 relate to the definition of fair value, framework for measuring fair value and the expanded disclosures about fair value measurements. ASC 820 applies to fair value measurements already required or permitted by other standards. In accordance with ASC 820, the fair value of our investments is defined as the price that we would receive upon selling an investment in an orderly transaction to an independent buyer in the principal or most advantageous market in which that investment is transacted.

Ongoing relationships with and monitoring of portfolio companies

Saratoga Investment Advisors closely monitors each investment we make and, when appropriate, conducts a regular dialogue with both the management team and other debtholders and seeks specifically tailored financial reporting. In addition, in certain circumstances, senior investment professionals of Saratoga Investment Advisors may take board seats or board observation seats.

Determinations in Connection with Offerings

In connection with any offering of shares of our common stock, our board of directors or one of its committees will be required to make the determination that we are not selling shares of our common stock at a price below the then current NAV of our common stock or, if our shareholders have granted us the authority to sell shares of our common stock at a price below the then current NAV per share, at a level consistent with such explicit authority, at the time at which the sale is made. Our board of directors or the applicable committee will consider the following factors, among others, in making such determination:

 

    the NAV of our common stock most recently disclosed by us in the most recent periodic report that we filed with the SEC;

 

    our management’s assessment of whether any material change in the NAV of our common stock has occurred (including through the realization of gains on the sale of our portfolio securities) during the period beginning on the date of the most recently disclosed NAV of our common stock in our most recent periodic report that we filed with the SEC and ending two days prior to the date of the sale of our common stock; and

 

    the magnitude of the difference between the NAV of our common stock most recently disclosed by us in our most recent periodic report that we filed with the SEC and our management’s assessment of any material change in the NAV of our common stock since that determination, and the offering price of the shares of our common stock in the proposed offering.

The processes and procedures set forth above are part of our compliance policies and procedures. In addition, we will make a record of any such determinations made and such documentation will be maintained in a manner consistent with the Company’s other 1940 Act related materials.

 

130


Table of Contents

SALES OF COMMON STOCK BELOW NET ASSET VALUE

At our 2014 Annual Meeting of Stockholders, we received approval from our stockholders to authorize us to sell or otherwise issue the Company’s common stock at an offering price per share to investors that is not less than 85% of the Company’s then current net asset value per share. This authorization is effective for a period of approximately one year, ending on the earlier of our next annual meeting of shareholders or September 30, 2015 and does not limit the number of offerings or the aggregate dollar amount of shares of common stock sold in offerings that we may undertake pursuant to this authority.

In order to sell shares of common stock pursuant to this authorization, no further authorization from our stockholders will need to be solicited, but a majority of our directors who have no financial interest in the sale and a majority of our independent directors will have to (a) find that the sale is in our best interests and in the best interests of our stockholders and (b) in consultation with any underwriter or underwriters of the offering, make a good faith determination as of a time either immediately prior to the first solicitation by us or on our behalf of firm commitments to purchase such shares of common stock, or immediately prior to the issuance of such common stock, that the price at which such shares of common stock are to be sold is not less than a price which closely approximates the market value of those shares of common stock, less any distributing commission or discount.

Any offering of common stock below its net asset value per share will be designed to raise capital for investment in accordance with our investment objective. In making a determination that an offering of common stock below its net asset value per share is in our and our stockholders’ best interests, our board of directors will consider a variety of factors including:

 

    the effect that an offering below net asset value per share would have on our stockholders, including the potential dilution to the net asset value per share of our common stock our stockholders would experience as a result of the offering;

 

    the amount per share by which the offering price per share and the net proceeds per share are less than our most recently determined net asset value per share;

 

    the relationship of recent market prices of par common stock to net asset value per share and the potential impact of the offering on the market price per share of our common stock;

 

    whether the estimated offering price would closely approximate the market value of shares of our common stock;

 

    the potential market impact of being able to raise capital during the current financial market difficulties;

 

    the nature of any new investors anticipated to acquire shares of our common stock in the offering;

 

    the anticipated rate of return on and quality, type and availability of investments; and

 

    the leverage available to us.

Our board of directors will also consider the fact that sales of shares of common stock at a discount will benefit our investment adviser as the investment adviser will earn additional investment management fees on the proceeds of such offerings, as it would from the offering of any other of our securities or from the offering of common stock at a premium to net asset value per share.

Pursuant to the stockholder proposal, we will not sell shares of our common stock under this prospectus and any accompanying prospectus supplement unless the offering price per share is equal to 85% of our then current NAV per share.

Sales by us of our common stock at a discount from net asset value per share pose potential risks for our existing stockholders whether or not they participate in the offering, as well as for new investors who participate

 

131


Table of Contents

in the offering. Any sale of common stock at a price below net asset value per share would result in an immediate dilution to existing common stockholders who do not participate in such sale on at least a pro-rata basis. See “Risk Factors—Risks Relating to Our Common Stock—Stockholders may incur dilution if we sell shares of our common stock in one or more offerings at prices below the then current net asset value per share of our common stock.”

The following three headings and accompanying tables explain and provide hypothetical examples on the impact of an offering of our common stock at a price less than net asset value per share on three different types of investors:

 

    existing stockholders who do not purchase any shares in the offering;

 

    existing stockholders who purchase a relatively small amount of shares in the offering or a relatively large amount of shares in the offering; and

 

    new investors who become stockholders by purchasing shares in the offering.

Impact On Existing Stockholders Who Do Not Participate in the Offering

Our current stockholders who do not participate in an offering below net asset value per share or who do not buy additional shares in the secondary market at the same or lower price as we obtain in the offering (after expenses and commissions) face the greatest potential risks. These stockholders will experience an immediate dilution in the net asset value of the shares of common stock they hold and their net asset value per share. These stockholders will also experience a disproportionately greater decrease in their participation in our earnings and assets and in their voting power than the increase we will experience in our assets, potential earning power and voting interests due to such offering. These stockholders may also experience a decline in the market price of their shares, which often reflects to some degree announced or potential increases and decreases in net asset value per share. This decrease could be more pronounced as the size of the offering and level of discounts increases. Further, if current stockholders do not purchase any shares to maintain their percentage interest, regardless of whether such offering is above or below the then current net asset value, their voting power will be diluted.

The following table illustrates the level of NAV dilution that would be experienced by a nonparticipating stockholder in three different hypothetical offerings of different sizes and levels of discount from NAV per share, all within the ranges provided in the Stockholder Proposal, although it is not possible to predict the level of market price decline that may occur. Actual sales prices and discounts may differ from the presentation below.

The examples assume that Company XYZ has 5,000,000 shares of common stock outstanding, $240,000,000 in total assets and $125,000,000 in total liabilities. The current NAV and NAV per share are thus $115,000,000 and $23.00. The table illustrates the dilutive effect on nonparticipating Stockholder A of (1) the issuance of 500,000 shares (10% of the outstanding shares) at an offering price of $20.70 per share to investors (a 10% discount from NAV); (2) the issuance of 1,000,000 shares (20% of the outstanding shares) at an offering price of $19.55 per share to investors (a 15% discount from NAV); (3) the issuance of 2,000,000 shares (40% of the outstanding shares) at an offering price of $19.55 per share to investors (a 15% discount from NAV); and (4) the issuance of 5,000,000 (100% of the outstanding shares) at an offering price of $19.55 per share to investors (a 15% discount from NAV).

 

132


Table of Contents
          Example 1
10% Offering
at 10% Discount
    Example 2
20% Offering
at 15% Discount
    Example 3
40% Offering
at 15% Discount
    Example 4
100% Offering
at 15% Discount
 
    Prior to
Sale Below
NAV
    Following
Sale
    % Change     Following
Sale
    % Change     Following
Sale
    % Change     Following
Sale
    % Change  

Offering Price

                 

Price per Share to Public

    —        $ 20.70        —          19.55        —        $ 19.55        —        $ 19.55        —     

Net Proceeds per Share to Issuer(1)

    —        $ 19.25        —          18.18        —        $ 18.18        —        $ 18.18        —     

Decrease to NAV

                 

Total Shares Outstanding

    5,000,000        5,500,000        10.00     6,000,000        20.00     7,000,000        40.00     10,000,000        100

NAV per Share

    23.00      $ 22.66        (1.48 )%    $ 22.19        (3.49 )%    $ 21.62        (5.99 )%    $ 20.59        (10.48 )% 

Dilution to Stockholder

                 

Shares Held by Stockholder A

    10,000        10,000        —          10,000        —          10,000        —          10,000        —     

Percentage Held by Stockholder A

    0.20     0.18     (9.09 )%      0.17     (16.67 )%      0.14     (28.57 )%      0.1     (50.00 )% 

Total Asset Values

                 

Total NAV Held by Stockholder A

  $ 230,000      $ 226,591        (1.48 )%      221,967        (3.49 )%    $ 216,229        (5.99 )%    $ 205,900        (10.48 )% 

Total Investment by Stockholder A (Assumed to be $23.00 per Share)

  $ —        $ 230,000        —        $ 230,000        —        $ 230,000        —        $ 230,000        —     

Total Dilution to Stockholder A (Total NAV Less Total Investment)

    —        $ (2,409     —          (8,033     —          (13,771     —        $ (24,100     —     

Per Share Amounts

                 

NAV per Share Held by Stockholder A

    —        $ 22.65        —          22.20        —        $ 21.62        —        $ 20.59        —     

Investment per Share Held by Stockholder A (Assumed to be $23.00 per Share on Shares Held Prior to Sale)

  $ —        $ 23.00        —          23.00        —        $ 23.00        —        $ 23.00        —     

Dilution per Share Held by Stockholder A (NAV per Share Less Investment per Share)

    —        $ (0.35     —        $ (0.80     —        $ (1.38     —        $ (2.41     —     

Percentage Dilution to Stockholder A (Dilution per Share Divided by Investment per Share)

    —          —          (1.5 )%      —          (3.5 )%      —          (6.0 )%      —          (10.50 )% 

 

(1) Assume 7% issuance discount.

 

133


Table of Contents

Impact on Existing Stockholders Who Do Participate in the Offering

Our existing stockholders who participate in an offering below net asset value per share or who buy additional shares in the secondary market at the same or lower price as we obtain in the offering (after expenses and commissions) will experience the same types of net asset value dilution as the nonparticipating stockholders, albeit at a lower level, to the extent they purchase less than the same percentage of the discounted offering as their interest in our shares immediately prior to the offering. The level of net asset value dilution to such stockholders will decrease as the number of shares such stockholders purchase increases. Existing stockholders who buy more than their proportionate percentage will experience net asset value dilution but will, in contrast to existing stockholders who purchase less than their proportionate share of the offering, experience an increase (often called accretion) in net asset value per share over their investment per share and will also experience a disproportionately greater increase in their participation in our earnings and assets and their voting power than our increase in assets, potential earning power and voting interests due to the offering. The level of accretion will increase as the excess number of shares purchased by such stockholder increases. Even a stockholder who over-participates will, however, be subject to the risk that we may make additional discounted offerings in which such stockholder does not participate, in which case such a stockholder will experience net asset value dilution as described above in any subsequent offerings. These stockholders may also experience a decline in the market price of their shares, which often reflects to some degree announced or potential decreases in net asset value per share. This decrease could be more pronounced as the size of the offering and the level of discount to net asset value increases.

The following chart illustrates the level of dilution and accretion in the hypothetical 20% offering at a 15% discount from the prior chart (Example 3) for a stockholder that acquires shares equal to (1) 50% of its proportionate share of the offering (i.e., 1,000) shares, which is 0.1% of an offering of 1,000,000 shares rather than its 0.2% proportionate share) and (2) 150% of such percentage (i.e., 33,000 shares, which is 0.3% of an offering of 1,000,000 shares rather than its 0.2% proportionate share). The prospectus supplement pursuant to which any discounted offering is made will include a chart for this example based on the actual number of shares in such offering and the actual discount from the most recently determined NAV per share.

 

           50% Participation     150% Participation  
     Prior to
Sale Below
NAV
    Following
Sale
    % Change     Following
Sale
    % Change  

Offering Price

          

Price per Share to Public

     —        $ 19.55        —     $ 19.55        —  

Net Proceeds per Share to Issuer(1)

     —        $ 18.18        —     $ 18.18        —  

Increase in Shares and Decrease to NAV

          

Total Shares Outstanding

     5,000,000        6,000,000        20     6,000,000        20

NAV per share

   $ 23.00      $ 22.19        (3.49 )%    $ 22.19        (3.49 )% 

Dilution/Accretion to Participating Stockholder A

          

Share Dilution/Accretion

          

Shares Held by Stockholder A

     10,000        11,000        10     13,000        30

Percentage Outstanding Held by Stockholder A

     0.2     0.18     (8.33 )%      0.21     8.33

NAV Dilution/Accretion

          

Total NAV Held by Stockholder A

   $ 230,000      $ 244,090        6.13   $ 288,470        25.42

Total Investment by Stockholder A (Assumed to be $23.00 per Share on Shares Held Prior to Sale)

     —        $ 248,180        —        $ 284,540        —     

Total Dilution/Accretion to Stockholder A (Total NAV Less Total Investment)

   $ —        $ (4,090     (1.68 )%    $ 3,930        1.36

NAV Dilution/Accretion per Share

          

NAV per Share Held by Stockholder A

   $ —        $ 22.19        (3.49 )%    $ 22.19        (3.49 )% 

Investment per Share Held by Stockholder A (Assumed to be $23.00 per Share on Shares Held Prior to Sale)

   $ —        $ 22.56        —     $ 21.89        —  

NAV Dilution/Accretion per Share Experienced by Stockholder A (NAV per Share Less Investment per Share)

     —        $ (0.37     —     $ (0.30     —  

Percentage NAV Dilution/Accretion Experienced by Stockholder A (NAV Dilution/Accretion per Share Divided by Investment per Share)

     —          —          (1.64 )%      —          1.37

 

(1) Assume 7% issuance discount.

 

134


Table of Contents

Impact on New Investors

Investors who are not currently stockholders, but who participate in an offering below NAV and whose investment per share is greater than the resulting NAV per share due to selling compensation and expenses paid by us will experience an immediate decrease, albeit small, in the NAV of their shares and their NAV per share compared to the price they pay for their shares (Example 1 below). On the other hand, investors who are not currently stockholders, but who participate in an offering below NAV per share and whose investment per share is also less than the resulting NAV per share will experience an immediate increase in the NAV of their shares and their NAV per share compared to the price they pay for their shares (Examples 2 and 3 below). These latter investors will experience a disproportionately greater participation in our earnings and assets and their voting power than our increase in assets, potential earning power and voting interests. These investors will, however, be subject to the risk that we may make additional discounted offerings in which such new stockholder does not participate, in which case such new stockholder will experience dilution as described above in any subsequent offerings. These investors may also experience a decline in the market price of their shares, which often reflects to some degree announced or potential decreases in NAV per share. This decrease could be more pronounced as the size of the offering and level of discount to NAV increases.

The following chart illustrates the level of dilution or accretion for new investors that would be experienced by a new investor in the same hypothetical discounted offerings as described in the first chart above. The illustration is for a new investor who purchases the same percentage (0.20%) of the shares in the offering as Stockholder A in the prior examples held immediately prior to the offering. The prospectus supplement pursuant to which any discounted offering is made will include a chart for these examples based on the actual number of shares in such offering and the actual discount from the most recently determined NAV per share.

 

    Prior to
Sale Below
NAV
    Example 1
10% Offering
at 10% Discount
    Example 2
20% Offering
at 15% Discount
    Example 3
40% Offering
at 15% Discount
    Example 4
100% Offering
at 15% Discount
 
      Following
Sale
    % Change     Following
Sale
    % Change     Following
Sale
    % Change     Following
Sale
    % Change  

Offering Price

                 

Price per Share to Public

    —        $ 20.70        —        $ 19.55        —     $ 19.55        —     $ 19.55        —  

Net Proceeds per Share to Issuer

    —        $ 19.25        —        $ 18.18        —     $ 18.18        —     $ 18.18        —  

Increase in Shares and Decrease to NAV

                 

Total Shares Outstanding

    5,000,000        5,500,000        10     6,000,000        20     7,000,000        40     10,000,000        100

NAV per Share

  $ 23.00      $ 22.66        (1.48 )%    $ 22.19        (3.49 )%    $ 21.62        (5.99 )%    $ 20.59        (10.48 )% 

Dilution/Accretion to New Investor A

                 

Share Dilution

                 

Shares held by Investor A

    —          1,000        —       2,000        —       4,000        —       10,000        —  

Percentage Outstanding Held by Investor A

    —       0.02     —       0.03     —       0.06        —       0.10        —  

NAV Dilution

                 

Total NAV Held by Investor A

    —        $ 22,660        —     $ 44,380        —     $ 86,480        —     $ 205,900        —  

Total Investment by Investor A (At Price to Public)

    —        $ 19,250        —     $ 36,360        —     $ 72,720        —     $ 181,800        —  

Total Dilution/Accretion to Investor A (Total NAV Less Total Investment)

    —        $ 3,410        17.71   $ 8,020        22.06   $ 13,760        18.92   $ 24,100        13.26

 

135


Table of Contents
    Prior to
Sale Below
NAV
    Example 1
10% Offering
at 10% Discount
    Example 2
20% Offering
at 15% Discount
    Example 3
40% Offering
at 15% Discount
    Example 4
100% Offering
at 15% Discount
 
      Following
Sale
    % Change     Following
Sale
    % Change     Following
Sale
    % Change     Following
Sale
    % Change  

NAV Dilution per Share

                 

NAV per Share Held by Investor A

    —        $ 22.66        —     $ 22.19        —     $ 21.62        —     $ 20.59        —  

Investment per Share Held by Investor A

    —        $ 19.25        —     $ 18.18        —     $ 18.18        —     $ 18.18        —  

NAV Dilution/Accretion per Share Experienced by Investor A (NAV per Share Less Investment per Share)

    —        $ 3.41        —     $ 4.01        —     $ 3.44        —     $ 2.41        —  

Percentage NAV Dilution/Accretion Experienced by Investor A (NAV Dilution/ Accretion per Share Divided by Investment per Share)

    —          —          17.71     —          22.06     —          18.92     —          13.26

 

136


Table of Contents

DESCRIPTION OF OUR CAPITAL STOCK

The following description is based on relevant portions of the Maryland General Corporation Law and our charter and bylaws, which we collectively refer to as our “governing documents.”

As of the date of this prospectus, our authorized stock consists of 100,000,000 shares of capital stock, $0.001 par value per share, all of which are designated as shares of common stock. Our common stock trades under the symbol “SAR” on the New York Stock Exchange. There are no outstanding options or warrants to purchase our common stock. No shares of common stock have been authorized for issuance under any equity compensation plans. Under Maryland law, our stockholders generally are not personally liable for our debts or obligations.

Under our governing documents, our board of directors is authorized to create new classes or series of shares of stock and to authorize the issuance of shares of stock without obtaining stockholder approval. Our charter provides that the board of directors, without any action by our stockholders, may amend the charter from time to time to increase or decrease the aggregate number of shares of stock or the number of shares of stock of any class or series that we have authority to issue.

Common Stock

Each share of our common stock has equal rights as to earnings, assets, dividends and voting and all of our outstanding shares of common stock are duly authorized, validly issued, fully paid and nonassessable. Distributions may be paid to the holders of our common stock if, as and when authorized by our board of directors and declared by us out of funds legally available therefor. Shares of our common stock have no preemptive, exchange, conversion or redemption rights.

In the event of our liquidation, dissolution or winding up, each share of common stock would be entitled to share ratably in all of our assets that are legally available for distribution after we pay all debts and other liabilities and subject to any preferential rights of holders of shares of our preferred stock, if any are outstanding at such time. Each share of our common stock entitles its holder to cast one vote on all matters submitted to a vote of stockholders, including the election and removal of directors.

The following table sets forth information regarding our authorized shares of stock under our charter and shares of stock outstanding as of the date of this prospectus.

 

Title of Class

   Shares Authorized      Amount Held by Us
or for Our Account
     Amount Outstanding
Exclusive of Amount Held
by Us or for Our Account
 

Common Stock

     100,000,000         —           5,379,616   

Preferred Stock

Our governing documents authorize our board of directors to classify and reclassify any unissued shares of stock into other classes or series of stock, including preferred stock. Prior to the issuance of shares of stock of each class or series, the board of directors is required by our governing documents to set the terms, preferences, conversion or other rights, voting powers, restrictions, limitations as to dividends or other distributions, qualifications and terms or conditions of redemption for each class or series of shares of stock. Thus, the board of directors could authorize the issuance of preferred stock with terms and conditions that could have the effect of delaying, deferring or preventing a transaction or a change in control that might involve a premium price for holders of our common stock or otherwise be in their best interest. In addition, as a business development company, any issuance of preferred stock must comply with the requirements of the 1940 Act. The 1940 Act requires, among other things, that (1) immediately after issuance and before any dividend or other distribution is made with respect to our common stock and before any purchase of common stock is made, the aggregate

 

137


Table of Contents

dividend or distribution on, or purchase price of, such shares of preferred stock together with all other indebtedness and senior securities must not exceed an amount equal to 50% of our total assets after deducting the amount of such dividend, distribution or purchase price, as the case may be, and (2) the holders of preferred stock, if any are issued, must be entitled as a class to elect two directors at all times and to elect a majority of the directors if dividends on such preferred stock is in arrears by two years or more. Certain matters under the 1940 Act require the separate vote of the holders of any issued and outstanding shares of preferred stock. We believe that the availability for issuance of preferred stock will provide us with increased flexibility in structuring future financings and acquisitions.

Limitation on Liability of Directors and Officers; Indemnification and Advance of Expenses

The Maryland General Corporation Law permits a Maryland corporation to include in its charter a provision limiting the liability of its directors and officers to the corporation and its stockholders for money damages except for liability resulting from (a) actual receipt of an improper benefit or profit in money, property or services or (b) active and deliberate dishonesty established by a final judgment as being material to the cause of action. Our governing documents contain a provision which eliminates directors’ and officers’ liability to the maximum extent permitted by the Maryland General Corporation Law, subject to the requirements of the 1940 Act.

Maryland law requires a corporation (unless its charter provides otherwise, which, our charter does not) to indemnify a director or officer who has been successful, on the merits or otherwise, in the defense of any proceeding to which he or she is made or threatened to be made a party by reason of his or her service in that capacity. Maryland law permits a corporation to indemnify its present and former directors and officers, among others, against judgments, penalties, fines, settlements and reasonable expenses actually incurred by them in connection with any proceeding to which they may be made or are threatened to be made a party by reason of their service in those or other capacities unless it is established that (a) the act or omission of the director or officer was material to the matter giving rise to the proceeding and (1) was committed in bad faith or (2) was the result of active and deliberate dishonesty, (b) the director or officer actually received an improper personal benefit in money, property or services or (c) in the case of any criminal proceeding, the director or officer had reasonable cause to believe that the act or omission was unlawful. However, under Maryland law, a Maryland corporation may not indemnify for an adverse judgment in a suit by or in the right of the corporation or for a judgment of liability on the basis that a personal benefit was improperly received unless, in either case, a court orders indemnification, and then only for expenses. In addition, Maryland law permits a corporation to advance reasonable expenses to a director or officer upon the corporation’s receipt of (a) a written affirmation by the director or officer of his or her good faith belief that he or she has met the standard of conduct necessary for indemnification by the corporation and (b) a written undertaking by him or her or on his or her behalf to repay the amount paid or reimbursed by the corporation if it is ultimately determined that the standard of conduct was not met.

Our charter authorizes us to obligate ourselves, and our bylaws do obligate us, to the maximum extent permitted by Maryland law and subject to any applicable requirements of the 1940 Act, to indemnify and to pay or reimburse reasonable expenses in advance of final disposition of a proceeding to (1) any present or former director or officer or (2) any individual who, while a director or officer and at our request, serves or has served another corporation, real estate investment trust, partnership, limited liability company, joint venture, trust, employee benefit plan or other enterprise as a director, officer, partner, manager, member or trustee, from and against any claim or liability to which that person may become subject for which that person may incur by reason of his or her service in such capacity. Our charter and bylaws also permit indemnification and the advancement of expenses to any person who served a predecessor to Saratoga Investment Corp. in any of the capacities described above and any of our employees or agents or any employees or agents of such predecessor.

As a business development company, and in accordance with the 1940 Act, we will not indemnify any person for any liability to which such person would be subject by reason of such person’s willful misfeasance, bad faith, gross negligence or reckless disregard of the duties involved in the conduct of his or her office.

 

138


Table of Contents

In addition to the indemnification provided for in our bylaws, we have entered into indemnification agreements with each of our current directors and officers and we intend to enter into indemnification agreements with each of our future directors and officers. The indemnification agreements attempt to provide these directors and officers the maximum indemnification permitted under Maryland law and the 1940 Act. The agreements provide, among other things, for the advancement of expenses and indemnification for liabilities incurred which such person may incur by reason of his or her status as a present or former director or officer in any action or proceeding arising out of the performance of such person’s services as a present or former director or officer.

Provisions of Our Governing Documents and the Maryland General Corporation Law

Our governing documents and the Maryland General Corporation Law contain provisions that could make it more difficult for a potential acquiror to acquire us by means of a tender offer, proxy contest or otherwise. These provisions are expected to discourage certain coercive takeover practices and inadequate takeover bids and to encourage persons seeking to acquire control of us to negotiate first with our board of directors. We believe that the benefits of these provisions outweigh the potential disadvantages of discouraging any such acquisition proposals because, among other things, the negotiation of such proposals may improve their terms.

Classified Board of Directors

Our board of directors is divided into three classes of directors serving staggered three-year terms. Directors of each class are elected to serve for three-year terms and until their successors are duly elected and qualify, and each year one class of directors is elected by the stockholders. A classified board may render a change in control of us or removal of our incumbent management more difficult. We believe, however, that the longer time required to elect a majority of a classified board of directors will help to ensure the continuity and stability of our management and policies.

Number of Directors; Vacancies; Removal

Our governing documents provide that the number of directors will be set only by our board of directors in accordance with our bylaws. Our bylaws provide that a majority of our entire board of directors may at any time increase or decrease the number of directors. However, unless our bylaws are amended, the number of directors may never be less than three nor more than eleven. Our charter provides that, except as may be provided by the board of directors in setting the terms of any class or series of shares of stock, so long as we have a class of securities registered under the Exchange Act and at least three independent directors, any and all vacancies on the board of directors may be filled only by the affirmative vote of a majority of the remaining directors in office, even if the remaining directors do not constitute a quorum, and any director elected to fill a vacancy will serve for the remainder of the full term of the directorship in which the vacancy occurred and until a successor is elected and qualifies, subject to any applicable requirements of the 1940 Act. If there are no directors then in office, vacancies may be filled by stockholders at a special meeting called for such purpose. Our charter provides that a director may be removed only by the affirmative vote of at least two-thirds of the votes entitled to be cast generally in the election of directors.

Election of Directors

Our charter and bylaws provide that the affirmative vote of the holders of a majority of the outstanding shares of stock entitled to vote in the election of directors will be required to elect each director. Pursuant to our charter and bylaws, our board of directors may amend the bylaws to alter the vote required to elect directors.

Action by Stockholders

All of our outstanding shares of common stock will generally be able to vote on any matter that is a proper subject for action by the stockholders of a Maryland corporation, including in respect of the election or removal of

 

139


Table of Contents

directors as well as other extraordinary matters. Under the Maryland General Corporation Law, stockholder action can be taken only at an annual or special meeting of stockholders or by written or electronically-transmitted unanimous consent in lieu of a meeting. These provisions, combined with the requirements of our governing documents regarding the calling of a stockholder-requested special meeting of stockholder discussed below, may have the effect of delaying consideration of a stockholder proposal until the next annual meeting.

Advance Notice Provisions for Stockholder Nominations and Stockholder Proposals

Our bylaws provide that, with respect to an annual meeting of our stockholders, nominations of individuals for election to the board of directors and the proposal of business to be considered by stockholders may be made only (1) pursuant to our notice of the meeting, (2) by or at the direction of the board of directors, (3) by any stockholder who is a stockholder of record both at the time of giving notice by the stockholder and at the time of the annual meeting, who is entitled to vote at the meeting and who has complied with the advance notice procedures of the bylaws. With respect to special meetings of stockholders, only the business specified in our notice of the meeting may be brought before the meeting. Nominations of individuals for election to the board of directors at a special meeting may be made only (1) pursuant to our notice of the meeting, (2) by or at the direction of the board of directors, (3) provided that the board of directors has determined that directors will be elected at the meeting, by a stockholder who is a stockholder of record both at the time of giving notice by the stockholder and at the time of the special meeting and who is entitled to vote at the meeting and who has complied with the advance notice provisions of our bylaws or (4) by a stockholder who is entitled to vote at the meeting in circumstances in which a special meeting of stockholders is called for the purpose of electing directors when no directors remain in office.

The purpose of requiring stockholders to give us advance notice of nominations and other business is to afford our board of directors a meaningful opportunity to consider the qualifications of the proposed nominees and the advisability of any other proposed business and, to the extent deemed necessary or desirable by our board of directors, to inform stockholders and make recommendations about such qualifications or business, as well as to provide a more orderly procedure for conducting meetings of stockholders. Although our bylaws do not give our board of directors any power to disapprove stockholder nominations for the election of directors or proposals recommending certain action, they may have the effect of precluding a contest for the election of directors or the consideration of stockholder proposals if proper procedures are not followed and of discouraging or deterring a third party from conducting a solicitation of proxies to elect its own slate of directors or to approve its own proposal without regard to whether consideration of such nominees or proposals might be harmful or beneficial to us and our stockholders.

Calling of Special Meetings of Stockholders

Our bylaws provide that special meetings of our stockholders may be called by our board of directors and certain of our officers. Additionally, our bylaws provide that, subject to the satisfaction of certain procedural and informational requirements by the stockholders requesting the meeting, a special meeting of our stockholders will be called by our secretary upon the written request of stockholders entitled to cast not less than a majority of all the votes entitled to be cast at such meeting, except that, if no directors remain in office, a special meeting of our stockholders shall be called to elect directors by the secretary upon the written request of holders entitled to cast at least 10% of the votes entitled to be cast generally in the election of directors.

Amendment of Governing Documents

Under Maryland law, a Maryland corporation generally cannot dissolve or amend its charter unless the corporation’s board of directors declares the dissolution or amendment to be advisable and the dissolution or amendment is approved by the affirmative vote of stockholders entitled to cast at least two-thirds of the votes entitled to be cast on the matter. A Maryland corporation may provide in its charter for approval of these matters by a lesser percentage, but not less than a majority of all of the votes entitled to be cast on the matter. Our charter

 

140


Table of Contents

generally provides for approval of amendments to our charter by the stockholders entitled to cast at least a majority of the votes entitled to be cast on the matter. However, our charter also provides that certain charter amendments and proposals for our liquidation, dissolution or conversion, whether by merger or otherwise, from a closed-end company to an open-end company require the approval of the stockholders entitled to cast at least two-thirds percent of the votes entitled to be cast on such matter. If such amendment or proposal is approved by at least two-thirds of our continuing directors (in addition to approval by our board of directors), such amendment or proposal may be approved by a majority of the votes entitled to be cast on such a matter. The “continuing directors” are, as defined in our charter, our current directors as well as those directors whose nomination for election by the stockholders or whose election by the directors to fill vacancies is approved by a majority of the continuing directors then on the board of directors.

Our governing documents provide that the board of directors has the exclusive power to adopt, alter or repeal any provision of our bylaws and to make new bylaws.

Approval of Extraordinary Actions

Under Maryland law, a Maryland corporation generally cannot amend its charter, merge, sell all or substantially all of its assets, engage in a share exchange or engage in similar transactions outside the ordinary course of business, unless the corporation’s board of directors declares action or transaction to be advisable and the action or transaction is approved by the affirmative vote of stockholders entitled to cast at least two-thirds of the votes entitled to be cast on the matter. A Maryland corporation may provide in its charter for approval of these matters by a lesser percentage, but not less than a majority of all of the votes entitled to be cast on the matter.

Except for a merger that would result in our conversion to an open-end company, which requires the approval described above, our charter provides that we may merge, sell all or substantially all of our assets, engage in a consolidation or share exchange or engage in similar transactions, if such transaction is declared advisable by our board of directors and approved by a majority of all of the votes entitled to be cast on the matter.

No Appraisal Rights

Except with respect to appraisal rights arising in connection with the Maryland Control Share Acquisition Act discussed below, as permitted by the Maryland General Corporation Law, our governing documents provide that our stockholders will not be entitled to exercise appraisal rights unless a majority of our board of directors determines that such rights will apply with respect to all or any classes or series of stock, to one or more transactions occurring after the date of such determination in connection with which holders of such shares would otherwise be entitled to exercise appraisal rights.

Control Share Acquisitions

The Control Share Acquisition Act provides that control shares of a Maryland corporation acquired in a control share acquisition have no voting rights except to the extent approved by a vote of two-thirds of the votes entitled to be cast on the matter. Shares owned by the acquiror, by officers or by directors who are employees of the corporation are excluded from shares entitled to vote on the matter. Control shares are voting shares of stock which, if aggregated with all other shares of stock owned by the acquiror or in respect of which the acquiror is able to exercise or direct the exercise of voting power (except solely by virtue of a revocable proxy), would entitle the acquiror to exercise voting power in electing directors within one of the following ranges of voting power:

 

    one-tenth or more but less than one-third;

 

    one-third or more but less than a majority; or

 

    a majority or more of all voting power.

 

141


Table of Contents

The requisite stockholder approval must be obtained each time an acquiror crosses one of the thresholds of voting power set forth above. Control shares do not include shares the acquiring person is then entitled to vote as a result of having previously obtained stockholder approval. A control share acquisition means the acquisition of control shares, subject to certain exceptions.

A person who has made or proposes to make a control share acquisition may compel the board of directors of the corporation to call a special meeting of stockholders to be held within 50 days of demand to consider the voting rights of the shares. The right to compel the calling of a special meeting is subject to the satisfaction of certain conditions, including an undertaking to pay the expenses of the meeting. If no request for a meeting is made, the corporation may itself present the question at any stockholder meeting.

If voting rights are not approved at the meeting or if the acquiring person does not deliver an acquiring person statement as required by the statute, then the corporation may repurchase for fair value any or all of the control shares, except those for which voting rights have previously been approved. The right of the corporation to repurchase control shares is subject to certain conditions and limitations, including, as provided in our bylaws, compliance with the 1940 Act, which will prohibit any such repurchase other than in limited circumstances. Fair value is determined, without regard to the absence of voting rights for the control shares, as of the date of the last control share acquisition by the acquiror or of any meeting of stockholders at which the voting rights of the shares are considered and not approved. If voting rights for control shares are approved at a stockholder meeting and the acquiror becomes entitled to vote a majority of the shares entitled to vote, all other stockholders may exercise appraisal rights. The fair value of the shares as determined for purposes of appraisal rights may not be less than the highest price per share paid by the acquiror in the control share acquisition.

The Control Share Acquisition Act does not apply (a) to shares acquired in a merger, consolidation or share exchange if the corporation is a party to the transaction or (b) to acquisitions approved or exempted by the charter or bylaws of the corporation.

Our bylaws contain a provision exempting from the Control Share Acquisition Act any and all acquisitions by any person of our common stock. Such provision could also be amended or eliminated at any time in the future. However, we will amend our bylaws to be subject to the Control Share Acquisition Act only if the board of directors determines that it would be in our best interests and if the SEC does not object to our determination that our being subject to the Control Share Acquisition Act does not conflict with the 1940 Act.

Business Combinations

Under Maryland law, “business combinations” between a Maryland corporation and an interested stockholder or an affiliate of an interested stockholder are prohibited for five years after the most recent date on which the interested stockholder becomes an interested stockholder. These business combinations include a merger, consolidation, share exchange or, in circumstances specified in the statute, an asset transfer or issuance or reclassification of equity securities. An interested stockholder is defined as:

 

    any person who beneficially owns 10% or more of the voting power of the corporation’s stock; or

 

    an affiliate or associate of the corporation who, at any time within the two-year period prior to the date in question, was the beneficial owner of 10% or more of the voting power of the then outstanding voting stock of the corporation.

A person is not an interested stockholder under this statute if the board of directors approved in advance the transaction by which he otherwise would have become an interested stockholder. However, in approving a transaction, the board of directors may provide that its approval is subject to compliance, at or after the time of approval, with any terms and conditions determined by the board.

 

142


Table of Contents

After the five-year prohibition, any business combination between the corporation and an interested stockholder generally must be recommended by the board of directors of the corporation and approved by the affirmative vote of at least:

 

    80% of the votes entitled to be cast by holders of outstanding shares of voting stock of the corporation; and

 

    two-thirds of the votes entitled to be cast by holders of voting stock of the corporation other than shares held by the interested stockholder with whom or with whose affiliate the business combination is to be effected or held by an affiliate or associate of the interested stockholder.

These super-majority vote requirements do not apply if the corporation’s stockholders receive a minimum price, as defined under Maryland law, for their shares in the form of cash or other consideration in the same form as previously paid by the interested stockholder for its shares.

The statute permits various exemptions from its provisions, including business combinations that are exempted by the board of directors before the time that the interested stockholder becomes an interested stockholder. Our board of directors has adopted a resolution exempting from the provisions of the Maryland Business Combination Act any business combination between us and any other person. If our board of directors adopts resolutions causing us to be subject to the provisions of the Business Combination Act, these provisions may discourage others from trying to acquire control of us and increase the difficulty of consummating any offer.

Conflict with 1940 Act

Our bylaws provide that, if and to the extent that any provision of the Maryland General Corporation Law, including the Control Share Acquisition Act or the Business Combination Act (if we amend our bylaws to be subject to such Acts), or any provision of our charter or bylaws conflicts with any provision of the 1940 Act, the applicable provision of the 1940 Act will control.

DESCRIPTION OF OUR SUBSCRIPTION RIGHTS

We may issue subscription rights to purchase common stock. Subscription rights may be issued independently or together with any other offered security and may or may not be transferable by the person purchasing or receiving the subscription rights. In connection with any subscription rights offering to our stockholders, we may enter into a standby underwriting or other arrangement with one or more underwriters or other persons pursuant to which such underwriters or other persons would purchase any offered securities remaining unsubscribed for after such subscription rights offering. We will not offer transferable subscription rights to our stockholders at a price equivalent to less than the then current net asset value per share of common stock, excluding underwriting commissions, unless we first file a post-effective amendment that is declared effective by the SEC with respect to such issuance and the common stock to be purchased in connection with the rights represents no more than one-third of our outstanding common stock at the time such rights are issued (i.e., the right to purchase one new share for a minimum of every three rights held). In connection with a subscription rights offering to our stockholders, we would distribute certificates evidencing the subscription rights and a prospectus supplement to our stockholders on the record date that we set for receiving subscription rights in such subscription rights offering. Our common stockholders will indirectly bear the expenses of such subscription rights offerings, regardless of whether our common stockholders exercise any subscription rights.

The applicable prospectus supplement would describe the following terms of subscription rights in respect of which this prospectus is being delivered:

 

    the title of such subscription rights;

 

    the exercise price or a formula for the determination of the exercise price for such subscription rights;

 

143


Table of Contents
    the number or a formula for the determination of the number of such subscription rights issued to each stockholder;

 

    the extent to which such subscription rights are transferable;

 

    if applicable, a discussion of the material U.S. federal income tax considerations applicable to the issuance or exercise of such subscription rights;

 

    the date on which the right to exercise such subscription rights would commence, and the date on which such rights shall expire (subject to any extension);

 

    the extent to which such subscription rights include an over-subscription privilege with respect to unsubscribed securities;

 

    if applicable, the material terms of any standby underwriting or other purchase arrangement that we may enter into in connection with the subscription rights offering; and

 

    any other terms of such subscription rights, including terms, procedures and limitations relating to the exchange and exercise of such subscription rights.

Exercise of Subscription Rights

Each subscription right would entitle the holder of the subscription right to purchase for cash such amount of shares of common stock or other securities at such exercise price as shall in each case be set forth in, or be determinable as set forth in, the prospectus supplement relating to the subscription rights offered thereby or another report filed with the SEC. Subscription rights may be exercised at any time up to the close of business on the expiration date for such subscription rights set forth in the applicable prospectus supplement. After the close of business on the expiration date, all unexercised subscription rights would become void. We have not previously completed such an offering of subscription rights.

Subscription rights may be exercised as set forth in the prospectus supplement relating to the subscription rights offered thereby. Upon receipt of payment and the subscription rights certificate properly completed and duly executed at the corporate trust office of the subscription rights agent or any other office indicated in the prospectus supplement, we will forward, as soon as practicable, the shares of common stock or other securities purchasable upon such exercise. We may determine to offer any unsubscribed offered securities directly to stockholders, persons other than stockholders, to or through agents, underwriters or dealers or through a combination of such methods, including pursuant to standby underwriting or other arrangements, as set forth in the applicable prospectus supplement.

 

144


Table of Contents

DESCRIPTION OF OUR DEBT SECURITIES

We may issue debt securities in one or more series. The specific terms of each series of debt securities will be described in the particular prospectus supplement relating to that series. The prospectus supplement may or may not modify the general terms found in this prospectus and will be filed with the SEC. For a complete description of the terms of a particular series of debt securities, you should read both this prospectus and the prospectus supplement relating to that particular series.

As required by federal law for all bonds and notes of companies that are publicly offered, the debt securities are governed by a document called an “indenture.” An indenture is a contract between us and the financial institution acting as trustee on your behalf, and is subject to and governed by the Trust Indenture Act of 1939, as amended. The trustee has two main roles. First, the trustee can enforce your rights against us if we default. There are some limitations on the extent to which the trustee acts on your behalf, described in the second paragraph under “—Events of Default—Remedies if an Event of Default Occurs.” Second, the trustee performs certain administrative duties for us with respect to our debt securities.

All the material terms of the indenture and the supplemental indenture, as well as an explanation of your rights as a holder of debt securities, are described in this prospectus and in the prospectus supplement accompanying this prospectus. Because this section is a summary, however, it does not describe every aspect of the debt securities and the indenture. We urge you to read the indenture because it, and not this description, defines your rights as a holder of debt securities. We have filed a form of the indenture with the SEC. See “Available Information” for information on how to obtain a copy of the indenture. We will file a supplemental indenture with the SEC in connection with any debt offering, at which time the supplemental indenture would be publicly available.

The prospectus supplement, which will accompany this prospectus, will describe the particular series of debt securities being offered by including:

 

    the designation or title of the series of debt securities;

 

    the total principal amount of the series of debt securities;

 

    the percentage of the principal amount at which the series of debt securities will be offered;

 

    the date or dates on which principal will be payable;

 

    the rate or rates (which may be either fixed or variable) and/or the method of determining such rate or rates of interest, if any;

 

    the date or dates from which any interest will accrue, or the method of determining such date or dates, and the date or dates on which any interest will be payable;

 

    whether any interest may be paid by issuing additional securities of the same series in lieu of cash (and the terms upon which any such interest may be paid by issuing additional securities);

 

    the terms for redemption, extension or early repayment, if any;

 

    the currencies in which the series of debt securities are issued and payable;

 

    whether the amount of payments of principal, premium or interest, if any, on a series of debt securities will be determined with reference to an index, formula or other method (which could be based on one or more currencies, commodities, equity indices or other indices) and how these amounts will be determined;

 

    the place or places, if any, other than or in addition to the Borough of Manhattan in the City of New York, of payment, transfer, conversion and/or exchange of the debt securities;

 

    the denominations in which the offered debt securities will be issued (if other than $1,000 and any integral multiple thereof);

 

145


Table of Contents
    the provision for any sinking fund;

 

    any restrictive covenants;

 

    any Events of Default (as defined in “Events of Default” below);

 

    whether the series of debt securities are issuable in certificated form;

 

    any provisions for defeasance or covenant defeasance;

 

    any special federal income tax implications, including, if applicable, federal income tax considerations relating to original issue discount;

 

    whether and under what circumstances we will pay additional amounts in respect of any tax, assessment or governmental charge and, if so, whether we will have the option to redeem the debt securities rather than pay the additional amounts (and the terms of this option);

 

    any provisions for convertibility or exchangeability of the debt securities into or for any other securities;

 

    whether the debt securities are subject to subordination and the terms of such subordination;

 

    whether the debt securities are secured and the terms of any security interest;

 

    the listing, if any, on a securities exchange; and

 

    any other terms.

The debt securities may be secured or unsecured obligations. Unless the prospectus supplement states otherwise, principal (and premium, if any) and interest, if any, will be paid by us in immediately available funds.

We are permitted, under specified conditions, to issue multiple classes of indebtedness if our asset coverage, as defined in the 1940 Act, is at least equal to 200% immediately after each such issuance after giving effect to any exemptive relief granted to us by the SEC. In addition, while any indebtedness and senior securities remain outstanding, we must make provisions to prohibit the distribution to our stockholders or the repurchase of such securities or shares unless we meet the applicable asset coverage ratios at the time of the distribution or repurchase. For a discussion of the risks associated with leverage, see “Risk Factors—Risks Related to Our Business and Structure—Regulations governing our operation as a BDC will affect our ability to raise additional capital.”

General

The indenture provides that any debt securities proposed to be sold under this prospectus and the accompanying prospectus supplement (“offered debt securities”) and any debt securities issuable upon the exercise of warrants or upon conversion or exchange of other offered securities (“underlying debt securities”) may be issued under the indenture in one or more series.

For purposes of this prospectus, any reference to the payment of principal of, or premium or interest, if any, on, debt securities will include additional amounts if required by the terms of the debt securities.

The indenture does not limit the amount of debt securities that may be issued thereunder from time to time. Debt securities issued under the indenture, when a single trustee is acting for all debt securities issued under the indenture, are called the “indenture securities.” The indenture also provides that there may be more than one trustee thereunder, each with respect to one or more different series of indenture securities. See “—Resignation of Trustee” below. At a time when two or more trustees are acting under the indenture, each with respect to only certain series, the term “indenture securities” means the one or more series of debt securities with respect to which each respective trustee is acting. In the event that there is more than one trustee under the indenture, the

 

146


Table of Contents

powers and trust obligations of each trustee described in this prospectus will extend only to the one or more series of indenture securities for which it is trustee. If two or more trustees are acting under the indenture, then the indenture securities for which each trustee is acting would be treated as if issued under separate indentures.

The indenture does not contain any provisions that give you protection in the event we issue a large amount of debt or we are acquired by another entity.

We refer you to the prospectus supplement for information with respect to any deletions from, modifications of or additions to the Events of Default or our covenants that are described below, including any addition of a covenant or other provision providing event risk protection or similar protection.

We have the ability to issue indenture securities with terms different from those of indenture securities previously issued and, without the consent of the holders thereof, to reopen a previous issue of a series of indenture securities and issue additional indenture securities of that series unless the reopening was restricted when that series was created.

Conversion and Exchange

If any debt securities are convertible into or exchangeable for other securities, the prospectus supplement will explain the terms and conditions of the conversion or exchange, including the conversion price or exchange ratio (or the calculation method), the conversion or exchange period (or how the period will be determined), if conversion or exchange will be mandatory or at the option of the holder or us, provisions for adjusting the conversion price or the exchange ratio and provisions affecting conversion or exchange in the event of the redemption of the underlying debt securities. These terms may also include provisions under which the number or amount of other securities to be received by the holders of the debt securities upon conversion or exchange would be calculated according to the market price of the other securities as of a time stated in the prospectus supplement.

Issuance of Securities in Registered Form

We may issue the debt securities in registered form, in which case we may issue them either in book-entry form only or in “certificated” form. Debt securities issued in book-entry form will be represented by global securities. We expect that we will usually issue debt securities in book-entry only form represented by global securities.

Book-Entry Holders

We will issue registered debt securities in book-entry form only, unless we specify otherwise in the applicable prospectus supplement. This means debt securities will be represented by one or more global securities registered in the name of a depositary that will hold them on behalf of financial institutions that participate in the depositary’s book-entry system. These participating institutions, in turn, hold beneficial interests in the debt securities held by the depositary or its nominee. These institutions may hold these interests on behalf of themselves or customers.

Under the indenture, only the person in whose name a debt security is registered is recognized as the holder of that debt security. Consequently, for debt securities issued in book-entry form, we will recognize only the depositary as the holder of the debt securities and we will make all payments on the debt securities to the depositary. The depositary will then pass along the payments it receives to its participants, which in turn will pass the payments along to their customers who are the beneficial owners. The depositary and its participants do so under agreements they have made with one another or with their customers; they are not obligated to do so under the terms of the debt securities.

 

147


Table of Contents

As a result, investors will not own debt securities directly. Instead, they will own beneficial interests in a global security, through a bank, broker or other financial institution that participates in the depositary’s book-entry system or holds an interest through a participant. As long as the debt securities are represented by one or more global securities, investors will be indirect holders, and not holders, of the debt securities.

Street Name Holders

In the future, we may issue debt securities in certificated form or terminate a global security. In these cases, investors may choose to hold their debt securities in their own names or in “street name.” Debt securities held in street name are registered in the name of a bank, broker or other financial institution chosen by the investor, and the investor would hold a beneficial interest in those debt securities through the account he or she maintains at that institution.

For debt securities held in street name, we will recognize only the intermediary banks, brokers and other financial institutions in whose names the debt securities are registered as the holders of those debt securities, and we will make all payments on those debt securities to them. These institutions will pass along the payments they receive to their customers who are the beneficial owners, but only because they agree to do so in their customer agreements or because they are legally required to do so. Investors who hold debt securities in street name will be indirect holders, and not holders, of the debt securities.

Legal Holders

Our obligations, as well as the obligations of the applicable trustee and those of any third parties employed by us or the applicable trustee, run only to the legal holders of the debt securities. We do not have obligations to investors who hold beneficial interests in global securities, in street name or by any other indirect means. This will be the case whether an investor chooses to be an indirect holder of a debt security or has no choice because we are issuing the debt securities only in book-entry form.

For example, once we make a payment or give a notice to the holder, we have no further responsibility for the payment or notice even if that holder is required, under agreements with depositary participants or customers or by law, to pass it along to the indirect holders but does not do so. Similarly, if we want to obtain the approval of the holders for any purpose (for example, to amend an indenture or to relieve us of the consequences of a default or of our obligation to comply with a particular provision of an indenture), we would seek the approval only from the holders, and not the indirect holders, of the debt securities. Whether and how the holders contact the indirect holders is up to the holders.

When we refer to you in this Description of Our Debt Securities, we mean those who invest in the debt securities being offered by this prospectus, whether they are the holders or only indirect holders of those debt securities. When we refer to your debt securities, we mean the debt securities in which you hold a direct or indirect interest.

Special Considerations for Indirect Holders

If you hold debt securities through a bank, broker or other financial institution, either in book-entry form or in street name, we urge you to check with that institution to find out:

 

    how it handles securities payments and notices;

 

    whether it imposes fees or charges;

 

    how it would handle a request for the holders’ consent, if ever required;

 

    whether and how you can instruct it to send you debt securities registered in your own name so you can be a holder, if that is permitted in the future for a particular series of debt securities;

 

148


Table of Contents
    how it would exercise rights under the debt securities if there were a default or other event triggering the need for holders to act to protect their interests; and

 

    if the debt securities are in book-entry form, how the depositary’s rules and procedures will affect these matters.

Global Securities

As noted above, we usually will issue debt securities as registered securities in book-entry form only. A global security represents one or any other number of individual debt securities. Generally, all debt securities represented by the same global securities will have the same terms.

Each debt security issued in book-entry form will be represented by a global security that we deposit with and register in the name of a financial institution or its nominee that we select. The financial institution that we select for this purpose is called the depositary. Unless we specify otherwise in the applicable prospectus supplement, The Depository Trust Company, New York, New York, known as DTC, will be the depositary for all debt securities issued in book-entry form.

A global security may not be transferred to or registered in the name of anyone other than the depositary or its nominee, unless special termination situations arise. We describe those situations below under “—Termination of a Global Security.” As a result of these arrangements, the depositary, or its nominee, will be the sole registered owner and holder of all debt securities represented by a global security, and investors will be permitted to own only beneficial interests in a global security. Beneficial interests must be held by means of an account with a broker, bank or other financial institution that in turn has an account with the depositary or with another institution that has an account with the depositary. Thus, an investor whose security is represented by a global security will not be a holder of the debt security, but only an indirect holder of a beneficial interest in the global security.

Special Considerations for Global Securities

As an indirect holder, an investor’s rights relating to a global security will be governed by the account rules of the investor’s financial institution and of the depositary, as well as general laws relating to securities transfers. The depositary that holds the global security will be considered the holder of the debt securities represented by the global security.

If debt securities are issued only in the form of a global security, an investor should be aware of the following:

 

    an investor cannot cause the debt securities to be registered in his or her name and cannot obtain certificates for his or her interest in the debt securities, except in the special situations we describe below;

 

    an investor will be an indirect holder and must look to his or her own bank or broker for payments on the debt securities and protection of his or her legal rights relating to the debt securities, as we describe under “—Issuance of Securities in Registered Form” above;

 

    an investor may not be able to sell interests in the debt securities to some insurance companies and other institutions that are required by law to own their securities in non-book-entry form;

 

    an investor may not be able to pledge his or her interest in a global security in circumstances where certificates representing the debt securities must be delivered to the lender or other beneficiary of the pledge in order for the pledge to be effective;

 

    the depositary’s policies, which may change from time to time, will govern payments, transfers, exchanges and other matters relating to an investor’s interest in a global security. We and the trustee have no responsibility for any aspect of the depositary’s actions or for its records of ownership interests in a global security. We and the trustee also do not supervise the depositary in any way;

 

149


Table of Contents
    if we redeem less than all the debt securities of a particular series being redeemed, DTC’s practice is to determine by lot the amount to be redeemed from each of its participants holding that series;

 

    an investor is required to give notice of exercise of any option to elect repayment of its debt securities, through its participant, to the applicable trustee and to deliver the related debt securities by causing its participant to transfer its interest in those debt securities, on DTC’s records, to the applicable trustee;

 

    DTC requires that those who purchase and sell interests in a global security deposited in its book-entry system use immediately available funds; your broker or bank may also require you to use immediately available funds when purchasing or selling interests in a global security; and

 

    financial institutions that participate in the depositary’s book-entry system, and through which an investor holds its interest in a global security, may also have their own policies affecting payments, notices and other matters relating to the debt securities; there may be more than one financial intermediary in the chain of ownership for an investor; we do not monitor and are not responsible for the actions of any of those intermediaries.

Termination of a Global Security

If a global security is terminated for any reason, interests in it will be exchanged for certificates in non-book-entry form (certificated securities). After that exchange, the choice of whether to hold the certificated debt securities directly or in street name will be up to the investor. Investors must consult their own banks or brokers to find out how to have their interests in a global security transferred on termination to their own names, so that they will be holders. We have described the rights of legal holders and street name investors under “—Issuance of Securities in Registered Form” above.

The prospectus supplement may list situations for terminating a global security that would apply only to the particular series of debt securities covered by the prospectus supplement. If a global security is terminated, only the depositary, and not we or the applicable trustee, is responsible for deciding the investors in whose names the debt securities represented by the global security will be registered and, therefore, who will be the holders of those debt securities.

Payment and Paying Agents

We will pay interest to the person listed in the applicable trustee’s records as the owner of the debt security at the close of business on a particular day in advance of each due date for interest, even if that person no longer owns the debt security on the interest due date. That day, usually about two weeks in advance of the interest due date, is called the “record date.” Because we will pay all the interest for an interest period to the holders on the record date, holders buying and selling debt securities must work out between themselves the appropriate purchase price. The most common manner is to adjust the sales price of the debt securities to prorate interest fairly between buyer and seller based on their respective ownership periods within the particular interest period. This prorated interest amount is called “accrued interest.”

Payments on Global Securities

We will make payments on a global security in accordance with the applicable policies of the depositary as in effect from time to time. Under those policies, we will make payments directly to the depositary, or its nominee, and not to any indirect holders who own beneficial interests in the global security. An indirect holder’s right to those payments will be governed by the rules and practices of the depositary and its participants, as described under “—Special Considerations for Global Securities.”

Payments on Certificated Securities

We will make payments on a certificated debt security as follows. We will pay interest that is due on an interest payment date to the holder of debt securities as shown on the trustee’s records as of the close of business

 

150


Table of Contents

on the regular record date at our office and/or at other offices that may be specified in the prospectus supplement. We will make all payments of principal and premium, if any, by check at the office of the applicable trustee and/or at other offices that may be specified in the prospectus supplement or in a notice to holders against surrender of the debt security.

Alternatively, at our option, we may pay any cash interest that becomes due on the debt security by mailing a check to the holder at his, her or its address shown on the trustee’s records as of the close of business on the regular record date or by transfer to an account at a bank in the United States, in either case, on the due date.

Payment When Offices Are Closed

If any payment is due on a debt security on a day that is not a business day, we will make the payment on the next day that is a business day. Payments made on the next business day in this situation will be treated under the indenture as if they were made on the original due date, except as otherwise indicated in the attached prospectus supplement. Such payment will not result in a default under any debt security or the indenture, and no interest will accrue on the payment amount from the original due date to the next day that is a business day.

Book-entry and other indirect holders should consult their banks or brokers for information on how they will receive payments on their debt securities.

Events of Default

You will have rights if an Event of Default occurs in respect of the debt securities of your series and is not cured, as described later in this subsection.

The term “Event of Default” in respect of the debt securities of your series means any of the following:

 

    we do not pay the principal of (or premium, if any, on) a debt security of the series when due;

 

    we do not pay interest on a debt security of the series when due, and such default is not cured within 30 days;

 

    we do not deposit any sinking fund payment in respect of debt securities of the series within two business days of its due date;

 

    we remain in breach of a covenant in respect of debt securities of the series for 60 days after we receive a written notice of default stating we are in breach (the notice must be sent by either the trustee or holders of at least 25% of the principal amount of the outstanding debt securities of the series);

 

    we file for bankruptcy or certain other events of bankruptcy, insolvency or reorganization occur and remain undischarged or unstayed for a period of 60 days;

 

    the series of debt securities has an asset coverage, as such term is defined in the 1940 Act, of less than 100 per centum on the last business day of each of twenty-four consecutive calendar months, after giving effect to any exemptive relief granted to the Company by the SEC; or

 

    any other Event of Default in respect of debt securities of the series described in the prospectus supplement occurs.

An Event of Default for a particular series of debt securities does not necessarily constitute an Event of Default for any other series of debt securities issued under the same or any other indenture. The trustee may withhold notice to the holders of debt securities of any default, except in the payment of principal, premium, interest, or sinking or purchase fund installment, if it in good faith considers the withholding of notice to be in the interest of the holders.

 

151


Table of Contents

Remedies if an Event of Default Occurs

If an Event of Default has occurred and is continuing, the trustee or the holders of not less than 25% in principal amount of the outstanding debt securities of the affected series may (and the trustee shall at the request of such holders) declare the entire principal amount of all the debt securities of that series to be due and immediately payable. This is called a declaration of acceleration of maturity. A declaration of acceleration of maturity may be canceled by the holders of a majority in principal amount of the outstanding debt securities of the affected series if (1) we have deposited with the trustee all amounts due and owing with respect to the securities (other than principal that has become due solely by reason of such acceleration) and certain other amounts, and (2) any other Events of Default have been cured or waived.

The trustee is not required to take any action under the indenture at the request of any holders unless the holders offer the trustee protection from expenses and liability reasonably satisfactory to it (called an “indemnity”). If indemnity reasonably satisfactory to it is provided, the holders of a majority in principal amount of the outstanding debt securities of the relevant series may direct the time, method and place of conducting any lawsuit or other formal legal action seeking any remedy available to the trustee. The trustee may refuse to follow those directions in certain circumstances. No delay or omission in exercising any right or remedy will be treated as a waiver of that right, remedy or Event of Default.

Before you are allowed to bypass your trustee and bring your own lawsuit or other formal legal action or take other steps to enforce your rights or protect your interests relating to the debt securities, the following must occur:

 

    you must give the trustee written notice that an Event of Default with respect to the relevant series of debt securities has occurred and remains uncured;

 

    the holders of at least 25% in principal amount of all outstanding debt securities of the relevant series must make a written request that the trustee take action because of the default and must offer the trustee indemnity, security or both reasonably satisfactory to it against the costs, expenses and other liabilities of taking that action;

 

    the trustee must not have taken action for 60 days after receipt of the above notice and offer of indemnity and/or security; and

 

    the holders of a majority in principal amount of the outstanding debt securities of that series must not have given the trustee a direction inconsistent with the above notice during that 60-day period.

However, you are entitled at any time to bring a lawsuit for the payment of money due on your debt securities on or after the due date.

Book-entry and other indirect holders should consult their banks or brokers for information on how to give notice or direction to or make a request of the trustee and how to declare or cancel an acceleration of maturity.

Each year, we will furnish to each trustee a written statement of certain of our officers certifying that to their knowledge we are in compliance with the indenture and the debt securities, or else specifying any default.

Waiver of Default

Holders of a majority in principal amount of the outstanding debt securities of the affected series may waive any past defaults other than

 

    the payment of principal, any premium or interest; or

 

    in respect of a covenant that cannot be modified or amended without the consent of each holder.

 

152


Table of Contents

Merger or Consolidation

Under the terms of the indenture, we are generally permitted to consolidate or merge with another corporation. We are also permitted to sell all or substantially all of our assets to another corporation. However, we may not take any of these actions unless all the following conditions are met:

 

    where we merge out of existence or sell substantially all our assets, the resulting corporation or transferee must agree to be legally responsible for our obligations under the debt securities;

 

    the merger or sale of assets must not cause a default on the debt securities and we must not already be in default (unless the merger or sale would cure the default). For purposes of this no-default test, a default would include an Event of Default that has occurred and has not been cured, as described under “Events of Default” above. A default for this purpose would also include any event that would be an Event of Default if the requirements for giving us a notice of default or our default having to exist for a specific period of time were disregarded;

 

    we must deliver certain certificates and documents to the trustee; and

 

    we must satisfy any other requirements specified in the prospectus supplement relating to a particular series of debt securities.

Modification or Waiver

There are three types of changes we can make to the indenture and the debt securities issued thereunder.

Changes Requiring Your Approval

First, there are changes that we cannot make to your debt securities without your specific approval. The following is a list of those types of changes:

 

    change the stated maturity of the principal of or interest on a debt security or the terms of any sinking fund with respect to any security;

 

    reduce any amounts due on a debt security;

 

    reduce the amount of principal payable upon acceleration of the maturity of an original issue discount or indexed security following a default or upon the redemption thereof or the amount thereof provable in a bankruptcy proceeding;

 

    adversely affect any right of repayment at the holder’s option;

 

    change the place or currency of payment on a debt security (except as otherwise described in the prospectus or prospectus supplement);

 

    impair your right to sue for payment;

 

    adversely affect any right to convert or exchange a debt security in accordance with its terms;

 

    modify the subordination provisions in the indenture in a manner that is adverse to outstanding holders of the debt securities;

 

    reduce the percentage of holders of debt securities whose consent is needed to modify or amend the indenture;

 

    reduce the percentage of holders of debt securities whose consent is needed to waive compliance with certain provisions of the indenture or to waive certain defaults;

 

    modify any other aspect of the provisions of the indenture dealing with supplemental indentures with the consent of holders, waiver of past defaults, changes to the quorum or voting requirements or the waiver of certain covenants; and

 

    change any obligation we have to pay additional amounts.

 

153


Table of Contents

Changes Not Requiring Approval

The second type of change does not require any vote by the holders of the debt securities. This type is limited to clarifications, establishment of the form or terms of new securities of any series as permitted by the indenture and certain other changes that would not adversely affect holders of the outstanding debt securities in any material respect. We also do not need any approval to make any change that affects only debt securities to be issued under the indenture after the change takes effect.

Changes Requiring Majority Approval

Any other change to the indenture and the debt securities would require the following approval:

 

    if the change affects only one series of debt securities, it must be approved by the holders of a majority in principal amount of that series; and

 

    if the change affects more than one series of debt securities issued under the same indenture, it must be approved by the holders of a majority in principal amount of all of the series affected by the change, with all affected series voting together as one class for this purpose.

In each case, the required approval must be given by written consent.

The holders of a majority in principal amount of a series of debt securities issued under the indenture, voting together as one class for this purpose, may waive our compliance with some of our covenants applicable to that series of debt securities. However, we cannot obtain a waiver of a payment default or of any of the matters covered by the bullet points included above under “—Changes Requiring Your Approval.”

Further Details Concerning Voting

When taking a vote, we will use the following rules to decide how much principal to attribute to a debt security:

 

    for original issue discount securities, we will use the principal amount that would be due and payable on the voting date if the maturity of these debt securities were accelerated to that date because of a default;

 

    for debt securities whose principal amount is not known (for example, because it is based on an index), we will use the principal face amount at original issuance or a special rule for that debt security described in the prospectus supplement; and

 

    for debt securities denominated in one or more foreign currencies, we will use the U.S. dollar equivalent.

Debt securities will not be considered outstanding, and therefore not eligible to vote, if we have deposited or set aside in trust money for their payment or redemption or if we, any other obligor, or any affiliate of us or any obligor own such debt securities. Debt securities will also not be eligible to vote if they have been fully defeased as described later under “—Defeasance—Full Defeasance.”

We will generally be entitled to set any day as a record date for the purpose of determining the holders of outstanding indenture securities that are entitled to vote or take other action under the indenture. However, the record date may not be more than 30 days before the date of the first solicitation of holders to vote on or take such action. If we set a record date for a vote or other action to be taken by holders of one or more series, that vote or action may be taken only by persons who are holders of outstanding indenture securities of those series on the record date and must be taken within eleven months following the record date.

Book-entry and other indirect holders should consult their banks or brokers for information on how approval may be granted or denied if we seek to change the indenture or the debt securities or request a waiver.

 

154


Table of Contents

Defeasance

The following provisions will be applicable to each series of debt securities unless we state in the applicable prospectus supplement that the provisions of covenant defeasance and full defeasance will not be applicable to that series.

Covenant Defeasance

Under current U.S. federal tax law and the indenture, we can make the deposit described below and be released from some of the restrictive covenants in the indenture under which the particular series was issued. This is called “covenant defeasance.” In that event, you would lose the protection of those restrictive covenants but would gain the protection of having money and government securities set aside in trust to repay your debt securities. If we achieved covenant defeasance and your debt securities were subordinated as described under “—Indenture Provisions—Subordination” below, such subordination would not prevent the trustee under the indenture from applying the funds available to it from the deposit described in the first bullet below to the payment of amounts due in respect of such debt securities for the benefit of the subordinated debt holders. In order to achieve covenant defeasance, we must do the following:

 

    we must deposit in trust for the benefit of all holders of a series of debt securities a combination of cash (in such currency in which such securities are then specified as payable at stated maturity) or government obligations applicable to such securities (determined on the basis of the currency in which such securities are then specified as payable at stated maturity) that will generate enough cash to make interest, principal and any other payments on the debt securities on their various due dates and any mandatory sinking fund payments or analogous payments;

 

    we must deliver to the trustee a legal opinion of our counsel confirming that, under current U.S. federal income tax law, we may make the above deposit without causing you to be taxed on the debt securities any differently than if we did not make the deposit;

 

    we must deliver to the trustee a legal opinion of our counsel stating that the above deposit does not require registration by us under the 1940 Act, as amended, and a legal opinion and officers’ certificate stating that all conditions precedent to covenant defeasance have been complied with;

 

    defeasance must not result in a breach or violation of, or result in a default under, of the indenture or any of our other material agreements or instruments;

 

    no default or event of default with respect to such debt securities shall have occurred and be continuing and no defaults or events of default related to bankruptcy, insolvency or reorganization shall occur during the next 90 days; and

 

    satisfy the conditions for covenant defeasance contained in any supplemental indentures.

If we accomplish covenant defeasance, you can still look to us for repayment of the debt securities if there were a shortfall in the trust deposit or the trustee is prevented from making payment. For example, if one of the remaining Events of Default occurred (such as our bankruptcy) and the debt securities became immediately due and payable, there might be such a shortfall. However, there is no assurance that we would have sufficient funds to make payment of the shortfall.

Full Defeasance

If there is a change in U.S. federal tax law or we obtain an IRS ruling, as described in the second bullet below, we can legally release ourselves from all payment and other obligations on the debt securities of a particular series (called “full defeasance”) if we put in place the following other arrangements for you to be repaid:

 

   

we must deposit in trust for the benefit of all holders of a series of debt securities a combination of cash (in such currency in which such securities are then specified as payable at stated maturity) or

 

155


Table of Contents
 

government obligations applicable to such securities (determined on the basis of the currency in which such securities are then specified as payable at stated maturity) that will generate enough cash to make interest, principal and any other payments on the debt securities on their various due dates and any mandatory sinking fund payments or analogous payments;

 

    we must deliver to the trustee a legal opinion confirming that there has been a change in current U.S. federal tax law or an IRS ruling that allows us to make the above deposit without causing you to be taxed on the debt securities any differently than if we did not make the deposit. Under current U.S. federal tax law, the deposit and our legal release from the debt securities would be treated as though we paid you your share of the cash and notes or bonds at the time the cash and notes or bonds were deposited in trust in exchange for your debt securities and you would recognize gain or loss on the debt securities at the time of the deposit;

 

    we must deliver to the trustee a legal opinion of our counsel stating that the above deposit does not require registration by us under the 1940 Act, as amended, and a legal opinion and officers’ certificate stating that all conditions precedent to defeasance have been complied with;

 

    defeasance must not result in a breach or violation of, or constitute a default under, of the indenture or any of our other material agreements or instruments;

 

    no default or event of default with respect to such debt securities shall have occurred and be continuing and no defaults or events of default related to bankruptcy, insolvency or reorganization shall occur during the next 90 days; and

 

    satisfy the conditions for full defeasance contained in any supplemental indentures.

If we ever did accomplish full defeasance, as described above, you would have to rely solely on the trust deposit for repayment of the debt securities. You could not look to us for repayment in the unlikely event of any shortfall. Conversely, the trust deposit would most likely be protected from claims of our lenders and other creditors if we ever became bankrupt or insolvent. If your debt securities were subordinated as described later under “—Indenture Provisions—Subordination”, such subordination would not prevent the trustee under the indenture from applying the funds available to it from the deposit referred to in the first bullet of the preceding paragraph to the payment of amounts due in respect of such debt securities for the benefit of the subordinated debt holders.

Form, Exchange and Transfer of Certificated Registered Securities

If registered debt securities cease to be issued in book-entry form, they will be issued:

 

    only in fully registered certificated form;

 

    without interest coupons; and

 

    unless we indicate otherwise in the prospectus supplement, in denominations of $1,000 and amounts that are multiples of $1,000.

Holders may exchange their certificated securities for debt securities of smaller denominations or combined into fewer debt securities of larger denominations, as long as the total principal amount is not changed and as long as the denomination is greater than the minimum denomination for such securities.

Holders may exchange or transfer their certificated securities at the office of the trustee. We have appointed the trustee to act as our agent for registering debt securities in the names of holders transferring debt securities. We may appoint another entity to perform these functions or perform them ourselves.

Holders will not be required to pay a service charge to transfer or exchange their certificated securities, but they may be required to pay any tax or other governmental charge associated with the transfer or exchange. The transfer or exchange will be made only if our transfer agent is satisfied with the holder’s proof of legal ownership.

 

156


Table of Contents

If we have designated additional transfer agents for your debt security, they will be named in the prospectus supplement. We may appoint additional transfer agents or cancel the appointment of any particular transfer agent. We may also approve a change in the office through which any transfer agent acts.

If any certificated securities of a particular series are redeemable and we redeem less than all the debt securities of that series, we may block the transfer or exchange of those debt securities during the period beginning 15 days before the day we mail the notice of redemption and ending on the day of that mailing, in order to freeze the list of holders to prepare the mailing. We may also refuse to register transfers or exchanges of any certificated securities selected for redemption, except that we will continue to permit transfers and exchanges of the unredeemed portion of any debt security that will be partially redeemed.

If a registered debt security is issued in book-entry form, only the depositary will be entitled to transfer and exchange the debt security as described in this subsection, since it will be the sole holder of the debt security.

Resignation of Trustee

Each trustee may resign or be removed with respect to one or more series of indenture securities provided that a successor trustee is appointed to act with respect to these series and has accepted such appointment. In the event that two or more persons are acting as trustee with respect to different series of indenture securities under the indenture, each of the trustees will be a trustee of a trust separate and apart from the trust administered by any other trustee.

Indenture Provisions—Subordination

Upon any distribution of our assets upon our dissolution, winding up, liquidation or reorganization, the payment of the principal of (and premium, if any) and interest, if any, on any indenture securities denominated as subordinated debt securities is to be subordinated to the extent provided in the indenture in right of payment to the prior payment in full of all Senior Indebtedness (as defined below), but our obligation to you to make payment of the principal of (and premium, if any) and interest, if any, on such subordinated debt securities will not otherwise be affected. In addition, no payment on account of principal (or premium, if any), sinking fund or interest, if any, may be made on such subordinated debt securities at any time unless full payment of all amounts due in respect of the principal (and premium, if any), sinking fund and interest on Senior Indebtedness has been made or duly provided for in money or money’s worth.

In the event that, notwithstanding the foregoing, any payment by us is received by the trustee in respect of subordinated debt securities or by the holders of any of such subordinated debt securities, upon our dissolution, winding up, liquidation or reorganization before all Senior Indebtedness is paid in full, the payment or distribution received by the trustee in respect of such subordinated debt securities or by the holders of any of such subordinated debt securities must be paid over to the holders of the Senior Indebtedness or on their behalf for application to the payment of all the Senior Indebtedness remaining unpaid until all the Senior Indebtedness has been paid in full, after giving effect to any concurrent payment or distribution to the holders of the Senior Indebtedness. Subject to the payment in full of all Senior Indebtedness upon this distribution by us, the holders of such subordinated debt securities will be subrogated to the rights of the holders of the Senior Indebtedness to the extent of payments made to the holders of the Senior Indebtedness out of the distributive share of such subordinated debt securities.

By reason of this subordination, in the event of a distribution of our assets upon our insolvency, certain of our senior creditors may recover more, ratably, than holders of any subordinated debt securities or the holders of any indenture securities that are not Senior Indebtedness. The indenture provides that these subordination provisions will not apply to money and securities held in trust under the defeasance provisions of the indenture.

 

157


Table of Contents

Senior Indebtedness is defined in the indenture as the principal of (and premium, if any) and unpaid interest on:

 

    our indebtedness (including indebtedness of others guaranteed by us), whenever created, incurred, assumed or guaranteed, for money borrowed, that we have designated as “Senior Indebtedness” for purposes of the indenture and in accordance with the terms of the indenture (including any indenture securities designated as Senior Indebtedness), and

 

    renewals, extensions, modifications and refinancings of any of this indebtedness.

If this prospectus is being delivered in connection with the offering of a series of indenture securities denominated as subordinated debt securities, the accompanying prospectus supplement will set forth the approximate amount of our Senior Indebtedness and of our other Indebtedness outstanding as of a recent date.

Secured Indebtedness and Ranking

Certain of our indebtedness, including certain series of indenture securities, may be secured. The prospectus supplement for each series of indenture securities will describe the terms of any security interest for such series and will indicate the approximate amount of our secured indebtedness as of a recent date. Any unsecured indenture securities will effectively rank junior to any secured indebtedness, including any secured indenture securities, that we incur in the future to the extent of the value of the assets securing such future secured indebtedness. The debt securities, whether secured or unsecured, of the Company will rank structurally junior to all existing and future indebtedness (including trade payables) incurred by our subsidiaries, financing vehicles or similar facilities (i.e., the holders of the debt securities will not have access to the assets of the Company’s subsidiaries, financing vehicles or similar facilities until after all of these entities’ creditors have been paid and the remaining assets have been distributed up to the Company as the equity holder of these entities). In this regard, any notes that we may issue will be strictly the obligation of the Company, and not of Saratoga CLO, or any subsidiary we may form in the future.

In the event of our bankruptcy, liquidation, reorganization or other winding up, any of our assets that secure secured debt will be available to pay obligations on unsecured debt securities only after all indebtedness under such secured debt has been repaid in full from such assets. We advise you that there may not be sufficient assets remaining to pay amounts due on any or all unsecured debt securities then outstanding after fulfillment of this obligation. As a result, the holders of unsecured indenture securities may recover less, ratably, than holders of any of our secured indebtedness.

The Trustee under the Indenture

U.S. Bank National Association serves as the trustee under the indenture.

Certain Considerations Relating to Foreign Currencies

Debt securities denominated or payable in foreign currencies may entail significant risks. These risks include the possibility of significant fluctuations in the foreign currency markets, the imposition or modification of foreign exchange controls and potential illiquidity in the secondary market. These risks will vary depending upon the currency or currencies involved and will be more fully described in the applicable prospectus supplement.

 

158


Table of Contents

DESCRIPTION OF OUR WARRANTS

The following is a general description of the terms of the warrants we may issue from time to time. Particular terms of any warrants we offer will be described in the prospectus supplement relating to such warrants and will be subject to compliance with the 1940 Act.

As described further below, subject to receiving shareholder approval to issue warrants at a future annual meeting of stockholders, we may issue warrants to purchase shares of our common stock or debt securities. Such warrants may be issued independently or together with shares of common stock or debt securities and may be attached or separate from such securities. We will issue each series of warrants under a separate warrant agreement to be entered into between us and a warrant agent. The warrant agent will act solely as our agent and will not assume any obligation or relationship of agency for or with holders or beneficial owners of warrants.

A prospectus supplement will describe the particular terms of any series of warrants we may issue, including the following:

 

    the title and aggregate number of such warrants;

 

    the price or prices at which such warrants will be issued;

 

    the currency or currencies, including composite currencies, in which the price of such warrants may be payable;

 

    if applicable, the designation and terms of the securities with which the warrants are issued and the number of warrants issued with each such security or each principal amount of such security;

 

    in the case of warrants to purchase debt securities, the principal amount of debt securities purchasable upon exercise of one warrant and the price at which and the currency or currencies, including composite currencies, in which this principal amount of debt securities may be purchased upon such exercise;

 

    in the case of warrants to purchase common stock, the number of shares of common stock purchasable upon exercise of one warrant and the price at which and the currency or currencies, including composite currencies, in which these shares may be purchased upon such exercise;

 

    the date on which the right to exercise such warrants shall commence and the date on which such right will expire (subject to any extension);

 

    whether such warrants will be issued in registered form or bearer form;

 

    if applicable, the minimum or maximum amount of such warrants that may be exercised at any one time;

 

    if applicable, the date on and after which such warrants and the related securities will be separately transferable;

 

    the terms of any rights to redeem, or call such warrants;

 

    information with respect to book-entry procedures, if any;

 

    the terms of the securities issuable upon exercise of the warrants;

 

    if applicable, a discussion of certain U.S. federal income tax considerations; and

 

    any other terms of such warrants, including terms, procedures and limitations relating to the exchange and exercise of such warrants.

We and the warrant agent may amend or supplement the warrant agreement for a series of warrants without the consent of the holders of the warrants issued thereunder to effect changes that are not inconsistent with the provisions of the warrants and that do not materially and adversely affect the interests of the holders of the warrants.

 

159


Table of Contents

Each warrant will entitle the holder to purchase for cash such common stock at the exercise price or such principal amount of debt securities as shall in each case be set forth in, or be determinable as set forth in, the prospectus supplement relating to the warrants offered thereby. Warrants may be exercised as set forth in the prospectus supplement beginning on the date specified therein and continuing until the close of business on the expiration date set forth in the prospectus supplement. After the close of business on the expiration date, unexercised warrants will become void.

Upon receipt of payment and a warrant certificate properly completed and duly executed at the corporate trust office of the warrant agent or any other office indicated in the prospectus supplement, we will, as soon as practicable, forward the securities purchasable upon such exercise. If less than all of the warrants represented by such warrant certificate are exercised, a new warrant certificate will be issued for the remaining warrants. If we so indicate in the applicable prospectus supplement, holders of the warrants may surrender securities as all or part of the exercise price for warrants.

Prior to exercising their warrants, holders of warrants will not have any of the rights of holders of the securities purchasable upon such exercise, including, in the case of warrants to purchase debt securities, the right to receive principal, premium, if any, or interest payments, on the debt securities purchasable upon exercise or to enforce covenants in the applicable indenture or, in the case of warrants to purchase common stock, the right to receive dividends or other distributions, if any, or payments upon our liquidation, dissolution or winding up or to exercise any voting rights.

Under the 1940 Act, we may generally only offer warrants provided that (i) the warrants expire by their terms within ten years, (ii) the exercise or conversion price is not less than the current market value at the date of issuance, (iii) our stockholders authorize the proposal to issue such warrants, and our board of directors approves such issuance on the basis that the issuance is in the best interests of us and our stockholders and (iv) if the warrants are accompanied by other securities, the warrants are not separately transferable unless no class of such warrants and the securities accompanying them has been publicly distributed. The 1940 Act also provides that the amount of our voting securities that would result from the exercise of all outstanding warrants, as well as options and rights, at the time of issuance may not exceed 25% of our outstanding voting securities.

We may in the future seek the approval of our stockholders to approve a proposal to authorize us to issue securities to subscribe to, convert to, or purchase shares of our common stock in one or more offerings. Such authorization will have no expiration. If we do not receive such stockholder approval, we will not issue any warrants.

 

160


Table of Contents

PLAN OF DISTRIBUTION

We may offer, from time to time, in one or more offerings or series, up to $50,000,000 of our common stock, debt securities or warrants to purchase common stock or debt securities, in one or more underwritten public offerings, at-the-market offerings, negotiated transactions, block trades, best efforts offerings or a combination of these methods. We may sell the securities through underwriters or dealers, directly to one or more purchasers through agents or through a combination of any such methods of sale. Any underwriter or agent involved in the offer and sale of the securities will be named in the applicable prospectus supplement. A prospectus supplement or supplements will also describe the terms of the offering of the securities, including: the purchase price of the securities and the proceeds we will receive from the sale; any over-allotment options under which underwriters may purchase additional securities from us; any agency fees or underwriting discounts and other items constituting agents’ or underwriters’ compensation; the public offering price; any discounts or concessions allowed or re-allowed or paid to dealers; and any securities exchange or market on which the securities may be listed. Only underwriters named in the prospectus supplement will be underwriters of the securities offered by the prospectus supplement.

The distribution of our securities may be effected from time to time in one or more transactions at a fixed price or prices, which may be changed, at prevailing market prices at the time of sale, at prices related to such prevailing market prices, or at negotiated prices, provided, however, that the offering price per share of our common stock, less any underwriting commissions and discounts or agency fees paid by us, must generally equal or exceed the net asset value per share of our common stock. We may under certain circumstances consider selling our securities at prices below our net asset value per share consistent with the terms of our stockholder approval to sell our shares of common stock at a price below our net asset value per share. Any offering of shares of our common stock at a price below our then current net asset value per share that requires shareholder approval must occur, if at all, within one year after receiving such shareholder approval.

In connection with the sale of our securities, underwriters or agents may receive compensation from us or from purchasers of our securities, for whom they may act as agents, in the form of discounts, concessions or commissions. Our common stockholders will bear, directly or indirectly, such expenses, as well as any other fees and the expenses incurred by us in connection with any offering of our securities, including debt securities.

Underwriters may sell our securities to or through dealers and such dealers may receive compensation in the form of discounts, concessions or commissions from the underwriters and/or commissions from the purchasers for whom they may act as agents. Underwriters, dealers and agents that participate in the distribution of our securities may be deemed to be underwriters under the Securities Act, and any discounts and commissions they receive from us and any profit realized by them on the resale of our securities may be deemed to be underwriting discounts and commissions under the Securities Act. Any such underwriter or agent will be identified and any such compensation received from us will be described in the applicable prospectus supplement.

We may enter into derivative transactions with third parties, or sell securities not covered by this prospectus to third parties in privately negotiated transactions. If the applicable prospectus supplement indicates, in connection with those derivatives, the third parties may sell securities covered by this prospectus and the applicable prospectus supplement, including in short sale transactions. If so, the third party may use securities pledged by us or borrowed from us or others to settle those sales or to close out any related open borrowings of stock, and may use securities received from us in settlement of those derivatives to close out any related open borrowings of stock. The third parties in such sale transactions will be underwriters and, if not identified in this prospectus, will be identified in the applicable prospectus supplement (or a post-effective amendment).

Any underwriter may engage in over-allotment, stabilizing transactions, short-covering transactions and penalty bids in accordance with Regulation M under the Exchange Act. Over-allotment involves sales in excess of the offering size, which create a short position. Stabilizing transactions permit bids to purchase the underlying security so long as the stabilizing bids do not exceed a specified maximum price. Syndicate-covering or other

 

161


Table of Contents

short-covering transactions involve purchases of the securities, either through exercise of the over-allotment option or in the open market after the distribution is completed, to cover short positions. Penalty bids permit the underwriters to reclaim a selling concession from a dealer when the securities originally sold by the dealer are purchased in a stabilizing or covering transaction to cover short positions. Those activities may cause the price of the securities to be higher than it would otherwise be. If commenced, the underwriters may discontinue any of the activities at any time.

Any underwriters that are qualified market makers on the NYSE may engage in passive market making transactions in our common stock on the NYSE in accordance with Regulation M under the Exchange Act, during the business day prior to the pricing of the offering, before the commencement of offers or sales of our common stock. Passive market makers must comply with applicable volume and price limitations and must be identified as passive market makers. In general, a passive market maker must display its bid at a price not in excess of the highest independent bid for such security; if all independent bids are lowered below the passive market maker’s bid, however, the passive market maker’s bid must then be lowered when certain purchase limits are exceeded. Passive market making may stabilize the market price of the securities at a level above that which might otherwise prevail in the open market and, if commenced, may be discontinued at any time.

We may sell securities directly or through agents we designate from time to time. We will name any agent involved in the offering and sale of securities and we will describe any commissions we will pay the agent in the prospectus supplement. Unless the prospectus supplement states otherwise, our agent will act on a best-efforts basis for the period of its appointment.

Unless otherwise specified in the applicable prospectus supplement, each class or series of securities will be a new issue with no trading market, other than our common stock, which is traded on the NYSE. We may elect to list any other class or series of securities on any exchanges, but we are not obligated to do so. We cannot guarantee the liquidity of the trading markets for any securities.

Under agreements into which we may enter, underwriters, dealers and agents who participate in the distribution of our securities may be entitled to indemnification by us against certain liabilities, including liabilities under the Securities Act. Underwriters, dealers and agents may engage in transactions with, or perform services for, us in the ordinary course of business.

If so indicated in the applicable prospectus supplement, we will authorize underwriters or other persons acting as our agents to solicit offers by certain institutions to purchase our securities from us pursuant to contracts providing for payment and delivery on a future date. Institutions with which such contracts may be made include commercial and savings banks, insurance companies, pension funds, investment companies, educational and charitable institutions and others, but in all cases such institutions must be approved by us. The obligations of any purchaser under any such contract will be subject to the condition that the purchase of our securities shall not at the time of delivery be prohibited under the laws of the jurisdiction to which such purchaser is subject. The underwriters and such other agents will not have any responsibility in respect of the validity or performance of such contracts. Such contracts will be subject only to those conditions set forth in the prospectus supplement, and the prospectus supplement will set forth the commission payable for solicitation of such contracts.

In order to comply with the securities laws of certain states, if applicable, our securities offered hereby will be sold in such jurisdictions only through registered or licensed brokers or dealers. In addition, in certain states, our securities may not be sold unless they have been registered or qualified for sale in the applicable state or an exemption from the registration or qualification requirement is available and is complied with.

The maximum commission or discount to be received by any member of the Financial Industry Regulatory Authority, Inc. will not be greater than 10% for the sale of any securities being registered.

 

162


Table of Contents

BROKERAGE ALLOCATION AND OTHER PRACTICES

Since we generally acquire and dispose of our investments in privately negotiated transactions, we infrequently use brokers in the normal course of our business. Subject to policies established by our Board of Directors, we generally do not execute transactions through any particular broker or dealer, but seek to obtain the best net results for us, taking into account such factors as price (including the applicable brokerage commission or dealer spread), size of order, difficulty of execution, operational facilities of the firm and the firm’s risk and skill in positioning blocks of securities. While we generally seek reasonably competitive trade execution costs, we do not necessarily pay the lowest spread or commission available. Subject to applicable legal requirements, we may select a broker based partly upon brokerage or research services provided to us. In return for such services, we may pay a higher commission than other brokers would charge if we determine in good faith that such commission is reasonable in relation to the services provided, and our management and employees are authorized to pay such commission under these circumstances.

CUSTODIAN, TRANSFER AND DIVIDEND PAYING AGENT AND REGISTRAR

Our investment securities are held under a custody agreement with U.S. Bank National Association. The address of the custodian is U.S. Bank National Association, Corporate Trust Services, One Federal Street, 3rd Floor, Boston, MA 02110. The transfer agent and registrar for our common stock, American Stock Transfer & Trust Company, acts as our transfer agent, dividend paying and reinvestment agent for our common stock. The principal business address of the transfer agent is 59 Maiden Lane, New York, New York 10038. U.S. Bank National Association, our trustee under an indenture and the first supplemental indenture thereto relating to the Notes, is the paying agent, registrar and transfer agent relating to the Notes. The principal business address of our trustee is 214 N. Tyron Street, 12th Floor, Charlotte, North Carolina 28202.

LEGAL MATTERS

Certain legal matters regarding the securities offered by this prospectus will be passed upon for us by Sutherland Asbill & Brennan LLP, Washington, D.C.

INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

Ernst & Young LLP, our independent registered public accounting firm, has audited our consolidated financial statements as of February 28, 2014 and February 28, 2013 and the three years ended February 28, 2014, February 28, 2013 and February 29, 2012 and the related senior securities table, as set forth in their reports. We have included our consolidated financial statements and our senior securities table in this prospectus and elsewhere in the registration statement in reliance on Ernst & Young LLP’s report, given on their authority as experts in accounting and auditing. Ernst & Young LLP’s principal business address is 5 Times Square, New York, New York 10036.

AVAILABLE INFORMATION

As a public company, we file with or submit to the SEC annual, quarterly and current periodic reports, proxy statements and other information meeting the informational requirements of the Exchange Act. You may inspect and copy these reports, proxy statements and other information, as well as the registration statement of which this prospectus forms a part and the related exhibits and schedules, at the Public Reference Room of the SEC at 100 F Street, N.E., Washington, D.C. 20549. You may obtain information on the operation of the Public Reference Room by calling the SEC at 1-800-SEC-0330. Copies of these reports, proxy and information

 

163


Table of Contents

statements and other information may be obtained, after paying a duplicating fee, by electronic request at the following e-mail address: publicinfo@sec.gov, or by writing the SEC’s Public Reference Section, Washington, D.C. 20549-0102. In addition, the SEC maintains an Internet website that contains reports, proxy and information statements and other information filed electronically by us with the SEC at http://www.sec.gov.

PRIVACY NOTICE

We are committed to protecting your privacy. This privacy notice explains the privacy policies of Saratoga Investment Corp. and its affiliated companies. This notice supersedes any other privacy notice you may have received from Saratoga Investment Corp.

We will safeguard, according to strict standards of security and confidentiality, all information we receive about you. The only information we collect from you is your name, address, number of shares you hold and your social security number. This information is used only so that we can send you annual reports and other information about us, and send you proxy statements or other information required by law.

We do not share this information with any non-affiliated third party except as described below:

 

    Authorized Employees of Our Investment Adviser. It is our policy that only authorized employees of our investment adviser who need to know your personal information will have access to it.

 

    Service Providers. We may disclose your personal information to companies that provide services on our behalf, such as recordkeeping, processing your trades, and mailing you information. These companies are required to protect your information and use it solely for the purpose for which they received it.

 

    Courts and Government Officials. If required by law, we may disclose your personal information in accordance with a court order or at the request of government regulators. Only that information required by law, subpoena, or court order will be disclosed.

 

164


Table of Contents

INDEX TO CONSOLIDATED FINANCIAL STATEMENTS

 

Audited Financial Statements

Report of Independent Registered Public Accounting Firm

  F-2   

Consolidated Statements of Assets and Liabilities as of February 28, 2014 and February 28, 2013

  F-3   

Consolidated Statements of Operations for the years ended February 28, 2014, February  28, 2013, and February 29, 2012

  F-4   

Consolidated Schedules of Investments as of February 28, 2014 and February 28, 2013

  F-5   

Consolidated Statements of Changes in Net Assets for the years ended February 28, 2014, February  28, 2013, and February 29, 2012

  F-12   

Consolidated Statements of Cash Flows for the years ended February 28, 2014, February  28, 2013, and February 29, 2012

  F-13   

Notes to Consolidated Financial Statements

  F-14   

Unaudited Financial Statements

Consolidated Statements of Assets and Liabilities as of August 31, 2014 (unaudited) and February  28, 2014

  F-39   

Consolidated Statements of Operations for the six months ended August 31, 2014 and August  31, 2013 (unaudited)

  F-40   

Consolidated Schedules of Investments as of August 31, 2014 (unaudited) and February 28, 2014

  F-41   

Consolidated Statements of Changes in Net Assets for the six months ended August 31, 2014 and August  31, 2013 (unaudited)

  F-49   

Consolidated Statements of Cash Flows for the six months ended August 31, 2014 and August  31, 2013 (unaudited)

  F-50   

Notes to Consolidated Financial Statements as of August 31, 2014 (unaudited)

  F-51   

 

F-1


Table of Contents

Report of Independent Registered Public Accounting Fir m

The Board of Directors and Stockholders of Saratoga Investment Corp.

We have audited the accompanying consolidated statement of assets and liabilities of Saratoga Investment Corp. (the “Company”) as of February 28, 2014 and February 28, 2013, including the consolidated schedule of investments, and the related consolidated statements of operations, changes in net assets and cash flows for the years ended February 28, 2014, February 28, 2013 and February 29, 2012. These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on these financial statements based on our audits.

We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. We were not engaged to perform an audit of the Company’s internal control over financial reporting. Our audits included consideration of internal control over financial reporting as a basis for designing audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion. An audit also includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements, assessing the accounting principles used and significant estimates made by management, and evaluating the overall financial statement presentation. Our procedures included confirmation of securities owned as of February 28, 2014, by correspondence with the custodian, debt agents and lenders. We believe that our audits provide a reasonable basis for our opinion.

In our opinion, the financial statements referred to above present fairly, in all material respects, the consolidated financial position of Saratoga Investment Corp. at February 28, 2014 and February 28, 2013, and the consolidated results of its operations, changes in its net assets and its cash flows for the years ended February 28, 2014, February 28, 2013 and February 29, 2012, in conformity with U.S. generally accepted accounting principles.

/s/ Ernst & Young LLP

New York, NY

May 27, 2014

 

F-2


Table of Contents

Saratoga Investment Corp.

Consolidated Statements of Assets and Liabilities

 

     As of  
     February 28, 2014     February 28, 2013  

ASSETS

    

Investments at fair value

    

Non-control/non-affiliate investments (amortized cost of $185,266,607 and $130,465,086, respectively)

   $ 186,275,106      $ 129,563,428   

Control investments (cost of $16,555,808 and $18,944,966 respectively)

     19,569,596        25,516,959   
  

 

 

   

 

 

 

Total investments at fair value (amortized cost of $201,822,415 and $149,410,052 respectively)

  205,844,702      155,080,387   

Cash and cash equivalents

  3,293,898      149,025   

Cash and cash equivalents, reserve accounts

  3,293,113      12,086,142   

Interest receivable, (net of reserve of $150,058 and $53,543, respectively)

  2,571,853      2,889,358   

Deferred debt financing costs, net

  4,008,704      2,090,184   

Management fee receivable

  150,106      215,853   

Other assets

  14,461      83,407   

Receivable from unsettled trades

  —        1,817,074   
  

 

 

   

 

 

 

Total assets

$ 219,176,837    $ 174,411,430   
  

 

 

   

 

 

 

LIABILITIES

Revolving credit facility

$ —      $ 24,300,000   

SBA debentures payable

  50,000,000      36,000,000   

Notes payable

  48,300,000      —     

Management and incentive fees payable

  3,856,962      4,509,322   

Accounts payable and accrued expenses

  824,568      435,038   

Interest and debt fees payable

  873,135      257,796   

Due to manager

  398,154      222,513   
  

 

 

   

 

 

 

Total liabilities

$ 104,252,819    $ 65,724,669   
  

 

 

   

 

 

 

Commitments and contingencies (See Note 8)

NET ASSETS

Common stock, par value $.001, 100,000,000 common shares authorized, 5,379,616 and 4,730,116 common shares issued and outstanding, respectively

$ 5,380    $ 4,730   

Capital in excess of par value

  184,851,154      174,824,076   

Distribution in excess of net investment income

  (29,627,578   (24,522,951

Accumulated net realized loss from investments and derivatives

  (44,327,225   (47,289,427

Net unrealized appreciation on investments and derivatives

  4,022,287      5,670,333   
  

 

 

   

 

 

 

Total Net Assets

  114,924,018      108,686,761   
  

 

 

   

 

 

 

Total liabilities and Net Assets

$ 219,176,837    $ 174,411,430   
  

 

 

   

 

 

 

NET ASSET VALUE PER SHARE

$ 21.36    $ 22.98   
  

 

 

   

 

 

 

See accompanying notes to consolidated financial statements.

 

F-3


Table of Contents

Saratoga Investment Corp.

Consolidated Statements of Operations

 

     For the year ended
February 28, 2014
    For the year ended
February 28, 2013
    For the year ended
February 29, 2012
 

INVESTMENT INCOME

      

Interest from investments

      

Non-control/Non-affiliate investments

   $ 15,832,083      $ 9,176,156      $ 5,613,705   

Payment-in-kind interest income from Non-control/Non-affiliate investments

     936,208        1,062,687        1,442,004   

Control investments

     3,410,868        4,205,509        4,198,007   
  

 

 

   

 

 

   

 

 

 

Total interest income

  20,179,159      14,444,352      11,253,716   

Interest from cash and cash equivalents

  7,932      5,956      7,865   

Management fee income

  1,775,141      2,000,072      2,011,516   

Other income

  931,513      556,427      238,579   
  

 

 

   

 

 

   

 

 

 

Total investment income

  22,893,745      17,006,807      13,511,676   
  

 

 

   

 

 

   

 

 

 

EXPENSES

Interest and debt financing expenses

  6,083,891      2,540,413      1,297,985   

Base management fees

  3,326,879      2,107,378      1,617,496   

Professional fees

  1,211,836      1,190,587      1,455,380   

Administrator expenses

  1,000,000      1,000,000      1,000,000   

Incentive management fees

  691,492      2,044,788      1,257,087   

Insurance

  442,977      516,121      578,746   

Directors fees and expenses

  204,607      206,705      208,851   

General & administrative

  789,208      368,815      389,825   

Other expense

  21,207      4,434      5,445   
  

 

 

   

 

 

   

 

 

 

Total expenses

  13,772,097      9,979,241      7,810,815   
  

 

 

   

 

 

   

 

 

 

NET INVESTMENT INCOME

  9,121,648      7,027,566      5,700,861   
  

 

 

   

 

 

   

 

 

 

REALIZED AND UNREALIZED GAIN (LOSS) ON INVESTMENTS:

Net realized gain (loss) from investments

  1,270,765      561,700      (12,185,997

Net realized loss from derivatives

  —        (131,000   —     

Net unrealized appreciation (depreciation) on investments

  (1,648,046   7,012,726      19,776,469   

Net unrealized appreciation (depreciation) on derivatives

  —        130,925      (16,190
  

 

 

   

 

 

   

 

 

 

Net gain (loss) on investments

  (377,281   7,574,351      7,574,282   
  

 

 

   

 

 

   

 

 

 

NET INCREASE IN NET ASSETS RESULTING FROM OPERATIONS

$ 8,744,367    $ 14,601,917    $ 13,275,143   
  

 

 

   

 

 

   

 

 

 

WEIGHTED AVERAGE—BASIC AND DILUTED EARNINGS PER COMMON SHARE

$ 1.78    $ 3.55    $ 3.87   

WEIGHTED AVERAGE COMMON STOCK OUTSTANDING—BASIC AND DILUTED

  4,920,517      4,110,484      3,434,345   

See accompanying notes to consolidated financial statements.

 

F-4


Table of Contents

Saratoga Investment Corp.

Consolidated Schedule of Investments

February 28, 2014

 

Company(a)

  Industry  

Investment
Interest Rate /
Maturity

  Principal/
Number of
Shares
    Cost     Fair Value(c)     % of
Net Assets
 

Non-control/Non-affiliated investments—162.1%(b)

           

PATS Aircraft, LLC

  Aerospace   Common Stock     51,813        89,636        89,636        0.1

PATS Aircraft, LLC

  Aerospace   First Lien Term Loan 8.50% Cash, 10/6/2016   $ 254,598        254,598        254,598        0.2
       

 

 

   

 

 

   

 

 

 
    Total Aerospace       344,234        344,234        0.3
       

 

 

   

 

 

   

 

 

 

National Truck Protection Co.,
Inc.(d)(g)

  Automotive   Common Stock     1,116        1,000,000        1,152,531        1.0

National Truck Protection Co., Inc.(d)

  Automotive   First Lien Term Loan 15.50% Cash, 9/13/2018   $ 8,250,000        8,250,000        8,250,000        7.2

Take 5 Oil Change, L.L.C.(d)(g)

  Automotive   Common Stock     7,128        712,800        1,217,747        1.1
       

 

 

   

 

 

   

 

 

 
    Total Automotive       9,962,800        10,620,278        9.3
       

 

 

   

 

 

   

 

 

 

Legacy Cabinets Holdings(d)(g)

  Building Products   Common Stock Voting A-1     2,535        220,900        552,351        0.5

Legacy Cabinets Holdings(d)(g)

  Building Products   Common Stock Voting B-1     1,600        139,424        348,624        0.3
       

 

 

   

 

 

   

 

 

 
    Total Building Products       360,324        900,975        0.8
       

 

 

   

 

 

   

 

 

 

ARSloane Acquistion, LLC

  Business Services   First Lien Term Loan 7.50% Cash, 10/1/2019   $ 997,500        988,200        1,004,981        0.9

BMC Software, Inc.(d)

  Business Services   First Lien Term Loan 5.00% Cash, 9/10/2020   $ 6,000,000        5,943,801        6,013,800        5.2

Dispensing Dynamics International(d)

  Business Services   Senior Secured Note 12.50% Cash, 1/1/2018   $ 7,000,000        6,882,278        7,525,000        6.5

Easy Ice, LLC(d)

  Business Services   First Lien Term Loan 14.00% (11.00% Cash 3.00% PIK), 3/29/2018   $ 7,507,024        7,387,970        7,507,024        6.5

Emily Street Enterprises, L.L.C.(d)

  Business Services   Senior Secured Note 12.00% (11.00% Cash/1.00% PIK), 12/28/2017   $ 5,767,983        5,680,703        5,767,983        5.0

Emily Street Enterprises, L.L.C.(d)(g)

  Business Services   Warrant Membership Interests     49,318        400,000        601,679        0.5

Help/Systems Holdings, Inc.(Help/Systems, LLC)(d)

  Business Services   First Lien Term Loan 5.50% Cash, 6/28/2019   $ 3,990,000        3,954,385        3,960,075        3.5

Help/Systems Holdings, Inc.(Help/Systems, LLC)(d)

  Business Services   Second Lien Term Loan 9.50% Cash, 6/28/2020   $ 2,000,000        1,972,758        2,000,000        1.7

Knowland Technology Holdings, L.L.C.(d)

  Business Services   First Lien Term Loan 11.00% Cash, 11/29/2017   $ 6,200,000        6,107,034        6,200,000        5.4

Trinet HR Corporation (SOI Holdings, Inc.)(d)

  Business Services   First Lien Term Loan 5.00% Cash, 8/20/2020   $ 4,987,500        4,941,335        5,018,921        4.4

Trinet HR Corporation (SOI Holdings, Inc.)(d)

  Business Services   Second Lien Term Loan 8.75% Cash, 2/20/2021   $ 2,500,000        2,453,145        2,518,750        2.2

Vector Controls Holding Co., LLC(d)

  Business Services   First Lien Term Loan, 14.00% (12.00% Cash, 2.00% PIK), 3/6/2018   $ 9,261,074        9,115,415        9,075,853        7.9

Vector Controls Holding Co.,
LLC(d)(g)

  Business Services   Warrants to Purchase Limited Liability Company Interests     101        —          136,217        0.1
       

 

 

   

 

 

   

 

 

 
    Total Business Services       55,827,024        57,330,283        49.8
       

 

 

   

 

 

   

 

 

 

 

F-5


Table of Contents

Company(a)

  Industry  

Investment
Interest Rate /
Maturity

  Principal/
Number of
Shares
    Cost     Fair Value(c)     % of
Net Assets
 

Targus Group International, Inc.(d)

  Consumer Products   First Lien Term Loan 11.00% Cash, 5/24/2016   $ 3,738,369        3,704,766        3,663,602        3.2

Targus Holdings, Inc.(d)(g)

  Consumer Products   Common Stock     62,413        566,765        730,232        0.6

Targus Holdings, Inc.(d)

  Consumer Products   Unsecured Note 10.00% PIK, 6/14/2019   $ 2,054,158        2,054,158        1,387,848        1.2

Targus Holdings, Inc.(d)

  Consumer Products   Unsecured Note 16.00% Cash, 10/26/2018   $ 384,577        379,471        336,505        0.3
       

 

 

   

 

 

   

 

 

 
    Total Consumer Products       6,705,160        6,118,187        5.3
       

 

 

   

 

 

   

 

 

 

Avionte Holdins, LLC

  Consumer Services   Common Stock   $ 100,000        100,000        100,000        0.1

Avionte Holdins, LLC

  Consumer Services   First Lien Term Loan 9.75% Cash, 1/8/2019   $ 3,000,000        2,940,000        3,000,000        2.6

CFF Acquisition L.L.C.(d)

  Consumer Services   First Lien Term Loan 7.50% Cash, 7/31/2015   $ 1,319,891        1,273,596        1,319,891        1.1

Expedited Travel L.L.C.(d)

  Consumer Services   First Lien Term Loan 9.00% Cash, 12/28/2017   $ 4,580,000        4,501,104        4,580,000        4.0

PrePaid Legal Services, Inc.(d)

  Consumer Services   First Lien Term Loan 6.25% Cash, 7/1/2019   $ 4,274,194        4,236,035        4,247,694        3.7

PrePaid Legal Services, Inc.(d)

  Consumer Services   Second Lien Term Loan 9.75% Cash, 7/1/2020   $ 5,000,000        4,931,888        5,044,000        4.4
       

 

 

   

 

 

   

 

 

 
    Total Consumer Services       17,982,623        18,291,585        15.9
       

 

 

   

 

 

   

 

 

 

M/C Acquisition Corp., L.L.C.(d)(g)

  Education   Class A Common Stock     544,761        30,241        —          0.0

M/C Acquisition Corp., L.L.C.(d)

  Education   First Lien Term Loan 1.00% Cash, 3/13/14   $ 2,512,184        1,358,250        90,128        0.1
       

 

 

   

 

 

   

 

 

 
    Total Education       1,388,491        90,128        0.1
       

 

 

   

 

 

   

 

 

 

Group Dekko, Inc.(d)

  Electronics   Second Lien Term Loan 11.00% (10.00% Cash/1.00% PIK), 5/1/2016   $ 6,901,547        6,901,547        6,741,431        5.9
       

 

 

   

 

 

   

 

 

 
    Total Electronics       6,901,547        6,741,431        5.9
       

 

 

   

 

 

   

 

 

 

USS Parent Holding Corp.(d)(g)

  Environmental   Non Voting Common Stock     765        133,002        220,992        0.2

USS Parent Holding Corp.(d)(g)

  Environmental   Voting Common Stock     17,396        3,025,798        5,027,574        4.4
       

 

 

   

 

 

   

 

 

 
    Total Environmental       3,158,800        5,248,566        4.6
       

 

 

   

 

 

   

 

 

 

DS Waters of America, Inc.(d)

  Food and Beverage   First Lien Term Loan 5.25% Cash, 8/30/2020   $ 2,493,750        2,470,506        2,531,156        2.2

HOA Restaurant Group, L.L.C.(d)

  Food and Beverage   Senior Secured Note 11.25% Cash, 4/1/2017   $ 4,000,000        3,918,437        4,240,000        3.7

TB Corp.(d)

  Food and Beverage   First Lien Term Loan 5.75% Cash, 6/19/2018   $ 5,101,971        5,082,013        5,127,481        4.5

TB Corp.(d)

  Food and Beverage   Unsecured Note 13.50% (12.00% Cash/1.50% PIK), 12/20/2018   $ 2,543,154        2,513,130        2,555,870        2.2

TM Restaurant Group L.L.C.(d)

  Food and Beverage   First Lien Term Loan 7.75% Cash, 7/16/2017   $ 2,845,690        2,831,271        2,831,462        2.5
       

 

 

   

 

 

   

 

 

 
    Total Food and Beverage       16,815,357        17,285,969        15.1
       

 

 

   

 

 

   

 

 

 

Bristol Hospice, LLC

  Healthcare Services   Senior Secured Note 11.00%(10.00% Cash/1.00% PIK), 11/29/2018   $ 5,509,782        5,405,325        5,509,782        4.8

Oceans Acquisition, Inc.(d)

  Healthcare Services   First Lien Term A Loan 10.75% Cash, 12/27/2017   $ 6,373,113        6,273,020        6,373,113        5.6

Oceans Acquisition, Inc.(d)

  Healthcare Services   First Lien Term B Loan 10.75% Cash, 12/27/2017   $ 500,000        490,224        500,000        0.4

 

F-6


Table of Contents

Company(a)

  Industry  

Investment
Interest Rate /
Maturity

  Principal/
Number of
Shares
    Cost     Fair Value(c)     % of
Net Assets
 

Smile Brands Group Inc.(d)

  Healthcare Services   First Lien Term Loan 7.50% Cash, 8/16/2019   $ 4,488,750        4,406,559        4,488,750        3.9

Surgical Specialties Corporation (US), Inc.(d)

  Healthcare Services   First Lien Term Loan 7.25% Cash, 8/22/2018   $ 2,437,500        2,415,591        2,449,688        2.1

Zest Holdings, LLC(d)

  Healthcare Services   First Lien Term Loan 6.50% Cash, 8/16/2020   $ 4,488,750        4,405,073        4,488,750        3.9
       

 

 

   

 

 

   

 

 

 
    Total Healthcare Services       23,395,792        23,810,083        20.7
       

 

 

   

 

 

   

 

 

 

McMillin Companies L.L.C.(d)(g)(h)

  Homebuilding   Senior Secured Note 0% Cash, 12/31/2013   $ 550,000        558,434        344,355        0.3
       

 

 

   

 

 

   

 

 

 
    Total Homebuilding       558,434        344,355        0.3
       

 

 

   

 

 

   

 

 

 

Distribution International, Inc.(d)

  Manufacturing   First Lien Term Loan 7.50% Cash, 7/16/2019   $ 5,970,000        5,916,094        5,970,000        5.2
       

 

 

   

 

 

   

 

 

 
    Total Manufacturing       5,916,094        5,970,000        5.2
       

 

 

   

 

 

   

 

 

 

Elyria Foundry Company, L.L.C.(d)

  Metals   Senior Secured Note 17.00% (13.00% Cash/4.00% PIK), 9/14/2014   $ 8,859,614        8,859,614        6,644,711        5.8

Elyria Foundry Company, L.L.C.(d)(g)

  Metals   Warrants to Purchase Limited Liability Company Interests (2008)     7,000        20        —          0.0

Elyria Foundry Company, L.L.C.(d)(g)

  Metals   Warrants to Purchase Limited Liability Company Interests (2013)     18,227        —          —          0.0
       

 

 

   

 

 

   

 

 

 
    Total Metals       8,859,634        6,644,711        5.8
       

 

 

   

 

 

   

 

 

 

Network Communications, Inc.(d)(g)

  Publishing   Common Stock     380,572        —          —          0.0

Network Communications, Inc.(d)

  Publishing   Unsecured Notes 8.60% PIK, 1/14/2020   $ 2,601,736        2,202,168        1,190,888        1.0
       

 

 

   

 

 

   

 

 

 
    Total Publishing       2,202,168        1,190,888        1.0
       

 

 

   

 

 

   

 

 

 

Community Investors, Inc.(d)(g)

  Software   Common Stock     1,282        1,282        1,449        0.0

Community Investors, Inc.(d)

  Software   First Lien Term Loan 9.75% Cash, 5/9/2018   $ 6,983,333        6,863,915        6,983,333        6.1

Community Investors, Inc.(d)

  Software   Revolver   $ 166,667        —          —          0.0

Community Investors, Inc.(d)(g)

  Software   Preferred Stock     135,584        135,584        153,210        0.1

Pen-Link, Ltd.

  Software   Second Lien Term Loan 12.50% Cash, 5/26/2019   $ 11,500,000        11,280,887        11,500,000        10.0
       

 

 

   

 

 

   

 

 

 
    Total Software       18,281,668        18,637,992        16.2
       

 

 

   

 

 

   

 

 

 

Advanced Air & Heat of Florida, LLC

  Utilities   First Lien Term Loan 10.00% Cash, 1/31/2019   $ 6,705,441        6,606,457        6,705,441        5.8
       

 

 

   

 

 

   

 

 

 
    Total Utilities       6,606,457        6,705,441        5.8
       

 

 

   

 

 

   

 

 

 

Sub Total Non-control/Non-affiliated
investments

          185,266,607        186,275,106        162.1
       

 

 

   

 

 

   

 

 

 

Control investments—17.0%(b)

         

Saratoga Investment Corp. CLO 2013-1, Ltd.(d)(e)(f)

  Structured Finance
Securities
  Other/Structured Finance Securities 15.16%, 10/17/2023   $ 30,000,000        16,555,808        19,569,596        17.0
       

 

 

   

 

 

   

 

 

 

Sub Total Control investments

          16,555,808        19,569,596        17.0
       

 

 

   

 

 

   

 

 

 

TOTAL INVESTMENTS—179.1%(b)

        $ 201,822,415      $ 205,844,702        179.1
       

 

 

   

 

 

   

 

 

 

 

F-7


Table of Contents

 

(a) All of our equity and debt investments are issued by eligible portfolio companies, as defined in the Investment Company Act of 1940, except Saratoga Investment Corp. CLO 2013-1, Ltd.
(b) Percentages are based on net assets of $114,924,018 as of February 28, 2014.
(c) Because there is no readily available market value for these investments, the fair value of these investments is approved in good faith by our board of directors. (see Note 3 to the consolidated financial statements).
(d) These securities are pledged as collateral under a senior secured revolving credit facility (see Note 6 to the consolidated financial statements).
(e) This investment does not have a stated interest rate that is payable thereon. As a result, the 15.16% interest rate in the table above represents the interest rate currently earned on the investment cost and is based on the current cash interest and other income generated by the investment.
(f) As defined in the Investment Company Act, we “Control” this portfolio company because we own more than 25% of the portfolio company’s outstanding voting securities. Transactions during the period in which the issuer was both an Affiliate and a portfolio company that we Control are as follows:

 

Company

   Purchases      Redemptions      Sales
(cost)
     Interest
Income
     Management
fee income
     Net
Realized
gains/(losses)
     Net
Unrealized
gains/(losses)
 

Saratoga Investment Corp. CLO 2013-1, Ltd.

   $ —         $ —         $ —         $ 3,410,868       $ 1,775,141       $ —         $ 3,013,788   

 

(g) Non-income producing at February 28, 2014.
(h) In connection with the restructuring of this investment, the Company agreed to forgo the receipt of any interest payments thereon.

 

F-8


Table of Contents

Saratoga Investment Corp.

Consolidated Schedule of Investments

February 28, 2013

 

Company(a)

 

Industry

 

Investment
Interest Rate /
Maturity

   Principal/
Number of
Shares
     Cost      Fair Value(c)      % of
Net Assets
 

Non-control/Non-affiliated
investments—119.2%(b)

               

Coast Plating, Inc.(d)

  Aerospace   First Lien Term Loan 11.70% Cash, 9/13/2014    $ 2,550,000       $ 2,550,000       $ 2,550,000         2.3

Coast Plating, Inc.(d)

  Aerospace   First Lien Term Loan 13.20% Cash, 9/13/2014    $ 950,000         950,000         950,000         0.9
         

 

 

    

 

 

    

 

 

 
    Total Aerospace         3,500,000         3,500,000         3.2
         

 

 

    

 

 

    

 

 

 

National Truck Protection
Co., Inc.(d)(h)

  Automotive   Common Stock      589         500,000         591,827         0.5

National Truck Protection
Co., Inc.(d)

  Automotive   First Lien Term Loan 15.50% Cash 8/10/2017    $ 5,500,000         5,500,000         5,500,000         5.1

Take 5 Oil Change, L.L.C.(d)

  Automotive   First Lien Term Loan 9.00% Cash, 11/28/2016    $ 6,000,000         6,000,000         6,000,000         5.5

Take 5 Oil Change, L.L.C.(d)

  Automotive   First Lien Term Loan 13.00% Cash, 11/28/2016    $ 2,000,000         1,961,761         2,000,000         1.8

Take 5 Oil Change, L.L.C.(d)(h)

  Automotive   Common Stock      7,128         712,800         712,800         0.7
         

 

 

    

 

 

    

 

 

 
    Total Automotive         14,674,561         14,804,627         13.6
         

 

 

    

 

 

    

 

 

 

Legacy Cabinets Holdings(d)(h)

  Building Products   Common Stock Voting A-1      2,535         220,900         —           0.0

Legacy Cabinets Holdings(d)(h)

  Building Products   Common Stock Voting B-1      1,600         139,424         —           0.0

Legacy Cabinets, Inc.(d)

  Building Products   First Lien Term Loan 7.25% (1.00% Cash/6.25% PIK), 5/3/2014    $ 332,229         332,229         267,378         0.2
         

 

 

    

 

 

    

 

 

 
    Total Building Products         692,553         267,378         0.2
         

 

 

    

 

 

    

 

 

 

Emily Street Enterprises, L.L.C.(d)

  Business Services   Senior Secured Note 14.00% (13.00% Cash/1.00% PIK), 12/28/2017    $ 5,705,384         5,595,317         5,705,384         5.2

Emily Street Enterprises,
L.L.C.(d)(h)

  Business Services   Warrant Membership Interests      49,318         400,000         399,969         0.4

Dispensing Dynamics
International(d)

  Business Services   Senior Secured Note 12.50% Cash, 1/1/2018    $ 7,000,000         6,860,186         7,000,000         6.4

Knowland Technology Holdings, L.L.C.(d)

  Business Services   First Lien Term Loan 11.00% Cash, 11/29/2017    $ 6,200,000         6,082,248         6,200,000         5.7

Sourcehov LLC(d)

  Business Services   Second Lien Term Loan 10.50% Cash, 4/29/2018    $ 3,000,000         2,648,298         2,850,000         2.6
         

 

 

    

 

 

    

 

 

 
    Total Business Services         21,586,049         22,155,353         20.3
         

 

 

    

 

 

    

 

 

 

C.H.I. Overhead Doors, Inc.(d)

  Consumer Products   First Lien Term Loan 7.25% Cash, 8/17/2017    $ 4,974,747         4,930,481         5,024,495         4.7

Targus Group International, Inc.(d)

  Consumer Products   First Lien Term Loan 11.00% Cash, 5/24/2016    $ 3,940,003         3,888,460         3,956,551         3.6

Targus Holdings, Inc.(d)

  Consumer Products   Unsecured Note 10.00% PIK, 6/14/2019    $ 1,914,341         1,914,341         1,116,252         1.0

Targus Holdings, Inc.(d)

  Consumer Products   Unsecured Note 16.00% Cash, 10/26/2018    $ 332,500         326,320         305,334         0.3

Targus Holdings, Inc.(d)(h)

  Consumer Products   Common Stock      62,413         566,765         3,324,741         3.1
         

 

 

    

 

 

    

 

 

 
    Total Consumer Products         11,626,367         13,727,373         12.7
         

 

 

    

 

 

    

 

 

 

 

F-9


Table of Contents

Company(a)

 

Industry

 

Investment
Interest Rate /
Maturity

   Principal/
Number of
Shares
     Cost      Fair Value(c)      % of
Net Assets
 

CFF Acquisition L.L.C.(d)

  Consumer Services   First Lien Term Loan 7.50% Cash, 7/31/2015    $ 2,161,391         2,032,060         2,154,475         2.0

Expedited Travel L.L.C.(d)

  Consumer Services   First Lien Term Loan 12.00% Cash, 12/28/2017    $ 5,500,000         5,380,520         5,500,000         5.0

PrePaid Legal Services, Inc.(d)

  Consumer Services   First Lien Term Loan 11.00% Cash, 12/31/2016    $ 3,000,000         2,936,860         3,000,000         2.8
         

 

 

    

 

 

    

 

 

 
    Total Consumer Services         10,349,440         10,654,475         9.8
         

 

 

    

 

 

    

 

 

 

M/C Acquisition Corp., L.L.C.(d)

  Education   First Lien Term Loan 1.00% Cash, 12/31/2012    $ 2,740,780         1,586,846         291,893         0.3

M/C Acquisition Corp., L.L.C.(d)(h)

 

Education

 

Class A Common Stock

     544,761         30,242         —           0.0
         

 

 

    

 

 

    

 

 

 
    Total Education         1,617,088         291,893         0.3
         

 

 

    

 

 

    

 

 

 

Group Dekko, Inc.(d)

  Electronics   Second Lien Term Loan 11.00% (10.00% Cash/1.00% PIK), 5/1/2016    $ 6,824,717         6,824,717         6,720,981         6.2
         

 

 

    

 

 

    

 

 

 
    Total Electronics         6,824,717         6,720,981         6.2
         

 

 

    

 

 

    

 

 

 

USS Parent Holding Corp.(d)(h)

  Environmental   Non Voting Common Stock      765         133,002         125,981         0.1

USS Parent Holding Corp.(d)(h)

  Environmental   Voting Common Stock      17,396         3,025,798         2,866,065         2.7
         

 

 

    

 

 

    

 

 

 
    Total Environmental         3,158,800         2,992,046         2.8
         

 

 

    

 

 

    

 

 

 

DS Waters of America, Inc.(d)

  Food and Beverage   First Lien Term Loan 10.50% Cash, 8/29/2017    $ 3,970,000         3,994,704         4,049,400         3.7

HOA Restaurant Group, L.L.C.(d)

  Food and Beverage   Senior Secured Note 11.25% Cash, 4/1/2017    $ 4,000,000         3,897,940         3,560,000         3.3

TB Corp.(d)

  Food and Beverage   First Lien Term Loan 5.81% Cash, 6/19/2018    $ 5,153,506         5,128,662         5,140,622         4.7

TB Corp.(d)

  Food and Beverage   Unsecured Note 13.50% (12.00% Cash/1.50% PIK), 2/19/2017    $ 2,504,585         2,468,317         2,492,062         2.3

TM Restaurant Group L.L.C.(d)

  Food and Beverage   First Lien Term Loan 7.75% Cash, 7/17/2017    $ 2,962,500         2,943,045         2,956,871         2.7
         

 

 

    

 

 

    

 

 

 
    Total Food and Beverage         18,432,668         18,198,955         16.7
         

 

 

    

 

 

    

 

 

 

Oceans Acquisition, Inc.(d)

  Healthcare Services   First Lien Term Loan 10.75% Cash, 12/27/2017    $ 7,500,000         7,351,433         7,500,000         6.9

Maverick Healthcare Group(d)

  Healthcare Services   First Lien Term Loan 10.75% Cash, 12/31/2016    $ 4,900,000         4,835,389         4,900,000         4.5
         

 

 

    

 

 

    

 

 

 
    Total Healthcare Services         12,186,822         12,400,000         11.4
         

 

 

    

 

 

    

 

 

 

McMillin Companies L.L.C.(d)(h)(i)

  Homebuilding   Senior Secured Note 0% Cash, 12/31/2013    $ 550,000         536,764         315,370         0.3
         

 

 

    

 

 

    

 

 

 
    Total Homebuilding         536,764         315,370         0.3
         

 

 

    

 

 

    

 

 

 

Capstone Logistics, L.L.C.(d)

  Logistics   First Lien Term Loan 7.50% Cash, 9/16/2016    $ 899,769         889,798         908,766         0.8

Capstone Logistics, L.L.C.(d)

  Logistics   First Lien Term Loan 13.50% Cash, 9/16/2016    $ 3,693,369         3,652,443         3,767,236         3.5

Worldwide Express Operations, L.L.C.(d)

  Logistics   First Lien Term Loan 7.50% Cash, 6/30/2013    $ 6,527,979         6,461,295         6,504,478         6.0
         

 

 

    

 

 

    

 

 

 
    Total Logistics         11,003,536         11,180,480         10.3
         

 

 

    

 

 

    

 

 

 

Elyria Foundry Company, L.L.C.(d)

  Metals   Senior Secured Note 17.00% (13.00% Cash/4.00% PIK), 3/1/2013    $ 7,728,566         7,728,566         6,723,852         6.2

Elyria Foundry Company,
L.L.C.(d)(h)

  Metals   Warrants to Purchase Limited Liability Company Interests      3,000         —           —           0.0
         

 

 

    

 

 

    

 

 

 
    Total Metals         7,728,566         6,723,852         6.2
         

 

 

    

 

 

    

 

 

 

 

F-10


Table of Contents

Company(a)

 

Industry

 

Investment
Interest Rate /
Maturity

   Principal/
Number of
Shares
     Cost      Fair Value(c)      % of
Net Assets
 

Network Communications, Inc.(d)

  Publishing   Unsecured Note 8.60% PIK, 1/14/2020    $ 2,500,198         2,049,660         960,827         0.9

Network Communications, Inc.(d)(h)

  Publishing   Common Stock      211,429         —           —           0.0

Penton Media, Inc.(d)

  Publishing   First Lien Term Loan 6.00% (4.00% Cash/2.00% PIK), 8/1/2014    $ 4,839,189         4,497,495         4,669,818         4.3
         

 

 

    

 

 

    

 

 

 
    Total Publishing         6,547,155         5,630,645         5.2
         

 

 

    

 

 

    

 

 

 

Sub Total Non-control/Non-affiliated investments 

            130,465,086         129,563,428         119.2
         

 

 

    

 

 

    

 

 

 

Control investments—23.5%(b)

               

GSC Partners CDO GP III, LP(g)(h)

  Financial Services   100% General Partnership Interest      —           —           —           0.0

GSC Investment Corp. CLO 2007
LTD.(d)(e)(g)

  Structured Finance Securities   Other/Structured Finance Securities 23.06%, 1/21/2020    $ 30,000,000         18,944,966         25,516,959         23.5
         

 

 

    

 

 

    

 

 

 

Sub Total Control investments

            18,944,966         25,516,959         23.5
         

 

 

    

 

 

    

 

 

 

Affiliate investments—0.0%(b)

               

GSC Partners CDO GP III, LP(f)(h)

  Financial Services   6.24% Limited Partnership Interest      —           —           —           0.0
         

 

 

    

 

 

    

 

 

 

Sub Total Affiliate investments 

            —           —           0.0
         

 

 

    

 

 

    

 

 

 

TOTAL INVESTMENTS—142.7%(b)

          $ 149,410,052       $ 155,080,387         142.7
         

 

 

    

 

 

    

 

 

 

 

(a) All of our equity and debt investments are issued by eligible portfolio companies, as defined in the Investment Company Act of 1940, except GSC Investment Corp. CLO 2007 Ltd. and GSC Partners CDO GP III, LP.
(b) Percentages are based on net assets of $108,686,761 as of February 28, 2013.
(c) Because there is no readily available market value for these investments, the fair value of these investments is approved in good faith by our board of directors. (see Note 3 to the consolidated financial statements).
(d) These securities are pledged as collateral under a senior secured revolving credit facility (see Note 6 to the consolidated financial statements).
(e) This investment does not have a stated interest rate that is payable thereon. As a result, the 23.06% figure above represents the interest rate earned on the investment (at cost) and is based on the current cash interest and other income generated by the investment.
(f) As defined in the Investment Company Act, we are an “Affiliate” of this portfolio company because we own 5% or more of the portfolio company’s outstanding voting securities. Transactions during the period in which the issuer was an Affiliate are as follows:

 

Company

  Purchases     Redemptions     Sales (cost)     Interest
Income
    Management
fee income
    Net Realized
gains/(losses)
    Net Unrealized
gains/(losses)
 

GSC Partners CDO GP III, LP

  $ —        $ —        $ —        $ —        $ —        $ —        $ —     

 

(g) As defined in the Investment Company Act, we “Control” this portfolio company because we own more than 25% of the portfolio company’s outstanding voting securities. Transactions during the period in which the issuer was both an Affiliate and a portfolio company that we Control are as follows:

 

Company

  Purchases     Redemptions     Sales (cost)     Interest
Income
    Management
fee income
    Net Realized
gains/(losses)
    Net Unrealized
gains/(losses)
 

GSC Investment Corp. CLO 2007 LTD.

  $ —        $ —        $ —        $ 4,205,509      $ 2,000,072      $ —        $ 6,571,992   

GSC Partners CDO GP III, LP

  $ —        $ —        $ —        $ —        $ —        $ —        $ —     

 

(h) Non-income producing at February 28, 2013.
(i) In connection with the restructuring of this investment, the Company agreed to forgo the receipt of any interest payments thereon.

 

F-11


Table of Contents

Saratoga Investment Corp.

Consolidated Statements of Changes in Net Assets

 

     For the year ended
February 28, 2014
    For the year ended
February 28, 2013
    For the year ended
February 29, 2012
 

INCREASE FROM OPERATIONS:

      

Net investment income

   $ 9,121,648      $ 7,027,566      $ 5,700,861   

Net realized gain (loss) from investments

     1,270,765        561,700        (12,185,997

Net realized loss from derivatives

     —          (131,000     —     

Net unrealized appreciation (depreciation) on investments

     (1,648,046     7,012,726        19,776,469   

Net unrealized appreciation (depreciation) on derivatives

     —          130,925        (16,190
  

 

 

   

 

 

   

 

 

 

Net increase in net assets from operations

  8,744,367      14,601,917      13,275,143   
  

 

 

   

 

 

   

 

 

 

DECREASE FROM SHAREHOLDER DISTRIBUTIONS:

Distributions declared

  (12,534,807   (16,475,809   (9,831,231
  

 

 

   

 

 

   

 

 

 

Net decrease in net assets from shareholder distributions

  (12,534,807   (16,475,809   (9,831,231
  

 

 

   

 

 

   

 

 

 

CAPITAL SHARE TRANSACTIONS:

Stock dividend distribution

  10,027,697      13,180,503      7,864,784   
  

 

 

   

 

 

   

 

 

 

Net increase in net assets from capital share transactions

  10,027,697      13,180,503      7,864,784   
  

 

 

   

 

 

   

 

 

 

Total increase in net assets

  6,237,257      11,306,611      11,308,696   

Net assets at beginning of period

  108,686,761      97,380,150      86,071,454   
  

 

 

   

 

 

   

 

 

 

Net assets at end of period

$ 114,924,018    $ 108,686,761    $ 97,380,150   
  

 

 

   

 

 

   

 

 

 

Net asset value per common share

$ 21.36    $ 22.98    $ 25.12   

Common shares outstanding at end of period

  5,379,616      4,730,116      3,876,661   

Distribution in excess of net investment income

$ (29,627,578 $ (24,522,951 $ (13,920,068

See accompanying notes to consolidated financial statements.

 

F-12


Table of Contents

Saratoga Investment Corp.

Consolidated Statements of Cash Flows

 

     For the year ended
February 28, 2014
    For the year ended
February 28, 2013
    For the year ended
February 29, 2012
 

Operating activities

      

NET INCREASE IN NET ASSETS FROM OPERATIONS

   $ 8,744,367      $ 14,601,917      $ 13,275,143   

ADJUSTMENTS TO RECONCILE NET INCREASE IN NET ASSETS FROM OPERATIONS TO NET CASH USED BY OPERATING ACTIVITIES:

      

Paid-in-kind interest income

     (1,007,494     (1,062,687     (1,442,004

Net accretion of discount on investments

     (666,849     (975,475     (1,191,822

Amortization of deferred debt financing costs

     903,289        482,306        674,724   

Net realized (gain) loss from investments

     (1,270,765     (561,700     12,185,997   

Net realized loss from derivatives

     —          131,000        —     

Net unrealized (appreciation) depreciation on investments

     1,648,046        (7,012,726     (19,776,469

Net unrealized (appreciation) depreciation on derivatives

     —          (130,925     16,190   

Proceeds from sale and redemption of investments

     71,606,736        21,487,698        33,568,147   

Purchase of investments

     (121,073,990     (71,595,649     (38,678,936

(Increase) decrease in operating assets:

      

Cash and cash equivalents, reserve accounts

     8,793,029        13,448,053        (21,164,208

Interest receivable

     317,505        (1,199,954     (23,321

Management fee receivable

     65,747        11,728        4,172   

Other assets

     68,946        11,416        (9,657

Receivable from unsettled trades

     1,817,074        (1,757,563     (59,511

Increase (decrease) in operating liabilities:

      

Payable for unsettled trades

     —          (4,072,500     (827,500

Management and incentive fees payable

     (652,360     1,623,652        681,864   

Accounts payable and accrued expenses

     389,530        (269,911     (80,537

Interest and credit facility fees payable

     615,339        204,534        (14,530

Due to manager

     175,641        (171,581     154,094   
  

 

 

   

 

 

   

 

 

 

NET CASH USED BY OPERATING ACTIVITIES

     (29,526,209     (36,808,367     (22,708,164
  

 

 

   

 

 

   

 

 

 

Financing activities

      

Borrowings on debt

     18,000,000        55,550,000        20,000,000   

Paydowns on debt

     (28,300,000     (15,250,000     (4,500,000

Issuance of notes

     48,300,000        —          —     

Debt financing cost

     (2,821,806     (1,373,000     (235,446

Payments of cash dividends

     (2,507,112     (3,295,306     (1,966,447
  

 

 

   

 

 

   

 

 

 

NET CASH PROVIDED BY FINANCING ACTIVITIES

     32,671,082        35,631,694        13,298,107   
  

 

 

   

 

 

   

 

 

 

NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS

     3,144,873        (1,176,673     (9,410,057

CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD

     149,025        1,325,698        10,735,755   
  

 

 

   

 

 

   

 

 

 

CASH AND CASH EQUIVALENTS, END OF PERIOD

   $ 3,293,898      $ 149,025      $ 1,325,698   
  

 

 

   

 

 

   

 

 

 

Supplemental Information:

      

Interest paid during the period

   $ 4,565,262      $ 1,853,573      $ 637,791   

Supplemental non-cash information:

      

Paid-in-kind interest income

   $ 1,007,494      $ 1,062,687      $ 1,442,004   

Net accretion of discount on investments

   $ 666,849      $ 975,475      $ 1,191,822   

Amortization of deferred credit facility financing costs

   $ 903,289      $ 482,306      $ 674,724   

Stock dividend distribution

   $ 10,027,697      $ 13,180,503      $ 7,864,784   

See accompanying notes to consolidated financial statements.

 

F-13


Table of Contents

SARATOGA INVESTMENT CORP.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

February 28, 2014

Note 1. Organization and Basis of Presentation

Saratoga Investment Corp. (the “Company”, “we”, “our” and “us”) is a non-diversified closed end management investment company incorporated in Maryland that has elected to be treated and is regulated as a business development company (“BDC”) under the Investment Company Act of 1940 (the “1940 Act”). We commenced operations on March 23, 2007 as GSC Investment Corp. and completed our initial public offering (“IPO”) on March 28, 2007. We have elected to be treated as a regulated investment company (“RIC”) under subchapter M of the Internal Revenue Code (the “Code”). We expect to continue to qualify and to elect to be treated for tax purposes as a RIC. Our investment objective is to generate current income and, to a lesser extent, capital appreciation from our investments.

GSC Investment, LLC (the “LLC”) was organized in May 2006 as a Maryland limited liability company. As of February 28, 2007, the LLC had not yet commenced its operations and investment activities.

On March 21, 2007, the Company was incorporated and concurrently therewith the LLC was merged with and into the Company, with the Company as the surviving entity, in accordance with the procedure for such merger in the LLC’s limited liability company agreement and Maryland law. In connection with such merger, each outstanding limited liability company interest of the LLC was converted into a share of common stock of the Company.

On July 30, 2010, the Company changed its name from “GSC Investment Corp.” to “Saratoga Investment Corp.” in conjunction with the transaction described in “Note 14. Recapitalization Transaction” below.

We are externally managed and advised by our investment adviser, Saratoga Investment Advisors, LLC (the “Manager”), pursuant to the Management Agreement. Prior to July 30, 2010, we were managed and advised by GSCP (NJ), L.P.

On March 28, 2012, our wholly-owned subsidiary, Saratoga Investment Corp. SBIC, LP (“SBIC LP”), received a Small Business Investment Company (“SBIC”) license from the Small Business Administration (“SBA”).

The accompanying consolidated financial statements have been prepared on the accrual basis of accounting in conformity with U.S. generally accepted accounting principles (“U.S. GAAP”) and include the accounts of the Company and its special purpose financing subsidiary, Saratoga Investment Funding, LLC (previously known as GSC Investment Funding LLC). All intercompany accounts and transactions have been eliminated in consolidation. All references made to the “Company,” “we,” and “us” herein include Saratoga Investment Corp. and its consolidated subsidiary, except as stated otherwise.

Note 2. Summary of Significant Accounting Policies

Use of Estimates in the Preparation of Financial Statements

The preparation of the accompanying consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, and disclosure of contingent assets and liabilities at the date of the financial statements, and income, gains (losses) and expenses during the period reported. Actual results could differ materially from those estimates.

 

F-14


Table of Contents

Cash and Cash Equivalents

Cash and cash equivalents include short-term, liquid investments in a money market fund. Cash and cash equivalents are carried at cost which approximates fair value. Per section 12(d)(1)(A) of the 1940 Act, the Company may not invest in another registered investment company such as, a money market fund if such investment would cause the Company to exceed any of the following limitations:

 

    we were to own more than 3.0% of the total outstanding voting stock of the money market fund;

 

    we were to hold securities in the money market fund having an aggregate value in excess of 5.0% of the value of our total assets; or

 

    we were to hold securities in money market funds and other registered investment companies and BDCs having an aggregate value in excess of 10.0% of the value of our total assets.

Cash and Cash Equivalents, Reserve Accounts

Cash and cash equivalents, reserve accounts include amounts held in designated bank accounts in the form of cash and short-term liquid investments in money market funds representing payments received on secured investments or other reserved amounts associated with our $45.0 million senior secured revolving credit facility with Madison Capital Funding LLC. The Company is required to use these amounts to pay interest expense, reduce borrowings, or pay other amounts in accordance with the terms of the senior secured revolving credit facility.

Investment Classification

The Company classifies its investments in accordance with the requirements of the 1940 Act. Under the 1940 Act, “Control Investments” are defined as investments in companies in which we own more than 25.0% of the voting securities or maintain greater than 50.0% of the board representation. Under the 1940 Act, “Affiliated Investments” are defined as those non-control investments in companies in which we own between 5.0% and 25.0% of the voting securities. Under the 1940 Act, “Non-affiliated Investments” are defined as investments that are neither Control Investments nor Affiliated Investments.

Investment Valuation

The Company accounts for its investments at fair value in accordance with the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 820, Fair Value Measurements and Disclosures (“ASC 820”). ASC 820 defines fair value, establishes a framework for measuring fair value, establishes a fair value hierarchy based on the quality of inputs used to measure fair value and enhances disclosure requirements for fair value measurements. ASC 820 requires the Company to assume that its investments are to be sold at the statement of assets and liabilities date in the principal market to independent market participants, or in the absence of a principal market, in the most advantageous market, which may be a hypothetical market. Market participants are defined as buyers and sellers in the principal or most advantageous market that are independent, knowledgeable, and willing and able to transact.

Investments for which market quotations are readily available are fair valued at such market quotations obtained from independent third party pricing services and market makers subject to any decision by our board of directors to approve a fair value determination to reflect significant events affecting the value of these investments. We value investments for which market quotations are not readily available at fair value as approved, in good faith, by our board of directors based on input from our Manager, the audit committee of our board of directors and a third party independent valuation firm. Determinations of fair value may involve subjective judgments and estimates. The types of factors that may be considered in determining the fair value of our investments include the nature and realizable value of any collateral, the portfolio company’s ability to make payments, market yield trend analysis, the markets in which the portfolio company does business, comparison to publicly traded companies, discounted cash flow and other relevant factors.

 

F-15


Table of Contents

We undertake a multi-step valuation process each quarter when valuing investments for which market quotations are not readily available, as described below:

 

    Each investment is initially valued by the responsible investment professionals of our Manager and preliminary valuation conclusions are documented and discussed with the senior management of our Manager; and

 

    An independent valuation firm engaged by our board of directors reviews approximately one quarter of these preliminary valuations each quarter so that the valuation of each investment for which market quotes are not readily available is reviewed by the independent valuation firm at least annually.

In addition, all our investments are subject to the following valuation process:

 

    The audit committee of our board of directors reviews each preliminary valuation and our Manager and independent valuation firm (if applicable) will supplement the preliminary valuation to reflect any comments provided by the audit committee; and

 

    Our board of directors discusses the valuations and approves the fair value of each investment, in good faith, based on the input of our Manager, independent valuation firm (to the extent applicable) and the audit committee of our board of directors.

Our investment in Saratoga Investment Corp. CLO 2013-1, Ltd. (“Saratoga CLO”) is carried at fair value, which is based on a discounted cash flow model that utilizes prepayment, re-investment and loss assumptions based on historical experience and projected performance, economic factors, the characteristics of the underlying cash flow, and comparable yields for equity interests in collateralized loan obligation funds similar to Saratoga CLO, when available, as determined by our Manager and recommended to our board of directors. Specifically, we use Intex cash flow models, or an appropriate substitute, to form the basis for the valuation of our investment in Saratoga CLO. The models use a set of assumptions including projected default rates, recovery rates, reinvestment rate and prepayment rates in order to arrive at estimated valuations. The assumptions are based on available market data and projections provided by third parties as well as management estimates. We use the output from the Intex models (i.e., the estimated cash flows) to perform a discounted cash flows analysis on expected future cash flows to determine a valuation for our investment in Saratoga CLO.

Because such valuations, and particularly valuations of private investments and private companies, are inherently uncertain, they may fluctuate over short periods of time and may be based on estimates. The determination of fair value may differ materially from the values that would have been used if a ready market for these investments existed. Our net asset value could be materially affected if the determinations regarding the fair value of our investments were materially higher or lower than the values that we ultimately realize upon the disposal of such investments.

Derivative Financial Instruments

We account for derivative financial instruments in accordance with ASC Topic 815, Derivatives and Hedging (“ASC 815”). ASC 815 requires recognizing all derivative instruments as either assets or liabilities on the consolidated statements of assets and liabilities at fair value. The Company values derivative contracts at the closing fair value provided by the counterparty. Changes in the values of derivative contracts are included in the consolidated statements of operations.

Investment Transactions and Income Recognition

Purchases and sales of investments and the related realized gains or losses are recorded on a trade-date basis. Interest income, adjusted for amortization of premium and accretion of discount, is recorded on an accrual basis to the extent that such amounts are expected to be collected. The Company stops accruing interest on its investments when it is determined that interest is no longer collectible. Discounts and premiums on investments

 

F-16


Table of Contents

purchased are accreted/amortized over the life of the respective investment using the effective yield method. The amortized cost of investments represents the original cost adjusted for the accretion of discounts and amortizations of premium on investments.

Loans are generally placed on non-accrual status when there is reasonable doubt that principal or interest will be collected. Accrued interest is generally reserved when a loan is placed on non-accrual status. Interest payments received on non-accrual loans may be recognized as a reduction in principal depending upon management’s judgment regarding collectability. Non-accrual loans are restored to accrual status when past due principal and interest is paid and, in management’s judgment, are likely to remain current, although we may make exceptions to this general rule if the loan has sufficient collateral value and is in the process of collection.

Interest income on our investment in Saratoga CLO is recorded using the effective interest method in accordance with the provisions of ASC Topic 325-40, Investments-Other, Beneficial Interests in Securitized Financial Assets, (“ASC 325-40”), based on the anticipated yield and the estimated cash flows over the projected life of the investment. Yields are revised when there are changes in actual or estimated cash flows due to changes in prepayments and/or re-investments, credit losses or asset pricing. Changes in estimated yield are recognized as an adjustment to the estimated yield over the remaining life of the investment from the date the estimated yield was changed.

Paid-in-Kind Interest

The Company holds debt investments in its portfolio that contain a payment-in-kind (“PIK”) interest provision. The PIK interest, which represents contractually deferred interest added to the investment balance that is generally due at maturity, is generally recorded on the accrual basis to the extent such amounts are expected to be collected. We stop accruing PIK interest if we do not expect the issuer to be able to pay all principal and interest when due.

Deferred Debt Financing Costs

Financing costs incurred in connection with our credit facility are deferred and amortized using the straight line method over the life of their respective facilities. Financing costs incurred in connection with our SBA debentures are deferred and amortized using the effective yield method over the life of the debentures.

Contingencies

In the ordinary course of its business, the Company may enter into contracts or agreements that contain indemnifications or warranties. Future events could occur that lead to the execution of these provisions against the Company. Based on its history and experience, management feels that the likelihood of such an event is remote.

In the ordinary course of business, the Company may directly or indirectly be a defendant or plaintiff in legal actions with respect to bankruptcy, insolvency or other types of proceedings. Such lawsuits may involve claims that could adversely affect the value of certain financial instruments owned by the Company.

Income Taxes

The Company has filed an election to be treated for tax purposes as a RIC under Subchapter M of the Code and, among other things, intends to make the requisite distributions to its stockholders which will relieve the Company from federal income taxes. Therefore, no provision has been recorded for federal income taxes.

In order to qualify as a RIC, among other requirements, the Company is required to timely distribute to its stockholders at least 90.0% of its investment company taxable income, as defined by the Code, for each fiscal tax

 

F-17


Table of Contents

year. The Company will be subject to a nondeductible U.S. federal excise tax of 4.0% on undistributed income if it does not distribute at least 98.0% of its ordinary income in any calendar year and 98.2% of its capital gain net income for each one-year period ending on October 31.

Depending on the level of taxable income earned in a tax year, the Company may choose to carry forward taxable income in excess of current year dividend distributions into the next tax year and pay a 4.0% excise tax on such income, as required. To the extent that the Company determines that its estimated current year annual taxable income will be in excess of estimated current year dividend distributions for excise tax purposes, the Company accrues excise tax, if any, on estimated excess taxable income as taxable income is earned.

In accordance with certain applicable Treasury regulations and private letter rulings issued by the Internal Revenue Service, a RIC may treat a distribution of its own stock as fulfilling its RIC distribution requirements if each stockholder may elect to receive his or her entire distribution in either cash or stock of the RIC subject to a limitation on the aggregate amount of cash to be distributed to all stockholders, which limitation must be at least 20.0% of the aggregate declared distribution. If too many stockholders elect to receive cash, each stockholder electing to receive cash will receive a pro rata amount of cash (with the balance of the distribution paid in stock). In no event will any stockholder, electing to receive cash, receive less than 20.0% of his or her entire distribution in cash. If these and certain other requirements are met, for U.S federal income tax purposes, the amount of the dividend paid in stock will be equal to the amount of cash that could have been received instead of stock.

ASC 740, Income Taxes, (“ASC 740”), provides guidance for how uncertain tax positions should be recognized, measured, presented and disclosed in the financial statements. ASC 740 requires the evaluation of tax positions taken or expected to be taken in the course of preparing the Company’s tax returns to determine whether the tax positions are “more-likely-than-not” of being sustained by the applicable tax authority. Tax positions deemed to meet a “more-likely-than-not” threshold would be recorded as a tax benefit or expense in the current period. The Company recognizes interest and penalties, if any, related to unrecognized tax benefits as income tax expense in the consolidated statements of operations. During the fiscal year ended February 28, 2014, the Company did not incur any interest or penalties. Although we file federal and state tax returns, our major tax jurisdiction is federal. The 2011, 2012 and 2013 federal tax years for the Company remain subject to examination by the IRS.

Dividends

Dividends to common stockholders are recorded on the ex-dividend date. The amount to be paid out as a dividend is determined by the board of directors. Net realized capital gains, if any, are generally distributed at least annually, although we may decide to retain such capital gains for reinvestment.

We have adopted a dividend reinvestment plan that provides for reinvestment of our dividend distributions on behalf of our stockholders unless a stockholder elects to receive cash. As a result, if our board of directors authorizes, and we declare, a cash dividend, then our stockholders who have not “opted out” of our dividend reinvestment plan will have their cash dividends automatically reinvested in additional shares of our common stock, rather than receiving the cash dividends. If our common stock is trading below net asset value at the time of valuation, the plan administrator may receive the dividend or distribution in cash and purchase common stock in the open market, on the New York Stock Exchange or elsewhere, for the account of each participant in our dividend reinvestment plan.

Capital Gains Incentive Fee

The Company records an expense accrual on the consolidated statements of operations, relating to the capital gains incentive fee payable on the consolidated statements of assets and liabilities, by the Company to its investment adviser when the unrealized gains on its investments exceed all realized capital losses on its investments given the fact that a capital gains incentive fee would be owed to the investment adviser if the

 

F-18


Table of Contents

Company were to liquidate its investment portfolio at such time. The actual incentive fee payable to the Company’s investment adviser related to capital gains will be determined and payable in arrears at the end of each fiscal year and will include only realized capital gains for the period.

New Accounting Pronouncements

In June 2013, the FASB issued ASU 2013-08, “Financial Services—Investment Companies (Topic 946): Amendments to the Scope, Measurement, and Disclosure Requirements,” which amends the criteria that define an investment company and clarifies the measurement guidance and requires new disclosures for investment companies. Under ASU 2013-08, an entity already regulated under the 1940 Act will be automatically deemed an investment company under the new GAAP definition. As such, the Company anticipates no impact from adopting this standard on the Company’s consolidated financial results. The Company is currently assessing the additional disclosure requirements. ASU 2013-08 will be effective for interim and annual reporting periods in fiscal years that begin after December 15, 2013.

Risk Management

In the ordinary course of its business, the Company manages a variety of risks, including market risk and credit risk. Market risk is the risk of potential adverse changes to the value of investments because of changes in market conditions such as interest rate movements and volatility in investment prices.

Credit risk is the risk of default or non-performance by portfolio companies, equivalent to the investment’s carrying amount.

The Company is also exposed to credit risk related to maintaining all of its cash and cash equivalents, including those in reserve accounts, at a major financial institution and credit risk related to any of its derivative counterparties.

The Company has investments in lower rated and comparable quality unrated high yield bonds and bank loans. Investments in high yield investments are accompanied by a greater degree of credit risk. The risk of loss due to default by the issuer is significantly greater for holders of high yield securities, because such investments are generally unsecured and are often subordinated to other creditors of the issuer.

Note 3. Investments

As noted above, the Company values all investments in accordance with ASC 820. ASC 820 requires enhanced disclosures about assets and liabilities that are measured and reported at fair value. As defined in ASC 820, fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date.

ASC 820 establishes a hierarchal disclosure framework which prioritizes and ranks the level of market price observability of inputs used in measuring investments at fair value. Market price observability is affected by a number of factors, including the type of investment and the characteristics specific to the investment. Investments with readily available active quoted prices or for which fair value can be measured from actively quoted prices generally will have a higher degree of market price observability and a lesser degree of judgment used in measuring fair value.

Based on the observability of the inputs used in the valuation techniques, the Company is required to provide disclosures on fair value measurements according to the fair value hierarchy. The fair value hierarchy ranks the observability of the inputs used to determine fair values. Investments carried at fair value are classified and disclosed in one of the following three categories:

 

    Level 1—Valuations based on quoted prices in active markets for identical assets or liabilities that the Company has the ability to access.

 

F-19


Table of Contents
    Level 2—Valuations based on inputs other than quoted prices in active markets, which are either directly or indirectly observable.

 

    Level 3—Valuations based on inputs that are unobservable and significant to the overall fair value measurement. The inputs used in the determination of fair value may require significant management judgment or estimation. Such information may be the result of consensus pricing information or broker quotes which include a disclaimer that the broker would not be held to such a price in an actual transaction. The non-binding nature of consensus pricing and/or quotes accompanied by disclaimer would result in classification as Level 3 asset, assuming no additional corroborating evidence.

In addition to using the above inputs in investment valuations, the Company continues to employ the valuation policy approved by the board of directors that is consistent with ASC 820 and the 1940 Act (see Note 2). Consistent with our Company’s valuation policy, we evaluate the source of inputs, including any markets in which our investments are trading, in determining fair value.

The following table presents fair value measurements of investments, by major class, as of February 28, 2014 (dollars in thousands), according to the fair value hierarchy:

 

     Fair Value Measurements  
     Level 1      Level 2      Level 3      Total  

Syndicated loans

   $ —         $ —         $ 32,390       $ 32,390   

First lien term loans

     —           —           80,246         80,246   

Second lien term loans

     —           —           27,804         27,804   

Senior secured notes

     —           —           30,032         30,032   

Unsecured notes

     —           —           5,471         5,471   

Structured finance securities

     —           —           19,570         19,570   

Equity interest

     —           —           10,332         10,332   
  

 

 

    

 

 

    

 

 

    

 

 

 

Total

$ —      $ —      $ 205,845    $ 205,845   
  

 

 

    

 

 

    

 

 

    

 

 

 

The following table presents fair value measurements of investments, by major class, as of February 28, 2013 (dollars in thousands), according to the fair value hierarchy:

 

     Fair Value Measurements  
     Level 1      Level 2      Level 3      Total  

First lien term loans

   $ —         $ —         $ 83,792       $ 83,792   

Second lien term loans

     —           —           9,571         9,571   

Senior secured notes

     —           —           23,305         23,305   

Unsecured notes

     —           —           4,874         4,874   

Structured finance securities

     —           —           25,517         25,517   

Equity interest

     —           —           8,021         8,021   
  

 

 

    

 

 

    

 

 

    

 

 

 

Total

$ —      $ —      $ 155,080    $ 155,080   
  

 

 

    

 

 

    

 

 

    

 

 

 

 

F-20


Table of Contents

The following table provides a reconciliation of the beginning and ending balances for investments that use Level 3 inputs for the year ended February 28, 2014 (dollars in thousands):

 

    Syndicated
loans
    First lien
term loans
    Second
lien
term loans
    Senior
secured
notes
    Unsecured
notes
    Structured
finance
securities
    Common
stock/equities
    Total  

Balance as of February 28, 2013

  $ —        $ 83,792      $ 9,571      $ 23,305      $ 4,874      $ 25,517      $ 8,021      $ 155,080   

Net unrealized gains (losses)

    407        (395     165        41        207        (3,558     1,485        (1,648

Purchases and other adjustments to cost

    37,048        49,329        20,727        14,414        390        —          841        122,749   

Sales and redemptions

    (5,138     (53,162     (3,030     (7,728     —          (2,389     (160     (71,607

Net realized gain (loss) from investments

    73        682        371        —          —          —          145        1,271   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Balance as of February 28, 2014

$ 32,390    $ 80,246    $ 27,804    $ 30,032    $ 5,471    $ 19,570    $ 10,332    $ 205,845   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Purchases and other adjustments to cost include purchases of new investments at cost, effects of refinancing/restructuring, accretion/amortization of income from discount/premium on debt securities, and PIK.

Sales and redemptions represent net proceeds received from investments sold, and principal paydowns received, during the period.

The net change in unrealized gain/(loss) on investments held as of February 28, 2014 is $(1,767,285) and is included in net unrealized appreciation (depreciation) on investments in the consolidated statements of operations.

The following table provides a reconciliation of the beginning and ending balances for investments that use Level 3 inputs for the year ended February 28, 2013 (dollars in thousands):

 

    First lien
term loans
    Second lien
term loans
    Senior
secured
notes
    Senior
unsecured
loans
    Unsecured
notes
    Structured
finance
securities
    Common
stock/equities
    Total  

Balance as of February 29, 2012

  $ 36,196      $ 8,914      $ 10,706      $ 6,000      $ 2,008      $ 25,846      $ 5,690      $ 95,360   

Net unrealized gains (losses)

    2,090        657        (403     (148     (169     4,267        719        7,013   

Purchases and other adjustments to cost

    52,872        3,005        13,002        107        3,035        —          1,612        73,633   

Sales and redemptions

    (7,564     (3,092     —          (6,090     —          (4,596     (146     (21,488

Net realized gain (loss) from investments

    198        87        —          131        —          —          146        562   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Balance as of February 28, 2013

$ 83,792    $ 9,571    $ 23,305    $ —      $ 4,874    $ 25,517    $ 8,021    $ 155,080   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Purchases and other adjustments to cost include purchases of new investments at cost, effects of refinancing/restructuring, accretion/amortization of income from discount/premium on debt securities, and PIK.

Sales and redemptions represent net proceeds received from investments sold, and principal paydowns received, during the period.

 

F-21


Table of Contents

The net change in unrealized gain/loss on investments held as of February 28, 2013 is $7,143,012 and is included in net unrealized appreciation (depreciation) on investments in the consolidated statements of operations.

The valuation techniques and significant unobservable inputs used in recurring Level 3 fair value measurements of assets as of February 28, 2014 were as follows (dollars in thousands):

 

     Fair Value     

Valuation Technique

  

Unobservable Input

   Range

Syndicated loans

   $ 32,390       Market Comparables    Third-Party Bid    99.5 - 100.6

First lien term loans

     80,246       Market Comparables   

Market Yield (%)

EBITDA Multiples (x) Third-Party Bid

   5.1% - 15.5%

3.0x

83.3 - 101.5

Second lien term loans

     27,804       Market Comparables   

Market Yield (%)

Third-Party Bid

   9.6% - 12.5%

100.0 - 101.8

Senior secured notes

     30,032       Market Comparables    Market Yield (%) EBITDA Multiples (x) Third-Party Bid    11.0% - 42.5%

5.0x

106.0 - 107.5

Unsecured notes

     5,471       Market Comparables    Market Yield (%)    12.8% - 20.3%

Structured finance securities

     19,570       Discounted Cash Flow    Discount Rate (%)    9.0%

Equity interests

     10,332       Market Comparables    EBITDA Multiples (x)    6.3x - 12.0x

The valuation techniques and significant unobservable inputs used in recurring Level 3 fair value measurements of assets as of February 28, 2013 were as follows (dollars in thousands):

 

     Fair Value      Valuation Technique   

Unobservable Input

   Range

First lien term loans

   $ 83,792       Market Comparables   

Market Yield (%)

EBITDA Multiples (x) Third-Party Bid

   5.8% - 26.9%

3.0x

96.5 - 102.0

Second lien term loans

     9,571       Market Comparables    Market Yield (%) Third-Party Bid    11.5%

90.5

Senior secured notes

     23,305       Market Comparables    Market Yield (%) EBITDA Multiples (x) Third-Party Bid    14.0% - 42.5%

5.5x

89.0 - 101.0

Unsecured notes

     4,874       Market Comparables    Market Yield (%)    13.6% - 23.8%

Structured finance securities

     25,517       Discounted Cash Flow    Discount Rate (%)    13.0%

Equity interests

     8,021       Market Comparables    EBITDA Multiples (x)    3.0x - 8.9x

For investments utilizing a market comparables valuation technique, a significant increase (decrease) in the market yield, in isolation, would result in a significantly lower (higher) fair value measurement, and a significant increase (decrease) in any of the EBITDA valuation multiples, in isolation, would result in a significantly higher (lower) fair value measurement. For investments utilizing a discounted cash flow valuation technique, a significant increase (decrease) in the discount rate, in isolation, would result in a significantly lower (higher) fair value measurement.

The composition of our investments as of February 28, 2014, at amortized cost and fair value were as follows (dollars in thousands):

 

     Investments at
Amortized Cost
     Amortized Cost
Percentage of
Total Portfolio
    Investments at
Fair Value
     Fair Value
Percentage of
Total Portfolio
 

Syndicated loans

   $ 31,983         15.8   $ 32,390         15.7

First lien term loans

     80,734         40.0        80,246         39.0   

Second lien term loans

     27,540         13.6        27,804         13.5   

 

F-22


Table of Contents
     Investments at
Amortized Cost
     Amortized Cost
Percentage of
Total Portfolio
    Investments at
Fair Value
     Fair Value
Percentage of
Total Portfolio
 

Senior secured notes

     31,304         15.6        30,032         14.6   

Unsecured notes

     7,149         3.5        5,471         2.7   

Structured finance securities

     16,556         8.2        19,570         9.5   

Equity interest

     6,556         3.3        10,332         5.0   
  

 

 

    

 

 

   

 

 

    

 

 

 

Total

   $ 201,822         100.0   $ 205,845         100.0
  

 

 

    

 

 

   

 

 

    

 

 

 

The composition of our investments as of February 28, 2013, at amortized cost and fair value were as follows (dollars in thousands):

 

     Investments at
Amortized Cost
     Amortized Cost
Percentage of
Total Portfolio
    Investments at
Fair Value
     Fair Value
Percentage of
Total Portfolio
 

First lien term loans

   $ 83,886         56.2   $ 83,792         54.0

Second lien term loans

     9,473         6.3        9,571         6.2   

Senior secured notes

     24,619         16.5        23,305         15.0   

Unsecured notes

     6,758         4.5        4,874         3.1   

Structured finance securities

     18,945         12.7        25,517         16.5   

Equity interest

     5,729         3.8        8,021         5.2   
  

 

 

    

 

 

   

 

 

    

 

 

 

Total

   $ 149,410         100.0   $ 155,080         100.0
  

 

 

    

 

 

   

 

 

    

 

 

 

For loans and debt securities for which market quotations are not available, we determine their fair value based on third party indicative broker quotes, where available, or the assumptions that a hypothetical market participant would use to value the security in a current hypothetical sale using a market yield valuation methodology. In applying the market yield valuation methodology, we determine the fair value based on such factors as market participant assumptions including synthetic credit ratings, estimated remaining life, current market yield and interest rate spreads of similar securities as of the measurement date. If, in our judgment, the market yield methodology is not sufficient or appropriate, we may use additional methodologies such as an asset liquidation or expected recovery model.

For equity securities of portfolio companies and partnership interests, we determine the fair value based on the market approach with value then attributed to equity or equity like securities using the enterprise value waterfall valuation methodology. Under the enterprise value waterfall valuation methodology, we determine the enterprise fair value of the portfolio company and then waterfall the enterprise value over the portfolio company’s securities in order of their preference relative to one another. To estimate the enterprise value of the portfolio company, we weigh some or all of the traditional market valuation methods and factors based on the individual circumstances of the portfolio company in order to estimate the enterprise value. The methodologies for performing investments may be based on, among other things: valuations of comparable public companies, recent sales of private and public comparable companies, discounting the forecasted cash flows of the portfolio company, third party valuations of the portfolio company, considering offers from third parties to buy the company, estimating the value to potential strategic buyers and considering the value of recent investments in the equity securities of the portfolio company. For non-performing investments, we may estimate the liquidation or collateral value of the portfolio company’s assets and liabilities. We also take into account historical and anticipated financial results.

Our investment in Saratoga Investment Corp. CLO 2013-1, Ltd. (“Saratoga CLO”) is carried at fair value, which is based on a discounted cash flow model that utilizes prepayment, re-investment and loss assumptions based on historical experience and projected performance, economic factors, the characteristics of the underlying cash flow, and comparable yields for equity interests in collateralized loan obligation funds similar to Saratoga

 

F-23


Table of Contents

CLO, when available, as determined by our Manager and recommended to our board of directors. Specifically, we use Intex cash flow models, or an appropriate substitute, to form the basis for the valuation of our investment in Saratoga CLO. The models use a set of assumptions including projected default rates, recovery rates, reinvestment rate and prepayment rates in order to arrive at estimated valuations. The assumptions are based on available market data and projections provided by third parties as well as management estimates. For the quarter ended November 30, 2013, in connection with the refinancing of the Saratoga CLO liabilities, we ran Intex models based on assumptions about the refinanced Saratoga CLO’s structure, including capital structure, cost of liabilities and reinvestment period. We use the output from the Intex models (i.e., the estimated cash flows) to perform a discounted cash flows analysis on expected future cash flows to determine a valuation for our investment in Saratoga CLO at February 28, 2014. The significant inputs for the valuation model include:

 

    Default rates: 2.0%

 

    Recovery rates: 35-75%

 

    Prepayment rate: 25.0%

 

    Reinvestment rate / price: L+375bps / $99.75

Note 4. Investment in Saratoga Investment Corp. CLO 2013-1, Ltd. (“Saratoga CLO”)

On January 22, 2008, we invested $30 million in all of the outstanding subordinated notes of GSC Investment Corp. CLO 2007, Ltd., a collateralized loan obligation fund managed by us that invests primarily in senior secured loans. Additionally, we entered into a collateral management agreement with GSC Investment Corp. CLO 2007, Ltd. pursuant to which we act as collateral manager to it. The Saratoga CLO was refinanced in October 2013 and its reinvestment period ends in October 2016. The Saratoga CLO remains 100% owned and managed by Saratoga Investment Corp. We receive a base management fee of 0.25% and a subordinated management fee of 0.25% of the Fee Basis Amount at the beginning of the Collection Period, paid quarterly to the extent of available proceeds. We are also entitled to an incentive management fee equal to 20.0% of the remaining interest proceeds and principal proceeds, if any, after the subordinated notes have realized the incentive management fee target return of 12.0%, in accordance with the Priority of Payments after making the prior distributions on the relevant payment date. For the years ended February 28, 2014 and 2013, and February 29, 2012, we accrued $1.8 million, $2.0 million and $2.0 million in management fee income, respectively, and $3.4 million, $4.2 million and $4.2 million in interest income, respectively, from Saratoga CLO. We did not accrue any amounts related to the incentive management fee as the 12.0% hurdle rate has not yet been achieved.

At February 28, 2014, the Company determined that the fair value of its investment in the subordinated notes of Saratoga CLO was $19.6 million. The Company determines the fair value of its investment in the subordinated notes of Saratoga CLO based on the present value of the projected future cash flows of the subordinated notes over the life of Saratoga CLO. At February 28, 2014, Saratoga CLO had investments with a principal balance of $301.3 million and a weighted average spread over LIBOR of 4.1%, and had debt with a principal balance of $284.1 million with a weighted average spread over LIBOR of 1.8%. As a result, Saratoga CLO earns a “spread” between the interest income it receives on its investments and the interest expense it pays on its debt and other operating expenses, which is distributed quarterly to the Company as the holder of its subordinated notes. At February 28, 2014, the total “spread”, or projected future cash flows of the subordinated notes, over the life of Saratoga CLO was $24.9 million, which had a present value of approximately $20.2 million, using a 9.0% discount rate.

At February 28, 2013, the Company determined that the fair value of its investment in the subordinated notes of Saratoga CLO was $25.5 million, whereas the net asset value of Saratoga CLO on such date was $30.8 million. The Company does not believe that the net asset value of Saratoga CLO, which is the difference between Saratoga CLO’s assets and liabilities at a given point in time, necessarily equates to the fair value of its

 

F-24


Table of Contents

investment in the subordinated notes of Saratoga CLO. Specifically, the Company determines the fair value of its investment in the subordinated notes of Saratoga CLO based on the present value of the projected future cash flows of the subordinated notes over the life of Saratoga CLO. At February 28, 2013, Saratoga CLO had investments with a principal balance of $383.3 million and a weighted average spread over LIBOR of 4.3%, and had debt with a principal balance of $366.0 million with a weighted average spread over LIBOR of 1.4%. As a result, Saratoga CLO earns a “spread” between the interest income it receives on its investments and the interest expense it pays on its debt and other operating expenses, which is distributed quarterly to the Company as the holder of its subordinated notes. At February 28, 2013, the total “spread”, or projected future cash flows of the subordinated notes, over the life of Saratoga CLO was $38.7 million, which had a present value of approximately $26.0 million, using a 13.0% discount rate. At February 28, 2013, the fair value of the subordinated notes, which we base upon the present value of the projected cash flows, was $25.5 million, which was less than the net asset value of Saratoga CLO on such date by approximately $5.3 million.

The separate audited financial statements of Saratoga CLO as of February 28, 2014 and 2013, pursuant to Rule 3-09 of SEC rules Regulation S-X, and for the twelve months ended February 28, 2014 and 2013 and February 29, 2012, are presented on page S-1.

Note 5. Income Taxes

The Company intends to operate so as to qualify to be taxed as a RIC under Subchapter M of the Code and, as such, will not be subject to federal income tax on the portion of taxable income and gains distributed to stockholders.

The Company owns 100.0% of Saratoga CLO, an exempted company incorporated in the Cayman Islands. For financial reporting purposes, the Saratoga CLO is not included as part of the consolidated financial statements. For federal income tax purposes, the Company has requested and received approval from the Internal Revenue Service to treat the Saratoga CLO as a disregarded entity. As such, for federal income tax purposes and for purposes of meeting the RIC qualification and diversification tests, the results of operations of the Saratoga CLO are included with those of the Company.

To qualify as a RIC, the Company is required to meet certain income and asset diversification tests in addition to distributing at least 90.0% of its investment company taxable income, as defined by the Code. Because federal income tax regulations differ from U.S. GAAP, distributions in accordance with tax regulations may differ from net investment income and realized gains recognized for financial reporting purposes. Differences may be permanent or temporary in nature. Permanent differences are reclassified among capital accounts in the financial statements to reflect their tax character. Differences in classification may also result from the treatment of short-term gains as ordinary income for tax purposes. As of February 28, 2014 and February 28, 2013, the Company reclassified for book purposes amounts arising from permanent book/tax differences primarily related to nondeductible excise tax, meals & entertainment, market discount, interest income with respect to the Saratoga CLO which is consolidated for tax purposes and the tax character of distributions as follows (dollars in thousands):

 

     February 28,
2014
     February 28,
2013
 

Accumulated net investment income/(loss)

   $ (1,691    $ (1,155

Accumulated net realized gains (losses) on investments

     1,691         1,155   

Additional paid-in-capital

     —           —     

 

F-25


Table of Contents

For income tax purposes, distributions paid to shareholders are reported as ordinary income, return of capital, long term capital gains or a combination thereof. The tax character of distributions paid for the years ended February 28, 2014 and February 28, 2013 was as follows (dollars in thousands):

 

     February 28,
2014
     February 28,
2013
 

Ordinary Income

   $ 12,535       $ 16,476   

Capital gains

     —           —     

Return of capital

     —           —     
  

 

 

    

 

 

 

Total

$ 12,535    $ 16,476   
  

 

 

    

 

 

 

For federal income tax purposes, as of February 28, 2014, the aggregate net unrealized depreciation for all securities is $0.04 million. The aggregate cost of securities for federal income tax purposes is $486.8 million.

For federal income tax purposes, as of February 28, 2013, the aggregate net unrealized depreciation for all securities is $2.7 million. The aggregate cost of securities for federal income tax purposes is $506.7 million.

At February 28, 2014 and February 28, 2013, the components of accumulated losses on a tax basis as detailed below differ from the amounts reflected per the Company’s consolidated statements of assets and liabilities by temporary book/tax differences primarily arising from the consolidation of the Saratoga CLO for tax purposes, market discount and original issue discount income, interest income accrual on defaulted bonds, write-off of investments, and amortization of organizational expenditures (dollars in thousands):

 

     February 28,
2014
     February 28,
2013
 

Post October loss deferred

   $ —         $ —     

Accumulated capital losses

     (64,101      (58,248

Other temporary differences

     (304      (1,515

Undistributed ordinary income

     963         3,927   

Unrealized depreciation

     (41      (2,750
  

 

 

    

 

 

 

Total components of accumulated losses

$ (63,483 $ (58,586
  

 

 

    

 

 

 

The Company has incurred capital losses of $19.3, $14.1 and $3.2 million for the years ended February 28, 2011, 2010 and 2009. Such capital losses will be available to offset future capital gains if any and if unused, will expire on February 28, 2019, 2018 and 2017.

At February 28, 2014, the Company had a short term capital loss of $11.2 million and a long-term capital loss of $16.3 million available to offset future capital gains. Post RIC-modernization act losses are deemed to arise on the first day of the fund’s following fiscal year and there is no expiration for these losses.

Management has analyzed the Company’s tax positions taken on federal income tax returns for all open years (fiscal years 2010-2014), and has concluded that no provision for uncertain income tax positions is required in the Company’s financial statements.

On December 22, 2010, the Regulated Investment Company Modernization Act of 2010 (the “Modernization Act”) was enacted, and the provisions with the Modernization Act are effective for the Company for the year ended February 29, 2012. The Modernization Act is the first major piece of legislation affecting RICs since 1986 and it modernizes several of the federal income and excise tax provisions related to RICs. Some highlights of the enacted provisions are as follows:

New capital losses may now be carried forward indefinitely, and retain the character of the original loss. Under pre-enactment law, capital losses could be carried forward for eight years, and carried forward as short-term capital, irrespective of the character of the original loss.

 

F-26


Table of Contents

The Modernization Act contains simplification provisions, which are aimed at preventing disqualification of a RIC for “inadvertent” failures of the asset diversification and/or qualifying income tests. Additionally, the Modernization Act exempts RICs from the preferential dividend rule, and repealed the 60-day designation requirement for certain types of pay-through income and gains.

Finally, the Modernization Act contains several provisions aimed at preserving the character of distributions made by a fiscal year RIC during the portion of its taxable year ending after October 31 or December 31, reducing the circumstances under which a RIC might be required to file amended Forms 1099 to restate previously reported distributions.

Note 6. Agreements and-Related Party Transactions

On July 30, 2010, the Company entered into the Management Agreement with our Manager. The initial term of the Management Agreement is two years, with automatic, one-year renewals at the end of each year subject to certain approvals by our board of directors and/or our stockholders. On July 15, 2013, our board of directors approved the renewal of the Management Agreement for an additional one-year term. Pursuant to the Management Agreement, our Manager implements our business strategy on a day-to-day basis and performs certain services for us, subject to oversight by our board of directors. Our Manager is responsible for, among other duties, determining investment criteria, sourcing, analyzing and executing investments transactions, asset sales, financings and performing asset management duties. Under the Management Agreement, we have agreed to pay our Manager a management fee for investment advisory and management services consisting of a base management fee and an incentive fee.

The base management fee of 1.75% is calculated based on the average value of our gross assets (other than cash or cash equivalents, but including assets purchased with borrowed funds) at the end of the two most recently completed fiscal quarters, and appropriately adjusted for any share issuances or repurchases during the applicable fiscal quarter.

The incentive fee consists of the following two parts:

The first, payable quarterly in arrears, equals 20.0% of our pre-incentive fee net investment income, expressed as a rate of return on the value of our net assets at the end of the immediately preceding quarter, that exceeds a 1.875% quarterly (7.5% annualized) hurdle rate measured as of the end of each fiscal quarter, subject to a “catch-up” provision. Under this provision, in any fiscal quarter, our Manager receives no incentive fee unless our pre-incentive fee net investment income exceeds the hurdle rate of 1.875%. Our Manager will receive 100.0% of pre-incentive fee net investment income, if any, that exceeds the hurdle rate but is less than or equal to 2.344% in any fiscal quarter (9.376% annualized); and 20.0% of the amount of the our pre-incentive fee net investment income, if any, that exceeds 2.344% in any fiscal quarter (9.376% annualized).

The second part of the incentive fee is determined and payable in arrears as of the end of each fiscal year (or upon termination of the Management Agreement) and equals 20.0% of our “incentive fee capital gains,” which equals our realized capital gains on a cumulative basis from May 31, 2010 through the end of the year, if any, computed net of all realized capital losses and unrealized capital depreciation on a cumulative basis, less the aggregate amount of any previously paid capital gain incentive fee. Importantly, the capital gains portion of the incentive fee is based on realized gains and realized and unrealized losses from May 31, 2010. Therefore, realized and unrealized losses incurred prior to such time will not be taken into account when calculating the capital gains portion of the incentive fee, and our Manager will be entitled to 20.0% of incentive fee capital gains that arise after May 31, 2010. In addition, for the purpose of the “incentive fee capital gains” calculations, the cost basis for computing realized gains and losses on investments held by us as of May 31, 2010 will equal the fair value of such investments as of such date.

For the years ended February 28, 2014, February 28, 2013, and February 29, 2012, we incurred $3.3 million, $2.1 million, and $1.6 million in base management fees, respectively. For the years ended February 28, 2014,

 

F-27


Table of Contents

February 28, 2013, and February 29, 2012, we incurred $0.7 million, $1.0 million, and $0.5 million in incentive fees related to pre-incentive fee net investment income. For the year ended February 28, 2014, there was a reduction of $0.3 million in incentive fees related to capital gains. For the years ended February 28, 2013 and February 29, 2012, we accrued $1.0 million and $0.7 million in incentive management fees related to capital gains, respectively. The accrual is calculated using both realized and unrealized capital gains for the period. The actual incentive fee related to capital gains will be determined and payable in arrears at the end of the fiscal year and will include only realized capital gains for the period. As of February 28, 2014, the base management fees accrual was $0.9 million and the incentive fees accrual was $3.0 million and is included in management and incentive fees payable in the accompanying consolidated statements of assets and liabilities. As of February 28, 2013, the base management fees accrual was $0.6 million and incentive fees accrual was $3.9 million and is included in management and incentive fees payable in the accompanying consolidated statements of assets and liabilities.

On July 30, 2010, the Company entered into a separate administration agreement (the “Administration Agreement”) with our Manager, pursuant to which our Manager, as our administrator, has agreed to furnish us with the facilities and administrative services necessary to conduct our day-to-day operations and provide managerial assistance on our behalf to those portfolio companies to which we are required to provide such assistance. The initial term of the Administration Agreement is two years, with automatic, one-year renewals at the end of each year subject to certain approvals by our board of directors and/or our stockholders. The amount of expenses payable or reimbursable thereunder by the Company is capped at $1.0 million for the initial two year term of the administration agreement. On July 15, 2013, our board of directors approved the renewal of the Administration Agreement for an additional one-year term and determined to maintain the cap on the payment or reimbursement of expenses by the Company thereunder to $1.0 million for the additional one-year term.

For the years ended February 28, 2014, February 28, 2013, and February 29, 2012, we recognized $1.0 million, $1.0 million, and $1.0 million in administrator expenses for the periods, respectively, pertaining to bookkeeping, record keeping and other administrative services provided to us in addition to our allocable portion of rent and other overhead related expenses. As of February 28, 2014, $0.4 million of administrator expenses were accrued and included in due to manager in the accompanying consolidated statements of assets and liabilities. As of February 28, 2013, $0.2 million of administrator expenses were accrued and included in due to manager in the accompanying consolidated statements of assets and liabilities. For the years ended February 28, 2014 and 2013, and February 29, 2012, the Company bought investments fair valued at $0.3 million, $0.0 million and $15.6 million, respectively, from the Saratoga CLO and sold no investments to related parties.

Note 7. Borrowings

Credit Facility

As a BDC, we are only allowed to employ leverage to the extent that our asset coverage, as defined in the 1940 Act, equals at least 200.0% after giving effect to such leverage. The amount of leverage that we employ at any time depends on our assessment of the market and other factors at the time of any proposed borrowing.

On April 11, 2007, we entered into a $100.0 million revolving securitized credit facility (the “Revolving Facility”). On May 1, 2007, we entered into a $25.7 million term securitized credit facility (the “Term Facility” and, together with the Revolving Facility, the “Facilities”), which was fully drawn at closing. In December 2007, we consolidated the Facilities by using a draw under the Revolving Facility to repay the Term Facility. In response to the market wide decline in financial asset prices, which negatively affected the value of our portfolio, we terminated the revolving period of the Revolving Facility effective January 14, 2009 and commenced a two-year amortization period during which all principal proceeds from the collateral was used to repay outstanding borrowings. A significant percentage of our total assets had been pledged under the Revolving Facility to secure our obligations thereunder. Under the Revolving Facility, funds were borrowed from or through certain lenders and interest was payable monthly at the greater of the commercial paper rate and our lender’s

 

F-28


Table of Contents

prime rate plus 4.00% plus a default rate of 2.00% or, if the commercial paper market was unavailable, the greater of the prevailing LIBOR rates and our lender’s prime rate plus 6.00% plus a default rate of 3.00%.

In March 2009, we amended the Revolving Facility to increase the portion of the portfolio that could be invested in “CCC” rated investments in return for an increased interest rate and expedited amortization. As a result of these transactions, we expected to have additional cushion under our borrowing base under the Revolving Facility that would allow us to better manage our capital in times of declining asset prices and market dislocation.

On July 30, 2009, we exceeded the permissible borrowing limit under the Revolving Facility for 30 consecutive days, resulting in an event of default under the Revolving Facility. As a result of this event of default, our lender had the right to accelerate repayment of the outstanding indebtedness under the Revolving Facility and to foreclose and liquidate the collateral pledged thereunder. Acceleration of the outstanding indebtedness and/or liquidation of the collateral could have had a material adverse effect on our liquidity, financial condition and operations.

On July 30, 2010, we used the net proceeds from (i) the stock purchase transaction and (ii) a portion of the funds available to us under the $45.0 million senior secured revolving credit facility (the “Credit Facility”) with Madison Capital Funding LLC, in each case, described in “Note 14. Recapitalization Transaction” below, to pay the full amount of principal and accrued interest, including default interest, outstanding under the Revolving Facility. As a result, the Revolving Facility was terminated in connection therewith. Substantially all of our total assets, other than those held by SBIC LP, have been pledged under the Credit Facility to secure our obligations thereunder.

On February 24, 2012, we amended our senior secured revolving credit facility with Madison Capital Funding LLC to, among other things:

 

    expand the borrowing capacity under the credit facility from $40.0 million to $45.0 million;

 

    extend the period during which we may make and repay borrowings under the credit facility from July 30, 2013 to February 24, 2015 (the “Revolving Period”). The Revolving Period may upon the occurrence of an event of default, by action of the lenders or automatically. All borrowings and other amounts payable under the credit facility are due and payable five years after the end of the Revolving Period; and

 

    remove the condition that we may not acquire additional loan assets without the prior written consent of Madison Capital Funding LLC.

As of February 28, 2014, there was no outstanding balance under the Credit Facility and the Company was in compliance with all of the limitations and requirements of the Credit Facility. $2.3 million of financing costs related to the Credit Facility have been capitalized and are being amortized over the term of the facility. For the years ended February 28, 2014, February 28, 2013 and February 29, 2012, we recorded $1.0 million, $2.0 million, and $0.6 million of interest expense, respectively. For the years ended February 28, 2014, February 28, 2013 and February 29, 2012, we recorded $0.4 million, $0.4 million and $0.7 million of amortization of deferred financing costs related to the Credit Facility and Revolving Facility, respectively. The interest rates during the years ended February 28, 2014, February 28, 2013 and February 29, 2012 on the outstanding borrowings under the Credit Facility ranged from 7.50% to 7.50%, 7.50% to 7.50%, and 7.50% to 7.50%, respectively.

The Credit Facility contains limitations as to how borrowed funds may be used, such as restrictions on industry concentrations, asset size, weighted average life, currency denomination and collateral interests. The Credit Facility also includes certain requirements relating to portfolio performance, the violation of which could result in the limit of further advances and, in some cases, result in an event of default, allowing the lenders to accelerate repayment of amounts owed thereunder. The Credit Facility has an eight year term, consisting of a

 

F-29


Table of Contents

three year period (the “Revolving Period”), under which the Company may make and repay borrowings, and a final maturity five years from the end of the Revolving Period. Availability on the Credit Facility will be subject to a borrowing base calculation, based on, among other things, applicable advance rates (which vary from 50.0% to 75.0% of par or fair value depending on the type of loan asset) and the value of certain “eligible” loan assets included as part of the Borrowing Base. Funds may be borrowed at the greater of the prevailing LIBOR rate and 2.00%, plus an applicable margin of 5.50%. At the Company’s option, funds may be borrowed based on an alternative base rate, which in no event will be less than 3.00%, and the applicable margin over such alternative base rate is 4.50%. In addition, the Company will pay the lenders a commitment fee of 0.75% per year on the unused amount of the Credit Facility for the duration of the Revolving Period.

Our borrowing base under the Credit Facility was $44.6 million subject to the Credit Facility cap of $45.0 million at February 28, 2014. For purposes of determining the borrowing base, most assets are assigned the values set forth in our most recent Annual Report on Form 10-K or Quarterly Report on Form 10-Q filed with the SEC. Accordingly, the February 28, 2014 borrowing base relies upon the valuations set forth in the Annual Report on Form 10-K for the year ended February 28, 2013. The valuations presented in this Annual Report on Form 10-K will not be incorporated into the borrowing base until after this Annual Report on Form 10-K is filed with the SEC.

SBA Debentures

SBIC LP is able to borrow funds from the SBA against regulatory capital (which approximates equity capital) that is paid in and is subject to customary regulatory requirements including but not limited to an examination by the SBA. As of February 28, 2014, we have funded SBIC LP with $32.0 million of equity capital, and have $50.0 million of SBA-guaranteed debentures outstanding. SBA debentures are non-recourse to us, have a 10-year maturity, and may be prepaid at any time without penalty. The interest rate of SBA debentures is fixed at the time of issuance, often referred to as pooling, at a market-driven spread over 10-year U.S. Treasury Notes. SBA current regulations limit the amount that SBIC LP may borrow to a maximum of $150.0 million, which is up to twice its potential regulatory capital.

SBICs are designed to stimulate the flow of private equity capital to eligible small businesses. Under SBA regulations, SBICs may make loans to eligible small businesses and invest in the equity securities of small businesses. Under present SBA regulations, eligible small businesses include businesses that have a tangible net worth not exceeding $18.0 million and have average annual fully taxed net income not exceeding $6.0 million for the two most recent fiscal years. In addition, an SBIC must devote 25.0% of its investment activity to “smaller” concerns as defined by the SBA. A smaller concern is one that has a tangible net worth not exceeding $6.0 million and has average annual fully taxed net income not exceeding $2.0 million for the two most recent fiscal years. SBA regulations also provide alternative size standard criteria to determine eligibility, which depend on the industry in which the business is engaged and are based on such factors as the number of employees and gross sales. According to SBA regulations, SBICs may make long-term loans to small businesses, invest in the equity securities of such businesses and provide them with consulting and advisory services.

SBIC LP is subject to regulation and oversight by the SBA, including requirements with respect to maintaining certain minimum financial ratios and other covenants. Receipt of an SBIC license does not assure that SBIC LP will receive SBA guaranteed debenture funding, which is dependent upon SBIC LP continuing to be in compliance with SBA regulations and policies. The SBA, as a creditor, will have a superior claim to SBIC LP’s assets over our stockholders and debtholders in the event we liquidate SBIC LP or the SBA exercises its remedies under the SBA-guaranteed debentures issued by SBIC LP upon an event of default.

The Company received exemptive relief from the Securities and Exchange Commission to permit it to exclude the debt of SBIC LP guaranteed by the SBA from the definition of senior securities in the 200.0% asset coverage test under the 1940 Act. This allows the Company increased flexibility under the 200.0% asset coverage test by permitting it to borrow up to $150.0 million more than it would otherwise be able to absent the receipt of this exemptive relief.

 

F-30


Table of Contents

As of February 28, 2014 and February 28, 2013, there was $50.0 million and $36.0 million outstanding of SBA debentures, respectively. The carrying amount of the amount outstanding of SBA debentures approximates its fair value. $1.7 million of financing costs related to the SBA debentures have been capitalized and are being amortized over the term of the commitment and drawdown. For the years ended February 28, 2014 and February 28, 2013, we recorded $1.3 million and $0.1 million of interest expense related to the SBA debentures. For the years ended February 28, 2014 and February 28, 2013, we recorded $0.2 million and $0.1 million of amortization of deferred financing costs related to the SBA debentures, respectively. The weighted average interest rate during the years ended February 28, 2014 and February 28, 2013 on the outstanding borrowings of the SBA debentures was 3.03% and 1.42%, respectively. There were no outstanding SBA debentures at February 29, 2012.

Notes

On May 10, 2013, the Company issued $42.0 million in aggregate principal amount of 7.50% fixed-rate notes due 2020 (the “Notes”). The Notes will mature on May 31, 2020, and may be redeemed in whole or in part at any time or from time to time at the Company’s option on or after May 31, 2016. Interest will be payable quarterly beginning August 15, 2013.

On May 17, 2013, the Company closed an additional $6.3 million in aggregate principal amount of the Notes, pursuant to the full exercise of the underwriters’ option to purchase additional Notes.

As of February 28, 2014, the carrying amount and fair value of the Notes was $48.3 million and $48.6 million, respectively. The fair value of the Notes, which are publicly traded, is based upon closing market quotes as of the measurement date and would be classified as a level 1 liability within the fair value hierarchy. As of February 28, 2014, $2.5 million of financing costs related to the Notes have been capitalized and are being amortized over the term of the Notes. For the year ended February 28, 2014, we recorded $2.9 million of interest expense and $0.3 million of amortization of deferred financing costs related to the Notes.

Note 8. Commitments and contingencies

Contractual obligations

The following table shows our payment obligations for repayment of debt and other contractual obligations at February 28, 2014:

 

            Payment Due by Period  
     Total      Less Than
1 Year
     1 - 3
Years
     3 - 5
Years
     More Than
5 Years
 
     ($ in thousands)                              

Long-Term Debt Obligations

   $ 98,300       $ —         $ —         $ —         $ 98,300   
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Off-balance sheet arrangements

The Company’s off-balance sheet arrangements consisted of $12.2 million and $0.0 million of unfunded commitments to provide debt financing to its portfolio companies or to fund limited partnership interests as of February 28, 2014 and 2013, respectively. Such commitments are generally up to the Company’s discretion to approve, or the satisfaction of certain financial and nonfinancial covenants and involve, to varying degrees, elements of credit risk in excess of the amount recognized in the Company’s Consolidated Statement of Assets and Liabilities and are not reflected in the Company’s Consolidated Statements of Assets and Liabilities.

 

F-31


Table of Contents

Note 9. Directors Fees

The independent directors receive an annual fee of $40,000. They also receive $2,500 plus reimbursement of reasonable out-of-pocket expenses incurred in connection with attending each board meeting and receive $1,000 plus reimbursement of reasonable out-of-pocket expenses incurred in connection with attending each committee meeting. In addition, the chairman of the Audit Committee receives an annual fee of $5,000 and the chairman of each other committee receives an annual fee of $2,000 for their additional services in these capacities. In addition, we have purchased directors’ and officers’ liability insurance on behalf of our directors and officers. Independent directors have the option to receive their directors’ fees in the form of our common stock issued at a price per share equal to the greater of net asset value or the market price at the time of payment. No compensation is paid to directors who are “interested persons” of the Company (as such term is defined in the 1940 Act). For the years ended February 28, 2014, February 28, 2013 and February 29, 2012, we accrued $0.2 million, $0.2 million, and $0.2 million for directors’ fees expense, respectively. As of February 28, 2014 and February 28, 2013, $0.05 million and $0.05 million in directors’ fees expense were unpaid and included in accounts payable and accrued expenses in the consolidated statements of assets and liabilities. As of February 28, 2014, we had not issued any common stock to our directors as compensation for their services.

Note 10. Stockholders’ Equity

On May 16, 2006, GSC Group, Inc. capitalized the LLC, by contributing $1,000 in exchange for 67 shares, constituting all of the issued and outstanding shares of the LLC.

On March 20, 2007, the Company issued 95,995.5 and 8,136.2 shares of common stock, priced at $150.00 per share, to GSC Group and certain individual employees of GSC Group, respectively, in exchange for the general partnership interest and a limited partnership interest in GSC Partners CDO III GP, LP, collectively valued at $15.6 million. At this time, the 6.7 shares owned by GSC Group in the LLC were exchanged for 6.7 shares of the Company.

On March 28, 2007, the Company completed its IPO of 725,000 shares of common stock, priced at $150.00 per share, before underwriting discounts and commissions. Total proceeds received from the IPO, net of $7.1 million in underwriter’s discount and commissions, and $1.0 million in offering costs, were $100.7 million.

On November 13, 2009, we declared a dividend of $18.25 per share payable on December 31, 2009. Shareholders had the option to receive payment of the dividend in cash, shares of common stock, or a combination of cash and shares of common stock, provided that the aggregate cash payable to all shareholders was limited to $2.1 million or $2.50 per share. Based on shareholder elections, the dividend consisted of $2.1 million in cash and 864,872.5 of newly issued shares of common stock.

On July 30, 2010, our Manager and its affiliates purchased 986,842 shares of common stock at $15.20 per share. Total proceeds received from this sale were $15.0 million. See “Note 14. Recapitalization Transaction.”

On August 12, 2010, we effected a one-for-ten reverse stock split of our outstanding common stock. As a result of the reverse stock split, every ten shares of our common stock were converted into one share of our common stock. Any fractional shares received as a result of the reverse stock split were redeemed for cash. The total cash payment in lieu of shares was $230. Immediately after the reverse stock split, we had 2,680,842 shares of our common stock outstanding.

On November 12, 2010, we declared a dividend of $4.40 per share payable on December 29, 2010. Shareholders had the option to receive payment of the dividend in cash, shares of common stock, or a combination of cash and shares of common stock, provided that the aggregate cash payable to all shareholders was limited to approximately $1.2 million or $0.44 per share. Based on shareholder elections, the dividend consisted of approximately $1.2 million in cash and 596,235 shares of common stock.

 

F-32


Table of Contents

On November 15, 2011, we declared a dividend of $3.00 per share payable on December 30, 2011. Shareholders had the option to receive payment of the dividend in cash, shares of common stock, or a combination of cash and shares of common stock, provided that the aggregate cash payable to all shareholders was limited to approximately $2.0 million or $0.60 per share. Based on shareholder elections, the dividend consisted of approximately $2.0 million in cash and 599,584 shares of common stock.

On November 9, 2012, the Company declared a dividend of $4.25 per share payable on December 31, 2012. Shareholders had the option to receive payment of the dividend in cash, shares of common stock, or a combination of cash and shares of common stock, provided that the aggregate cash payable to all shareholders was limited to approximately $3.3 million or $0.85 per share. Based on shareholder elections, the dividend consisted of approximately $3.3 million in cash and 853,455 shares of common stock.

On October 30, 2013, the Company declared a dividend of $2.65 per share payable on December 27, 2013. Shareholders had the option to receive payment of the dividend in cash, shares of common stock, or a combination of cash and shares of common stock, provided that the aggregate cash payable to all shareholders was limited to approximately $2.5 million or $0.53 per share. Based on shareholder elections, the dividend consisted of approximately $2.5 million in cash and 649,500 shares of common stock.

Note 11. Earnings Per Share

In accordance with the provisions of FASB ASC 260, “Earnings per Share” (“ASC 260”), basic earnings per share is computed by dividing earnings available to common shareholders by the weighted average number of shares outstanding during the period. Other potentially dilutive common shares, and the related impact to earnings, are considered when calculating earnings per share on a diluted basis.

The following information sets forth the computation of the weighted average basic and diluted net decrease in net assets per share from operations for the years ended February 28, 2014, February 28, 2013 and February 29, 2012 (dollars in thousands except share and per share amounts):

 

Basic and diluted

  February 28,
2014
    February 28,
2013
    February 29,
2012
 

Net increase in net assets from operations

  $ 8,744      $ 14,602      $ 13,275   

Weighted average common shares outstanding

    4,920,517        4,110,484        3,434,345   

Earnings per common share—basic and diluted

  $ 1.78      $ 3.55      $ 3.87   

Note 12. Dividend

On October 30, 2013, the Company declared a dividend of $2.65 per share payable on December 27, 2013. Shareholders had the option to receive payment of the dividend in cash, shares of common stock, or a combination of cash and shares of common stock, provided that the aggregate cash payable to all shareholders was limited to approximately $2.5 million or $0.53 per share.

Based on shareholder elections, the dividend consisted of approximately $2.5 million in cash and 649,500 shares of common stock, or 13.7% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $15.439 per share, which equaled the volume weighted average trading price per share of the common stock on December 11, 13, and 16, 2013.

On November 9, 2012, the Company declared a dividend of $4.25 per share payable on December 31, 2012. Shareholders had the option to receive payment of the dividend in cash, shares of common stock, or a combination of cash and shares of common stock, provided that the aggregate cash payable to all shareholders was limited to approximately $3.3 million or $0.85 per share.

 

F-33


Table of Contents

Based on shareholder elections, the dividend consisted of approximately $3.3 million in cash and 853,455 shares of common stock, or 22.0% of our outstanding common stock prior to the dividend payment. The amount of cash elected to be received was greater than the cash limit of 20.0% of the aggregate dividend amount, thus resulting in the payment of a combination of cash and stock to shareholders who elected to receive cash. The number of shares of common stock comprising the stock portion was calculated based on a price of $15.444 per share, which equaled the volume weighted average trading price per share of the common stock on December 14, 17, 19, 2012.

On November 15, 2011, we declared a dividend of $3.00 per share payable on December 30, 2011. Shareholders had the option to receive payment of the dividend in cash, shares of common stock, or a combination of cash and shares of common stock, provided that the aggregate cash payable to all shareholders was limited to approximately $2.0 million or $0.60 per share.

Based on shareholder elections, the dividend consisted of approximately $2.0 million in cash and 599,584 shares of common stock, or 18.0% of our outstanding common stock prior to the dividend payment. The amount of cash elected to be received was greater than the cash limit of 20.0% of the aggregate dividend amount, thus resulting in the payment of a combination of cash and stock to shareholders who elected to receive cash. The number of shares of common stock comprising the stock portion was calculated based on a price of $13.1171 per share, which equaled the volume weighted average trading price per share of the common stock on December 20, 21 and 22, 2011.

On November 12, 2010, we declared a dividend of $4.40 per share payable on December 23, 2010. Shareholders had the option to receive payment of the dividend in cash, shares of common stock, or a combination of cash and shares of common stock, provided that the aggregate cash payable to all shareholders was limited to approximately $1.2 million or $0.44 per share.

Based on shareholder elections, the dividend consisted of approximately $1.2 million in cash and 596,235 shares of common stock, or 22.0% of our outstanding common stock prior to the dividend payment. The amount of cash elected to be received was greater than the cash limit of 10.0% of the aggregate dividend amount, thus resulting in the payment of a combination of cash and stock to shareholders who elected to receive cash. The number of shares of common stock comprising the stock portion was calculated based on a price of $17.8049 per share, which equaled the volume weighted average trading price per share of the common stock on December 20, 21 and 22, 2010. The financial statements for the period ended November 30, 2010 have been retroactively adjusted to reflect the increase in common stock as a result of the dividend in accordance with the provisions of ASC 505-20-S50 regarding disclosure of a capital structure change after the interim balance sheet but before the release of the financial statements.

The following tables summarize dividends declared during the years ended February 28, 2014, February 28, 2013, February 29, 2012 and February 28, 2011 (dollars in thousands except per share amounts):

 

Date Declared

   Record Date    Payment Date    Amount
Per Share*
     Total
Amount
 

October 30, 2013

   November 13, 2013    December 27, 2013    $ 2.65       $ 12,535   
        

 

 

    

 

 

 

Total dividends declared

$ 2.65    $ 12,535   
        

 

 

    

 

 

 

Date Declared

   Record Date    Payment Date    Amount
Per Share*
     Total
Amount
 

November 9, 2012

   November 20, 2012    December 31, 2012    $ 4.25       $ 16,476   
        

 

 

    

 

 

 

Total dividends declared

$ 4.25    $ 16,476   
        

 

 

    

 

 

 

 

F-34


Table of Contents

Date Declared

   Record Date    Payment Date    Amount
Per Share*
     Total
Amount
 

November 15, 2011

   November 25, 2011    December 30, 2011    $ 3.00       $ 9,831   
        

 

 

    

 

 

 

Total dividends declared

$ 3.00    $ 9,831   
        

 

 

    

 

 

 

Date Declared

   Record Date    Payment Date    Amount
Per Share*
     Total
Amount
 

November 12, 2010

   November 19, 2010    December 29, 2010    $ 4.40       $ 11,796   
        

 

 

    

 

 

 

Total dividends declared

$ 4.40    $ 11,796   
        

 

 

    

 

 

 

 

* Amount per share is calculated based on the number of shares outstanding at the date of declaration.

Note 13. Financial Highlights

The following is a schedule of financial highlights for the years ended February 28, 2014, February 28, 2013, February 29, 2012, February 28, 2011, and February 28, 2010:

For 2010, the amount per share has been adjusted to reflect a one-for-ten reverse stock split effectuated in August 2010.

 

     February 28,
2014
    February 28,
2013
    February 29,
2012
    February 28,
2011
    February 28,
2010
 

Per share data:(7)

          

Net asset value at beginning of period

   $ 22.98      $ 25.12      $ 26.26      $ 32.75      $ 82.00   

Net investment income(1)

     1.85        1.71        1.66        2.15        5.40   

Net realized and unrealized gains and losses on investments and derivatives

     (0.07     1.84        2.21        4.81        (15.30
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) in net assets from operations

  1.78      3.55      3.87      6.96      (9.90

Distributions declared from net investment income

  (2.65   (4.25   (3.00   (4.40   (18.25

Distributions declared from net realized capital gains

  —        —        —        —        —     
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total distributions to stockholders

  (2.65   (4.25   (3.00   (4.40   (18.25

Other(5)

  (0.75   (1.44   (2.01   (9.05   (21.10

Net asset value at end of period

$ 21.36    $ 22.98    $ 25.12    $ 26.26    $ 32.75   

Net assets at end of period

$ 114,924,018    $ 108,686,761    $ 97,380,150    $ 86,071,454    $ 55,478,152   

Shares outstanding at end of period

  5,379,616      4,730,116      3,876,661      3,277,077      1,694,010   

Per share market value at end of period(7)

$ 15.85    $ 17.02    $ 15.88    $ 21.25    $ 19.20   

Total return based on market value(2)

  9.11   36.67   12.82   38.25   113.10

Total return based on net asset value(3)

  8.92   16.65   17.51   0.16   (11.92 )% 

 

F-35


Table of Contents
     February 28,
2014
    February 28,
2013
    February 29,
2012
    February 28,
2011
    February 28,
2010
 

Ratio/Supplemental data:(6)

          

Ratio of net investment income to average, net assets(4)(6)

     8.09     6.73     6.11     6.53     8.10

Ratio of operating expenses to average net assets(4)

     6.20     5.17     5.63     12.05     9.78

Ratio of incentive management fees to average net assets

     0.61     1.96     1.35     2.45     0.52

Ratio of credit facility related expenses to average net assets

     5.40     2.43     1.39     3.42     6.54

Ratio of total expenses to average net assets(4)

     12.21     9.56     8.36     12.02     16.84

Portfolio turnover rate(8)

     37.82     17.30     36.34     10.14     14.68

 

(1) Net investment income per share is calculated using the weighted average shares outstanding during the period. Net investment income excluding expense waiver and reimbursement equals $2.05 and $4.75 per share for the years ended February 28, 2011 and 2010, respectively.
(2) Total investment return is calculated assuming a purchase of common shares at the current market value on the first day and a sale at the current market value on the last day of the periods reported. Dividends and distributions, if any, are assumed for purposes of this calculation to be reinvested at prices obtained under the Company’s dividend reinvestment plan. Total investment return does not reflect brokerage commissions. Total investment returns covering less than a full period are not annualized.
(3) Total investment return is calculated assuming a purchase of common shares at the current net asset value on the first day and a sale at the current net asset value on the last day of the periods reported. Dividends and distributions, if any, are assumed for purposes of this calculation to be reinvested at prices obtained under the Company’s dividend reinvestment plan. Total investment return does not reflect brokerage commissions.
(4) For the year ended February 28, 2011, net of the expense waiver and reimbursement arrangement, the ratio of net investment income, operating expenses, total expenses to average net assets is 6.87%, 11.71%, and 11.68%, respectively. For the year ended February 28, 2010, net of the expense waiver and reimbursement arrangement, the ratio of net investment income, operating expenses, total expenses to average net assets is 9.12%, 8.71% and 15.77%, respectively.
(5) Represents the dilutive effect of issuing common stock below net asset value per share during the period in connection with the satisfaction of the Company’s annual RIC distribution requirement. See Note 12, Dividend.
(6) The ratio for the year ended February 28, 2010 do not include the effect of the waiver of deferred incentive fees which is (3.83)% on a non-annualized basis as this is a one time waiver.
(7) February 28, 2010 data has been adjusted to reflect a one-for-ten reverse stock split effectuated in August 2010.
(8) Portfolio turnover rate is calculated using the lesser of year-to-date sales or year-to-date purchases over the average of the invested assets at fair value.

Note 14. Recapitalization Transaction

In July 2010, we consummated a recapitalization transaction that was necessitated by the fact that we had exceeded permissible borrowing limits under the Revolving Facility in July 2009, which resulted in an event of default under the Revolving Facility. As a result of the event of default under the Revolving Facility, the lender had the right to accelerate repayment of the outstanding indebtedness under the Revolving Facility and to foreclose and liquidate the collateral pledged thereunder. We engaged the investment banking firm of Stifel, Nicolaus & Company to evaluate strategic transaction opportunities and consider alternatives for us in December 2008. On April 14, 2010, we entered into a stock purchase agreement with our Manager and certain of its affiliates and an assignment, assumption and novation agreement with our Manager, pursuant to which we

 

F-36


Table of Contents

assumed certain rights and obligations of our Manager under a debt commitment letter our Manager received from Madison Capital Funding LLC, indicating Madison Capital Funding’s willingness to provide us with the Credit Facility, subject to the satisfaction of certain terms and conditions. In addition, we and GSCP (NJ), L.P., our then external investment adviser, entered into a termination and release agreement, to be effective as of the closing of the transaction contemplated by the stock purchase agreement, pursuant to which GSCP (NJ), L.P., among other things, agreed to waive any and all accrued and unpaid deferred incentive management fees up to and as of the closing of the transaction contemplated by the stock purchase agreement but continued to be entitled to receive the base management fees earned through the date of the closing of the transaction contemplated by the stock purchase agreement.

On July 30, 2010, the transactions contemplated by the stock purchase agreement with our Manager and certain of its affiliates was completed, and included the following actions:

 

    the private sale of shares of our common stock for $15.0 million in aggregate purchase price to our Manager and certain of its affiliates;

 

    the closing of the $40.0 million Credit Facility with Madison Capital Funding;

 

    the execution of a registration rights agreement with the investors in the private sale transaction, pursuant to which we agreed to file a registration statement with the SEC to register for resale the shares of our common stock sold in the private sale transaction;

 

    the execution of a trademark license agreement with our Manager pursuant to which our Manager granted us a non-exclusive, royalty-free license to use the “Saratoga” name, for so long as our Manager or one of its affiliates remains our investment adviser;

 

    replacing GSCP (NJ), L.P. as our investment adviser and administrator with our Manager by executing the Management Agreement, which was approved by our stockholders, and an administration agreement with our Manager;

 

    the resignations of Robert F. Cummings, Jr. and Richard M. Hayden, both of whom are affiliates of GSCP (NJ) L.P., as members of the board of directors and the election of Christian L. Oberbeck and Richard A. Petrocelli, both of whom are affiliates of our Manager, as members of the board of directors;

 

    the resignation of all of our then existing executive officers and the appointment by our board of directors of Mr. Oberbeck as our chief executive officer and Mr. Petrocelli as our chief financial officer, secretary and chief compliance officer; and

 

    our name change from “GSC Investment Corp.” to “Saratoga Investment Corp.”

We used the net proceeds from the private sale transaction and a portion of the funds available to us under the Credit Facility to pay the full amount of principal and accrued interest, including default interest, outstanding under Revolving Facility. The Revolving Facility with Deutsche Bank was terminated in connection with our payment of all amounts outstanding thereunder on July 30, 2010.

 

F-37


Table of Contents

Note 15. Selected Quarterly Data (Unaudited)

 

     2014  

($ in thousands, except per share numbers)

   Qtr 4      Qtr 3     Qtr 2     Qtr 1  

Interest and related portfolio income

   $ 5,218       $ 4,997      $ 4,792      $ 5,172   

Net investment income

     1,482         2,898        2,272        2,470   

Net realized and unrealized gain (loss)

     2,236         (1,630     (2,313     1,330   

Net increase (decrease) in net assets resulting from operations

     3,718         1,268        (41     3,800   

Net investment income per common share at end of each quarter

   $ 0.28       $ 0.60      $ 0.48      $ 0.52   

Net realized and unrealized gain (loss) per common share at end of each quarter

   $ 0.42       $ (0.34   $ (0.49   $ 0.28   

Dividends declared per common share

   $ —         $ 2.65      $ —        $ —     

Net asset value per common share

   $ 21.36       $ 20.67      $ 23.77      $ 23.78   
     2013  

($ in thousands, except per share numbers)

   Qtr 4      Qtr 3     Qtr 2     Qtr 1  

Interest and related portfolio income

   $ 4,306       $ 3,513      $ 3,514      $ 3,111   

Net investment income

     1,952         2,489        1,314        1,273   

Net realized and unrealized gain (loss)

     3,843         (1,744     3,557        1,918   

Net increase in net assets resulting from operations

     5,795         745        4,871        3,191   

Net investment income per common share at end of each quarter

   $ 0.42       $ 0.63      $ 0.34      $ 0.33   

Net realized and unrealized gain (loss) per common share at end of each quarter

   $ 0.81       $ (0.44   $ 0.92      $ 0.49   

Dividends declared per common share

   $ —         $ 4.25      $ —        $ —     

Net asset value per common share

   $ 22.98       $ 21.75      $ 27.20      $ 25.94   
     2012  

($ in thousands, except per share numbers)

   Qtr 4      Qtr 3     Qtr 2     Qtr 1  

Interest and related portfolio income

   $ 2,946       $ 3,033      $ 2,887      $ 2,387   

Net investment income

     1,578         824        2,720        578   

Net realized and unrealized gain (loss)

     1,502         5,389        (4,448     5,131   

Net increase (decrease) in net assets resulting from operations

     3,080         6,213        (1,728     5,709   

Net investment income per common share at end of each quarter

   $ 0.40       $ 0.25      $ 0.83      $ 0.17   

Net realized and unrealized gain (loss) per common share at end of each quarter

   $ 0.39       $ 1.63      $ (1.36   $ 1.57   

Dividends declared per common share

   $ —         $ 3.00      $ —        $ —     

Net asset value per common share

   $ 25.12       $ 24.32      $ 27.48      $ 28.01   

Note 16. Subsequent Events

Management has evaluated subsequent events through the date of issuance of the consolidated financial statements included herein. There have been no subsequent events that occurred during such period that would require disclosure in this Form 10-K or would be required to be recognized in the consolidated financial statements as of and for the year ended February 28, 2014.

 

F-38


Table of Contents

Saratoga Investment Corp.

Consolidated Statements of Assets and Liabilities

 

     As of  
     August 31, 2014     February 28, 2014  
     (unaudited)        

ASSETS

    

Investments at fair value

    

Non-control/non-affiliate investments (amortized cost of $215,422,798 and $185,266,607, respectively)

   $ 216,229,627      $ 186,275,106   

Control investments (cost of $16,555,808 and $16,555,808, respectively)

     20,090,075        19,569,596   
  

 

 

   

 

 

 

Total investments at fair value (amortized cost of $231,978,606 and $201,822,415, respectively)

  236,319,702      205,844,702   

Cash and cash equivalents

  271,378      3,293,898   

Cash and cash equivalents, reserve accounts

  3,215,671      3,293,113   

Interest receivable (net of reserve of $184,818 and $150,058, respectively)

  3,314,407      2,571,853   

Deferred debt financing costs, net

  3,879,035      4,008,704   

Management fee receivable

  167,031      150,106   

Other assets

  62,769      14,461   
  

 

 

   

 

 

 

Total assets

$ 247,229,993    $ 219,176,837   
  

 

 

   

 

 

 

LIABILITIES

Revolving credit facility

$ 8,900,000    $ —     

SBA debentures payable

  64,000,000      50,000,000   

Notes payable

  48,300,000      48,300,000   

Management and incentive fees payable

  4,221,591      3,856,962   

Accounts payable and accrued expenses

  536,355      824,568   

Interest and debt fees payable

  1,036,073      873,135   

Due to manager

  418,154      398,154   
  

 

 

   

 

 

 

Total liabilities

$ 127,412,173    $ 104,252,819   
  

 

 

   

 

 

 

Commitments and contingencies (See Note 7)

  

NET ASSETS

Common stock, par value $.001, 100,000,000 common shares authorized, 5,379,616 and 5,379,616 common shares issued and outstanding, respectively

$ 5,380    $ 5,380   

Capital in excess of par value

  184,851,154      184,851,154   

Distribution in excess of net investment income

  (25,494,426   (29,627,578

Accumulated net realized loss from investments and derivatives

  (43,885,384   (44,327,225

Net unrealized appreciation on investments and derivatives

  4,341,096      4,022,287   
  

 

 

   

 

 

 

Total Net Assets

  119,817,820      114,924,018   
  

 

 

   

 

 

 

Total liabilities and Net Assets

$ 247,229,993    $ 219,176,837   
  

 

 

   

 

 

 

NET ASSET VALUE PER SHARE

$ 22.27    $ 21.36   
  

 

 

   

 

 

 

See accompanying notes to consolidated financial statements.

 

F-39


Table of Contents

Saratoga Investment Corp.

Consolidated Statements of Operations

(unaudited)

 

     For the three months ended
August 31
    For the six months ended
August 31
 
     2014      2013     2014      2013  

INVESTMENT INCOME

          

Interest from investments

          

Non-control/Non-affiliate investments

   $ 5,047,571       $ 3,385,362      $ 9,755,465       $ 7,254,826   

Payment-in-kind interest income from Non-control/Non-affiliate investments

     329,614         296,802        582,542         472,923   

Control investments

     660,031         1,109,535        1,301,369         2,235,539   
  

 

 

    

 

 

   

 

 

    

 

 

 

Total interest income

  6,037,216      4,791,699      11,639,376      9,963,288   

Interest from cash and cash equivalents

  1,120      3,959      1,714      5,865   

Management fee income

  375,459      480,750      767,493      978,841   

Other income

  61,495      111,300      210,830      457,476   
  

 

 

    

 

 

   

 

 

    

 

 

 

Total investment income

  6,475,290      5,387,708      12,619,413      11,405,470   
  

 

 

    

 

 

   

 

 

    

 

 

 

EXPENSES

Interest and debt financing expenses

  1,809,516      1,603,581      3,597,103      2,731,436   

Base management fees

  1,037,186      811,106      2,005,665      1,547,822   

Professional fees

  275,933      235,191      711,307      566,255   

Administrator expenses

  250,000      250,000      500,000      500,000   

Incentive management fees

  789,714      (39,770   1,170,617      781,352   

Insurance

  84,127      119,234      168,614      239,229   

Directors fees and expenses

  55,586      45,000      108,761      96,000   

General & administrative

  100,568      91,425      224,194      189,786   

Other expense

  —        75      —        12,035   
  

 

 

    

 

 

   

 

 

    

 

 

 

Total expenses

  4,402,630      3,115,842      8,486,261      6,663,915   
  

 

 

    

 

 

   

 

 

    

 

 

 

NET INVESTMENT INCOME

  2,072,660      2,271,866      4,133,152      4,741,555   
  

 

 

    

 

 

   

 

 

    

 

 

 

REALIZED AND UNREALIZED GAIN (LOSS) ON INVESTMENTS:

Net realized gain from investments

  360,161      545,642      441,841      1,074,942   

Net unrealized appreciation (depreciation) on investments

  703,506      (2,858,805   318,809      (2,057,943
  

 

 

    

 

 

   

 

 

    

 

 

 

Net gain/(loss) on investments

  1,063,667      (2,313,163   760,650      (983,001
  

 

 

    

 

 

   

 

 

    

 

 

 

NET INCREASE (DECREASE) IN NET ASSETS RESULTING FROM OPERATIONS

$ 3,136,327    $ (41,297 $ 4,893,802    $ 3,758,554   
  

 

 

    

 

 

   

 

 

    

 

 

 

WEIGHTED AVERAGE - BASIC AND DILUTED EARNINGS (LOSS) PER COMMON SHARE

$ 0.58    $ (0.01 $ 0.91    $ 0.79   

WEIGHTED AVERAGE COMMON STOCK OUTSTANDING - BASIC AND DILUTED

  5,379,616      4,730,116      5,379,616      4,730,116   

See accompanying notes to consolidated financial statements.

 

F-40


Table of Contents

Saratoga Investment Corp.

Consolidated Schedule of Investments

August 31, 2014

(unaudited)

 

Company

  Industry  

Investment
Interest Rate /
Maturity

  Principal/
Number of
Shares
    Cost     Fair Value (c)     % of
Net Assets
 

Non-control/Non-affiliated investments—180.5%(b)

           

National Truck Protection Co., Inc.(d),(g)

  Automotive   Common Stock     1,116      $ 1,000,000      $ 1,473,053        1.2

National Truck Protection Co., Inc.(d)

  Automotive   First Lien Term Loan 15.50% Cash, 9/13/2018   $ 7,737,848        7,737,848        7,737,848        6.5

Take 5 Oil Change,
L.L.C.(d),(g)

  Automotive   Common Stock     7,128        712,800        1,460,954        1.2
       

 

 

   

 

 

   

 

 

 
    Total Automotive       9,450,648        10,671,855        8.9
       

 

 

   

 

 

   

 

 

 

Legacy Cabinets
Holdings(d),(g)

  Building Products  

Common Stock

Voting A-1

    2,535        220,900        1,199,055        1.0

Legacy Cabinets
Holdings(d),(g)

  Building Products  

Common Stock

Voting B-1

    1,600        139,424        756,800        0.6
       

 

 

   

 

 

   

 

 

 
    Total Building Products       360,324        1,955,855        1.6
       

 

 

   

 

 

   

 

 

 

BMC Software, Inc.(d)

  Business Services   First Lien Term Loan 5.00% Cash, 9/10/2020   $ 5,761,667        5,713,227        5,742,077        4.8

Dispensing Dynamics
International(d)

  Business Services   Senior Secured Note 12.50% Cash, 1/1/2018   $ 7,000,000        6,897,469        7,560,000        6.3

Easy Ice, LLC(d)

  Business Services   First Lien Term Loan 14.00% (11.00% Cash/3.00% PIK), 3/29/2018   $ 7,603,228        7,603,231        7,603,228        6.3

Emily Street Enterprises, L.L.C.

 


Business Services

  Senior Secured Note 12.00% (11.00% Cash/1.00% PIK), 12/28/2017   $ 5,792,538        5,709,596        5,792,538        4.8

Emily Street Enterprises,
L.L.C.(g)

  Business Services   Warrant Membership Interests     49,318        400,000        385,174        0.3

Help/Systems Holdings, Inc. (Help/Systems,
LLC)(d)

  Business Services   First Lien Term Loan 5.50% Cash, 6/28/2019   $ 3,970,000        3,936,883        3,930,300        3.3

Help/Systems Holdings, Inc. (Help/Systems,
LLC)(d)

  Business Services   Second Lien Term Loan 9.50% Cash, 6/28/2020   $ 2,000,000        1,973,818        2,000,000        1.7

Knowland Technology Holdings, L.L.C.

  Business Services   First Lien Term Loan 11.00% Cash, 11/29/2017   $ 5,259,171        5,215,608        5,259,171        4.4

Vector Controls Holding Co., LLC(d)

  Business Services   First Lien Term Loan, 14.00% (12.00% Cash/2.00% PIK), 3/6/2018   $ 9,340,061        9,195,124        9,340,061        7.8

Vector Controls Holding Co., LLC(d),(g)

  Business Services   Warrants to Purchase Limited Liability Company Interests     101        —          87,600        0.1
       

 

 

   

 

 

   

 

 

 
    Total Business Services       46,644,956        47,700,149        39.8
       

 

 

   

 

 

   

 

 

 

Targus Group International,
Inc.(d)

  Consumer Products   First Lien Term Loan 11.00% Cash, 5/24/2016   $ 3,661,247        3,612,910        3,503,447        2.9

Targus Holdings,
Inc.(d),(g)

  Consumer Products   Common Stock     62,413        566,765        —          0.0

Targus Holdings,
Inc.(d)

  Consumer Products   Unsecured Note 10.00% PIK, 6/14/2019   $ 2,054,158        2,054,158        1,499,104        1.3

 

F-41


Table of Contents

Company

  Industry  

Investment
Interest Rate /
Maturity

  Principal/
Number of
Shares
    Cost     Fair Value (c)     % of
Net Assets
 

Targus Holdings,
Inc.(d)

  Consumer Products   Unsecured Note 16.00% Cash, 10/26/2018   $ 399,152        394,283        375,489        0.3
       

 

 

   

 

 

   

 

 

 
    Total Consumer Products       6,628,116        5,378,040        4.5
       

 

 

   

 

 

   

 

 

 

Avionte Holdings,
LLC(g)

  Consumer Services   Common Stock     100,000        100,000        139,000        0.1

Avionte Holdings, LLC

  Consumer Services   First Lien Term Loan 8.25% Cash, 1/8/2019   $ 3,000,000        2,946,920        3,000,000        2.5

CFF Acquisition
L.L.C.(d)

  Consumer Services   First Lien Term Loan 7.50% Cash, 7/31/2015   $ 996,679        990,974        996,679        0.9

Expedited Travel L.L.C.

  Consumer Services   First Lien Term Loan 9.00% Cash, 12/28/2017   $ 3,830,000        3,768,632        3,830,000        3.2

PrePaid Legal Services,
Inc.(d)

  Consumer Services   First Lien Term Loan 6.25% Cash, 7/1/2019   $ 3,951,613        3,917,123        3,950,427        3.3

PrePaid Legal Services,
Inc.(d)

  Consumer Services   Second Lien Term Loan 9.75% Cash, 7/1/2020   $ 5,000,000        4,933,418        5,047,000        4.2
       

 

 

   

 

 

   

 

 

 
    Total Consumer Services       16,657,067        16,963,106        14.2
       

 

 

   

 

 

   

 

 

 

M/C Acquisition Corp., L.L.C.(d),(g)

  Education   Class A Common Stock     544,761        30,241        —          0.0

M/C Acquisition Corp.,
L.L.C.(d)

  Education   First Lien Term Loan 1.00% Cash, 3/13/14   $ 2,444,027        1,295,285        100,597        0.1
       

 

 

   

 

 

   

 

 

 
    Total Education       1,325,526        100,597        0.1
       

 

 

   

 

 

   

 

 

 

Group Dekko, Inc.(d)

  Electronics   Second Lien Term Loan 11.00% (10.00% Cash/1.00% PIK), 5/1/2016   $ 6,935,934        6,935,934        6,554,458        5.5
       

 

 

   

 

 

   

 

 

 
    Total Electronics       6,935,934        6,554,458        5.5
       

 

 

   

 

 

   

 

 

 

USS Parent Holding
Corp.(d),(g)

  Environmental   Non Voting Common Stock     765        133,002        244,698        0.2

USS Parent Holding
Corp.(d),(g)

  Environmental   Voting Common Stock     17,396        3,025,798        5,566,864        4.7
       

 

 

   

 

 

   

 

 

 
    Total Environmental       3,158,800        5,811,562        4.9
       

 

 

   

 

 

   

 

 

 

DS Waters of America,
Inc.(d)

  Food and Beverage   First Lien Term Loan 5.25% Cash, 8/30/2020   $ 2,481,250        2,459,770        2,487,453        2.2

TB Corp.(d)

  Food and Beverage   First Lien Term Loan 5.75% Cash, 6/19/2018   $ 5,076,203        5,064,962        5,076,203        4.2

TB Corp.(d)

  Food and Beverage   Unsecured Note 13.50% (12.00% Cash/1.50% PIK), 12/20/2018   $ 2,546,121        2,517,122        2,546,121        2.1

TM Restaurant Group L.L.C.

  Food and Beverage   First Lien Term Loan 7.75% Cash, 7/16/2017   $ 2,808,190        2,808,190        2,802,855        2.3
       

 

 

   

 

 

   

 

 

 
    Total Food and Beverage       12,850,044        12,912,632        10.8
       

 

 

   

 

 

   

 

 

 

Bristol Hospice, LLC

  Healthcare Services   Senior Secured Note 11.00%(10.00% Cash/1.00% PIK), 11/29/2018   $ 5,486,532        5,390,528        5,486,532        4.6

IDOC, LLC

  Healthcare Services   First Lien Term Loan 9.75% Cash, 8/2/2017   $ 13,831,583        13,831,583        13,831,583        11.5

Oceans Acquisition, Inc.

  Healthcare Services   First Lien Term A Loan 10.75% Cash, 12/27/2017   $ 6,246,226        6,154,475        6,121,301        5.1

Oceans Acquisition, Inc.

  Healthcare Services   First Lien Term B Loan 10.75% Cash, 12/27/2017   $ 1,000,000        991,202        980,000        0.8

Roscoe Medical,
Inc.(d),(g)

  Healthcare Services   Common Stock     5,000        500,000        446,800        0.4

Roscoe Medical, Inc.

  Healthcare Services   Second Lien Term Loan 11.25% Cash, 9/26/2019   $ 4,200,000        4,123,141        4,160,100        3.5

 

F-42


Table of Contents

Company

  Industry  

Investment
Interest Rate /
Maturity

  Principal/
Number of
Shares
    Cost     Fair Value (c)     % of
Net Assets
 

Smile Brands Group
Inc.(d)

  Healthcare Services   First Lien Term Loan 7.50% Cash, 8/16/2019   $ 4,466,250        4,390,964        4,354,594        3.6

Surgical Specialties Corporation (US),
Inc.(d)

  Healthcare Services   First Lien Term Loan 7.25% Cash, 8/22/2018   $ 2,375,000        2,355,380        2,369,063        2.0

Zest Holdings, LLC(d)

  Healthcare Services   First Lien Term Loan 6.50% Cash, 8/16/2020   $ 4,466,250        4,377,323        4,477,416        3.7
       

 

 

   

 

 

   

 

 

 
    Total Healthcare Services       42,114,596        42,227,389        35.2
       

 

 

   

 

 

   

 

 

 

McMillin Companies
L.L.C.(d),(g)

  Homebuilding   Senior Secured Note 0% Cash, 12/31/2013   $ 550,000        558,434        410,740        0.3
       

 

 

   

 

 

   

 

 

 
    Total Homebuilding       558,434        410,740        0.3
       

 

 

   

 

 

   

 

 

 

Distribution International,
Inc.(d)

  Manufacturing   First Lien Term Loan 7.50% Cash, 7/16/2019   $ 5,940,000        5,888,342        5,940,000        5.0
       

 

 

   

 

 

   

 

 

 
    Total Manufacturing       5,888,342        5,940,000        5.0
       

 

 

   

 

 

   

 

 

 

HMN Holdco, LLC

  Media   First Lien Term Loan 14.00% Cash, 5/16/2019   $ 9,540,696        9,360,503        9,206,771        7.7

HMN Holdco, LLC(g)

  Media   Warrants to Purchase Limited Liability Company Interests (Common)     57,783        —          179,127        0.1

HMN Holdco, LLC(g)

  Media   Warrants to Purchase Limited Liability Company Interests     8,139        —          67,798        0.1
       

 

 

   

 

 

   

 

 

 
    Total Media       9,360,503        9,453,696        7.9
       

 

 

   

 

 

   

 

 

 

Elyria Foundry Company,
L.L.C.(d)

  Metals   Senior Secured Note 17.00% (13.00% Cash/4.00% PIK), 9/14/2014   $ 8,859,616        8,859,614        5,785,311        4.8

Elyria Foundry Company, L.L.C.(d),(g)

  Metals   Warrants to Purchase Limited Liability Company Interests (2008)     7,000        20        —          0.0

Elyria Foundry Company, L.L.C.(d),(g)

  Metals   Warrants to Purchase Limited Liability Company Interests (2013)     18,227        —          —          0.0
       

 

 

   

 

 

   

 

 

 
    Total Metals       8,859,634        5,785,311        4.8
       

 

 

   

 

 

   

 

 

 

Network Communications,
Inc.(d),(g)

  Publishing   Common Stock     380,572        —          —          0.0

Network Communications,
Inc.(d)

  Publishing   Unsecured Notes 8.60% PIK, 1/14/2020   $ 2,657,971        2,299,254        1,488,510        1.2
       

 

 

   

 

 

   

 

 

 
    Total Publishing       2,299,254        1,488,510        1.2
       

 

 

   

 

 

   

 

 

 

Community Investors,
Inc.(g)

  Software   Common Stock     1,282        1,282        2,449        0.0

Community Investors, Inc.

  Software   First Lien Term Loan 9.75% Cash, 5/9/2018   $ 6,896,042        6,784,964        6,896,042        5.8

Community Investors, Inc.

  Software   Revolver   $ 166,667        —          —          0.0

Community Investors,
Inc.(g)

  Software   Preferred Stock     63,463        149,138        121,214        0.1

Community Investors,
Inc.(g)

  Software   Preferred Stock—A Shares     135,584        135,584        258,965        0.2

Identity Automation
Systems(g)

  Software   Common Stock Class A Units     232,616        232,616        232,616        0.2

Identity Automation Systems

  Software   First Lien Term Loan 10.25% Cash, 8/25/2019   $ 5,000,000        4,950,321        5,000,000        4.2

Pen-Link, Ltd.(d)

  Software   Second Lien Term Loan 12.50% Cash, 5/26/2019   $ 11,500,000        11,294,269        11,500,000        9.6
       

 

 

   

 

 

   

 

 

 
    Total Software       23,548,174        24,011,286        20.1
       

 

 

   

 

 

   

 

 

 

 

F-43


Table of Contents

Company

  Industry  

Investment
Interest Rate /
Maturity

  Principal/
Number of
Shares
    Cost     Fair Value (c)     % of
Net Assets
 

Censis Technologies, Inc.

  Technology   First Lien Term Loan B 11.00% Cash, 7/24/2019   $  12,000,000        11,761,173        11,760,000        9.8

Censis Technologies,
Inc.(g),(h)

  Technology   Limited Partner Interests     999        999,000        999,000        0.8
       

 

 

   

 

 

   

 

 

 
    Total Technology       12,760,173        12,759,000        10.6
       

 

 

   

 

 

   

 

 

 

Advanced Air & Heat of Florida, LLC

  Utilities   First Lien Term Loan 10.00% Cash, 1/31/2019   $ 6,105,441        6,022,273        6,105,441        5.1
       

 

 

   

 

 

   

 

 

 
    Total Utilities       6,022,273        6,105,441        5.1
       

 

 

   

 

 

   

 

 

 

Sub Total Non-control/
Non-affiliated investments

          215,422,798        216,229,627        180.5
       

 

 

   

 

 

   

 

 

 

Control investments—16.8%(b)

           

Saratoga Investment Corp. CLO 2013-1,
Ltd.(a),(d),(e),(f)

  Structured Finance
Securities
  Other/Structured Finance Securities 16.01%, 10/17/2023   $ 30,000,000        16,555,808        20,090,075        16.8
       

 

 

   

 

 

   

 

 

 

Sub Total Control investments

          16,555,808        20,090,075        16.8
       

 

 

   

 

 

   

 

 

 

TOTAL INVESTMENTS—197.3%(b)

        $ 231,978,606      $ 236,319,702        197.3
       

 

 

   

 

 

   

 

 

 

 

(a) Represents a non-qualifyng investment as defined under Section 55 (a) of the Investment Company Act of 1940, as amended. Non-qualifying assets represent 9.2% of the Company’s portfolio at fair value. As a BDC, the Company can only invest 30% of its portfolio in non-qualifying assets.
(b) Percentages are based on net assets of $119,817,820 as of August 31, 2014.
(c) Because there is no readily available market value for these investments, the fair value of these investments is approved in good faith by our board of directors (see Note 3 to the consolidated financial statements).
(d) These securities are pledged as collateral under a senior secured revolving credit facility (see Note 6 to the consolidated financial statements).
(e) This investment does not have a stated interest rate that is payable thereon. As a result, the 16.01% interest rate in the table above represents the annualized interest rate currently earned on the investment cost and is based on the current cash interest and other income generated by the investment for the six months ended August 31, 2014 (which was approximately $1.3 million for the six-month period).
(f) As defined in the Investment Company Act, we “Control” this portfolio company because we own more than 25% of the portfolio company’s outstanding voting securities. Transactions during the period in which the issuer was both an Affiliate and a portfolio company that we Control are as follows:

 

Company

   Purchases      Redemptions      Sales
(cost)
     Interest
Income
     Management
fee income
     Net
Realized

gains/(losses)
     Net
Unrealized

gains/(losses)
 

Saratoga Investment Corp. CLO 2013-1, Ltd.

   $ —         $ —         $ —         $ 1,301,369       $ 767,493       $ —         $ 3,534,267   
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

 

(g) Non-income producing at August 31, 2014. All of the Company’s non-income producing investments at August 31, 2014 were equity investments that did not carry any stated dividend or interest rate payable thereon except with respect to the Company’s debt investment in McMillin Companies L.L.C., which was in default under the terms of the debt investment at August 31, 2014. Subsequently, a payment was received by McMillan Companies L.L.C. in excess of the August 31, 2014 fair value thereof.
(h) Includes securities issued by an affiliate of the company.

 

F-44


Table of Contents

Saratoga Investment Corp.

Consolidated Schedule of Investments

February 28, 2014

 

Company

  

Industry

  

Investment

Interest Rate /
Maturity

  Principal/
Number of
Shares
    Cost     Fair Value (c)     % of
Net Assets
 

Non-control/Non-affiliated investments—162.1%(b)

             

PATS Aircraft, LLC(d)(g)

   Aerospace    Common Stock     51,813      $ 89,636      $ 89,636        0.1

PATS Aircraft, LLC(d)

   Aerospace   

First Lien Term Loan

8.50% Cash, 10/6/2016

  $ 254,598        254,598        254,598        0.2
         

 

 

   

 

 

   

 

 

 
      Total Aerospace       344,234        344,234        0.3
         

 

 

   

 

 

   

 

 

 

National Truck Protection
Co., Inc.(d),(g)

   Automotive    Common Stock     1,116        1,000,000        1,152,531        1.0

National Truck Protection
Co., Inc.(d)

   Automotive    First Lien Term Loan 15.50% Cash, 9/13/2018   $ 8,250,000        8,250,000        8,250,000        7.2

Take 5 Oil Change,
L.L.C.(d),(g)

   Automotive    Common Stock     7,128        712,800        1,217,747        1.1
         

 

 

   

 

 

   

 

 

 
      Total Automotive       9,962,800        10,620,278        9.3
         

 

 

   

 

 

   

 

 

 

Legacy Cabinets
Holdings(d),(g)

   Building Products   

Common Stock

Voting A-1

    2,535        220,900        552,351        0.5

Legacy Cabinets
Holdings(d),(g)

   Building Products   

Common Stock

Voting B-1

    1,600        139,424        348,624        0.3
         

 

 

   

 

 

   

 

 

 
      Total Building Products       360,324        900,975        0.8
         

 

 

   

 

 

   

 

 

 

ARSloane Acquistion,
LLC(d)

   Business Services   

First Lien Term Loan

7.50% Cash, 10/1/2019

  $ 997,500        988,200        1,004,981        0.9

BMC Software, Inc.(d)

   Business Services   

First Lien Term Loan

5.00% Cash, 9/10/2020

  $ 6,000,000        5,943,801        6,013,800        5.2

Dispensing Dynamics
International(d)

   Business Services   

Senior Secured Note

12.50% Cash, 1/1/2018

  $ 7,000,000        6,882,278        7,525,000        6.5

Easy Ice, LLC(d)

   Business Services    First Lien Term Loan 14.00% (11.00% Cash/3.00% PIK), 3/29/2018   $ 7,507,024        7,387,970        7,507,024        6.5

Emily Street Enterprises,
L.L.C.

   Business Services   

Senior Secured Note

12.00% (11.00% Cash/1.00% PIK), 12/28/2017

  $ 5,767,983        5,680,703        5,767,983        5.0

Emily Street Enterprises,
L.L.C.(g)

   Business Services    Warrant Membership Interests     49,318        400,000        601,679        0.5

Help/Systems Holdings,
Inc.(Help/Systems,
LLC)(d)

   Business Services   

First Lien Term Loan

5.50% Cash, 6/28/2019

  $ 3,990,000        3,954,385        3,960,075        3.5

Help/Systems Holdings, Inc.(Help/Systems,
LLC)(d)

   Business Services    Second Lien Term Loan 9.50% Cash, 6/28/2020   $ 2,000,000        1,972,758        2,000,000        1.7

Knowland Technology
Holdings, L.L.C.

   Business Services    First Lien Term Loan 11.00% Cash, 11/29/2017   $ 6,200,000        6,107,034        6,200,000        5.4

Trinet HR Corporation
(SOI Holdings, Inc.)(d)

   Business Services   

First Lien Term Loan

5.00% Cash, 8/20/2020

  $ 4,987,500        4,941,335        5,018,921        4.4

Trinet HR Corporation(SOI
Holdings, Inc.)(d)

   Business Services    Second Lien Term Loan 8.75% Cash, 2/20/2021   $ 2,500,000        2,453,145        2,518,750        2.2

Vector Controls Holding Co., LLC(d)

   Business Services    First Lien Term Loan, 14.00% (12.00% Cash/2.00% PIK), 3/6/2018   $ 9,261,074        9,115,415        9,075,853        7.9

Vector Controls Holding Co., LLC (d),(g)

   Business Services    Warrants to Purchase Limited Liability Company Interests     101        —          136,217        0.1
         

 

 

   

 

 

   

 

 

 
      Total Business Services       55,827,024        57,330,283        49.8
         

 

 

   

 

 

   

 

 

 

 

F-45


Table of Contents

Company

 

Industry

  

Investment

Interest Rate /
Maturity

  Principal/
Number of
Shares
    Cost     Fair Value (c)     % of
Net Assets
 

Targus Group International,
Inc.(d)

  Consumer Products    First Lien Term Loan 11.00% Cash, 5/24/2016   $ 3,738,369        3,704,766        3,663,602        3.2

Targus Holdings,
Inc.(d),(g)

  Consumer Products    Common Stock     62,413        566,765        730,232        0.6

Targus Holdings,
Inc.(d)

  Consumer Products   

Unsecured Note

10.00% PIK, 6/14/2019

  $ 2,054,158        2,054,158        1,387,848        1.2

Targus Holdings,
Inc.(d)

  Consumer Products   

Unsecured Note

16.00% Cash, 10/26/2018

  $ 384,577        379,471        336,505        0.3
        

 

 

   

 

 

   

 

 

 
     Total Consumer Products       6,705,160        6,118,187        5.3
        

 

 

   

 

 

   

 

 

 

Avionte Holdings, LL(g)

  Consumer Services    Common Stock   $ 100,000        100,000        100,000        0.1

Avionte Holdings, LLC

  Consumer Services   

First Lien Term Loan

9.75% Cash, 1/8/2019

  $ 3,000,000        2,940,000        3,000,000        2.6

CFF Acquisition L.L.C.(d)

  Consumer Services   

First Lien Term Loan

7.50% Cash, 7/31/2015

  $ 1,319,891        1,273,596        1,319,891        1.1

Expedited Travel L.L.C.

  Consumer Services   

First Lien Term Loan

9.00% Cash, 12/28/2017

  $ 4,580,000        4,501,104        4,580,000        4.0

PrePaid Legal Services,
Inc.(d)

  Consumer Services   

First Lien Term Loan

6.25% Cash, 7/1/2019

  $ 4,274,194        4,236,035        4,247,694        3.7

PrePaid Legal Services,
Inc.(d)

  Consumer Services    Second Lien Term Loan 9.75% Cash, 7/1/2020   $ 5,000,000        4,931,888        5,044,000        4.4
        

 

 

   

 

 

   

 

 

 
     Total Consumer Services       17,982,623        18,291,585        15.9
        

 

 

   

 

 

   

 

 

 

M/C Acquisition Corp.,
L.L.C.(d),(g)

  Education    Class A Common Stock     544,761        30,241        —          0.0

M/C Acquisition Corp., L.L.C.(d)

  Education   

First Lien Term Loan

1.00% Cash, 3/13/14

  $ 2,512,184        1,358,250        90,128        0.1
        

 

 

   

 

 

   

 

 

 
     Total Education       1,388,491        90,128        0.1
        

 

 

   

 

 

   

 

 

 

Group Dekko, Inc.(d)

  Electronics    Second Lien Term Loan 11.00% (10.00% Cash/1.00% PIK), 5/1/2016   $ 6,901,547        6,901,547        6,741,431        5.9
        

 

 

   

 

 

   

 

 

 
     Total Electronics       6,901,547        6,741,431        5.9
        

 

 

   

 

 

   

 

 

 

USS Parent Holding
Corp.(d),(g)

  Environmental    Non Voting Common Stock     765        133,002        220,992        0.2

USS Parent Holding
Corp.(d),(g)

  Environmental    Voting Common Stock     17,396        3,025,798        5,027,574        4.4
        

 

 

   

 

 

   

 

 

 
     Total Environmental       3,158,800        5,248,566        4.6
        

 

 

   

 

 

   

 

 

 

DS Waters of America,
Inc.(d)

  Food and Beverage   

First Lien Term Loan

5.25% Cash, 8/30/2020

  $ 2,493,750        2,470,506        2,531,156        2.2

HOA Restaurant Group, L.L.C.(d)

  Food and Beverage   

Senior Secured Note

11.25% Cash, 4/1/2017

  $ 4,000,000        3,918,437        4,240,000        3.7

TB Corp.(d)

  Food and Beverage   

First Lien Term Loan

5.75% Cash, 6/19/2018

  $ 5,101,971        5,082,013        5,127,481        4.5

TB Corp.(d)

  Food and Beverage    Unsecured Note 13.50% (12.00% Cash/1.50% PIK), 12/20/2018   $ 2,543,154        2,513,130        2,555,870        2.2

TM Restaurant Group L.L.C.

  Food and Beverage   

First Lien Term Loan

7.75% Cash, 7/16/2017

  $ 2,845,690        2,831,271        2,831,462        2.5
        

 

 

   

 

 

   

 

 

 
     Total Food and Beverage       16,815,357        17,285,969        15.1
        

 

 

   

 

 

   

 

 

 

 

F-46


Table of Contents

Company

 

Industry

  

Investment

Interest Rate /
Maturity

  Principal/
Number of
Shares
    Cost     Fair Value (c)     % of
Net Assets
 

Bristol Hospice, LLC

  Healthcare Services    Senior Secured Note 11.00%(10.00% Cash/1.00% PIK), 11/29/2018   $ 5,509,782        5,405,325        5,509,782        4.8

Oceans Acquisition, Inc.

  Healthcare Services    First Lien Term A Loan 10.75% Cash, 12/27/2017   $ 6,373,113        6,273,020        6,373,113        5.6

Oceans Acquisition, Inc.

  Healthcare Services    First Lien Term B Loan 10.75% Cash, 12/27/2017   $ 500,000        490,224        500,000        0.4

Smile Brands Group
Inc.(d)

  Healthcare Services    First Lien Term Loan 7.50% Cash, 8/16/2019   $ 4,488,750        4,406,559        4,488,750        3.9

Surgical Specialties Corporation (US),
Inc.(d)

  Healthcare Services    First Lien Term Loan 7.25% Cash, 8/22/2018   $ 2,437,500        2,415,591        2,449,688        2.1

Zest Holdings, LLC(d)

  Healthcare Services    First Lien Term Loan 6.50% Cash, 8/16/2020   $ 4,488,750        4,405,073        4,488,750        3.9
        

 

 

   

 

 

   

 

 

 
     Total Healthcare Services       23,395,792        23,810,083        20.7
        

 

 

   

 

 

   

 

 

 

McMillin Companies L.L.C.(d),(g)

  Homebuilding   

Senior Secured Note

0% Cash, 12/31/2013

  $ 550,000        558,434        344,355        0.3
        

 

 

   

 

 

   

 

 

 
     Total Homebuilding       558,434        344,355        0.3
        

 

 

   

 

 

   

 

 

 

Distribution International, Inc.(d)

  Manufacturing    First Lien Term Loan 7.50% Cash, 7/16/2019   $ 5,970,000        5,916,094        5,970,000        5.2
        

 

 

   

 

 

   

 

 

 
     Total Manufacturing       5,916,094        5,970,000        5.2
        

 

 

   

 

 

   

 

 

 

Elyria Foundry Company, L.L.C.(d)

  Metals    Senior Secured Note 17.00% (13.00% Cash/4.00% PIK), 9/14/2014   $ 8,859,614        8,859,614        6,644,711        5.8

Elyria Foundry Company, L.L.C.(d),(g)

  Metals    Warrants to Purchase Limited Liability Company Interests (2008)     7,000        20        —          0.0

Elyria Foundry Company, L.L.C.(d),(g)

  Metals    Warrants to Purchase Limited Liability Company Interests (2013)     18,227        —          —          0.0
        

 

 

   

 

 

   

 

 

 
     Total Metals       8,859,634        6,644,711        5.8
        

 

 

   

 

 

   

 

 

 

Network Communications, Inc.(d),(g)

  Publishing    Common Stock     380,572        —          —          0.0

Network Communications,
Inc.(d)

  Publishing   

Unsecured Notes

8.60% PIK, 1/14/2020

  $ 2,601,736        2,202,168        1,190,888        1.0
        

 

 

   

 

 

   

 

 

 
     Total Publishing       2,202,168        1,190,888        1.0
        

 

 

   

 

 

   

 

 

 

Community Investors,
Inc.(g)

  Software    Common Stock     1,282        1,282        1,449        0.0

Community Investors, Inc.

  Software    First Lien Term Loan 9.75% Cash, 5/9/2018   $ 6,983,333        6,863,915        6,983,333        6.1

Community Investors, Inc.

  Software    Revolver   $ 166,667        —          —          0.0

Community Investors,
Inc.(g)

  Software    Preferred Stock     135,584        135,584        153,210        0.1

Pen-Link, Ltd.

  Software    Second Lien Term Loan 12.50% Cash, 5/26/2019   $ 11,500,000        11,280,887        11,500,000        10.0
        

 

 

   

 

 

   

 

 

 
     Total Software       18,281,668        18,637,992        16.2
        

 

 

   

 

 

   

 

 

 

Advanced Air & Heat of Florida, LLC

  Utilities    First Lien Term Loan 10.00% Cash, 1/31/2019   $ 6,705,441        6,606,457        6,705,441        5.8
        

 

 

   

 

 

   

 

 

 
     Total Utilities       6,606,457        6,705,441        5.8
        

 

 

   

 

 

   

 

 

 

Sub Total Non-control/
Non-affiliated investments

           185,266,607        186,275,106        162.1
        

 

 

   

 

 

   

 

 

 

 

F-47


Table of Contents

Company

 

Industry

  

Investment

Interest Rate /
Maturity

  Principal/
Number of
Shares
    Cost     Fair Value (c)     % of
Net Assets
 

Control investments—
17.0%(b)

          

Saratoga Investment Corp. CLO 2013-1,

Ltd.(a),(d),(e),(f)

  Structured Finance Securities    Other/Structured Finance Securities 15.16%, 10/17/2023   $ 30,000,000        16,555,808        19,569,596        17.0
        

 

 

   

 

 

   

 

 

 

Sub Total Control investments

           16,555,808        19,569,596        17.0
        

 

 

   

 

 

   

 

 

 

TOTAL INVESTMENTS—179.1%(b)

         $ 201,822,415      $ 205,844,702        179.1
        

 

 

   

 

 

   

 

 

 

 

(a) Represents a non-qualifying investment as defined under Section 55 (a) of the Investment Company Act of 1940, as amended. Non-qualifying assets represent 9.5% of the Company’s portfolio at fair value. As a BDC, the Company can only invest 30% of its portfolio in non-qualifying assets.
(b) Percentages are based on net assets of $114,924,018 as of February 28, 2014.
(c) Because there is no readily available market value for these investments, the fair value of these investments is approved in good faith by our board of directors (see Note 3 to the consolidated financial statements).
(d) These securities are pledged as collateral under a senior secured revolving credit facility (see Note 6 to the consolidated financial statements).
(e) This investment does not have a stated interest rate that is payable thereon. As a result, the 15.16% interest rate in the table above represents the interest rate currently earned on the investment cost and is based on the current cash interest and other income generated by the investment.
(f) As defined in the Investment Company Act, we “Control” this portfolio company because we own more than 25% of the portfolio company’s outstanding voting securities. Transactions during the period in which the issuer was both an Affiliate and a portfolio company that we Control are as follows:

 

Company

   Purchases      Redemptions      Sales
(cost)
     Interest
Income
     Management
fee income
     Net
Realized
gains/(losses)
     Net
Unrealized
gains/(losses)
 

Saratoga Investment Corp. CLO 2013-1, Ltd.

   $ —         $ —         $ —         $ 3,410,868       $ 1,775,141       $ —         $ 3,013,788   

 

(g) Non-income producing at February 28, 2014.
(h) In connection with the restructuring of this investment, the Company agreed to forgo the receipt of any interest payments thereon.

 

F-48


Table of Contents

Saratoga Investment Corp.

Consolidated Statements of Changes in Net Assets

(unaudited)

 

     For the
six months ended
August 31, 2014
    For the
six months ended
August 31, 2013
 

INCREASE FROM OPERATIONS:

    

Net investment income

   $ 4,133,152      $ 4,741,555   

Net realized gain from investments

     441,841        1,074,942   

Net unrealized appreciation (depreciation) on investments

     318,809        (2,057,943
  

 

 

   

 

 

 

Net increase in net assets from operations

  4,893,802      3,758,554   
  

 

 

   

 

 

 

Total increase in net assets

  4,893,802      3,758,554   

Net assets at beginning of period

  114,924,018      108,686,761   
  

 

 

   

 

 

 

Net assets at end of period

$ 119,817,820    $ 112,445,315   
  

 

 

   

 

 

 

Net asset value per common share

$ 22.27    $ 23.77   

Common shares outstanding at end of period

  5,379,616      4,730,116   

Distribution in excess of net investment income

$ (25,494,426 $ (19,781,396

See accompanying notes to consolidated financial statements.

 

F-49


Table of Contents

Saratoga Investment Corp.

Consolidated Statements of Cash Flows

(unaudited)

 

     For the six months ended
August 31, 2014
    For the six months ended
August 31, 2013
 

Operating activities

    

NET INCREASE IN NET ASSETS FROM OPERATIONS

   $ 4,893,802      $ 3,758,554   

ADJUSTMENTS TO RECONCILE NET INCREASE IN NET ASSETS FROM OPERATIONS TO NET CASH USED BY OPERATING ACTIVITIES:

    

Paid-in-kind interest income

     (371,527     (472,923

Net accretion of discount on investments

     (382,571     (224,598

Amortization of deferred debt financing costs

     512,481        419,294   

Net realized gain from investments

     (441,841     (1,074,942

Net unrealized (appreciation) depreciation on investments

     (318,809     2,057,943   

Proceeds from sale and redemption of investments

     24,387,382        54,849,577   

Purchase of investments

     (53,347,634     (87,854,349

(Increase) decrease in operating assets:

    

Cash and cash equivalents, reserve accounts

     77,442        (4,506,556

Interest receivable

     (742,554     828,945   

Due from manager

     —          (4,929

Management fee receivable

     (16,925     17,331   

Other assets

     (48,308     (7,938

Receivable from unsettled trades

     —          316,489   

Increase (decrease) in operating liabilities:

    

Payable for unsettled trades

     —          16,270,000   

Management and incentive fees payable

     364,629        977,424   

Accounts payable and accrued expenses

     (288,213     66,602   

Interest and debt fees payable

     162,938        487,255   

Due to manager

     20,000        85,888   
  

 

 

   

 

 

 

NET CASH USED BY OPERATING ACTIVITIES

  (25,539,708   (14,010,933
  

 

 

   

 

 

 

Financing activities

Borrowings on debt

  27,600,000      4,000,000   

Paydowns on debt

  (4,700,000   (24,300,000

Issuance of notes

  —        48,300,000   

Debt financing cost

  (382,812   (2,579,309
  

 

 

   

 

 

 

NET CASH PROVIDED BY FINANCING ACTIVITIES

  22,517,188      25,420,691   
  

 

 

   

 

 

 

NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS

  (3,022,520   11,409,758   

CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD

  3,293,898      149,025   
  

 

 

   

 

 

 

CASH AND CASH EQUIVALENTS, END OF PERIOD

$ 271,378    $ 11,558,783   
  

 

 

   

 

 

 

Supplemental Information:

Interest paid during the period

$ 2,921,683    $ 1,824,887   

Supplemental non-cash information:

Paid-in-kind interest income

$ 371,527    $ 472,923   

Net accretion of discount on investments

$ 382,571    $ 224,598   

Amortization of deferred debt financing costs

$ 512,481    $ 419,294   

See accompanying notes to consolidated financial statements.

 

F-50


Table of Contents

SARATOGA INVESTMENT CORP.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

August 31, 2014

(unaudited)

Note 1. Organization and Basis of Presentation

Saratoga Investment Corp. (the “Company”, “we”, “our” and “us”) is a non-diversified closed end management investment company incorporated in Maryland that has elected to be treated and is regulated as a business development company (“BDC”) under the Investment Company Act of 1940 (the “1940 Act”). We commenced operations on March 23, 2007 as GSC Investment Corp. and completed our initial public offering (“IPO”) on March 28, 2007. We have elected to be treated as a regulated investment company (“RIC”) under subchapter M of the Internal Revenue Code (the “Code”). We expect to continue to qualify and to elect to be treated for tax purposes as a RIC. Our investment objective is to generate current income and, to a lesser extent, capital appreciation from our investments.

GSC Investment, LLC (the “LLC”) was organized in May 2006 as a Maryland limited liability company. As of February 28, 2007, the LLC had not yet commenced its operations and investment activities.

On March 21, 2007, the Company was incorporated and concurrently therewith the LLC was merged with and into the Company, with the Company as the surviving entity, in accordance with the procedure for such merger in the LLC’s limited liability company agreement and Maryland law. In connection with such merger, each outstanding limited liability company interest of the LLC was converted into a share of common stock of the Company.

On July 30, 2010, the Company changed its name from “GSC Investment Corp.” to “Saratoga Investment Corp.” in conjunction with the transaction described in “Note 13. Recapitalization Transaction” below.

We are externally managed and advised by our investment adviser, Saratoga Investment Advisors, LLC (the “Manager”), pursuant an investment advisory and management agreement dated July 30, 2010 (the “Management Agreement”). Prior to July 30, 2010, we were managed and advised by GSCP (NJ), L.P.

On March 28, 2012, our wholly-owned subsidiary, Saratoga Investment Corp. SBIC, LP (“SBIC LP”), received a Small Business Investment Company (“SBIC”) license from the Small Business Administration (“SBA”).

The accompanying consolidated financial statements have been prepared on the accrual basis of accounting in conformity with U.S. generally accepted accounting principles (“U.S. GAAP”) and include the accounts of the Company its special purpose financing subsidiary, Saratoga Investment Funding, LLC (previously known as GSC Investment Funding LLC) and SBIC LP. All intercompany accounts and transactions have been eliminated in consolidation. All references made to the “Company,” “we,” and “us” herein include Saratoga Investment Corp. and its consolidated subsidiaries, except as stated otherwise.

Note 2. Summary of Significant Accounting Policies

Use of Estimates in the Preparation of Financial Statements

The preparation of the accompanying consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, and disclosure of contingent assets and liabilities at the date of the financial statements, and income, gains (losses) and expenses during the period reported. Actual results could differ materially from those estimates.

 

F-51


Table of Contents

Cash and Cash Equivalents

Cash and cash equivalents include short-term, liquid investments in a money market fund. Cash and cash equivalents are carried at cost which approximates fair value. Per section 12(d)(1)(A) of the 1940 Act, the Company may not invest in another registered investment company such as, a money market fund if such investment would cause the Company to exceed any of the following limitations:

 

    we were to own more than 3.0% of the total outstanding voting stock of the money market fund;

 

    we were to hold securities in the money market fund having an aggregate value in excess of 5.0% of the value of our total assets; or

 

    we were to hold securities in money market funds and other registered investment companies and BDCs having an aggregate value in excess of 10.0% of the value of our total assets.

Cash and Cash Equivalents, Reserve Accounts

Cash and cash equivalents, reserve accounts include amounts held in designated bank accounts in the form of cash and short-term liquid investments in money market funds representing payments received on secured investments or other reserved amounts associated with our $45.0 million senior secured revolving credit facility with Madison Capital Funding LLC. The Company is required to use these amounts to pay interest expense, reduce borrowings, or pay other amounts in accordance with the terms of the senior secured revolving credit facility.

Investment Classification

The Company classifies its investments in accordance with the requirements of the 1940 Act. Under the 1940 Act, “Control Investments” are defined as investments in companies in which we own more than 25.0% of the voting securities or maintain greater than 50.0% of the board representation. Under the 1940 Act, “Affiliated Investments” are defined as those non-control investments in companies in which we own between 5.0% and 25.0% of the voting securities. Under the 1940 Act, “Non-affiliated Investments” are defined as investments that are neither Control Investments nor Affiliated Investments.

Investment Valuation

The Company accounts for its investments at fair value in accordance with the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 820, Fair Value Measurements and Disclosures (“ASC 820”). ASC 820 defines fair value, establishes a framework for measuring fair value, establishes a fair value hierarchy based on the quality of inputs used to measure fair value and enhances disclosure requirements for fair value measurements. ASC 820 requires the Company to assume that its investments are to be sold at the statement of assets and liabilities date in the principal market to independent market participants, or in the absence of a principal market, in the most advantageous market, which may be a hypothetical market. Market participants are defined as buyers and sellers in the principal or most advantageous market that are independent, knowledgeable, and willing and able to transact.

Investments for which market quotations are readily available are fair valued at such market quotations obtained from independent third party pricing services and market makers subject to any decision by our board of directors to approve a fair value determination to reflect significant events affecting the value of these investments. We value investments for which market quotations are not readily available at fair value as approved, in good faith, by our board of directors based on input from our Manager, the audit committee of our board of directors and a third party independent valuation firm. Determinations of fair value may involve subjective judgments and estimates. The types of factors that may be considered in determining the fair value of our investments include the nature and realizable value of any collateral, the portfolio company’s ability to make payments, market yield trend analysis, the markets in which the portfolio company does business, comparison to publicly traded companies, discounted cash flow and other relevant factors.

 

F-52


Table of Contents

We undertake a multi-step valuation process each quarter when valuing investments for which market quotations are not readily available, as described below:

 

    Each investment is initially valued by the responsible investment professionals of our Manager and preliminary valuation conclusions are documented and discussed with the senior management of our Manager; and

 

    An independent valuation firm engaged by our board of directors reviews approximately one quarter of these preliminary valuations each quarter so that the valuation of each investment for which market quotes are not readily available is reviewed by the independent valuation firm at least annually.

In addition, all our investments are subject to the following valuation process:

 

    The audit committee of our board of directors reviews each preliminary valuation and our Manager and independent valuation firm (if applicable) will supplement the preliminary valuation to reflect any comments provided by the audit committee; and

 

    Our board of directors discusses the valuations and approves the fair value of each investment, in good faith, based on the input of our Manager, independent valuation firm (to the extent applicable) and the audit committee of our board of directors.

Our investment in Saratoga Investment Corp. CLO 2013-1, Ltd. (“Saratoga CLO”) is carried at fair value, which is based on a discounted cash flow model that utilizes prepayment, re-investment and loss assumptions based on historical experience and projected performance, economic factors, the characteristics of the underlying cash flow, and comparable yields for equity interests in collateralized loan obligation funds similar to Saratoga CLO, when available, as determined by our Manager and recommended to our board of directors. Specifically, we use Intex cash flow models, or an appropriate substitute, to form the basis for the valuation of our investment in Saratoga CLO. The models use a set of assumptions including projected default rates, recovery rates, reinvestment rate and prepayment rates in order to arrive at estimated valuations. The assumptions are based on available market data and projections provided by third parties as well as management estimates. We use the output from the Intex models (i.e., the estimated cash flows) to perform a discounted cash flows analysis on expected future cash flows to determine a valuation for our investment in Saratoga CLO.

Because such valuations, and particularly valuations of private investments and private companies, are inherently uncertain, they may fluctuate over short periods of time and may be based on estimates. The determination of fair value may differ materially from the values that would have been used if a ready market for these investments existed. Our net asset value could be materially affected if the determinations regarding the fair value of our investments were materially higher or lower than the values that we ultimately realize upon the disposal of such investments.

Investment Transactions and Income Recognition

Purchases and sales of investments and the related realized gains or losses are recorded on a trade-date basis. Interest income, adjusted for amortization of premium and accretion of discount, is recorded on an accrual basis to the extent that such amounts are expected to be collected. The Company stops accruing interest on its investments when it is determined that interest is no longer collectible. Discounts and premiums on investments purchased are accreted/amortized over the life of the respective investment using the effective yield method. The amortized cost of investments represents the original cost adjusted for the accretion of discounts and amortizations of premium on investments.

Loans are generally placed on non-accrual status when there is reasonable doubt that principal or interest will be collected. Accrued interest is generally reserved when a loan is placed on non-accrual status. Interest payments received on non-accrual loans may be recognized as a reduction in principal depending upon management’s judgment regarding collectability. Non-accrual loans are restored to accrual status when past due principal and interest is paid and, in management’s judgment, are likely to remain current, although we may make exceptions to this general rule if the loan has sufficient collateral value and is in the process of collection.

 

F-53


Table of Contents

Interest income on our investment in Saratoga CLO is recorded using the effective interest method in accordance with the provisions of ASC Topic 325-40, Investments-Other, Beneficial Interests in Securitized Financial Assets, (“ASC 325-40”), based on the anticipated yield and the estimated cash flows over the projected life of the investment. Yields are revised when there are changes in actual or estimated cash flows due to changes in prepayments and/or re-investments, credit losses or asset pricing. Changes in estimated yield are recognized as an adjustment to the estimated yield over the remaining life of the investment from the date the estimated yield was changed.

Paid-in-Kind Interest

The Company holds debt investments in its portfolio that contain a payment-in-kind (“PIK”) interest provision. The PIK interest, which represents contractually deferred interest added to the investment balance that is generally due at maturity, is generally recorded on the accrual basis to the extent such amounts are expected to be collected. We stop accruing PIK interest if we do not expect the issuer to be able to pay all principal and interest when due.

Deferred Debt Financing Costs

Financing costs incurred in connection with our credit facility are deferred and amortized using the straight line method over the life of their respective facilities. Financing costs incurred in connection with our SBA debentures are deferred and amortized using the effective yield method over the life of the debentures.

Contingencies

In the ordinary course of its business, the Company may enter into contracts or agreements that contain indemnifications or warranties. Future events could occur that lead to the execution of these provisions against the Company. Based on its history and experience, management feels that the likelihood of such an event is remote.

In the ordinary course of business, the Company may directly or indirectly be a defendant or plaintiff in legal actions with respect to bankruptcy, insolvency or other types of proceedings. Such lawsuits may involve claims that could adversely affect the value of certain financial instruments owned by the Company.

Income Taxes

The Company has filed an election to be treated for tax purposes as a RIC under Subchapter M of the Code and, among other things, intends to make the requisite distributions to its stockholders which will relieve the Company from federal income taxes. Therefore, no provision has been recorded for federal income taxes.

In order to qualify as a RIC, among other requirements, the Company is required to timely distribute to its stockholders at least 90.0% of its investment company taxable income, as defined by the Code, for each fiscal tax year. The Company will be subject to a nondeductible U.S. federal excise tax of 4.0% on undistributed income if it does not distribute at least 98.0% of its ordinary income in any calendar year and 98.2% of its capital gain net income for each one-year period ending on October 31.

Depending on the level of taxable income earned in a tax year, the Company may choose to carry forward taxable income in excess of current year dividend distributions into the next tax year and pay a 4.0% excise tax on such income, as required. To the extent that the Company determines that its estimated current year annual taxable income will be in excess of estimated current year dividend distributions for excise tax purposes, the Company accrues excise tax, if any, on estimated excess taxable income as taxable income is earned.

In accordance with certain applicable Treasury regulations and private letter rulings issued by the Internal Revenue Service, a RIC may treat a distribution of its own stock as fulfilling its RIC distribution requirements if

 

F-54


Table of Contents

each stockholder may elect to receive his or her entire distribution in either cash or stock of the RIC subject to a limitation on the aggregate amount of cash to be distributed to all stockholders, which limitation must be at least 20.0% of the aggregate declared distribution. If too many stockholders elect to receive cash, each stockholder electing to receive cash will receive a pro rata amount of cash (with the balance of the distribution paid in stock). In no event will any stockholder, electing to receive cash, receive less than 20.0% of his or her entire distribution in cash. If these and certain other requirements are met, for U.S federal income tax purposes, the amount of the dividend paid in stock will be equal to the amount of cash that could have been received instead of stock.

ASC 740, Income Taxes, (“ASC 740”), provides guidance for how uncertain tax positions should be recognized, measured, presented and disclosed in the financial statements. ASC 740 requires the evaluation of tax positions taken or expected to be taken in the course of preparing the Company’s tax returns to determine whether the tax positions are “more-likely-than-not” of being sustained by the applicable tax authority. Tax positions deemed to meet a “more-likely-than-not” threshold would be recorded as a tax benefit or expense in the current period. The Company recognizes interest and penalties, if any, related to unrecognized tax benefits as income tax expense in the consolidated statements of operations. During the fiscal year ended February 28, 2014, the Company did not incur any interest or penalties. Although we file federal and state tax returns, our major tax jurisdiction is federal. The 2011, 2012 and 2013 federal tax years for the Company remain subject to examination by the IRS. As of August 31, 2014 and February 28, 2014, there were no uncertain tax positions.

Dividends

Dividends to common stockholders are recorded on the ex-dividend date. The amount to be paid out as a dividend is determined by the board of directors. Net realized capital gains, if any, are generally distributed at least annually, although we may decide to retain such capital gains for reinvestment.

We have adopted a dividend reinvestment plan (“DRIP”) that provides for reinvestment of our dividend distributions on behalf of our stockholders unless a stockholder elects to receive cash. As a result, if our board of directors authorizes, and we declare, a cash dividend, then our stockholders who have not “opted out” of our dividend reinvestment plan will have their cash dividends automatically reinvested in additional shares of our common stock, rather than receiving the cash dividends. We have the option to satisfy the share requirements of the DRIP through the issuance of new shares of common stock or through open market purchases of common stock by the DRIP plan administrator.

Capital Gains Incentive Fee

The Company records an expense accrual on the consolidated statements of operations, relating to the capital gains incentive fee payable on the consolidated statements of assets and liabilities, by the Company to its investment adviser when the unrealized gains on its investments exceed all realized capital losses on its investments given the fact that a capital gains incentive fee would be owed to the investment adviser if the Company were to liquidate its investment portfolio at such time. The actual incentive fee payable to the Company’s investment adviser related to capital gains will be determined and payable in arrears at the end of each fiscal year and will include only realized capital gains for the period.

New Accounting Pronouncements

In June 2014, the FASB issued ASU 2014-11, Repurchase-to-Maturity Transactions, Repurchase Financings, and Disclosures, (“ASU 2014-11”). ASU 2014-11 makes limited changes to the accounting for repurchase agreements, clarifies when repurchase agreements and securities lending transactions should be accounted for as secured borrowings, and requires additional disclosures regarding these types of transactions. The guidance is effective for fiscal years beginning on or after December 15, 2014, and for interim periods within those fiscal years. Management is currently evaluating the impact these changes will have on the Company’s consolidated financial statement disclosures.

 

F-55


Table of Contents

Risk Management

In the ordinary course of its business, the Company manages a variety of risks, including market risk and credit risk. Market risk is the risk of potential adverse changes to the value of investments because of changes in market conditions such as interest rate movements and volatility in investment prices.

Credit risk is the risk of default or non-performance by portfolio companies, equivalent to the investment’s carrying amount.

The Company is also exposed to credit risk related to maintaining all of its cash and cash equivalents, including those in reserve accounts, at a major financial institution and credit risk related to any of its derivative counterparties.

The Company has investments in lower rated and comparable quality unrated high yield bonds and bank loans. Investments in high yield investments are accompanied by a greater degree of credit risk. The risk of loss due to default by the issuer is significantly greater for holders of high yield securities, because such investments are generally unsecured and are often subordinated to other creditors of the issuer.

Note 3. Investments

As noted above, the Company values all investments in accordance with ASC 820. ASC 820 requires enhanced disclosures about assets and liabilities that are measured and reported at fair value. As defined in ASC 820, fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date.

ASC 820 establishes a hierarchal disclosure framework which prioritizes and ranks the level of market price observability of inputs used in measuring investments at fair value. Market price observability is affected by a number of factors, including the type of investment and the characteristics specific to the investment. Investments with readily available active quoted prices or for which fair value can be measured from actively quoted prices generally will have a higher degree of market price observability and a lesser degree of judgment used in measuring fair value.

Based on the observability of the inputs used in the valuation techniques, the Company is required to provide disclosures on fair value measurements according to the fair value hierarchy. The fair value hierarchy ranks the observability of the inputs used to determine fair values. Investments carried at fair value are classified and disclosed in one of the following three categories:

 

    Level 1—Valuations based on quoted prices in active markets for identical assets or liabilities that the Company has the ability to access.

 

    Level 2—Valuations based on inputs other than quoted prices in active markets, which are either directly or indirectly observable.

 

    Level 3—Valuations based on inputs that are unobservable and significant to the overall fair value measurement. The inputs used in the determination of fair value may require significant management judgment or estimation. Such information may be the result of consensus pricing information or broker quotes which include a disclaimer that the broker would not be held to such a price in an actual transaction. The non-binding nature of consensus pricing and/or quotes accompanied by disclaimer would result in classification as Level 3 asset, assuming no additional corroborating evidence.

In addition to using the above inputs in investment valuations, the Company continues to employ the valuation policy approved by the board of directors that is consistent with ASC 820 and the 1940 Act (see Note 2). Consistent with our Company’s valuation policy, we evaluate the source of inputs, including any markets in which our investments are trading, in determining fair value.

 

F-56


Table of Contents

The following table presents fair value measurements of investments, by major class, as of August 31, 2014 (dollars in thousands), according to the fair value hierarchy:

 

     Fair Value Measurements  
     Level 1      Level 2      Level 3      Total  

Middle market loans

   $ —         $ —         $ 26,814       $ 26,814   

First lien term loans

     —           —           115,589         115,589   

Second lien term loans

     —           —           29,262         29,262   

Senior secured notes

     —           —           25,035         25,035   

Unsecured notes

     —           —           5,909         5,909   

Structured finance securities

     —           —           20,090         20,090   

Equity interest

     —           —           13,621         13,621   
  

 

 

    

 

 

    

 

 

    

 

 

 

Total

$ —      $ —      $ 236,320    $ 236,320   
  

 

 

    

 

 

    

 

 

    

 

 

 

The following table presents fair value measurements of investments, by major class, as of February 28, 2014 (dollars in thousands), according to the fair value hierarchy:

 

     Fair Value Measurements  
     Level 1      Level 2      Level 3      Total  

Middle market loans

   $ —         $ —         $ 32,390       $ 32,390   

First lien term loans

     —           —           80,246         80,246   

Second lien term loans

     —           —           27,804         27,804   

Senior secured notes

     —           —           30,032         30,032   

Unsecured notes

     —           —           5,471         5,471   

Structured finance securities

     —           —           19,570         19,570   

Equity interest

     —           —           10,332         10,332   
  

 

 

    

 

 

    

 

 

    

 

 

 

Total

$ —      $ —      $ 205,845    $ 205,845   
  

 

 

    

 

 

    

 

 

    

 

 

 

The following table provides a reconciliation of the beginning and ending balances for investments that use Level 3 inputs for the six months ended August 31, 2014 (dollars in thousands):

 

    Middle
market
loans
    First lien
term loans
    Second lien
term loans
    Senior
secured
notes
    Unsecured
notes
    Structured
finance
securities
    Common
stock/
equities
    Total  

Balance as of February 28, 2014

  $ 32,390      $ 80,246      $ 27,804      $ 30,032      $ 5,471      $ 19,570      $ 10,332      $ 205,845   

Net unrealized gains (losses)

    (256     (395     (263     (1,108     322        520        1,499        319   

Purchases and other adjustments to cost

    28        40,446        11,175        76        116        —          2,260        54,101   

Sales and redemptions

    (5,383     (5,155     (9,500     (4,253     —          —          (96     (24,387

Net realized gains/(losses) from investments

    35        447        46        288        —          —          (374     442   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Balance as of August 31, 2014

$ 26,814    $ 115,589    $ 29,262    $ 25,035    $ 5,909    $ 20,090    $ 13,621    $ 236,320   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

F-57


Table of Contents

The following table provides a reconciliation of the beginning and ending balances for investments that use Level 3 inputs for the six months ended August 31, 2013 (dollars in thousands):

 

    Middle
market
loans
    First
lien term
loans
    Second lien
term loans
    Senior
secured
notes
    Unsecured
notes
    Structured
finance
securities
    Common
stock/equities
    Total  

Balance as of February 28, 2013

  $ —        $ 83,792      $ 9,571      $ 23,305      $ 4,874      $ 25,517      $ 8,021      $ 155,080   

Net unrealized gains (losses)

    222        38        (29     (122     432        (3,635     1,037        (2,057

Purchases and other adjustments to cost

    37,013        32,924        9,400        8,938        127        —          150        88,552   

Sales and redemptions

    —          (41,650     (3,030     (7,728     —          (2,140     (301     (54,849

Net realized gains from investments

    —          403        370        —          —          —          301        1,074   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Balance as of August 31, 2013

$ 37,235    $ 75,507    $ 16,282    $ 24,393    $ 5,433    $ 19,742    $ 9,208    $ 187,800   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Purchases and other adjustments to cost include purchases of new investments at cost, effects of refinancing/restructuring, accretion/amortization of income from discount/premium on debt securities, and PIK.

Sales and redemptions represent net proceeds received from investments sold, and principal paydowns received, during the period.

The net change in unrealized gain/(loss) for the six months ended August 31, 2014 and 2013, on investments held as of August 31, 2014 and 2013, was $734,740 and $(2,349,502), respectively, and is included in net unrealized appreciation (depreciation) on investments in the consolidated statements of operations.

The valuation techniques and significant unobservable inputs used in recurring Level 3 fair value measurements of assets as of August 31, 2014 were as follows (dollars in thousands):

 

     Fair Value     

Valuation Technique

  

Unobservable Input

  

Range

  

Weighted
Average Yield

Middle market loans

   $ 26,814       Market Comparables    Third-Party Bid    97.5 - 100.3    99.4%

First lien term loans

     115,589       Market Comparables    Market Yield (%)    5.5% - 15.7%    11.2%
         EBITDA Multiples (x)    3.0x    3.0x
         Third-Party Bid    83.7 - 101.0    96.1%

Second lien term loans

     29,262       Market Comparables    Market Yield (%)    8.8% - 14.8%    12.2%
         Third-Party Bid    100.0 - 101.9    101.3%

Senior secured notes

     25,035       Market Comparables    Market Yield (%)    11.0% - 42.5%    12.6%
         EBITDA Multiples (x)    5.0x    5.0x
         Third-Party Bid    108.0    108.0%

Unsecured notes

     5,909       Market Comparables    Market Yield (%)    13.2% - 22.2%    17.0%

Structured finance securities

     20,090       Discounted Cash Flow    Discount Rate (%)    7.5%    7.5%

Equity interests

     13,621       Market Comparables    EBITDA Multiples (x)    6.3x - 14.0x    8.1x

 

F-58


Table of Contents

The valuation techniques and significant unobservable inputs used in recurring Level 3 fair value measurements of assets as of February 28, 2014 were as follows (dollars in thousands):

 

     Fair Value     

Valuation Technique

  

Unobservable Input

  

Range

  

Weighted
Average Yield

Middle market loans

   $   32,390       Market Comparables    Third-Party Bid    99.5 - 100.6    100.1%

First lien term loans

     80,246       Market Comparables    Market Yield (%)    5.1% - 15.5%    10.4%
         EBITDA Multiples (x)    3.0x    3.0x
         Third-Party Bid    83.3 - 101.5    97.0%

Second lien term loans

     27,804       Market Comparables    Market Yield (%)    9.6% - 12.5%    11.7%
         Third-Party Bid    100.0 - 101.8    101.1%

Senior secured notes

     30,032       Market Comparables    Market Yield (%)    11.0% - 42.5%    12.4%
         EBITDA Multiples (x)    5.0x    5.0x
         Third-Party Bid    106.0 - 107.5    107.0%

Unsecured notes

     5,471       Market Comparables    Market Yield (%)    12.8% - 20.3%    16.5%

Structured finance securities

     19,570       Discounted Cash Flow    Discount Rate (%)    9.0%    9.0%

Equity interests

     10,332       Market Comparables    EBITDA Multiples (x)    6.3x - 12.0x    7.8x

For investments utilizing a market comparables valuation technique, a significant increase (decrease) in the market yield, in isolation, would result in a significantly lower (higher) fair value measurement, and a significant increase (decrease) in any of the EBITDA valuation multiples, in isolation, would result in a significantly higher (lower) fair value measurement. For investments utilizing a discounted cash flow valuation technique, a significant increase (decrease) in the discount rate, in isolation, would result in a significantly lower (higher) fair value measurement.

The composition of the Company’s investments as of August 31, 2014, at amortized cost and fair value were as follows (dollars in thousands):

 

     Investments at
Amortized Cost
     Amortized Cost
Percentage of
Total Portfolio
    Investments at
Fair Value
     Fair Value
Percentage of
Total Portfolio
 

Middle market loans

   $ 26,662         11.5   $ 26,814         11.3

First lien term loans

     116,473         50.2        115,589         48.9   

Second lien term loans

     29,261         12.6        29,262         12.4   

Senior secured notes

     27,416         11.8        25,035         10.6   

Unsecured notes

     7,265         3.2        5,909         2.5   

Structured finance securities

     16,556         7.1        20,090         8.5   

Equity interest

     8,346         3.6        13,621         5.8   
  

 

 

    

 

 

   

 

 

    

 

 

 

Total

$ 231,979      100.0 $ 236,320      100.0
  

 

 

    

 

 

   

 

 

    

 

 

 

 

F-59


Table of Contents

The composition of the Company’s investments as of February 28, 2014, at amortized cost and fair value were as follows (dollars in thousands):

 

     Investments at
Amortized Cost
     Amortized Cost
Percentage of
Total Portfolio
    Investments at
Fair Value
     Fair Value
Percentage of
Total Portfolio
 

Middle market loans

   $ 31,983         15.8   $ 32,390         15.7

First lien term loans

     80,734         40.0        80,246         39.0   

Second lien term loans

     27,540         13.6        27,804         13.5   

Senior secured notes

     31,304         15.6        30,032         14.6   

Unsecured notes

     7,149         3.5        5,471         2.7   

Structured finance securities

     16,556         8.2        19,570         9.5   

Equity interest

     6,556         3.3        10,332         5.0   
  

 

 

    

 

 

   

 

 

    

 

 

 

Total

   $ 201,822         100.0   $ 205,845         100.0
  

 

 

    

 

 

   

 

 

    

 

 

 

For loans and debt securities for which market quotations are not available, we determine their fair value based on third party indicative broker quotes, where available, or the assumptions that a hypothetical market participant would use to value the security in a current hypothetical sale using a market yield valuation methodology. In applying the market yield valuation methodology, we determine the fair value based on such factors as market participant assumptions including synthetic credit ratings, estimated remaining life, current market yield and interest rate spreads of similar securities as of the measurement date. If, in our judgment, the market yield methodology is not sufficient or appropriate, we may use additional methodologies such as an asset liquidation or expected recovery model.

For equity securities of portfolio companies and partnership interests, we determine the fair value based on the market approach with value then attributed to equity or equity like securities using the enterprise value waterfall valuation methodology. Under the enterprise value waterfall valuation methodology, we determine the enterprise fair value of the portfolio company and then waterfall the enterprise value over the portfolio company’s securities in order of their preference relative to one another. To estimate the enterprise value of the portfolio company, we weigh some or all of the traditional market valuation methods and factors based on the individual circumstances of the portfolio company in order to estimate the enterprise value. The methodologies for performing investments may be based on, among other things: valuations of comparable public companies, recent sales of private and public comparable companies, discounting the forecasted cash flows of the portfolio company, third party valuations of the portfolio company, considering offers from third parties to buy the company, estimating the value to potential strategic buyers and considering the value of recent investments in the equity securities of the portfolio company. For non-performing investments, we may estimate the liquidation or collateral value of the portfolio company’s assets and liabilities. We also take into account historical and anticipated financial results.

Our investment in Saratoga CLO is carried at fair value, which is based on a discounted cash flow model that utilizes prepayment, re-investment and loss assumptions based on historical experience and projected performance, economic factors, the characteristics of the underlying cash flow, and comparable yields for equity interests in collateralized loan obligation funds similar to Saratoga CLO, when available, as determined by our Manager and recommended to our board of directors. Specifically, we use Intex cash flow models, or an appropriate substitute, to form the basis for the valuation of our investment in Saratoga CLO. The models use a set of assumptions including projected default rates, recovery rates, reinvestment rate and prepayment rates in order to arrive at estimated valuations. The assumptions are based on available market data and projections provided by third parties as well as management estimates. We use the output from the Intex models (i.e., the estimated cash flows) to perform a discounted cash flows analysis on expected future cash flows to determine a valuation for our investment in Saratoga CLO at August 31, 2014. The significant inputs for the valuation model include:

 

    Default rates: 2.0%

 

F-60


Table of Contents
    Recovery rates: 35-75%

 

    Prepayment rate: 25.0%

 

    Reinvestment rate / price: L+375bps / $99.75

The Company and SBIC are both considered to be investment companies for financial reporting purposes and have applied the guidance in Topic 946, “Financial Services — Investment Companies”. There have been no changes to the Company or SBIC’s status as investment companies during the quarterly period ended August 31, 2014.

Note 4. Investment in Saratoga Investment Corp. CLO 2013-1, Ltd. (“Saratoga CLO”)

On January 22, 2008, we invested $30.0 million in all of the outstanding subordinated notes of GSC Investment Corp. CLO 2007, Ltd., a collateralized loan obligation fund managed by us that invests primarily in senior secured loans. Additionally, we entered into a collateral management agreement with GSC Investment Corp. CLO 2007, Ltd. pursuant to which we act as collateral manager to it. The Saratoga CLO was refinanced in October 2013 and its reinvestment period ends in October 2016. The Saratoga CLO remains 100% owned and managed by Saratoga Investment Corp. We receive a base management fee of 0.25% and a subordinated management fee of 0.25% of the Fee Basis Amount at the beginning of the Collection Period, paid quarterly to the extent of available proceeds. We are also entitled to an incentive management fee equal to 20.0% of the remaining interest proceeds and principal proceeds, if any, after the subordinated notes have realized the incentive management fee target return of 12.0%, in accordance with the Priority of Payments after making the prior distributions on the relevant payment date. For the three months ended August 31, 2014 and August 31, 2013, we accrued $0.4 million and $0.5 million in management fee income, respectively, and $0.7 million and $1.1 million in interest income, respectively, from Saratoga CLO. For the six months ended August 31, 2014 and August 31, 2013, we accrued $0.8 million and $1.0 million in management fee income, respectively, and $1.3 million and $2.2 million in interest income, respectively, from Saratoga CLO. We did not accrue any amounts related to the incentive management fee as the 12.0% hurdle rate has not yet been achieved.

At August 31, 2014, the Company determined that the fair value of its investment in the subordinated notes of Saratoga CLO was $20.1 million. The Company determines the fair value of its investment in the subordinated notes of Saratoga CLO based on the present value of the projected future cash flows of the subordinated notes over the life of Saratoga CLO. At August 31, 2014, Saratoga CLO had investments with a principal balance of $304.4 million and a weighted average spread over LIBOR of 4.1%, and had debt with a principal balance of $282.4 million with a weighted average spread over LIBOR of 1.8%. As a result, Saratoga CLO earns a “spread” between the interest income it receives on its investments and the interest expense it pays on its debt and other operating expenses, which is distributed quarterly to the Company as the holder of its subordinated notes. At August 31, 2014, the total “spread”, or projected future cash flows of the subordinated notes, over the life of Saratoga CLO was $24.3 million, which had a present value of approximately $20.9 million, using a 7.5% discount rate.

Below is certain financial information from the separate unaudited financial statements of Saratoga CLO as of August 31, 2014 and February 28, 2014, pursuant to Rule 3-09 of SEC rules Regulation S-X, and for the three and six months ended August 31, 2014 and August 31, 2013.

 

F-61


Table of Contents

Saratoga Investment Corp. CLO 2013-1, Ltd.

Statements of Assets and Liabilities

 

     As of  
     August 31, 2014     February 28, 2014  
     (unaudited)        

ASSETS

    

Investments

    

Fair Value Loans (amortized cost of $302,554,790 and $299,137,566, respectively)

   $ 301,019,691      $ 300,491,077   
  

 

 

   

 

 

 

Total investments at fair value (amortized cost of $302,554,790 and $299,137,566, respectively)

  301,019,691      300,491,077   

Cash and cash equivalents

  2,809,601      8,018,933   

Receivable from open trades

  2,223,951      1,801,266   

Interest receivable

  1,293,973      1,450,952   

Deferred debt financing costs, net

  2,054,114      2,166,633   

Other assets

  91,331      91,336   
  

 

 

   

 

 

 

Total assets

$ 309,492,661    $ 314,020,197   
  

 

 

   

 

 

 

LIABILITIES

Interest payable

$ 668,293    $ 622,476   

Payable from open trades

  7,427,661      9,445,000   

Accrued base management fee

  83,515      75,053   

Accrued subordinated management fee

  83,515      75,053   

Class X Notes—SIC CLO 2013-1, Ltd.

  —        1,666,666   

Class A-1 Notes—SIC CLO 2013-1, Ltd.

  170,000,000      170,000,000   

Discount on Class A-1 Notes—SIC CLO 2013-1, Ltd.

  (1,583,109   (1,671,864

Class A-2 Notes—SIC CLO 2013-1, Ltd.

  20,000,000      20,000,000   

Discount on Class A-2 Notes—SIC CLO 2013-1, Ltd.

  (164,100   (173,300

Class B Notes—SIC CLO 2013-1, Ltd.

  44,800,000      44,800,000   

Discount on Class B Notes—SIC CLO 2013-1, Ltd.

  (1,065,994   (1,125,757

Class C Notes—SIC CLO 2013-1, Ltd.

  16,000,000      16,000,000   

Discount on Class C Notes—SIC CLO 2013-1, Ltd.

  (663,693   (700,902

Class D Notes—SIC CLO 2013-1, Ltd.

  14,000,000      14,000,000   

Discount on Class D Notes—SIC CLO 2013-1, Ltd.

  (861,525   (909,825

Class E Notes—SIC CLO 2013-1, Ltd.

  13,100,000      13,100,000   

Discount on Class E Notes—SIC CLO 2013-1, Ltd.

  (1,624,225   (1,715,285

Class F Notes—SIC CLO 2013-1, Ltd.

  4,500,000      4,500,000   

Discount on Class F Notes—SIC CLO 2013-1, Ltd.

  (590,760   (623,880

Subordinated Notes

  30,000,000      30,000,000   
  

 

 

   

 

 

 

Total liabilities

$ 314,109,578    $ 317,363,435   
  

 

 

   

 

 

 

Commitments and contingencies

NET ASSETS

Ordinary equity, par value $1.00, 250 ordinary shares authorized, 250 and 250 issued and outstanding, respectively

$ 250    $ 250   

Accumulated gain (loss)

  (3,343,489   838,567   

Net loss

  (1,273,678   (4,182,055
  

 

 

   

 

 

 

Total net assets

  (4,616,917   (3,343,238
  

 

 

   

 

 

 

Total liabilities and net assets

$ 309,492,661    $ 314,020,197   
  

 

 

   

 

 

 

 

F-62


Table of Contents

Saratoga Investment Corp. CLO 2013-1, Ltd.

Statements of Operations

(unaudited)

 

     For the three months ended
August 31
    For the six months ended
August 31
 
     2014     2013     2014     2013  

INVESTMENT INCOME

        

Interest from investments

   $ 3,323,320      $ 4,201,548      $ 6,480,838      $ 8,607,828   

Interest from cash and cash equivalents

     562        1,295        838        4,451   

Other income

     42,007        325,629        140,930        677,266   
  

 

 

   

 

 

   

 

 

   

 

 

 

Total investment income

  3,365,889      4,528,472      6,622,606      9,289,545   
  

 

 

   

 

 

   

 

 

   

 

 

 

EXPENSES

Interest expense

  1,997,155      1,472,007      4,124,139      3,037,996   

Professional fees

  24,142      208,576      94,360      324,928   

Miscellaneous fee expense

  3,263      8,681      26,396      160,791   

Base management fee

  187,730      96,150      383,747      195,768   

Subordinated management fee

  187,730      384,601      383,747      783,073   

Trustee expenses

  27,313      23,839      53,928      48,371   

Amortization expense

  239,963      254,427      479,926      508,854   
  

 

 

   

 

 

   

 

 

   

 

 

 

Total expenses

  2,667,296      2,448,281      5,546,243      5,059,781   
  

 

 

   

 

 

   

 

 

   

 

 

 

NET INVESTMENT INCOME

  698,593      2,080,191      1,076,363      4,229,764   
  

 

 

   

 

 

   

 

 

   

 

 

 

REALIZED AND UNREALIZED GAIN (LOSS) ON INVESTMENTS:

Net realized gain on investments

  147,951      213,058      528,570      451,600   

Net unrealized depreciation on investments

  (1,425,262   (4,139,484   (2,878,611   (3,499,811
  

 

 

   

 

 

   

 

 

   

 

 

 

Net loss on investments

  (1,277,311   (3,926,426   (2,350,041   (3,048,211
  

 

 

   

 

 

   

 

 

   

 

 

 

NET INCREASE (DECREASE) IN NET ASSETS RESULTING FROM OPERATIONS

$ (578,718 $ (1,846,235 $ (1,273,678 $ 1,181,553   
  

 

 

   

 

 

   

 

 

   

 

 

 

 

F-63


Table of Contents

Saratoga Investment Corp. CLO 2013-1 Ltd.

Schedule of Investments

August 31, 2014

(unaudited)

 

Issuer Name

 

Industry

 

Asset Name

  Asset
Type
    Current
Rate
    Maturity
Date
    Principal     Cost     Fair Value  

24 Hour Holdings III LLC

  Leisure Goods/Activities/Movies   Term Loan     Loan        3.75     5/28/2021      $ 500,000      $ 495,123      $ 498,750   

Academy, LTD.

  Retailers (Except Food and Drugs)   Initial Term Loan (2012)     Loan        4.50     8/3/2018        1,950,262        1,939,947        1,944,412   

Acosta Holdco.

  Media   Term B Loan     Loan        5.00     8/13/2021        2,000,000        1,985,000        2,007,500   

Acosta, Inc.

  Food Products   Term B Loan (2013)     Loan        4.25     3/1/2018        4,141,844        4,092,120        4,133,436   

Aderant North America, Inc.

  Business Equipment and Services   Term Loan (First Lien)     Loan        5.25     12/20/2018        3,260,898        3,260,898        3,264,974   

Advantage Sales

  Business Equipment and Services   Term Loan     Loan        4.25     7/25/2021        1,935,484        1,934,245        1,916,129   

Aegis Toxicology Science Corporation

  Healthcare   Term B Loan     Loan        5.50     2/24/2021        1,000,000        1,000,000        1,003,750   

Aeroflex Incorporated

  Aerospace and Defense   Tranche B-1 Term Loan     Loan        4.50     1/18/2019        3,208,854        3,195,483        3,204,843   

Akorn, Inc.

  Healthcare   Term Loan B     Loan        4.50     4/16/2021        500,000        497,769        498,750   

Albertson’s

  Retailers (Except Food and Drugs)   Term Loan B-4     Loan        5.50     8/25/2021        1,000,000        985,000        1,002,080   

Alere Inc. (fka IM US Holdings, LLC)

  Healthcare   Incremental B-1 Term Loan     Loan        4.25     6/30/2017        1,949,993        1,949,993        1,939,034   

American Tire Distributors

  Automotive   Term Loan     Loan        5.75     6/1/2018        498,988        498,988        499,612   

Anchor Glass

  Containers/Glass Products   Term Loan     Loan        3.25     5/16/2021        2,000,000        1,995,000        1,998,760   

Applied Systems, Inc.

  Business Equipment and Services   Initial Term Loan (First Lien)     Loan        4.25     1/25/2021        497,500        496,392        494,545   

Aramark Corporation

  Food Products   LC-2 Facility     Loan        3.69     7/26/2016        79,187        79,187        78,692   

Aramark Corporation

  Food Products   LC-3 Facility     Loan        3.69     7/26/2016        43,961        43,961        43,686   

Aramark Corporation

  Food Products   U.S. Term F Loan     Loan        3.25     2/24/2021        3,198,521        3,198,521        3,148,944   

ARG IH Corp

  Food Services   Term Loan     Loan        4.75     11/15/2020        497,500        496,469        497,500   

Asurion, LLC (fka Asurion Corporation)

  Insurance   Incremental Tranche B-1 Term Loan     Loan        5.00     5/24/2019        5,480,487        5,434,635        5,481,638   

Auction.Com, LLC

  Business Equipment and Services   Term Loan A-4     Loan        4.40     2/28/2017        914,567        913,866        905,422   

Avantor Performance Materials Holdings, Inc.

  Chemicals/Plastics   Term Loan     Loan        5.25     6/26/2017        4,454,250        4,442,046        4,454,250   

Avast Software

  Electronics/Electric   Term Loan     Loan        4.00     3/20/2020        1,975,000        1,972,619        1,975,000   

AZ Chem US Inc.

  Chemicals/Plastics   Term Loan     Loan        5.25     12/22/2017        492,466        490,056        493,608   

Bass Pro Group, LLC

  Retailers (Except Food and Drugs)   New Term Loan     Loan        3.75     11/20/2019        496,174        495,632        492,041   

Bayonne Energy Center

  Oil & Gas   Term Loan B     Loan        4.50     8/19/2021        1,000,000        995,008        1,000,000   

Belmond Hotels

  Lodging & Casinos   Term Loan     Loan        4.00     3/19/2021        498,750        496,353        497,503   

Berry Plastics Corporation

  Chemicals/Plastics   Term E Loan     Loan        3.75     1/6/2021        1,496,250        1,493,014        1,479,836   

Big Heart Pet Brands (fka Del Monte Corporation)

  Food/Drug Retailers   Initial Term Loan     Loan        3.50     3/9/2020        2,992,500        3,013,405        2,937,648   

Biomet, Inc.

  Healthcare   Dollar Term B-2 Loan     Loan        3.65     7/25/2017        1,840,718        1,840,718        1,836,116   

BJ’s Wholesale Club, Inc.

  Food/Drug Retailers   New 2013 (November) Replacement Loan (First Lien)     Loan        4.50     9/26/2019        1,497,500        1,496,307        1,483,558   

Bombardier Recreational Products Inc.

  Leisure Goods/Activities/Movies   Term B Loan     Loan        4.00     1/30/2019        754,286        749,824        745,332   

 

F-64


Table of Contents

Issuer Name

 

Industry

 

Asset Name

  Asset
Type
    Current
Rate
    Maturity
Date
    Principal     Cost     Fair Value  

Brickman Group Ltd. LLC, The

  Brokers/Dealers/Investment Houses   Initial Term Loan (First Lien)     Loan        4.00     12/18/2020        1,498,750        1,485,345        1,470,963   

Brock Holdings III, Inc.

  Industrial Equipment   Term Loan (First Lien)     Loan        6.00     3/16/2017        1,949,171        1,966,066        1,950,399   

Burlington Coat Factory Warehouse Corporation

  Retailers (Except Food and Drugs)   Term B-2 Loan     Loan        4.25     2/23/2017        2,000,000        1,990,010        1,990,000   

BWAY

  Leisure Goods/Activities/Movies   Term Loan B     Loan        5.50     8/14/2020        1,000,000        990,072        1,004,170   

Camp International Holding Company

  Aerospace and Defense   2013 Replacement Term Loan (First Lien)     Loan        4.75     5/31/2019        1,970,023        1,976,344        1,970,023   

Capital Automotive L.P.

  Conglomerate   Tranche B-1 Term Loan Facility     Loan        4.00     4/10/2019        2,090,570        2,095,324        2,083,775   

Capsugel Holdings US, Inc.

  Drugs   Initial Term Loan     Loan        3.50     8/1/2018        3,110,785        3,104,540        3,082,259   

Catalent Pharma Solutions

  Drugs   Initial Term B Loan     Loan        3.50     9/15/2021        500,000        497,561        499,645   

Ceasars Entertainment Corp.

  Lodging & Casinos   Term B-7 Loan     Loan        6.25     3/1/2017        1,000,000        993,142        973,910   

Celanese US Holdings LLC

  Chemicals/Plastics   Dollar Term C-2 Commitment     Loan        2.25     10/31/2016        2,165,387        2,188,463        2,165,387   

Cengage Learning

  Publishing   Term Loan     Loan        7.00     3/31/2020        2,244,375        2,275,315        2,251,669   

Charter Communications Operating, LLC

  Cable and Satellite Television   Term F Loan     Loan        3.00     12/31/2020        2,669,226        2,659,702        2,581,996   

CHS/Community Health Systems, Inc.

  Healthcare   2017 Term E Loan     Loan        3.48     1/25/2017        1,103,364        1,074,608        1,100,727   

CHS/Community Health Systems, Inc.

  Healthcare   2021 Term D Loan     Loan        4.25     1/27/2021        2,940,830        2,853,404        2,939,418   

Cinedigm Digital Funding I, LLC

  Business Equipment and Services   Term Loan     Loan        3.75     2/28/2018        702,747        697,657        702,747   

CITGO Petroleum

  Oil & Gas   Term Loan B     Loan        4.50     7/29/2021        500,000        495,047        500,625   

Covanta Energy Corporation

  Ecological Services and Equipment   Term Loan     Loan        3.25     3/28/2019        331,667        330,203        329,491   

CPI International Acquisition, Inc. (f/k/a Catalyst Holdings, Inc.)

  Electronics/Electric   Term B Loan     Loan        4.25     4/7/2021        3,613,444        3,613,444        3,593,859   

Crosby US Acquisition Corp.

  Industrial Equipment   Initial Term Loan (First Lien)     Loan        4.00     11/23/2020        746,250        745,404        739,720   

Crown Castle Operating Company

 

Telecommunications/

Cellular

  Extended Incremental Tranche B-2 Term Loan     Loan        3.00     1/31/2021        2,447,895        2,445,617        2,422,657   

Culligan International Company

  Conglomerate   Dollar Loan (First Lien)     Loan        6.25     12/19/2017        783,162        740,581        773,204   

Culligan International Company

  Conglomerate   Dollar Loan (Second Lien)     Loan        9.50     6/19/2018        783,650        741,308        730,299   

Cumulus Media Holdings Inc.

  Broadcast Radio and Television   Term Loan     Loan        4.25     12/23/2020        492,315        487,783        489,484   

Custom Sensors

  Industrial Equipment   Term Loan     Loan        4.50     6/18/2021        500,000        498,800        497,500   

DaVita HealthCare Partners Inc. (fka DaVita Inc.)

  Healthcare   Tranche B Term Loan     Loan        4.50     10/20/2016        500,000        497,534        496,815   

DCS Business Services, Inc.

  Financial Intermediaries   Term B Loan     Loan        7.25     3/19/2018        3,477,807        3,450,350        3,390,862   

Dealertrack Technologies, Inc.

  Leisure Goods/Activities/Movies   Term B Loan     Loan        3.50     2/26/2021        477,011        475,941        474,425   

Dell International LLC

  Retailers (Except Food and Drugs)   Term B Loan     Loan        4.50     4/29/2020        1,985,000        1,974,309        1,971,363   

Delos Finance SARL

  Financial Intermediaries   Term Loan     Loan        3.50     3/6/2021        500,000        497,626        495,625   

Delta 2 (Lux) S.a.r.l.

  Lodging & Casinos   Term Loan B-3     Loan        4.75     7/30/2021        1,000,000        995,017        994,290   

Deluxe Entertainment Service Group, Inc.

  Leisure Goods/Activities/Movies   Term Loan (First Lien)     Loan        6.50     2/28/2020        1,993,750        1,995,044        1,983,781   

Devix

  Chemicals/Plastics   Term Loan     Loan        4.25     4/30/2021        250,000        247,593        250,000   

Devix

  Chemicals/Plastics   Term Loan (Second Lien)     Loan        8.00     5/2/2022        500,000        497,630        498,000   

 

F-65


Table of Contents

Issuer Name

 

Industry

 

Asset Name

  Asset
Type
    Current
Rate
    Maturity
Date
    Principal     Cost     Fair Value  

Diamond Resorts International

  Lodging & Casinos   Term Loan     Loan        5.50     5/9/2021        1,000,000        995,141        1,002,500   

Drew Marine Group Inc.

  Chemicals/Plastics   Term Loan (First Lien)     Loan        4.50     11/19/2020        1,497,500        1,503,089        1,503,116   

Dunkin’ Brands, Inc.

  Food Services   Term B-4 Loan     Loan        3.25     2/7/2021        3,942,384        3,933,660        3,857,150   

Education Management LLC

  Leisure Goods/Activities/Movies   Tranche C-2 Term Loan     Loan        4.25     6/1/2016        3,860,726        3,759,583        2,440,172   

EIG Investors Corp.

  Business Equipment and Services   Term Loan     Loan        5.00     11/8/2019        992,500        988,161        991,259   

Emerald Performance Materials, LLC

  Chemicals/Plastics   Term Loan (First Lien)     Loan        4.50     8/1/2021        500,000        497,515        497,500   

Emerald Performance Materials, LLC

  Chemicals/Plastics   Term Loan (Second Lien)     Loan        7.75     8/1/2022        500,000        497,500        496,250   

EnergySolutions, LLC

  Oil & Gas   Term Loan B     Loan        6.75     5/29/2020        1,000,000        980,709        1,004,380   

Enviromental Resources Management

  Business Equipment and Services   Term Loan     Loan        5.00     5/16/2021        1,000,000        990,621        1,000,000   

Evergreen Acqco 1 LP

  Retailers (Except Food and Drugs)   New Term Loan     Loan        5.00     7/9/2019        980,044        976,268        979,799   

EWT Holdings III Corp. (fka WTG Holdings III Corp.)

  Industrial Equipment   Term Loan (First Lien)     Loan        4.75     1/15/2021        995,000        990,648        991,687   

Federal-Mogul Corporation

  Automotive   Tranche C Term Loan     Loan        4.75     4/15/2021        3,000,000        2,985,847        2,986,260   

First Data Corporation

  Financial Intermediaries   2017 Second New Dollar Term Loan     Loan        4.15     3/24/2017        2,111,028        2,015,273        2,094,541   

First Data Corporation

  Financial Intermediaries   2018 Dollar Term Loan     Loan        4.15     3/23/2018        2,290,451        2,228,007        2,254,674   

Fitness International, LLC

  Leisure Goods/Activities/Movies   Term Loan B     Loan        5.50     7/1/2020        1,500,000        1,488,994        1,483,125   

FMG Resources (August 2006) Pty LTD (FMG America Finance, Inc.)

  Nonferrous Metals/Minerals   Loan     Loan        3.75     6/28/2019        1,992,500        1,992,008        1,972,954   

Four Seasons Holdings Inc.

  Lodging & Casinos   Term Loan (First Lien)     Loan        3.50     6/29/2020        496,250        496,250        492,776   

Garda World Security Corporation

  Business Equipment and Services   Term B Delayed Draw Loan     Loan        4.00     11/6/2020        202,176        201,269        200,787   

Garda World Security Corporation

  Business Equipment and Services   Term B Loan     Loan        4.00     11/6/2020        790,324        786,877        784,895   

Gardner Denver, Inc.

  Oil & Gas   Initial Dollar Term Loan     Loan        4.25     7/30/2020        2,488,750        2,478,058        2,470,358   

Gates Global LLC

  Leisure Goods/Activities/Movies   Term Loan (First Lien)     Loan        4.25     7/2/2021        500,000        495,109        494,030   

Generac Power Systems, Inc.

  Industrial Equipment   Term Loan B     Loan        3.25     5/29/2020        857,504        842,443        842,498   

General Nutrition Centers, Inc.

  Retailers (Except Food and Drugs)   Amended Tranche B Term Loan     Loan        3.25     3/4/2019        4,732,124        4,715,732        4,669,424   

Global Tel*Link Corporation

  Business Equipment and Services   Term Loan (First Lien)     Loan        5.00     5/26/2020        2,770,614        2,761,855        2,749,834   

Goodyear Tire & Rubber Company, The

  Chemicals/Plastics   Loan (Second Lien)     Loan        4.75     4/30/2019        4,000,000        3,951,481        4,006,000   

Grosvenor Capital Management Holdings, LP

  Brokers/Dealers/Investment Houses   Initial Term Loan     Loan        3.75     1/4/2021        3,482,500        3,466,019        3,449,138   

Harland Clarke Holdings Corp. (fka Clarke American Corp.)

  Publishing   Tranche B-4 Term Loan     Loan        6.00     8/2/2019        493,750        491,629        499,922   

HCA Inc.

  Healthcare   Tranche B-4 Term Loan     Loan        2.94     5/1/2018        5,691,680        5,400,424        5,664,132   

Hertz Corporation, The

  Automotive   Tranche B-1 Term Loan     Loan        3.75     3/12/2018        2,955,000        2,989,719        2,938,393   

Hologic, Inc.

  Healthcare   Refinancing Tranche A Term Loan     Loan        2.15     8/1/2017        2,250,000        2,245,260        2,240,865   

 

F-66


Table of Contents

Issuer Name

 

Industry

 

Asset Name

  Asset
Type
    Current
Rate
    Maturity
Date
    Principal     Cost     Fair Value  

Hoofmaster Group, Inc.

  Containers/Glass Products   Term Loan     Loan        5.25     5/8/2020        2,000,000        1,980,684        1,995,000   

Huntsman International LLC

  Chemicals/Plastics   Extended Term B Loan     Loan        2.69     4/19/2017        3,880,270        3,852,485        3,863,313   

Husky Injection

  Business Equipment and Services   Term Loan B     Loan        4.25     6/30/2021        500,000        497,075        497,500   

Ikaria, Inc.

  Healthcare   Initial Term Loan (First Lien)     Loan        5.00     2/12/2021        471,910        469,803        471,419   

Infor (US), Inc. (fka Lawson Software Inc.)

  Business Equipment and Services   Tranche B-5 Term Loan     Loan        3.75     6/30/2020        2,222,406        2,203,207        2,188,514   

J. Crew Group, Inc.

  Retailers (Except Food and Drugs)   Term B-1 Loan Retired 03/05/2014     Loan        4.00     3/5/2021        970,069        970,068        939,269   

Jazz Acquisition

  Aerospace and Defense   First Lien 6/14     Loan        4.50     6/19/2021        500,000        498,754        497,500   

JFB Firth Rixson Inc.

  Industrial Equipment   2013 Replacement Dollar Term Facility Loan     Loan        4.25     6/30/2017        2,551,360        2,541,993        2,548,170   

Kinetic Concepts, Inc.

  Healthcare   Dollar Term D-1 Loan     Loan        4.00     5/4/2018        487,607        472,811        485,778   

Koosharem, LLC

  Business Equipment and Services   Term Loan     Loan        7.50     4/29/2020        1,000,000        992,822        1,004,380   

La Quinta Holdings, Inc.

  Lodging & Casinos   Term Loan (First Lien)     Loan        4.00     4/14/2021        480,952        478,688        477,648   

Mauser Holdings, Inc.

  Containers/Glass Products   Term Loan     Loan        4.50     8/2/2021        500,000        497,526        496,250   

Michaels Stores, Inc.

  Retailers (Except Food and Drugs)   Term B Loan     Loan        3.75     1/28/2020        493,750        493,750        488,284   

Michaels Stores, Inc.

  Retailers (Except Food and Drugs)   Term Loan B-2     Loan        3.75     1/28/2020        500,000        497,573        495,940   

Microsemi Corporation

  Electronics/Electric   Incremental Term Loan     Loan        3.50     2/19/2020        2,393,981        2,389,500        2,376,027   

Microsemi Corporation

  Electronics/Electric   Term Loan     Loan        3.75     2/19/2020        172,170        172,170        171,524   

Millenium Laboratories

  Drugs   Term Loan     Loan        5.25     4/16/2021        1,500,000        1,485,513        1,492,500   

Mitel US Holdings, Inc.

  Telecommunications   Term Loan     Loan        5.25     1/31/2020        214,164        213,177        214,431   

MPH Acquisition Holdings LLC

  Health Insurance   Term Loan     Loan        4.00     3/31/2021        486,364        485,222        482,628   

MSC Software Corp.

  Business Equipment and Services   Term Loan     Loan        4.00     5/29/2020        1,000,000        990,321        1,001,250   

National CineMedia, LLC

  Leisure Goods/Activities/Movies   Term Loan (2013)     Loan        2.95     11/26/2019        1,086,207        1,056,330        1,064,483   

National Veterinary Associates

  Healthcare   Term Loan B     Loan        4.75     8/14/2021        1,000,000        995,094        1,002,500   

National Vision, Inc.

  Retailers (Except Food and Drugs)   Term Loan (Second Lien)     Loan        6.75     3/11/2022        250,000        249,690        244,063   

Newsday, LLC

  Publishing   Term Loan     Loan        3.69     10/12/2016        2,215,385        2,213,965        2,215,385   

Nortek, Inc.

  Electronics/Electric   Term B Loan     Loan        3.75     10/30/2020        1,000,000        997,657        994,170   

Novelis, Inc.

  Conglomerate   Initial Term Loan     Loan        3.75     3/10/2017        4,832,525        4,844,857        4,820,444   

NPC International, Inc.

  Food Services   Term Loan (2013)     Loan        4.00     12/28/2018        488,750        488,750        486,712   

NRG Energy, Inc.

  Utilities   Term Loan (2013)     Loan        2.75     7/2/2018        3,880,875        3,858,512        3,820,062   

NuSil Technology LLC.

  Chemicals/Plastics   Term Loan     Loan        5.25     4/7/2017        802,457        802,457        786,408   

OEP Pearl Dutch Acquisition B.V.

  Chemicals/Plastics   Initial BV Term Loan     Loan        6.50     3/30/2018        136,371        135,141        136,882   

Ollie’s Bargain Outlet

  Retailers (Except Food and Drugs)   Term Loan     Loan        6.00     9/30/2019        982,101        977,482        982,101   

On Assignment, Inc.

  Business Equipment and Services   Initial Term B Loan     Loan        3.50     5/15/2020        1,311,364        1,302,764        1,305,633   

Onex Carestream Finance LP

  Healthcare   Term Loan (First Lien 2013)     Loan        5.00     6/7/2019        4,282,361        4,263,330        4,279,021   

OpenLink International LLC

  Business Equipment and Services   Term B Loan     Loan        6.25     10/27/2017        975,000        975,000        975,000   

Orbitz Worldwide, Inc.

  Business Equipment and Services   Term Loan (First Lien)     Loan        4.50     4/15/2021        500,000        498,785        498,905   

P.F. Chang’s China Bistro, Inc. (Wok Acquisition Corp.)

  Food/Drug Retailers   Term Borrowing     Loan        4.25     6/24/2019        1,455,477        1,443,484        1,419,090   

 

F-67


Table of Contents

Issuer Name

 

Industry

 

Asset Name

  Asset
Type
    Current
Rate
    Maturity
Date
    Principal     Cost     Fair Value  

P2 Upstream Acquisition Co. (P2 Upstream Canada BC ULC)

  Business Equipment and Services   Term Loan (First Lien)     Loan        5.00     10/30/2020        995,000        990,753        998,313   

Paragon Offshore Finance

  Oil & Gas   Term Loan B     Loan        3.75     7/18/2021        750,000        746,314        738,750   

Patheon Inc.

  Healthcare & Pharmaceuticals   Term Loan     Loan        4.25     3/11/2021        3,000,000        2,992,669        2,960,640   

PetCo Animal Supplies, Inc.

  Retailers (Except Food and Drugs)   New Loans     Loan        4.00     11/24/2017        1,477,041        1,476,121        1,471,502   

Pharmaceutical Product Development, Inc. (Jaguar Holdings, LLC)

  Conglomerate   2013 Term Loan     Loan        4.00     12/5/2018        1,950,300        1,925,362        1,941,251   

Phillips-Medisize Corporation

  Healthcare   Term Loan     Loan        4.75     6/16/2021        500,000        497,575        498,125   

Pinnacle Foods Finance LLC

  Food Products   New Term Loan G     Loan        3.25     4/29/2020        2,581,332        2,575,965        2,551,337   

Planet Fitness Holdings LLC

  Leisure Goods/Activities/Movies   Term Loan     Loan        4.75     3/31/2021        1,496,250        1,489,018        1,492,973   

Polymer Group, Inc.

  Chemicals/Plastics   Initial Loan     Loan        5.25     12/19/2019        497,500        495,282        497,500   

Prestige Brands, Inc.

  Drugs   Term B-1 Loan     Loan        3.75     1/31/2019        435,606        430,604        434,081   

Prestige Brands, Inc.

  Leisure Goods/Activities/Movies   Term Loan     Loan        4.50     9/3/2021        1,000,000        1,000,000        1,005,000   

Pro Mach, Inc.

  Industrial Equipment   Term Loan     Loan        4.50     7/6/2017        1,891,863        1,883,473        1,895,420   

Progressive Waste Solutions Ltd.

  Ecological Services and Equipment   Term B Loan     Loan        3.00     10/24/2019        496,222        496,222        496,013   

QoL Meds

  Healthcare   Term Loan B     Loan        5.50     7/15/2020        2,000,000        1,990,049        2,005,000   

Quintiles Transnational Corp.

  Conglomerate   Term B-3 Loan     Loan        3.75     6/8/2018        3,681,541        3,649,943        3,652,383   

Redtop Acquisitions Limited

  Electronics/Electric   Initial Dollar Term Loan (First Lien)     Loan        4.50     12/3/2020        497,500        494,218        497,913   

Rexnord LLC/RBS Global, Inc.

  Industrial Equipment   Term B Loan     Loan        4.00     8/21/2020        1,655,137        1,655,137        1,646,630   

Reynolds Group Holdings Inc.

  Industrial Equipment   Incremental U.S. Term Loan     Loan        4.00     12/1/2018        1,970,100        1,970,100        1,962,929   

Rocket Software, Inc.

  Business Equipment and Services   Term Loan (First Lien)     Loan        5.75     2/8/2018        1,916,674        1,896,090        1,916,080   

Rovi Solutions Corporation / Rovi Guides, Inc.

  Electronics/Electric   Tranche B-3 Term Loan     Loan        3.50     3/29/2019        1,500,000        1,492,617        1,486,245   

RPI Finance Trust

  Drugs   Term B-2 Term Loan     Loan        3.25     5/9/2018        5,233,797        5,212,118        5,219,091   

SBP Holdings LP

  Industrial Equipment   Term Loan (First Lien)     Loan        5.00     3/27/2021        1,000,000        995,167        1,001,670   

Scitor Corporation

  Business Equipment and Services   Term Loan     Loan        5.00     2/15/2017        463,977        462,503        459,337   

Sensata Technologies B.V./Sensata Technology Finance Company, LLC

  Industrial Equipment   Term Loan     Loan        3.25     5/13/2019        1,517,088        1,517,088        1,515,540   

Sensus USA Inc. (fka Sensus Metering Systems)

  Utilities   Term Loan (First Lien)     Loan        4.75     5/9/2017        1,935,040        1,929,701        1,934,228   

ServiceMaster Company, The

  Conglomerate   Tranche B Term Loan     Loan        4.40     1/31/2017        2,000,000        1,980,369        1,970,000   

Shearers Foods

  Food Services   Term Loan (First Lien)     Loan        4.50     6/30/2021        1,000,000        997,522        995,000   

Sonneborn, LLC

  Chemicals/Plastics   Initial US Term Loan     Loan        6.50     3/30/2018        772,768        759,467        775,666   

Sophia, L.P.

  Electronics/Electric   Term B Loan     Loan        4.00     7/19/2018        923,543        912,021        917,771   

Southwire Company, LLC (f.k.a Southwire Company)

  Building and Development   Initial Term Loan     Loan        3.25     2/10/2021        498,750        497,580        493,972   

SRAM, LLC

  Industrial Equipment   Term Loan (First Lien)     Loan        5.25     4/10/2020        3,138,397        3,123,509        3,067,783   

SS&C Technologies Holdings Europe S.A.R.L.

  Business Equipment and Services   2013 Replacement Term B-2 Loan     Loan        3.25     6/7/2019        523,600        518,916        522,291   

SS&C Technologies, Inc., /Sunshine Acquisition II, Inc.

  Business Equipment and Services   2013 Replacement Term B-1 Loan     Loan        3.25     6/7/2019        54,165        53,675        54,030   

 

F-68


Table of Contents

Issuer Name

 

Industry

 

Asset Name

  Asset
Type
    Current
Rate
    Maturity
Date
    Principal     Cost     Fair Value  

Steak ‘n Shake Operations, Inc.

  Food Services   Term Loan     Loan        4.75     3/19/2021        997,500        987,960        996,672   

STHI Holding

  Healthcare   Term Loan     Loan        4.50     8/6/2021        1,000,000        995,003        995,630   

SunGard Data Systems Inc (Solar Capital Corp.)

  Conglomerate   Tranche C Term Loan     Loan        3.90     2/28/2017        285,352        282,591        285,232   

SunGard Data Systems Inc (Solar Capital Corp.)

  Conglomerate   Tranche E Term Loan     Loan        4.00     3/9/2020        3,707,953        3,610,543        3,689,413   

SuperMedia Inc. (fka Idearc Inc.)

  Publishing   Loan     Loan        11.60     12/30/2016        252,782        244,705        218,183   

Syniverse Holdings, Inc.

  Telecommunications   Initial Term Loan     Loan        4.00     4/23/2019        479,913        475,748        474,816   

Taminco Global Chemical Corporation

  Chemicals/Plastics   Initial Tranche B-3 Dollar Term Loan     Loan        3.25     2/15/2019        1,466,493        1,457,915        1,455,495   

Team Health, Inc.

  Healthcare   Tranche B Term Loan     Loan        3.75     6/29/2018        4,365,000        4,349,553        4,343,175   

TGI Friday’s

  Food Services   Term Loan B     Loan        5.25     7/15/2020        1,000,000        995,076        995,630   

TransDigm Inc.

  Aerospace and Defense   Tranche C Term Loan     Loan        3.75     2/28/2020        4,871,784        4,881,456        4,818,341   

TransUnion

  Financial Intermediaries   Term Loan     Loan        4.00     4/9/2021        498,750        497,586        495,508   

Tricorbraun Inc. (fka Kranson Industries, Inc.)

  Containers/Glass Products   Term Loan     Loan        4.00     5/3/2018        1,902,083        1,893,866        1,897,328   

Truven Health Analytics Inc. (fka Thomson Reuters (Healthcare) Inc.)

  Healthcare   New Tranche B Term Loan     Loan        4.50     6/6/2019        490,047        481,472        485,759   

Twin River Management

  Lodging & Casinos   Term Loan B     Loan        5.25     7/10/2020        1,000,000        1,002,256        999,170   

U.S. Security Associates Holdings, Inc.

  Business Equipment and Services   Delayed Draw Loan     Loan        6.00     7/28/2017        159,332        158,264        158,536   

U.S. Security Associates Holdings, Inc.

  Business Equipment and Services   Term B Loan     Loan        6.00     7/28/2017        935,857        930,087        931,177   

United Surgical Partners International, Inc.

  Healthcare   New Tranche B Term Loan     Loan        4.75     4/3/2019        2,444,124        2,418,323        2,431,904   

Univar Inc.

  Chemicals/Plastics   Term B Loan     Loan        5.00     6/30/2017        3,864,954        3,864,526        3,854,325   

Univision Communications Inc.

  Telecommunications   Replacement First-Lien Term Loan     Loan        4.00     3/1/2020        2,962,612        2,945,669        2,938,290   

Valeant Pharmaceuticals International, Inc.

  Drugs   Series D2 Term Loan B     Loan        3.75     2/13/2019        2,545,588        2,536,761        2,532,861   

Verint Systems Inc.

  Business Equipment and Services   Term Loan     Loan        3.50     9/6/2019        1,264,058        1,259,071        1,258,370   

Vertafore, Inc.

  Business Equipment and Services   Term Loan (2013)     Loan        4.25     10/3/2019        2,881,003        2,881,003        2,873,800   

Visant Corporation (fka Jostens)

  Leisure Goods/Activities/Movies   Tranche B Term Loan (2011)     Loan        5.25     12/22/2016        3,604,551        3,604,551        3,584,726   

Vouvray

  Industrial Equipment   Term Loan     Loan        5.00     6/28/2021        500,000        497,539        500,000   

Washington Inventory Service

  Business Equipment and Services   U.S. Term Loan (First Lien)     Loan        6.75     12/20/2018        1,896,034        1,918,563        1,888,924   

Wendy’s International, Inc

  Food Services   Term B Loan     Loan        3.25     5/15/2019        677,050        670,886        673,184   

West Corporation

  Telecommunications   Term B-10 Loan     Loan        3.25     6/30/2018        2,571,560        2,610,717        2,535,738   
             

 

 

   

 

 

 
              $ 302,544,790      $ 301,019,691   
             

 

 

   

 

 

 

 

F-69


Table of Contents

Saratoga Investment Corp. CLO 2013-1, Ltd.

Schedule of Investments

February 28, 2014

 

Issuer Name

  Industry   Asset Name   Asset
Type
  Current
Rate
    Maturity
Date
    Principal     Cost     Fair Value  

Academy, LTD.

  Retailers (Except
Food and Drugs)
  Initial Term Loan
(2012)
  Loan     4.50     8/3/2018      $ 1,960,187      $ 1,948,853      $ 1,969,969   

Acosta, Inc.

  Food Products   Term B Loan
(2013)
  Loan     4.25     3/2/2018        4,162,740        4,101,035        4,177,310   

Aderant North America, Inc.

  Business Equipment
and Services
  Term Loan (First
Lien)
  Loan     6.25     12/20/2018        3,473,750        3,470,186        3,482,434   

Aegis Toxicology Sciences Corporation

  Healthcare   Initial Term Loan
(First Lien)
  Loan     5.50     2/24/2021        1,000,000        990,000        990,000   

Aegis Toxicology Sciences Corporation

  Healthcare   Initial Term Loan
(Second Lien)
  Loan     9.50     8/24/2021        500,000        492,500        492,500   

Aeroflex Incorporated

  Aerospace and
Defense
  Tranche B-1
Term Loan
  Loan     4.50     11/9/2019        3,208,854        3,194,690        3,223,550   

Akorn, Inc.

  Healthcare   Term Loan B   Loan     4.50     11/13/2020        500,000        497,500        503,125   

Alere Inc. (fka IM US Holdings, LLC)

  Healthcare   Incremental B-1
Term Loan
  Loan     4.25     6/30/2017        1,960,000        1,930,566        1,968,173   

Applied Systems, Inc.

  Business Equipment
and Services
  Term Loan   Loan     4.25     12/8/2016        500,000        498,750        498,750   

Aramark Corporation

  Food Products   LC-2 Facility   Loan     3.69     7/26/2016        79,187        79,187        79,206   

Aramark Corporation

  Food Products   LC-3 Facility   Loan     3.69     7/26/2016        43,961        43,961        43,971   

Aramark Corporation

  Food Products   U.S. Term F
Loan
  Loan     3.25     2/24/2021        3,206,537        3,206,537        3,207,307   

Ardagh Holdings USA Inc. (Ardagh Packaging Finance S.A.)

  Containers/Glass
Products
  Dollar Term
Loan
  Loan     4.25     12/17/2019        1,000,000        995,109        1,002,500   

ARG IH Corporation

  Food Services   Term Loan   Loan     5.00     11/15/2020        500,000        498,797        502,500   

Asurion, LLC (fka Asurion Corporation)

  Insurance   Incremental
Tranche B-1
Term Loan
  Loan     4.50     5/24/2019        5,508,783        5,462,695        5,516,660   

Auction.Com, LLC

  Business Equipment
and Services
  Term Loan A-4   Loan     4.66     2/28/2017        980,651        979,812        970,845   

Autotrader.com, Inc.

  Automotive   Tranche B-1
Term Loan
  Loan     4.00     12/15/2016        3,791,778        3,791,778        3,805,997   

Avantor Performance Materials Holdings, Inc.

  Chemicals/Plastics   Term Loan   Loan     5.25     6/24/2017        4,875,000        4,861,403        4,875,000   

AZ Chem US Inc.

  Chemicals/Plastics   Term Loan   Loan     5.25     12/22/2017        1,355,941        1,329,859        1,362,720   

Bass Pro Group, LLC

  Retailers (Except
Food and Drugs)
  New Term Loan   Loan     3.75     11/20/2019        498,725        498,126        500,715   

Berry Plastics Corporation

  Chemicals/Plastics   Term E Loan   Loan     3.75     1/6/2021        1,500,000        1,496,250        1,495,500   

Big Heart Pet Brands (fka Del Monte Corporation)

  Food/Drug Retailers   Initial Term Loan   Loan     3.50     3/9/2020        3,000,000        3,022,866        2,999,250   

Biomet, Inc.

  Healthcare   Dollar Term B-2
Loan
  Loan     3.65     7/25/2017        1,970,137        1,970,137        1,972,797   

BJ’s Wholesale Club, Inc.

  Food/Drug Retailers   New 2013
(November)
Replacement
Loan (First Lien)
  Loan     4.50     9/26/2019        500,000        497,592        502,750   

Bombardier Recreational Products Inc.

  Leisure Goods/
Activities/Movies
  Term B Loan   Loan     4.00     1/30/2019        754,286        748,080        756,647   

Brickman Group Ltd. LLC, The

  Brokers/Dealers/
Investment Houses
  Initial Term Loan
(First Lien)
  Loan     4.00     12/18/2020        250,000        248,750        250,937   

 

F-70


Table of Contents

Issuer Name

  Industry   Asset Name   Asset
Type
  Current
Rate
    Maturity
Date
    Principal     Cost     Fair Value  

Brock Holdings III, Inc.

  Industrial Equipment   Term Loan (First
Lien)
  Loan     6.75     3/16/2017        1,959,839        1,976,826        1,967,188   

Burlington Coat Factory Warehouse Corporation

  Retailers (Except
Food and Drugs)
  Term B-2 Loan   Loan     4.25     2/23/2017        2,660,377        2,653,889        2,675,675   

C.H.I. Overhead Doors, Inc.

  Building and
Development
  Term Loan (First
Lien)
  Loan     5.50     3/18/2019        2,739,013        2,692,934        2,745,861   

Camp International Holding Company

  Aerospace and
Defense
  2013
Replacement
Term Loan (First
Lien)
  Loan     4.75     5/31/2019        990,000        990,000        999,900   

Capital Automotive L.P.

  Conglomerate   Tranche B-1
Term Loan
Facility
  Loan     4.00     4/10/2019        2,137,369        2,141,920        2,142,712   

Capstone Logistics, LLC

  Business Equipment
and Services
  Term Note A   Loan     6.50     9/16/2016        2,658,626        2,637,550        2,618,899   

Capsugel Holdings US, Inc.

  Drugs   Initial Term Loan   Loan     3.50     8/1/2018        3,145,521        3,138,959        3,141,589   

Celanese US Holdings LLC

  Chemicals/Plastics   Dollar Term C-2
Commitment
  Loan     2.25     10/31/2016        2,176,323        2,201,894        2,192,254   

Charter Communications Operating, LLC

  Cable and Satellite
Television
  Term F Loan   Loan     3.00     12/31/2020        2,682,707        2,672,727        2,666,369   

CHS/Community Health Systems, Inc.

  Healthcare   2017 Term E
Loan
  Loan     3.48     1/25/2017        1,108,908        1,082,718        1,113,987   

CHS/Community Health Systems, Inc.

  Healthcare   2021 Term D
Loan
  Loan     4.25     1/27/2021        2,955,608        2,862,024        2,980,228   

Cinedigm Digital Funding I, LLC

  Business Equipment
and Services
  Term Loan   Loan     3.75     2/28/2018        825,121        820,892        825,121   

Covanta Energy Corporation

  Ecological Services
and Equipment
  Term Loan   Loan     3.50     3/28/2019        491,250        489,468        492,788   

CPI International Acquisition, Inc. (f/k/a Catalyst Holdings, Inc.)

  Electronics/Electric   Term B Loan   Loan     5.00     2/13/2017        4,622,500        4,611,092        4,622,500   

Crosby US Acquisition Corp.

  Industrial Equipment   Initial Term Loan
(First Lien)
  Loan     4.00     11/23/2020        750,000        749,094        748,312   

Crown Castle Operating Company

  Telecommunications/

Cellular

  Extended
Incremental
Tranche B-2
Term Loan
  Loan     3.25     1/31/2019        2,460,196        2,441,025        2,460,316   

Culligan International Company

  Conglomerate   Dollar Loan
(First Lien)
  Loan     6.25     12/19/2017        787,658        738,102        734,491   

Culligan International Company

  Conglomerate   Dollar Loan
(Second Lien)
  Loan     9.50     6/19/2018        783,162        732,061        657,856   

Cumulus Media Holdings Inc.

  Broadcast Radio and
Television
  Term Loan   Loan     4.25     12/23/2020        500,000        495,000        502,815   

DaVita HealthCare Partners Inc. (fka DaVita Inc.)

  Healthcare   Tranche B Term
Loan
  Loan     4.50     10/20/2016        3,909,320        3,909,320        3,927,655   

DCS Business Services, Inc.

  Financial
Intermediaries
  Term B Loan   Loan     7.25     3/19/2018        3,831,595        3,792,824        3,735,805   

DealerTrack Technologies, Inc.

  Computers &
Electronics
  Term Loan   Loan     3.50     2/28/2021        500,000        498,750        498,750   

Dell International LLC

  Retailers (Except
Food and Drugs)
  Term B Loan   Loan     4.50     4/29/2020        1,995,000        1,982,818        1,988,935   

Delos Finance S.à r.l.

  Leasing   Loan   Loan     3.50     2/26/2021        500,000        497,500        497,500   

Deluxe Entertainment Services Group Inc.

  Media   Initial Term Loan   Loan     6.50     2/28/2020        1,000,000        1,000,000        1,000,000   

Digitalglobe, Inc.

  Ecological Services
and Equipment
  Term Loan   Loan     3.75     1/31/2020        248,125        248,125        247,815   

Drew Marine Group Inc.

  Chemicals/Plastics   Term Loan (First
Lien)
  Loan     4.50     11/19/2020        500,000        499,397        502,500   

 

F-71


Table of Contents

Issuer Name

  Industry   Asset Name   Asset
Type
  Current
Rate
    Maturity
Date
    Principal     Cost     Fair Value  

Dunkin’ Brands, Inc.

  Food Services   Term B-4 Loan   Loan     3.25     2/7/2021        3,956,731        3,946,925        3,936,948   

DynCorp International Inc.

  Aerospace and
Defense
  Term Loan   Loan     6.25     7/7/2016        486,442        482,619        488,573   

Education Management LLC

  Leisure Goods/
Activities/Movies
  Tranche C-2
Term Loan
  Loan     4.31     6/1/2016        3,882,152        3,746,734        3,544,405   

EIG Investors Corp.

  Business Equipment
and Services
  Term Loan   Loan     5.00     11/9/2019        997,500        992,713        1,003,734   

Energy Transfer Equity, L.P.

  Oil & Gas   Loan   Loan     3.25     12/2/2019        1,000,000        997,599        998,750   

Evergreen Acqco 1 LP

  Retailers (Except
Food and Drugs)
  New Term Loan   Loan     5.00     7/9/2019        492,516        488,615        493,900   

EWT Holdings III Corp. (fka WTG Holdings III Corp.)

  Industrial Equipment   Term Loan (First
Lien)
  Loan     4.75     1/15/2021        1,000,000        995,084        1,002,500   

Federal-Mogul Corporation

  Automotive   Tranche B Term
Loan
  Loan     2.14     12/29/2014        2,220,981        2,187,068        2,202,747   

Federal-Mogul Corporation

  Automotive   Tranche C Term
Loan
  Loan     2.14     12/28/2015        1,307,032        1,270,847        1,296,301   

First Data Corporation

  Financial
Intermediaries
  2017 Second
New Dollar
Term Loan
  Loan     4.20     3/24/2017        2,111,028        2,010,799        2,109,276   

First Data Corporation

  Financial
Intermediaries
  2018 Dollar
Term Loan
  Loan     4.20     3/23/2018        2,290,451        2,231,370        2,292,741   

FMG Resources (August 2006) Pty LTD (FMG America Finance, Inc.)

  Nonferrous Metals/
Minerals
  Loan   Loan     4.25     6/28/2019        997,500        995,122        1,006,438   

Four Seasons Holdings Inc.

  Lodging & Casinos   Term Loan (First
Lien)
  Loan     3.50     6/27/2020        498,750        498,750        498,750   

Garda World Security Corporation

  Business Equipment
and Services
  Term B Delayed
Draw Loan
  Loan     4.00     11/6/2020        203,194        202,218        203,363   

Garda World Security Corporation

  Business Equipment
and Services
  Term B Loan   Loan     4.00     11/6/2020        794,306        790,489        794,965   

Gardner Denver, Inc.

  Oil & Gas   Initial Dollar
Term Loan
  Loan     4.25     7/30/2020        1,496,250        1,485,394        1,489,337   

Generac Power Systems, Inc.

  Industrial Equipment   Term Loan B   Loan     3.50     5/31/2020        868,414        852,908        868,258   

General Nutrition Centers, Inc.

  Retailers (Except
Food and Drugs)
  Amended
Tranche B Term
Loan
  Loan     3.25     3/4/2019        4,740,112        4,722,664        4,725,892   

Global Tel*Link Corporation

  Business Equipment
and Services
  Term Loan (First
Lien)
  Loan     5.00     5/23/2020        1,920,175        1,915,905        1,900,014   

Goodyear Tire & Rubber Company, The

  Chemicals/Plastics   Loan (Second
Lien)
  Loan     4.75     4/30/2019        4,000,000        3,941,039        4,037,000   

Grosvenor Capital Management
Holdings, LP

  Brokers/Dealers/
Investment Houses
  Initial Term Loan   Loan     3.75     1/4/2021        3,500,000        3,482,803        3,489,080   

Harland Clarke Holdings Corp. (fka Clarke American Corp.)

  Publishing   Tranche B-4
Term Loan
  Loan     6.00     8/4/2019        500,000        497,500        500,780   

HCA Inc.

  Healthcare   Tranche B-4
Term Loan
  Loan     2.94     5/1/2018        5,720,353        5,390,148        5,713,947   

Hertz Corporation, The

  Automotive   Tranche B-1
Term Loan
  Loan     3.75     3/11/2018        2,970,000        3,005,791        2,973,683   

Hologic, Inc.

  Healthcare   Refinancing
Tranche A Term
Loan
  Loan     2.19     8/1/2017        2,312,500        2,307,973        2,313,425   

Hunter Defense Technologies, Inc.

  Aerospace and
Defense
  Term Loan   Loan     3.45     8/22/2014        3,470,285        3,460,723        3,262,068   

 

F-72


Table of Contents

Issuer Name

  Industry   Asset Name   Asset
Type
  Current
Rate
    Maturity
Date
    Principal     Cost     Fair Value  

Huntsman International LLC

  Chemicals/Plastics   Extended Term
B Loan
  Loan     2.73     4/19/2017        3,920,000        3,892,467        3,919,020   

Ikaria, Inc.

  Healthcare   Initial Term Loan
(First Lien)
  Loan     5.00     2/12/2021        500,000        497,515        502,815   

Infor (US), Inc. (fka Lawson Software Inc.)

  Business Equipment
and Services
  Tranche B-5
Term Loan
  Loan     3.75     6/3/2020        1,776,183        1,758,861        1,772,488   

Inventiv Health, Inc. (fka Ventive Health, Inc)

  Conglomerate   Consolidated
Term Loan
  Loan     7.50     8/4/2016        492,090        492,090        491,105   

J. Crew Group, Inc.

  Retailers (Except
Food and Drugs)
  Term B-1 Loan
Retired
03/05/2014
  Loan     4.00     3/7/2018        972,500        972,500        972,656   

JFB Firth Rixson Inc.

  Industrial Equipment   2013
Replacement
Dollar Term
Facility Loan
  Loan     4.25     6/30/2017        2,564,311        2,554,534        2,568,054   

Kinetic Concepts, Inc.

  Healthcare   Dollar Term D-1
Loan
  Loan     4.00     5/4/2018        490,057        475,404        492,508   

La Quinta Intermediate Holdings L.L.C.

  Gaming And Hotels   Initial Term Loan   Loan     4.00     2/19/2021        500,000        500,000        500,000   

Michaels Stores, Inc.

  Retailers (Except
Food and Drugs)
  Term B Loan   Loan     3.75     1/28/2020        496,250        496,250        497,302   

Microsemi Corporation

  Electronics/Electric   Incremental
Term Loan
  Loan     3.75     2/19/2020        498,750        498,750        499,373   

Microsemi Corporation

  Electronics/Electric   Term Loan   Loan     3.50     2/19/2020        2,393,981        2,389,463        2,398,482   

Mitel US Holdings, Inc.

  Telecommunications   Term Loan   Loan     5.25     1/31/2020        250,000        248,753        252,083   

National CineMedia, LLC

  Leisure Goods/
Activities/Movies
  Term Loan
(2013)
  Loan     2.95     11/26/2019        1,086,207        1,054,177        1,082,134   

Newsday, LLC

  Publishing   Term Loan   Loan     3.69     10/12/2016        2,215,385        2,213,416        2,215,385   

Novelis, Inc.

  Conglomerate   Initial Term Loan   Loan     3.75     3/10/2017        4,857,520        4,868,347        4,873,452   

NPC International, Inc.

  Food Services   Term Loan
(2013)
  Loan     4.00     12/28/2018        490,833        490,833        493,597   

NRG Energy, Inc.

  Utilities   Term Loan
(2013)
  Loan     2.75     7/1/2018        3,900,525        3,875,534        3,872,168   

NuSil Technology LLC

  Chemicals/Plastics   Term Loan   Loan     5.25     4/7/2017        809,163        809,163        799,558   

OEP Pearl Dutch Acquisition B.V.

  Chemicals/Plastics   Initial BV Term
Loan
  Loan     6.50     3/30/2018        142,422        140,466        143,846   

On Assignment, Inc.

  Business Equipment
and Services
  Initial Term B
Loan
  Loan     3.50     5/15/2020        1,311,364        1,303,125        1,312,190   

Onex Carestream Finance LP

  Healthcare   Term Loan (First
Lien 2013)
  Loan     5.00     2/25/2017        4,531,159        4,511,264        4,582,135   

OpenLink International, Inc.

  Computers &
Electronics
  Replacement
Term Loan
  Loan     6.25     10/30/2017        980,000        980,000        980,000   

P.F. Chang’s China Bistro, Inc. (Wok Acquisition Corp.)

  Food/Drug Retailers   Term Borrowing   Loan     5.50     6/22/2019        1,496,212        1,488,641        1,509,675   

P2 Upstream Acquisition Co.
(P2 Upstream Canada BC ULC)

  Business Equipment
and Services
  Term Loan (First
Lien)
  Loan     5.00     10/30/2020        1,000,000        995,186        1,008,750   

Patheon Inc.

  Healthcare   Term Loan   Loan     4.25     3/11/2021        3,000,000        2,992,500        2,990,640   

PetCo Animal Supplies, Inc.

  Retailers (Except
Food and Drugs)
  New Loans   Loan     4.00     11/24/2017        1,484,694        1,483,250        1,489,103   

Pharmaceutical Product Development, Inc. (Jaguar Holdings, LLC)

  Conglomerate   2013 Term Loan   Loan     4.00     12/5/2018        1,960,200        1,936,226        1,967,845   

Pinnacle Foods Finance LLC

  Food Products   New Term
Loan G
  Loan     3.25     4/29/2020        4,962,500        4,951,514        4,942,352   

Polymer Group, Inc.

  Chemicals/Plastics   Initial Loan   Loan     5.25     12/19/2019        500,000        497,500        501,875   

Prestige Brands, Inc.

  Drugs   Term B-1 Loan   Loan     3.75     1/31/2019        435,606        430,195        437,022   

Pro Mach, Inc.

  Industrial Equipment   Term Loan   Loan     4.50     7/6/2017        1,945,655        1,934,699        1,955,383   

 

F-73


Table of Contents

Issuer Name

  Industry   Asset Name   Asset
Type
  Current
Rate
    Maturity
Date
    Principal     Cost     Fair Value  

Progressive Waste Solutions Ltd.

  Ecological Services
and Equipment
  Term B Loan   Loan     3.00     10/24/2019        498,741        498,741        500,486   

Quintiles Transnational Corp.

  Conglomerate   Term B-3 Loan   Loan     3.75     6/8/2018        3,681,541        3,646,328        3,685,186   

Redtop Acquisitions Limited

  Electronics/Electric   Initial Dollar
Term Loan (First
Lien)
  Loan     4.50     12/3/2020        500,000        496,369        502,915   

Rexnord LLC/RBS Global, Inc.

  Industrial Equipment   Term B Loan   Loan     4.00     8/21/2020        1,663,476        1,663,476        1,667,035   

Reynolds Group Holdings Inc.

  Industrial Equipment   Incremental U.S.
Term Loan
  Loan     4.00     12/1/2018        1,980,000        1,980,000        1,993,365   

Rocket Software, Inc.

  Business Equipment
and Services
  Term Loan (First
Lien)
  Loan     5.75     2/8/2018        1,960,025        1,934,083        1,960,515   

Rovi Solutions Corporation / Rovi Guides, Inc.

  Electronics/Electric   Tranche A-2
Loan
  Loan     2.45     3/29/2017        1,562,552        1,552,098        1,562,552   

Rovi Solutions Corporation / Rovi Guides, Inc.

  Electronics/Electric   Tranche B-3
Term Loan
  Loan     3.50     3/29/2019        1,344,450        1,339,560        1,341,088   

RPI Finance Trust

  Drugs   Term B-2 Term
Loan
  Loan     3.25     5/9/2018        5,308,218        5,283,397        5,339,165   

Scitor Corporation

  Business Equipment
and Services
  Term Loan   Loan     5.00     2/15/2017        463,977        462,831        460,354   

Sensata Technologies B.V./Sensata Technology Finance Company, LLC

  Industrial Equipment   Term Loan   Loan     3.25     5/12/2019        1,524,730        1,524,730        1,529,106   

Sensus USA Inc. (fka Sensus Metering Systems)

  Utilities   Term Loan (First
Lien)
  Loan     5.75     5/9/2017        1,945,013        1,939,821        1,957,987   

ServiceMaster Company, The

  Conglomerate   Tranche B Term
Loan
  Loan     4.45     1/31/2017        2,822,729        2,830,165        2,825,552   

SI Organization, Inc., The

  Aerospace and
Defense
  New Tranche B
Term Loan
  Loan     5.50     11/22/2016        3,880,675        3,863,008        3,800,655   

Sonneborn, LLC

  Chemicals/Plastics   Initial US Term
Loan
  Loan     6.50     3/30/2018        807,059        795,976        815,130   

Sophia, L.P.

  Electronics/Electric   Term B Loan   Loan     4.50     7/19/2018        928,389        917,174        934,191   

Southwire Company, LLC (f.k.a Southwire Company)

  Building and
Development
  Initial Term Loan   Loan     3.25     2/10/2021        500,000        498,758        499,730   

SRA International Inc.

  Aerospace and
Defense
  Term Loan   Loan     6.50     7/20/2018        3,268,571        3,184,532        3,276,743   

SRAM, LLC

  Industrial Equipment   Term Loan (First
Lien)
  Loan     4.01     4/10/2020        3,304,614        3,278,551        3,304,614   

SS&C Technologies Holdings Europe S.A.R.L.

  Business Equipment
and Services
  2013
Replacement
Term B-2 Loan
  Loan     3.25     6/7/2019        64,638        64,070        64,839   

SS&C Technologies, Inc., /Sunshine Acquisition II, Inc.

  Business Equipment
and Services
  2013
Replacement
Term B-1 Loan
  Loan     3.25     6/7/2019        624,838        619,344        626,782   

SunCoke Energy, Inc.

  Nonferrous Metals/
Minerals
  Tranche B Term
Loan
  Loan     4.00     7/26/2018        1,367,311        1,359,200        1,367,311   

SunGard Data Systems Inc (Solar Capital Corp.)

  Conglomerate   Tranche C Term
Loan
  Loan     3.95     2/28/2017        304,311        302,167        305,452   

SunGard Data Systems Inc (Solar Capital Corp.)

  Conglomerate   Tranche E Term
Loan
  Loan     4.00     3/8/2020        4,221,845        4,096,936        4,238,944   

SuperMedia Inc. (fka Idearc Inc.)

  Publishing   Loan   Loan     11.60     12/30/2016        264,330        257,131        196,762   

Syniverse Holdings, Inc.

  Telecommunications   Initial Term Loan   Loan     4.00     4/23/2019        479,913        476,371        480,911   

Taminco Global Chemical Corporation

 


Chemicals/Plastics

  Initial Tranche
B-3 Dollar Term
Loan
  Loan     3.25     2/15/2019        1,473,863        1,464,165        1,473,406   

 

F-74


Table of Contents

Issuer Name

  Industry   Asset Name   Asset
Type
  Current
Rate
    Maturity
Date
    Principal     Cost     Fair Value  

Team Health, Inc.

  Healthcare   Tranche B Term
Loan
  Loan     3.75     6/29/2018        4,387,500        4,373,856        4,387,500   

TECTUM HOLDINGS INC.

  Industrial Equipment   Term Loan   Loan     6.50     12/3/2015        3,800,160        3,788,706        3,762,159   

Tomkins, LLC / Tomkins, Inc. (f/k/a Pinafore, LLC / Pinafore, Inc.)

  Conglomerate   Term B-2 Loan   Loan     3.75     9/29/2016        2,356,680        2,360,795        2,361,982   

TransDigm Inc.

  Aerospace and
Defense
  Tranche C Term
Loan
  Loan     3.75     2/28/2020        4,896,514        4,904,843        4,914,876   

Tricorbraun Inc. (fka Kranson Industries, Inc.)

  Containers/Glass
Products
  Term Loan   Loan     4.00     5/3/2018        1,902,083        1,895,432        1,903,282   

Truven Health Analytics Inc. (fka Thomson Reuters (Healthcare) Inc.)

  Healthcare   New Tranche B
Term Loan
  Loan     4.50     6/6/2019        492,528        484,755        493,513   

U.S. Security Associates Holdings, Inc.

  Business Equipment
and Services
  Delayed Draw
Loan
  Loan     6.00     7/28/2017        160,148        159,235        160,348   

U.S. Security Associates Holdings, Inc.

  Business Equipment
and Services
  Term B Loan   Loan     6.00     7/28/2017        122,494        122,109        122,648   

U.S. Security Associates Holdings, Inc.

  Business Equipment
and Services
  Term B Loan   Loan     6.00     7/28/2017        818,172        813,513        819,195   

U.S. Silica Company

  Nonferrous Metals/
Minerals
  Term Loan   Loan     4.00     7/23/2020        1,950,200        1,941,292        1,954,256   

U.S. Xpress Enterprises, Inc.

  Industrial Equipment   Extended Term
Loan
  Loan     9.38     11/13/2016        2,805,278        2,766,405        2,777,225   

United Surgical Partners International, Inc.

  Healthcare   New Tranche B
Term Loan
  Loan     4.75     4/3/2019        2,456,500        2,429,626        2,470,821   

Univar Inc.

  Chemicals/Plastics   Term B Loan   Loan     5.00     6/30/2017        3,884,944        3,884,238        3,859,225   

Univision Communications Inc.

  Telecommunications   Replacement
First-Lien Term
Loan
  Loan     4.00     3/1/2020        2,977,500        2,959,200        2,984,467   

UPC Financing Partnership

  Broadcast Radio and
Television
  Facility AF   Loan     4.00     1/31/2021        1,000,000        974,618        1,002,500   

Valeant Pharmaceuticals International, Inc.

  Drugs   Series D2 Term
Loan B
  Loan     3.75     2/13/2019        2,947,688        2,936,432        2,955,528   

Verint Systems Inc.

  Business Equipment
and Services
  Term Loan   Loan     4.00     9/6/2019        1,900,800        1,892,737        1,904,602   

Verint Systems Inc.

  Business Equipment
and Services
  Tranche B
Incremental
Term Loan
  Loan     3.50     9/6/2019        1,000,000        997,521        1,000,000   

Vertafore, Inc.

  Business Equipment
and Services
  Term Loan
(2013)
  Loan     4.25     10/3/2019        2,899,621        2,899,621        2,909,770   

Visant Corporation (fka Jostens)

  Leisure Goods/
Activities/Movies
  Tranche B Term
Loan (2011)
  Loan     5.25     12/22/2016        3,658,446        3,658,446        3,607,008   

W.R. Grace & Co.-CONN

  Chemicals/Plastics   Delayed Draw
Term Loan
  Loan     0.00     2/3/2021        —          (328     —     

W.R. Grace & Co.-CONN

  Chemicals/Plastics   U.S. Term Loan   Loan     3.00     2/3/2021        368,421        367,502        367,828   

Washington Inventory Service

  Business Equipment
and Services
  U.S. Term Loan
(First Lien)
  Loan     6.75     12/20/2018        1,980,000        2,004,187        1,965,150   

Wendy’s International, Inc.

  Food Services   Term B Loan   Loan     3.25     5/15/2019        680,470        674,563        679,197   

Wesco Aircraft Hardware Corp.

  Aerospace/Defense   Tranche B Term
Loan
  Loan     4.75     2/28/2021        500,000        498,750        498,750   

West Corporation

  Telecommunications   Term B-10 Loan   Loan     3.25     6/30/2018        2,926,111        2,976,179        2,909,666   
             

 

 

   

 

 

 
              $ 299,137,566      $ 300,491,077   
             

 

 

   

 

 

 

 

F-75


Table of Contents

Note 5. Agreements and Related Party Transactions

On July 30, 2010, the Company entered into the Management Agreement with our Manager. The initial term of the Management Agreement is two years, with automatic, one-year renewals at the end of each year subject to certain approvals by our board of directors and/or our stockholders. On July 10, 2014, our board of directors approved the renewal of the Management Agreement for an additional one-year term. Pursuant to the Management Agreement, our Manager implements our business strategy on a day-to-day basis and performs certain services for us, subject to oversight by our board of directors. Our Manager is responsible for, among other duties, determining investment criteria, sourcing, analyzing and executing investments transactions, asset sales, financings and performing asset management duties. Under the Management Agreement, we have agreed to pay our Manager a management fee for investment advisory and management services consisting of a base management fee and an incentive fee.

The base management fee of 1.75% is calculated based on the average value of our gross assets (other than cash or cash equivalents, but including assets purchased with borrowed funds) at the end of the two most recently completed fiscal quarters, and appropriately adjusted for any share issuances or repurchases during the applicable fiscal quarter.

The incentive fee consists of the following two parts:

The first, payable quarterly in arrears, equals 20.0% of our pre-incentive fee net investment income, expressed as a rate of return on the value of our net assets at the end of the immediately preceding quarter, that exceeds a 1.875% quarterly (7.5% annualized) hurdle rate measured as of the end of each fiscal quarter, subject to a “catch-up” provision. Under this provision, in any fiscal quarter, our Manager receives no incentive fee unless our pre-incentive fee net investment income exceeds the hurdle rate of 1.875%. Our Manager will receive 100.0% of pre-incentive fee net investment income, if any, that exceeds the hurdle rate but is less than or equal to 2.344% in any fiscal quarter (9.376% annualized); and 20.0% of the amount of the our pre-incentive fee net investment income, if any, that exceeds 2.344% in any fiscal quarter (9.376% annualized).

The second part of the incentive fee is determined and payable in arrears as of the end of each fiscal year (or upon termination of the Management Agreement) and equals 20.0% of our “incentive fee capital gains,” which equals our realized capital gains on a cumulative basis from May 31, 2010 through the end of the year, if any, computed net of all realized capital losses and unrealized capital depreciation on a cumulative basis, less the aggregate amount of any previously paid capital gain incentive fee. Importantly, the capital gains portion of the incentive fee is based on realized gains and realized and unrealized losses from May 31, 2010. Therefore, realized and unrealized losses incurred prior to such time will not be taken into account when calculating the capital gains portion of the incentive fee, and our Manager will be entitled to 20.0% of incentive fee capital gains that arise after May 31, 2010. In addition, for the purpose of the “incentive fee capital gains” calculations, the cost basis for computing realized gains and losses on investments held by us as of May 31, 2010 will equal the fair value of such investments as of such date.

For the three months ended August 31, 2014 and 2013, we incurred $1.0 million and $0.8 million in base management fees, respectively. For the three months ended August 31, 2014 and 2013, we accrued $0.6 million and $0.1 million in incentive fees related to pre-incentive fee net investment income. For the three months ended August 31, 2014, we accrued $0.2 million in incentive fees related to capital gains. For the three months ended August 31, 2013, there was a reduction of $0.2 million in incentive management fees related to capital gains. For the six months ended August 31, 2014 and 2013, we incurred $2.0 million and $1.5 million in base management fees, respectively. For the six months ended August 31, 2014 and 2013, we accrued $0.9 million and $0.8 million in incentive fees related to pre-incentive fee net investment income. For the six months ended August 31, 2014, we accrued $0.3 million in incentive management fees related to capital gains. For the six months ended August 31, 2013, we did not accrue incentive management fees related to capital gains. The accrual is calculated

 

F-76


Table of Contents

using both realized and unrealized capital gains for the period. The actual incentive fee related to capital gains will be determined and payable in arrears at the end of the fiscal year and will include only realized capital gains for the period. As of August 31, 2014, the base management fees accrual was $1.0 million, and the incentive fees accrual was $3.2 million and is included in management and incentive fees payable in the accompanying consolidated statements of assets and liabilities. As of February 28, 2014, the base management fees accrual was $0.9 million and the incentive fees accrual was $3.0 million and is included in management and incentive fees payable in the accompanying consolidated statements of assets and liabilities.

On July 30, 2010, the Company entered into a separate administration agreement (the “Administration Agreement”) with our Manager, pursuant to which our Manager, as our administrator, has agreed to furnish us with the facilities and administrative services necessary to conduct our day-to-day operations and provide managerial assistance on our behalf to those portfolio companies to which we are required to provide such assistance. The initial term of the Administration Agreement is two years, with automatic, one-year renewals at the end of each year subject to certain approvals by our board of directors and/or our stockholders. The amount of expenses payable or reimbursable thereunder by the Company is capped at $1.0 million for the initial two year term of the administration agreement. On July 10, 2014, our board of directors approved the renewal of the Administration Agreement for an additional one-year term and determined to maintain the cap on the payment or reimbursement of expenses by the Company thereunder to $1.0 million for the additional one-year term.

For the three months ended August 31, 2014 and 2013, we recognized $0.3 million and $0.3 million in administrator expenses for the periods, pertaining to bookkeeping, record keeping and other administrative services provided to us in addition to our allocable portion of rent and other overhead related expenses, respectively. For the six months ended August 31, 2014 and 2013, we recognized $0.5 million and $0.5 million in administrator expenses for the periods, pertaining to bookkeeping, record keeping and other administrative services provided to us in addition to our allocable portion of rent and other overhead related expenses, respectively. As of August 31, 2014 and February 28, 2014, $0.4 million and $0.4 million, respectively, of administrator expenses were accrued and included in due to manager in the accompanying consolidated statements of assets and liabilities.

Note 6. Borrowings

Credit Facility

As a BDC, we are only allowed to employ leverage to the extent that our asset coverage, as defined in the 1940 Act, equals at least 200.0% after giving effect to such leverage. The amount of leverage that we employ at any time depends on our assessment of the market and other factors at the time of any proposed borrowing.

On April 11, 2007, we entered into a $100.0 million revolving securitized credit facility (the “Revolving Facility”). On May 1, 2007, we entered into a $25.7 million term securitized credit facility (the “Term Facility” and, together with the Revolving Facility, the “Facilities”), which was fully drawn at closing. In December 2007, we consolidated the Facilities by using a draw under the Revolving Facility to repay the Term Facility. In response to the market wide decline in financial asset prices, which negatively affected the value of our portfolio, we terminated the revolving period of the Revolving Facility effective January 14, 2009 and commenced a two-year amortization period during which all principal proceeds from the collateral was used to repay outstanding borrowings. A significant percentage of our total assets had been pledged under the Revolving Facility to secure our obligations thereunder. Under the Revolving Facility, funds were borrowed from or through certain lenders and interest was payable monthly at the greater of the commercial paper rate and our lender’s prime rate plus 4.00% plus a default rate of 2.00% or, if the commercial paper market was unavailable, the greater of the prevailing LIBOR rates and our lender’s prime rate plus 6.00% plus a default rate of 3.00%.

 

F-77


Table of Contents

In March 2009, we amended the Revolving Facility to increase the portion of the portfolio that could be invested in “CCC” rated investments in return for an increased interest rate and expedited amortization. As a result of these transactions, we expected to have additional cushion under our borrowing base under the Revolving Facility that would allow us to better manage our capital in times of declining asset prices and market dislocation.

On July 30, 2009, we exceeded the permissible borrowing limit under the Revolving Facility for 30 consecutive days, resulting in an event of default under the Revolving Facility. As a result of this event of default, our lender had the right to accelerate repayment of the outstanding indebtedness under the Revolving Facility and to foreclose and liquidate the collateral pledged thereunder. Acceleration of the outstanding indebtedness and/or liquidation of the collateral could have had a material adverse effect on our liquidity, financial condition and operations.

On July 30, 2010, we used the net proceeds from (i) the stock purchase transaction and (ii) a portion of the funds available to us under the $45.0 million senior secured revolving credit facility (the “Credit Facility”) with Madison Capital Funding LLC, in each case, described in “Note 13. Recapitalization Transaction” below, to pay the full amount of principal and accrued interest, including default interest, outstanding under the Revolving Facility. As a result, the Revolving Facility was terminated in connection therewith. Substantially all of our total assets, other than those held by SBIC LP, have been pledged under the Credit Facility to secure our obligations thereunder.

On February 24, 2012, we amended our senior secured revolving credit facility with Madison Capital Funding LLC to, among other things:

 

    expand the borrowing capacity under the credit facility from $40.0 million to $45.0 million;

 

    extend the period during which we may make and repay borrowings under the credit facility from July 30, 2013 to February 24, 2015 (the “Revolving Period”). The Revolving Period may upon the occurrence of an event of default, by action of the lenders or automatically. All borrowings and other amounts payable under the credit facility are due and payable five years after the end of the Revolving Period; and

 

    remove the condition that we may not acquire additional loan assets without the prior written consent of Madison Capital Funding LLC.

As of August 31, 2014 and February 28, 2014, there was $8.9 million and $0.0 million outstanding under the Credit Facility, respectively, and the Company was in compliance with all of the limitations and requirements of the Credit Facility. The carrying amount of the amount outstanding under the Credit Facility approximates its fair value. $2.3 million of financing costs related to the Credit Facility have been capitalized and are being amortized over the term of the facility. For the three months ended August 31, 2014 and 2013, we recorded $0.2 million and $0.1 million of interest expense related to the Credit Facility, respectively. For the three months ended August 31, 2014 and 2013, we recorded $0.1 million and $0.1 million of amortization of deferred financing costs related to the Credit Facility, respectively. The interest rates during the three and six months ended August 31, 2014 on the outstanding borrowings under the Credit Facility were 7.50% and 7.50%, respectively. The interest rates during the three and six months ended August 31, 2013 on the outstanding borrowings under the Credit Facility were 7.50% and 7.50%, respectively. For the six months ended August 31, 2014 and 2013, we recorded $0.4 million and $0.6 million of interest expense related to the Credit Facility, respectively. For the six months ended August 31, 2014 and 2013, we recorded $0.2 million and $0.2 million of amortization of deferred financing costs related to the Credit Facility, respectively.

The Credit Facility contains limitations as to how borrowed funds may be used, such as restrictions on industry concentrations, asset size, weighted average life, currency denomination and collateral interests. The

 

F-78


Table of Contents

Credit Facility also includes certain requirements relating to portfolio performance, the violation of which could result in the limit of further advances and, in some cases, result in an event of default, allowing the lenders to accelerate repayment of amounts owed thereunder. The Credit Facility has an eight year term, consisting of a three year period (the “Revolving Period”), under which the Company may make and repay borrowings, and a final maturity five years from the end of the Revolving Period. Availability on the Credit Facility will be subject to a borrowing base calculation, based on, among other things, applicable advance rates (which vary from 50.0% to 75.0% of par or fair value depending on the type of loan asset) and the value of certain “eligible” loan assets included as part of the Borrowing Base. Funds may be borrowed at the greater of the prevailing LIBOR rate and 2.00%, plus an applicable margin of 5.50%. At the Company’s option, funds may be borrowed based on an alternative base rate, which in no event will be less than 3.00%, and the applicable margin over such alternative base rate is 4.50%. In addition, the Company will pay the lenders a commitment fee of 0.75% per year on the unused amount of the Credit Facility for the duration of the Revolving Period.

Our borrowing base under the Credit Facility was $42.2 million subject to the Credit Facility cap of $45.0 million at August 31, 2014 For purposes of determining the borrowing base, most assets are assigned the values set forth in our most recent Annual Report on Form 10-K or Quarterly Report on Form 10-Q filed with the SEC. Accordingly, the August 31, 2014 borrowing base relies upon the valuations set forth in the Annual Report on Form 10-K for the year ended February 28, 2014. The valuations presented in this Quarterly Report on Form 10-Q will not be incorporated into the borrowing base until after this Quarterly Report on Form 10-Q is filed with the SEC.

SBA Debentures

SBIC LP is able to borrow funds from the SBA against regulatory capital (which approximates equity capital) that is paid in and is subject to customary regulatory requirements including but not limited to an examination by the SBA. As of August 31, 2014, we have funded SBIC LP with $45.5 million of equity capital, and have $64.0 million of SBA-guaranteed debentures outstanding. SBA debentures are non-recourse to us, have a 10-year maturity, and may be prepaid at any time without penalty. The interest rate of SBA debentures is fixed at the time of issuance, often referred to as pooling, at a market-driven spread over 10-year U.S. Treasury Notes. SBA current regulations limit the amount that SBIC LP may borrow to a maximum of $150.0 million, which is up to twice its potential regulatory capital.

SBICs are designed to stimulate the flow of private equity capital to eligible small businesses. Under SBA regulations, SBICs may make loans to eligible small businesses and invest in the equity securities of small businesses. Under present SBA regulations, eligible small businesses include businesses that have a tangible net worth not exceeding $18.0 million and have average annual fully taxed net income not exceeding $6.0 million for the two most recent fiscal years. In addition, an SBIC must devote 25.0% of its investment activity to ‘‘smaller’’ concerns as defined by the SBA. A smaller concern is one that has a tangible net worth not exceeding $6.0 million and has average annual fully taxed net income not exceeding $2.0 million for the two most recent fiscal years. SBA regulations also provide alternative size standard criteria to determine eligibility, which depend on the industry in which the business is engaged and are based on such factors as the number of employees and gross sales. According to SBA regulations, SBICs may make long-term loans to small businesses, invest in the equity securities of such businesses and provide them with consulting and advisory services.

SBIC LP is subject to regulation and oversight by the SBA, including requirements with respect to maintaining certain minimum financial ratios and other covenants. Receipt of an SBIC license does not assure that SBIC LP will receive SBA guaranteed debenture funding, which is dependent upon SBIC LP continuing to be in compliance with SBA regulations and policies. The SBA, as a creditor, will have a superior claim to SBIC LP’s assets over our stockholders and debtholders in the event we liquidate SBIC LP or the SBA exercises its remedies under the SBA-guaranteed debentures issued by SBIC LP upon an event of default.

 

F-79


Table of Contents

The Company received exemptive relief from the Securities and Exchange Commission to permit it to exclude the debt of SBIC LP guaranteed by the SBA from the definition of senior securities in the 200.0% asset coverage test under the 1940 Act. This allows the Company increased flexibility under the 200.0% asset coverage test by permitting it to borrow up to $150.0 million more than it would otherwise be able to absent the receipt of this exemptive relief.

As of August 31, 2014 and February 28, 2014, there was $64.0 million and $50.0 million outstanding of SBA debentures, respectively. The carrying amount of the amount outstanding of SBA debentures approximates its fair value. $2.1 million of financing costs related to the SBA debentures have been capitalized and are being amortized over the term of the commitment and drawdown. For the three and six months ended August 31, 2014, the Company recorded $0.4 million and $0.8 million, respectively, of interest expense related to the SBA debentures. For the three and six months ended August 31, 2013, the Company recorded $0.3 million and $0.6 million, respectively, of interest expense related to the SBA debentures. For the three and six months ended August 31, 2014, the Company recorded $0.1 million and $0.1 million, respectively, of amortization of deferred financing costs related to the SBA debentures. For the three and six months ended August 31, 2013, the Company recorded $0.05 million and $0.1 million, respectively, of amortization of deferred financing costs related to the SBA debentures. The weighted average interest rate during the six months ended August 31, 2014 and 2013 on the outstanding borrowings of the SBA debentures was 3.16% and 2.90%, respectively.

Notes

On May 10, 2013, the Company issued $42.0 million in aggregate principal amount of 7.50% fixed-rate notes due 2020 (the “Notes”). The Notes will mature on May 31, 2020, and may be redeemed in whole or in part at any time or from time to time at the Company’s option on or after May 31, 2016. Interest will be payable quarterly beginning August 15, 2013.

On May 17, 2013, the Company closed an additional $6.3 million in aggregate principal amount of the Notes, pursuant to the full exercise of the underwriters’ option to purchase additional Notes.

As of August 31, 2014, the carrying amount and fair value of the Notes was $48.3 million and $49.4 million, respectively. The fair value of the Notes, which are publicly traded, is based upon closing market quotes as of the measurement date and would be classified as a level 1 liability within the fair value hierarchy. As of August 31, 2014, $2.5 million of financing costs related to the Notes have been capitalized and are being amortized over the term of the Notes. For the three and six months ended August 31, 2014, we recorded $0.9 million and $1.8 million, respectively, of interest expense and $0.1 million and $0.2 million, respectively, of amortization of deferred financing costs related to the Notes. For the three and six months ended August 31, 2013, we recorded $0.9 million and $1.1 million, respectively, of interest expense and $0.09 million and $0.1 million, respectively, of amortization of deferred financing costs related to the Notes.

Note 7. Commitments and Contingencies

Contractual obligations

The following table shows our payment obligations for repayment of debt and other contractual obligations at August 31, 2014:

 

            Payment Due by Period  
     Total      Less Than
1 Year
     1 - 3
Years
     3 - 5
Years
     More Than
5 Years
 
     ($ in thousands)                              

Long-Term Debt Obligations

   $ 121,200       $ 8,900       $ —         $ —         $ 112,300   
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

 

F-80


Table of Contents

Off-balance sheet arrangements

The Company’s off-balance sheet arrangements consisted of $13.1 million and $12.2 million of unfunded commitments to provide debt financing to its portfolio companies or to fund limited partnership interests as of August 31, 2014 and February 28, 2014, respectively. Such commitments are generally up to the Company’s discretion to approve, or the satisfaction of certain financial and nonfinancial covenants and involve, to varying degrees, elements of credit risk in excess of the amount recognized in the Company’s Consolidated Statement of Assets and Liabilities and are not reflected in the Company’s Consolidated Statements of Assets and Liabilities.

Note 8. Directors Fees

The independent directors receive an annual fee of $40,000. They also receive $2,500 plus reimbursement of reasonable out-of-pocket expenses incurred in connection with attending each board meeting and receive $1,000 plus reimbursement of reasonable out-of-pocket expenses incurred in connection with attending each committee meeting. In addition, the chairman of the Audit Committee receives an annual fee of $5,000 and the chairman of each other committee receives an annual fee of $2,000 for their additional services in these capacities. In addition, we have purchased directors’ and officers’ liability insurance on behalf of our directors and officers. Independent directors have the option to receive their directors’ fees in the form of our common stock issued at a price per share equal to the greater of net asset value or the market price at the time of payment. No compensation is paid to directors who are “interested persons” of the Company (as such term is defined in the 1940 Act). For the three months ended August 31, 2014 and 2013, we accrued $0.05 million and $0.05 million for directors’ fees expense, respectively. For the six months ended August 31, 2014 and 2013, we accrued $0.1 million and $0.1 million for directors’ fees expense, respectively. As of August 31, 2014 and February 28, 2014, $0.05 million and $0.05 million in directors’ fees expense were unpaid and included in accounts payable and accrued expenses in the consolidated statements of assets and liabilities. As of August 31, 2014, we had not issued any common stock to our directors as compensation for their services.

Note 9. Stockholders’ Equity

On May 16, 2006, GSC Group, Inc. capitalized the LLC, by contributing $1,000 in exchange for 67 shares, constituting all of the issued and outstanding shares of the LLC.

On March 20, 2007, the Company issued 95,995.5 and 8,136.2 shares of common stock, priced at $150.00 per share, to GSC Group and certain individual employees of GSC Group, respectively, in exchange for the general partnership interest and a limited partnership interest in GSC Partners CDO III GP, LP, collectively valued at $15.6 million. At this time, the 6.7 shares owned by GSC Group in the LLC were exchanged for 6.7 shares of the Company.

On March 28, 2007, the Company completed its IPO of 725,000 shares of common stock, priced at $150.00 per share, before underwriting discounts and commissions. Total proceeds received from the IPO, net of $7.1 million in underwriter’s discount and commissions, and $1.0 million in offering costs, were $100.7 million.

On November 13, 2009, we declared a dividend of $18.25 per share payable on December 31, 2009. Shareholders had the option to receive payment of the dividend in cash, shares of common stock, or a combination of cash and shares of common stock, provided that the aggregate cash payable to all shareholders was limited to $2.1 million or $2.50 per share. Based on shareholder elections, the dividend consisted of $2.1 million in cash and 864,872.5 of newly issued shares of common stock.

On July 30, 2010, our Manager and its affiliates purchased 986,842 shares of common stock at $15.20 per share. Total proceeds received from this sale were $15.0 million. See “Note 13. Recapitalization Transaction.”

 

F-81


Table of Contents

On August 12, 2010, we effected a one-for-ten reverse stock split of our outstanding common stock. As a result of the reverse stock split, every ten shares of our common stock were converted into one share of our common stock. Any fractional shares received as a result of the reverse stock split were redeemed for cash. The total cash payment in lieu of shares was $230. Immediately after the reverse stock split, we had 2,680,842 shares of our common stock outstanding.

On November 12, 2010, we declared a dividend of $4.40 per share payable on December 29, 2010. Shareholders had the option to receive payment of the dividend in cash, shares of common stock, or a combination of cash and shares of common stock, provided that the aggregate cash payable to all shareholders was limited to approximately $1.2 million or $0.44 per share. Based on shareholder elections, the dividend consisted of approximately $1.2 million in cash and 596,235 shares of common stock.

On November 15, 2011, we declared a dividend of $3.00 per share payable on December 30, 2011. Shareholders had the option to receive payment of the dividend in cash, shares of common stock, or a combination of cash and shares of common stock, provided that the aggregate cash payable to all shareholders was limited to approximately $2.0 million or $0.60 per share. Based on shareholder elections, the dividend consisted of approximately $2.0 million in cash and 599,584 shares of common stock.

On November 9, 2012, the Company declared a dividend of $4.25 per share payable on December 31, 2012. Shareholders had the option to receive payment of the dividend in cash, shares of common stock, or a combination of cash and shares of common stock, provided that the aggregate cash payable to all shareholders was limited to approximately $3.3 million or $0.85 per share. Based on shareholder elections, the dividend consisted of approximately $3.3 million in cash and 853,455 shares of common stock.

On October 30, 2013, the Company declared a dividend of $2.65 per share payable on December 27, 2013. Shareholders had the option to receive payment of the dividend in cash, shares of common stock, or a combination of cash and shares of common stock, provided that the aggregate cash payable to all shareholders was limited to approximately $2.5 million or $0.53 per share. Based on shareholder elections, the dividend consisted of approximately $2.5 million in cash and 649,500 shares of common stock.

Note 10. Earnings Per Share

In accordance with the provisions of FASB ASC 260, “Earnings per Share” (“ASC 260”), basic earnings per share is computed by dividing earnings available to common shareholders by the weighted average number of shares outstanding during the period. Other potentially dilutive common shares, and the related impact to earnings, are considered when calculating earnings per share on a diluted basis.

The following information sets forth the computation of the weighted average basic and diluted net increase in net assets per share from operations for the three and six months ended August 31, 2014 and 2013 (dollars in thousands except share and per share amounts):

 

     For the three months ended      For the six months ended  

Basic and diluted

   August 31,
2014
     August 31,
2013
     August 31,
2014
     August 31,
2013
 

Net increase (decrease) in net assets from operations

   $ 3,136       $ (41    $ 4,894       $ 3,759   

Weighted average common shares outstanding

     5,379,616         4,730,116         5,379,616         4,730,116   

Earnings (loss) per common share-basic and diluted

   $ 0.58       $ (0.01    $ 0.91       $ 0.79   

 

F-82


Table of Contents

Note 11. Dividend

The Company did not declare any dividend payments during the quarters ended August 31, 2014 and August 31, 2013.

Note 12. Financial Highlights

The following is a schedule of financial highlights for the six months ended August 31, 2014 and 2013:

 

     For the six months ended  
     August 31,
2014
    August 31,
2013
 

Per share data:

  

Net asset value at beginning of period

   $ 21.36      $ 22.98   

Net investment income(1)

     0.77        1.00   

Net realized and unrealized gains and (losses) on investments and derivatives

     0.14        (0.21
  

 

 

   

 

 

 

Net increase in net assets from operations

  0.91      0.79   

Net asset value at end of period

$ 22.27    $ 23.77   

Net assets at end of period

$ 119,817,820    $ 112,445,315   

Shares outstanding at end of period

  5,379,616      4,730,116   

Per share market value at end of period

$ 16.06    $ 18.31   

Total return based on market value(2)

  1.31   7.58

Total return based on net asset value(3)

  4.26   3.45

Ratio/Supplemental data:

Ratio of net investment income to average, net assets(4)

  7.09   8.62

Ratio of operating expenses to average net assets(4)

  6.38   5.73

Ratio of incentive management fees to average net assets(4)

  2.01   1.42

Ratio of debt related expenses to average net assets(4)

  6.17   4.97

Ratio of total expenses to average net assets(4)

  14.56   12.11

Portfolio turnover rate(5)

  11.35   32.41

 

(1) Net investment income per share is calculated using the weighted average shares outstanding during the period.
(2) Total investment return is calculated assuming a purchase of common shares at the current market value on the first day and a sale at the current market value on the last day of the periods reported. Dividends and distributions, if any, are assumed for purposes of this calculation to be reinvested at prices obtained under the Company’s dividend reinvestment plan. Total investment return does not reflect brokerage commissions. Total investment returns covering less than a full period are not annualized.
(3) Total investment return is calculated assuming a purchase of common shares at the current net asset value on the first day and a sale at the current net asset value on the last day of the periods reported. Dividends and distributions, if any, are assumed for purposes of this calculation to be reinvested at prices obtained under the Company’s dividend reinvestment plan. Total investment return does not reflect brokerage commissions.
(4) Ratios are annualized.
(5) Portfolio turnover rate is calculated using the lesser of year-to-date sales or year-to-date purchases over the average of the invested assets at fair value.

Note 13. Recapitalization Transaction

In July 2010, we consummated a recapitalization transaction that was necessitated by the fact that we had exceeded permissible borrowing limits under the Revolving Facility in July 2009, which resulted in an event of default under the Revolving Facility. As a result of the event of default under the Revolving Facility, the lender

 

F-83


Table of Contents

had the right to accelerate repayment of the outstanding indebtedness under the Revolving Facility and to foreclose and liquidate the collateral pledged thereunder. We engaged the investment banking firm of Stifel, Nicolaus & Company to evaluate strategic transaction opportunities and consider alternatives for us in December 2008. On April 14, 2010, we entered into a stock purchase agreement with our Manager and certain of its affiliates and an assignment, assumption and novation agreement with our Manager, pursuant to which we assumed certain rights and obligations of our Manager under a debt commitment letter our Manager received from Madison Capital Funding LLC, indicating Madison Capital Funding’s willingness to provide us with the Credit Facility, subject to the satisfaction of certain terms and conditions. In addition, we and GSCP (NJ), L.P., our then external investment adviser, entered into a termination and release agreement, to be effective as of the closing of the transaction contemplated by the stock purchase agreement, pursuant to which GSCP (NJ), L.P., among other things, agreed to waive any and all accrued and unpaid deferred incentive management fees up to and as of the closing of the transaction contemplated by the stock purchase agreement but continued to be entitled to receive the base management fees earned through the date of the closing of the transaction contemplated by the stock purchase agreement.

On July 30, 2010, the transactions contemplated by the stock purchase agreement with our Manager and certain of its affiliates was completed, and included the following actions:

 

    the private sale of shares of our common stock for $15.0 million in aggregate purchase price to our Manager and certain of its affiliates;

 

    the closing of the $40.0 million Credit Facility with Madison Capital Funding;

 

    the execution of a registration rights agreement with the investors in the private sale transaction, pursuant to which we agreed to file a registration statement with the SEC to register for resale the shares of our common stock sold in the private sale transaction;

 

    the execution of a trademark license agreement with our Manager pursuant to which our Manager granted us a non-exclusive, royalty-free license to use the “Saratoga” name, for so long as our Manager or one of its affiliates remains our investment adviser;

 

    replacing GSCP (NJ), L.P. as our investment adviser and administrator with our Manager by executing the Management Agreement, which was approved by our stockholders, and an administration agreement with our Manager;

 

    the resignations of Robert F. Cummings, Jr. and Richard M. Hayden, both of whom are affiliates of GSCP (NJ) L.P., as members of the board of directors and the election of Christian L. Oberbeck and Richard A. Petrocelli, both of whom are affiliates of our Manager, as members of the board of directors;

 

    the resignation of all of our then existing executive officers and the appointment by our board of directors of Mr. Oberbeck as our chief executive officer and Mr. Petrocelli as our chief financial officer, secretary and chief compliance officer; and

 

    our name change from “GSC Investment Corp.” to “Saratoga Investment Corp.”

We used the net proceeds from the private sale transaction and a portion of the funds available to us under the Credit Facility to pay the full amount of principal and accrued interest, including default interest, outstanding under Revolving Facility. The Revolving Facility with Deutsche Bank was terminated in connection with our payment of all amounts outstanding thereunder on July 30, 2010.

Note 14. Subsequent Events

Management has evaluated subsequent events through the date of issuance of the consolidated financial statements included herein. There have been no further subsequent events that occurred during such period that would require disclosure in this Form 10-Q or would be required to be recognized in the consolidated financial statements as of and for the quarter ended August 31, 2014, except as disclosed below.

 

F-84


Table of Contents

On September 17, 2014, the Company entered into a second amendment to the Revolving Facility with Madison Capital Funding LLC to, among other things, (1) extend the commitment termination date from February 24, 2015 to September 17, 2017; (2) extend the maturity date of the Revolving Facility from February 24, 2020 to September 17, 2022 (unless terminated sooner upon certain events); (3) reduce the applicable margin rate on base rate borrowings from 4.50% to 3.75%; (4) reduce the applicable margin rate on LIBOR borrowings from 5.50% to 4.75%; (5) reduce the floor on base rate borrowings from 3.00% to 2.25%; and (6) reduce the floor on LIBOR borrowings from 2.00% to 1.25%.

On September 24, 2014, the Company announced that its Board of Directors adopted a new dividend policy to pay a regular quarterly cash dividend to shareholders. The Company will pay a quarterly dividend of $0.18 per share for the quarter ended August 31, 2014, which will be payable on November 28, 2014 to all stockholders of record at the close of business on November 3, 2014. The second dividend of $0.22 per share for the quarter ended November 30, 2014, will be payable on February 27, 2015 to all stockholders of record at the close of business on February 2, 2015.

On September 24, 2014, the Board of Directors also adopted a new dividend reinvestment plan (“DRIP”) that provides for the reinvestment of dividends on behalf of its stockholders, unless a stockholder has elected to receive dividends in cash. If the Company declares a dividend, its stockholders who have not “opted out” of the DRIP by the dividend record date will have their dividend automatically reinvested into additional shares of the Company’s common stock.

On the same day, the Company also announced the approval of an open market share repurchase plan that allows it to repurchase up to 200,000 shares of its common stock at prices below its NAV as reported in its then most recently published financial statements.

 

F-85


Table of Contents

INDEX TO OTHER FINANCIAL STATEMENTS

Saratoga Investment Corp. CLO 2013-1, Ltd.

 

Report of Independent Auditors

  S-2   

Statements of Assets and Liabilities as of February 28, 2014 and 2013

  S-3   

Statements of Operations for the years ended February 28, 2014, February  28, 2013, and February 29, 2012

  S-4   

Schedules of Investments as of February 28, 2014 and 2013

  S-5   

Statements of Changes in Net Assets for the years ended February 28, 2014, February  28, 2013 and February 29, 2012

  S-17   

Statements of Cash Flows for the years ended February 28, 2014, February  28, 2013 and February 29, 2012

  S-18   

Notes to Financial Statements

  S-19   

IMPORTANT NOTE

In accordance with certain SEC rules, Saratoga Investment Corp. (the “Company”) is providing additional information regarding one of its portfolio companies, Saratoga Investment Corp. CLO 2013-1, Ltd. (“Saratoga CLO”). The Company owns 100% of the subordinated notes of the Saratoga CLO. The additional financial information regarding the Saratoga CLO does not directly impact the Company’s financial position, results of operations or cash flows.

 

S-1


Table of Contents

Report of Independent Auditors

The Collateral Manager and Directors,

Saratoga Investment Corp. CLO 2013-1, Ltd.

We have audited the accompanying financial statements of Saratoga Investment Corp. CLO 2013-1, Ltd. (the “Issuer”), which comprise the statements of assets and liabilities, as of February 28, 2014 and February 28, 2013, including the schedules of investments, and the statements of operations, changes in net assets, and cash flows for the years ended February 28, 2014, February 28, 2013 and February 29, 2012, and the related notes to the financial statements.

Management’s Responsibility for the Financial Statements

Management is responsible for the preparation and fair presentation of these financial statements in conformity with U.S. generally accepted accounting principles; this includes the design, implementation, and maintenance of internal control relevant to the preparation and fair presentation of financial statements that are free of material misstatement, whether due to fraud or error.

Auditor’s Responsibility

Our responsibility is to express an opinion on these financial statements based on our audits. We conducted our audits in accordance with auditing standards generally accepted in the United States. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement.

An audit involves performing procedures to obtain audit evidence about the amounts and disclosures in the financial statements. The procedures selected depend on the auditor’s judgment, including the assessment of the risks of material misstatement of the financial statements, whether due to fraud or error. In making those risk assessments, the auditor considers internal control relevant to the Issuer’s preparation and fair presentation of the financial statements in order to design audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Issuer’s internal control. Accordingly, we express no such opinion. An audit also includes evaluating the appropriateness of accounting policies used and the reasonableness of significant accounting estimates made by management, as well as evaluating the overall presentation of the financial statements.

We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our audit opinion.

Opinion

In our opinion, the financial statements referred to above present fairly, in all material respects, the financial position of Saratoga Investment Corp. CLO 2013-1, Ltd. at February 28, 2014 and February 28, 2013, and the results of its operations, changes in its net assets and its cash flows for the years ended February 28, 2014, February 28, 2013 and February 29, 2012, in conformity with U.S. generally accepted accounting principles.

/s/ Ernst & Young LLP

New York, NY

May 27, 2014

 

S-2


Table of Contents

Saratoga Investment Corp. CLO 2013-1, Ltd.

Statements of Assets and Liabilities

 

     As of  
     February 28, 2014     February 28, 2013  

ASSETS

    

Investments

    

Fair Value Loans (amortized cost of $299,137,566 and $366,099,395, respectively)

   $ 300,491,077      $ 362,494,006   

Fair Value Other/Structured finance securities (amortized cost of $0 and $13,743,946, respectively)

     —          11,925,973   
  

 

 

   

 

 

 

Total investments at fair value (amortized cost of $299,137,566 and $379,843,341, respectively)

     300,491,077        374,419,979   

Cash and cash equivalents

     8,018,933        28,804,871   

Receivable from open trades

     1,801,266        5,131,538   

Interest receivable

     1,450,952        1,584,985   

Deferred debt financing costs, net

     2,166,633        2,092,787   

Other assets

     91,336        —     
  

 

 

   

 

 

 

Total assets

   $ 314,020,197      $ 412,034,160   
  

 

 

   

 

 

 

LIABILITIES

    

Interest payable

   $ 622,476      $ 666,121   

Payable from open trades

     9,445,000        16,346,250   

Accrued base management fee

     75,053        43,171   

Accrued subordinated management fee

     75,053        172,682   

Class A notes—GSCIC CLO 2007, Ltd.

     —          296,000,000   

Class B notes—GSCIC CLO 2007, Ltd.

     —          22,000,000   

Discount on class B notes—GSCIC CLO 2007, Ltd.

     —          (417,011

Class C notes—GSCIC CLO 2007, Ltd.

     —          14,000,000   

Class D notes—GSCIC CLO 2007, Ltd.

     —          16,000,000   

Discount on class D notes—GSCIC CLO 2007, Ltd.

     —          (441,136

Class E notes—GSCIC CLO 2007, Ltd.

     —          17,960,044   

Discount on class E notes—GSCIC CLO 2007, Ltd.

     —          (1,134,778

Class X Notes—SIC CLO 2013-1, Ltd.

     1,666,666        —     

Class A-1 Notes—SIC CLO 2013-1, Ltd.

     170,000,000        —     

Discount on Class A-1 Notes—SIC CLO 2013-1, Ltd.

     (1,671,864     —     

Class A-2 Notes—SIC CLO 2013-1, Ltd.

     20,000,000        —     

Discount on Class A-2 Notes—SIC CLO 2013-1, Ltd.

     (173,300     —     

Class B Notes—SIC CLO 2013-1, Ltd.

     44,800,000        —     

Discount on Class B Notes—SIC CLO 2013-1, Ltd.

     (1,125,757     —     

Class C Notes—SIC CLO 2013-1, Ltd.

     16,000,000        —     

Discount on Class C Notes—SIC CLO 2013-1, Ltd.

     (700,902     —     

Class D Notes—SIC CLO 2013-1, Ltd.

     14,000,000        —     

Discount on Class D Notes—SIC CLO 2013-1, Ltd.

     (909,825     —     

Class E Notes—SIC CLO 2013-1, Ltd.

     13,100,000        —     

Discount on Class E Notes—SIC CLO 2013-1, Ltd.

     (1,715,285     —     

Class F Notes—SIC CLO 2013-1, Ltd.

     4,500,000        —     

Discount on Class F Notes—SIC CLO 2013-1, Ltd.

     (623,880     —     

Subordinated Notes

     30,000,000        30,000,000   
  

 

 

   

 

 

 

Total liabilities

   $ 317,363,435      $ 411,195,343   
  

 

 

   

 

 

 

Commitments and contingencies (See Note 6)

    

NET ASSETS

    

Ordinary equity, par value $1.00, 250 ordinary shares authorized, 250 and 250 issued and outstanding, respectively

   $ 250      $ 250   

Accumulated gain (loss)

     838,567        (5,963,092

Net income (loss)

     (4,182,055     6,801,659   
  

 

 

   

 

 

 

Total net assets

     (3,343,238     838,817   
  

 

 

   

 

 

 

Total liabilities and net assets

   $ 314,020,197      $ 412,034,160   
  

 

 

   

 

 

 

See accompanying notes to financial statements.

 

S-3


Table of Contents

Saratoga Investment Corp. CLO 2013-1, Ltd.

Statements of Operations

 

     For the year ended
February 28, 2014
    For the year ended
February 28, 2013
     For the year ended
February 29, 2012
 

INVESTMENT INCOME

       

Interest from investments

   $ 15,486,413      $ 19,328,855       $ 20,032,687   

Interest from cash and cash equivalents

     6,792        16,587         12,165   

Other income

     945,441        967,991         509,365   
  

 

 

   

 

 

    

 

 

 

Total investment income

  16,438,646      20,313,433      20,554,217   
  

 

 

   

 

 

    

 

 

 

EXPENSES

Interest expense

  11,678,514      15,613,003      14,480,621   

Professional fees

  433,073      417,086      400,628   

Misc. Fee Expense

  175,283      133,794      176,768   

Base management fee

  517,563      400,014      402,303   

Subordinated management fee

  1,257,578      1,600,057      1,609,213   

Trustee expenses

  83,221      100,820      100,551   

Amortization expense

  994,602      1,015,332      1,016,124   

Loss on extinguishment of debt

  3,442,442      —        —     
  

 

 

   

 

 

    

 

 

 

Total expenses

  18,582,276      19,280,106      18,186,208   
  

 

 

   

 

 

    

 

 

 

NET INVESTMENT INCOME (LOSS)

  (2,143,630   1,033,327      2,368,009   
  

 

 

   

 

 

    

 

 

 

REALIZED AND UNREALIZED GAIN (LOSS) ON INVESTMENTS:

Net realized gain (loss) on investments

  (8,815,296   2,532,558      (4,547,952

Net unrealized appreciation/(depreciation) on investments

  6,776,871      3,235,774      (650,241
  

 

 

   

 

 

    

 

 

 

Net gain (loss) on investments

  (2,038,425   5,768,332      (5,198,193
  

 

 

   

 

 

    

 

 

 

NET INCREASE (DECREASE) IN NET ASSETS RESULTING FROM OPERATIONS

$ (4,182,055 $ 6,801,659    $ (2,830,184
  

 

 

   

 

 

    

 

 

 

See accompanying notes to financial statements.

 

S-4


Table of Contents

Saratoga Investment Corp. CLO 2013-1 Ltd.

Schedule of Investments

February 28, 2014

 

Issuer Name

 

Industry

 

Asset Name

  Asset
Type
  Current
Rate
    Maturity
Date
    Principal     Cost     Fair Value  

Academy, LTD.

  Retailers (Except Food and Drugs)   Initial Term Loan (2012)   Loan     4.50     8/3/2018      $ 1,960,187      $ 1,948,853      $ 1,969,969   

Acosta, Inc.

  Food Products   Term B Loan (2013)   Loan     4.25     3/2/2018        4,162,740        4,101,035        4,177,310   

Aderant North America, Inc.

  Business Equipment and Services   Term Loan (First Lien)   Loan     6.25     12/20/2018        3,473,750        3,470,186        3,482,434   

Aegis Toxicology Sciences Corporation

  Healthcare   Initial Term Loan (First Lien)   Loan     5.50     2/24/2021        1,000,000        990,000        990,000   

Aegis Toxicology Sciences Corporation

  Healthcare   Initial Term Loan (Second Lien)   Loan     9.50     8/24/2021        500,000        492,500        492,500   

Aeroflex Incorporated

  Aerospace and Defense   Tranche B-1 Term Loan   Loan     4.50     11/9/2019        3,208,854        3,194,690        3,223,550   

Akorn, Inc.

  Healthcare   Term Loan B   Loan     4.50     11/13/2020        500,000        497,500        503,125   

Alere Inc. (fka IM US Holdings, LLC)

  Healthcare   Incremental B-1 Term Loan   Loan     4.25     6/30/2017        1,960,000        1,930,566        1,968,173   

Applied Systems, Inc.

  Business Equipment and Services   Term Loan   Loan     4.25     12/8/2016        500,000        498,750        498,750   

Aramark Corporation

  Food Products   LC-2 Facility   Loan     3.69     7/26/2016        79,187        79,187        79,206   

Aramark Corporation

  Food Products   LC-3 Facility   Loan     3.69     7/26/2016        43,961        43,961        43,971   

Aramark Corporation

  Food Products   U.S. Term F Loan   Loan     3.25     2/24/2021        3,206,537        3,206,537        3,207,307   

Ardagh Holdings USA Inc. (Ardagh Packaging Finance S.A.)

  Containers/Glass Products   Dollar Term Loan   Loan     4.25     12/17/2019        1,000,000        995,109        1,002,500   

ARG IH Corporation

  Food Services   Term Loan   Loan     5.00     11/15/2020        500,000        498,797        502,500   

Asurion, LLC (fka Asurion Corporation)

  Insurance   Incremental Tranche B-1 Term Loan   Loan     4.50     5/24/2019        5,508,783        5,462,695        5,516,660   

Auction.Com, LLC

  Business Equipment and Services   Term Loan A-4   Loan     4.66     2/28/2017        980,651        979,812        970,845   

Autotrader.com, Inc.

  Automotive   Tranche B-1 Term Loan   Loan     4.00     12/15/2016        3,791,778        3,791,778        3,805,997   

Avantor Performance Materials Holdings, Inc.

  Chemicals/Plastics   Term Loan   Loan     5.25     6/24/2017        4,875,000        4,861,403        4,875,000   

AZ Chem US Inc.

  Chemicals/Plastics   Term Loan   Loan     5.25     12/22/2017        1,355,941        1,329,859        1,362,720   

Bass Pro Group, LLC

  Retailers (Except Food and Drugs)   New Term Loan   Loan     3.75     11/20/2019        498,725        498,126        500,715   

Berry Plastics Corporation

  Chemicals/Plastics   Term E Loan   Loan     3.75     1/6/2021        1,500,000        1,496,250        1,495,500   

Big Heart Pet Brands (fka Del Monte Corporation)

  Food/Drug Retailers   Initial Term Loan   Loan     3.50     3/9/2020        3,000,000        3,022,866        2,999,250   

Biomet, Inc.

  Healthcare   Dollar Term B-2 Loan   Loan     3.65     7/25/2017        1,970,137        1,970,137        1,972,797   

BJ’s Wholesale Club, Inc.

 

Food/Drug Retailers

  New 2013 (November) Replacement Loan (First Lien)   Loan     4.50     9/26/2019        500,000        497,592        502,750   

Bombardier Recreational Products Inc.

  Leisure Goods/Activities/Movies   Term B Loan   Loan     4.00     1/30/2019        754,286        748,080        756,647   

Brickman Group Ltd. LLC, The

  Brokers/Dealers/Investment Houses   Initial Term Loan (First Lien)   Loan     4.00     12/18/2020        250,000        248,750        250,937   

Brock Holdings III, Inc.

  Industrial Equipment   Term Loan (First Lien)   Loan     6.75     3/16/2017        1,959,839        1,976,826        1,967,188   

 

S-5


Table of Contents

Issuer Name

 

Industry

 

Asset Name

  Asset
Type
  Current
Rate
    Maturity
Date
    Principal     Cost     Fair Value  

Burlington Coat Factory Warehouse Corporation

  Retailers (Except Food and Drugs)   Term B-2 Loan   Loan     4.25     2/23/2017        2,660,377        2,653,889        2,675,675   

C.H.I. Overhead Doors, Inc.

  Building and Development   Term Loan (First Lien)   Loan     5.50     3/18/2019        2,739,013        2,692,934        2,745,861   

Camp International Holding Company

 

Aerospace and Defense

  2013 Replacement Term Loan (First Lien)   Loan     4.75     5/31/2019        990,000        990,000        999,900   

Capital Automotive L.P.

  Conglomerate   Tranche B-1 Term Loan Facility   Loan     4.00     4/10/2019        2,137,369        2,141,920        2,142,712   

Capstone Logistics, LLC

  Business Equipment and Services   Term Note A   Loan     6.50     9/16/2016        2,658,626        2,637,550        2,618,899   

Capsugel Holdings US, Inc.

  Drugs   Initial Term Loan   Loan     3.50     8/1/2018        3,145,521        3,138,959        3,141,589   

Celanese US Holdings LLC

  Chemicals/Plastics   Dollar Term C-2 Commitment   Loan     2.25     10/31/2016        2,176,323        2,201,894        2,192,254   

Charter Communications Operating, LLC

  Cable and Satellite Television   Term F Loan   Loan     3.00     12/31/2020        2,682,707        2,672,727        2,666,369   

CHS/Community Health Systems, Inc.

  Healthcare   2017 Term E Loan   Loan     3.48     1/25/2017        1,108,908        1,082,718        1,113,987   

CHS/Community Health Systems, Inc.

  Healthcare   2021 Term D Loan   Loan     4.25     1/27/2021        2,955,608        2,862,024        2,980,228   

Cinedigm Digital Funding I, LLC

  Business Equipment and Services   Term Loan   Loan     3.75     2/28/2018        825,121        820,892        825,121   

Covanta Energy Corporation

  Ecological Services and Equipment   Term Loan   Loan     3.50     3/28/2019        491,250        489,468        492,788   

CPI International Acquisition, Inc. (f/k/a Catalyst Holdings, Inc.)

  Electronics/Electric   Term B Loan   Loan     5.00     2/13/2017        4,622,500        4,611,092        4,622,500   

Crosby US Acquisition Corp.

 

Industrial Equipment

  Initial Term Loan (First Lien)   Loan     4.00     11/23/2020        750,000        749,094        748,312   

Crown Castle Operating Company

 

Telecommunications/Cellular

  Extended Incremental Tranche B-2 Term Loan   Loan     3.25     1/31/2019        2,460,196        2,441,025        2,460,316   

Culligan International Company

  Conglomerate   Dollar Loan (First Lien)   Loan     6.25     12/19/2017        787,658        738,102        734,491   

Culligan International Company

  Conglomerate   Dollar Loan (Second Lien)   Loan     9.50     6/19/2018        783,162        732,061        657,856   

Cumulus Media Holdings Inc.

  Broadcast Radio and Television   Term Loan   Loan     4.25     12/23/2020        500,000        495,000        502,815   

DaVita HealthCare Partners Inc. (fka DaVita Inc.)

  Healthcare   Tranche B Term Loan   Loan     4.50     10/20/2016        3,909,320        3,909,320        3,927,655   

DCS Business Services, Inc.

  Financial Intermediaries   Term B Loan   Loan     7.25     3/19/2018        3,831,595        3,792,824        3,735,805   

DealerTrack Technologies, Inc.

  Computers & Electronics   Term Loan   Loan     3.50     2/28/2021        500,000        498,750        498,750   

Dell International LLC

  Retailers (Except Food and Drugs)   Term B Loan   Loan     4.50     4/29/2020        1,995,000        1,982,818        1,988,935   

Delos Finance S.à r.l.

  Leasing   Loan   Loan     3.50     2/26/2021        500,000        497,500        497,500   

Deluxe Entertainment Services Group Inc.

  Media   Initial Term Loan   Loan     6.50     2/28/2020        1,000,000        1,000,000        1,000,000   

Digitalglobe, Inc.

  Ecological Services and Equipment   Term Loan   Loan     3.75     1/31/2020        248,125        248,125        247,815   

Drew Marine Group Inc.

  Chemicals/Plastics   Term Loan (First Lien)   Loan     4.50     11/19/2020        500,000        499,397        502,500   

Dunkin’ Brands, Inc.

  Food Services   Term B-4 Loan   Loan     3.25     2/7/2021        3,956,731        3,946,925        3,936,948   

DynCorp International Inc.

  Aerospace and Defense   Term Loan   Loan     6.25     7/7/2016        486,442        482,619        488,573   

Education Management LLC

  Leisure Goods/Activities/Movies   Tranche C-2 Term Loan   Loan     4.31     6/1/2016        3,882,152        3,746,734        3,544,405   

 

S-6


Table of Contents

Issuer Name

 

Industry

 

Asset Name

  Asset
Type
  Current
Rate
    Maturity
Date
    Principal     Cost     Fair Value  

EIG Investors Corp.

  Business Equipment and Services   Term Loan   Loan     5.00     11/9/2019        997,500        992,713        1,003,734   

Energy Transfer Equity, L.P.

  Oil & Gas   Loan   Loan     3.25     12/2/2019        1,000,000        997,599        998,750   

Evergreen Acqco 1 LP

  Retailers (Except Food and Drugs)   New Term Loan   Loan     5.00     7/9/2019        492,516        488,615        493,900   

EWT Holdings III Corp. (fka WTG Holdings III Corp.)

  Industrial Equipment   Term Loan (First Lien)   Loan     4.75     1/15/2021        1,000,000        995,084        1,002,500   

Federal-Mogul Corporation

  Automotive   Tranche B Term Loan   Loan     2.14     12/29/2014        2,220,981        2,187,068        2,202,747   

Federal-Mogul Corporation

  Automotive   Tranche C Term Loan   Loan     2.14     12/28/2015        1,307,032        1,270,847        1,296,301   

First Data Corporation

  Financial Intermediaries   2017 Second New Dollar Term Loan   Loan     4.20     3/24/2017        2,111,028        2,010,799        2,109,276   

First Data Corporation

  Financial Intermediaries   2018 Dollar Term Loan   Loan     4.20     3/23/2018        2,290,451        2,231,370        2,292,741   

FMG Resources (August 2006) Pty LTD (FMG America Finance, Inc.)

  Nonferrous Metals/Minerals   Loan   Loan     4.25     6/28/2019        997,500        995,122        1,006,438   

Four Seasons Holdings Inc.

  Lodging & Casinos   Term Loan (First Lien)   Loan     3.50     6/27/2020        498,750        498,750        498,750   

Garda World Security Corporation

  Business Equipment and Services   Term B Delayed Draw Loan   Loan     4.00     11/6/2020        203,194        202,218        203,363   

Garda World Security Corporation

  Business Equipment and Services   Term B Loan   Loan     4.00     11/6/2020        794,306        790,489        794,965   

Gardner Denver, Inc.

  Oil & Gas   Initial Dollar Term Loan   Loan     4.25     7/30/2020        1,496,250        1,485,394        1,489,337   

Generac Power Systems, Inc.

  Industrial Equipment   Term Loan B   Loan     3.50     5/31/2020        868,414        852,908        868,258   

General Nutrition Centers, Inc.

  Retailers (Except Food and Drugs)   Amended Tranche B Term Loan   Loan     3.25     3/4/2019        4,740,112        4,722,664        4,725,892   

Global Tel*Link Corporation

  Business Equipment and Services   Term Loan (First Lien)   Loan     5.00     5/23/2020        1,920,175        1,915,905        1,900,014   

Goodyear Tire & Rubber Company, The

  Chemicals/Plastics   Loan (Second Lien)   Loan     4.75     4/30/2019        4,000,000        3,941,039        4,037,000   

Grosvenor Capital Management Holdings, LP

  Brokers/Dealers/Investment Houses   Initial Term Loan   Loan     3.75     1/4/2021        3,500,000        3,482,803        3,489,080   

Harland Clarke Holdings Corp. (fka Clarke American Corp.)

  Publishing   Tranche B-4 Term Loan   Loan     6.00     8/4/2019        500,000        497,500        500,780   

HCA Inc.

  Healthcare   Tranche B-4 Term Loan   Loan     2.94     5/1/2018        5,720,353        5,390,148        5,713,947   

Hertz Corporation, The

  Automotive   Tranche B-1 Term Loan   Loan     3.75     3/11/2018        2,970,000        3,005,791        2,973,683   

Hologic, Inc.

  Healthcare   Refinancing Tranche A Term Loan   Loan     2.19     8/1/2017        2,312,500        2,307,973        2,313,425   

Hunter Defense Technologies, Inc.

  Aerospace and Defense   Term Loan   Loan     3.45     8/22/2014        3,470,285        3,460,723        3,262,068   

Huntsman International LLC

  Chemicals/Plastics   Extended Term B Loan   Loan     2.73     4/19/2017        3,920,000        3,892,467        3,919,020   

Ikaria, Inc.

  Healthcare   Initial Term Loan (First Lien)   Loan     5.00     2/12/2021        500,000        497,515        502,815   

Infor (US), Inc. (fka Lawson Software Inc.)

  Business Equipment and Services   Tranche B-5 Term Loan   Loan     3.75     6/3/2020        1,776,183        1,758,861        1,772,488   

Inventiv Health, Inc. (fka Ventive Health, Inc)

  Conglomerate   Consolidated Term Loan   Loan     7.50     8/4/2016        492,090        492,090        491,105   

 

S-7


Table of Contents

Issuer Name

 

Industry

 

Asset Name

  Asset
Type
  Current
Rate
    Maturity
Date
    Principal     Cost     Fair Value  

J. Crew Group, Inc.

  Retailers (Except Food and Drugs)   Term B-1 Loan Retired 03/05/2014   Loan     4.00     3/7/2018        972,500        972,500        972,656   

JFB Firth Rixson Inc.

  Industrial Equipment   2013 Replacement Dollar Term Facility Loan   Loan     4.25     6/30/2017        2,564,311        2,554,534        2,568,054   

Kinetic Concepts, Inc.

  Healthcare   Dollar Term D-1 Loan   Loan     4.00     5/4/2018        490,057        475,404        492,508   

La Quinta Intermediate Holdings L.L.C.

  Gaming And Hotels   Initial Term Loan   Loan     4.00     2/19/2021        500,000        500,000        500,000   

Michaels Stores, Inc.

  Retailers (Except Food and Drugs)   Term B Loan   Loan     3.75     1/28/2020        496,250        496,250        497,302   

Microsemi Corporation

  Electronics/Electric   Incremental Term Loan   Loan     3.75     2/19/2020        498,750        498,750        499,373   

Microsemi Corporation

  Electronics/Electric   Term Loan   Loan     3.50     2/19/2020        2,393,981        2,389,463        2,398,482   

Mitel US Holdings, Inc.

  Telecommunications   Term Loan   Loan     5.25     1/31/2020        250,000        248,753        252,083   

National CineMedia, LLC

  Leisure Goods/Activities/Movies   Term Loan (2013)   Loan     2.95     11/26/2019        1,086,207        1,054,177        1,082,134   

Newsday, LLC

  Publishing   Term Loan   Loan     3.69     10/12/2016        2,215,385        2,213,416        2,215,385   

Novelis, Inc.

  Conglomerate   Initial Term Loan   Loan     3.75     3/10/2017        4,857,520        4,868,347        4,873,452   

NPC International, Inc.

  Food Services   Term Loan (2013)   Loan     4.00     12/28/2018        490,833        490,833        493,597   

NRG Energy, Inc.

  Utilities   Term Loan (2013)   Loan     2.75     7/1/2018        3,900,525        3,875,534        3,872,168   

NuSil Technology LLC.

  Chemicals/Plastics   Term Loan   Loan     5.25     4/7/2017        809,163        809,163        799,558   

OEP Pearl Dutch Acquisition B.V.

  Chemicals/Plastics   Initial BV Term Loan   Loan     6.50     3/30/2018        142,422        140,466        143,846   

On Assignment, Inc.

  Business Equipment and Services   Initial Term B Loan   Loan     3.50     5/15/2020        1,311,364        1,303,125        1,312,190   

Onex Carestream Finance LP

  Healthcare   Term Loan (First Lien 2013)   Loan     5.00     2/25/2017        4,531,159        4,511,264        4,582,135   

OpenLink International, Inc.

  Computers & Electronics   Replacement Term Loan   Loan     6.25     10/30/2017        980,000        980,000        980,000   

P.F. Chang’s China Bistro, Inc. (Wok Acquisition Corp.)

  Food/Drug Retailers   Term Borrowing   Loan     5.50     6/22/2019        1,496,212        1,488,641        1,509,675   

P2 Upstream Acquisition Co. (P2 Upstream Canada BC ULC)

  Business Equipment and Services   Term Loan (First Lien)   Loan     5.00     10/30/2020        1,000,000        995,186        1,008,750   

Patheon Inc.

  Healthcare   Term Loan   Loan     4.25     3/11/2021        3,000,000        2,992,500        2,990,640   

PetCo Animal Supplies, Inc.

  Retailers (Except Food and Drugs)   New Loans   Loan     4.00     11/24/2017        1,484,694        1,483,250        1,489,103   

Pharmaceutical Product Development, Inc. (Jaguar Holdings, LLC)

  Conglomerate   2013 Term Loan   Loan     4.00     12/5/2018        1,960,200        1,936,226        1,967,845   

Pinnacle Foods Finance LLC

  Food Products   New Term Loan G   Loan     3.25     4/29/2020        4,962,500        4,951,514        4,942,352   

Polymer Group, Inc.

  Chemicals/Plastics   Initial Loan   Loan     5.25     12/19/2019        500,000        497,500        501,875   

Prestige Brands, Inc.

  Drugs   Term B-1 Loan   Loan     3.75     1/31/2019        435,606        430,195        437,022   

Pro Mach, Inc.

  Industrial Equipment   Term Loan   Loan     4.50     7/6/2017        1,945,655        1,934,699        1,955,383   

Progressive Waste Solutions Ltd.

  Ecological Services and Equipment   Term B Loan   Loan     3.00     10/24/2019        498,741        498,741        500,486   

Quintiles Transnational Corp.

  Conglomerate   Term B-3 Loan   Loan     3.75     6/8/2018        3,681,541        3,646,328        3,685,186   

Redtop Acquisitions Limited

  Electronics/Electric   Initial Dollar Term Loan (First Lien)   Loan     4.50     12/3/2020        500,000        496,369        502,915   

Rexnord LLC/RBS Global, Inc.

  Industrial Equipment   Term B Loan   Loan     4.00     8/21/2020        1,663,476        1,663,476        1,667,035   

Reynolds Group Holdings Inc.

  Industrial Equipment   Incremental U.S. Term Loan   Loan     4.00     12/1/2018        1,980,000        1,980,000        1,993,365   

Rocket Software, Inc.

  Business Equipment and Services   Term Loan (First Lien)   Loan     5.75     2/8/2018        1,960,025        1,934,083        1,960,515   

Rovi Solutions Corporation / Rovi Guides, Inc.

  Electronics/Electric   Tranche A-2 Loan   Loan     2.45     3/29/2017        1,562,552        1,552,098        1,562,552   

 

S-8


Table of Contents

Issuer Name

 

Industry

 

Asset Name

  Asset
Type
  Current
Rate
    Maturity
Date
    Principal     Cost     Fair Value  

Rovi Solutions Corporation / Rovi Guides, Inc.

  Electronics/Electric   Tranche B-3 Term Loan   Loan     3.50     3/29/2019        1,344,450        1,339,560        1,341,088   

RPI Finance Trust

  Drugs   Term B-2 Term Loan   Loan     3.25     5/9/2018        5,308,218        5,283,397        5,339,165   

Scitor Corporation

  Business Equipment and Services   Term Loan   Loan     5.00     2/15/2017        463,977        462,831        460,354   

Sensata Technologies B.V./Sensata Technology Finance Company, LLC

  Industrial Equipment   Term Loan   Loan     3.25     5/12/2019        1,524,730        1,524,730        1,529,106   

Sensus USA Inc. (fka Sensus Metering Systems)

  Utilities   Term Loan (First Lien)   Loan     5.75     5/9/2017        1,945,013        1,939,821        1,957,987   

ServiceMaster Company, The

  Conglomerate   Tranche B Term Loan   Loan     4.45     1/31/2017        2,822,729        2,830,165        2,825,552   

SI Organization, Inc., The

  Aerospace and Defense   New Tranche B Term Loan   Loan     5.50     11/22/2016        3,880,675        3,863,008        3,800,655   

Sonneborn, LLC

  Chemicals/Plastics   Initial US Term Loan   Loan     6.50     3/30/2018        807,059        795,976        815,130   

Sophia, L.P.

  Electronics/Electric   Term B Loan   Loan     4.50     7/19/2018        928,389        917,174        934,191   

Southwire Company, LLC (f.k.a Southwire Company)

  Building and Development   Initial Term Loan   Loan     3.25     2/10/2021        500,000        498,758        499,730   

SRA International Inc.

  Aerospace and Defense   Term Loan   Loan     6.50     7/20/2018        3,268,571        3,184,532        3,276,743   

SRAM, LLC

  Industrial Equipment   Term Loan (First Lien)   Loan     4.01     4/10/2020        3,304,614        3,278,551        3,304,614   

SS&C Technologies Holdings Europe S.A.R.L.

 

Business Equipment and Services

  2013 Replacement Term B-2 Loan   Loan     3.25     6/7/2019        64,638        64,070        64,839   

SS&C Technologies, Inc., /Sunshine Acquisition II, Inc.

  Business Equipment and Services   2013 Replacement Term B-1 Loan   Loan     3.25     6/7/2019        624,838        619,344        626,782   

SunCoke Energy, Inc.

  Nonferrous Metals/Minerals   Tranche B Term Loan   Loan     4.00     7/26/2018        1,367,311        1,359,200        1,367,311   

SunGard Data Systems Inc (Solar Capital Corp.)

  Conglomerate   Tranche C Term Loan   Loan     3.95     2/28/2017        304,311        302,167        305,452   

SunGard Data Systems Inc (Solar Capital Corp.)

  Conglomerate   Tranche E Term Loan   Loan     4.00     3/8/2020        4,221,845        4,096,936        4,238,944   

SuperMedia Inc. (fka Idearc Inc.)

  Publishing   Loan   Loan     11.60     12/30/2016        264,330        257,131        196,762   

Syniverse Holdings, Inc.

  Telecommunications   Initial Term Loan   Loan     4.00     4/23/2019        479,913        476,371        480,911   

Taminco Global Chemical Corporation

 

Chemicals/Plastics

  Initial Tranche B-3 Dollar Term Loan   Loan     3.25     2/15/2019        1,473,863        1,464,165        1,473,406   

Team Health, Inc.

  Healthcare   Tranche B Term Loan   Loan     3.75     6/29/2018        4,387,500        4,373,856        4,387,500   

TECTUM HOLDINGS INC

  Industrial Equipment   Term Loan   Loan     6.50     12/3/2015        3,800,160        3,788,706        3,762,159   

Tomkins, LLC / Tomkins, Inc. (f/k/a Pinafore, LLC / Pinafore, Inc.)

  Conglomerate   Term B-2 Loan   Loan     3.75     9/29/2016        2,356,680        2,360,795        2,361,982   

TransDigm Inc.

  Aerospace and Defense   Tranche C Term Loan   Loan     3.75     2/28/2020        4,896,514        4,904,843        4,914,876   

Tricorbraun Inc. (fka Kranson Industries, Inc.)

  Containers/Glass Products   Term Loan   Loan     4.00     5/3/2018        1,902,083        1,895,432        1,903,282   

Truven Health Analytics Inc. (fka Thomson Reuters (Healthcare) Inc.)

  Healthcare   New Tranche B Term Loan   Loan     4.50     6/6/2019        492,528        484,755        493,513   

 

S-9


Table of Contents

Issuer Name

 

Industry

 

Asset Name

  Asset
Type
  Current
Rate
    Maturity
Date
    Principal     Cost     Fair Value  

U.S. Security Associates Holdings, Inc.

  Business Equipment and Services   Delayed Draw Loan   Loan     6.00     7/28/2017        160,148        159,235        160,348   

U.S. Security Associates Holdings, Inc.

  Business Equipment and Services   Term B Loan   Loan     6.00     7/28/2017        122,494        122,109        122,648   

U.S. Security Associates Holdings, Inc.

  Business Equipment and Services   Term B Loan   Loan     6.00     7/28/2017        818,172        813,513        819,195   

U.S. Silica Company

  Nonferrous Metals/Minerals   Term Loan   Loan     4.00     7/23/2020        1,950,200        1,941,292        1,954,256   

U.S. Xpress Enterprises, Inc.

  Industrial Equipment   Extended Term Loan   Loan     9.38     11/13/2016        2,805,278        2,766,405        2,777,225   

United Surgical Partners International, Inc.

  Healthcare   New Tranche B Term Loan   Loan     4.75     4/3/2019        2,456,500        2,429,626        2,470,821   

Univar Inc.

  Chemicals/Plastics   Term B Loan   Loan     5.00     6/30/2017        3,884,944        3,884,238        3,859,225   

Univision Communications Inc.

 

Telecommunications

  Replacement First-Lien Term Loan   Loan     4.00     3/1/2020        2,977,500        2,959,200        2,984,467   

UPC Financing Partnership

  Broadcast Radio and Television   Facility AF   Loan     4.00     1/31/2021        1,000,000        974,618        1,002,500   

Valeant Pharmaceuticals International, Inc.

  Drugs   Series D2 Term Loan B   Loan     3.75     2/13/2019        2,947,688        2,936,432        2,955,528   

Verint Systems Inc.

  Business Equipment and Services   Term Loan   Loan     4.00     9/6/2019        1,900,800        1,892,737        1,904,602   

Verint Systems Inc.

  Business Equipment and Services   Tranche B Incremental Term Loan   Loan     3.50     9/6/2019        1,000,000        997,521        1,000,000   

Vertafore, Inc.

  Business Equipment and Services   Term Loan (2013)   Loan     4.25     10/3/2019        2,899,621        2,899,621        2,909,770   

Visant Corporation (fka Jostens)

  Leisure Goods/Activities/Movies   Tranche B Term Loan (2011)   Loan     5.25     12/22/2016        3,658,446        3,658,446        3,607,008   

W.R. Grace & Co.-CONN

  Chemicals/Plastics   Delayed Draw Term Loan   Loan     0.00     2/3/2021        —          (328     —     

W.R. Grace & Co.-CONN

  Chemicals/Plastics   U.S. Term Loan   Loan     3.00     2/3/2021        368,421        367,502        367,828   

Washington Inventory Service

  Business Equipment and Services   U.S. Term Loan (First Lien)   Loan     6.75     12/20/2018        1,980,000        2,004,187        1,965,150   

Wendy’s International, Inc

  Food Services   Term B Loan   Loan     3.25     5/15/2019        680,470        674,563        679,197   

Wesco Aircraft Hardware Corp.

  Aerospace/Defense   Tranche B Term Loan   Loan     4.75     2/28/2021        500,000        498,750        498,750   

West Corporation

  Telecommunications   Term B-10 Loan   Loan     3.25     6/30/2018        2,926,111        2,976,179        2,909,666   
             

 

 

   

 

 

 
              $ 299,137,566      $ 300,491,077   
             

 

 

   

 

 

 

 

S-10


Table of Contents

Issuer Name

 

Industry

  

Asset Name

  Asset
Type
  Current
Rate
    Maturity
Date
    Principal /
Number
of Shares
    Cost     Fair Value  

Elyria Foundry Company, LLC

  Industrial Equipment    Warrants   Equity     0.00       —        $ —        $ —     

Network Communications, Inc.

  Business Equipment and Services    Common   Equity     0.00       169,143        169,143        659,658   

OLD AII, Inc (fka Aleris International Inc.)

  Conglomerate    Common   Equity     0.00       2,624        224,656        128,576   

PATS Aircraft, LLC

  Aerospace and Defense    Common   Equity     0.00       51,813        282,326        282,329   

SuperMedia Inc. (fka Idearc Inc.)

  Publishing    Common Stock   Equity     0.00       10,821        28,784        5,411   

Academy, LTD.

  Retailers (Except Food and Drugs)    Initial Term Loan (2012)   Loan     4.75     8/3/2018      $ 1,980,037        1,966,002        2,000,927   

ACCO Brands Corporation

  Conglomerate    Term B Loan   Loan     4.25     5/1/2019      $ 351,944        348,847        354,584   

Acosta, Inc.

  Food Products    Term D Loan   Loan     5.00     3/2/2018      $ 4,183,659        4,120,774        4,216,082   

Aderant North America, Inc.

  Business Equipment and Services    Term Loan (First Lien)   Loan     6.25     12/20/2018      $ 3,500,000        3,495,662        3,552,500   

Aeroflex Incorporated

  Aerospace and Defense    Tranche B Term Loan   Loan     5.75     5/9/2018      $ 3,345,517        3,333,081        3,369,204   

Alcatel-Lucent USA Inc.

  Telecommunications/Cellular    US Term Loan   Loan     0.00     1/30/2019      $ 1,075,000        1,069,625        1,087,008   

Alere Inc. (fka IM US Holdings, LLC)

  Healthcare    Incremental B-1 Term Loan   Loan     4.75     6/30/2017      $ 1,980,000        1,941,348        1,999,444   

Aptalis Pharma, Inc. (fka Axcan Intermediate Holdings Inc.)

  Drugs    Term B-1 Loan   Loan     5.50     2/10/2017      $ 1,960,000        1,953,535        1,963,920   

Aramark Corporation

  Food Products    LC-2 Facility   Loan     3.45     7/26/2016      $ 79,187        79,187        79,600   

Aramark Corporation

  Food Products    LC-3 Facility   Loan     3.45     7/26/2016      $ 43,961        43,961        44,190   

Aramark Corporation

  Food Products    U.S. Term B Loan (Extending)   Loan     3.45     7/26/2016      $ 1,204,093        1,204,093        1,210,366   

Aramark Corporation

  Food Products    U.S. Term C Loan   Loan     3.52     7/26/2016      $ 2,545,700        2,545,700        2,558,963   

Armstrong World Industries, Inc

  Building and Development    Term Loan B-1   Loan     4.00     3/10/2018      $ 2,122,931        2,109,740        2,124,268   

Asurion, LLC (fka Asurion Corporation)

  Insurance    Amortizing Term Loan   Loan     4.75     7/23/2017      $ 968,750        960,226        973,594   

Asurion, LLC (fka Asurion Corporation)

  Insurance    Incremental Tranche B-1 Term Loan   Loan     4.50     5/24/2019      $ 5,659,091        5,602,698        5,674,144   

Auction.Com, LLC

  Business Equipment and Services    Term Loan A-4   Loan     4.96     8/30/2016      $ 1,018,699        1,017,479        1,013,606   

Aurora Diagnostics, LLC

  Conglomerate    Tranche B Term Loan   Loan     6.25     5/26/2016      $ 3,188,889        3,198,281        3,077,278   

Autotrader.com, Inc.

  Automotive    Tranche B-1 Term Loan   Loan     4.00     12/15/2016      $ 3,830,768        3,830,768        3,853,522   

Avantor Performance Materials Holdings, Inc.

  Chemicals/Plastics    Term Loan   Loan     5.25     6/24/2017      $ 4,925,000        4,907,124        4,925,000   

AZ Chem US Inc.

  Chemicals/Plastics    Term Loan   Loan     5.25     12/22/2017      $ 1,570,579        1,532,447        1,585,170   

Biomet, Inc.

  Healthcare    Dollar Term B-1 Loan   Loan     4.00     7/25/2017      $ 1,990,013        1,990,013        2,003,445   

Bombardier Recreational Products Inc.

  Leisure Goods/Activities/Movies    Term B Loan   Loan     5.00     1/30/2019      $ 1,000,000        990,101        1,007,500   

Brock Holdings III, Inc.

  Industrial Equipment    Term Loan (First Lien)   Loan     0.00     3/16/2017      $ 2,000,000        2,022,500        2,013,340   

Burlington Coat Factory Warehouse Corporation

  Retailers (Except Food and Drugs)    Term B-1 Loan   Loan     5.50     2/23/2017      $ 2,776,843        2,767,803        2,802,306   

 

S-11


Table of Contents

Issuer Name

 

Industry

  

Asset Name

  Asset
Type
  Current
Rate
    Maturity
Date
    Principal /
Number
of Shares
    Cost     Fair Value  

C.H.I. Overhead Doors, Inc. (CHI)

  Home Furnishings    Term Loan (First Lien)   Loan     7.25     8/17/2017      $ 2,976,290        2,931,556        2,983,730   

Camp International Holding Company

  Aerospace and Defense    Refinanced Term Loan (First Lien)   Loan     5.25     5/31/2019      $ 997,500        988,136        1,005,400   

Capital Automotive L.P.

  Conglomerate    Tranche B Term Loan   Loan     5.25     3/11/2017      $ 2,811,086        2,817,777        2,823,961   

Capstone Logistics, LLC

  Business Equipment and Services    Term Note A   Loan     7.50     9/16/2016      $ 2,699,305        2,669,394        2,658,816   

Capsugel Holdings US, Inc.

  Drugs    Initial Term Loan (New)   Loan     4.75     8/1/2018      $ 3,605,198        3,595,976        3,641,214   

Celanese US Holdings LLC

  Chemicals/Plastics    Dollar Term C Loan (Extended)   Loan     3.06     10/31/2016      $ 2,198,534        2,219,212        2,208,911   

Cenveo Corporation

  Publishing    Term B Facility   Loan     7.00     12/21/2016      $ 2,437,399        2,421,925        2,444,516   

Charter Communications Operating, LLC

  Cable and Satellite Television    Term C Loan   Loan     3.46     9/6/2016      $ 2,047,547        2,044,048        2,057,785   

Charter Communications Operating, LLC

  Cable and Satellite Television    Term D Loan   Loan     4.00     5/15/2019      $ 1,985,000        1,976,313        2,000,503   

CHS/ Community Health Systems, Inc.

  Healthcare    Extended Term Loan   Loan     3.79     1/25/2017      $ 4,064,516        3,963,653        4,090,935   

Cinedigm Digital Funding I, LLC

  Business Equipment and Services    Term Loan   Loan     5.75     2/28/2018      $ 1,066,260        1,059,429        1,068,925   

Contec, LLC

  Electronics/Electric    Second Lien Term Notes   Loan     10.00     11/2/2016      $ 401,202        2,400,891        2,578,210   

Covanta Energy Corporation

  Ecological Services and Equipment    Term Loan   Loan     4.00     3/28/2019      $ 496,250        494,095        501,833   

CPI International Acquisition, Inc. (f/k/a Catalyst Holdings, Inc.)

  Electronics/Electric    Term B Loan   Loan     5.00     2/13/2017      $ 4,805,833        4,789,964        4,829,862   

Crown Castle Operating Company

  Telecommunications
/Cellular
   Tranche B Term Loan   Loan     4.00     1/31/2019      $ 1,980,000        1,963,120        1,989,484   

Culligan International Company

  Conglomerate    Dollar Loan (First Lien)   Loan     6.25     12/19/2017      $ 795,675        732,459        729,372   

Culligan International Company

  Conglomerate    Dollar Loan (Second Lien)   Loan     9.50     6/19/2018      $ 783,162        720,189        604,343   

DaVita HealthCare Partners Inc. (fka DaVita Inc.)

  Healthcare    Tranche B Term Loan   Loan     4.50     10/20/2016      $ 3,949,622        3,949,622        3,977,822   

DCS Business Services, Inc.

  Financial Intermediaries    Term B Loan   Loan     7.25     3/19/2018      $ 3,970,010        3,919,904        3,910,460   

Del Monte Foods Company

  Food Products    Initial Term Loan   Loan     4.00     3/8/2018      $ 4,438,139        4,473,061        4,443,687   

Delphi Corporation

  Electronics/Electric    Tranche A Term Loan Retired 03/01/2013   Loan     4.25     3/31/2016      $ 1,683,357        1,685,403        1,682,650   

Digitalglobe, Inc.

  Ecological Services and Equipment    Term Loan   Loan     0.00     1/31/2020      $ 250,000        250,000        250,783   

DS Waters of America, Inc.

  Beverage and Tobacco    Term Loan (First Lien)   Loan     10.50     8/29/2017      $ 2,977,500        2,928,511        3,037,050   

Dunkin’ Brands, Inc.

  Food Services    Term B-3 Loan   Loan     0.00     2/14/2020      $ 4,000,000        3,990,000        3,990,000   

DynCorp International Inc.

  Aerospace and Defense    Term Loan   Loan     6.25     7/7/2016      $ 574,161        567,732        577,606   

Education Management LLC

  Leisure Goods/Activities/Movies    Tranche C-2 Term Loan   Loan     4.31     6/1/2016      $ 3,925,006        3,727,372        3,263,878   

eInstruction Corporation

  Electronics/Electric    Initial Term Loan   Loan     0.00     7/2/2013      $ 2,997,722        2,931,236        899,317   

Electrical Components International, Inc.

  Electronics/Electric    Synthetic Revolving Loan   Loan     6.75     2/4/2016      $ 117,647        116,611        117,647   

Electrical Components International, Inc.

  Electronics/Electric    Term Loan   Loan     6.75     2/4/2017      $ 1,786,475        1,768,892        1,786,475   

 

S-12


Table of Contents

Issuer Name

 

Industry

  

Asset Name

  Asset
Type
  Current
Rate
    Maturity
Date
    Principal /
Number
of Shares
    Cost     Fair Value  

Evergreen Acqco 1 LP

  Retailers (Except Food and Drugs)    New Term Loan   Loan     5.00     7/9/2019      $ 497,503        492,828        501,702   

Federal-Mogul Corporation

  Automotive    Tranche B Term Loan   Loan     2.14     12/29/2014      $ 2,589,036        2,498,894        2,467,351   

Federal-Mogul Corporation

  Automotive    Tranche C Term Loan   Loan     2.14     12/28/2015      $ 1,320,937        1,264,234        1,258,853   

First Data Corporation

  Financial Intermediaries    2017 Dollar Term Loan   Loan     5.20     3/24/2017      $ 2,111,028        2,027,434        2,111,914   

First Data Corporation

  Financial Intermediaries    2018 Dollar Term Loan   Loan     4.20     3/23/2018      $ 2,290,451        2,216,829        2,261,591   

Freescale Semiconductor, Inc.

  Electronics/Electric    Tranche B-1 Term Loan Retired 03/01/2013   Loan     4.45     12/1/2016      $ 2,534,348        2,450,139        2,535,945   

FTD Group, Inc.

  Retailers (Except Food and Drugs)    Initial Term Loan   Loan     4.75     6/11/2018      $ 3,715,723        3,683,533        3,715,723   

Generac Power Systems, Inc.

  Industrial Equipment    Term Loan   Loan     6.25     5/30/2018      $ 906,111        890,154        923,590   

General Nutrition Centers, Inc.

  Retailers (Except Food and Drugs)    Amended Tranche B Term Loan   Loan     3.75     3/2/2018      $ 4,746,591        4,757,841        4,774,548   

Global Tel*Link Corporation

  Business Equipment and Services    Replacement Term Loan   Loan     6.00     12/14/2017      $ 1,964,912        1,960,077        1,967,368   

Goodyear Tire & Rubber Company, The

  Chemicals/Plastics    Loan (Second Lien)   Loan     4.75     4/30/2019      $ 4,000,000        3,929,629        4,015,000   

Grifols Inc.

  Drugs    New U.S. Tranche B Term Loan   Loan     4.25     6/1/2017      $ 3,465,982        3,457,357        3,481,371   

Grosvenor Capital Management Holdings, LLLP

  Brokers/Dealers/Investment Houses    Tranche C Term Loan   Loan     4.25     12/5/2016      $ 3,336,378        3,252,391        3,311,355   

Hanger Orthopedic Group, Inc.

  Healthcare    Term C Loan   Loan     4.00     12/1/2016      $ 3,910,667        3,920,277        3,925,332   

HCA Inc.

  Healthcare    Tranche B-3 Term Loan   Loan     3.45     5/1/2018      $ 5,734,690        5,440,293        5,764,912   

Health Management Associates, Inc.

  Healthcare    Term B Loan   Loan     4.50     11/16/2018      $ 2,970,000        2,945,366        2,993,344   

Hertz Corporation, The

  Automotive    Tranche B-1 Term Loan   Loan     0.00     3/11/2018      $ 3,000,000        3,045,000        3,045,000   

HIBU PLC (fka Yell Group PLC)

  Business Equipment and Services    Facility B1-YB (USA) LLC (11/2009)   Loan     3.95     7/31/2014      $ 3,030,606        2,983,167        530,356   

HMH Holdings (Delaware) Inc.

  Conglomerate    Term Loan (Exit Facility)   Loan     7.25     5/22/2018      $ 992,500        974,925        997,463   

Hologic, Inc.

  Healthcare    Tranche A Term Loan   Loan     3.20     8/1/2017      $ 2,437,500        2,432,069        2,439,328   

Hunter Defense Technologies, Inc.

  Aerospace and Defense    Term Loan   Loan     3.54     8/22/2014      $ 3,679,939        3,647,610        3,385,544   

Huntsman International LLC

  Chemicals/Plastics    Extended Term B Loan   Loan     2.75     4/19/2017      $ 3,920,000        3,883,690        3,920,000   

Infor (US), Inc. (fka Lawson Software Inc.)

  Business Equipment and Services    Tranche B-2 Term Loan   Loan     5.25     4/5/2018      $ 1,990,013        1,971,642        2,011,166   

Inventiv Health, Inc. (fka Ventive Health, Inc)

  Conglomerate    Consolidated Term Loan   Loan     7.50     8/4/2016      $ 492,090        492,090        484,093   

J. Crew Group, Inc.

  Retailers (Except Food and Drugs)    Term B-1 Loan   Loan     4.00     3/7/2018      $ 982,500        982,500        982,726   

JFB Firth Rixson Inc.

  Industrial Equipment    2013 Replacement Dollar Term Facility Loan   Loan     4.25     6/30/2017      $ 2,590,213        2,577,375        2,598,838   

Kalispel Tribal Economic Authority

  Lodging and Casinos    Term Loan   Loan     7.50     2/24/2017      $ 3,625,323        3,577,074        3,634,387   

 

S-13


Table of Contents

Issuer Name

 

Industry

  

Asset Name

  Asset
Type
  Current
Rate
    Maturity
Date
    Principal /
Number
of Shares
    Cost     Fair Value  

Kinetic Concepts, Inc.

  Healthcare    Dollar Term C-1 Loan   Loan     5.50     5/4/2018      $ 495,000        478,661        501,034   

Kronos Worldwide, Inc.

  Chemicals/Plastics    Initial Term Loan   Loan     7.00     6/13/2018      $ 500,000        500,000        504,065   

MetroPCS Wireless, Inc.

  Telecommunications    Tranche B-2 Term Loan   Loan     4.07     11/3/2016      $ 2,489,192        2,491,685        2,495,938   

Michaels Stores, Inc.

  Retailers (Except Food and Drugs)    Term B Loan   Loan     3.75     1/28/2020      $ 500,000        500,000        501,110   

Microsemi Corporation

  Electronics/Electric    Term Loan   Loan     3.75     2/20/2020      $ 2,688,796        2,682,872        2,697,212   

National CineMedia, LLC

  Leisure Goods/Activities/Movies    Term Loan   Loan     3.46     11/26/2019      $ 1,086,207        1,050,910        1,089,607   

Newsday, LLC

  Publishing    Term Loan   Loan     3.70     10/12/2016      $ 3,000,000        2,996,317        2,992,500   

Novelis, Inc.

  Conglomerate    Term B-2 Loan   Loan     4.00     3/10/2017      $ 987,500        968,539        988,734   

Novelis, Inc.

  Conglomerate    Term Loan   Loan     4.00     3/10/2017      $ 3,920,009        3,946,297        3,924,909   

NPC International, Inc.

  Food Services    Term Loan   Loan     4.50     12/28/2018      $ 490,833        490,833        495,128   

NRG Energy, Inc.

  Utilities    Term Loan   Loan     3.25     7/1/2018      $ 3,940,000        3,910,795        3,958,557   

NuSil Technology LLC.

  Chemicals/Plastics    Term Loan   Loan     5.00     4/7/2017      $ 820,339        820,339        824,695   

OEP Pearl Dutch Acquisition B.V.

  Chemicals/Plastics    Initial BV Term Loan   Loan     6.50     3/30/2018      $ 148,875        146,330        149,992   

On Assignment, Inc.

  Business Equipment and Services    Initial Term B Loan   Loan     5.00     5/15/2019      $ 2,413,048        2,399,166        2,434,114   

Onex Carestream Finance LP

  Healthcare    Term Loan   Loan     5.00     2/25/2017      $ 4,909,816        4,893,453        4,916,739   

OpenLink International, Inc.

  Business Equipment and Services    Initial Term Loan   Loan     7.75     10/30/2017      $ 990,000        974,594        988,763   

P.F. Chang’s China Bistro, Inc. (Wok Acquisition Corp.)

  Food/Drug Retailers    Term Borrowing   Loan     5.25     6/22/2019      $ 997,500        988,412        1,007,475   

PATS Aircraft, LLC

  Aerospace and Defense    Term Loan   Loan     8.50     10/6/2016      $ 357,331        239,023        276,932   

Penn National Gaming, Inc.

  Lodging and Casinos    Term A Facility   Loan     1.72     7/14/2016      $ 2,775,888        2,719,125        2,776,748   

Penn National Gaming, Inc.

  Lodging and Casinos    Term B Facility   Loan     3.75     7/16/2018      $ 985,013        983,123        988,431   

PetCo Animal Supplies, Inc.

  Retailers (Except Food and Drugs)    New Loans   Loan     4.00     11/24/2017      $ 1,496,173        1,494,329        1,501,784   

Pharmaceutical Product Development, Inc. (Jaguar Holdings, LLC)

  Conglomerate    2013 Term Loan   Loan     4.25     12/5/2018      $ 1,980,000        1,950,704        1,989,583   

Physician Oncology Services, LP

  Healthcare    Delayed Draw Term Loan   Loan     7.75     1/31/2017      $ 51,020        50,682        50,765   

Physician Oncology Services, LP

  Healthcare    Effective Date Term Loan   Loan     7.75     1/31/2017      $ 419,961        417,178        417,861   

Pinnacle Foods Finance LLC

  Food Products    Extended Initial Term Loan   Loan     3.70     10/2/2016      $ 5,726,579        5,491,534        5,761,168   

Preferred Proppants, LLC

  Nonferrous Metals/Minerals    Term B Loan   Loan     7.50     12/15/2016      $ 1,980,000        1,949,170        1,841,400   

Prestige Brands, Inc.

  Drugs    Term B-1 Loan   Loan     3.76     1/31/2019      $ 679,545        669,390        683,507   

Pro Mach, Inc.

  Industrial Equipment    Term Loan   Loan     5.00     7/6/2017      $ 1,956,155        1,941,853        1,961,045   

Quintiles Transnational Corp.

  Conglomerate    Term B-2 Loan   Loan     4.50     6/8/2018      $ 3,681,541        3,653,803        3,716,810   

Ranpak Corp.

  Food/Drug Retailers    USD Term Loan (First Lien)   Loan     4.75     4/20/2017      $ 2,396,012        2,387,700        2,384,032   

Rexnord LLC/RBS Global, Inc.

  Industrial Equipment    Term B Loan Refinancing   Loan     4.50     4/1/2018      $ 1,995,000        1,995,000        2,005,454   

Reynolds Group Holdings Inc.

  Industrial Equipment    U.S. Term Loan   Loan     4.75     9/28/2018      $ 1,995,000        1,995,000        2,017,244   

Rocket Software, Inc.

  Business Equipment and Services    Term Loan (First Lien)   Loan     5.75     2/8/2018      $ 1,980,000        1,947,152        1,986,197   

Roundy’s Supermarkets, Inc.

  Food/Drug Retailers    Tranche B Term Loan   Loan     5.75     2/13/2019      $ 992,500        979,782        937,297   

 

S-14


Table of Contents

Issuer Name

 

Industry

  

Asset Name

  Asset
Type
  Current
Rate
    Maturity
Date
    Principal /
Number
of Shares
    Cost     Fair Value  

Rovi Solutions Corporation / Rovi Guides, Inc.

  Electronics/Electric    Tranche A-2 Loan   Loan     2.46     3/29/2017      $ 1,860,226        1,843,739        1,855,576   

Rovi Solutions Corporation / Rovi Guides, Inc.

  Electronics/Electric    Tranche B-2 Loan   Loan     4.00     3/29/2019      $ 1,384,706        1,378,679        1,389,899   

Royal Adhesives and Sealants, LLC

  Chemicals/Plastics    Term A Loan   Loan     7.25     11/29/2015      $ 4,498,210        4,459,450        4,432,399   

RPI Finance Trust

  Drugs    6.75 Year Term Loan (2012)   Loan     3.50     5/9/2018      $ 5,398,833        5,373,794        5,449,474   

Scientific Games International Inc.

  Electronics/Electric    Tranche B-1 Term Loan   Loan     3.21     6/30/2015      $ 1,977,810        1,965,672        1,985,226   

Scitor Corporation

  Business Equipment and Services    Term Loan   Loan     5.00     2/15/2017      $ 463,977        462,444        460,692   

Securus Technologies Holdings, Inc (fka Securus Technologies, Inc.)

  Telecommunications    Tranche 2 Term Loan (First Lien)   Loan     6.50     5/31/2017      $ 1,985,000        1,967,961        1,975,075   

Sensata Technology BV/Sensata Technology Finance Company, LLC

  Electronics/Electric    Term Loan   Loan     3.75     5/12/2018      $ 2,969,849        2,969,849        2,986,540   

Sensus USA Inc. (fka Sensus Metering Systems)

  Utilities    Term Loan (First Lien)   Loan     4.75     5/9/2017      $ 1,965,000        1,958,111        1,961,070   

ServiceMaster Company, The

  Conglomerate    Tranche B Term Loan   Loan     4.45     1/31/2017      $ 2,851,387        2,861,398        2,857,089   

SI Organization, Inc., The

  Aerospace and Defense    New Tranche B Term Loan   Loan     4.50     11/22/2016      $ 3,920,000        3,895,621        3,906,946   

Sonneborn, LLC

  Chemicals/Plastics    Initial US Term Loan   Loan     6.50     3/30/2018      $ 843,625        829,202        849,952   

Sophia, L.P.

  Electronics/Electric    Term B Loan   Loan     4.50     7/19/2018      $ 969,244        954,866        976,310   

SRA International Inc.

  Aerospace and Defense    Term Loan   Loan     6.50     7/20/2018      $ 3,268,571        3,165,384        3,154,171   

SRAM, LLC

  Industrial Equipment    Term Loan (First Lien)   Loan     4.77     6/7/2018      $ 3,441,181        3,411,986        3,458,386   

SS&C Technologies, Inc., /Sunshine Acquisition II, Inc.

  Business Equipment and Services    Funded Term B-1 Loan   Loan     5.00     6/7/2019      $ 811,071        803,796        817,138   

SS&C Technologies, Inc., /Sunshine Acquisition II, Inc.

  Business Equipment and Services    Funded Term B-2 Loan   Loan     5.00     6/7/2019      $ 83,904        83,151        84,531   

SunCoke Energy, Inc.

  Nonferrous Metals/Minerals    Tranche B Term Loan   Loan     4.00     7/26/2018      $ 1,367,311        1,357,359        1,370,729   

SunGard Data Systems Inc (Solar Capital Corp.)

  Conglomerate    Tranche B U.S. Term Loan   Loan     3.85     2/28/2016      $ 4,253,748        4,184,167        4,260,086   

SunGard Data Systems Inc (Solar Capital Corp.)

  Conglomerate    Tranche C Term Loan   Loan     3.95     2/28/2017      $ 497,687        493,012        500,544   

SuperMedia Inc. (fka Idearc Inc.)

  Publishing    Loan   Loan     11.00     12/31/2015      $ 289,811        281,918        214,875   

Syniverse Holdings, Inc.

  Telecommunications    Initial Term Loan   Loan     5.00     4/23/2019      $ 497,500        493,115        500,609   

Taminco Global Chemical Corporation

  Chemicals/Plastics    Tranche B-2 Dollar Term Loan   Loan     4.25     2/15/2019      $ 1,488,750        1,478,991        1,498,859   

Team Health, Inc.

  Healthcare    Tranche B Term Loan   Loan     3.75     6/29/2018      $ 4,432,500        4,415,534        4,432,500   

TECTUM HOLDINGS INC

  Industrial Equipment    Term Loan   Loan     7.50     12/3/2015      $ 4,000,000        3,981,089        3,980,000   

Texas Competitive Electric Holdings Company, LLC (TXU)

  Utilities    2014 Term Loan (Non-Extending)   Loan     3.73     10/10/2014      $ 5,580,862        5,527,535        4,012,249   

Tomkins, LLC / Tomkins, Inc. (f/k/a Pinafore, LLC / Pinafore, Inc.)

  Conglomerate    Term B-2 Loan   Loan     3.75     9/29/2016      $ 2,431,854        2,437,744        2,450,093   

TransDigm Inc.

  Aerospace and Defense    Tranche C Term Loan   Loan     3.75     2/28/2020      $ 4,945,974        4,955,789        4,955,587   

 

S-15


Table of Contents

Issuer Name

 

Industry

  

Asset Name

  Asset
Type
  Current
Rate
    Maturity
Date
    Principal /
Number
of Shares
    Cost     Fair Value  

Tricorbraun Inc. (fka Kranson Industries, Inc.)

  Containers/Glass Products    Term Loan   Loan     5.50     5/3/2018      $ 1,990,000        1,981,374        2,008,666   

Truven Health Analytics Inc. (fka Thomson Reuters (Healthcare) Inc.)

  Healthcare    New Tranche B Term Loan   Loan     5.75     6/6/2019      $ 497,500        488,158        501,853   

Tube City IMS Corporation

  Steel    Term Loan   Loan     5.75     3/20/2019      $ 992,500        983,864        1,001,184   

U.S. Security Associates Holdings, Inc.

  Business Equipment and Services    Delayed Draw Term Loan   Loan     6.00     7/28/2017      $ 161,778        160,586        162,688   

U.S. Security Associates Holdings, Inc.

  Business Equipment and Services    Term Loan B   Loan     6.00     7/28/2017      $ 123,747        123,243        124,444   

U.S. Security Associates Holdings, Inc.

  Business Equipment and Services    Term Loan B   Loan     6.00     7/28/2017      $ 826,540        820,452        831,193   

U.S. Silica Company

  Nonferrous Metals/Minerals    Loan   Loan     4.75     6/8/2017      $ 1,970,000        1,962,974        1,974,925   

U.S. Xpress Enterprises, Inc.

  Industrial Equipment    Extended Term Loan   Loan     9.00     11/13/2016      $ 2,913,628        2,858,339        2,906,344   

United Surgical Partners International, Inc.

  Healthcare    New Tranche B Term Loan   Loan     6.00     4/3/2019      $ 2,481,281        2,448,808        2,486,715   

Univar Inc.

  Chemicals/Plastics    Term B Loan   Loan     5.00     6/30/2017      $ 3,924,924        3,924,007        3,902,670   

Univision Communications Inc.

 

Telecommunications

   2013 Converted Extended First-Lien Term Loan   Loan     4.75     3/1/2020      $ 3,000,000        2,981,257        3,000,870   

UPC Financing Partnership

  Broadcast Radio and Television    Facility AF   Loan     4.00     1/31/2021      $ 1,000,000        970,954        1,010,000   

Valeant Pharmaceuticals International, Inc.

  Drugs    Series D-1 Tranche B Term Loan   Loan     3.50     2/13/2019      $ 2,985,000        2,972,608        3,006,462   

Vantiv, LLC (fka Fifth Third Processing Solutions, LLC)

  Financial Intermediaries    Tranche B Term Loan   Loan     3.75     3/27/2019      $ 1,063,393        1,058,765        1,065,520   

Verint Systems Inc.

  Business Equipment and Services    Term Loan 2011   Loan     4.50     10/27/2017      $ 1,920,000        1,913,087        1,921,920   

Vertafore, Inc.

  Business Equipment and Services    Term Loan (First Lien)   Loan     5.25     7/29/2016      $ 2,984,781        2,984,781        3,018,360   

Visant Corporation (fka Jostens)

  Leisure Goods/Activities/Movies    Tranche B Term Loan (2011)   Loan     5.25     12/22/2016      $ 3,696,942        3,696,942        3,518,269   

Washington Inventory Service

  Business Equipment and Services    U.S. Term Loan (First Lien)   Loan     5.75     12/20/2018      $ 2,000,000        2,029,513        2,007,500   

Weight Watchers International, Inc.

  Food Products    Term D Loan   Loan     2.56     6/30/2016      $ 2,700,529        2,667,383        2,701,879   

Wendy’s International, Inc

  Food Services    Term Loan   Loan     4.75     5/15/2019      $ 997,500        988,532        1,006,098   

West Corporation

  Telecommunications    Term B-8 Loan   Loan     4.25     6/30/2018      $ 2,971,535        3,023,298        2,978,964   

Wolverine World Wide, Inc.

  Clothing/Textiles    Tranche B Term Loan   Loan     4.00     10/9/2019      $ 854,821        846,633        861,233   

Yankee Candle Company, Inc., The

  Retailers (Except Food and Drugs)    Initial Term Loan   Loan     5.25     4/2/2019      $ 2,256,466        2,236,833        2,268,877   

BABSN 2007-1A

  Financial Intermediaries    Floating-01/2021-
D1-05617AAA9
  ABS     3.55     1/18/2021      $ 1,500,000        1,258,888        1,050,000   

GALE 2007-3A

  Financial Intermediaries    Floating-04/2021-
E-363205AA3
  ABS     3.80     4/19/2021      $ 4,000,000        3,386,571        2,800,000   

KATO 2006-9A

  Financial Intermediaries    Floating-01/2019-
B2L-486010AA9
  ABS     3.80     1/25/2019      $ 5,000,000        4,339,337        3,500,000   

STCLO 2007-6A

  Financial Intermediaries    Floating-04/2021-
D-86176YAG7
  ABS     3.90     4/17/2021      $ 5,000,000        4,054,244        3,500,000   
              

 

 

   

 

 

 
               $ 379,843,341      $ 374,419,979   
              

 

 

   

 

 

 

 

S-16


Table of Contents

Saratoga Investment Corp. CLO 2013-1, Ltd.

Statements of Changes in Net Assets

 

     For the year ended
February 28, 2014
    For the year ended
February 28, 2013
    For the year ended
February 29, 2012
 

INCREASE FROM OPERATIONS:

      

Net investment income (loss)

   $ (2,143,630   $ 1,033,327      $ 2,368,009   

Net realized gain (loss) from investments

     (8,815,296     2,532,558        (4,547,952

Net unrealized appreciation (depreciation) on investments

     6,776,871        3,235,774        (650,241
  

 

 

   

 

 

   

 

 

 

Net increase (decrease) in net assets from operations

  (4,182,055   6,801,659      (2,830,184
  

 

 

   

 

 

   

 

 

 

Total increase (decrease) in net assets

  (4,182,055   6,801,659      (2,830,184

Net assets at beginning of period

  838,817      (5,962,842   (3,132,658
  

 

 

   

 

 

   

 

 

 

Net assets at end of period

$ (3,343,238 $ 838,817    $ (5,962,842
  

 

 

   

 

 

   

 

 

 

See accompanying notes to financial statements.

 

S-17


Table of Contents

Saratoga Investment Corp. CLO 2013-1, Ltd.

Statements of Cash Flows

 

     For the year ended
February 28, 2014
    For the year ended
February 28, 2013
    For the year ended
February 29, 2012
 

Operating activities

      

NET INCREASE (DECREASE) IN NET ASSETS FROM OPERATIONS

   $ (4,182,055   $ 6,801,659      $ (2,830,184

ADJUSTMENTS TO RECONCILE NET INCREASE (DECREASE) IN NET ASSETS FROM OPERATIONS TO NET CASH PROVIDED BY (USED BY) OPERATING ACTIVITIES:

      

Paid-in-kind interest income

     (10,122     —          (223,448

Net accretion of discount on investments

     (568,674     (1,383,978     (2,997,514

Amortization of deferred debt financing costs

     994,602        1,015,332        1,016,124   

Loss on extinguishment of debt

     3,442,442        —          —     

Net realized (gain) loss from investments

     8,815,296        (2,532,558     4,547,952   

Net unrealized (appreciation) depreciation on investments

     (6,776,871     (3,235,774     650,241   

Proceeds from sale and redemption of investments

     128,190,654        165,363,963        216,319,521   

Purchase of investments

     (55,721,381     (151,267,166     (208,491,101

(Increase) decrease in operating assets:

      

Interest receivable

     134,033        (3,547     155,579   

Receivable from open trades

     3,330,272        4,915,102        (10,046,640

Other Assets

     (91,336     —          —     

Increase (decrease) in operating liabilities:

      

Interest Payable

     (43,645     (160,620     125,101   

Payable for open trades

     (6,901,250     (8,510,897     (293,957

Accrued base management fee

     31,882        (2,345     (835

Accrued subordinated management fee

     (97,629     (9,382     (3,338
  

 

 

   

 

 

   

 

 

 

NET CASH PROVIDED BY (USED BY) OPERATING ACTIVITIES

  70,546,218      10,989,789      (2,072,499
  

 

 

   

 

 

   

 

 

 

Financing activities

Borrowings on debt

  277,711,620      —        —     

Paydowns on debt

  (366,793,378   —        —     

Deferred debt financing costs

  (2,250,398   —        —     
  

 

 

   

 

 

   

 

 

 

NET CASH USED BY FINANCING ACTIVITIES

  (91,332,156   —        —     
  

 

 

   

 

 

   

 

 

 

NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS

  (20,785,938   10,989,789      (2,072,499

CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD

  28,804,871      17,815,082      19,887,581   
  

 

 

   

 

 

   

 

 

 

CASH AND CASH EQUIVALENTS, END OF PERIOD

$ 8,018,933    $ 28,804,871    $ 17,815,082   
  

 

 

   

 

 

   

 

 

 

Supplemental Information:

Interest paid during the period

$ 11,722,159    $ 15,773,621    $ 14,355,520   

Supplemental non-cash information:

Paid-in-kind interest income

$ 10,122    $ —      $ 223,448   

Net accretion of discount on investments

$ 568,674    $ 1,383,978    $ 2,997,514   

Amortization of deferred debt financing costs

$ 994,602    $ 1,015,332    $ 1,016,124   

See accompanying notes to financial statements.

 

S-18


Table of Contents

SARATOGA INVESTMENT CORP. CLO 2013-1, LTD.

NOTES TO FINANCIAL STATEMENTS

1. Organization and Purpose

Saratoga Investment Corp. CLO 2013-1, Ltd. (the “Issuer”, “we”, “our”, “us”, “CLO” and “Saratoga CLO”), an exempted company with limited liability incorporated under the laws of the Cayman Islands was formed on November 28, 2007 and commenced operations on January 22, 2008. The Issuer was established to acquire or participate in U.S. dollar-denominated corporate debt obligations.

On January 22, 2008, the Issuer issued $400.0 million of notes, consisting of Class A Floating Rate Senior Notes, Class B Floating Rate Senior Notes, Class C Deferrable Floating Rate Notes, Class D Deferrable Floating Rate Notes, Class E Deferrable Floating Rate Notes (collectively the “Secured Notes”), and Subordinated Notes. The notes were issued pursuant to an indenture, dated January 22, 2008 (the “Indenture”), with U.S. Bank National Association (the “Trustee”) servicing as the Trustee there under.

On October 17, 2013, in a refinancing transaction, the Issuer issued $284.9 million of notes (the “2013-1 CLO Notes”), consisting of Class X Floating Rate Senior Notes, Class A-1 Floating Rate Senior Notes, Class A-2 Floating Rate Senior Notes, Class B Floating Rate Senior Notes, Class C Deferrable Floating Rate Notes, Class D Deferrable Floating Rate Notes, Class E Deferrable Floating Rate Notes, and Class F Deferrable Floating Rate Notes. The 2013-1 CLO Notes were issued pursuant to the Indenture with the same Trustee. Proceeds of the issuance of the 2013-1 CLO Notes were used, along with existing assets held by the Trustee, to redeem all of the Secured Notes issued in 2008. As of February 28, 2014, Saratoga Investment Corp. owned 100% of the Subordinated Notes of the CLO.

Pursuant to an investment management agreement (the “Investment Management Agreement”), Saratoga Investment Corp. (the “Investment Manager”), provides investment management services to the Issuer, and makes day-to-day investment decisions concerning the assets of the Issuer. The Investment Manager also performs certain administrative services on behalf of the Issuer under the Investment Management Agreement.

2. Significant Accounting Policies

Basis of Presentation

The accompanying financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) and are stated in U.S. dollars. The following is a summary of the significant accounting policies followed by the Issuer in the preparation of its financial statements.

Use of Estimates

The preparation of the financial statements in conformity with U.S. GAAP requires the Investment Manager to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements, including the fair value of investments, and the amounts of income and expenses during the reporting period. Actual results could differ from these estimates and such differences could be material.

Cash and Cash Equivalents

The Issuer defines cash and cash equivalents as highly liquid financial instruments with original maturities of three months or less. Cash and cash equivalents may include investments in money market mutual funds, which are carried at fair value. At February 28, 2014 and February 28, 2013, cash and cash equivalents amounted to $8.0 million and $28.8 million, respectively, and are swept on an overnight basis into a money market deposit account and invested in shares of JP Morgan Liquidity Institutional fund held at the Trustee.

 

S-19


Table of Contents

Valuation of Investments

The Issuer accounts for its investments at fair value in accordance with the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 820, Fair Value Measurements and Disclosures (“ASC 820”). ASC 820 defines fair value, establishes a framework for measuring fair value, establishes a fair value hierarchy based on the quality of inputs used to measure fair value and enhances disclosure requirements for fair value measurements. ASC 820 requires the Issuer to assume that its investments are to be sold at the Statement of Assets and Liabilities date in the principal market to independent market participants, or in the absence of a principal market, in the most advantageous market, which may be a hypothetical market. Market participants are defined as buyers and sellers in the principal or most advantageous market that are independent, knowledgeable, and willing and able to transact.

Investments for which market quotations are readily available are fair valued at such market quotations obtained from independent third party pricing services and market makers subject to any decision by the Investment Manager to approve a fair value determination to reflect significant events affecting the value of these investments. The Investment Manager values investments for which market quotations are not readily available at fair value. Determinations of fair value may involve significant judgments and estimates. The types of factors that may be considered in determining the fair value of investments include the nature and realizable value of any collateral, the portfolio company’s ability to make payments, market yield trend analysis, the markets in which the portfolio company does business, comparison to publicly traded companies, discounted cash flow and other relevant factors.

Because such valuations, and particularly valuations of private investments and private companies, are inherently uncertain, they may fluctuate over short periods of time and may be based on estimates. The determination of fair value may differ materially from the values that would have been used if a ready market for these investments existed. Our net asset value could be materially affected if the determinations regarding the fair value of our investments were materially higher or lower than the values that are ultimately realized upon the disposal of such investments.

Investment Transactions and Income Recognition

Purchases and sales of investments and the related realized gains or losses are recorded on a trade-date basis. Interest income, adjusted for amortization of premium and accretion of discount, is recorded on an accrual basis to the extent that such amounts are expected to be collected. The Issuer stops accruing interest on its investments when it is determined that interest is no longer collectible. Discounts and premiums on investments purchased are accreted/amortized over the life of the respective investment using the effective yield method. The amortized cost of investments represents the original cost adjusted for the accretion of discounts and amortizations of premium on investments.

Loans are generally placed on non-accrual status when there is reasonable doubt that principal or interest will be collected. Accrued interest is generally reserved when a loan is placed on non-accrual status. Interest payments received on non-accrual loans may be recognized as a reduction in principal depending upon the Investment Manager’s judgment regarding collectability. Non-accrual loans are restored to accrual status when past due principal and interest is paid and, in management’s judgment, are likely to remain current, although we may make exceptions to this general rule if the loan has sufficient collateral value and is in the process of collection.

Paid-in-Kind Interest

The Issuer holds debt investments in its portfolio that contain a PIK interest provision. The PIK interest, which represents contractually deferred interest added to the investment balance that is generally due at maturity, is generally recorded on the accrual basis to the extent such amounts are expected to be collected. We stop accruing PIK interest if we do not expect the issuer to be able to pay all principal and interest when due.

 

S-20


Table of Contents

Deferred Debt Financing Costs, net

Included in deferred debt financing costs of $2.2 million as of February 28, 2014 are structuring fees of the investment bank, rating agency fees and legal fees associated with the issuance of the 2013-1 CLO Notes on October 17, 2013. Such costs have been capitalized and amortized using an effective yield method, over the life of the related notes.

Deferred debt financing costs of $1.6 million, incurred in connection with the issuance of the Secured Notes, were expensed when the Secured Notes were extinguished on October 17, 2013.

Deferred debt financing cost of $2.1 million as of February 28, 2013 included structuring fees of the investment bank, rating agency fees and legal fees associated with the associated with the establishment of the Issuer in 2007. Such costs have been capitalized and amortized using an effective yield method, over the life of the facility.

Management Fees

The Issuer is externally managed by the Investment Manager pursuant to the Investment Management Agreement. As compensation for the performance of its obligations under the Investment Management Agreement, the Investment Manager is entitled to receive from the Issuer a base management fee (the “Base Management Fee”), a subordinated management fee (the “Subordinated Management Fee”) and an incentive management fee (the “Incentive Management Fee”). The Base Management Fee is payable in arrears quarterly (subject to availability of funds and to the satisfaction of payment obligations on the debt obligations of the Issuer (the “Priority of Payments”) in an amount equal to 0.25% per annum of the Fee Basis Amount at the beginning of the Collection Period. The Subordinated Management Fee is payable in arrears quarterly (subject to availability of funds and to the Priority of Payments) in an amount equal to 0.25% per annum of the Fee Basis Amount at the beginning of the Collection Period. The Incentive Management Fee equals 20% of the remaining interest proceeds and principal proceeds, if any, after the Subordinated Notes have realized the incentive management fee target return of 12.0%, in accordance with the Priority of Payments after making the prior distributions on the relevant payment date. For the years ended February 28, 2014 and 2013, and February 29, 2012, no Incentive Management Fee’s have been paid.

Expenses

The Issuer bears its own organizational and offering expenses, all expenses related to its investment program and expenses incurred in connection with its operations including, but not limited to, external legal, administrative, trustee, accounting, tax and audit expenses, costs related to trading, acquiring, monitoring or disposing of investments of the Issuer, and interest and other borrowing expenses, expenses of preparing and distributing reports, financial statements, and litigation or other extraordinary expenses. The Issuer has retained the Trustee to provide trustee services. Additionally, the Trustee performs loan administration, debt covenant compliance calculations, and monitoring and reporting services. For the years ended February 28, 2014 and 2013, and February 29, 2012, the Issuer paid $0.1 million, $0.1 million and $0.1 million, respectively, for trustee services provided and is included in other expenses in the Statement of Operations.

Interest Expense

The Issuer has issued rated and unrated notes to finance its operations. Interest on debt is calculated by the Trustee for the Issuer. Interest is accrued and generally paid quarterly. For the years ended February 28, 2014 and 2013, and February 29, 2012, $5.7 million, $8.8 million and $7.9 million of payments to the Subordinated Notes were included in interest expense in the Statement of Operations, respectively.

 

S-21


Table of Contents

Risk Management

In the ordinary course of its business, the Issuer manages a variety of risks, including market risk and credit risk. Market risk is the risk of potential adverse changes to the value of investments because of changes in market conditions such as interest rate movements and volatility in investment prices.

Credit risk is the risk of default or non-performance by portfolio companies, equivalent to the investment’s carrying amount.

The Issuer is also exposed to credit risk related to maintaining all of its cash and cash equivalents, including those in reserve accounts, at a major financial institution.

The Issuer has investments in lower rated and comparable quality unrated high yield bonds and bank loans. Investments in high yield investments are accompanied by a greater degree of credit risk. The risk of loss due to default by the issuer is significantly greater for holders of high yield securities, because such investments are generally unsecured and are often subordinated to other creditors of the issuer.

3. Fair Value Measurements

As noted above, the Issuer values all investments in accordance with ASC 820. ASC 820 requires enhanced disclosures about assets and liabilities that are measured and reported at fair value. As defined in ASC 820, fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date.

ASC 820 establishes a hierarchal disclosure framework which prioritizes and ranks the level of market price observability of inputs used in measuring investments at fair value. Market price observability is affected by a number of factors, including the type of investment and the characteristics specific to the investment. Investments with readily available active quoted prices or for which fair value can be measured from actively quoted prices generally will have a higher degree of market price observability and a lesser degree of judgment used in measuring fair value.

Based on the observability of the inputs used in the valuation techniques, the Issuer is required to provide disclosures on fair value measurements according to the fair value hierarchy. The fair value hierarchy ranks the observability of the inputs used to determine fair values. Investments carried at fair value are classified and disclosed in one of the following three categories:

 

    Level 1—Valuations based on quoted prices in active markets for identical assets or liabilities that the Issuer has the ability to access.

 

    Level 2—Valuations based on inputs other than quoted prices in active markets, which are either directly or indirectly observable.

 

    Level 3—Valuations based on inputs that are unobservable and significant to the overall fair value measurement. The inputs used in the determination of fair value may require significant management judgment or estimation. Such information may be the result of consensus pricing information or broker quotes which include a disclaimer that the broker would not be held to such a price in an actual transaction. The non-binding nature of consensus pricing and/or quotes accompanied by disclaimer would result in classification as Level 3 asset, assuming no additional corroborating evidence.

In addition to using the above inputs in investment valuations, the Issuer continues to employ the valuation policy that is consistent with ASC 820 and the 1940 Act.

 

S-22


Table of Contents

The following table presents fair value measurements of investments, by major class, as of February 28, 2014, according to the fair value hierarchy:

 

     Fair Value Measurements  
     Level 1      Level 2      Level 3      Total  

Term loans

   $ —         $ 297,872,178       $ 2,618,899       $ 300,491,077   

Structured finance securities

     —           —           —           —     

Equity interest

     —           —           —           —     
  

 

 

    

 

 

    

 

 

    

 

 

 

Total

$ —      $ 297,872,178    $ 2,618,899    $ 300,491,077   
  

 

 

    

 

 

    

 

 

    

 

 

 

The following table presents fair value measurements of investments, by major class, as of February 28, 2013, according to the fair value hierarchy:

 

     Fair Value Measurements  
     Level 1      Level 2      Level 3      Total  

Term loans

   $ —         $ 358,237,074       $ 4,256,932       $ 362,494,006   

Structured finance securities

     —           —           10,850,000         10,850,000   

Equity interest

     5,410         —           1,070,563         1,075,973   
  

 

 

    

 

 

    

 

 

    

 

 

 

Total

$ 5,410    $ 358,237,074    $ 16,177,495    $ 374,419,979   
  

 

 

    

 

 

    

 

 

    

 

 

 

Transfers into or out of Level 1, 2 or 3 are recognized at the reporting date.

The following table provides a reconciliation of the beginning and ending balances for investments that use Level 3 inputs for the year ended February 28, 2014:

 

     Term Loans      Structured Finance
Securities
     Equity Interest  

Balance as of February 28, 2013

   $ 4,256,932       $ 10,850,000       $ 1,070,563   

Net unrealized gains (losses)

     (45,982      2,189,036         (394,438

Purchases and other adjustments to cost

     34,872         203,167         —     

Sales and redemptions

     (408,133      (13,846,450      (181,476

Net realized gain (loss) from investments

     102,394         604,247         (494,649

Net transfers in and/or out of Level 3(1)

     (1,321,184      —           —     
  

 

 

    

 

 

    

 

 

 

Balance as of February 28, 2014

$ 2,618,899    $ —      $ —     
  

 

 

    

 

 

    

 

 

 

 

(1) The Issuer’s investment in Tectum Holdings Inc. was transferred into Level 2 during the year ended February, 28, 2014, as the reliability of market quotes became available for this investment and have been subsequently used for valuation purposes.

 

S-23


Table of Contents

The following table provides a reconciliation of the beginning and ending balances for investments that use Level 3 inputs for the year ended February 28, 2013:

 

     Term Loans      Structured Finance
Securities
     Equity
Interest
 

Balance as of February 29, 2012

   $ —         $ 14,507,600       $ 1,070,563   

Net unrealized gains (losses)

     (102,541      (126,657      —     

Purchases and other adjustments to cost

     4,018,668         219,455         —     

Sales and redemptions

     (74,141      (4,000,000      —     

Net realized gain (loss) from investments

     26,621         249,602         —     

Net transfers in and/or out of Level 3(2)

     388,325         —           —     
  

 

 

    

 

 

    

 

 

 

Balance as of February 28, 2013

$ 4,256,932    $ 10,850,000    $ 1,070,563   
  

 

 

    

 

 

    

 

 

 

 

(2) The Issuer’s investment in PATS Aircraft, LLC was transferred into Level 3 during the year ended February, 28, 2013 due to changes in liquidity. These changes impacted the Investment Manager’s ability to obtain observable market information. Accordingly, the determination of fair value for this investment required significant management judgment and estimation, resulting in a Level 3 classification for the year ended February 28, 2013.

Transfers into or out of Level 3 are recognized at the reporting date.

Purchases and other adjustments to cost include purchases of new investments at cost, effects of refinancing/restructuring, accretion/amortization of income from discount/premium on debt securities, and PIK.

Sales and redemptions represent net proceeds received from investments sold, and principal paydowns received, during the period.

The net unrealized loss on level 3 investments held as of February 28, 2014 and February 28, 2013, was $0.02 million and $1.8 million, respectively, and is included in net unrealized appreciation on investments in the Statements of Operations.

The valuation techniques and significant unobservable inputs used in recurring Level 3 fair value measurements of assets as of February 28, 2013 were as follows:

 

     Fair Value      Valuation Technique    Unobservable Input    Range

Term loans

   $ 4,256,932       Yield Analysis    Market Yield    7.7% - 17.0%

Structured finance securities

   $ 10,850,000       Yield Analysis    Market Yield    8.9% - 10.7%

Equity interest

   $ 1,070,563       Market Comparable    EBITDA Multiples    5.5x - 8.0x

Significant unobservable inputs used in the fair value measurement of the Issuer’s term loans and structured finance securities include comparable market yields. For investments utilizing a yield analysis valuation technique, a significant increase (decrease) in the market yield, in isolation, would result in a significantly lower (higher) fair value measurement. Generally, a change in the assumption for comparable yields is accompanied by a directionally opposite change in the assumption used for pricing.

Significant unobservable inputs used in the fair value measurement of the Issuer’s equity interests include EBITDA multiples. For investments utilizing EBITDA multiples, a significant increase (decrease) in the EBITDA multiple, in isolation, would result in a significant higher (lower) fair value measurement.

 

S-24


Table of Contents

4. Financing

On January 22, 2008, the Issuer issued $400.0 million of notes, consisting of Class A Floating Rate Senior Notes, Class B Floating Rate Senior Notes, Class C Deferrable Floating Rate Notes, Class D Deferrable Floating Rate Notes, Class E Deferrable Floating Rate Notes (collectively the “Secured Notes”), and Subordinated Notes. The notes were issued pursuant to the Indenture.

The Secured Notes are limited recourse obligations of the Issuer. The Subordinated Notes are unsecured, limited recourse debt obligations of the Issuer.

On October 17, 2013, the Issuer issued $284.9 million of notes (the “2013-1 CLO Notes”), consisting of Class X Floating Rate Senior Notes, Class A-1 Floating Rate Senior Notes, Class A-2 Floating Rate Senior Notes, Class B Floating Rate Senior Notes, Class C Deferrable Floating Rate Notes, Class D Deferrable Floating Rate Notes, Class E Deferrable Floating Rate Notes, and Class F Deferrable Floating Rate Notes. The 2013-1 CLO Notes were issued pursuant to the Indenture with the same Trustee. Proceeds of the issuance of the 2013-1 CLO Notes were used along with existing assets held by the Trustee to redeem all of the Secured Notes issued in 2008. The Subordinated Notes were not included in the refinancing transaction.

The 2013-1 CLO Notes are limited recourse obligations of the Issuer. The Subordinated Notes are unsecured, limited recourse debt obligations of the Issuer.

The relative order of seniority of payment of each class of securities is, as follows: first, Class X Notes, second, Class A-1 Notes, third, Class A-2 Notes, fourth, Class B Notes, fifth, Class C Notes, sixth, Class D Notes, seventh, Class E Notes, eighth, Class F Notes, and ninth, the Subordinated Notes, with (a) each class of securities (other than the Subordinated Notes) in such list being senior to each other class of securities that follows such class of securities in such list and (b) each class of securities (other than the Class X Notes) in such list being subordinate to each other class of securities that precedes such class of securities in such list. The Subordinated Notes are subordinated to the 2013-1 CLO Notes and are entitled to periodic payments from interest proceeds available in accordance with the Priority of Payments.

The table below sets forth certain information for each outstanding class of notes issued, pursuant to the Indenture on October 17, 2013, at February 28, 2014:

 

Debt Security

   Interest Rate     Maturity      Principal
Amount
     Amount
Outstanding
 

Class X Floating Rate Senior Notes

     LIBOR + 1.05     October 20, 2023       $ 2,500,000       $ 1,666,666   

Class A-1 Floating Rate Senior Notes

     LIBOR + 1.30     October 20, 2023         170,000,000         170,000,000   

Class A-2 Floating Rate Senior Notes

     LIBOR + 1.50     October 20, 2023         20,000,000         20,000,000   

Class B Floating Rate Senior Notes

     LIBOR + 2.00     October 20, 2023         44,800,000         44,800,000   

Class C Deferrable Floating Rate Notes

     LIBOR + 2.90     October 20, 2023         16,000,000         16,000,000   

Class D Deferrable Floating Rate Notes

     LIBOR + 3.50     October 20, 2023         14,000,000         14,000,000   

Class E Deferrable Floating Rate Notes

     LIBOR + 4.50     October 20, 2023         13,100,000         13,100,000   

Class F Deferrable Floating Rate Notes

     LIBOR + 5.75     October 20, 2023         4,500,000         4,500,000   

Subordinated Notes

     N/A        October 20, 2023         30,000,000         30,000,000   
       

 

 

    

 

 

 
$ 314,900,000    $ 314,066,666   
       

 

 

    

 

 

 

 

S-25


Table of Contents

The table below sets forth certain information for each outstanding class of notes issued, pursuant to the Indenture on January 22, 2008, at February 28, 2013:

 

Debt Security

   Interest Rate     Maturity      Principal
Amount
     Amount
Outstanding
 

Class A Floating Rate Senior Notes

     LIBOR + 0.75     January 21, 2020       $ 296,000,000       $ 296,000,000   

Class B Floating Rate Senior Notes

     LIBOR + 2.50     January 21, 2020         22,000,000         22,000,000   

Class C Deferrable Floating Rate Notes

     LIBOR + 3.75     January 21, 2020         14,000,000         14,000,000   

Class D Deferrable Floating Rate Notes

     LIBOR + 4.70     January 21, 2020         16,000,000         16,000,000   

Class E Deferrable Floating Rate Notes

     LIBOR + 6.45     January 21, 2020         22,000,000         17,960,044   

Subordinated Notes

     N/A        January 21, 2020         30,000,000         30,000,000   
       

 

 

    

 

 

 
$ 400,000,000    $ 395,960,044   
       

 

 

    

 

 

 

The following table shows each outstanding class of notes issued, pursuant to the Indenture, at fair value at February 28, 2014:

 

Debt Security

   February 28, 2014  

Class X Floating Rate Senior Notes

   $ 1,664,666   

Class A-1 Floating Rate Senior Notes

     168,878,000   

Class A-2 Floating Rate Senior Notes

     20,000,000   

Class B Floating Rate Senior Notes

     44,679,040   

Class C Deferrable Floating Rate Notes

     15,944,000   

Class D Deferrable Floating Rate Notes

     13,766,200   

Class E Deferrable Floating Rate Notes

     12,481,680   

Class F Deferrable Floating Rate Notes

     4,398,300   

Subordinated Notes

     19,569,596   
  

 

 

 
$ 301,381,482   
  

 

 

 

These notes are fair valued based on a discounted cash flow model, specifically using Intex cash flow models, to form the basis for the valuation and would be classified as level 3 liabilities within the fair value hierarchy.

The following table shows each outstanding class of notes issued, pursuant to the Indenture, at fair value at February 28, 2013:

 

Debt Security

   February 28, 2013  

Class A Floating Rate Senior Notes

   $ 292,879,007   

Class B Floating Rate Senior Notes

     22,900,917   

Class C Deferrable Floating Rate Notes

     14,592,983   

Class D Deferrable Floating Rate Notes

     16,414,949   

Class E Deferrable Floating Rate Notes

     17,999,348   

Subordinated Notes

     25,516,959   
  

 

 

 
$ 390,304,163   
  

 

 

 

 

S-26


Table of Contents

The following table provides the weighted average interest rate for the years ended February 28, 2014, February 28, 2013 and February 29, 2012:

 

            Weighted Average Interest Rate  

Debt Security

   Interest Rate      February 28,
2014
     February 28,
2013
     February 29,
2012
 

2013-1 CLO Notes

           

Class X Floating Rate Senior Notes

     LIBOR + 1.05%         1.29%         N/A         N/A   

Class A-1 Floating Rate Senior Notes

     LIBOR + 1.30%         1.54%         N/A         N/A   

Class A-2 Floating Rate Senior Notes

     LIBOR + 1.50%         1.74%         N/A         N/A   

Class B Floating Rate Senior Notes

     LIBOR + 2.00%         2.24%         N/A         N/A   

Class C Deferrable Floating Rate Notes

     LIBOR + 2.90%         3.14%         N/A         N/A   

Class D Deferrable Floating Rate Notes

     LIBOR + 3.50%         3.74%         N/A         N/A   

Class E Deferrable Floating Rate Notes

     LIBOR + 4.50%         4.74%         N/A         N/A   

Class F Deferrable Floating Rate Notes

     LIBOR + 5.75%         5.99%         N/A         N/A   

Subordinated Notes

     N/A         N/A         N/A         N/A   

Secured Notes

           

Class A Floating Rate Senior Notes

     LIBOR + 0.75%         1.03%         1.15%         1.12%   

Class B Floating Rate Senior Notes

     LIBOR + 2.50%         2.78%         2.90%         2.87%   

Class C Deferrable Floating Rate Notes

     LIBOR + 3.75%         4.03%         4.15%         4.12%   

Class D Deferrable Floating Rate Notes

     LIBOR + 4.70%         4.98%         5.10%         5.07%   

Class E Deferrable Floating Rate Notes

     LIBOR + 6.45%         6.73%         6.85%         6.82%   

The Indenture provides that payments on the Subordinated Notes shall rank subordinate in priority of payment to payments due on all classes of 2013-1 CLO Notes and subordinate in priority of payment to the payment of fees and expenses. Distributions on the Subordinated Notes are limited to the assets of the Issuer remaining after payment of all of the liabilities of the Issuer that rank senior in priority of payment to the Subordinated Notes. To the extent that the proceeds from the collateral are not sufficient to make distributions on the Subordinated Notes the Issuer will have no further obligation in respect of the Subordinated Notes.

Interest proceeds and, after the 2013-1 CLO Notes have been paid in full, principal proceeds, in each case will be distributed to the holders of the Subordinated Notes in accordance with the Indenture.

Distributions, if any, on the Subordinated Notes will be payable quarterly on the 20th day of each January, April, July and October of each calendar year or, if any such day is not a business day, on the next succeeding business day (each, a “Payment Date”), commencing on the first Payment Date, and on January 21, 2020 (or if any such day is not a business day, the next succeeding business day) (the “Stated Redemption Date”) (if not redeemed prior to such date) sequentially in order of seniority. At the Stated Redemption Date, the Subordinated Notes will be redeemed after payment in full of all of the 2013-1 CLO Notes and the payment of all administrative and other fees and expenses. The failure to pay interest proceeds or principal proceeds to the holders of the Subordinated Notes will not be an event of default under the Indenture.

In May of 2009, the Issuer defaulted on its Class E overcollateralization ratio of 105.10%, at which point, $4.0 million of interest proceeds were used to repay the Class E Notes through November 2009. Interest on the

 

S-27


Table of Contents

Class C, Class D, and Class E Notes was deferred and repaid in January of 2010 upon the Issuer’s return to compliance. Distributions to the Subordinated Notes resumed in April of 2010.

As of February 28, 2014, the remaining unamortized discount on the Class X, Class A-1 Notes, Class A-2 Notes, Class B Notes, Class C Notes, Class D Notes, Class E Notes, and Class F Notes were $0.0 million, $1.7 million, $0.2 million, $1.1 million, $0.7 million, $0.9 million, $1.7 million and $0.6 million, respectively.

The remaining unamortized deferred debt financing costs, on the Secured Notes, of $1.6 million, and unamortized discount on the Secured Notes of $1.8 million, were recognized as additional amortization expense when the related notes were extinguished and recorded within loss on extinguishment of debt in the Statement of Operations.

5. Income Tax

Under the current laws, the Issuer is not subject to net income taxation in the United States or the Cayman Islands. Accordingly, no provision for income taxes has been made in the accompanying financial statements.

Pursuant to ASC Topic 740, Accounting for Uncertainty in Income Taxes, the Issuer adopted the provisions of FASB relating to accounting for uncertainty in income taxes which clarifies the accounting for income taxes by prescribing the minimum recognition threshold a tax position must meet before being recognized in the financial statements and applies to all open tax years as of the effective date. The Investment Manager has analyzed such tax positions for uncertain tax positions for tax years that may be open (2011 - 2014). The Issuer identifies its major tax jurisdictions as U.S. Federal, state and foreign jurisdictions where the Issuer makes investments. As of February 28, 2014 and 2013, there was no impact to the financial statements as a result of the Issuer’s accounting for uncertainty in income taxes. The Issuer does not have any unrecognized tax benefits or liabilities for the years ended February 28, 2014 and 2013, and February 29, 2012. Also, the Issuer recognizes interest and, if applicable, penalties for any uncertain tax positions, as a component of income tax expense. No interest or penalty expense was recorded by the Issuer for the years ended February 28, 2014 and 2013, and February 29, 2012.

6. Commitments and Contingencies

In the ordinary course of its business, the Issuer may enter into contracts or agreements that contain indemnifications or warranties. Future events could occur that lead to the execution of these provisions against the Issuer. Based on its history and experience, the Investment Manager feels that the likelihood of such an event is remote.

In the ordinary course of business, the Issuer may directly or indirectly be a defendant or plaintiff in legal actions with respect to bankruptcy, insolvency or other types of proceedings. Such lawsuits may involve claims that could adversely affect the value of certain financial instruments owned by the Issuer. As of February 28, 2014 and 2013, the Issuer is not subject to any material legal proceedings.

The terms of Collateralized Debt Investments may require the Issuer to provide funding for any unfunded portion of a Collateralized Debt Investment at the request of the borrower. At February 28, 2014 and 2013, the Issuer had no unfunded commitments.

7. Related-Party Transactions

In the ordinary course of business and as permitted per the terms of the Indenture, the Issuer may acquire or sell investments to or from related parties at the fair value at such time. For the years ended February 28, 2014 and 2013, and February 29, 2012, the Issuer bought no investments from related parties and sold investments fair valued at $0.3 million, $0.0 million and $15.6 million, respectively, to the Investment Manager.

 

S-28


Table of Contents

The Subordinated Notes are wholly owned by the Investment Manager. The Subordinated Notes do not have a stated coupon rates, but are entitled to residual cash flows from the CLO’s investments after all of the other tranches of debt and certain other fees and expenses are paid. For the years ended February 28, 2014 and 2013, and February 29, 2012, $5.7 million, $8.8 million, and $7.9 million of payments to the Subordinated Notes were included in interest expense in the Statement of Operations, respectively.

8. Shareholders’ Capital

Capital contributions and distributions shall be made at such time and in such amounts as determined by the Investment Manager and the Indenture.

The majority holder of the Subordinated Notes has various control rights over the CLO, including the ability to call the CLO prior to its legal maturity, replace the Investment Manager under certain circumstances, and refinance any of the outstanding debt tranches. The voting structure of the Subordinated Notes may require either majority or unanimous approval depending upon the issue.

The authorized share capital of the Issuer consists of 50,000 ordinary shares, 250 of which are owned by Maples Finance Limited and are held under the terms of a declaration of trust.

As of February 28, 2014 and February 28, 2013, net assets were $(3.3) million and $0.8 million, respectively. These amounts include accumulated gains of $0.8 million and accumulated losses of $(6.0) million, respectively, which includes cumulative net investment income or loss, cumulative amounts of gains and losses realized from investment transactions, net unrealized appreciation or depreciation of investments, as well as the cumulative effect of accounting mismatches between investments accounted for at fair value and amortized cost or accrual-basis assets and liabilities as discussed in Significant Accounting Policies, above. The Issuer’s investments continue to generate sufficient liquidity to satisfy its obligations on periodic payment dates as well as comply with all performance criteria as of the Statements of Assets and Liabilities date.

9. Financial Highlights

The following is a schedule of financial highlights for the years ended February 28, 2014 and 2013 and February 29, 2012:

 

     February 28,
2014
     February 28,
2013
     February 29,
2012
 

Average subordinated notes’ capital balance(1)

   $ 28,471,910       $ 27,165,497       $ 20,808,673   

Ratio and supplemental data:

        

Total Return(2)

     4.65%         73.51%         41.28%   

Net investment income(3)

     (7.53)%         3.80%         11.38%   

Total expenses(3)

     65.27%         70.97%         87.40%   

Base management fee(3)

     1.82%         1.47%         1.93%   

Subordinated management fee(3)

     4.42%         5.89%         7.73%   

 

(1) Subordinated notes’ capital balance is calculated based on the sum of the subordinated notes outstanding amount and total net assets, net of ordinary equity.
(2) Total return is calculated based on a time-weighted rate of return methodology. Quarterly rates of return are compounded to derive the total return reflected above. Total return is calculated for the subordinated notes’ capital taken as a whole and assumes the purchase of the subordinated notes’ capital on the first day of the period and the sale of the last day of the period.
(3) Calculated based on the average subordinated notes’ capital balance.

 

S-29


Table of Contents

10. Subsequent Events

The Investment Manager has evaluated events or transactions that have occurred since February 28, 2014 through May 27, 2014, the date the financial statements were available for issuance. The Investment Manager has determined that there are no material events that would require the disclosure in the financial statements.

 

S-30


Table of Contents

 

 

Up to $ 20,000,000

Saratoga Investment Corp.

7.50% Notes Due 2020

 

 

 

PROSPECTUS SUPPLEMENT

 

 

Ladenburg Thalmann

 

 

 

July 17, 2015